<?xml version="1.0" ?>
<document id="expert_go">
  <sentence id="s0" text="In the present study, we characterize SIRT2 inhibition activity of the brain-permeable compound AK7 and examine the efficacy of this small molecule in models of Parkinson's disease, amyotrophic lateral sclerosis and cerebral ischemia.">
    <entity charOffset="38-43" id="s0.e0" ontology_id="22933" text="SIRT2" type="GENE"/>
    <entity charOffset="216-233" id="s0.e1" ontology_id="HP_0002637" text="cerebral ischemia" type="HP"/>
    <pair e1="s0.e0" e2="s0.e1" id="s0.p0" relation="false"/>
  </sentence>
  <sentence id="s1" text="Results after perturbing EPAC activity suggests its involvement in cancer cell migration, proliferation, and cytoskeleton remodeling which makes it a potential therapeutic target for cancer treatments">
    <entity charOffset="25-29" id="s1.e0" ontology_id="10411" text="EPAC" type="GENE"/>
    <entity charOffset="67-73" id="s1.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1.e0" e2="s1.e1" id="s1.p0" relation="true"/>
  </sentence>
  <sentence id="s2" text="EPAC is also known for its dual role in cancer as pro- and anti-proliferative in addition to metastasis.">
    <entity charOffset="0-4" id="s2.e0" ontology_id="10411" text="EPAC" type="GENE"/>
    <entity charOffset="40-46" id="s2.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2.e0" e2="s2.e1" id="s2.p0" relation="true"/>
  </sentence>
  <sentence id="s3" text="In this study, we conducted targeted sequencing in 246 clinically heterogeneous patients, mainly with early-onset and/or familial neurodegenerative dementia, using a custom-designed next-generation sequencing panel covering 27 genes known to harbor mutations that can cause different types of dementia, in addition to the detection of C9orf72 repeat expansions.">
    <entity charOffset="66-79" id="s3.e0" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <entity charOffset="335-342" id="s3.e1" ontology_id="203228" text="C9orf72" type="GENE"/>
    <pair e1="s3.e0" e2="s3.e1" id="s3.p0" relation="false"/>
  </sentence>
  <sentence id="s4" text="Identifying genetic risk alleles for ovarian cancer has had a significant impact on disease prevention strategies; for example it is now routine clinical practice for individuals with germline BRCA1 and BRCA2 mutations to undergo risk reducing salpingo-oophorectomy.">
    <entity charOffset="45-51" id="s4.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="193-198" id="s4.e1" ontology_id="672" text="BRCA1" type="GENE"/>
    <pair e1="s4.e0" e2="s4.e1" id="s4.p0" relation="false"/>
  </sentence>
  <sentence id="s5" text="Identifying genetic risk alleles for ovarian cancer has had a significant impact on disease prevention strategies; for example it is now routine clinical practice for individuals with germline BRCA1 and BRCA2 mutations to undergo risk reducing salpingo-oophorectomy.">
    <entity charOffset="45-51" id="s5.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="203-208" id="s5.e1" ontology_id="675" text="BRCA2" type="GENE"/>
    <pair e1="s5.e0" e2="s5.e1" id="s5.p0" relation="false"/>
  </sentence>
  <sentence id="s6" text="We then validated the anti-SMARCE1 antibody specificity by analyzing additional 305 pediatric and adult meningiomas of various subtypes and 15 non-meningioma clear cell tumors by SMARCE1 immunohistochemistry.">
    <entity charOffset="27-34" id="s6.e0" ontology_id="6605" text="SMARCE1" type="GENE"/>
    <entity charOffset="104-114" id="s6.e1" ontology_id="HP_0002858" text="meningioma" type="HP"/>
    <pair e1="s6.e0" e2="s6.e1" id="s6.p0" relation="true"/>
  </sentence>
  <sentence id="s7" text="We then validated the anti-SMARCE1 antibody specificity by analyzing additional 305 pediatric and adult meningiomas of various subtypes and 15 non-meningioma clear cell tumors by SMARCE1 immunohistochemistry.">
    <entity charOffset="27-34" id="s7.e0" ontology_id="6605" text="SMARCE1" type="GENE"/>
    <entity charOffset="169-175" id="s7.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s7.e0" e2="s7.e1" id="s7.p0" relation="true"/>
  </sentence>
  <sentence id="s8" text="Machine learning search further revealed that the likelihood of HER2-positive breast cancer is almost 100% in a patient with the high NRF1 expression combined with expression patterns of high E2F3, GSK3B, and MAPK1, low or no change in E2F1 and FGFR1, and high or no change in PIK3R3.">
    <entity charOffset="64-68" id="s8.e0" ontology_id="2064" text="HER2" type="GENE"/>
    <entity charOffset="85-91" id="s8.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s8.e0" e2="s8.e1" id="s8.p0" relation="true"/>
  </sentence>
  <sentence id="s9" text="Machine learning search further revealed that the likelihood of HER2-positive breast cancer is almost 100% in a patient with the high NRF1 expression combined with expression patterns of high E2F3, GSK3B, and MAPK1, low or no change in E2F1 and FGFR1, and high or no change in PIK3R3.">
    <entity charOffset="85-91" id="s9.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="277-283" id="s9.e1" ontology_id="8503" text="PIK3R3" type="GENE"/>
    <pair e1="s9.e0" e2="s9.e1" id="s9.p0" relation="true"/>
  </sentence>
  <sentence id="s10" text="Machine learning search further revealed that the likelihood of HER2-positive breast cancer is almost 100% in a patient with the high NRF1 expression combined with expression patterns of high E2F3, GSK3B, and MAPK1, low or no change in E2F1 and FGFR1, and high or no change in PIK3R3.">
    <entity charOffset="85-91" id="s10.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="209-214" id="s10.e1" ontology_id="5594" text="MAPK1" type="GENE"/>
    <pair e1="s10.e0" e2="s10.e1" id="s10.p0" relation="true"/>
  </sentence>
  <sentence id="s11" text="In addition, we found using Bayesian network-based machine learning that 30 NRF1 motif-enriched genes including growth factor receptors-FGFR1, IGF1R; E2Fs transcription factor family-E2F1, E2F3; MAPK pathway-SHC2, GRB2, MAPK1; PI3K-AKT-mTOR signaling pathway-PIK3CD, PIK3R1, PIK3R3, RPS6KB2; WNT signaling pathway-WNT7B, DLV1, DLV2, GSK3B, NRF1, and DDB2, known for its role in DNA repair and involvement in early events associated with metastatic progression of breast cancer cells, were associated with HER2-amplified breast cancer.">
    <entity charOffset="208-212" id="s11.e0" ontology_id="25759" text="SHC2" type="GENE"/>
    <entity charOffset="470-476" id="s11.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s11.e0" e2="s11.e1" id="s11.p0" relation="true"/>
  </sentence>
  <sentence id="s12" text="In addition, we found using Bayesian network-based machine learning that 30 NRF1 motif-enriched genes including growth factor receptors-FGFR1, IGF1R; E2Fs transcription factor family-E2F1, E2F3; MAPK pathway-SHC2, GRB2, MAPK1; PI3K-AKT-mTOR signaling pathway-PIK3CD, PIK3R1, PIK3R3, RPS6KB2; WNT signaling pathway-WNT7B, DLV1, DLV2, GSK3B, NRF1, and DDB2, known for its role in DNA repair and involvement in early events associated with metastatic progression of breast cancer cells, were associated with HER2-amplified breast cancer.">
    <entity charOffset="236-240" id="s12.e0" ontology_id="2475" text="mTOR" type="GENE"/>
    <entity charOffset="470-476" id="s12.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s12.e0" e2="s12.e1" id="s12.p0" relation="true"/>
  </sentence>
  <sentence id="s13" text="In addition, we found using Bayesian network-based machine learning that 30 NRF1 motif-enriched genes including growth factor receptors-FGFR1, IGF1R; E2Fs transcription factor family-E2F1, E2F3; MAPK pathway-SHC2, GRB2, MAPK1; PI3K-AKT-mTOR signaling pathway-PIK3CD, PIK3R1, PIK3R3, RPS6KB2; WNT signaling pathway-WNT7B, DLV1, DLV2, GSK3B, NRF1, and DDB2, known for its role in DNA repair and involvement in early events associated with metastatic progression of breast cancer cells, were associated with HER2-amplified breast cancer.">
    <entity charOffset="314-319" id="s13.e0" ontology_id="7477" text="WNT7B" type="GENE"/>
    <entity charOffset="470-476" id="s13.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s13.e0" e2="s13.e1" id="s13.p0" relation="true"/>
  </sentence>
  <sentence id="s14" text="In addition, we found using Bayesian network-based machine learning that 30 NRF1 motif-enriched genes including growth factor receptors-FGFR1, IGF1R; E2Fs transcription factor family-E2F1, E2F3; MAPK pathway-SHC2, GRB2, MAPK1; PI3K-AKT-mTOR signaling pathway-PIK3CD, PIK3R1, PIK3R3, RPS6KB2; WNT signaling pathway-WNT7B, DLV1, DLV2, GSK3B, NRF1, and DDB2, known for its role in DNA repair and involvement in early events associated with metastatic progression of breast cancer cells, were associated with HER2-amplified breast cancer.">
    <entity charOffset="333-338" id="s14.e0" ontology_id="2932" text="GSK3B" type="GENE"/>
    <entity charOffset="470-476" id="s14.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s14.e0" e2="s14.e1" id="s14.p0" relation="true"/>
  </sentence>
  <sentence id="s15" text="We found that both mRNA and protein levels of NRF1 and its transcriptional activity were significantly higher in ER/PR-ve HER2+ve breast cancer samples compared to normal breast tissues.">
    <entity charOffset="46-50" id="s15.e0" ontology_id="4779" text="NRF1" type="GENE"/>
    <entity charOffset="139-145" id="s15.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s15.e0" e2="s15.e1" id="s15.p0" relation="true"/>
  </sentence>
  <sentence id="s16" text="We found that both mRNA and protein levels of NRF1 and its transcriptional activity were significantly higher in ER/PR-ve HER2+ve breast cancer samples compared to normal breast tissues.">
    <entity charOffset="123-127" id="s16.e0" ontology_id="2064" text="HER2" type="GENE"/>
    <entity charOffset="139-145" id="s16.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s16.e0" e2="s16.e1" id="s16.p0" relation="true"/>
  </sentence>
  <sentence id="s17" text="Our findings show that a high percentage of known HER2+ breast cancer susceptibility genes, including EGFR, IGFR, and E2F1, are under transcriptional control of NRF1.">
    <entity charOffset="63-69" id="s17.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="102-106" id="s17.e1" ontology_id="1956" text="EGFR" type="GENE"/>
    <pair e1="s17.e0" e2="s17.e1" id="s17.p0" relation="true"/>
  </sentence>
  <sentence id="s18" text="Promoters of several genes from the KEGG HER2+ breast cancer pathway and 11 signaling pathways linked to 6 hallmarks of cancer contain the NRF1 motif.">
    <entity charOffset="41-45" id="s18.e0" ontology_id="2064" text="HER2" type="GENE"/>
    <entity charOffset="54-60" id="s18.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s18.e0" e2="s18.e1" id="s18.p0" relation="true"/>
  </sentence>
  <sentence id="s19" text="Promoters of several genes from the KEGG HER2+ breast cancer pathway and 11 signaling pathways linked to 6 hallmarks of cancer contain the NRF1 motif.">
    <entity charOffset="54-60" id="s19.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="139-143" id="s19.e1" ontology_id="4779" text="NRF1" type="GENE"/>
    <pair e1="s19.e0" e2="s19.e1" id="s19.p0" relation="true"/>
  </sentence>
  <sentence id="s20" text="Clinical confirmation of our machine learned Bayesian networks will have significant impact on our understanding of the role of NRF1 as a valuable biomarker for breast cancer diagnosis and prognosis as well as provide strong rationale for future studies to develop NRF1 signaling-based therapeutics to target HER2+ breast cancer">
    <entity charOffset="128-132" id="s20.e0" ontology_id="4779" text="NRF1" type="GENE"/>
    <entity charOffset="168-174" id="s20.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s20.e0" e2="s20.e1" id="s20.p0" relation="true"/>
  </sentence>
  <sentence id="s21" text="This case of adult-diagnosed MTP deficiency was characterized by slowly progressive peripheral neuropathy masquerading CMT in addition to muscular symptoms.">
    <entity charOffset="29-32" id="s21.e0" ontology_id="4547" text="MTP" type="GENE"/>
    <entity charOffset="84-94" id="s21.e1" ontology_id="HP_0030646" text="peripheral" type="HP"/>
    <pair e1="s21.e0" e2="s21.e1" id="s21.p0" relation="true"/>
  </sentence>
  <sentence id="s22" text="MTP deficiency should be considered in patients with the combination of peripheral neuropathy and recurrent rhabdomyolysis">
    <entity charOffset="0-3" id="s22.e0" ontology_id="4547" text="MTP" type="GENE"/>
    <entity charOffset="72-82" id="s22.e1" ontology_id="HP_0030646" text="peripheral" type="HP"/>
    <pair e1="s22.e0" e2="s22.e1" id="s22.p0" relation="true"/>
  </sentence>
  <sentence id="s23" text="An oncogenic role for CHD4, a NuRD component, is defined for initiating and supporting tumor suppressor gene (TSG) silencing in human colorectal cancer.">
    <entity charOffset="110-113" id="s23.e0" ontology_id="57045" text="TSG" type="GENE"/>
    <entity charOffset="145-151" id="s23.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s23.e0" e2="s23.e1" id="s23.p0" relation="true"/>
  </sentence>
  <sentence id="s24" text="CHD4 knockdown activates silenced TSGs, revealing their role for blunting colorectal cancer cell proliferation, invasion, and metastases.">
    <entity charOffset="34-37" id="s24.e0" ontology_id="57045" text="TSG" type="GENE"/>
    <entity charOffset="85-91" id="s24.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s24.e0" e2="s24.e1" id="s24.p0" relation="true"/>
  </sentence>
  <sentence id="s25" text="To date, researchers have discovered that Nrf2 deletion results in high susceptibility and severity of insults in various models of respiratory diseases, including bronchopulmonary dysplasia (BPD), respiratory infections, acute respiratory distress syndrome (ARDS), chronic obstructive pulmonary disease (COPD), asthma, idiopathic pulmonary fibrosis (IPF), and lung cancer.">
    <entity charOffset="42-46" id="s25.e0" ontology_id="2551" text="Nrf2" type="GENE"/>
    <entity charOffset="366-372" id="s25.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s25.e0" e2="s25.e1" id="s25.p0" relation="true"/>
  </sentence>
  <sentence id="s26" text="We generated a transgenic rat strain with a missense mutation in V286L (V286L-TG), in the gene encoding the neuronal nicotinic acetylcholine receptor 2 subunit (CHRNB2) found in patients with autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE).">
    <entity charOffset="162-168" id="s26.e0" ontology_id="1141" text="CHRNB2" type="GENE"/>
    <entity charOffset="212-221" id="s26.e1" ontology_id="HP_0025301" text="nocturnal" type="HP"/>
    <pair e1="s26.e0" e2="s26.e1" id="s26.p0" relation="true"/>
  </sentence>
  <sentence id="s27" text="We generated a transgenic rat strain with a missense mutation in V286L (V286L-TG), in the gene encoding the neuronal nicotinic acetylcholine receptor 2 subunit (CHRNB2) found in patients with autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE).">
    <entity charOffset="162-168" id="s27.e0" ontology_id="1141" text="CHRNB2" type="GENE"/>
    <entity charOffset="235-243" id="s27.e1" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <pair e1="s27.e0" e2="s27.e1" id="s27.p0" relation="true"/>
  </sentence>
  <sentence id="s28" text="Our findings provide exploratory evidence for hypermethylation of the key tumour suppressor gene APC being implicated in smoking-associated colorectal carcinogenesis.">
    <entity charOffset="74-80" id="s28.e0" ontology_id="HP_0002664" text="tumour" type="HP"/>
    <entity charOffset="97-100" id="s28.e1" ontology_id="324" text="APC" type="GENE"/>
    <pair e1="s28.e0" e2="s28.e1" id="s28.p0" relation="true"/>
  </sentence>
  <sentence id="s29" text="Our analyses identified 15 CpG sites within the APC 1A promoter that were significantly hypermethylated and 14 CpG loci within the NFATC1 gene body that were significantly hypomethylated (pLIS&amp;lt;1  10&lt;sup&gt;-5&lt;/sup&gt; ) in the tumours of active smokers.">
    <entity charOffset="48-51" id="s29.e0" ontology_id="324" text="APC" type="GENE"/>
    <entity charOffset="227-233" id="s29.e1" ontology_id="HP_0002664" text="tumour" type="HP"/>
    <pair e1="s29.e0" e2="s29.e1" id="s29.p0" relation="true"/>
  </sentence>
  <sentence id="s30" text="Overall, our results suggest that PQQ neuroprotection may be mediated by the inhibition of mitochondrial dysfunction and oxidative stress as well as by the gene modulation of Ndufs1 and Ndufs4">
    <entity charOffset="91-116" id="s30.e0" ontology_id="HP_0003287" text="mitochondrial dysfunction" type="HP"/>
    <entity charOffset="175-181" id="s30.e1" ontology_id="4719" text="Ndufs1" type="GENE"/>
    <pair e1="s30.e0" e2="s30.e1" id="s30.p0" relation="false"/>
  </sentence>
  <sentence id="s31" text="Using clinical blood samples, we compared the diagnostic values of serum exosomal ZIP4 levels between malignant pancreatic cancer patients (n=24) and benign pancreatic disease patients (n=32, AUC=.89), and between biliary disease patients (n=32, AUC=.8112) and healthy controls (n=46, AUC=.8931).">
    <entity charOffset="82-86" id="s31.e0" ontology_id="55630" text="ZIP4" type="GENE"/>
    <entity charOffset="123-129" id="s31.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s31.e0" e2="s31.e1" id="s31.p0" relation="true"/>
  </sentence>
  <sentence id="s32" text="In conclusion, exosomal ZIP4 promotes cancer growth and is a novel diagnostic biomarker for pancreatic cancer">
    <entity charOffset="24-28" id="s32.e0" ontology_id="55630" text="ZIP4" type="GENE"/>
    <entity charOffset="38-44" id="s32.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s32.e0" e2="s32.e1" id="s32.p0" relation="true"/>
  </sentence>
  <sentence id="s33" text="By combining meta-analysis results and identification of two unrelated HCM patients with homozygous CSRP3 truncating variants, we suggest that the association of CSRP3 as a validated HCM-causing gene require additional studies and those CSRP3 variants could result in HCM with an autosomal recessive inheritance rather than with an autosomal dominant transmission as usually reported on HCM (OMIM 612124)">
    <entity charOffset="100-105" id="s33.e0" ontology_id="8048" text="CSRP3" type="GENE"/>
    <entity charOffset="280-299" id="s33.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s33.e0" e2="s33.e1" id="s33.p0" relation="false"/>
  </sentence>
  <sentence id="s34" text="The aim of this study was to explore the relationship between ALDH5A1 and the prognosis of patients with ovarian cancer (OC).">
    <entity charOffset="62-69" id="s34.e0" ontology_id="7915" text="ALDH5A1" type="GENE"/>
    <entity charOffset="113-119" id="s34.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s34.e0" e2="s34.e1" id="s34.p0" relation="true"/>
  </sentence>
  <sentence id="s35" text="In survival analyses, we found that ALDH5A1 was positively linked to prognosis in patients with OC, particularly in those with serous ovarian cancer (SOC).">
    <entity charOffset="36-43" id="s35.e0" ontology_id="7915" text="ALDH5A1" type="GENE"/>
    <entity charOffset="142-148" id="s35.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s35.e0" e2="s35.e1" id="s35.p0" relation="true"/>
  </sentence>
  <sentence id="s36" text="c.886G&amp;gt;T is a novel idiopathic congenital nystagmusinducing mutation in the FRMD7 gene.">
    <entity charOffset="45-54" id="s36.e0" ontology_id="HP_0000639" text="nystagmus" type="HP"/>
    <entity charOffset="80-85" id="s36.e1" ontology_id="90167" text="FRMD7" type="GENE"/>
    <pair e1="s36.e0" e2="s36.e1" id="s36.p0" relation="true"/>
  </sentence>
  <sentence id="s37" text="The known pathogenic molecules involved in ichthyosis syndromes with prominent hair abnormalities include SPINK5, ERCC2, ERCC3, GTF2H5, MPLKIP, ST14, CLDN1 and MBTPS2.">
    <entity charOffset="79-97" id="s37.e0" ontology_id="HP_0001595" text="hair abnormalities" type="HP"/>
    <entity charOffset="121-126" id="s37.e1" ontology_id="2071" text="ERCC3" type="GENE"/>
    <pair e1="s37.e0" e2="s37.e1" id="s37.p0" relation="true"/>
  </sentence>
  <sentence id="s38" text="A GARP complex mutation analogous to a VPS53 allele causing progressive cerebello-cerebral atrophy type 2 (PCCA2) in humans exhibits similar, albeit weaker, phenotypes in yeast, providing mechanistic insights into disease pathogenesis.">
    <entity charOffset="2-6" id="s38.e0" ontology_id="1258" text="GARP" type="GENE"/>
    <entity charOffset="82-98" id="s38.e1" ontology_id="HP_0002059" text="cerebral atrophy" type="HP"/>
    <pair e1="s38.e0" e2="s38.e1" id="s38.p0" relation="true"/>
  </sentence>
  <sentence id="s39" text="A GARP complex mutation analogous to a VPS53 allele causing progressive cerebello-cerebral atrophy type 2 (PCCA2) in humans exhibits similar, albeit weaker, phenotypes in yeast, providing mechanistic insights into disease pathogenesis.">
    <entity charOffset="39-44" id="s39.e0" ontology_id="55275" text="VPS53" type="GENE"/>
    <entity charOffset="82-98" id="s39.e1" ontology_id="HP_0002059" text="cerebral atrophy" type="HP"/>
    <pair e1="s39.e0" e2="s39.e1" id="s39.p0" relation="false"/>
  </sentence>
  <sentence id="s40" text="A rare syndromic form of intellectual disability with impaired speech was recently found associated with mutations in CHAMP1 (chromosome alignment-maintaining phosphoprotein 1), the protein product of which is directly involved in microtubule-kinetochore attachment.">
    <entity charOffset="25-48" id="s40.e0" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <entity charOffset="118-124" id="s40.e1" ontology_id="283489" text="CHAMP1" type="GENE"/>
    <pair e1="s40.e0" e2="s40.e1" id="s40.p0" relation="true"/>
  </sentence>
  <sentence id="s41" text="Through whole-exome sequencing in six unrelated nonconsanguineous families having a sporadic case of intellectual disability, we identified six novel de novo truncating mutations in CHAMP1: c.1880C&amp;gt;G p.(Ser627*), c.1489C&amp;gt;T; p.(Arg497*), c.1876_1877delAG; p.(Ser626Leufs*4), c.1043G&amp;gt;A; p.(Trp348*), c.1002G&amp;gt;A; p.(Trp334*), and c.958_959delCC; p.(Pro320*).">
    <entity charOffset="84-92" id="s41.e0" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <entity charOffset="182-188" id="s41.e1" ontology_id="283489" text="CHAMP1" type="GENE"/>
    <pair e1="s41.e0" e2="s41.e1" id="s41.p0" relation="true"/>
  </sentence>
  <sentence id="s42" text="The four large extracellular domains of EMP2 and its association with the extracellular matrix makes it an attractive target for future cancer therapies.">
    <entity charOffset="40-44" id="s42.e0" ontology_id="2013" text="EMP2" type="GENE"/>
    <entity charOffset="136-142" id="s42.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s42.e0" e2="s42.e1" id="s42.p0" relation="true"/>
  </sentence>
  <sentence id="s43" text="Translational research suggests that EMP2 may be targeted with antibodies to improve tumor control and survival in a variety of murine models and cancer types.">
    <entity charOffset="37-41" id="s43.e0" ontology_id="2013" text="EMP2" type="GENE"/>
    <entity charOffset="146-152" id="s43.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s43.e0" e2="s43.e1" id="s43.p0" relation="true"/>
  </sentence>
  <sentence id="s44" text="In humans, mutations in several genes involved in the Notch pathway are associated with SDV, with both autosomal recessive (MESP2, DLL3, LFNG, HES7) and autosomal dominant (TBX6) inheritance.">
    <entity charOffset="103-122" id="s44.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="124-129" id="s44.e1" ontology_id="145873" text="MESP2" type="GENE"/>
    <pair e1="s44.e0" e2="s44.e1" id="s44.p0" relation="true"/>
  </sentence>
  <sentence id="s45" text="In humans, mutations in several genes involved in the Notch pathway are associated with SDV, with both autosomal recessive (MESP2, DLL3, LFNG, HES7) and autosomal dominant (TBX6) inheritance.">
    <entity charOffset="103-122" id="s45.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="173-177" id="s45.e1" ontology_id="6911" text="TBX6" type="GENE"/>
    <pair e1="s45.e0" e2="s45.e1" id="s45.p0" relation="false"/>
  </sentence>
  <sentence id="s46" text="In humans, mutations in several genes involved in the Notch pathway are associated with SDV, with both autosomal recessive (MESP2, DLL3, LFNG, HES7) and autosomal dominant (TBX6) inheritance.">
    <entity charOffset="103-122" id="s46.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="131-135" id="s46.e1" ontology_id="10683" text="DLL3" type="GENE"/>
    <pair e1="s46.e0" e2="s46.e1" id="s46.p0" relation="true"/>
  </sentence>
  <sentence id="s47" text="The correlation between the tumor size and the amount of CHL1 secretion could be examined in this study, and showed a significant positive correlation in a tumor size-dependent manner.">
    <entity charOffset="28-33" id="s47.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="57-61" id="s47.e1" ontology_id="1663" text="CHL1" type="GENE"/>
    <pair e1="s47.e0" e2="s47.e1" id="s47.p0" relation="true"/>
  </sentence>
  <sentence id="s48" text="We expand the knowledge about TTC7A deficiency, describing a patient with the mild phenotype of TTC7A deficiency but presenting overlapping features of SD/THE and MIA-CID: intestinal atresia and inflammatory bowel disease evocative of MIA-CID, but also dental abnormalities, huge forehead, liver abnormalities, autoimmune thyroiditis and hypogammaglobulinemia, evocative of SD/THE">
    <entity charOffset="30-35" id="s48.e0" ontology_id="57217" text="TTC7A" type="GENE"/>
    <entity charOffset="253-273" id="s48.e1" ontology_id="HP_0000164" text="dental abnormalities" type="HP"/>
    <pair e1="s48.e0" e2="s48.e1" id="s48.p0" relation="true"/>
  </sentence>
  <sentence id="s49" text="There are two different phenotypes of patients with TTC7A mutations: the severe form, caused by null mutations and leading to the classical MIA-CID; and the mild form, caused by missense mutations and leading to predominant features of VEO-IBD, less severe immunological involvement and hair abnormalities.">
    <entity charOffset="52-57" id="s49.e0" ontology_id="57217" text="TTC7A" type="GENE"/>
    <entity charOffset="287-305" id="s49.e1" ontology_id="HP_0001595" text="hair abnormalities" type="HP"/>
    <pair e1="s49.e0" e2="s49.e1" id="s49.p0" relation="true"/>
  </sentence>
  <sentence id="s50" text="We identified novel ALK fusions in a neuroblastoma (BEND5-ALK) and an astrocytoma (PPP1CB-ALK), novel BRAF fusions in an astrocytoma (BCAS1-BRAF) and a ganglioglioma (TMEM106B-BRAF), and a novel PAX3-GLI2 fusion in a rhabdomyosarcoma.">
    <entity charOffset="37-50" id="s50.e0" ontology_id="HP_0003006" text="neuroblastoma" type="HP"/>
    <entity charOffset="102-106" id="s50.e1" ontology_id="673" text="BRAF" type="GENE"/>
    <pair e1="s50.e0" e2="s50.e1" id="s50.p0" relation="false"/>
  </sentence>
  <sentence id="s51" text="We identified novel ALK fusions in a neuroblastoma (BEND5-ALK) and an astrocytoma (PPP1CB-ALK), novel BRAF fusions in an astrocytoma (BCAS1-BRAF) and a ganglioglioma (TMEM106B-BRAF), and a novel PAX3-GLI2 fusion in a rhabdomyosarcoma.">
    <entity charOffset="37-50" id="s51.e0" ontology_id="HP_0003006" text="neuroblastoma" type="HP"/>
    <entity charOffset="200-204" id="s51.e1" ontology_id="2736" text="GLI2" type="GENE"/>
    <pair e1="s51.e0" e2="s51.e1" id="s51.p0" relation="false"/>
  </sentence>
  <sentence id="s52" text="We identified novel ALK fusions in a neuroblastoma (BEND5-ALK) and an astrocytoma (PPP1CB-ALK), novel BRAF fusions in an astrocytoma (BCAS1-BRAF) and a ganglioglioma (TMEM106B-BRAF), and a novel PAX3-GLI2 fusion in a rhabdomyosarcoma.">
    <entity charOffset="70-81" id="s52.e0" ontology_id="HP_0009592" text="astrocytoma" type="HP"/>
    <entity charOffset="200-204" id="s52.e1" ontology_id="2736" text="GLI2" type="GENE"/>
    <pair e1="s52.e0" e2="s52.e1" id="s52.p0" relation="false"/>
  </sentence>
  <sentence id="s53" text="We identified novel ALK fusions in a neuroblastoma (BEND5-ALK) and an astrocytoma (PPP1CB-ALK), novel BRAF fusions in an astrocytoma (BCAS1-BRAF) and a ganglioglioma (TMEM106B-BRAF), and a novel PAX3-GLI2 fusion in a rhabdomyosarcoma.">
    <entity charOffset="70-81" id="s53.e0" ontology_id="HP_0009592" text="astrocytoma" type="HP"/>
    <entity charOffset="102-106" id="s53.e1" ontology_id="673" text="BRAF" type="GENE"/>
    <pair e1="s53.e0" e2="s53.e1" id="s53.p0" relation="true"/>
  </sentence>
  <sentence id="s54" text="A MMP9 inhibitor significantly inhibited cell invasion and migration in ALDOA-HIF-1 axis-induced lung cancer.">
    <entity charOffset="72-77" id="s54.e0" ontology_id="226" text="ALDOA" type="GENE"/>
    <entity charOffset="103-109" id="s54.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s54.e0" e2="s54.e1" id="s54.p0" relation="true"/>
  </sentence>
  <sentence id="s55" text="Haploinsufficiency of USP9X in females has been associated with ID and congenital malformations that include heart defects, scoliosis, dental abnormalities, anal atresia, polydactyly, Dandy Walker malformation and hypoplastic corpus callosum.">
    <entity charOffset="22-27" id="s55.e0" ontology_id="8239" text="USP9X" type="GENE"/>
    <entity charOffset="214-241" id="s55.e1" ontology_id="HP_0002079" text="hypoplastic corpus callosum" type="HP"/>
    <pair e1="s55.e0" e2="s55.e1" id="s55.p0" relation="true"/>
  </sentence>
  <sentence id="s56" text="Its restricted expression in normal tissues and unique early upregulation during tumor development make CRG-L2 an excellent candidate as a new clinical marker of HCC">
    <entity charOffset="81-86" id="s56.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="104-110" id="s56.e1" ontology_id="342035" text="CRG-L2" type="GENE"/>
    <pair e1="s56.e0" e2="s56.e1" id="s56.p0" relation="true"/>
  </sentence>
  <sentence id="s57" text="Mutations have previously been reported in several members of the TRAPP complex of proteins, including TRAPPC2, TRAPPC9 and TRAPPC11, resulting in disorders involving skeletal abnormalities, intellectual disability, speech impairment and developmental delay.">
    <entity charOffset="103-110" id="s57.e0" ontology_id="6399" text="TRAPPC2" type="GENE"/>
    <entity charOffset="238-257" id="s57.e1" ontology_id="HP_0001263" text="developmental delay" type="HP"/>
    <pair e1="s57.e0" e2="s57.e1" id="s57.p0" relation="true"/>
  </sentence>
  <sentence id="s58" text="Mutations have previously been reported in several members of the TRAPP complex of proteins, including TRAPPC2, TRAPPC9 and TRAPPC11, resulting in disorders involving skeletal abnormalities, intellectual disability, speech impairment and developmental delay.">
    <entity charOffset="103-110" id="s58.e0" ontology_id="6399" text="TRAPPC2" type="GENE"/>
    <entity charOffset="216-233" id="s58.e1" ontology_id="HP_0002167" text="speech impairment" type="HP"/>
    <pair e1="s58.e0" e2="s58.e1" id="s58.p0" relation="true"/>
  </sentence>
  <sentence id="s59" text="Mutations have previously been reported in several members of the TRAPP complex of proteins, including TRAPPC2, TRAPPC9 and TRAPPC11, resulting in disorders involving skeletal abnormalities, intellectual disability, speech impairment and developmental delay.">
    <entity charOffset="103-110" id="s59.e0" ontology_id="6399" text="TRAPPC2" type="GENE"/>
    <entity charOffset="191-214" id="s59.e1" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <pair e1="s59.e0" e2="s59.e1" id="s59.p0" relation="true"/>
  </sentence>
  <sentence id="s60" text="Mutations have previously been reported in several members of the TRAPP complex of proteins, including TRAPPC2, TRAPPC9 and TRAPPC11, resulting in disorders involving skeletal abnormalities, intellectual disability, speech impairment and developmental delay.">
    <entity charOffset="124-132" id="s60.e0" ontology_id="60684" text="TRAPPC11" type="GENE"/>
    <entity charOffset="167-189" id="s60.e1" ontology_id="HP_0000924" text="skeletal abnormalities" type="HP"/>
    <pair e1="s60.e0" e2="s60.e1" id="s60.p0" relation="true"/>
  </sentence>
  <sentence id="s61" text="In addition, forced expression of RANK-c in ER-negative breast cancer cell lines inhibited stimuli-induced NF-B activation and attenuated migration, invasion, colony formation, and adhesion of cancer cells.">
    <entity charOffset="34-38" id="s61.e0" ontology_id="8792" text="RANK" type="GENE"/>
    <entity charOffset="63-69" id="s61.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s61.e0" e2="s61.e1" id="s61.p0" relation="true"/>
  </sentence>
  <sentence id="s62" text="In addition, forced expression of RANK-c in ER-negative breast cancer cell lines inhibited stimuli-induced NF-B activation and attenuated migration, invasion, colony formation, and adhesion of cancer cells.">
    <entity charOffset="63-69" id="s62.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="107-109" id="s62.e1" ontology_id="23114" text="NF" type="GENE"/>
    <pair e1="s62.e0" e2="s62.e1" id="s62.p0" relation="true"/>
  </sentence>
  <sentence id="s63" text="Additional protein interaction characterization revealed epidermal growth factor receptor (EGFR) as a novel interacting partner for RANK-c in breast cancer cells with a negative effect on EGFR phosphorylation and EGF-dependent downstream signaling pathway activation.">
    <entity charOffset="149-155" id="s63.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="213-216" id="s63.e1" ontology_id="1950" text="EGF" type="GENE"/>
    <pair e1="s63.e0" e2="s63.e1" id="s63.p0" relation="true"/>
  </sentence>
  <sentence id="s64" text="The RANK-c-mediated inhibition of cancer cell aggressiveness and nuclear factor-B (NF-B) activation in breast cancer cells seems to rely on a RANK-c/TNF receptor-associated factor-2 (TRAF2) protein interaction.">
    <entity charOffset="4-8" id="s64.e0" ontology_id="8792" text="RANK" type="GENE"/>
    <entity charOffset="34-40" id="s64.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s64.e0" e2="s64.e1" id="s64.p0" relation="true"/>
  </sentence>
  <sentence id="s65" text="The RANK-c-mediated inhibition of cancer cell aggressiveness and nuclear factor-B (NF-B) activation in breast cancer cells seems to rely on a RANK-c/TNF receptor-associated factor-2 (TRAF2) protein interaction.">
    <entity charOffset="46-60" id="s65.e0" ontology_id="HP_0000718" text="aggressiveness" type="HP"/>
    <entity charOffset="185-190" id="s65.e1" ontology_id="10010" text="TRAF2" type="GENE"/>
    <pair e1="s65.e0" e2="s65.e1" id="s65.p0" relation="true"/>
  </sentence>
  <sentence id="s66" text="The RANK/RANKL axis emerges as a key regulator of breast cancer initiation, progression, and metastasis.">
    <entity charOffset="4-8" id="s66.e0" ontology_id="8792" text="RANK" type="GENE"/>
    <entity charOffset="57-63" id="s66.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s66.e0" e2="s66.e1" id="s66.p0" relation="true"/>
  </sentence>
  <sentence id="s67" text="Patients did not present with visual impairment as observed in a previously reported SPG57 family (c.316C&amp;gt;T (p.(Arg106Cys)) in coiled-coil domain), suggesting unique contributions of the PB1 and coiled-coil domains in TFG complex formation/function and a possible phenotype correlation to variant location.">
    <entity charOffset="30-47" id="s67.e0" ontology_id="HP_0000505" text="visual impairment" type="HP"/>
    <entity charOffset="221-224" id="s67.e1" ontology_id="10342" text="TFG" type="GENE"/>
    <pair e1="s67.e0" e2="s67.e1" id="s67.p0" relation="true"/>
  </sentence>
  <sentence id="s68" text="Our study expands the genetic heterogeneity of RTT and RTT-like phenotypes.">
    <entity charOffset="30-43" id="s68.e0" ontology_id="HP_0001425" text="heterogeneity" type="HP"/>
    <entity charOffset="47-50" id="s68.e1" ontology_id="4204" text="RTT" type="GENE"/>
    <pair e1="s68.e0" e2="s68.e1" id="s68.p0" relation="true"/>
  </sentence>
  <sentence id="s69" text="In zebrafish, downregulation of slc7a14 expression leads to an abnormal eye phenotype and defective light-induced locomotor response.">
    <entity charOffset="32-39" id="s69.e0" ontology_id="57709" text="slc7a14" type="GENE"/>
    <entity charOffset="63-75" id="s69.e1" ontology_id="HP_0000478" text="abnormal eye" type="HP"/>
    <pair e1="s69.e0" e2="s69.e1" id="s69.p0" relation="true"/>
  </sentence>
  <sentence id="s70" text="However, the underlying mechanism of HtrA3 function is unclear in endometrial hyperplasia and cancer.">
    <entity charOffset="37-42" id="s70.e0" ontology_id="726" text="HtrA3" type="GENE"/>
    <entity charOffset="94-100" id="s70.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s70.e0" e2="s70.e1" id="s70.p0" relation="true"/>
  </sentence>
  <sentence id="s71" text="In an effort to identify new mutations responsible for DBA, we performed whole-exome sequencing analysis of 48 patients with no documented mutations/deletions in our first screening and identified a de novo splicing error mutation in RPL27 and a frameshift deletion in RPS27 in sporadic patients with DBA.">
    <entity charOffset="234-239" id="s71.e0" ontology_id="6155" text="RPL27" type="GENE"/>
    <entity charOffset="278-286" id="s71.e1" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <pair e1="s71.e0" e2="s71.e1" id="s71.p0" relation="true"/>
  </sentence>
  <sentence id="s72" text="The purpose of the present study was to evaluate the expression of Lin28A, let-7a, and c-Myc in human papillary thyroid carcinoma (PTC) and to investigate their potential mechanisms in the progression of PTC.">
    <entity charOffset="87-92" id="s72.e0" ontology_id="4609" text="c-Myc" type="GENE"/>
    <entity charOffset="102-129" id="s72.e1" ontology_id="HP_0002895" text="papillary thyroid carcinoma" type="HP"/>
    <pair e1="s72.e0" e2="s72.e1" id="s72.p0" relation="true"/>
  </sentence>
  <sentence id="s73" text="BACKGROUND Lin28 is a gene involved in many biological processes, including development, glucose metabolism, and tumorigenesis.">
    <entity charOffset="11-16" id="s73.e0" ontology_id="79727" text="Lin28" type="GENE"/>
    <entity charOffset="113-118" id="s73.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s73.e0" e2="s73.e1" id="s73.p0" relation="true"/>
  </sentence>
  <sentence id="s74" text="Depletion of ASS1 led to inhibition of tumor growth and decreased cell invasion via induction of autophagy-lysosome machinery, resulting in degradation of active -catenin, Snail, and Twist.">
    <entity charOffset="39-44" id="s74.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="173-178" id="s74.e1" ontology_id="6615" text="Snail" type="GENE"/>
    <pair e1="s74.e0" e2="s74.e1" id="s74.p0" relation="true"/>
  </sentence>
  <sentence id="s75" text="Depletion of ASS1 led to inhibition of tumor growth and decreased cell invasion via induction of autophagy-lysosome machinery, resulting in degradation of active -catenin, Snail, and Twist.">
    <entity charOffset="39-44" id="s75.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="184-189" id="s75.e1" ontology_id="7291" text="Twist" type="GENE"/>
    <pair e1="s75.e0" e2="s75.e1" id="s75.p0" relation="false"/>
  </sentence>
  <sentence id="s76" text="Mutations in SLC4A11, a Na&lt;sup&gt;+&lt;/sup&gt; dependent OH&lt;sup&gt;-&lt;/sup&gt; transporter, cause congenital hereditary endothelial dystrophy (CHED) and Fuchs' endothelial corneal dystrophy (FECD), the two most common forms of endothelial degeneration.">
    <entity charOffset="13-20" id="s76.e0" ontology_id="83959" text="SLC4A11" type="GENE"/>
    <entity charOffset="157-174" id="s76.e1" ontology_id="HP_0001131" text="corneal dystrophy" type="HP"/>
    <pair e1="s76.e0" e2="s76.e1" id="s76.p0" relation="true"/>
  </sentence>
  <sentence id="s77" text="A further XX male, ascertained because of intellectual disability, carried a de novo cryptic duplication at Xq27.1, involving SOX3.">
    <entity charOffset="42-65" id="s77.e0" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <entity charOffset="126-130" id="s77.e1" ontology_id="6658" text="SOX3" type="GENE"/>
    <pair e1="s77.e0" e2="s77.e1" id="s77.p0" relation="true"/>
  </sentence>
  <sentence id="s78" text="We analyzed, by conventional and molecular cytogenetics, 19 novel SRY-negative unrelated 46,XX subjects both familial and sporadic, with isolated DSD.">
    <entity charOffset="66-69" id="s78.e0" ontology_id="6736" text="SRY" type="GENE"/>
    <entity charOffset="122-130" id="s78.e1" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <pair e1="s78.e0" e2="s78.e1" id="s78.p0" relation="true"/>
  </sentence>
  <sentence id="s79" text="However, there was no research elucidating the genetic association of entire NER pathway with ovarian cancer susceptibility.">
    <entity charOffset="77-80" id="s79.e0" ontology_id="7376" text="NER" type="GENE"/>
    <entity charOffset="102-108" id="s79.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s79.e0" e2="s79.e1" id="s79.p0" relation="true"/>
  </sentence>
  <sentence id="s80" text="Therefore, we conducted genotyping for 17 SNPs of six NER core genes (&lt;i&gt;XPA, XPC, XPG, ERCC1, ERCC2&lt;/i&gt;, and &lt;i&gt;ERCC4&lt;/i&gt;) in 89 ovarian cancer cases and 356 cancer-free controls.">
    <entity charOffset="88-93" id="s80.e0" ontology_id="2067" text="ERCC1" type="GENE"/>
    <entity charOffset="138-144" id="s80.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s80.e0" e2="s80.e1" id="s80.p0" relation="true"/>
  </sentence>
  <sentence id="s81" text="However, no study has investigated the relationship between aromatase in living brains and personality traits including aggression.">
    <entity charOffset="60-69" id="s81.e0" ontology_id="1588" text="aromatase" type="GENE"/>
    <entity charOffset="120-130" id="s81.e1" ontology_id="HP_0000718" text="aggression" type="HP"/>
    <pair e1="s81.e0" e2="s81.e1" id="s81.p0" relation="true"/>
  </sentence>
  <sentence id="s82" text="Concerning LEP G2548A polymorphism, our results showed that the OR of obesity associated with 2548 AA/GG was 1.87[1.106-2.78] P=.028 vs 1.41[1.035-1.85] P=.045 for 223AA/GG polymorphism.">
    <entity charOffset="11-14" id="s82.e0" ontology_id="3952" text="LEP" type="GENE"/>
    <entity charOffset="70-77" id="s82.e1" ontology_id="HP_0001513" text="obesity" type="HP"/>
    <pair e1="s82.e0" e2="s82.e1" id="s82.p0" relation="true"/>
  </sentence>
  <sentence id="s83" text="Here, we investigated the biological functions and clinical significance of TRIM44 in human esophageal cancer (HEC).">
    <entity charOffset="76-80" id="s83.e0" ontology_id="50852" text="TRIM" type="GENE"/>
    <entity charOffset="103-109" id="s83.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s83.e0" e2="s83.e1" id="s83.p0" relation="true"/>
  </sentence>
  <sentence id="s84" text="The molecular basis of this condition started to be defined recently, and the genes related to the syndrome (ACTG2-heterozygous variant in sporadic cases; and MYH11 (myosin heavy chain 11), LMOD1 (leiomodin 1) and MYLK (myosin light chain (MLC) kinase)-autosomal recessive inheritance), encode proteins involved in the smooth muscle contraction, supporting a myopathic basis for the disease.">
    <entity charOffset="139-147" id="s84.e0" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <entity charOffset="190-195" id="s84.e1" ontology_id="25802" text="LMOD1" type="GENE"/>
    <pair e1="s84.e0" e2="s84.e1" id="s84.p0" relation="false"/>
  </sentence>
  <sentence id="s85" text="The molecular basis of this condition started to be defined recently, and the genes related to the syndrome (ACTG2-heterozygous variant in sporadic cases; and MYH11 (myosin heavy chain 11), LMOD1 (leiomodin 1) and MYLK (myosin light chain (MLC) kinase)-autosomal recessive inheritance), encode proteins involved in the smooth muscle contraction, supporting a myopathic basis for the disease.">
    <entity charOffset="240-243" id="s85.e0" ontology_id="23209" text="MLC" type="GENE"/>
    <entity charOffset="273-284" id="s85.e1" ontology_id="HP_0000005" text="inheritance" type="HP"/>
    <pair e1="s85.e0" e2="s85.e1" id="s85.p0" relation="true"/>
  </sentence>
  <sentence id="s86" text="The genetic testing revealed a de novo heterozygous mutation of c.2452G&amp;gt;A (p.Glu818Lys) in the ATP1A3 gene, which was compatible with the clinical phenotype of CAPOS (cerebellar ataxia, areflexia, pes cavus, optic atrophy, and sensorineural hearing loss)/CAOS syndrome.">
    <entity charOffset="100-106" id="s86.e0" ontology_id="478" text="ATP1A3" type="GENE"/>
    <entity charOffset="246-258" id="s86.e1" ontology_id="HP_0000365" text="hearing loss" type="HP"/>
    <pair e1="s86.e0" e2="s86.e1" id="s86.p0" relation="true"/>
  </sentence>
  <sentence id="s87" text="The genetic testing revealed a de novo heterozygous mutation of c.2452G&amp;gt;A (p.Glu818Lys) in the ATP1A3 gene, which was compatible with the clinical phenotype of CAPOS (cerebellar ataxia, areflexia, pes cavus, optic atrophy, and sensorineural hearing loss)/CAOS syndrome.">
    <entity charOffset="100-106" id="s87.e0" ontology_id="478" text="ATP1A3" type="GENE"/>
    <entity charOffset="191-200" id="s87.e1" ontology_id="HP_0001284" text="areflexia" type="HP"/>
    <pair e1="s87.e0" e2="s87.e1" id="s87.p0" relation="true"/>
  </sentence>
  <sentence id="s88" text="The genetic testing revealed a de novo heterozygous mutation of c.2452G&amp;gt;A (p.Glu818Lys) in the ATP1A3 gene, which was compatible with the clinical phenotype of CAPOS (cerebellar ataxia, areflexia, pes cavus, optic atrophy, and sensorineural hearing loss)/CAOS syndrome.">
    <entity charOffset="100-106" id="s88.e0" ontology_id="478" text="ATP1A3" type="GENE"/>
    <entity charOffset="183-189" id="s88.e1" ontology_id="HP_0001251" text="ataxia" type="HP"/>
    <pair e1="s88.e0" e2="s88.e1" id="s88.p0" relation="true"/>
  </sentence>
  <sentence id="s89" text="Mutations in the gene encoding the single transmembrane receptor multiple epidermal growth factor-like domain 10 (MEGF10) cause an autosomal recessive congenital muscle disease in humans.">
    <entity charOffset="114-120" id="s89.e0" ontology_id="84466" text="MEGF10" type="GENE"/>
    <entity charOffset="131-150" id="s89.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s89.e0" e2="s89.e1" id="s89.p0" relation="true"/>
  </sentence>
  <sentence id="s90" text="The copy number variations and mutations were also used to identify single nucleotide variations (SNVs) in crystallin mu (CRYM), RAB3 GTPase activating protein catalytic subunit1 (RAB3GAP1) and Wnt family member10A (WNT10A), implicated in deafness, hypogonadism and tooth/skin abnormalities, respectively.">
    <entity charOffset="181-189" id="s90.e0" ontology_id="22930" text="RAB3GAP1" type="GENE"/>
    <entity charOffset="251-263" id="s90.e1" ontology_id="HP_0000135" text="hypogonadism" type="HP"/>
    <pair e1="s90.e0" e2="s90.e1" id="s90.p0" relation="true"/>
  </sentence>
  <sentence id="s91" text="The copy number variations and mutations were also used to identify single nucleotide variations (SNVs) in crystallin mu (CRYM), RAB3 GTPase activating protein catalytic subunit1 (RAB3GAP1) and Wnt family member10A (WNT10A), implicated in deafness, hypogonadism and tooth/skin abnormalities, respectively.">
    <entity charOffset="218-224" id="s91.e0" ontology_id="80326" text="WNT10A" type="GENE"/>
    <entity charOffset="251-263" id="s91.e1" ontology_id="HP_0000135" text="hypogonadism" type="HP"/>
    <pair e1="s91.e0" e2="s91.e1" id="s91.p0" relation="true"/>
  </sentence>
  <sentence id="s92" text="The present findings did not identify copy number variation and mutations in EDA; therefore, excluding the possibility of EDAinitiated ectodermal dysplasia syndrome.">
    <entity charOffset="77-80" id="s92.e0" ontology_id="1896" text="EDA" type="GENE"/>
    <entity charOffset="136-156" id="s92.e1" ontology_id="HP_0000968" text="ectodermal dysplasia" type="HP"/>
    <pair e1="s92.e0" e2="s92.e1" id="s92.p0" relation="true"/>
  </sentence>
  <sentence id="s93" text="The WNT10A p.G213S mutation was confirmed to be the etiological cause of tooth agenesis and ectodermal dysplasia as previously described.">
    <entity charOffset="4-10" id="s93.e0" ontology_id="80326" text="WNT10A" type="GENE"/>
    <entity charOffset="92-112" id="s93.e1" ontology_id="HP_0000968" text="ectodermal dysplasia" type="HP"/>
    <pair e1="s93.e0" e2="s93.e1" id="s93.p0" relation="true"/>
  </sentence>
  <sentence id="s94" text="The present study screened pathogenic genes, ectodysplasinA (EDA) and lamin A/C (LMNA), in a patient with suspected syndromic hearing impairment and various other symptoms including tooth and skin abnormalities.">
    <entity charOffset="62-65" id="s94.e0" ontology_id="1896" text="EDA" type="GENE"/>
    <entity charOffset="193-211" id="s94.e1" ontology_id="HP_0000951" text="skin abnormalities" type="HP"/>
    <pair e1="s94.e0" e2="s94.e1" id="s94.p0" relation="true"/>
  </sentence>
  <sentence id="s95" text="All these findings implied the important roles of FBP1 expression in lung cancer development and progression and the potential use of the methylation status detected in FBP1 promoter region as a novel predictor for prognosis and therapeutic target for NSCLC patients">
    <entity charOffset="50-54" id="s95.e0" ontology_id="2203" text="FBP1" type="GENE"/>
    <entity charOffset="74-80" id="s95.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s95.e0" e2="s95.e1" id="s95.p0" relation="true"/>
  </sentence>
  <sentence id="s96" text="Moreover, a series of LDHA gain-of-function and rescore experiments were carried out in breast cancer MCF7 cells expressing endogenous wt-p53, showing that ectopic expression of p53 decreases aerobic glycolysis, cell proliferation, migration, invasion and tumor formation of breast cancer cells and that restoration of the expression of LDHA in p53-overexpressing cells could abolish the suppressive effect of p53 on aerobic glycolysis and other malignant phenotypes.">
    <entity charOffset="22-26" id="s96.e0" ontology_id="3939" text="LDHA" type="GENE"/>
    <entity charOffset="256-261" id="s96.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s96.e0" e2="s96.e1" id="s96.p0" relation="false"/>
  </sentence>
  <sentence id="s97" text="We found that NTS inhibits RANKL- or cancer cell-mediated osteoclastogenesis via blockade of TRAF6 and NF-B activation.">
    <entity charOffset="27-32" id="s97.e0" ontology_id="8600" text="RANKL" type="GENE"/>
    <entity charOffset="37-43" id="s97.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s97.e0" e2="s97.e1" id="s97.p0" relation="false"/>
  </sentence>
  <sentence id="s98" text="Here, we show that ablating or silencing the transcription factor Nfix ameliorates pathology in several forms of muscular dystrophy.">
    <entity charOffset="66-70" id="s98.e0" ontology_id="4784" text="Nfix" type="GENE"/>
    <entity charOffset="113-131" id="s98.e1" ontology_id="HP_0003560" text="muscular dystrophy" type="HP"/>
    <pair e1="s98.e0" e2="s98.e1" id="s98.p0" relation="true"/>
  </sentence>
  <sentence id="s99" text="Mutations of the five genes (ARHGEF5, ANKRD20A2, ZNF595, ZNF812, MYO18B) may be potential germline mutations of lung cancer.">
    <entity charOffset="38-47" id="s99.e0" ontology_id="441430" text="ANKRD20A2" type="GENE"/>
    <entity charOffset="117-123" id="s99.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s99.e0" e2="s99.e1" id="s99.p0" relation="true"/>
  </sentence>
  <sentence id="s100" text="These analyses revealed significantly higher methylation frequencies in high-grade tumors relative to low-intermediate-grade tumors for the ATP5G2, IRX1 and VAX2 genes (P&amp;lt;0.05), and similarly significant increases in mean levels of methylation in high-grade tumors for the ATP5G2, VAX2, INSRR, PRDM14, VSX1, TFAP2b, PRRX1, and HIST1H4F genes (P&amp;lt;0.05).">
    <entity charOffset="83-88" id="s100.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="148-152" id="s100.e1" ontology_id="79192" text="IRX1" type="GENE"/>
    <pair e1="s100.e0" e2="s100.e1" id="s100.p0" relation="true"/>
  </sentence>
  <sentence id="s101" text="Here we present a case of a 3-year-old boy with compound heterozygous missense mutations in the TMEM67 gene manifesting features of both JBTS and NPHP syndromes, with neonatal onset of end-stage renal disease (ESRD) and associated microcephaly.">
    <entity charOffset="96-102" id="s101.e0" ontology_id="91147" text="TMEM67" type="GENE"/>
    <entity charOffset="231-243" id="s101.e1" ontology_id="HP_0000252" text="microcephaly" type="HP"/>
    <pair e1="s101.e0" e2="s101.e1" id="s101.p0" relation="true"/>
  </sentence>
  <sentence id="s102" text="EEF1A2 gene is highly expressed in the central nervous system and Eef1a2 knockout mice show the neuronal degeneration.">
    <entity charOffset="39-46" id="s102.e0" ontology_id="HP_0030645" text="central" type="HP"/>
    <entity charOffset="66-72" id="s102.e1" ontology_id="1917" text="Eef1a2" type="GENE"/>
    <pair e1="s102.e0" e2="s102.e1" id="s102.p0" relation="false"/>
  </sentence>
  <sentence id="s103" text="Novel targets ANTXR1 and RSPO2 were confirmed to be suppressed by miR-493 directly, and overexpression of ANTXR1 and RSPO2 could restore tumorigenesis in miR-493 treated HCC cell.">
    <entity charOffset="25-30" id="s103.e0" ontology_id="340419" text="RSPO2" type="GENE"/>
    <entity charOffset="137-142" id="s103.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s103.e0" e2="s103.e1" id="s103.p0" relation="false"/>
  </sentence>
  <sentence id="s104" text="These findings suggest that miR-493 acts as a negative regulator in hepatocellular carcinoma progression and may be a potential therapeutic target for HCC">
    <entity charOffset="28-31" id="s104.e0" ontology_id="220972" text="miR" type="GENE"/>
    <entity charOffset="68-92" id="s104.e1" ontology_id="HP_0001402" text="hepatocellular carcinoma" type="HP"/>
    <pair e1="s104.e0" e2="s104.e1" id="s104.p0" relation="true"/>
  </sentence>
  <sentence id="s105" text="Moreover, Wnt/-catenin signaling pathway, which was reported to be activated by ANTXR1 and RSPO2, was also inhibited by miR-493 overexpression and might be involved in anti-tumor function of miR-493.">
    <entity charOffset="81-87" id="s105.e0" ontology_id="84168" text="ANTXR1" type="GENE"/>
    <entity charOffset="174-179" id="s105.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s105.e0" e2="s105.e1" id="s105.p0" relation="false"/>
  </sentence>
  <sentence id="s106" text="Mutations in POMT1, POMT2, POMGNT1, FKTN, FKRP, LARGE, GMPPB, TMEM5 and COL4A1 and ISPD lead to a wide spectrum of phenotypes of congenital muscular dystrophies with or without eye and brain abnormalities.">
    <entity charOffset="20-25" id="s106.e0" ontology_id="29954" text="POMT2" type="GENE"/>
    <entity charOffset="140-160" id="s106.e1" ontology_id="HP_0003560" text="muscular dystrophies" type="HP"/>
    <pair e1="s106.e0" e2="s106.e1" id="s106.p0" relation="true"/>
  </sentence>
  <sentence id="s107" text="Mutations in POMT1, POMT2, POMGNT1, FKTN, FKRP, LARGE, GMPPB, TMEM5 and COL4A1 and ISPD lead to a wide spectrum of phenotypes of congenital muscular dystrophies with or without eye and brain abnormalities.">
    <entity charOffset="42-46" id="s107.e0" ontology_id="79147" text="FKRP" type="GENE"/>
    <entity charOffset="140-160" id="s107.e1" ontology_id="HP_0003560" text="muscular dystrophies" type="HP"/>
    <pair e1="s107.e0" e2="s107.e1" id="s107.p0" relation="true"/>
  </sentence>
  <sentence id="s108" text="Mutations in POMT1, POMT2, POMGNT1, FKTN, FKRP, LARGE, GMPPB, TMEM5 and COL4A1 and ISPD lead to a wide spectrum of phenotypes of congenital muscular dystrophies with or without eye and brain abnormalities.">
    <entity charOffset="55-60" id="s108.e0" ontology_id="29925" text="GMPPB" type="GENE"/>
    <entity charOffset="140-160" id="s108.e1" ontology_id="HP_0003560" text="muscular dystrophies" type="HP"/>
    <pair e1="s108.e0" e2="s108.e1" id="s108.p0" relation="true"/>
  </sentence>
  <sentence id="s109" text="Mutations in POMT1, POMT2, POMGNT1, FKTN, FKRP, LARGE, GMPPB, TMEM5 and COL4A1 and ISPD lead to a wide spectrum of phenotypes of congenital muscular dystrophies with or without eye and brain abnormalities.">
    <entity charOffset="83-87" id="s109.e0" ontology_id="729920" text="ISPD" type="GENE"/>
    <entity charOffset="140-160" id="s109.e1" ontology_id="HP_0003560" text="muscular dystrophies" type="HP"/>
    <pair e1="s109.e0" e2="s109.e1" id="s109.p0" relation="true"/>
  </sentence>
  <sentence id="s110" text="Besides, we screened for all the known genes related to axonal autosomal recessive Charcot-Marie-Tooth disease (CMT2A2/HMSN2A2/MFN2, CMT2B1/LMNA, CMT2B2/MED25, CMT2B5/NEFL, ARCMT2F/dHMN2B/HSPB1, CMT2K/GDAP1, CMT2P/LRSAM1, CMT2R/TRIM2, CMT2S/IGHMBP2, CMT2T/HSJ1, CMTRID/COX6A1, ARAN-NM/HINT and GAN/GAN), for the genes related to autosomal recessive hereditary spastic paraplegia with thin corpus callosum and axonal peripheral neuropathy (SPG7/PGN, SPG15/ZFYVE26, SPG21/ACP33, SPG35/FA2H, SPG46/GBA2, SPG55/C12orf65 and SPG56/CYP2U1), as well as for the causative gene of peripheral neuropathy with or without agenesis of the corpus callosum (SLC12A6).">
    <entity charOffset="63-82" id="s110.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="643-650" id="s110.e1" ontology_id="9990" text="SLC12A6" type="GENE"/>
    <pair e1="s110.e0" e2="s110.e1" id="s110.p0" relation="false"/>
  </sentence>
  <sentence id="s111" text="FBXL4 potentially controls cancer metastasis through regulation of ERLEC1 levels.">
    <entity charOffset="0-5" id="s111.e0" ontology_id="26235" text="FBXL4" type="GENE"/>
    <entity charOffset="27-33" id="s111.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s111.e0" e2="s111.e1" id="s111.p0" relation="true"/>
  </sentence>
  <sentence id="s112" text="FBXL4 potentially controls cancer metastasis through regulation of ERLEC1 levels.">
    <entity charOffset="27-33" id="s112.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="67-73" id="s112.e1" ontology_id="27248" text="ERLEC1" type="GENE"/>
    <pair e1="s112.e0" e2="s112.e1" id="s112.p0" relation="true"/>
  </sentence>
  <sentence id="s113" text="Loss of FBXL4 was also detected in primary tumours and it was highly associated with prognostic factors including high Gleason score, clinical stage, prostate-specific antigen (PSA) and extent of disease, as well as poor patient survival, suggesting that FBXL4 loss contributes to prostate cancer progression.">
    <entity charOffset="8-13" id="s113.e0" ontology_id="26235" text="FBXL4" type="GENE"/>
    <entity charOffset="290-296" id="s113.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s113.e0" e2="s113.e1" id="s113.p0" relation="false"/>
  </sentence>
  <sentence id="s114" text="The enriched genes included MMP9, SERPINE2, CAV1, KRT14, and RASA3 in basal tumors, and PPARG, LY6E, CTSE, CDK3, and TBX2 in luminal tumors.">
    <entity charOffset="28-32" id="s114.e0" ontology_id="4318" text="MMP9" type="GENE"/>
    <entity charOffset="76-81" id="s114.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s114.e0" e2="s114.e1" id="s114.p0" relation="true"/>
  </sentence>
  <sentence id="s115" text="The enriched genes included MMP9, SERPINE2, CAV1, KRT14, and RASA3 in basal tumors, and PPARG, LY6E, CTSE, CDK3, and TBX2 in luminal tumors.">
    <entity charOffset="44-48" id="s115.e0" ontology_id="857" text="CAV1" type="GENE"/>
    <entity charOffset="76-81" id="s115.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s115.e0" e2="s115.e1" id="s115.p0" relation="true"/>
  </sentence>
  <sentence id="s116" text="The enriched genes included MMP9, SERPINE2, CAV1, KRT14, and RASA3 in basal tumors, and PPARG, LY6E, CTSE, CDK3, and TBX2 in luminal tumors.">
    <entity charOffset="50-55" id="s116.e0" ontology_id="3861" text="KRT14" type="GENE"/>
    <entity charOffset="76-81" id="s116.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s116.e0" e2="s116.e1" id="s116.p0" relation="true"/>
  </sentence>
  <sentence id="s117" text="The enriched genes included MMP9, SERPINE2, CAV1, KRT14, and RASA3 in basal tumors, and PPARG, LY6E, CTSE, CDK3, and TBX2 in luminal tumors.">
    <entity charOffset="76-81" id="s117.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="107-111" id="s117.e1" ontology_id="1018" text="CDK3" type="GENE"/>
    <pair e1="s117.e0" e2="s117.e1" id="s117.p0" relation="true"/>
  </sentence>
  <sentence id="s118" text="The enriched genes included MMP9, SERPINE2, CAV1, KRT14, and RASA3 in basal tumors, and PPARG, LY6E, CTSE, CDK3, and TBX2 in luminal tumors.">
    <entity charOffset="76-81" id="s118.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="117-121" id="s118.e1" ontology_id="6909" text="TBX2" type="GENE"/>
    <pair e1="s118.e0" e2="s118.e1" id="s118.p0" relation="false"/>
  </sentence>
  <sentence id="s119" text="AMPK phosphorylates PRPS1/2, converts PRPS1/2 hexamers to monomers, and inhibits PRPS1/2 activity and subsequent nucleotide and NAD synthesis to maintain tumor cell growth and survival.">
    <entity charOffset="0-4" id="s119.e0" ontology_id="5563" text="AMPK" type="GENE"/>
    <entity charOffset="154-159" id="s119.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s119.e0" e2="s119.e1" id="s119.p0" relation="true"/>
  </sentence>
  <sentence id="s120" text="AMPK phosphorylates PRPS1/2, converts PRPS1/2 hexamers to monomers, and inhibits PRPS1/2 activity and subsequent nucleotide and NAD synthesis to maintain tumor cell growth and survival.">
    <entity charOffset="20-25" id="s120.e0" ontology_id="5631" text="PRPS1" type="GENE"/>
    <entity charOffset="154-159" id="s120.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s120.e0" e2="s120.e1" id="s120.p0" relation="false"/>
  </sentence>
  <sentence id="s121" text="Knock-in of nonphosphorylatable PRPS1/2 mutants, which have uninhibited activity, in brain tumor cells under energy stress exhausts cellular ATP and NADPH and increases reactive oxygen species levels, thereby promoting cell apoptosis.">
    <entity charOffset="32-37" id="s121.e0" ontology_id="5631" text="PRPS1" type="GENE"/>
    <entity charOffset="91-96" id="s121.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s121.e0" e2="s121.e1" id="s121.p0" relation="true"/>
  </sentence>
  <sentence id="s122" text="Mutations in ganglioside-induced differentiation-associated-protein 1 (GDAP1) have been associated with both subtypes of Charcot-Marie-Tooth (CMT) disease, autosomal recessive (CMT4A and AR-CMT2K) and autosomal dominant (AD-CMT2K).">
    <entity charOffset="71-76" id="s122.e0" ontology_id="54332" text="GDAP1" type="GENE"/>
    <entity charOffset="156-175" id="s122.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s122.e0" e2="s122.e1" id="s122.p0" relation="true"/>
  </sentence>
  <sentence id="s123" text="Our study expands the mutational spectrum of GDAP1-related CMT disease with the identification of new and unreported GDAP1 variants and demonstrates the predominance of the axonal form of neuropathy in CMT disease associated with GDAP1.">
    <entity charOffset="45-50" id="s123.e0" ontology_id="54332" text="GDAP1" type="GENE"/>
    <entity charOffset="188-198" id="s123.e1" ontology_id="HP_0009830" text="neuropathy" type="HP"/>
    <pair e1="s123.e0" e2="s123.e1" id="s123.p0" relation="true"/>
  </sentence>
  <sentence id="s124" text="Here, a novel animal model was used to study how vIL-6 affects tumor development.">
    <entity charOffset="49-52" id="s124.e0" ontology_id="7429" text="vIL" type="GENE"/>
    <entity charOffset="63-68" id="s124.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s124.e0" e2="s124.e1" id="s124.p0" relation="true"/>
  </sentence>
  <sentence id="s125" text="The KSHV viral homolog of interleukin-6 gene (vIL-6) may play a significant role in tumor development and may serve as a new anti-cancer target, but its role in tumor formation is only partially understood.">
    <entity charOffset="46-49" id="s125.e0" ontology_id="7429" text="vIL" type="GENE"/>
    <entity charOffset="84-89" id="s125.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s125.e0" e2="s125.e1" id="s125.p0" relation="true"/>
  </sentence>
  <sentence id="s126" text="The KSHV viral homolog of interleukin-6 gene (vIL-6) may play a significant role in tumor development and may serve as a new anti-cancer target, but its role in tumor formation is only partially understood.">
    <entity charOffset="46-49" id="s126.e0" ontology_id="7429" text="vIL" type="GENE"/>
    <entity charOffset="130-136" id="s126.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s126.e0" e2="s126.e1" id="s126.p0" relation="true"/>
  </sentence>
  <sentence id="s127" text="Additional validation efforts and functional studies are warranted to demonstrate whether PAIP2B is a novel tumor suppressor gene and a potential therapeutic target for pancreatic cancer">
    <entity charOffset="90-96" id="s127.e0" ontology_id="400961" text="PAIP2B" type="GENE"/>
    <entity charOffset="108-113" id="s127.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s127.e0" e2="s127.e1" id="s127.p0" relation="true"/>
  </sentence>
  <sentence id="s128" text="In a two-stage study, we analyzed the existing genome-wide association study dataset of 868 pancreatic cancer patients from MD Anderson Cancer Center in relation to overall survival using Cox regression.">
    <entity charOffset="103-109" id="s128.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="188-191" id="s128.e1" ontology_id="1351" text="Cox" type="GENE"/>
    <pair e1="s128.e0" e2="s128.e1" id="s128.p0" relation="true"/>
  </sentence>
  <sentence id="s129" text="FGD is a heterogeneous disorder for which causal mutations have been identified in MC2R, MRAP, MCM4 and TXNRD2.">
    <entity charOffset="9-22" id="s129.e0" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <entity charOffset="95-99" id="s129.e1" ontology_id="4173" text="MCM4" type="GENE"/>
    <pair e1="s129.e0" e2="s129.e1" id="s129.p0" relation="true"/>
  </sentence>
  <sentence id="s130" text="Here, we summarize thecellular functions of PGRN, itsroles in the nervous system, and its link to multiple neurodegenerative diseases, with a particular focus dedicated to recent lysosome-related mechanistic developments">
    <entity charOffset="45-49" id="s130.e0" ontology_id="2896" text="PGRN" type="GENE"/>
    <entity charOffset="109-135" id="s130.e1" ontology_id="HP_0002180" text="neurodegenerative diseases" type="HP"/>
    <pair e1="s130.e0" e2="s130.e1" id="s130.p0" relation="true"/>
  </sentence>
  <sentence id="s131" text="&lt;i&gt;In silico&lt;/i&gt; human gene expression analysis confirmed the down regulation of PrKD1 in metastatic prostate cancer correlated inversely with the expression of MAX, but not MYC, and positively with MXD1, a competing heterodimer of MAX, suggesting that the dimerization of MAX with either MYC or MXD1 regulates &lt;i&gt;PrKD1&lt;/i&gt; gene expression.">
    <entity charOffset="110-116" id="s131.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="199-203" id="s131.e1" ontology_id="4084" text="MXD1" type="GENE"/>
    <pair e1="s131.e0" e2="s131.e1" id="s131.p0" relation="true"/>
  </sentence>
  <sentence id="s132" text="Because we had demonstrated that PrKD1 is the only known kinase to phosphorylate threonine 120 (T120) of beta-catenin in prostate cancer resulting in increased nuclear beta-catenin, we explored the role of beta-catenin in gene regulation of &lt;i&gt;PrKD1&lt;/i&gt;.">
    <entity charOffset="33-38" id="s132.e0" ontology_id="5587" text="PrKD1" type="GENE"/>
    <entity charOffset="130-136" id="s132.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s132.e0" e2="s132.e1" id="s132.p0" relation="true"/>
  </sentence>
  <sentence id="s133" text="Down regulation of Protein Kinase D1 (PrKD1), a novel serine threonine kinase, in prostate, gastric, breast and colon cancers in humans leads to disease progression.">
    <entity charOffset="38-43" id="s133.e0" ontology_id="5587" text="PrKD1" type="GENE"/>
    <entity charOffset="118-124" id="s133.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s133.e0" e2="s133.e1" id="s133.p0" relation="true"/>
  </sentence>
  <sentence id="s134" text="Somatic genetic rearrangements that juxtapose the PAX3 DNA binding domain to the transcriptional activation domain of other transcription factors deregulate PAX3 function and contribute to the pathogenesis of the soft tissue cancers alveolar rhabdomyosarcoma and biphenotypic sinonasal sarcoma.">
    <entity charOffset="50-54" id="s134.e0" ontology_id="5077" text="PAX3" type="GENE"/>
    <entity charOffset="242-258" id="s134.e1" ontology_id="HP_0002859" text="rhabdomyosarcoma" type="HP"/>
    <pair e1="s134.e0" e2="s134.e1" id="s134.p0" relation="false"/>
  </sentence>
  <sentence id="s135" text="Overexpression of Pmp22 in rodent models recapitulates several aspects of neuropathy, and reduction of Pmp22 in such models results in amelioration of the neuropathy phenotype.">
    <entity charOffset="18-23" id="s135.e0" ontology_id="5827" text="Pmp22" type="GENE"/>
    <entity charOffset="74-84" id="s135.e1" ontology_id="HP_0009830" text="neuropathy" type="HP"/>
    <pair e1="s135.e0" e2="s135.e1" id="s135.p0" relation="true"/>
  </sentence>
  <sentence id="s136" text="Mutations of the succinate dehydrogenase (SDH) complex subunits (A, B, C, D, and SDHAF2) have been implicated in predicting metastatic behavior and in identifying possible paraganglioma syndromes.">
    <entity charOffset="42-45" id="s136.e0" ontology_id="1757" text="SDH" type="GENE"/>
    <entity charOffset="172-185" id="s136.e1" ontology_id="HP_0002668" text="paraganglioma" type="HP"/>
    <pair e1="s136.e0" e2="s136.e1" id="s136.p0" relation="true"/>
  </sentence>
  <sentence id="s137" text="Genome-wide association studies have identified SNPs near ZNF365 at 10q21.2 that are associated with both breast cancer risk and mammographic density.">
    <entity charOffset="58-64" id="s137.e0" ontology_id="22891" text="ZNF365" type="GENE"/>
    <entity charOffset="113-119" id="s137.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s137.e0" e2="s137.e1" id="s137.p0" relation="true"/>
  </sentence>
  <sentence id="s138" text="Luciferase assays did not identify SNPs that affect transactivation of ZNF365, but identified a protective haplotype in iCHAV2, associated with silencing of the NRBF2 promoter, implicating this gene in the etiology of breast cancer.">
    <entity charOffset="71-77" id="s138.e0" ontology_id="22891" text="ZNF365" type="GENE"/>
    <entity charOffset="225-231" id="s138.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s138.e0" e2="s138.e1" id="s138.p0" relation="false"/>
  </sentence>
  <sentence id="s139" text="Glycine cleavage system (GCS) catalyzes the degradation of glycine and disruption of its components encoded by GLDC, AMT and GCSH are the only known causes of glycine encephalopathy, also known as non-ketotic hyperglycinemia (NKH).">
    <entity charOffset="111-115" id="s139.e0" ontology_id="2731" text="GLDC" type="GENE"/>
    <entity charOffset="209-224" id="s139.e1" ontology_id="HP_0002154" text="hyperglycinemia" type="HP"/>
    <pair e1="s139.e0" e2="s139.e1" id="s139.p0" relation="true"/>
  </sentence>
  <sentence id="s140" text="Different corneal dystrophies are caused by mutations in the CHST6, KRT3, KRT12, PIP5K3, SLC4A11, TACSTD2, TGFBI, and UBIAD1 genes.">
    <entity charOffset="10-29" id="s140.e0" ontology_id="HP_0001131" text="corneal dystrophies" type="HP"/>
    <entity charOffset="74-79" id="s140.e1" ontology_id="3859" text="KRT12" type="GENE"/>
    <pair e1="s140.e0" e2="s140.e1" id="s140.p0" relation="true"/>
  </sentence>
  <sentence id="s141" text="Different corneal dystrophies are caused by mutations in the CHST6, KRT3, KRT12, PIP5K3, SLC4A11, TACSTD2, TGFBI, and UBIAD1 genes.">
    <entity charOffset="10-29" id="s141.e0" ontology_id="HP_0001131" text="corneal dystrophies" type="HP"/>
    <entity charOffset="81-87" id="s141.e1" ontology_id="200576" text="PIP5K3" type="GENE"/>
    <pair e1="s141.e0" e2="s141.e1" id="s141.p0" relation="true"/>
  </sentence>
  <sentence id="s142" text="Different corneal dystrophies are caused by mutations in the CHST6, KRT3, KRT12, PIP5K3, SLC4A11, TACSTD2, TGFBI, and UBIAD1 genes.">
    <entity charOffset="10-29" id="s142.e0" ontology_id="HP_0001131" text="corneal dystrophies" type="HP"/>
    <entity charOffset="118-124" id="s142.e1" ontology_id="29914" text="UBIAD1" type="GENE"/>
    <pair e1="s142.e0" e2="s142.e1" id="s142.p0" relation="true"/>
  </sentence>
  <sentence id="s143" text="By using three human tumor cell lines of different tissue origin (epidermoid HEp-3 and prostate PC-3 carcinomas and HT-1080 fibrosarcoma) and several metastasis models conducted in both mammalian and avian settings, we show that LTBP3 is involved in the early dissemination of primary cancer cells, namely in the intravasation step of the metastatic cascade.">
    <entity charOffset="101-111" id="s143.e0" ontology_id="HP_0030731" text="carcinomas" type="HP"/>
    <entity charOffset="229-234" id="s143.e1" ontology_id="4054" text="LTBP3" type="GENE"/>
    <pair e1="s143.e0" e2="s143.e1" id="s143.p0" relation="false"/>
  </sentence>
  <sentence id="s144" text="By using three human tumor cell lines of different tissue origin (epidermoid HEp-3 and prostate PC-3 carcinomas and HT-1080 fibrosarcoma) and several metastasis models conducted in both mammalian and avian settings, we show that LTBP3 is involved in the early dissemination of primary cancer cells, namely in the intravasation step of the metastatic cascade.">
    <entity charOffset="229-234" id="s144.e0" ontology_id="4054" text="LTBP3" type="GENE"/>
    <entity charOffset="285-291" id="s144.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s144.e0" e2="s144.e1" id="s144.p0" relation="true"/>
  </sentence>
  <sentence id="s145" text="LTBP3 was dispensable in the late steps of carcinoma cell metastasis that follow tumor cell intravasation, including vascular arrest, extravasation, and tissue colonization.">
    <entity charOffset="0-5" id="s145.e0" ontology_id="4054" text="LTBP3" type="GENE"/>
    <entity charOffset="81-86" id="s145.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s145.e0" e2="s145.e1" id="s145.p0" relation="false"/>
  </sentence>
  <sentence id="s146" text="Knockdown of LTBP3 in all tested cell lines led to significant inhibition of tumor cell intravasation, but did not affect primary tumor growth.">
    <entity charOffset="13-18" id="s146.e0" ontology_id="4054" text="LTBP3" type="GENE"/>
    <entity charOffset="77-82" id="s146.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s146.e0" e2="s146.e1" id="s146.p0" relation="true"/>
  </sentence>
  <sentence id="s147" text="All tumors were positive for AE1-AE3, CK18, PAX 8, antimitochondrial antigen, and SDHB.">
    <entity charOffset="4-10" id="s147.e0" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <entity charOffset="29-32" id="s147.e1" ontology_id="6521" text="AE1" type="GENE"/>
    <pair e1="s147.e0" e2="s147.e1" id="s147.p0" relation="true"/>
  </sentence>
  <sentence id="s148" text="All tumors were positive for AE1-AE3, CK18, PAX 8, antimitochondrial antigen, and SDHB.">
    <entity charOffset="4-10" id="s148.e0" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <entity charOffset="33-36" id="s148.e1" ontology_id="6508" text="AE3" type="GENE"/>
    <pair e1="s148.e0" e2="s148.e1" id="s148.p0" relation="true"/>
  </sentence>
  <sentence id="s149" text="HOT should be considered as an emerging renal entity because it does not meet the diagnostic criteria for other recognized eosinophilic renal tumors, such as oncocytoma, chromophobe renal cell carcinoma (RCC), TFE3 and TFEB RCC, SDH-deficient RCC, and eosinophilic solid and cystic RCC">
    <entity charOffset="142-148" id="s149.e0" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <entity charOffset="219-223" id="s149.e1" ontology_id="7942" text="TFEB" type="GENE"/>
    <pair e1="s149.e0" e2="s149.e1" id="s149.p0" relation="true"/>
  </sentence>
  <sentence id="s150" text="HOT should be considered as an emerging renal entity because it does not meet the diagnostic criteria for other recognized eosinophilic renal tumors, such as oncocytoma, chromophobe renal cell carcinoma (RCC), TFE3 and TFEB RCC, SDH-deficient RCC, and eosinophilic solid and cystic RCC">
    <entity charOffset="182-202" id="s150.e0" ontology_id="HP_0005584" text="renal cell carcinoma" type="HP"/>
    <entity charOffset="229-232" id="s150.e1" ontology_id="1757" text="SDH" type="GENE"/>
    <pair e1="s150.e0" e2="s150.e1" id="s150.p0" relation="false"/>
  </sentence>
  <sentence id="s151" text="HOT should be considered as an emerging renal entity because it does not meet the diagnostic criteria for other recognized eosinophilic renal tumors, such as oncocytoma, chromophobe renal cell carcinoma (RCC), TFE3 and TFEB RCC, SDH-deficient RCC, and eosinophilic solid and cystic RCC">
    <entity charOffset="182-202" id="s151.e0" ontology_id="HP_0005584" text="renal cell carcinoma" type="HP"/>
    <entity charOffset="210-214" id="s151.e1" ontology_id="7030" text="TFE3" type="GENE"/>
    <pair e1="s151.e0" e2="s151.e1" id="s151.p0" relation="false"/>
  </sentence>
  <sentence id="s152" text="HOT should be considered as an emerging renal entity because it does not meet the diagnostic criteria for other recognized eosinophilic renal tumors, such as oncocytoma, chromophobe renal cell carcinoma (RCC), TFE3 and TFEB RCC, SDH-deficient RCC, and eosinophilic solid and cystic RCC">
    <entity charOffset="182-202" id="s152.e0" ontology_id="HP_0005584" text="renal cell carcinoma" type="HP"/>
    <entity charOffset="219-223" id="s152.e1" ontology_id="7942" text="TFEB" type="GENE"/>
    <pair e1="s152.e0" e2="s152.e1" id="s152.p0" relation="false"/>
  </sentence>
  <sentence id="s153" text="Altogether, our data strongly suggest that mutations in CEP78 cause a previously undescribed clinical entity of a ciliary nature characterized by blindness and deafness but clearly distinct from Usher syndrome, a condition for which visual impairment is due to retinitis pigmentosa.">
    <entity charOffset="56-61" id="s153.e0" ontology_id="84131" text="CEP78" type="GENE"/>
    <entity charOffset="146-155" id="s153.e1" ontology_id="HP_0000618" text="blindness" type="HP"/>
    <pair e1="s153.e0" e2="s153.e1" id="s153.p0" relation="true"/>
  </sentence>
  <sentence id="s154" text="Altogether, our data strongly suggest that mutations in CEP78 cause a previously undescribed clinical entity of a ciliary nature characterized by blindness and deafness but clearly distinct from Usher syndrome, a condition for which visual impairment is due to retinitis pigmentosa.">
    <entity charOffset="56-61" id="s154.e0" ontology_id="84131" text="CEP78" type="GENE"/>
    <entity charOffset="160-168" id="s154.e1" ontology_id="HP_0000365" text="deafness" type="HP"/>
    <pair e1="s154.e0" e2="s154.e1" id="s154.p0" relation="true"/>
  </sentence>
  <sentence id="s155" text="Our most significant AM association was upstream of RSF1, a gene implicated in ovarian and breast cancers (rs11604207, p=1.610).">
    <entity charOffset="52-56" id="s155.e0" ontology_id="51773" text="RSF1" type="GENE"/>
    <entity charOffset="98-104" id="s155.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s155.e0" e2="s155.e1" id="s155.p0" relation="true"/>
  </sentence>
  <sentence id="s156" text="Accordingly, overexpression of the A mutants in EC cells harboring wild-type PPP2R1A increased anchorage-independent growth and tumor formation, and triggered hyperphosphorylation of oncogenic PP2A-B56/B' substrates in the GSK3, Akt, and mTOR/p70S6K signaling pathways.">
    <entity charOffset="129-134" id="s156.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="231-234" id="s156.e1" ontology_id="207" text="Akt" type="GENE"/>
    <pair e1="s156.e0" e2="s156.e1" id="s156.p0" relation="false"/>
  </sentence>
  <sentence id="s157" text="By pooling genetic findings across multiple studies, we have identified six individuals with severe developmental delay (6/6), refractory seizures (5/6), and similar dysmorphic features (3/6), each harboring a de novo mutation in PPP3CA.">
    <entity charOffset="138-146" id="s157.e0" ontology_id="HP_0001250" text="seizures" type="HP"/>
    <entity charOffset="230-236" id="s157.e1" ontology_id="5530" text="PPP3CA" type="GENE"/>
    <pair e1="s157.e0" e2="s157.e1" id="s157.p0" relation="true"/>
  </sentence>
  <sentence id="s158" text="Several gene encoding proteins related to collagen metabolism have been described in some cases of autosomal recessive OI (including CRTAP, LEPRE1, PPIB, FKBP65, SERPINF1, BMP1, WNT1, FKBP10).">
    <entity charOffset="99-118" id="s158.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="178-182" id="s158.e1" ontology_id="7471" text="WNT1" type="GENE"/>
    <pair e1="s158.e0" e2="s158.e1" id="s158.p0" relation="true"/>
  </sentence>
  <sentence id="s159" text="Several gene encoding proteins related to collagen metabolism have been described in some cases of autosomal recessive OI (including CRTAP, LEPRE1, PPIB, FKBP65, SERPINF1, BMP1, WNT1, FKBP10).">
    <entity charOffset="99-118" id="s159.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="184-190" id="s159.e1" ontology_id="60681" text="FKBP10" type="GENE"/>
    <pair e1="s159.e0" e2="s159.e1" id="s159.p0" relation="true"/>
  </sentence>
  <sentence id="s160" text="Several gene encoding proteins related to collagen metabolism have been described in some cases of autosomal recessive OI (including CRTAP, LEPRE1, PPIB, FKBP65, SERPINF1, BMP1, WNT1, FKBP10).">
    <entity charOffset="99-118" id="s160.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="162-170" id="s160.e1" ontology_id="5176" text="SERPINF1" type="GENE"/>
    <pair e1="s160.e0" e2="s160.e1" id="s160.p0" relation="true"/>
  </sentence>
  <sentence id="s161" text="Recently, TMEM38B, a gene that encodes TRIC-B, a monovalent cation-specific channel involved in calcium flux from intracellular stores and in cell differentiation, has been associated with autosomal recessive OI.">
    <entity charOffset="10-17" id="s161.e0" ontology_id="55151" text="TMEM38B" type="GENE"/>
    <entity charOffset="189-208" id="s161.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s161.e0" e2="s161.e1" id="s161.p0" relation="true"/>
  </sentence>
  <sentence id="s162" text="Mutations in the mitochondrial alanyl-transfer (t)RNA synthetase 2 (AARS2; OMIM 612035) have been linked to leukoencephalopathy recently.">
    <entity charOffset="68-73" id="s162.e0" ontology_id="57505" text="AARS2" type="GENE"/>
    <entity charOffset="108-127" id="s162.e1" ontology_id="HP_0002352" text="leukoencephalopathy" type="HP"/>
    <pair e1="s162.e0" e2="s162.e1" id="s162.p0" relation="true"/>
  </sentence>
  <sentence id="s163" text="We report a case with novel AARS2 gene mutations with developed striking cerebellar atrophy and leukoencephalopathy, which helps to further understand the clinical and genetic heterogeneity of AARS2-L">
    <entity charOffset="28-33" id="s163.e0" ontology_id="57505" text="AARS2" type="GENE"/>
    <entity charOffset="176-189" id="s163.e1" ontology_id="HP_0001425" text="heterogeneity" type="HP"/>
    <pair e1="s163.e0" e2="s163.e1" id="s163.p0" relation="false"/>
  </sentence>
  <sentence id="s164" text="Here we report a patient with a congenital syndrome consisting of severe global developmental delay, microcephaly, heart defects, failure to thrive and liver disease with a previously unreported homozygous NM_015352.1: c.485C&amp;gt;T variant (p.Ser162Leu) in POFUT1 detected by exome sequencing.">
    <entity charOffset="130-147" id="s164.e0" ontology_id="HP_0001508" text="failure to thrive" type="HP"/>
    <entity charOffset="256-262" id="s164.e1" ontology_id="23509" text="POFUT1" type="GENE"/>
    <pair e1="s164.e0" e2="s164.e1" id="s164.p0" relation="true"/>
  </sentence>
  <sentence id="s165" text="OBJECTIVES We hypothesised that p16 ink4a methylation might have a role in cancer development driven by HPV16, mainly in the presence of intact E1/E2 genes.">
    <entity charOffset="36-41" id="s165.e0" ontology_id="1029" text="ink4a" type="GENE"/>
    <entity charOffset="75-81" id="s165.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s165.e0" e2="s165.e1" id="s165.p0" relation="true"/>
  </sentence>
  <sentence id="s166" text="BACKGROUND Epigenetic modifications in host cells, like p16 ink4a methylation, have been considered as putative complementary mechanisms for cancer development.">
    <entity charOffset="60-65" id="s166.e0" ontology_id="1029" text="ink4a" type="GENE"/>
    <entity charOffset="141-147" id="s166.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s166.e0" e2="s166.e1" id="s166.p0" relation="true"/>
  </sentence>
  <sentence id="s167" text="Antiepileptic drugs remain the treatment of choice for PKD and episodic ataxia type 1, benzodiazepines are often useful for PNKD, and episodic ataxia type 2 benefits from acetazolamide regardless of the genetic etiology">
    <entity charOffset="72-78" id="s167.e0" ontology_id="HP_0001251" text="ataxia" type="HP"/>
    <entity charOffset="124-128" id="s167.e1" ontology_id="25953" text="PNKD" type="GENE"/>
    <pair e1="s167.e0" e2="s167.e1" id="s167.p0" relation="false"/>
  </sentence>
  <sentence id="s168" text="Chemical inhibition of epigenetic regulatory proteins BrdT and Brd4 is emerging as a promising therapeutic strategy in contraception, cancer, and heart disease.">
    <entity charOffset="63-67" id="s168.e0" ontology_id="23476" text="Brd4" type="GENE"/>
    <entity charOffset="134-140" id="s168.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s168.e0" e2="s168.e1" id="s168.p0" relation="true"/>
  </sentence>
  <sentence id="s169" text="However, all experimental models of electrolytic deep vein thrombosis, tissue factor-induced pulmonary embolism, transient focal brain ischaemic stroke, or skin-wound healing showed largely similar phenotypes between PlgT/T mice and wild-type mice.">
    <entity charOffset="49-69" id="s169.e0" ontology_id="HP_0002625" text="deep vein thrombosis" type="HP"/>
    <entity charOffset="217-220" id="s169.e1" ontology_id="5340" text="Plg" type="GENE"/>
    <pair e1="s169.e0" e2="s169.e1" id="s169.p0" relation="true"/>
  </sentence>
  <sentence id="s170" text="DNA was extracted from paraffin-embedded tumor specimens from the patients and peripheral blood lymphocytes from the controls and used for LMP2/LMP7 genotyping.">
    <entity charOffset="41-46" id="s170.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="139-143" id="s170.e1" ontology_id="5698" text="LMP2" type="GENE"/>
    <pair e1="s170.e0" e2="s170.e1" id="s170.p0" relation="false"/>
  </sentence>
  <sentence id="s171" text="DNA was extracted from paraffin-embedded tumor specimens from the patients and peripheral blood lymphocytes from the controls and used for LMP2/LMP7 genotyping.">
    <entity charOffset="41-46" id="s171.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="144-148" id="s171.e1" ontology_id="5696" text="LMP7" type="GENE"/>
    <pair e1="s171.e0" e2="s171.e1" id="s171.p0" relation="false"/>
  </sentence>
  <sentence id="s172" text="Cervical cancer patients with genotypes GA/AA in WWOX SNP rs12918952 were associated with parametrium invasion and pelvic lymph node metastasis.">
    <entity charOffset="9-15" id="s172.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="49-53" id="s172.e1" ontology_id="51741" text="WWOX" type="GENE"/>
    <pair e1="s172.e0" e2="s172.e1" id="s172.p0" relation="true"/>
  </sentence>
  <sentence id="s173" text="Whole-genome sequencing documented two rare truncating variants in DOCK6, a gene associated with a type of autosomal recessive AOS that recurrently features periventricular calcification and impaired neurodevelopment.">
    <entity charOffset="67-72" id="s173.e0" ontology_id="57572" text="DOCK6" type="GENE"/>
    <entity charOffset="107-126" id="s173.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s173.e0" e2="s173.e1" id="s173.p0" relation="true"/>
  </sentence>
  <sentence id="s174" text="Our findings establish that defective TBCD function underlies a recognizable encephalopathy and drives accelerated microtubule polymerization and enhanced microtubule stability, underscoring an additional cause of altered microtubule dynamics with impact on neuronal function and survival in the developing brain">
    <entity charOffset="38-42" id="s174.e0" ontology_id="6904" text="TBCD" type="GENE"/>
    <entity charOffset="77-91" id="s174.e1" ontology_id="HP_0001298" text="encephalopathy" type="HP"/>
    <pair e1="s174.e0" e2="s174.e1" id="s174.p0" relation="true"/>
  </sentence>
  <sentence id="s175" text="To understand the importance of chr11q22.3-23.2 region in the development of cervical cancer, we have studied the genetic and epigenetic alterations of the candidate genes ATM, PPP2R1B, SDHD and CADM1 in cervical intraepithelial neoplasia (CIN) and cervical carcinoma (CACX) samples.">
    <entity charOffset="86-92" id="s175.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="186-190" id="s175.e1" ontology_id="6392" text="SDHD" type="GENE"/>
    <pair e1="s175.e0" e2="s175.e1" id="s175.p0" relation="true"/>
  </sentence>
  <sentence id="s176" text="To understand the importance of chr11q22.3-23.2 region in the development of cervical cancer, we have studied the genetic and epigenetic alterations of the candidate genes ATM, PPP2R1B, SDHD and CADM1 in cervical intraepithelial neoplasia (CIN) and cervical carcinoma (CACX) samples.">
    <entity charOffset="172-175" id="s176.e0" ontology_id="472" text="ATM" type="GENE"/>
    <entity charOffset="229-238" id="s176.e1" ontology_id="HP_0002664" text="neoplasia" type="HP"/>
    <pair e1="s176.e0" e2="s176.e1" id="s176.p0" relation="true"/>
  </sentence>
  <sentence id="s177" text="To understand the importance of chr11q22.3-23.2 region in the development of cervical cancer, we have studied the genetic and epigenetic alterations of the candidate genes ATM, PPP2R1B, SDHD and CADM1 in cervical intraepithelial neoplasia (CIN) and cervical carcinoma (CACX) samples.">
    <entity charOffset="177-184" id="s177.e0" ontology_id="5519" text="PPP2R1B" type="GENE"/>
    <entity charOffset="229-238" id="s177.e1" ontology_id="HP_0002664" text="neoplasia" type="HP"/>
    <pair e1="s177.e0" e2="s177.e1" id="s177.p0" relation="true"/>
  </sentence>
  <sentence id="s178" text="To understand the importance of chr11q22.3-23.2 region in the development of cervical cancer, we have studied the genetic and epigenetic alterations of the candidate genes ATM, PPP2R1B, SDHD and CADM1 in cervical intraepithelial neoplasia (CIN) and cervical carcinoma (CACX) samples.">
    <entity charOffset="195-200" id="s178.e0" ontology_id="23705" text="CADM1" type="GENE"/>
    <entity charOffset="229-238" id="s178.e1" ontology_id="HP_0002664" text="neoplasia" type="HP"/>
    <pair e1="s178.e0" e2="s178.e1" id="s178.p0" relation="true"/>
  </sentence>
  <sentence id="s179" text="The alterations of ATM and CADM1 are associated with the progression of tumor from CIN to Stage I/II, thus implying their role in early invasiveness.">
    <entity charOffset="27-32" id="s179.e0" ontology_id="23705" text="CADM1" type="GENE"/>
    <entity charOffset="72-77" id="s179.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s179.e0" e2="s179.e1" id="s179.p0" relation="true"/>
  </sentence>
  <sentence id="s180" text="PINK1, a mitochondrial serine/threonine kinase, is the product of a gene mutated in an autosomal recessive form of Parkinson disease.">
    <entity charOffset="0-5" id="s180.e0" ontology_id="65018" text="PINK1" type="GENE"/>
    <entity charOffset="87-106" id="s180.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s180.e0" e2="s180.e1" id="s180.p0" relation="true"/>
  </sentence>
  <sentence id="s181" text="Transcriptomic analysis revealed significant alterations in a number of genes associated with autism, such as adsl, mbd5, shank3, and tsc1b.">
    <entity charOffset="94-100" id="s181.e0" ontology_id="HP_0000717" text="autism" type="HP"/>
    <entity charOffset="122-128" id="s181.e1" ontology_id="85358" text="shank3" type="GENE"/>
    <pair e1="s181.e0" e2="s181.e1" id="s181.p0" relation="true"/>
  </sentence>
  <sentence id="s182" text="Conversely, Th17 cells and their effector molecules interleukin 17A (IL-17A), IL-17F, interferon (IFN), tumor necrosis factor (TNF), and granulocyte-macrophage colony-stimulating factor (GM-CSF) are implicated in the pathology of rheumatoid arthritis (RA).">
    <entity charOffset="98-101" id="s182.e0" ontology_id="3439" text="IFN" type="GENE"/>
    <entity charOffset="105-110" id="s182.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s182.e0" e2="s182.e1" id="s182.p0" relation="true"/>
  </sentence>
  <sentence id="s183" text="Our data suggest that mutations of the SRD5A2 gene are the main causes of posterior hypospadias and seem to affect the semen quality of adult patients, whereas mutations in AR and HSD17B3 gene were rare in these hypospadias patients.">
    <entity charOffset="39-45" id="s183.e0" ontology_id="6716" text="SRD5A2" type="GENE"/>
    <entity charOffset="84-95" id="s183.e1" ontology_id="HP_0000047" text="hypospadias" type="HP"/>
    <pair e1="s183.e0" e2="s183.e1" id="s183.p0" relation="true"/>
  </sentence>
  <sentence id="s184" text="Our data suggest that mutations of the SRD5A2 gene are the main causes of posterior hypospadias and seem to affect the semen quality of adult patients, whereas mutations in AR and HSD17B3 gene were rare in these hypospadias patients.">
    <entity charOffset="84-95" id="s184.e0" ontology_id="HP_0000047" text="hypospadias" type="HP"/>
    <entity charOffset="180-187" id="s184.e1" ontology_id="3293" text="HSD17B3" type="GENE"/>
    <pair e1="s184.e0" e2="s184.e1" id="s184.p0" relation="false"/>
  </sentence>
  <sentence id="s185" text="Recently, it has been demonstrated that, mutations of LRTOMT are associated with profound nonsyndromic hearing impairment at the DFNB63 locus.">
    <entity charOffset="54-60" id="s185.e0" ontology_id="220074" text="LRTOMT" type="GENE"/>
    <entity charOffset="81-89" id="s185.e1" ontology_id="HP_0012829" text="profound" type="HP"/>
    <pair e1="s185.e0" e2="s185.e1" id="s185.p0" relation="false"/>
  </sentence>
  <sentence id="s186" text="Recently, it has been demonstrated that, mutations of LRTOMT are associated with profound nonsyndromic hearing impairment at the DFNB63 locus.">
    <entity charOffset="103-121" id="s186.e0" ontology_id="HP_0000365" text="hearing impairment" type="HP"/>
    <entity charOffset="129-135" id="s186.e1" ontology_id="220074" text="DFNB63" type="GENE"/>
    <pair e1="s186.e0" e2="s186.e1" id="s186.p0" relation="false"/>
  </sentence>
  <sentence id="s187" text="A third proband was doubly heterozygous for inherited rare variants in additional components of complex I, NDUFAF2 and NDUFB9, confirming that Histiocytoid CM is genetically heterogeneous.">
    <entity charOffset="107-114" id="s187.e0" ontology_id="91942" text="NDUFAF2" type="GENE"/>
    <entity charOffset="174-187" id="s187.e1" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <pair e1="s187.e0" e2="s187.e1" id="s187.p0" relation="false"/>
  </sentence>
  <sentence id="s188" text="A third proband was doubly heterozygous for inherited rare variants in additional components of complex I, NDUFAF2 and NDUFB9, confirming that Histiocytoid CM is genetically heterogeneous.">
    <entity charOffset="119-125" id="s188.e0" ontology_id="4715" text="NDUFB9" type="GENE"/>
    <entity charOffset="174-187" id="s188.e1" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <pair e1="s188.e0" e2="s188.e1" id="s188.p0" relation="false"/>
  </sentence>
  <sentence id="s189" text="Today, more than a dozen human CaM missense mutations have been described, all found in patients with severe cardiac arrhythmias.">
    <entity charOffset="31-34" id="s189.e0" ontology_id="889" text="CaM" type="GENE"/>
    <entity charOffset="109-128" id="s189.e1" ontology_id="HP_0011675" text="cardiac arrhythmias" type="HP"/>
    <pair e1="s189.e0" e2="s189.e1" id="s189.p0" relation="true"/>
  </sentence>
  <sentence id="s190" text="Hypomorphic IKBKG mutations in males are typically associated with anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID).">
    <entity charOffset="12-17" id="s190.e0" ontology_id="8517" text="IKBKG" type="GENE"/>
    <entity charOffset="78-98" id="s190.e1" ontology_id="HP_0000968" text="ectodermal dysplasia" type="HP"/>
    <pair e1="s190.e0" e2="s190.e1" id="s190.p0" relation="true"/>
  </sentence>
  <sentence id="s191" text="As rare polymorphisms have been described in IKBKG and polygenic inheritance remains an option in the presented case, this study emphasizes the need for thorough functional and genetic evaluation when encountering and interpreting suspected disease-causing NEMO-ID variants">
    <entity charOffset="55-76" id="s191.e0" ontology_id="HP_0010982" text="polygenic inheritance" type="HP"/>
    <entity charOffset="257-261" id="s191.e1" ontology_id="8517" text="NEMO" type="GENE"/>
    <pair e1="s191.e0" e2="s191.e1" id="s191.p0" relation="false"/>
  </sentence>
  <sentence id="s192" text="Monogenic hypertriglyceridemia is the result of mutations in genes that regulate the metabolism of triglyceride rich lipoproteins (eg LPL, APOC2, APOA5, LMF1, GPIHBP1).">
    <entity charOffset="10-30" id="s192.e0" ontology_id="HP_0002155" text="hypertriglyceridemia" type="HP"/>
    <entity charOffset="159-166" id="s192.e1" ontology_id="338328" text="GPIHBP1" type="GENE"/>
    <pair e1="s192.e0" e2="s192.e1" id="s192.p0" relation="true"/>
  </sentence>
  <sentence id="s193" text="Monogenic hypertriglyceridemia is the result of mutations in genes that regulate the metabolism of triglyceride rich lipoproteins (eg LPL, APOC2, APOA5, LMF1, GPIHBP1).">
    <entity charOffset="10-30" id="s193.e0" ontology_id="HP_0002155" text="hypertriglyceridemia" type="HP"/>
    <entity charOffset="134-137" id="s193.e1" ontology_id="4023" text="LPL" type="GENE"/>
    <pair e1="s193.e0" e2="s193.e1" id="s193.p0" relation="true"/>
  </sentence>
  <sentence id="s194" text="Monogenic hypertriglyceridemia is the result of mutations in genes that regulate the metabolism of triglyceride rich lipoproteins (eg LPL, APOC2, APOA5, LMF1, GPIHBP1).">
    <entity charOffset="10-30" id="s194.e0" ontology_id="HP_0002155" text="hypertriglyceridemia" type="HP"/>
    <entity charOffset="146-151" id="s194.e1" ontology_id="116519" text="APOA5" type="GENE"/>
    <pair e1="s194.e0" e2="s194.e1" id="s194.p0" relation="true"/>
  </sentence>
  <sentence id="s195" text="Monogenic hypertriglyceridemia is the result of mutations in genes that regulate the metabolism of triglyceride rich lipoproteins (eg LPL, APOC2, APOA5, LMF1, GPIHBP1).">
    <entity charOffset="10-30" id="s195.e0" ontology_id="HP_0002155" text="hypertriglyceridemia" type="HP"/>
    <entity charOffset="153-157" id="s195.e1" ontology_id="64788" text="LMF1" type="GENE"/>
    <pair e1="s195.e0" e2="s195.e1" id="s195.p0" relation="true"/>
  </sentence>
  <sentence id="s196" text="Consistent with this pattern of activity, polr1c and polr1d homozygous mutant zebrafish exhibit cartilage hypoplasia and cranioskeletal anomalies characteristic of humans with Treacher Collins syndrome.">
    <entity charOffset="53-59" id="s196.e0" ontology_id="51082" text="polr1d" type="GENE"/>
    <entity charOffset="127-145" id="s196.e1" ontology_id="HP_0000924" text="skeletal anomalies" type="HP"/>
    <pair e1="s196.e0" e2="s196.e1" id="s196.p0" relation="true"/>
  </sentence>
  <sentence id="s197" text="Somewhat arbitrarily, three disorders were successively put forward as the underlying cause of HIES: autosomal dominant (AD) STAT3 deficiency, the only disorder corresponding to the original definition of HIES, and autosomal recessive (AR) DOCK8 and PGM3 deficiencies, in which atopy and high serum IgE levels occur in a context of manifestations not seen in patients with typical HIES.">
    <entity charOffset="125-130" id="s197.e0" ontology_id="6774" text="STAT3" type="GENE"/>
    <entity charOffset="215-234" id="s197.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s197.e0" e2="s197.e1" id="s197.p0" relation="false"/>
  </sentence>
  <sentence id="s198" text="In this report, we describe a patient with a phenotype compatible with MOTA syndrome (aberrant anterior hair line, hypertelorism, unilateral anophthalmia, and bifid and broad nasal tip) in whom two novel FREM1 mutations (c.305A&amp;gt;G, p.Asp102Gly; and c.2626delG, p.Val876Tyrfs*16) were identified in the compound heterozygous state, thus broadening the mutational spectrum of the disease.">
    <entity charOffset="130-140" id="s198.e0" ontology_id="HP_0012833" text="unilateral" type="HP"/>
    <entity charOffset="204-209" id="s198.e1" ontology_id="158326" text="FREM1" type="GENE"/>
    <pair e1="s198.e0" e2="s198.e1" id="s198.p0" relation="true"/>
  </sentence>
  <sentence id="s199" text="We examined the diagnostic and prognostic value of altered reticulin framework and the immunoprofile of biomarkers including IGF-2, proteins involved in cell proliferation and mitotic spindle regulation (Ki67, p53, BUB1B, HURP, NEK2), DNA damage repair (PBK, -H2AX), telomere regulation (DAX, ATRX), wnt-signaling pathway (beta-catenin) and PI3K signaling pathway (PTEN, phospho-mTOR) in a tissue microarray of 50 adenomas and 43 carcinomas that were characterized for angioinvasion as defined by strict criteria, Weiss score, and mitotic rate-based tumor grade.">
    <entity charOffset="215-220" id="s199.e0" ontology_id="701" text="BUB1B" type="GENE"/>
    <entity charOffset="431-441" id="s199.e1" ontology_id="HP_0030731" text="carcinomas" type="HP"/>
    <pair e1="s199.e0" e2="s199.e1" id="s199.p0" relation="true"/>
  </sentence>
  <sentence id="s200" text="We examined the diagnostic and prognostic value of altered reticulin framework and the immunoprofile of biomarkers including IGF-2, proteins involved in cell proliferation and mitotic spindle regulation (Ki67, p53, BUB1B, HURP, NEK2), DNA damage repair (PBK, -H2AX), telomere regulation (DAX, ATRX), wnt-signaling pathway (beta-catenin) and PI3K signaling pathway (PTEN, phospho-mTOR) in a tissue microarray of 50 adenomas and 43 carcinomas that were characterized for angioinvasion as defined by strict criteria, Weiss score, and mitotic rate-based tumor grade.">
    <entity charOffset="228-232" id="s200.e0" ontology_id="4751" text="NEK2" type="GENE"/>
    <entity charOffset="431-441" id="s200.e1" ontology_id="HP_0030731" text="carcinomas" type="HP"/>
    <pair e1="s200.e0" e2="s200.e1" id="s200.p0" relation="true"/>
  </sentence>
  <sentence id="s201" text="We examined the diagnostic and prognostic value of altered reticulin framework and the immunoprofile of biomarkers including IGF-2, proteins involved in cell proliferation and mitotic spindle regulation (Ki67, p53, BUB1B, HURP, NEK2), DNA damage repair (PBK, -H2AX), telomere regulation (DAX, ATRX), wnt-signaling pathway (beta-catenin) and PI3K signaling pathway (PTEN, phospho-mTOR) in a tissue microarray of 50 adenomas and 43 carcinomas that were characterized for angioinvasion as defined by strict criteria, Weiss score, and mitotic rate-based tumor grade.">
    <entity charOffset="254-257" id="s201.e0" ontology_id="55872" text="PBK" type="GENE"/>
    <entity charOffset="431-441" id="s201.e1" ontology_id="HP_0030731" text="carcinomas" type="HP"/>
    <pair e1="s201.e0" e2="s201.e1" id="s201.p0" relation="true"/>
  </sentence>
  <sentence id="s202" text="We examined the diagnostic and prognostic value of altered reticulin framework and the immunoprofile of biomarkers including IGF-2, proteins involved in cell proliferation and mitotic spindle regulation (Ki67, p53, BUB1B, HURP, NEK2), DNA damage repair (PBK, -H2AX), telomere regulation (DAX, ATRX), wnt-signaling pathway (beta-catenin) and PI3K signaling pathway (PTEN, phospho-mTOR) in a tissue microarray of 50 adenomas and 43 carcinomas that were characterized for angioinvasion as defined by strict criteria, Weiss score, and mitotic rate-based tumor grade.">
    <entity charOffset="324-336" id="s202.e0" ontology_id="1499" text="beta-catenin" type="GENE"/>
    <entity charOffset="431-441" id="s202.e1" ontology_id="HP_0030731" text="carcinomas" type="HP"/>
    <pair e1="s202.e0" e2="s202.e1" id="s202.p0" relation="true"/>
  </sentence>
  <sentence id="s203" text="We examined the diagnostic and prognostic value of altered reticulin framework and the immunoprofile of biomarkers including IGF-2, proteins involved in cell proliferation and mitotic spindle regulation (Ki67, p53, BUB1B, HURP, NEK2), DNA damage repair (PBK, -H2AX), telomere regulation (DAX, ATRX), wnt-signaling pathway (beta-catenin) and PI3K signaling pathway (PTEN, phospho-mTOR) in a tissue microarray of 50 adenomas and 43 carcinomas that were characterized for angioinvasion as defined by strict criteria, Weiss score, and mitotic rate-based tumor grade.">
    <entity charOffset="366-370" id="s203.e0" ontology_id="5728" text="PTEN" type="GENE"/>
    <entity charOffset="551-556" id="s203.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s203.e0" e2="s203.e1" id="s203.p0" relation="false"/>
  </sentence>
  <sentence id="s204" text="We examined the diagnostic and prognostic value of altered reticulin framework and the immunoprofile of biomarkers including IGF-2, proteins involved in cell proliferation and mitotic spindle regulation (Ki67, p53, BUB1B, HURP, NEK2), DNA damage repair (PBK, -H2AX), telomere regulation (DAX, ATRX), wnt-signaling pathway (beta-catenin) and PI3K signaling pathway (PTEN, phospho-mTOR) in a tissue microarray of 50 adenomas and 43 carcinomas that were characterized for angioinvasion as defined by strict criteria, Weiss score, and mitotic rate-based tumor grade.">
    <entity charOffset="366-370" id="s204.e0" ontology_id="5728" text="PTEN" type="GENE"/>
    <entity charOffset="431-441" id="s204.e1" ontology_id="HP_0030731" text="carcinomas" type="HP"/>
    <pair e1="s204.e0" e2="s204.e1" id="s204.p0" relation="true"/>
  </sentence>
  <sentence id="s205" text="We examined the diagnostic and prognostic value of altered reticulin framework and the immunoprofile of biomarkers including IGF-2, proteins involved in cell proliferation and mitotic spindle regulation (Ki67, p53, BUB1B, HURP, NEK2), DNA damage repair (PBK, -H2AX), telomere regulation (DAX, ATRX), wnt-signaling pathway (beta-catenin) and PI3K signaling pathway (PTEN, phospho-mTOR) in a tissue microarray of 50 adenomas and 43 carcinomas that were characterized for angioinvasion as defined by strict criteria, Weiss score, and mitotic rate-based tumor grade.">
    <entity charOffset="380-384" id="s205.e0" ontology_id="2475" text="mTOR" type="GENE"/>
    <entity charOffset="551-556" id="s205.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s205.e0" e2="s205.e1" id="s205.p0" relation="true"/>
  </sentence>
  <sentence id="s206" text="IGF-2 and proteins involved in cell proliferation and mitotic spindle regulation (Ki67, p53, BUB1B, HURP, NEK2), DNA damage proteins (PBK, -H2AX), regulators of telomeres (DAXX, ATRX), and beta-catenin revealed characteristic expression profiles enabling the distinction of carcinomas from adenomas.">
    <entity charOffset="93-98" id="s206.e0" ontology_id="701" text="BUB1B" type="GENE"/>
    <entity charOffset="275-285" id="s206.e1" ontology_id="HP_0030731" text="carcinomas" type="HP"/>
    <pair e1="s206.e0" e2="s206.e1" id="s206.p0" relation="true"/>
  </sentence>
  <sentence id="s207" text="IGF-2 and proteins involved in cell proliferation and mitotic spindle regulation (Ki67, p53, BUB1B, HURP, NEK2), DNA damage proteins (PBK, -H2AX), regulators of telomeres (DAXX, ATRX), and beta-catenin revealed characteristic expression profiles enabling the distinction of carcinomas from adenomas.">
    <entity charOffset="179-183" id="s207.e0" ontology_id="546" text="ATRX" type="GENE"/>
    <entity charOffset="275-285" id="s207.e1" ontology_id="HP_0030731" text="carcinomas" type="HP"/>
    <pair e1="s207.e0" e2="s207.e1" id="s207.p0" relation="true"/>
  </sentence>
  <sentence id="s208" text="Mutations in ST3GAL5, which codes for an enzyme early in brain ganglioside biosynthesis, result in an early-onset seizure disorder with profound motor and cognitive decay, whereas mutations in B4GALNT1, a gene encoding a later step, result in hereditary spastic paraplegia accompanied by intellectual deficits.">
    <entity charOffset="13-20" id="s208.e0" ontology_id="8869" text="ST3GAL5" type="GENE"/>
    <entity charOffset="114-121" id="s208.e1" ontology_id="HP_0001250" text="seizure" type="HP"/>
    <pair e1="s208.e0" e2="s208.e1" id="s208.p0" relation="true"/>
  </sentence>
  <sentence id="s209" text="Possible candidate genes in 6q14 for intellectual disability might be FILIP1, MYO6, HTR1B, and SNX14">
    <entity charOffset="37-60" id="s209.e0" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <entity charOffset="78-82" id="s209.e1" ontology_id="4646" text="MYO6" type="GENE"/>
    <pair e1="s209.e0" e2="s209.e1" id="s209.p0" relation="true"/>
  </sentence>
  <sentence id="s210" text="CHIP plays a protective role in mouse models of neurodegenerative disease, and in humans, mutations in CHIP cause spinocerebellar ataxia autosomal recessive type 16 (SCAR16), a fatal neurodegenerative disease characterized by truncal and limb ataxia that results in gait instability.">
    <entity charOffset="0-4" id="s210.e0" ontology_id="10273" text="CHIP" type="GENE"/>
    <entity charOffset="137-156" id="s210.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s210.e0" e2="s210.e1" id="s210.p0" relation="false"/>
  </sentence>
  <sentence id="s211" text="TNF-related apoptosis-inducing ligand (TRAIL) was initially described to induce apoptosis of tumor cells and/or virally infected cells, although sparing normal cells, and has been implicated in the pathogenesis of HIV disease.">
    <entity charOffset="39-44" id="s211.e0" ontology_id="8743" text="TRAIL" type="GENE"/>
    <entity charOffset="93-98" id="s211.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s211.e0" e2="s211.e1" id="s211.p0" relation="true"/>
  </sentence>
  <sentence id="s212" text="In the present study, we evaluated the association of SENPs polymorphism with susceptibility as well as clinicopathologic features and patients' response of breast cancer (BC) in a Chinese population.We genotyped SENP1 (rs61918808), SENP2 (rs6762208), SENP7 (rs61697963) by sequencing in a case-control study including 210 BC patients and 225 healthy volunteers.">
    <entity charOffset="164-170" id="s212.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="213-218" id="s212.e1" ontology_id="29843" text="SENP1" type="GENE"/>
    <pair e1="s212.e0" e2="s212.e1" id="s212.p0" relation="false"/>
  </sentence>
  <sentence id="s213" text="In the present study, we evaluated the association of SENPs polymorphism with susceptibility as well as clinicopathologic features and patients' response of breast cancer (BC) in a Chinese population.We genotyped SENP1 (rs61918808), SENP2 (rs6762208), SENP7 (rs61697963) by sequencing in a case-control study including 210 BC patients and 225 healthy volunteers.">
    <entity charOffset="164-170" id="s213.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="233-238" id="s213.e1" ontology_id="59343" text="SENP2" type="GENE"/>
    <pair e1="s213.e0" e2="s213.e1" id="s213.p0" relation="false"/>
  </sentence>
  <sentence id="s214" text="Notably, in two lung cancer models with FGFR1 amplification, the antitumor efficacy was higher, suggesting that the simultaneous inhibition of VEGF and FGF receptors in FGFR1 dependent tumors can be therapeutically advantageous.">
    <entity charOffset="40-45" id="s214.e0" ontology_id="2260" text="FGFR1" type="GENE"/>
    <entity charOffset="69-74" id="s214.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s214.e0" e2="s214.e1" id="s214.p0" relation="true"/>
  </sentence>
  <sentence id="s215" text="In cell assays, lucitanib potently inhibited the growth of tumor cell lines with amplified FGFR1 or mutated/amplified FGFR2.">
    <entity charOffset="59-64" id="s215.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="91-96" id="s215.e1" ontology_id="2260" text="FGFR1" type="GENE"/>
    <pair e1="s215.e0" e2="s215.e1" id="s215.p0" relation="true"/>
  </sentence>
  <sentence id="s216" text="Lucitanib is a small molecule inhibitor of vascular endothelial growth factor (VEGF) receptors 1 to 3 (VEGFR1 to 3), platelet derived growth factor / (PDGFR/) and FGFR1-3 tyrosine kinases and has demonstrated activity in a phase I/II clinical study, with objective RECIST responses in breast cancer patients with FGFR1 or FGF3/4/19 gene amplification, as well as in patients anticipated to benefit from anti-angiogenic agents.">
    <entity charOffset="167-172" id="s216.e0" ontology_id="2260" text="FGFR1" type="GENE"/>
    <entity charOffset="296-302" id="s216.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s216.e0" e2="s216.e1" id="s216.p0" relation="false"/>
  </sentence>
  <sentence id="s217" text="Increasing evidence has shown that WT1-interacting protein (WTIP) plays important roles both physiologically and pathologically in humans; however, the role of WTIP in cancer is unknown.">
    <entity charOffset="60-64" id="s217.e0" ontology_id="126374" text="WTIP" type="GENE"/>
    <entity charOffset="168-174" id="s217.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s217.e0" e2="s217.e1" id="s217.p0" relation="false"/>
  </sentence>
  <sentence id="s218" text="Here, we investigated the role and mechanism of WTIP in cell proliferation and tumorigenesis of non-small-cell lung cancer (NSCLC).">
    <entity charOffset="48-52" id="s218.e0" ontology_id="126374" text="WTIP" type="GENE"/>
    <entity charOffset="116-122" id="s218.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s218.e0" e2="s218.e1" id="s218.p0" relation="true"/>
  </sentence>
  <sentence id="s219" text="IL17RD expression was increased in ulcerative colitis cancers, and miR-193a-3p treatment decreased growth and EGFR signaling of HCT116 cells in xenografts expressing both IL17RD with WT 3'UTR compared with cells expressing IL17RD with mutant 3'UTR.&lt;b&gt;Conclusions:&lt;/b&gt; miR-193a-3p is downregulated in ulcerative colitis neoplasia, and its loss promotes carcinogenesis through upregulation of IL17RD.">
    <entity charOffset="54-60" id="s219.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="110-114" id="s219.e1" ontology_id="1956" text="EGFR" type="GENE"/>
    <pair e1="s219.e0" e2="s219.e1" id="s219.p0" relation="false"/>
  </sentence>
  <sentence id="s220" text="Several studies have demonstrated that N-butyldeoxynojirimycin (NB-DNJ, also known as miglustat), an inhibitor of the enzyme glucosylceramide synthase (GCS), successfully delays the onset of motor deficits, improves longevity, and rescues some of the cerebellar abnormalities (e.g., Purkinje cell death) seen in another lysosomal disease known as Niemann-Pick type C (NPC).">
    <entity charOffset="152-155" id="s220.e0" ontology_id="2729" text="GCS" type="GENE"/>
    <entity charOffset="251-275" id="s220.e1" ontology_id="HP_0001317" text="cerebellar abnormalities" type="HP"/>
    <pair e1="s220.e0" e2="s220.e1" id="s220.p0" relation="false"/>
  </sentence>
  <sentence id="s221" text="We identified a highly significant enrichment of de novo variants in YWHAG, establishing their role in early-onset epilepsy, and we provide additional support for the prior assignment of SLC1A2.">
    <entity charOffset="69-74" id="s221.e0" ontology_id="7532" text="YWHAG" type="GENE"/>
    <entity charOffset="115-123" id="s221.e1" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <pair e1="s221.e0" e2="s221.e1" id="s221.p0" relation="true"/>
  </sentence>
  <sentence id="s222" text="We identified a highly significant enrichment of de novo variants in YWHAG, establishing their role in early-onset epilepsy, and we provide additional support for the prior assignment of SLC1A2.">
    <entity charOffset="115-123" id="s222.e0" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <entity charOffset="187-193" id="s222.e1" ontology_id="6506" text="SLC1A2" type="GENE"/>
    <pair e1="s222.e0" e2="s222.e1" id="s222.p0" relation="true"/>
  </sentence>
  <sentence id="s223" text="The brains of &lt;i&gt;Ube3b&lt;/i&gt;&lt;sup&gt;-/-&lt;/sup&gt; mice had hypoplasia of the corpus callosum, enlarged ventricles, and decreased thickness of the somatosensory cortex.">
    <entity charOffset="17-22" id="s223.e0" ontology_id="89910" text="Ube3b" type="GENE"/>
    <entity charOffset="50-83" id="s223.e1" ontology_id="HP_0002079" text="hypoplasia of the corpus callosum" type="HP"/>
    <pair e1="s223.e0" e2="s223.e1" id="s223.p0" relation="true"/>
  </sentence>
  <sentence id="s224" text="A heterozygous mutation (c.643C&amp;gt;A; p.Q215X) in the monocarboxylate transporter 12-encoding gene MCT12 (also known as SLC16A12) that mediates creatine transport was recently identified as the cause of a syndrome with juvenile cataracts, microcornea, and glucosuria in a single family.">
    <entity charOffset="99-104" id="s224.e0" ontology_id="387700" text="MCT12" type="GENE"/>
    <entity charOffset="228-237" id="s224.e1" ontology_id="HP_0000518" text="cataracts" type="HP"/>
    <pair e1="s224.e0" e2="s224.e1" id="s224.p0" relation="true"/>
  </sentence>
  <sentence id="s225" text="The tumor cells resembled pro-B cells, and were CD19&lt;sup&gt;+&lt;/sup&gt;IgM&lt;sup&gt;-&lt;/sup&gt;IgD&lt;sup&gt;-&lt;/sup&gt;CD93&lt;sup&gt;+&lt;/sup&gt;CD43&lt;sup&gt;+&lt;/sup&gt;CD21&lt;sup&gt;-&lt;/sup&gt;CD23&lt;sup&gt;-&lt;/sup&gt;VpreB&lt;sup&gt;+&lt;/sup&gt;CXCR4&lt;sup&gt;+&lt;/sup&gt; Consistent with the pro-B-cell stage of B-cell development, microarray analysis revealed enrichment of transcripts, including Rag1, Rag2, CD93, Vpreb1, Vpreb3, and Igll1 We confirmed RAG1 expression in Tg26 tumors, and hypothesized that HIV-1 matrix protein p17 may directly induce RAG1 in B cells.">
    <entity charOffset="4-9" id="s225.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="357-362" id="s225.e1" ontology_id="3543" text="Igll1" type="GENE"/>
    <pair e1="s225.e0" e2="s225.e1" id="s225.p0" relation="false"/>
  </sentence>
  <sentence id="s226" text="The tumor cells resembled pro-B cells, and were CD19&lt;sup&gt;+&lt;/sup&gt;IgM&lt;sup&gt;-&lt;/sup&gt;IgD&lt;sup&gt;-&lt;/sup&gt;CD93&lt;sup&gt;+&lt;/sup&gt;CD43&lt;sup&gt;+&lt;/sup&gt;CD21&lt;sup&gt;-&lt;/sup&gt;CD23&lt;sup&gt;-&lt;/sup&gt;VpreB&lt;sup&gt;+&lt;/sup&gt;CXCR4&lt;sup&gt;+&lt;/sup&gt; Consistent with the pro-B-cell stage of B-cell development, microarray analysis revealed enrichment of transcripts, including Rag1, Rag2, CD93, Vpreb1, Vpreb3, and Igll1 We confirmed RAG1 expression in Tg26 tumors, and hypothesized that HIV-1 matrix protein p17 may directly induce RAG1 in B cells.">
    <entity charOffset="4-9" id="s226.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="376-380" id="s226.e1" ontology_id="5896" text="RAG1" type="GENE"/>
    <pair e1="s226.e0" e2="s226.e1" id="s226.p0" relation="false"/>
  </sentence>
  <sentence id="s227" text="SNORD115-TAF1 and SNORD-DPM2 dysfunction introduce possible clues to the parkinsonism and increased creatinine phosphokinase in NMS, while abnormalities of SNORD115-RALGPS1 suggest links to both anti-NMDAR encephalitis and the proven predisposing catatonic SHANK3 gene.">
    <entity charOffset="165-172" id="s227.e0" ontology_id="9649" text="RALGPS1" type="GENE"/>
    <entity charOffset="206-218" id="s227.e1" ontology_id="HP_0002383" text="encephalitis" type="HP"/>
    <pair e1="s227.e0" e2="s227.e1" id="s227.p0" relation="true"/>
  </sentence>
  <sentence id="s228" text="The polo family serine threonine kinase Plk4 has been proposed as a therapeutic target in advanced cancers based on increased expression in primary human cancers, facilitation of tumor growth in murine xenograft models, and centrosomal amplification induced by its overexpression.">
    <entity charOffset="40-44" id="s228.e0" ontology_id="10733" text="Plk4" type="GENE"/>
    <entity charOffset="99-105" id="s228.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s228.e0" e2="s228.e1" id="s228.p0" relation="true"/>
  </sentence>
  <sentence id="s229" text="The polo family serine threonine kinase Plk4 has been proposed as a therapeutic target in advanced cancers based on increased expression in primary human cancers, facilitation of tumor growth in murine xenograft models, and centrosomal amplification induced by its overexpression.">
    <entity charOffset="40-44" id="s229.e0" ontology_id="10733" text="Plk4" type="GENE"/>
    <entity charOffset="179-184" id="s229.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s229.e0" e2="s229.e1" id="s229.p0" relation="true"/>
  </sentence>
  <sentence id="s230" text="Our results validate Plk4 as a therapeutic target in cancer patients and reveal a new role for Plk4 in regulating Arp2/3-mediated actin cytoskeletal rearrangement.">
    <entity charOffset="53-59" id="s230.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="114-118" id="s230.e1" ontology_id="10097" text="Arp2" type="GENE"/>
    <pair e1="s230.e0" e2="s230.e1" id="s230.p0" relation="false"/>
  </sentence>
  <sentence id="s231" text="Polymorphisms in the MED13L gene have been linked to congenital heart anomalies and intellectual disabilities.">
    <entity charOffset="21-27" id="s231.e0" ontology_id="23389" text="MED13L" type="GENE"/>
    <entity charOffset="84-109" id="s231.e1" ontology_id="HP_0001249" text="intellectual disabilities" type="HP"/>
    <pair e1="s231.e0" e2="s231.e1" id="s231.p0" relation="true"/>
  </sentence>
  <sentence id="s232" text="FOXRED1 encodes a complex I-specific assembly factor and mutations in this gene result in complex I deficiency, infantile onset encephalomyopathy and Leigh syndrome.">
    <entity charOffset="0-7" id="s232.e0" ontology_id="55572" text="FOXRED1" type="GENE"/>
    <entity charOffset="112-127" id="s232.e1" ontology_id="HP_0003593" text="infantile onset" type="HP"/>
    <pair e1="s232.e0" e2="s232.e1" id="s232.p0" relation="true"/>
  </sentence>
  <sentence id="s233" text="Our data, for the first time, functionally link Jalili syndrome gene CNNM4 to LCA gene IQCB1, providing important insights into the molecular pathogenic mechanism of retinal dystrophy in Jalili syndrome">
    <entity charOffset="78-81" id="s233.e0" ontology_id="1211" text="LCA" type="GENE"/>
    <entity charOffset="166-183" id="s233.e1" ontology_id="HP_0000556" text="retinal dystrophy" type="HP"/>
    <pair e1="s233.e0" e2="s233.e1" id="s233.p0" relation="false"/>
  </sentence>
  <sentence id="s234" text="In fact, WRAP53 has been considered as a candidate cancer susceptibility gene.">
    <entity charOffset="9-15" id="s234.e0" ontology_id="55135" text="WRAP53" type="GENE"/>
    <entity charOffset="51-57" id="s234.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s234.e0" e2="s234.e1" id="s234.p0" relation="true"/>
  </sentence>
  <sentence id="s235" text="We show that genetic defects in CABP2 cause moderate-to-severe sensorineural hearing impairment.">
    <entity charOffset="32-37" id="s235.e0" ontology_id="51475" text="CABP2" type="GENE"/>
    <entity charOffset="77-95" id="s235.e1" ontology_id="HP_0000365" text="hearing impairment" type="HP"/>
    <pair e1="s235.e0" e2="s235.e1" id="s235.p0" relation="true"/>
  </sentence>
  <sentence id="s236" text="It has been proposed that transcobalamin 2 (TCN2) and the transcobalamin 2 receptor (TCN2R) are associated with idiopathic recurrent spontaneous abortion (RSA).">
    <entity charOffset="44-48" id="s236.e0" ontology_id="6948" text="TCN2" type="GENE"/>
    <entity charOffset="133-153" id="s236.e1" ontology_id="HP_0005268" text="spontaneous abortion" type="HP"/>
    <pair e1="s236.e0" e2="s236.e1" id="s236.p0" relation="true"/>
  </sentence>
  <sentence id="s237" text="The present study was designed to survey the mutation spectrum of common pathogenic genes (OPA1, OPA3 and mtDNA genes) and to analyze the genotype-phenotype characteristics of Chinese patients with suspected childhood-onset hereditary optic neuropathy.">
    <entity charOffset="91-95" id="s237.e0" ontology_id="9968" text="OPA1" type="GENE"/>
    <entity charOffset="241-251" id="s237.e1" ontology_id="HP_0009830" text="neuropathy" type="HP"/>
    <pair e1="s237.e0" e2="s237.e1" id="s237.p0" relation="false"/>
  </sentence>
  <sentence id="s238" text="This study expanded the OPA1 mutation spectrum, and our results showed that OPA1 mutation is another common cause of childhood-onset hereditary optic neuropathy in Chinese pediatric patients, especially those with disease onset during preschool age">
    <entity charOffset="24-28" id="s238.e0" ontology_id="9968" text="OPA1" type="GENE"/>
    <entity charOffset="150-160" id="s238.e1" ontology_id="HP_0009830" text="neuropathy" type="HP"/>
    <pair e1="s238.e0" e2="s238.e1" id="s238.p0" relation="true"/>
  </sentence>
  <sentence id="s239" text="Finally, we demonstrate that TRPS1 expression is elevated in luminal breast cancer cells and luminal breast cancer tissues as compared with other breast cancer subtypes.">
    <entity charOffset="29-34" id="s239.e0" ontology_id="7227" text="TRPS1" type="GENE"/>
    <entity charOffset="76-82" id="s239.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s239.e0" e2="s239.e1" id="s239.p0" relation="true"/>
  </sentence>
  <sentence id="s240" text="We report four individuals from three unrelated families who have homozygous missense or compound heterozygous truncating mutations in UNC80 and persistent hypotonia, encephalopathy, growth failure, and severe intellectual disability.">
    <entity charOffset="135-140" id="s240.e0" ontology_id="285175" text="UNC80" type="GENE"/>
    <entity charOffset="167-181" id="s240.e1" ontology_id="HP_0001298" text="encephalopathy" type="HP"/>
    <pair e1="s240.e0" e2="s240.e1" id="s240.p0" relation="true"/>
  </sentence>
  <sentence id="s241" text="T cell-produced TNF and IL-17A further contribute to bone loss in hyperparathyroidism, while T cell production of the anabolic Wingless integration site (Wnt) ligand, Wnt10b, promotes bone formation in response to anabolic parathyroid hormone and the immunomodulatory costimulation inhibitor cytotoxic T lymphocyte-associated protein-4-IgG (abatacept).">
    <entity charOffset="66-85" id="s241.e0" ontology_id="HP_0000843" text="hyperparathyroidism" type="HP"/>
    <entity charOffset="167-173" id="s241.e1" ontology_id="7480" text="Wnt10b" type="GENE"/>
    <pair e1="s241.e0" e2="s241.e1" id="s241.p0" relation="false"/>
  </sentence>
  <sentence id="s242" text="We hypothesized therefore that some children with hypercalciuria and kidney stones harbor a CLDN14 variant that inappropriately increases gene expression.">
    <entity charOffset="50-64" id="s242.e0" ontology_id="HP_0002150" text="hypercalciuria" type="HP"/>
    <entity charOffset="92-98" id="s242.e1" ontology_id="23562" text="CLDN14" type="GENE"/>
    <pair e1="s242.e0" e2="s242.e1" id="s242.p0" relation="true"/>
  </sentence>
  <sentence id="s243" text="Our data suggest that children with the INSM1 binding site within the CLDN14 risk haplotype have a higher likelihood of hypercalciuria and kidney stones.">
    <entity charOffset="40-45" id="s243.e0" ontology_id="3642" text="INSM1" type="GENE"/>
    <entity charOffset="120-134" id="s243.e1" ontology_id="HP_0002150" text="hypercalciuria" type="HP"/>
    <pair e1="s243.e0" e2="s243.e1" id="s243.p0" relation="true"/>
  </sentence>
  <sentence id="s244" text="Our data suggest that children with the INSM1 binding site within the CLDN14 risk haplotype have a higher likelihood of hypercalciuria and kidney stones.">
    <entity charOffset="70-76" id="s244.e0" ontology_id="23562" text="CLDN14" type="GENE"/>
    <entity charOffset="120-134" id="s244.e1" ontology_id="HP_0002150" text="hypercalciuria" type="HP"/>
    <pair e1="s244.e0" e2="s244.e1" id="s244.p0" relation="true"/>
  </sentence>
  <sentence id="s245" text="To test this hypothesis, we sequenced the CLDN14 risk haplotype in a cohort of children with idiopathic hypercalciuria and kidney stones.">
    <entity charOffset="42-48" id="s245.e0" ontology_id="23562" text="CLDN14" type="GENE"/>
    <entity charOffset="104-118" id="s245.e1" ontology_id="HP_0002150" text="hypercalciuria" type="HP"/>
    <pair e1="s245.e0" e2="s245.e1" id="s245.p0" relation="true"/>
  </sentence>
  <sentence id="s246" text="Feingold syndrome is a skeletal dysplasia caused by loss-of-function mutations of either MYCN (type 1) or MIR17HG that encodes miR-17-92 microRNAs (type 2).">
    <entity charOffset="23-41" id="s246.e0" ontology_id="HP_0002652" text="skeletal dysplasia" type="HP"/>
    <entity charOffset="89-93" id="s246.e1" ontology_id="4613" text="MYCN" type="GENE"/>
    <pair e1="s246.e0" e2="s246.e1" id="s246.p0" relation="true"/>
  </sentence>
  <sentence id="s247" text="uPA may enhance the migratory and invasive capabilities of endometrial tumor cells by the phosphorylation of ERK1/2, Akt and p38 molecules.">
    <entity charOffset="71-76" id="s247.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="117-120" id="s247.e1" ontology_id="207" text="Akt" type="GENE"/>
    <pair e1="s247.e0" e2="s247.e1" id="s247.p0" relation="true"/>
  </sentence>
  <sentence id="s248" text="VPS13C mutations are associated with a distinct form of early-onset parkinsonism characterized by rapid and severe disease progression and early cognitive decline; the pathological features were striking and reminiscent of diffuse Lewy body disease.">
    <entity charOffset="0-6" id="s248.e0" ontology_id="54832" text="VPS13C" type="GENE"/>
    <entity charOffset="68-80" id="s248.e1" ontology_id="HP_0001300" text="parkinsonism" type="HP"/>
    <pair e1="s248.e0" e2="s248.e1" id="s248.p0" relation="true"/>
  </sentence>
  <sentence id="s249" text="Targeted deletion of Wnt1 in mesenchymal progenitors led to spontaneous fractures due to impaired osteoblast function and increased bone resorption, mimicking the severe OI phenotype in humans with homozygous WNT1 mutations.">
    <entity charOffset="21-25" id="s249.e0" ontology_id="7471" text="Wnt1" type="GENE"/>
    <entity charOffset="122-147" id="s249.e1" ontology_id="HP_0002797" text="increased bone resorption" type="HP"/>
    <pair e1="s249.e0" e2="s249.e1" id="s249.p0" relation="true"/>
  </sentence>
  <sentence id="s250" text="Targeted deletion of Wnt1 in mesenchymal progenitors led to spontaneous fractures due to impaired osteoblast function and increased bone resorption, mimicking the severe OI phenotype in humans with homozygous WNT1 mutations.">
    <entity charOffset="122-147" id="s250.e0" ontology_id="HP_0002797" text="increased bone resorption" type="HP"/>
    <entity charOffset="209-213" id="s250.e1" ontology_id="7471" text="WNT1" type="GENE"/>
    <pair e1="s250.e0" e2="s250.e1" id="s250.p0" relation="false"/>
  </sentence>
  <sentence id="s251" text="Finally, we report that 9 retained cytotoxicity against several pediatric cancer cell lines with EC&lt;sub&gt;50&lt;/sub&gt; values comparable to BET inhibitor (BETi) clinical candidates">
    <entity charOffset="74-80" id="s251.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="134-137" id="s251.e1" ontology_id="92737" text="BET" type="GENE"/>
    <pair e1="s251.e0" e2="s251.e1" id="s251.p0" relation="false"/>
  </sentence>
  <sentence id="s252" text="Taken together, our data provide insight into the molecular pathways of dominantly and recessively acting BEST1 missense mutations suggesting that the site of subcellular protein quality control as well as the rate and degree of mutant protein degradation are ultimately responsible for the distinct retinal disease phenotypes in BD and ARB">
    <entity charOffset="106-111" id="s252.e0" ontology_id="7439" text="BEST1" type="GENE"/>
    <entity charOffset="300-315" id="s252.e1" ontology_id="HP_0000479" text="retinal disease" type="HP"/>
    <pair e1="s252.e0" e2="s252.e1" id="s252.p0" relation="false"/>
  </sentence>
  <sentence id="s253" text="Herein, we report a third patient (not related to the previously reported family) with bilateral colobomatous microphthalmia and developmental delay in whom genetic studies identified a homozygous TENM3 splicing mutation c.2968-2A&amp;gt;T (p.Val990Cysfs*13).">
    <entity charOffset="110-124" id="s253.e0" ontology_id="HP_0000568" text="microphthalmia" type="HP"/>
    <entity charOffset="197-202" id="s253.e1" ontology_id="55714" text="TENM3" type="GENE"/>
    <pair e1="s253.e0" e2="s253.e1" id="s253.p0" relation="true"/>
  </sentence>
  <sentence id="s254" text="Herein, we report a third patient (not related to the previously reported family) with bilateral colobomatous microphthalmia and developmental delay in whom genetic studies identified a homozygous TENM3 splicing mutation c.2968-2A&amp;gt;T (p.Val990Cysfs*13).">
    <entity charOffset="129-148" id="s254.e0" ontology_id="HP_0001263" text="developmental delay" type="HP"/>
    <entity charOffset="197-202" id="s254.e1" ontology_id="55714" text="TENM3" type="GENE"/>
    <pair e1="s254.e0" e2="s254.e1" id="s254.p0" relation="true"/>
  </sentence>
  <sentence id="s255" text="In a recent study combining autozygome and exome analysis, a homozygous loss of function mutation in TENM3 (previously named ODZ3) was reported in two siblings with isolated bilateral colobomatous microphthalmia from a consanguineous Saudi family.">
    <entity charOffset="101-106" id="s255.e0" ontology_id="55714" text="TENM3" type="GENE"/>
    <entity charOffset="197-211" id="s255.e1" ontology_id="HP_0000568" text="microphthalmia" type="HP"/>
    <pair e1="s255.e0" e2="s255.e1" id="s255.p0" relation="true"/>
  </sentence>
  <sentence id="s256" text="RESULTS A nonsynonymous mutation at ovine Chr3:193,691,195, which generated a glycine-to-arginine amino acid change within the predicted Slco1b3 protein, was significantly associated with hyperbilirubinemia and predicted to be deleterious.">
    <entity charOffset="137-144" id="s256.e0" ontology_id="28234" text="Slco1b3" type="GENE"/>
    <entity charOffset="188-206" id="s256.e1" ontology_id="HP_0002904" text="hyperbilirubinemia" type="HP"/>
    <pair e1="s256.e0" e2="s256.e1" id="s256.p0" relation="false"/>
  </sentence>
  <sentence id="s257" text="UBE2A deficiency is a syndromic condition of X-linked intellectual disability (ID) characterized by typical dysmorphic features that include synophrys, prominent supraorbital ridges, almond-shaped, and deep-set eyes, large ears, wide mouth, myxedematous appearance, hirsutism, micropenis, and onychodystrophy.">
    <entity charOffset="0-5" id="s257.e0" ontology_id="7319" text="UBE2A" type="GENE"/>
    <entity charOffset="217-227" id="s257.e1" ontology_id="HP_0000400" text="large ears" type="HP"/>
    <pair e1="s257.e0" e2="s257.e1" id="s257.p0" relation="true"/>
  </sentence>
  <sentence id="s258" text="UBE2A deficiency is a syndromic condition of X-linked intellectual disability (ID) characterized by typical dysmorphic features that include synophrys, prominent supraorbital ridges, almond-shaped, and deep-set eyes, large ears, wide mouth, myxedematous appearance, hirsutism, micropenis, and onychodystrophy.">
    <entity charOffset="0-5" id="s258.e0" ontology_id="7319" text="UBE2A" type="GENE"/>
    <entity charOffset="202-215" id="s258.e1" ontology_id="HP_0000490" text="deep-set eyes" type="HP"/>
    <pair e1="s258.e0" e2="s258.e1" id="s258.p0" relation="true"/>
  </sentence>
  <sentence id="s259" text="UBE2A deficiency is a syndromic condition of X-linked intellectual disability (ID) characterized by typical dysmorphic features that include synophrys, prominent supraorbital ridges, almond-shaped, and deep-set eyes, large ears, wide mouth, myxedematous appearance, hirsutism, micropenis, and onychodystrophy.">
    <entity charOffset="0-5" id="s259.e0" ontology_id="7319" text="UBE2A" type="GENE"/>
    <entity charOffset="266-275" id="s259.e1" ontology_id="HP_0001007" text="hirsutism" type="HP"/>
    <pair e1="s259.e0" e2="s259.e1" id="s259.p0" relation="true"/>
  </sentence>
  <sentence id="s260" text="These results expand the genetic heterogeneity of EKVP and the human disease phenotypes associated with GJA1 mutations.">
    <entity charOffset="33-46" id="s260.e0" ontology_id="HP_0001425" text="heterogeneity" type="HP"/>
    <entity charOffset="104-108" id="s260.e1" ontology_id="2697" text="GJA1" type="GENE"/>
    <pair e1="s260.e0" e2="s260.e1" id="s260.p0" relation="false"/>
  </sentence>
  <sentence id="s261" text="Erythrokeratodermia variabilis et progressiva (EKVP) is a genodermatosis with clinical and genetic heterogeneity, most often transmitted in an autosomal dominant manner, caused by mutations in GJB3 and GJB4 genes encoding connexins (Cx)31 and 30.3, respectively.">
    <entity charOffset="99-112" id="s261.e0" ontology_id="HP_0001425" text="heterogeneity" type="HP"/>
    <entity charOffset="202-206" id="s261.e1" ontology_id="127534" text="GJB4" type="GENE"/>
    <pair e1="s261.e0" e2="s261.e1" id="s261.p0" relation="true"/>
  </sentence>
  <sentence id="s262" text="NKX2.5-R142C is a mutation that was reported to be associated with atrial septal defect (ASD) and atrioventricular (AV) block in 13-patients from one family.">
    <entity charOffset="0-6" id="s262.e0" ontology_id="1482" text="NKX2.5" type="GENE"/>
    <entity charOffset="67-87" id="s262.e1" ontology_id="HP_0001631" text="atrial septal defect" type="HP"/>
    <pair e1="s262.e0" e2="s262.e1" id="s262.p0" relation="true"/>
  </sentence>
  <sentence id="s263" text="Up to this time, only heterozygous mutations of COL9A3 gene have been reported in human and related to: (1) multiple epiphyseal dysplasia type 3, (2) susceptibility to an intervertebral disc disease, and (3) hearing loss.">
    <entity charOffset="48-54" id="s263.e0" ontology_id="1299" text="COL9A3" type="GENE"/>
    <entity charOffset="117-137" id="s263.e1" ontology_id="HP_0002656" text="epiphyseal dysplasia" type="HP"/>
    <pair e1="s263.e0" e2="s263.e1" id="s263.p0" relation="true"/>
  </sentence>
  <sentence id="s264" text="In clinical specimens, elevated LAMB3 expression correlated with poorer survival in lung cancer patients with an oncogenic KRAS gene signature, suggesting a novel candidate biomarker in this disease setting.">
    <entity charOffset="89-95" id="s264.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="123-127" id="s264.e1" ontology_id="3845" text="KRAS" type="GENE"/>
    <pair e1="s264.e0" e2="s264.e1" id="s264.p0" relation="true"/>
  </sentence>
  <sentence id="s265" text="Silencing of FAK or LAMB3 recapitulated the synthetic lethal effects of miR-1298 expression in KRAS-driven cancer cells, whereas coexpression of both proteins was critical to rescue miR-1298-induced cell death.">
    <entity charOffset="20-25" id="s265.e0" ontology_id="3914" text="LAMB3" type="GENE"/>
    <entity charOffset="107-113" id="s265.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s265.e0" e2="s265.e1" id="s265.p0" relation="true"/>
  </sentence>
  <sentence id="s266" text="Mutations in PLA2G6 (PARK14) cause neurodegenerative disorders in humans, including autosomal recessive neuroaxonal dystrophy and early-onset parkinsonism.">
    <entity charOffset="13-19" id="s266.e0" ontology_id="8398" text="PLA2G6" type="GENE"/>
    <entity charOffset="142-154" id="s266.e1" ontology_id="HP_0001300" text="parkinsonism" type="HP"/>
    <pair e1="s266.e0" e2="s266.e1" id="s266.p0" relation="true"/>
  </sentence>
  <sentence id="s267" text="Aspm knockout ferrets exhibit severe microcephaly (25-40% decreases in brain weight), reflecting reduced cortical surface area without significant change in cortical thickness, as has been found in human patients&lt;sup&gt;3,4&lt;/sup&gt;, suggesting that loss of 'cortical units' has occurred.">
    <entity charOffset="0-4" id="s267.e0" ontology_id="259266" text="Aspm" type="GENE"/>
    <entity charOffset="37-49" id="s267.e1" ontology_id="HP_0000252" text="microcephaly" type="HP"/>
    <pair e1="s267.e0" e2="s267.e1" id="s267.p0" relation="true"/>
  </sentence>
  <sentence id="s268" text="We demonstrate spatial genomic heterogeneity in more than 75% of patients, including inactivation of CDKN2C and TP53, and mutations affecting mitogen-activated protein kinase genes.">
    <entity charOffset="31-44" id="s268.e0" ontology_id="HP_0001425" text="heterogeneity" type="HP"/>
    <entity charOffset="101-107" id="s268.e1" ontology_id="1031" text="CDKN2C" type="GENE"/>
    <pair e1="s268.e0" e2="s268.e1" id="s268.p0" relation="true"/>
  </sentence>
  <sentence id="s269" text="Recently, the roles of FAM83H in tumorigenesis have been interested and increased expression of FAM83H and MYC in hepatocellular carcinoma (HCC) have been reported.">
    <entity charOffset="33-38" id="s269.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="107-110" id="s269.e1" ontology_id="4609" text="MYC" type="GENE"/>
    <pair e1="s269.e0" e2="s269.e1" id="s269.p0" relation="false"/>
  </sentence>
  <sentence id="s270" text="In conclusion, we present an oncogenic role of FAM83H in liver cancer, which is closely associated with the oncogene MYC.">
    <entity charOffset="63-69" id="s270.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="117-120" id="s270.e1" ontology_id="4609" text="MYC" type="GENE"/>
    <pair e1="s270.e0" e2="s270.e1" id="s270.p0" relation="true"/>
  </sentence>
  <sentence id="s271" text="ZEB2 overexpression rescued the inhibition of liver cancer cell proliferation, migration, and invasion by miR498, indicating that ZEB2 acts as a downstream effector of miR498 in liver cancer cells.">
    <entity charOffset="0-4" id="s271.e0" ontology_id="9839" text="ZEB2" type="GENE"/>
    <entity charOffset="52-58" id="s271.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s271.e0" e2="s271.e1" id="s271.p0" relation="true"/>
  </sentence>
  <sentence id="s272" text="Heterozygous missense mutations in ANK3 have been associated with autism spectrum disorder.">
    <entity charOffset="35-39" id="s272.e0" ontology_id="288" text="ANK3" type="GENE"/>
    <entity charOffset="66-72" id="s272.e1" ontology_id="HP_0000717" text="autism" type="HP"/>
    <pair e1="s272.e0" e2="s272.e1" id="s272.p0" relation="true"/>
  </sentence>
  <sentence id="s273" text="Although the 4 PKPs displayed different levels and patterns of subcellular distribution in tumors, there was a positive correlation between immunoreactivity for PKP2 and PKP3, as well as for PKP2 and p0071, suggesting possible functional similarities associated with differentiation, tumor growth, and disease prognosis.">
    <entity charOffset="91-96" id="s273.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="161-165" id="s273.e1" ontology_id="5318" text="PKP2" type="GENE"/>
    <pair e1="s273.e0" e2="s273.e1" id="s273.p0" relation="true"/>
  </sentence>
  <sentence id="s274" text="In contrast, strong PKP2 immunoreactivity was observed in 85.7% of metastatic tumors.">
    <entity charOffset="20-24" id="s274.e0" ontology_id="5318" text="PKP2" type="GENE"/>
    <entity charOffset="78-83" id="s274.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s274.e0" e2="s274.e1" id="s274.p0" relation="true"/>
  </sentence>
  <sentence id="s275" text="Our association analysis revealed a uniform pattern of Warburg effect mutations influencing prognosis across all tumor types, while copy number alterations in the electron transport chain gene SCO2, fatty acid uptake (CAV1, CD36) and lipogenesis (PPARA, PPARD, MLXIPL) genes were enriched in metastatic tumors.">
    <entity charOffset="113-118" id="s275.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="254-259" id="s275.e1" ontology_id="5467" text="PPARD" type="GENE"/>
    <pair e1="s275.e0" e2="s275.e1" id="s275.p0" relation="false"/>
  </sentence>
  <sentence id="s276" text="Our association analysis revealed a uniform pattern of Warburg effect mutations influencing prognosis across all tumor types, while copy number alterations in the electron transport chain gene SCO2, fatty acid uptake (CAV1, CD36) and lipogenesis (PPARA, PPARD, MLXIPL) genes were enriched in metastatic tumors.">
    <entity charOffset="113-118" id="s276.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="247-252" id="s276.e1" ontology_id="5465" text="PPARA" type="GENE"/>
    <pair e1="s276.e0" e2="s276.e1" id="s276.p0" relation="false"/>
  </sentence>
  <sentence id="s277" text="This includes unaffected women who have completed their family and have RAD51C, RAD51D, or BRIP1 gene mutations; first-degree relatives of women with invasive epithelial ovarian cancer; BRCA mutation-negative women from high-risk breast-and-ovarian cancer or ovarian-cancer-only families.">
    <entity charOffset="80-86" id="s277.e0" ontology_id="5892" text="RAD51D" type="GENE"/>
    <entity charOffset="178-184" id="s277.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s277.e0" e2="s277.e1" id="s277.p0" relation="false"/>
  </sentence>
  <sentence id="s278" text="MAGEL2 mutations, first reported to be the cause of the Prader-Willi like syndrome with autism by Schaaf et al. (2013) Nature Genetics, 45: 1405-1408 show the wide range of phenotypic spectrum from lethal arthrogryposis multiplex congenital to autism spectrum disorder (ASD) and mild intellectual disability (ID).">
    <entity charOffset="0-6" id="s278.e0" ontology_id="54551" text="MAGEL2" type="GENE"/>
    <entity charOffset="88-94" id="s278.e1" ontology_id="HP_0000717" text="autism" type="HP"/>
    <pair e1="s278.e0" e2="s278.e1" id="s278.p0" relation="true"/>
  </sentence>
  <sentence id="s279" text="Our results indicate that MAGEL2 mutations cause multiple congenital anomalies and intellectual disability accompanied by arthrogryposis multiplex congenita and various endocrinologic abnormalities, supporting that the view that clinical phenotypes of MAGEL2 mutations are variable">
    <entity charOffset="26-32" id="s279.e0" ontology_id="54551" text="MAGEL2" type="GENE"/>
    <entity charOffset="83-106" id="s279.e1" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <pair e1="s279.e0" e2="s279.e1" id="s279.p0" relation="true"/>
  </sentence>
  <sentence id="s280" text="Using human neuroblastoma SH-SY5Y cells, we found that the neuroprotective function of CHRNA7 is blocked by CHRNA7 knockdown using RNA interference.">
    <entity charOffset="12-25" id="s280.e0" ontology_id="HP_0003006" text="neuroblastoma" type="HP"/>
    <entity charOffset="87-93" id="s280.e1" ontology_id="1139" text="CHRNA7" type="GENE"/>
    <pair e1="s280.e0" e2="s280.e1" id="s280.p0" relation="true"/>
  </sentence>
  <sentence id="s281" text="Mutations in human crumbs 1 (&lt;i&gt;CRB1&lt;/i&gt;) are a major cause of retinal diseases that lead to blindness.">
    <entity charOffset="32-36" id="s281.e0" ontology_id="23418" text="CRB1" type="GENE"/>
    <entity charOffset="93-102" id="s281.e1" ontology_id="HP_0000618" text="blindness" type="HP"/>
    <pair e1="s281.e0" e2="s281.e1" id="s281.p0" relation="true"/>
  </sentence>
  <sentence id="s282" text="by reactivating pre-existing anti-tumor immune responses against GSC antigens.">
    <entity charOffset="34-39" id="s282.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="65-68" id="s282.e1" ontology_id="145258" text="GSC" type="GENE"/>
    <pair e1="s282.e0" e2="s282.e1" id="s282.p0" relation="false"/>
  </sentence>
  <sentence id="s283" text="After exclusive analysis of 10 common variations of three hearing loss-related genes, GJB2, mtDNA12srRNA and SLC26A4, a novel truncated variant of SMPX, c.87dupA (p.Gly30Argfs*12) (NCBI ClinVar Submission ID: SUB3136126), was identified by whole-exome sequencing.">
    <entity charOffset="58-70" id="s283.e0" ontology_id="HP_0000365" text="hearing loss" type="HP"/>
    <entity charOffset="147-151" id="s283.e1" ontology_id="23676" text="SMPX" type="GENE"/>
    <pair e1="s283.e0" e2="s283.e1" id="s283.p0" relation="false"/>
  </sentence>
  <sentence id="s284" text="In this study, the correlation between H19 and vitamin D receptor (VDR) signaling and the underlying mechanisms in colon cancer were investigated both in vitro and in vivo.">
    <entity charOffset="67-70" id="s284.e0" ontology_id="7421" text="VDR" type="GENE"/>
    <entity charOffset="121-127" id="s284.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s284.e0" e2="s284.e1" id="s284.p0" relation="true"/>
  </sentence>
  <sentence id="s285" text="In conclusion, CPS1 4217C&amp;gt;A polymorphism may not be associated with the development of hyperammonemia in Japanese population">
    <entity charOffset="15-19" id="s285.e0" ontology_id="1589" text="CPS1" type="GENE"/>
    <entity charOffset="90-104" id="s285.e1" ontology_id="HP_0001987" text="hyperammonemia" type="HP"/>
    <pair e1="s285.e0" e2="s285.e1" id="s285.p0" relation="true"/>
  </sentence>
  <sentence id="s286" text="Polymorphisms in the genes encoding carbamoyl-phosphate synthase 1 (CPS1) and N-acetylglutamate synthase (NAGS) were recently reported to be risk factors for the development of hyperammonemia during valproic acid-based therapy.">
    <entity charOffset="68-72" id="s286.e0" ontology_id="1589" text="CPS1" type="GENE"/>
    <entity charOffset="177-191" id="s286.e1" ontology_id="HP_0001987" text="hyperammonemia" type="HP"/>
    <pair e1="s286.e0" e2="s286.e1" id="s286.p0" relation="true"/>
  </sentence>
  <sentence id="s287" text="COG5-CDG (COG5 subunit deficiency) is a multisystem disease with dysmorphic features, intellectual disability of variable degree, seizures, acquired microcephaly, sensory defects and autistic behavior.">
    <entity charOffset="0-4" id="s287.e0" ontology_id="10466" text="COG5" type="GENE"/>
    <entity charOffset="86-109" id="s287.e1" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <pair e1="s287.e0" e2="s287.e1" id="s287.p0" relation="true"/>
  </sentence>
  <sentence id="s288" text="Xenograft pancreatic tumors derived from high B7-H5 expression PC cells exhibited attenuated growth compared to tumors from low B7-H5 expression cells after transfusion with T lymphocytes in immune-deficient mice.">
    <entity charOffset="21-26" id="s288.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="49-51" id="s288.e1" ontology_id="2260" text="H5" type="GENE"/>
    <pair e1="s288.e0" e2="s288.e1" id="s288.p0" relation="true"/>
  </sentence>
  <sentence id="s289" text="Xenograft pancreatic tumors derived from high B7-H5 expression PC cells exhibited attenuated growth compared to tumors from low B7-H5 expression cells after transfusion with T lymphocytes in immune-deficient mice.">
    <entity charOffset="21-26" id="s289.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="46-48" id="s289.e1" ontology_id="10233" text="B7" type="GENE"/>
    <pair e1="s289.e0" e2="s289.e1" id="s289.p0" relation="true"/>
  </sentence>
  <sentence id="s290" text="Mutations in the D40/KNL1/CASC5 gene, which was initially characterized as a gene involved in chromosomal translocation in leukemia and as a member of the cancer/testis gene family, was later found to encode a kinetochore protein essential for mitotic cell division and to cause MCPH4.">
    <entity charOffset="155-161" id="s290.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="279-284" id="s290.e1" ontology_id="22995" text="MCPH4" type="GENE"/>
    <pair e1="s290.e0" e2="s290.e1" id="s290.p0" relation="false"/>
  </sentence>
  <sentence id="s291" text="Although overlapping features with Bohring-Opitz and Bainbridge-Ropers syndromes exist, features that distinguish the ASXL2-associated condition from ASXL1- and ASXL3-related disorders are macrocephaly, absence of growth retardation, and more variability in the degree of intellectual disabilities.">
    <entity charOffset="150-155" id="s291.e0" ontology_id="171023" text="ASXL1" type="GENE"/>
    <entity charOffset="272-297" id="s291.e1" ontology_id="HP_0001249" text="intellectual disabilities" type="HP"/>
    <pair e1="s291.e0" e2="s291.e1" id="s291.p0" relation="true"/>
  </sentence>
  <sentence id="s292" text="Although overlapping features with Bohring-Opitz and Bainbridge-Ropers syndromes exist, features that distinguish the ASXL2-associated condition from ASXL1- and ASXL3-related disorders are macrocephaly, absence of growth retardation, and more variability in the degree of intellectual disabilities.">
    <entity charOffset="150-155" id="s292.e0" ontology_id="171023" text="ASXL1" type="GENE"/>
    <entity charOffset="189-201" id="s292.e1" ontology_id="HP_0000256" text="macrocephaly" type="HP"/>
    <pair e1="s292.e0" e2="s292.e1" id="s292.p0" relation="true"/>
  </sentence>
  <sentence id="s293" text="Although overlapping features with Bohring-Opitz and Bainbridge-Ropers syndromes exist, features that distinguish the ASXL2-associated condition from ASXL1- and ASXL3-related disorders are macrocephaly, absence of growth retardation, and more variability in the degree of intellectual disabilities.">
    <entity charOffset="161-166" id="s293.e0" ontology_id="80816" text="ASXL3" type="GENE"/>
    <entity charOffset="189-201" id="s293.e1" ontology_id="HP_0000256" text="macrocephaly" type="HP"/>
    <pair e1="s293.e0" e2="s293.e1" id="s293.p0" relation="true"/>
  </sentence>
  <sentence id="s294" text="Although overlapping features with Bohring-Opitz and Bainbridge-Ropers syndromes exist, features that distinguish the ASXL2-associated condition from ASXL1- and ASXL3-related disorders are macrocephaly, absence of growth retardation, and more variability in the degree of intellectual disabilities.">
    <entity charOffset="161-166" id="s294.e0" ontology_id="80816" text="ASXL3" type="GENE"/>
    <entity charOffset="272-297" id="s294.e1" ontology_id="HP_0001249" text="intellectual disabilities" type="HP"/>
    <pair e1="s294.e0" e2="s294.e1" id="s294.p0" relation="true"/>
  </sentence>
  <sentence id="s295" text="Our findings open new opportunities for targeted therapy, as tumors with GLI1 oncogenic activation, and subsequent PTCH1 overexpression, might be sensitive to sonic hedgehog pathway inhibitors">
    <entity charOffset="61-67" id="s295.e0" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <entity charOffset="73-77" id="s295.e1" ontology_id="2735" text="GLI1" type="GENE"/>
    <pair e1="s295.e0" e2="s295.e1" id="s295.p0" relation="true"/>
  </sentence>
  <sentence id="s296" text="During drug discovery efforts targeting inhibition of cytochrome P450 11B2 (CYP11B2)-mediated production of aldosterone as a therapeutic approach for the treatment of chronic kidney disease and hypertension, (&lt;i&gt;S&lt;/i&gt;)-6-(5-fluoro-4-(1-hydroxyethyl)pyridin-3-yl)-3,4-dihydro-1,8-naphthyridine-1(&lt;i&gt;2H&lt;/i&gt;)-carboxamide (1) was identified as a potent and selective inhibitor of CYP11B2.">
    <entity charOffset="76-83" id="s296.e0" ontology_id="1585" text="CYP11B2" type="GENE"/>
    <entity charOffset="194-206" id="s296.e1" ontology_id="HP_0000822" text="hypertension" type="HP"/>
    <pair e1="s296.e0" e2="s296.e1" id="s296.p0" relation="true"/>
  </sentence>
  <sentence id="s297" text="In order to address these questions, we searched for alterations in PLCB4, GNAI3, and EDN1 in patients with typical Auriculocondylar syndrome (n=3), Pierre Robin sequence-plus (n=3), micrognathia with additional craniofacial malformations (n=4), or non-specific auricular dysplasia (n=1), which could represent subtypes of Auriculocondylar syndrome.">
    <entity charOffset="68-73" id="s297.e0" ontology_id="5332" text="PLCB4" type="GENE"/>
    <entity charOffset="187-199" id="s297.e1" ontology_id="HP_0000347" text="micrognathia" type="HP"/>
    <pair e1="s297.e0" e2="s297.e1" id="s297.p0" relation="true"/>
  </sentence>
  <sentence id="s298" text="In order to address these questions, we searched for alterations in PLCB4, GNAI3, and EDN1 in patients with typical Auriculocondylar syndrome (n=3), Pierre Robin sequence-plus (n=3), micrognathia with additional craniofacial malformations (n=4), or non-specific auricular dysplasia (n=1), which could represent subtypes of Auriculocondylar syndrome.">
    <entity charOffset="75-80" id="s298.e0" ontology_id="2773" text="GNAI3" type="GENE"/>
    <entity charOffset="187-199" id="s298.e1" ontology_id="HP_0000347" text="micrognathia" type="HP"/>
    <pair e1="s298.e0" e2="s298.e1" id="s298.p0" relation="true"/>
  </sentence>
  <sentence id="s299" text="Methylation profiling, metabolite assessment and additional analyses were also performed in selected cases.&lt;b&gt;Results:&lt;/b&gt; One of the 11 tumors was found to carry a known cancer-predisposing somatic mutation in &lt;i&gt;IDH1&lt;/i&gt; A variant in &lt;i&gt;GOT2&lt;/i&gt;, c.357A&amp;gt;T, found in a patient with multiple tumors, was associated with higher tumor mRNA and protein expression levels, increased GOT2 enzymatic activity in lymphoblastic cells, and altered metabolite ratios both in tumors and in GOT2 knockdown HeLa cells transfected with the variant.">
    <entity charOffset="191-207" id="s299.e0" ontology_id="HP_0001428" text="somatic mutation" type="HP"/>
    <entity charOffset="239-243" id="s299.e1" ontology_id="2806" text="GOT2" type="GENE"/>
    <pair e1="s299.e0" e2="s299.e1" id="s299.p0" relation="false"/>
  </sentence>
  <sentence id="s300" text="Methylation profiling, metabolite assessment and additional analyses were also performed in selected cases.&lt;b&gt;Results:&lt;/b&gt; One of the 11 tumors was found to carry a known cancer-predisposing somatic mutation in &lt;i&gt;IDH1&lt;/i&gt; A variant in &lt;i&gt;GOT2&lt;/i&gt;, c.357A&amp;gt;T, found in a patient with multiple tumors, was associated with higher tumor mRNA and protein expression levels, increased GOT2 enzymatic activity in lymphoblastic cells, and altered metabolite ratios both in tumors and in GOT2 knockdown HeLa cells transfected with the variant.">
    <entity charOffset="239-243" id="s300.e0" ontology_id="2806" text="GOT2" type="GENE"/>
    <entity charOffset="330-335" id="s300.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s300.e0" e2="s300.e1" id="s300.p0" relation="true"/>
  </sentence>
  <sentence id="s301" text="The novel potential autism susceptibility genes PTDSS1 and AREG were uncovered and warrant further genetic and functional analyses.">
    <entity charOffset="20-26" id="s301.e0" ontology_id="HP_0000717" text="autism" type="HP"/>
    <entity charOffset="48-54" id="s301.e1" ontology_id="9791" text="PTDSS1" type="GENE"/>
    <pair e1="s301.e0" e2="s301.e1" id="s301.p0" relation="true"/>
  </sentence>
  <sentence id="s302" text="The novel potential autism susceptibility genes PTDSS1 and AREG were uncovered and warrant further genetic and functional analyses.">
    <entity charOffset="20-26" id="s302.e0" ontology_id="HP_0000717" text="autism" type="HP"/>
    <entity charOffset="59-63" id="s302.e1" ontology_id="374" text="AREG" type="GENE"/>
    <pair e1="s302.e0" e2="s302.e1" id="s302.p0" relation="true"/>
  </sentence>
  <sentence id="s303" text="These results highlight CRAFT as a systems-level framework for target discovery and suggest Csf1R blockade as a novel therapeutic strategy in epilepsy.">
    <entity charOffset="92-97" id="s303.e0" ontology_id="1436" text="Csf1R" type="GENE"/>
    <entity charOffset="142-150" id="s303.e1" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <pair e1="s303.e0" e2="s303.e1" id="s303.p0" relation="true"/>
  </sentence>
  <sentence id="s304" text="Subsequently, we identified another homozygous variant in 2 of the 10 probands with microphthalmia we specifically screened for mutations in ALDH1A3.">
    <entity charOffset="84-98" id="s304.e0" ontology_id="HP_0000568" text="microphthalmia" type="HP"/>
    <entity charOffset="141-148" id="s304.e1" ontology_id="220" text="ALDH1A3" type="GENE"/>
    <pair e1="s304.e0" e2="s304.e1" id="s304.p0" relation="true"/>
  </sentence>
  <sentence id="s305" text="Our data support the very recent and independent identification of ALDH1A3 as a disease gene in microphthalmia.">
    <entity charOffset="67-74" id="s305.e0" ontology_id="220" text="ALDH1A3" type="GENE"/>
    <entity charOffset="96-110" id="s305.e1" ontology_id="HP_0000568" text="microphthalmia" type="HP"/>
    <pair e1="s305.e0" e2="s305.e1" id="s305.p0" relation="true"/>
  </sentence>
  <sentence id="s306" text="This report identifies the first breast cancer risk locus specific to a BRCA2 mutation background.">
    <entity charOffset="40-46" id="s306.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="72-77" id="s306.e1" ontology_id="675" text="BRCA2" type="GENE"/>
    <pair e1="s306.e0" e2="s306.e1" id="s306.p0" relation="true"/>
  </sentence>
  <sentence id="s307" text="We replicated previously reported breast cancer susceptibility alleles in these BRCA2 mutation carriers and for several regions (including FGFR2, MAP3K1, CDKN2A/B, and PTHLH) identified SNPs that have stronger evidence of association than those previously published.">
    <entity charOffset="41-47" id="s307.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="139-144" id="s307.e1" ontology_id="2263" text="FGFR2" type="GENE"/>
    <pair e1="s307.e0" e2="s307.e1" id="s307.p0" relation="true"/>
  </sentence>
  <sentence id="s308" text="DNA samples from 3,881 breast cancer affected and 4,330 unaffected BRCA2 mutation carriers from 47 studies belonging to the Consortium of Investigators of Modifiers of BRCA1/2 were genotyped and available for analysis.">
    <entity charOffset="30-36" id="s308.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="168-173" id="s308.e1" ontology_id="672" text="BRCA1" type="GENE"/>
    <pair e1="s308.e0" e2="s308.e1" id="s308.p0" relation="true"/>
  </sentence>
  <sentence id="s309" text="This comprehensive update of novel and previously reported breast cancer susceptibility loci contributes to the establishment of a panel of SNPs that modify breast cancer risk in BRCA2 mutation carriers.">
    <entity charOffset="66-72" id="s309.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="179-184" id="s309.e1" ontology_id="675" text="BRCA2" type="GENE"/>
    <pair e1="s309.e0" e2="s309.e1" id="s309.p0" relation="true"/>
  </sentence>
  <sentence id="s310" text="To comprehensively identify breast cancer risk modifying loci for BRCA2 mutation carriers, we conducted a deep replication of an ongoing GWAS discovery study.">
    <entity charOffset="35-41" id="s310.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="66-71" id="s310.e1" ontology_id="675" text="BRCA2" type="GENE"/>
    <pair e1="s310.e0" e2="s310.e1" id="s310.p0" relation="true"/>
  </sentence>
  <sentence id="s311" text="Misregulation of vascular endothelial growth factorA (VEGFA) has been implicated in numerous types of ovarian disease, such as polycystic ovarian syndrome, ovarian hyperstimulation syndrome, endometriosis and ovarian cancer.">
    <entity charOffset="55-59" id="s311.e0" ontology_id="7422" text="VEGF" type="GENE"/>
    <entity charOffset="219-225" id="s311.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s311.e0" e2="s311.e1" id="s311.p0" relation="true"/>
  </sentence>
  <sentence id="s312" text="Through the examination of 48 candidate genes known to be responsible for autosomal recessive SPG, we identified a novel homozygous 4-bp deletion, c.914_917delGTAA, p.Ser305Ilefs*2 in exon2 of the DDHD1 gene encoding phosphatidic acid-preferring phospholipase A1 (PA-PLA1).">
    <entity charOffset="74-93" id="s312.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="264-271" id="s312.e1" ontology_id="80821" text="PA-PLA1" type="GENE"/>
    <pair e1="s312.e0" e2="s312.e1" id="s312.p0" relation="true"/>
  </sentence>
  <sentence id="s313" text="Spastic paraplegia (SPG) type 28 is an autosomal recessive SPG caused by mutations in the DDHD1 gene.">
    <entity charOffset="39-58" id="s313.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="90-95" id="s313.e1" ontology_id="80821" text="DDHD1" type="GENE"/>
    <pair e1="s313.e0" e2="s313.e1" id="s313.p0" relation="true"/>
  </sentence>
  <sentence id="s314" text="Therefore our study identifies a compartmentalized PtdIns(3,4,5)P&lt;sub&gt;3&lt;/sub&gt;/AKT/GSK3 signaling axis at cilia in SHH-dependent medulloblastoma that is regulated by INPP5E to maintain tumor cell cilia, promote SHH signaling and thereby medulloblastoma progression">
    <entity charOffset="115-118" id="s314.e0" ontology_id="6469" text="SHH" type="GENE"/>
    <entity charOffset="129-144" id="s314.e1" ontology_id="HP_0002885" text="medulloblastoma" type="HP"/>
    <pair e1="s314.e0" e2="s314.e1" id="s314.p0" relation="true"/>
  </sentence>
  <sentence id="s315" text="Therefore our study identifies a compartmentalized PtdIns(3,4,5)P&lt;sub&gt;3&lt;/sub&gt;/AKT/GSK3 signaling axis at cilia in SHH-dependent medulloblastoma that is regulated by INPP5E to maintain tumor cell cilia, promote SHH signaling and thereby medulloblastoma progression">
    <entity charOffset="166-172" id="s315.e0" ontology_id="23203" text="INPP5E" type="GENE"/>
    <entity charOffset="185-190" id="s315.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s315.e0" e2="s315.e1" id="s315.p0" relation="true"/>
  </sentence>
  <sentence id="s316" text="PI3-kinase inhibition or expression of wild-type, but not catalytically inactive HA-INPP5E partially rescued cilia loss in Inpp5e-null tumor cells in vitro.">
    <entity charOffset="84-90" id="s316.e0" ontology_id="23203" text="INPP5E" type="GENE"/>
    <entity charOffset="135-140" id="s316.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s316.e0" e2="s316.e1" id="s316.p0" relation="true"/>
  </sentence>
  <sentence id="s317" text="Conditional deletion of Inpp5e in a murine model of constitutively active Smoothened-driven medulloblastoma slowed tumor progression, suppressed cell proliferation, reduced SHH signaling and promoted tumor cell cilia loss.">
    <entity charOffset="24-30" id="s317.e0" ontology_id="23203" text="Inpp5e" type="GENE"/>
    <entity charOffset="92-107" id="s317.e1" ontology_id="HP_0002885" text="medulloblastoma" type="HP"/>
    <pair e1="s317.e0" e2="s317.e1" id="s317.p0" relation="true"/>
  </sentence>
  <sentence id="s318" text="Sonic Hedgehog (SHH) signaling at primary cilia drives the proliferation and progression of a subset of medulloblastomas, the most common malignant paediatric brain tumor.">
    <entity charOffset="16-19" id="s318.e0" ontology_id="6469" text="SHH" type="GENE"/>
    <entity charOffset="165-170" id="s318.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s318.e0" e2="s318.e1" id="s318.p0" relation="true"/>
  </sentence>
  <sentence id="s319" text="Here, we reveal INPP5E promotes SHH signaling in SHH medulloblastoma by negatively regulating a cilia-compartmentalized PI3-kinase signaling axis that maintains primary cilia on tumor cells.">
    <entity charOffset="32-35" id="s319.e0" ontology_id="6469" text="SHH" type="GENE"/>
    <entity charOffset="178-183" id="s319.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s319.e0" e2="s319.e1" id="s319.p0" relation="true"/>
  </sentence>
  <sentence id="s320" text="In addition, we also found that upregulation of the Kankl gene resulted in the inhibition of tumor cell invasion and metastasis.">
    <entity charOffset="52-56" id="s320.e0" ontology_id="23189" text="Kank" type="GENE"/>
    <entity charOffset="93-98" id="s320.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s320.e0" e2="s320.e1" id="s320.p0" relation="true"/>
  </sentence>
  <sentence id="s321" text="However, there is no study concerning the specific role of Kank1 in the development and progression of lung cancer.">
    <entity charOffset="59-63" id="s321.e0" ontology_id="23189" text="Kank" type="GENE"/>
    <entity charOffset="108-114" id="s321.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s321.e0" e2="s321.e1" id="s321.p0" relation="true"/>
  </sentence>
  <sentence id="s322" text="In the present study, we found that the Kankl gene was significantly downregulated in human lung cancer and lung cancer cells.">
    <entity charOffset="40-44" id="s322.e0" ontology_id="23189" text="Kank" type="GENE"/>
    <entity charOffset="97-103" id="s322.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s322.e0" e2="s322.e1" id="s322.p0" relation="true"/>
  </sentence>
  <sentence id="s323" text="When the Kankl gene was upregulated, we found that the proliferation of lung cancer cells was significantly inhibited, the cells were arrested in the G0/G1phase, the apoptosis of cells was observed, the expression of the caspase family of genes was altered with mainly the activation of caspase-3and-9, and Bcl-2/Bax ratio was significantly imbalanced.">
    <entity charOffset="9-13" id="s323.e0" ontology_id="23189" text="Kank" type="GENE"/>
    <entity charOffset="77-83" id="s323.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s323.e0" e2="s323.e1" id="s323.p0" relation="true"/>
  </sentence>
  <sentence id="s324" text="As a brand new tumor-suppressor gene, the expression of Kank1 gene has been revealed to be downregulated or absent in many malignant tumors.">
    <entity charOffset="56-60" id="s324.e0" ontology_id="23189" text="Kank" type="GENE"/>
    <entity charOffset="133-139" id="s324.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s324.e0" e2="s324.e1" id="s324.p0" relation="true"/>
  </sentence>
  <sentence id="s325" text="In dogs, myotonia is associated with mutations in CLCN1.">
    <entity charOffset="9-17" id="s325.e0" ontology_id="HP_0002486" text="myotonia" type="HP"/>
    <entity charOffset="50-55" id="s325.e1" ontology_id="1180" text="CLCN1" type="GENE"/>
    <pair e1="s325.e0" e2="s325.e1" id="s325.p0" relation="true"/>
  </sentence>
  <sentence id="s326" text="Recently, loss-of-function mutations in BCAP31 were reported in association with severe developmental delay, deafness and dystonia.">
    <entity charOffset="40-46" id="s326.e0" ontology_id="10134" text="BCAP31" type="GENE"/>
    <entity charOffset="122-130" id="s326.e1" ontology_id="HP_0001332" text="dystonia" type="HP"/>
    <pair e1="s326.e0" e2="s326.e1" id="s326.p0" relation="true"/>
  </sentence>
  <sentence id="s327" text="&lt;b&gt;Results&lt;/b&gt;: AMACR overexpression was significantly associated with advanced tumor status (&lt;i&gt;P&lt;/i&gt;=0.001), advanced nodal status (&lt;i&gt;P&lt;/i&gt;=0.036), increased vascular invasion (&lt;i&gt;P&lt;/i&gt;=0.026) and increased perineural invasion (&lt;i&gt;P&lt;/i&gt;=0.004).">
    <entity charOffset="16-21" id="s327.e0" ontology_id="23600" text="AMACR" type="GENE"/>
    <entity charOffset="80-85" id="s327.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s327.e0" e2="s327.e1" id="s327.p0" relation="true"/>
  </sentence>
  <sentence id="s328" text="Uveal melanomas are molecularly distinct from cutaneous melanomas and lack mutations in BRAF, NRAS, KIT, and NF1.">
    <entity charOffset="46-65" id="s328.e0" ontology_id="HP_0012056" text="cutaneous melanomas" type="HP"/>
    <entity charOffset="88-92" id="s328.e1" ontology_id="673" text="BRAF" type="GENE"/>
    <pair e1="s328.e0" e2="s328.e1" id="s328.p0" relation="true"/>
  </sentence>
  <sentence id="s329" text="Six genes (ACOX2, MUC1, CRYBB2, PSPH, SQLE, TYMS) were differentially expressed by race among Luminal A breast cancers and were associated with survival (HR &amp;lt;0.8, HR &amp;gt;1.25).">
    <entity charOffset="18-22" id="s329.e0" ontology_id="4582" text="MUC1" type="GENE"/>
    <entity charOffset="111-117" id="s329.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s329.e0" e2="s329.e1" id="s329.p0" relation="true"/>
  </sentence>
  <sentence id="s330" text="Six genes (ACOX2, MUC1, CRYBB2, PSPH, SQLE, TYMS) were differentially expressed by race among Luminal A breast cancers and were associated with survival (HR &amp;lt;0.8, HR &amp;gt;1.25).">
    <entity charOffset="24-30" id="s330.e0" ontology_id="1415" text="CRYBB2" type="GENE"/>
    <entity charOffset="111-117" id="s330.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s330.e0" e2="s330.e1" id="s330.p0" relation="true"/>
  </sentence>
  <sentence id="s331" text="Six genes (ACOX2, MUC1, CRYBB2, PSPH, SQLE, TYMS) were differentially expressed by race among Luminal A breast cancers and were associated with survival (HR &amp;lt;0.8, HR &amp;gt;1.25).">
    <entity charOffset="38-42" id="s331.e0" ontology_id="6713" text="SQLE" type="GENE"/>
    <entity charOffset="111-117" id="s331.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s331.e0" e2="s331.e1" id="s331.p0" relation="true"/>
  </sentence>
  <sentence id="s332" text="Overexpression of Rab3IP in gastric cancer was verified at both transcriptional and translational levels.">
    <entity charOffset="18-24" id="s332.e0" ontology_id="117177" text="Rab3IP" type="GENE"/>
    <entity charOffset="36-42" id="s332.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s332.e0" e2="s332.e1" id="s332.p0" relation="true"/>
  </sentence>
  <sentence id="s333" text="In addition, we verified the co-expression of and interplay between Rab3IP and SSX2 during gastric cancer progression.">
    <entity charOffset="79-83" id="s333.e0" ontology_id="6757" text="SSX2" type="GENE"/>
    <entity charOffset="99-105" id="s333.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s333.e0" e2="s333.e1" id="s333.p0" relation="true"/>
  </sentence>
  <sentence id="s334" text="Cellular studies showed that Rab3IP could induce an aggressive phenotype in gastric cancer cells and that its expression was correlated with markers of the epithelial-mesenchymal transition (EMT).">
    <entity charOffset="29-35" id="s334.e0" ontology_id="117177" text="Rab3IP" type="GENE"/>
    <entity charOffset="84-90" id="s334.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s334.e0" e2="s334.e1" id="s334.p0" relation="true"/>
  </sentence>
  <sentence id="s335" text="Exome and targeted sequencing has recently identified four new genes causing ataxia: TGM6, ANO10, SYT14, and rundataxin.">
    <entity charOffset="77-83" id="s335.e0" ontology_id="HP_0001251" text="ataxia" type="HP"/>
    <entity charOffset="91-96" id="s335.e1" ontology_id="55129" text="ANO10" type="GENE"/>
    <pair e1="s335.e0" e2="s335.e1" id="s335.p0" relation="true"/>
  </sentence>
  <sentence id="s336" text="Exome and targeted sequencing has recently identified four new genes causing ataxia: TGM6, ANO10, SYT14, and rundataxin.">
    <entity charOffset="77-83" id="s336.e0" ontology_id="HP_0001251" text="ataxia" type="HP"/>
    <entity charOffset="98-103" id="s336.e1" ontology_id="255928" text="SYT14" type="GENE"/>
    <pair e1="s336.e0" e2="s336.e1" id="s336.p0" relation="true"/>
  </sentence>
  <sentence id="s337" text="Only a few genes, including SMARCA4, SMO, ZNF44 and CHD2, were recurrently and specifically mutated in the SS group, confirming the low recurrence of common mutations in this tumor.">
    <entity charOffset="37-40" id="s337.e0" ontology_id="54498" text="SMO" type="GENE"/>
    <entity charOffset="175-180" id="s337.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s337.e0" e2="s337.e1" id="s337.p0" relation="false"/>
  </sentence>
  <sentence id="s338" text="Only a few genes, including SMARCA4, SMO, ZNF44 and CHD2, were recurrently and specifically mutated in the SS group, confirming the low recurrence of common mutations in this tumor.">
    <entity charOffset="52-56" id="s338.e0" ontology_id="1106" text="CHD2" type="GENE"/>
    <entity charOffset="175-180" id="s338.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s338.e0" e2="s338.e1" id="s338.p0" relation="false"/>
  </sentence>
  <sentence id="s339" text="It is reported the expression of HCRP1 is inversely related to epidermal growth factor receptor (EGFR) in breast cancer and lead to resistance to cetuximab in ovarian cancer.">
    <entity charOffset="97-101" id="s339.e0" ontology_id="1956" text="EGFR" type="GENE"/>
    <entity charOffset="113-119" id="s339.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s339.e0" e2="s339.e1" id="s339.p0" relation="true"/>
  </sentence>
  <sentence id="s340" text="PKD1 and PKD2 germline mutations are found in patients with autosomal dominant polycystic kidney disease (ADPKD).">
    <entity charOffset="9-13" id="s340.e0" ontology_id="25865" text="PKD2" type="GENE"/>
    <entity charOffset="90-104" id="s340.e1" ontology_id="HP_0000077" text="kidney disease" type="HP"/>
    <pair e1="s340.e0" e2="s340.e1" id="s340.p0" relation="true"/>
  </sentence>
  <sentence id="s341" text="Biallelic UNC80 mutations cause infantile hypotonia with psychomotor retardation and characteristic facies 2 (IHPRF2), which is characterized by hypotonia, developmental delay (DD)/intellectual disability (ID), intrauterine growth retardation, postnatal growth retardation and characteristic facial features.">
    <entity charOffset="10-15" id="s341.e0" ontology_id="285175" text="UNC80" type="GENE"/>
    <entity charOffset="181-204" id="s341.e1" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <pair e1="s341.e0" e2="s341.e1" id="s341.p0" relation="true"/>
  </sentence>
  <sentence id="s342" text="The importance of PKC enzymes in Purkinje neuron health is apparent as mutations in PRKCG (encoding PKC) cause cerebellar ataxia.">
    <entity charOffset="84-89" id="s342.e0" ontology_id="5582" text="PRKCG" type="GENE"/>
    <entity charOffset="112-129" id="s342.e1" ontology_id="HP_0001251" text="cerebellar ataxia" type="HP"/>
    <pair e1="s342.e0" e2="s342.e1" id="s342.p0" relation="true"/>
  </sentence>
  <sentence id="s343" text="Using mouse models of spinocerebellar ataxia type 1 (SCA1) and 2 (SCA2) we identify an increase in PKC-mediated substrate phosphorylation in two different forms of inherited cerebellar ataxia.">
    <entity charOffset="27-44" id="s343.e0" ontology_id="HP_0001251" text="cerebellar ataxia" type="HP"/>
    <entity charOffset="53-57" id="s343.e1" ontology_id="6310" text="SCA1" type="GENE"/>
    <pair e1="s343.e0" e2="s343.e1" id="s343.p0" relation="false"/>
  </sentence>
  <sentence id="s344" text="RHOA, SMAD2, SMAD4, SMAD5, SMAD6, BMPR1A, SMAD7 and MYC-, which thereby emerge as candidate genes to play an important role in CRC tumor metastasis">
    <entity charOffset="6-11" id="s344.e0" ontology_id="4087" text="SMAD2" type="GENE"/>
    <entity charOffset="131-136" id="s344.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s344.e0" e2="s344.e1" id="s344.p0" relation="true"/>
  </sentence>
  <sentence id="s345" text="RHOA, SMAD2, SMAD4, SMAD5, SMAD6, BMPR1A, SMAD7 and MYC-, which thereby emerge as candidate genes to play an important role in CRC tumor metastasis">
    <entity charOffset="13-18" id="s345.e0" ontology_id="4089" text="SMAD4" type="GENE"/>
    <entity charOffset="131-136" id="s345.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s345.e0" e2="s345.e1" id="s345.p0" relation="true"/>
  </sentence>
  <sentence id="s346" text="RHOA, SMAD2, SMAD4, SMAD5, SMAD6, BMPR1A, SMAD7 and MYC-, which thereby emerge as candidate genes to play an important role in CRC tumor metastasis">
    <entity charOffset="27-32" id="s346.e0" ontology_id="4091" text="SMAD6" type="GENE"/>
    <entity charOffset="131-136" id="s346.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s346.e0" e2="s346.e1" id="s346.p0" relation="true"/>
  </sentence>
  <sentence id="s347" text="RHOA, SMAD2, SMAD4, SMAD5, SMAD6, BMPR1A, SMAD7 and MYC-, which thereby emerge as candidate genes to play an important role in CRC tumor metastasis">
    <entity charOffset="52-55" id="s347.e0" ontology_id="4609" text="MYC" type="GENE"/>
    <entity charOffset="131-136" id="s347.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s347.e0" e2="s347.e1" id="s347.p0" relation="true"/>
  </sentence>
  <sentence id="s348" text="Recent studies have linked mutations in the SLC24A4 (NCKX4) and SLC24A5 (NCKX5) genes to amylogenesis imperfecta (AI) and non-syndromic oculocutaneous albinism (OCA6), respectively.">
    <entity charOffset="44-51" id="s348.e0" ontology_id="123041" text="SLC24A4" type="GENE"/>
    <entity charOffset="151-159" id="s348.e1" ontology_id="HP_0001022" text="albinism" type="HP"/>
    <pair e1="s348.e0" e2="s348.e1" id="s348.p0" relation="false"/>
  </sentence>
  <sentence id="s349" text="Recent studies have linked mutations in the SLC24A4 (NCKX4) and SLC24A5 (NCKX5) genes to amylogenesis imperfecta (AI) and non-syndromic oculocutaneous albinism (OCA6), respectively.">
    <entity charOffset="53-58" id="s349.e0" ontology_id="123041" text="NCKX4" type="GENE"/>
    <entity charOffset="151-159" id="s349.e1" ontology_id="HP_0001022" text="albinism" type="HP"/>
    <pair e1="s349.e0" e2="s349.e1" id="s349.p0" relation="false"/>
  </sentence>
  <sentence id="s350" text="Recent studies have linked mutations in the SLC24A4 (NCKX4) and SLC24A5 (NCKX5) genes to amylogenesis imperfecta (AI) and non-syndromic oculocutaneous albinism (OCA6), respectively.">
    <entity charOffset="73-77" id="s350.e0" ontology_id="9187" text="NCKX" type="GENE"/>
    <entity charOffset="151-159" id="s350.e1" ontology_id="HP_0001022" text="albinism" type="HP"/>
    <pair e1="s350.e0" e2="s350.e1" id="s350.p0" relation="true"/>
  </sentence>
  <sentence id="s351" text="This arrangement is required for filament formation and is directed by an ordered ZP-N/ZP-C linker that is not observed in ZP2 but is conserved in the sequence of deafness/Crohn's disease-associated homopolymeric glycoproteins -tectorin (TECTA) and glycoprotein 2 (GP2).">
    <entity charOffset="163-171" id="s351.e0" ontology_id="HP_0000365" text="deafness" type="HP"/>
    <entity charOffset="239-244" id="s351.e1" ontology_id="7007" text="TECTA" type="GENE"/>
    <pair e1="s351.e0" e2="s351.e1" id="s351.p0" relation="true"/>
  </sentence>
  <sentence id="s352" text="Gain-of-function mutations in the human PIEZO2 gene cause three clinical types of autosomal dominant distal arthrogryposis.">
    <entity charOffset="40-46" id="s352.e0" ontology_id="63895" text="PIEZO2" type="GENE"/>
    <entity charOffset="101-107" id="s352.e1" ontology_id="HP_0012839" text="distal" type="HP"/>
    <pair e1="s352.e0" e2="s352.e1" id="s352.p0" relation="true"/>
  </sentence>
  <sentence id="s353" text="Gain-of-function mutations in the human PIEZO2 gene cause three clinical types of autosomal dominant distal arthrogryposis.">
    <entity charOffset="40-46" id="s353.e0" ontology_id="63895" text="PIEZO2" type="GENE"/>
    <entity charOffset="108-122" id="s353.e1" ontology_id="HP_0002804" text="arthrogryposis" type="HP"/>
    <pair e1="s353.e0" e2="s353.e1" id="s353.p0" relation="true"/>
  </sentence>
  <sentence id="s354" text="Pathogenic sequence variants in the Sorting Nexin 10 (SNX10) gene have been associated with autosomal recessive osteopetrosis (ARO) in human.">
    <entity charOffset="54-59" id="s354.e0" ontology_id="29887" text="SNX10" type="GENE"/>
    <entity charOffset="92-111" id="s354.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s354.e0" e2="s354.e1" id="s354.p0" relation="true"/>
  </sentence>
  <sentence id="s355" text="In our study, we aim to investigate whether variants of KCNA1, KCNA2, and KCNV2 genes influence susceptibility to genetic generalized epilepsies (GGEs) and the efficacy of AEDs.">
    <entity charOffset="74-79" id="s355.e0" ontology_id="169522" text="KCNV2" type="GENE"/>
    <entity charOffset="134-144" id="s355.e1" ontology_id="HP_0001250" text="epilepsies" type="HP"/>
    <pair e1="s355.e0" e2="s355.e1" id="s355.p0" relation="true"/>
  </sentence>
  <sentence id="s356" text="These results suggest that MAFB and MAFF play critical roles in the antitumor effects of retinoids by regulating the expression of retinoid target genes such as TFPI2 and can be promising for developing therapies to combat HCC invasion">
    <entity charOffset="27-31" id="s356.e0" ontology_id="9935" text="MAFB" type="GENE"/>
    <entity charOffset="72-77" id="s356.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s356.e0" e2="s356.e1" id="s356.p0" relation="true"/>
  </sentence>
  <sentence id="s357" text="These results suggest that MAFB and MAFF play critical roles in the antitumor effects of retinoids by regulating the expression of retinoid target genes such as TFPI2 and can be promising for developing therapies to combat HCC invasion">
    <entity charOffset="72-77" id="s357.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="161-166" id="s357.e1" ontology_id="7980" text="TFPI2" type="GENE"/>
    <pair e1="s357.e0" e2="s357.e1" id="s357.p0" relation="false"/>
  </sentence>
  <sentence id="s358" text="In the present study, we sought to identify the factors involved in the RAR&amp;amp;alpha;-mediated transcriptional regulation of the tumor suppressor gene and the tissue factor pathway inhibitor 2 (TFPI2) in hepatocellular carcinoma (HCC).">
    <entity charOffset="130-135" id="s358.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="195-200" id="s358.e1" ontology_id="7980" text="TFPI2" type="GENE"/>
    <pair e1="s358.e0" e2="s358.e1" id="s358.p0" relation="false"/>
  </sentence>
  <sentence id="s359" text="The musculo-aponeurotic fibrosarcoma oncogene homolog B (MAFB) significantly enhanced the activation of the TFPI2 promoter via RAR&amp;amp;alpha; while MAFF inhibited it.">
    <entity charOffset="24-36" id="s359.e0" ontology_id="HP_0100244" text="fibrosarcoma" type="HP"/>
    <entity charOffset="57-61" id="s359.e1" ontology_id="9935" text="MAFB" type="GENE"/>
    <pair e1="s359.e0" e2="s359.e1" id="s359.p0" relation="true"/>
  </sentence>
  <sentence id="s360" text="In human breast cancer xenografts in humanized mice, blocking the recruitment of naive CD4&lt;sup&gt;+&lt;/sup&gt; T cells into tumor by knocking down the expression of PITPNM3, a CCL18 receptor, significantly reduces intratumoral Tregs and inhibits tumor progression.">
    <entity charOffset="116-121" id="s360.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="157-164" id="s360.e1" ontology_id="83394" text="PITPNM3" type="GENE"/>
    <pair e1="s360.e0" e2="s360.e1" id="s360.p0" relation="true"/>
  </sentence>
  <sentence id="s361" text="Inhibiting naive CD4&lt;sup&gt;+&lt;/sup&gt; T cell recruitment into tumors by interfering with PITPNM3 recognition of CCL18 may be an attractive strategy for anticancer immunotherapy">
    <entity charOffset="57-62" id="s361.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="84-91" id="s361.e1" ontology_id="83394" text="PITPNM3" type="GENE"/>
    <pair e1="s361.e0" e2="s361.e1" id="s361.p0" relation="true"/>
  </sentence>
  <sentence id="s362" text="Fungal immunomodulatory protein from &lt;i&gt;Nectria haematococca&lt;/i&gt; (FIP-nha) has potential as a lung cancer therapeutic; as such, illuminating its anti-tumor mechanism is expected to facilitate novel treatment options.">
    <entity charOffset="66-69" id="s362.e0" ontology_id="7392" text="FIP" type="GENE"/>
    <entity charOffset="150-155" id="s362.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s362.e0" e2="s362.e1" id="s362.p0" relation="true"/>
  </sentence>
  <sentence id="s363" text="To evaluate the role of constitutive epigenetic changes in normal body cells of BRCA1/BRCA2-mutation negative patients, we have developed a deep bisulfite sequencing assay targeting the promoter regions of 8 tumor suppressor (TS) genes (BRCA1, BRCA2, RAD51C, ATM, PTEN, TP53, MLH1, RB1) and the estrogene receptor gene (ESR1), which plays a role in tumor progression.">
    <entity charOffset="208-213" id="s363.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="264-268" id="s363.e1" ontology_id="5728" text="PTEN" type="GENE"/>
    <pair e1="s363.e0" e2="s363.e1" id="s363.p0" relation="true"/>
  </sentence>
  <sentence id="s364" text="Perhaps unusually for autosomal recessive diseases, heterozygotes for mutations in NPC1 manifest many biological variations.">
    <entity charOffset="22-41" id="s364.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="83-87" id="s364.e1" ontology_id="4864" text="NPC1" type="GENE"/>
    <pair e1="s364.e0" e2="s364.e1" id="s364.p0" relation="true"/>
  </sentence>
  <sentence id="s365" text="Mice lacking Zbtb20 in the liver exhibit hypolipidemia and reduced levels of liver triglycerides, along with impaired hepatic lipogenesis.">
    <entity charOffset="13-19" id="s365.e0" ontology_id="26137" text="Zbtb20" type="GENE"/>
    <entity charOffset="41-54" id="s365.e1" ontology_id="HP_0045014" text="hypolipidemia" type="HP"/>
    <pair e1="s365.e0" e2="s365.e1" id="s365.p0" relation="true"/>
  </sentence>
  <sentence id="s366" text="The progressive neurological abnormalities, congenital hypopituitarism and post-retinal visual pathway dysfunction in affected individuals demonstrates for the first time the essential role of ARNT2 in the development of the hypothalamo-pituitary axis, post-natal brain growth, and visual and renal function in humans.">
    <entity charOffset="16-42" id="s366.e0" ontology_id="HP_0000707" text="neurological abnormalities" type="HP"/>
    <entity charOffset="193-198" id="s366.e1" ontology_id="9915" text="ARNT2" type="GENE"/>
    <pair e1="s366.e0" e2="s366.e1" id="s366.p0" relation="false"/>
  </sentence>
  <sentence id="s367" text="Here we describe novel sequence variants in SBF1 (c.1168C&amp;gt;G and c.2209_2210del) as the potential causative mutations in two siblings with severe axonal neuropathy, hearing loss, facial weakness and bulbar features.">
    <entity charOffset="44-48" id="s367.e0" ontology_id="6305" text="SBF1" type="GENE"/>
    <entity charOffset="181-196" id="s367.e1" ontology_id="HP_0010628" text="facial weakness" type="HP"/>
    <pair e1="s367.e0" e2="s367.e1" id="s367.p0" relation="true"/>
  </sentence>
  <sentence id="s368" text="Our findings enlarge the spectrum of tubulinopathies and emphasize that mutations of TUBB6 should be considered in patients with congenital non-progressive facial palsy.">
    <entity charOffset="85-90" id="s368.e0" ontology_id="84617" text="TUBB6" type="GENE"/>
    <entity charOffset="156-168" id="s368.e1" ontology_id="HP_0010628" text="facial palsy" type="HP"/>
    <pair e1="s368.e0" e2="s368.e1" id="s368.p0" relation="true"/>
  </sentence>
  <sentence id="s369" text="Here we show that mitochondrial Sirtuin5 (SIRT5), which mediates lysine desuccinylation, deglutarylation, and demalonylation, plays a role in colorectal cancer (CRC) glutamine metabolic rewiring.">
    <entity charOffset="42-47" id="s369.e0" ontology_id="23408" text="SIRT5" type="GENE"/>
    <entity charOffset="153-159" id="s369.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s369.e0" e2="s369.e1" id="s369.p0" relation="true"/>
  </sentence>
  <sentence id="s370" text="High expression of Chemokine receptor 4 (CXCR4) is important in tumor invasion, metastasis, drug-resistance and maintenance of stemness in non-small cell lung cancer (NSCLC).">
    <entity charOffset="41-46" id="s370.e0" ontology_id="7852" text="CXCR4" type="GENE"/>
    <entity charOffset="159-165" id="s370.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s370.e0" e2="s370.e1" id="s370.p0" relation="true"/>
  </sentence>
  <sentence id="s371" text="Friedreich's ataxia (FRDA) is an autosomal recessive neurodegenerative disorder resulting from reduced expression of the protein frataxin (FXN).">
    <entity charOffset="13-19" id="s371.e0" ontology_id="HP_0001251" text="ataxia" type="HP"/>
    <entity charOffset="139-142" id="s371.e1" ontology_id="2395" text="FXN" type="GENE"/>
    <pair e1="s371.e0" e2="s371.e1" id="s371.p0" relation="true"/>
  </sentence>
  <sentence id="s372" text="In the present article, we describe an infant who smelt of ketones during examination and who was diagnosed with transient NDM caused by a ZFP57 mutation, accompanied by ketoacidosis.">
    <entity charOffset="139-144" id="s372.e0" ontology_id="346171" text="ZFP57" type="GENE"/>
    <entity charOffset="170-182" id="s372.e1" ontology_id="HP_0001993" text="ketoacidosis" type="HP"/>
    <pair e1="s372.e0" e2="s372.e1" id="s372.p0" relation="true"/>
  </sentence>
  <sentence id="s373" text="TRAPPC9 gene mutations have been linked recently to autosomal recessive mental retardation 13 (MRT13; MIM#613192) with only eight families reported world-wide.">
    <entity charOffset="52-71" id="s373.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="95-100" id="s373.e1" ontology_id="83696" text="MRT13" type="GENE"/>
    <pair e1="s373.e0" e2="s373.e1" id="s373.p0" relation="true"/>
  </sentence>
  <sentence id="s374" text="The tumor cells with immunoreactivity to CK7, CK19, Cam5.2, COX2, EMA, BCL-2, MOC-31 and AE1/AE3, supported a diagnosis of intrahepatic cholangiocarcinoma.">
    <entity charOffset="4-9" id="s374.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="71-76" id="s374.e1" ontology_id="596" text="BCL-2" type="GENE"/>
    <pair e1="s374.e0" e2="s374.e1" id="s374.p0" relation="true"/>
  </sentence>
  <sentence id="s375" text="Mutations in CASK cause a wide spectrum of phenotypes in humans ranging from mild X-linked intellectual disability to a severe microcephaly (MC) and pontocerebellar hypoplasia syndrome.">
    <entity charOffset="13-17" id="s375.e0" ontology_id="8573" text="CASK" type="GENE"/>
    <entity charOffset="91-114" id="s375.e1" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <pair e1="s375.e0" e2="s375.e1" id="s375.p0" relation="true"/>
  </sentence>
  <sentence id="s376" text="These results demonstrate that Piccolo contributes to tumor aggressiveness in ESCC, likely by stabilizing EGFR and promoting EGFR-dependent signaling.">
    <entity charOffset="60-74" id="s376.e0" ontology_id="HP_0000718" text="aggressiveness" type="HP"/>
    <entity charOffset="106-110" id="s376.e1" ontology_id="1956" text="EGFR" type="GENE"/>
    <pair e1="s376.e0" e2="s376.e1" id="s376.p0" relation="true"/>
  </sentence>
  <sentence id="s377" text="These results indicated that the HFD aggravates BDE47-inhibited testosterone production through hyperinsulinemia, and the accumulation of testicular BDE47 that induces the up-regulation of DAX-1 and the subsequent down-regulation of steroidogenic proteins, i.e., StAR and 3-HSD, in Leydig cells">
    <entity charOffset="96-112" id="s377.e0" ontology_id="HP_0000842" text="hyperinsulinemia" type="HP"/>
    <entity charOffset="263-267" id="s377.e1" ontology_id="2984" text="StAR" type="GENE"/>
    <pair e1="s377.e0" e2="s377.e1" id="s377.p0" relation="false"/>
  </sentence>
  <sentence id="s378" text="In a cohort of Australians of European descent, consisting of 385 keratoconus cases and 396 controls, we screened 21 keratoconus candidate genes: BANP, CAST, COL4A3, COL4A4, COL5A1, FOXO1, FNDC3B, HGF, IL1A, IL1B, ILRN, IMMP2L, MPDZ, NFIB, RAB3GAP1, RAD51, RXRA, SLC4A11, SOD1, TF and VSX1.">
    <entity charOffset="66-77" id="s378.e0" ontology_id="HP_0000563" text="keratoconus" type="HP"/>
    <entity charOffset="285-289" id="s378.e1" ontology_id="30813" text="VSX1" type="GENE"/>
    <pair e1="s378.e0" e2="s378.e1" id="s378.p0" relation="true"/>
  </sentence>
  <sentence id="s379" text="In a cohort of Australians of European descent, consisting of 385 keratoconus cases and 396 controls, we screened 21 keratoconus candidate genes: BANP, CAST, COL4A3, COL4A4, COL5A1, FOXO1, FNDC3B, HGF, IL1A, IL1B, ILRN, IMMP2L, MPDZ, NFIB, RAB3GAP1, RAD51, RXRA, SLC4A11, SOD1, TF and VSX1.">
    <entity charOffset="66-77" id="s379.e0" ontology_id="HP_0000563" text="keratoconus" type="HP"/>
    <entity charOffset="257-261" id="s379.e1" ontology_id="6256" text="RXRA" type="GENE"/>
    <pair e1="s379.e0" e2="s379.e1" id="s379.p0" relation="true"/>
  </sentence>
  <sentence id="s380" text="In a cohort of Australians of European descent, consisting of 385 keratoconus cases and 396 controls, we screened 21 keratoconus candidate genes: BANP, CAST, COL4A3, COL4A4, COL5A1, FOXO1, FNDC3B, HGF, IL1A, IL1B, ILRN, IMMP2L, MPDZ, NFIB, RAB3GAP1, RAD51, RXRA, SLC4A11, SOD1, TF and VSX1.">
    <entity charOffset="66-77" id="s380.e0" ontology_id="HP_0000563" text="keratoconus" type="HP"/>
    <entity charOffset="174-180" id="s380.e1" ontology_id="1289" text="COL5A1" type="GENE"/>
    <pair e1="s380.e0" e2="s380.e1" id="s380.p0" relation="true"/>
  </sentence>
  <sentence id="s381" text="In a cohort of Australians of European descent, consisting of 385 keratoconus cases and 396 controls, we screened 21 keratoconus candidate genes: BANP, CAST, COL4A3, COL4A4, COL5A1, FOXO1, FNDC3B, HGF, IL1A, IL1B, ILRN, IMMP2L, MPDZ, NFIB, RAB3GAP1, RAD51, RXRA, SLC4A11, SOD1, TF and VSX1.">
    <entity charOffset="66-77" id="s381.e0" ontology_id="HP_0000563" text="keratoconus" type="HP"/>
    <entity charOffset="263-270" id="s381.e1" ontology_id="83959" text="SLC4A11" type="GENE"/>
    <pair e1="s381.e0" e2="s381.e1" id="s381.p0" relation="true"/>
  </sentence>
  <sentence id="s382" text="In a cohort of Australians of European descent, consisting of 385 keratoconus cases and 396 controls, we screened 21 keratoconus candidate genes: BANP, CAST, COL4A3, COL4A4, COL5A1, FOXO1, FNDC3B, HGF, IL1A, IL1B, ILRN, IMMP2L, MPDZ, NFIB, RAB3GAP1, RAD51, RXRA, SLC4A11, SOD1, TF and VSX1.">
    <entity charOffset="66-77" id="s382.e0" ontology_id="HP_0000563" text="keratoconus" type="HP"/>
    <entity charOffset="166-172" id="s382.e1" ontology_id="1286" text="COL4A4" type="GENE"/>
    <pair e1="s382.e0" e2="s382.e1" id="s382.p0" relation="true"/>
  </sentence>
  <sentence id="s383" text="In a cohort of Australians of European descent, consisting of 385 keratoconus cases and 396 controls, we screened 21 keratoconus candidate genes: BANP, CAST, COL4A3, COL4A4, COL5A1, FOXO1, FNDC3B, HGF, IL1A, IL1B, ILRN, IMMP2L, MPDZ, NFIB, RAB3GAP1, RAD51, RXRA, SLC4A11, SOD1, TF and VSX1.">
    <entity charOffset="66-77" id="s383.e0" ontology_id="HP_0000563" text="keratoconus" type="HP"/>
    <entity charOffset="197-200" id="s383.e1" ontology_id="3569" text="HGF" type="GENE"/>
    <pair e1="s383.e0" e2="s383.e1" id="s383.p0" relation="true"/>
  </sentence>
  <sentence id="s384" text="In a cohort of Australians of European descent, consisting of 385 keratoconus cases and 396 controls, we screened 21 keratoconus candidate genes: BANP, CAST, COL4A3, COL4A4, COL5A1, FOXO1, FNDC3B, HGF, IL1A, IL1B, ILRN, IMMP2L, MPDZ, NFIB, RAB3GAP1, RAD51, RXRA, SLC4A11, SOD1, TF and VSX1.">
    <entity charOffset="66-77" id="s384.e0" ontology_id="HP_0000563" text="keratoconus" type="HP"/>
    <entity charOffset="146-150" id="s384.e1" ontology_id="54971" text="BANP" type="GENE"/>
    <pair e1="s384.e0" e2="s384.e1" id="s384.p0" relation="true"/>
  </sentence>
  <sentence id="s385" text="In a cohort of Australians of European descent, consisting of 385 keratoconus cases and 396 controls, we screened 21 keratoconus candidate genes: BANP, CAST, COL4A3, COL4A4, COL5A1, FOXO1, FNDC3B, HGF, IL1A, IL1B, ILRN, IMMP2L, MPDZ, NFIB, RAB3GAP1, RAD51, RXRA, SLC4A11, SOD1, TF and VSX1.">
    <entity charOffset="66-77" id="s385.e0" ontology_id="HP_0000563" text="keratoconus" type="HP"/>
    <entity charOffset="240-248" id="s385.e1" ontology_id="22930" text="RAB3GAP1" type="GENE"/>
    <pair e1="s385.e0" e2="s385.e1" id="s385.p0" relation="true"/>
  </sentence>
  <sentence id="s386" text="In gene-level analyses, CDC25C, SCC1/RAD21, TLK2, and SMC6L1 were associated (P&amp;lt;0.05) with overall breast cancer risk, CDC6, CDC27, SUMO3, RASSF1, KIF2, and CDC14A were associated with high grade breast cancer risk, and EIF3S10 and CDC25A were associated with both.">
    <entity charOffset="24-30" id="s386.e0" ontology_id="995" text="CDC25C" type="GENE"/>
    <entity charOffset="111-117" id="s386.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s386.e0" e2="s386.e1" id="s386.p0" relation="true"/>
  </sentence>
  <sentence id="s387" text="Functional inhibition of HMGB1 and its receptors abrogated HMGB1-induced angiogenic properties of ECs co-cultured with tumour cells.">
    <entity charOffset="25-30" id="s387.e0" ontology_id="3146" text="HMGB1" type="GENE"/>
    <entity charOffset="119-125" id="s387.e1" ontology_id="HP_0002664" text="tumour" type="HP"/>
    <pair e1="s387.e0" e2="s387.e1" id="s387.p0" relation="true"/>
  </sentence>
  <sentence id="s388" text="Together, our findings suggest that in CRC TIAM1 suppresses tumor progression by regulating YAP/TAZ activity">
    <entity charOffset="43-48" id="s388.e0" ontology_id="7074" text="TIAM1" type="GENE"/>
    <entity charOffset="60-65" id="s388.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s388.e0" e2="s388.e1" id="s388.p0" relation="true"/>
  </sentence>
  <sentence id="s389" text="A case with GAMT deficiency (homozygous c.64dupG mutation) presented with neurodevelopmental delay, rare seizures, behavioral disturbances, and mild hypotonia, posing diagnostic challenges.">
    <entity charOffset="12-16" id="s389.e0" ontology_id="2593" text="GAMT" type="GENE"/>
    <entity charOffset="105-113" id="s389.e1" ontology_id="HP_0001250" text="seizures" type="HP"/>
    <pair e1="s389.e0" e2="s389.e1" id="s389.p0" relation="true"/>
  </sentence>
  <sentence id="s390" text="In addition, reduced hair follicles (HFs) while the enlarged and increased number of sebaceous glands (SGs) were also found in the Hoxc13&lt;sup&gt;-/-&lt;/sup&gt; rabbits, showing that the disrupted balance between HFs and SGs may respond to hypotrichosis of ECTD-9 in an animal model and clinically.">
    <entity charOffset="131-137" id="s390.e0" ontology_id="3229" text="Hoxc13" type="GENE"/>
    <entity charOffset="231-244" id="s390.e1" ontology_id="HP_0001006" text="hypotrichosis" type="HP"/>
    <pair e1="s390.e0" e2="s390.e1" id="s390.p0" relation="false"/>
  </sentence>
  <sentence id="s391" text="Here, the homozygous Hoxc13&lt;sup&gt;-/-&lt;/sup&gt; rabbits showed complete loss of hair on the head and dorsum, whereas hypotrichosis in the limbs and tail were determined in the Hoxc13&lt;sup&gt;-/-&lt;/sup&gt; rabbits.">
    <entity charOffset="21-27" id="s391.e0" ontology_id="3229" text="Hoxc13" type="GENE"/>
    <entity charOffset="111-124" id="s391.e1" ontology_id="HP_0001006" text="hypotrichosis" type="HP"/>
    <pair e1="s391.e0" e2="s391.e1" id="s391.p0" relation="false"/>
  </sentence>
  <sentence id="s392" text="We present a family in which we found both germline and somatic mosaicism for MEN1.">
    <entity charOffset="56-73" id="s392.e0" ontology_id="HP_0001442" text="somatic mosaicism" type="HP"/>
    <entity charOffset="78-82" id="s392.e1" ontology_id="4221" text="MEN1" type="GENE"/>
    <pair e1="s392.e0" e2="s392.e1" id="s392.p0" relation="true"/>
  </sentence>
  <sentence id="s393" text="This study illustrates that germline mosaicism is important to consider in apparently sporadic de novo MEN1 mutations, because of its particular importance for genetic counseling, specifically when evaluating the risk for family members and when considering the possibility of somatic mosaicism in the parent with germline mosaicism">
    <entity charOffset="86-94" id="s393.e0" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <entity charOffset="103-107" id="s393.e1" ontology_id="4221" text="MEN1" type="GENE"/>
    <pair e1="s393.e0" e2="s393.e1" id="s393.p0" relation="true"/>
  </sentence>
  <sentence id="s394" text="This study illustrates that germline mosaicism is important to consider in apparently sporadic de novo MEN1 mutations, because of its particular importance for genetic counseling, specifically when evaluating the risk for family members and when considering the possibility of somatic mosaicism in the parent with germline mosaicism">
    <entity charOffset="103-107" id="s394.e0" ontology_id="4221" text="MEN1" type="GENE"/>
    <entity charOffset="277-294" id="s394.e1" ontology_id="HP_0001442" text="somatic mosaicism" type="HP"/>
    <pair e1="s394.e0" e2="s394.e1" id="s394.p0" relation="false"/>
  </sentence>
  <sentence id="s395" text="Studying consanguineous families with Ghosal hematodiaphyseal dysplasia syndrome (GHDD), a disorder of increased bone density, we identified mutations in TBXAS1, which encodes thromboxane synthase (TXAS).">
    <entity charOffset="103-125" id="s395.e0" ontology_id="HP_0011001" text="increased bone density" type="HP"/>
    <entity charOffset="198-202" id="s395.e1" ontology_id="6916" text="TXAS" type="GENE"/>
    <pair e1="s395.e0" e2="s395.e1" id="s395.p0" relation="true"/>
  </sentence>
  <sentence id="s396" text="Various genes (eg, SPG7, SYNE1, PNPLA6) traditionally rooted in either the ataxia or hereditary spastic paraplegia classification system have now been shown to cause ataxia on the one end of the disease continuum and hereditary spastic paraplegia on the other.">
    <entity charOffset="19-23" id="s396.e0" ontology_id="6687" text="SPG7" type="GENE"/>
    <entity charOffset="75-81" id="s396.e1" ontology_id="HP_0001251" text="ataxia" type="HP"/>
    <pair e1="s396.e0" e2="s396.e1" id="s396.p0" relation="true"/>
  </sentence>
  <sentence id="s397" text="Various genes (eg, SPG7, SYNE1, PNPLA6) traditionally rooted in either the ataxia or hereditary spastic paraplegia classification system have now been shown to cause ataxia on the one end of the disease continuum and hereditary spastic paraplegia on the other.">
    <entity charOffset="25-30" id="s397.e0" ontology_id="23345" text="SYNE1" type="GENE"/>
    <entity charOffset="75-81" id="s397.e1" ontology_id="HP_0001251" text="ataxia" type="HP"/>
    <pair e1="s397.e0" e2="s397.e1" id="s397.p0" relation="true"/>
  </sentence>
  <sentence id="s398" text="Genetic rearrangements involving androgen-regulated transmembrane protease serine 2 (TMPRSS2) and genes from the ETS transcription factor family, most commonly ERG and ETV1, result in alteration that responsible for oncogenic activity in prostate cancer (PC).">
    <entity charOffset="160-163" id="s398.e0" ontology_id="2078" text="ERG" type="GENE"/>
    <entity charOffset="247-253" id="s398.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s398.e0" e2="s398.e1" id="s398.p0" relation="true"/>
  </sentence>
  <sentence id="s399" text="Furthermore, cardiovascular risk factors such hyperthyroidism, hypertension and redox homeostasis have been identified to modulate PITX2 driven gene regulatory networks.">
    <entity charOffset="46-61" id="s399.e0" ontology_id="HP_0000836" text="hyperthyroidism" type="HP"/>
    <entity charOffset="131-136" id="s399.e1" ontology_id="5308" text="PITX2" type="GENE"/>
    <pair e1="s399.e0" e2="s399.e1" id="s399.p0" relation="true"/>
  </sentence>
  <sentence id="s400" text="We describe a female proband with primordial dwarfism, skeletal dysplasia, facial dysmorphism, extreme dyslipidaemic insulin resistance and fatty liver associated with a novel homozygous frameshift mutation in POC1A, predicted to affect two of the three protein products of the gene.">
    <entity charOffset="55-73" id="s400.e0" ontology_id="HP_0002652" text="skeletal dysplasia" type="HP"/>
    <entity charOffset="210-215" id="s400.e1" ontology_id="25886" text="POC1A" type="GENE"/>
    <pair e1="s400.e0" e2="s400.e1" id="s400.p0" relation="true"/>
  </sentence>
  <sentence id="s401" text="Pre-NACT core needle biopsies and postoperative tumor samples were immunohistochemically stained for nuclear factor erythroid 2-related factor 2 (Nrf2), Kelch-like ECH-associated protein 1 (Keap1), thioredoxin (Trx), and peroxiredoxin I (Prx I).">
    <entity charOffset="48-53" id="s401.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="146-150" id="s401.e1" ontology_id="2551" text="Nrf2" type="GENE"/>
    <pair e1="s401.e0" e2="s401.e1" id="s401.p0" relation="true"/>
  </sentence>
  <sentence id="s402" text="Pre-NACT core needle biopsies and postoperative tumor samples were immunohistochemically stained for nuclear factor erythroid 2-related factor 2 (Nrf2), Kelch-like ECH-associated protein 1 (Keap1), thioredoxin (Trx), and peroxiredoxin I (Prx I).">
    <entity charOffset="48-53" id="s402.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="190-195" id="s402.e1" ontology_id="9817" text="Keap1" type="GENE"/>
    <pair e1="s402.e0" e2="s402.e1" id="s402.p0" relation="true"/>
  </sentence>
  <sentence id="s403" text="Mutations in LCA5 are a rare cause of childhood retinal dystrophy accounting for 2% of disease in this cohort, and the majority of LCA5 mutations are likely null.">
    <entity charOffset="13-17" id="s403.e0" ontology_id="167691" text="LCA5" type="GENE"/>
    <entity charOffset="48-65" id="s403.e1" ontology_id="HP_0000556" text="retinal dystrophy" type="HP"/>
    <pair e1="s403.e0" e2="s403.e1" id="s403.p0" relation="true"/>
  </sentence>
  <sentence id="s404" text="MVA due to biallelic CEP57 mutations, or of unknown cause, is not associated with embryonal tumors and cells from these individuals show minimal SAC deficiency.">
    <entity charOffset="21-26" id="s404.e0" ontology_id="9702" text="CEP57" type="GENE"/>
    <entity charOffset="92-97" id="s404.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s404.e0" e2="s404.e1" id="s404.p0" relation="false"/>
  </sentence>
  <sentence id="s405" text="Following examination of the association of the identified SNPs to serum concentrations of triglycerides, HDLcholesterol, or LDLcholesterol, linkage disequilibrium of the SNPs, and results of previous genomewide association studies, we newly identified chromosomal region 19p12 as a susceptibility locus for hypertriglyceridemia, eight loci (MOB3CTMOD4, LPGAT1, EHD3, COL6A3, ZNF860CACNA1D, COL6A5, DCLRE1C, ZNF77) for hypoHDLcholesterolemia, and three loci (KIAA0319FAM65B, UBD, LOC105375015) for hyperLDLcholesterolemia.">
    <entity charOffset="311-331" id="s405.e0" ontology_id="HP_0002155" text="hypertriglyceridemia" type="HP"/>
    <entity charOffset="358-364" id="s405.e1" ontology_id="9926" text="LPGAT1" type="GENE"/>
    <pair e1="s405.e0" e2="s405.e1" id="s405.p0" relation="false"/>
  </sentence>
  <sentence id="s406" text="Additional functional analyses suggested that CWC27 played an oncogenic role in bladder cancer by inducing cell proliferation and suppressing apoptosis.">
    <entity charOffset="46-51" id="s406.e0" ontology_id="10283" text="CWC27" type="GENE"/>
    <entity charOffset="88-94" id="s406.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s406.e0" e2="s406.e1" id="s406.p0" relation="true"/>
  </sentence>
  <sentence id="s407" text="The rs2042329 risk allele was also related to significantly increased expression levels of CWC27 mRNA and protein in bladder cancer tissues from Chinese patients.">
    <entity charOffset="91-96" id="s407.e0" ontology_id="10283" text="CWC27" type="GENE"/>
    <entity charOffset="125-131" id="s407.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s407.e0" e2="s407.e1" id="s407.p0" relation="true"/>
  </sentence>
  <sentence id="s408" text="To evaluate the effectiveness of TGE and MPS on screening sporadic NSHL patients, we recruited 63 unrelated sporadic NSHL probands, who had various levels of HL and were excluded for mutations in GJB2, MT-RNR1, and SLC26A4 genes.">
    <entity charOffset="33-36" id="s408.e0" ontology_id="7053" text="TGE" type="GENE"/>
    <entity charOffset="58-66" id="s408.e1" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <pair e1="s408.e0" e2="s408.e1" id="s408.p0" relation="true"/>
  </sentence>
  <sentence id="s409" text="To evaluate the effectiveness of TGE and MPS on screening sporadic NSHL patients, we recruited 63 unrelated sporadic NSHL probands, who had various levels of HL and were excluded for mutations in GJB2, MT-RNR1, and SLC26A4 genes.">
    <entity charOffset="58-66" id="s409.e0" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <entity charOffset="202-204" id="s409.e1" ontology_id="27349" text="MT" type="GENE"/>
    <pair e1="s409.e0" e2="s409.e1" id="s409.p0" relation="false"/>
  </sentence>
  <sentence id="s410" text="To evaluate the effectiveness of TGE and MPS on screening sporadic NSHL patients, we recruited 63 unrelated sporadic NSHL probands, who had various levels of HL and were excluded for mutations in GJB2, MT-RNR1, and SLC26A4 genes.">
    <entity charOffset="58-66" id="s410.e0" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <entity charOffset="205-209" id="s410.e1" ontology_id="4929" text="RNR1" type="GENE"/>
    <pair e1="s410.e0" e2="s410.e1" id="s410.p0" relation="false"/>
  </sentence>
  <sentence id="s411" text="We examined the effects of a mutation in the Sh3pxd2b gene (Sh3pxd2b(nee)) on the progression of otitis media and hearing impairment at various developmental stages.">
    <entity charOffset="45-53" id="s411.e0" ontology_id="285590" text="Sh3pxd2b" type="GENE"/>
    <entity charOffset="114-132" id="s411.e1" ontology_id="HP_0000365" text="hearing impairment" type="HP"/>
    <pair e1="s411.e0" e2="s411.e1" id="s411.p0" relation="true"/>
  </sentence>
  <sentence id="s412" text="Our study suggests that miR-9 functions as a tumor suppressor in HCC progression by inhibiting a series of target genes, including the newly validated miR-9/IGF2BP1/AKT&amp;amp;ERK axis, thus providing potential therapeutic targets and novel prognostic biomarkers for HCC patients.">
    <entity charOffset="45-50" id="s412.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="157-164" id="s412.e1" ontology_id="10642" text="IGF2BP1" type="GENE"/>
    <pair e1="s412.e0" e2="s412.e1" id="s412.p0" relation="false"/>
  </sentence>
  <sentence id="s413" text="Mechanically, miR-9 plays a tumor suppressive role partially through a functional miR-9/IGF2BP1/AKT&amp;amp;ERK axis.">
    <entity charOffset="28-33" id="s413.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="88-95" id="s413.e1" ontology_id="10642" text="IGF2BP1" type="GENE"/>
    <pair e1="s413.e0" e2="s413.e1" id="s413.p0" relation="false"/>
  </sentence>
  <sentence id="s414" text="Nuclear receptor small heterodimer partner (SHP/Nr0b2) is a hepatic tumor suppressor and a critical regulator of liver function.">
    <entity charOffset="44-47" id="s414.e0" ontology_id="8431" text="SHP" type="GENE"/>
    <entity charOffset="68-73" id="s414.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s414.e0" e2="s414.e1" id="s414.p0" relation="false"/>
  </sentence>
  <sentence id="s415" text="However, more recently, inherited SWI/SNF-deficiency has been linked to several benign syndromic tumors including a subset of familial schwannomatosis (linked to SMARCB1) and multiple meningiomas (linked to SMARCE1) as well as others.">
    <entity charOffset="184-195" id="s415.e0" ontology_id="HP_0002858" text="meningiomas" type="HP"/>
    <entity charOffset="207-214" id="s415.e1" ontology_id="6605" text="SMARCE1" type="GENE"/>
    <pair e1="s415.e0" e2="s415.e1" id="s415.p0" relation="true"/>
  </sentence>
  <sentence id="s416" text="Approximately one-third of pediatric malignant rhabdoid tumors are linked to germline SWI/SNF alterations (SMARCB1/INI1, rarely SMARCA4) resulting in occasional familial clustering of these highly aggressive malignancies (so-called rhabdoid tumor predisposition syndrome, RTPS, types 1 and 2, respectively).">
    <entity charOffset="56-62" id="s416.e0" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <entity charOffset="107-114" id="s416.e1" ontology_id="6598" text="SMARCB1" type="GENE"/>
    <pair e1="s416.e0" e2="s416.e1" id="s416.p0" relation="true"/>
  </sentence>
  <sentence id="s417" text="Approximately one-third of pediatric malignant rhabdoid tumors are linked to germline SWI/SNF alterations (SMARCB1/INI1, rarely SMARCA4) resulting in occasional familial clustering of these highly aggressive malignancies (so-called rhabdoid tumor predisposition syndrome, RTPS, types 1 and 2, respectively).">
    <entity charOffset="56-62" id="s417.e0" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <entity charOffset="128-135" id="s417.e1" ontology_id="6597" text="SMARCA4" type="GENE"/>
    <pair e1="s417.e0" e2="s417.e1" id="s417.p0" relation="true"/>
  </sentence>
  <sentence id="s418" text="Approximately one-third of pediatric malignant rhabdoid tumors are linked to germline SWI/SNF alterations (SMARCB1/INI1, rarely SMARCA4) resulting in occasional familial clustering of these highly aggressive malignancies (so-called rhabdoid tumor predisposition syndrome, RTPS, types 1 and 2, respectively).">
    <entity charOffset="107-114" id="s418.e0" ontology_id="6598" text="SMARCB1" type="GENE"/>
    <entity charOffset="241-246" id="s418.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s418.e0" e2="s418.e1" id="s418.p0" relation="false"/>
  </sentence>
  <sentence id="s419" text="This chapter focuses on the current data covering the etiology and epidemiology, clinical presentation, and pathogenesis of four monogenic forms of isolated dystonia: DYT-TOR1A, DYT-THAP1, DYT-GCH1, and DYT-GNAL">
    <entity charOffset="157-165" id="s419.e0" ontology_id="HP_0001332" text="dystonia" type="HP"/>
    <entity charOffset="171-176" id="s419.e1" ontology_id="1861" text="TOR1A" type="GENE"/>
    <pair e1="s419.e0" e2="s419.e1" id="s419.p0" relation="true"/>
  </sentence>
  <sentence id="s420" text="This chapter focuses on the current data covering the etiology and epidemiology, clinical presentation, and pathogenesis of four monogenic forms of isolated dystonia: DYT-TOR1A, DYT-THAP1, DYT-GCH1, and DYT-GNAL">
    <entity charOffset="157-165" id="s420.e0" ontology_id="HP_0001332" text="dystonia" type="HP"/>
    <entity charOffset="193-197" id="s420.e1" ontology_id="2643" text="GCH1" type="GENE"/>
    <pair e1="s420.e0" e2="s420.e1" id="s420.p0" relation="true"/>
  </sentence>
  <sentence id="s421" text="Interestingly, heterogeneous nuclear RNA (hnRNA) for insulin and INS-IGF2, both originating from the INS promoter, were essentially undetectable in T1D pancreata, arguing for a silent INSpromoter.">
    <entity charOffset="15-28" id="s421.e0" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <entity charOffset="69-73" id="s421.e1" ontology_id="3481" text="IGF2" type="GENE"/>
    <pair e1="s421.e0" e2="s421.e1" id="s421.p0" relation="true"/>
  </sentence>
  <sentence id="s422" text="As poor differentiation and low apoptosis are closely associated with poor survival rates and a poor response to radio/chemotherapy in patients with cancer, the prognostic value of Dec1 expression was examined in the present study and its correlation with response to temozolomide (TMZ) chemotherapy was analyzed in patients with glioma.">
    <entity charOffset="149-155" id="s422.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="181-185" id="s422.e1" ontology_id="8553" text="dez1" type="GENE"/>
    <pair e1="s422.e0" e2="s422.e1" id="s422.p0" relation="false"/>
  </sentence>
  <sentence id="s423" text="High expression of Dec1, which was significantly associated with high pathological tumor grade and poor response to TMZ chemotherapy, was demonstrated to be an unfavorable independent prognostic factor and predicted poor survival in patients with newly diagnosed glioma.">
    <entity charOffset="19-23" id="s423.e0" ontology_id="8553" text="dez1" type="GENE"/>
    <entity charOffset="263-269" id="s423.e1" ontology_id="HP_0009733" text="glioma" type="HP"/>
    <pair e1="s423.e0" e2="s423.e1" id="s423.p0" relation="true"/>
  </sentence>
  <sentence id="s424" text="Dec1 expression was analyzed by immunohistochemistry in 157 samples of newly diagnosed glioma and 63 recurrent glioblastoma cases that relapsed during TMZ chemotherapy.">
    <entity charOffset="0-4" id="s424.e0" ontology_id="8553" text="dez1" type="GENE"/>
    <entity charOffset="111-123" id="s424.e1" ontology_id="HP_0012174" text="glioblastoma" type="HP"/>
    <pair e1="s424.e0" e2="s424.e1" id="s424.p0" relation="true"/>
  </sentence>
  <sentence id="s425" text="Mutations in CNNM2 were shown to cause hypomagnesemia, seizures and intellectual disability.">
    <entity charOffset="13-18" id="s425.e0" ontology_id="54805" text="CNNM2" type="GENE"/>
    <entity charOffset="55-63" id="s425.e1" ontology_id="HP_0001250" text="seizures" type="HP"/>
    <pair e1="s425.e0" e2="s425.e1" id="s425.p0" relation="true"/>
  </sentence>
  <sentence id="s426" text="BCOR staining was weakly positive in &amp;lt;5% of tumor cells in 4 of 66 (6%) low-grade endometrial stromal sarcomas and 1 of 18 (6%) endometrial stromal nodules and weakly to moderately positive in &amp;lt;5-40% of tumor cells in 6 of 31 (19%) leiomyosarcomas.">
    <entity charOffset="0-4" id="s426.e0" ontology_id="54880" text="BCOR" type="GENE"/>
    <entity charOffset="105-112" id="s426.e1" ontology_id="HP_0100242" text="sarcoma" type="HP"/>
    <pair e1="s426.e0" e2="s426.e1" id="s426.p0" relation="true"/>
  </sentence>
  <sentence id="s427" text="Strong diffuse nuclear BCOR staining (defined as &amp;gt;95% of tumor cells) was seen in the round cell component of all 20 (100%) classic YWHAE-NUTM2 high-grade endometrial stromal sarcomas and the 3 unusual high-grade endometrial stromal sarcomas which prompted FISH studies confirming YWHAE rearrangement in 2 tumors.">
    <entity charOffset="23-27" id="s427.e0" ontology_id="54880" text="BCOR" type="GENE"/>
    <entity charOffset="60-65" id="s427.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s427.e0" e2="s427.e1" id="s427.p0" relation="true"/>
  </sentence>
  <sentence id="s428" text="Strong diffuse nuclear BCOR staining (defined as &amp;gt;95% of tumor cells) was seen in the round cell component of all 20 (100%) classic YWHAE-NUTM2 high-grade endometrial stromal sarcomas and the 3 unusual high-grade endometrial stromal sarcomas which prompted FISH studies confirming YWHAE rearrangement in 2 tumors.">
    <entity charOffset="23-27" id="s428.e0" ontology_id="54880" text="BCOR" type="GENE"/>
    <entity charOffset="309-315" id="s428.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s428.e0" e2="s428.e1" id="s428.p0" relation="false"/>
  </sentence>
  <sentence id="s429" text="Strong diffuse nuclear BCOR staining (defined as &amp;gt;95% of tumor cells) was seen in the round cell component of all 20 (100%) classic YWHAE-NUTM2 high-grade endometrial stromal sarcomas and the 3 unusual high-grade endometrial stromal sarcomas which prompted FISH studies confirming YWHAE rearrangement in 2 tumors.">
    <entity charOffset="60-65" id="s429.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="135-140" id="s429.e1" ontology_id="7531" text="YWHAE" type="GENE"/>
    <pair e1="s429.e0" e2="s429.e1" id="s429.p0" relation="false"/>
  </sentence>
  <sentence id="s430" text="Strong diffuse nuclear BCOR staining (defined as &amp;gt;95% of tumor cells) was seen in the round cell component of all 20 (100%) classic YWHAE-NUTM2 high-grade endometrial stromal sarcomas and the 3 unusual high-grade endometrial stromal sarcomas which prompted FISH studies confirming YWHAE rearrangement in 2 tumors.">
    <entity charOffset="135-140" id="s430.e0" ontology_id="7531" text="YWHAE" type="GENE"/>
    <entity charOffset="309-315" id="s430.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s430.e0" e2="s430.e1" id="s430.p0" relation="true"/>
  </sentence>
  <sentence id="s431" text="BCOR immunoexpression was studied in these tumors and their morphologic mimics to assess its diagnostic utility.">
    <entity charOffset="0-4" id="s431.e0" ontology_id="54880" text="BCOR" type="GENE"/>
    <entity charOffset="43-49" id="s431.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s431.e0" e2="s431.e1" id="s431.p0" relation="true"/>
  </sentence>
  <sentence id="s432" text="BCOR immunohistochemical staining is a highly sensitive marker for YWHAE-NUTM2 high-grade endometrial stromal sarcoma with both classic and unusual morphology and identifies a subset of high-grade endometrial stromal sarcoma with BCOR alterations, including BCOR rearrangement and internal tandem duplication">
    <entity charOffset="0-4" id="s432.e0" ontology_id="54880" text="BCOR" type="GENE"/>
    <entity charOffset="110-117" id="s432.e1" ontology_id="HP_0100242" text="sarcoma" type="HP"/>
    <pair e1="s432.e0" e2="s432.e1" id="s432.p0" relation="true"/>
  </sentence>
  <sentence id="s433" text="Morphologic features of YWHAE-NUTM2 high-grade endometrial stromal sarcoma may overlap with other uterine sarcoma types.">
    <entity charOffset="24-29" id="s433.e0" ontology_id="7531" text="YWHAE" type="GENE"/>
    <entity charOffset="67-74" id="s433.e1" ontology_id="HP_0100242" text="sarcoma" type="HP"/>
    <pair e1="s433.e0" e2="s433.e1" id="s433.p0" relation="true"/>
  </sentence>
  <sentence id="s434" text="Our data suggest that increased expressions in certain mt genes and elevated levels of ROS may potentially play a critical role in the colorectal tumors evolving from adenopolyps to malignant lesions">
    <entity charOffset="87-90" id="s434.e0" ontology_id="6098" text="ROS" type="GENE"/>
    <entity charOffset="146-151" id="s434.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s434.e0" e2="s434.e1" id="s434.p0" relation="true"/>
  </sentence>
  <sentence id="s435" text="Inactivating mutations in Eda or Edar cause hypohidrotic ectodermal dysplasia (HED), a condition characterized by malformations of the teeth, hair and glands, with milder deficiencies affecting only the teeth.">
    <entity charOffset="26-29" id="s435.e0" ontology_id="1896" text="Eda" type="GENE"/>
    <entity charOffset="57-77" id="s435.e1" ontology_id="HP_0000968" text="ectodermal dysplasia" type="HP"/>
    <pair e1="s435.e0" e2="s435.e1" id="s435.p0" relation="true"/>
  </sentence>
  <sentence id="s436" text="Citrin deficiency is an autosomal recessive metabolic disorder, which is caused by pathogenic mutations in the SLC25A13 gene on chromosome 7q21.3, as the causative gene that encodes the liver type aspartate/glutamate carrier isoform 2 (AGC2).">
    <entity charOffset="24-43" id="s436.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="111-119" id="s436.e1" ontology_id="10165" text="SLC25A13" type="GENE"/>
    <pair e1="s436.e0" e2="s436.e1" id="s436.p0" relation="true"/>
  </sentence>
  <sentence id="s437" text="These results indicate that Smad4 acts as a tumor suppressor by activating FOXH1, and then suppressing the expression of estrogen receptor, in addition to tumor migration and invasion.">
    <entity charOffset="28-33" id="s437.e0" ontology_id="4089" text="Smad4" type="GENE"/>
    <entity charOffset="44-49" id="s437.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s437.e0" e2="s437.e1" id="s437.p0" relation="true"/>
  </sentence>
  <sentence id="s438" text="These results indicate that Smad4 acts as a tumor suppressor by activating FOXH1, and then suppressing the expression of estrogen receptor, in addition to tumor migration and invasion.">
    <entity charOffset="44-49" id="s438.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="75-80" id="s438.e1" ontology_id="8928" text="FOXH1" type="GENE"/>
    <pair e1="s438.e0" e2="s438.e1" id="s438.p0" relation="true"/>
  </sentence>
  <sentence id="s439" text="Smad4 has recently been identified as a tumor suppressor gene in a variety of cancers, yet the role of Smad4 in renal cell carcinoma (RCC) remained to be elusive.">
    <entity charOffset="0-5" id="s439.e0" ontology_id="4089" text="Smad4" type="GENE"/>
    <entity charOffset="40-45" id="s439.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s439.e0" e2="s439.e1" id="s439.p0" relation="true"/>
  </sentence>
  <sentence id="s440" text="Tubulin alpha 8 (TUBA8) is highly abundant in murine liver tumors suggesting a role in hepatocellular carcinoma (HCC).">
    <entity charOffset="17-22" id="s440.e0" ontology_id="51807" text="TUBA8" type="GENE"/>
    <entity charOffset="59-65" id="s440.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s440.e0" e2="s440.e1" id="s440.p0" relation="true"/>
  </sentence>
  <sentence id="s441" text="The review then discusses the diseases associated with ClC2, including degeneration of the retina, Sjgren's syndrome, agerelated cataracts, degeneration of the testes, azoospermia, lung cancer, constipation, repair of impaired intestinal mucosa barrier, leukemia, cystic fibrosis, leukoencephalopathy, epilepsy and diabetes mellitus.">
    <entity charOffset="55-58" id="s441.e0" ontology_id="23529" text="ClC" type="GENE"/>
    <entity charOffset="284-303" id="s441.e1" ontology_id="HP_0002352" text="leukoencephalopathy" type="HP"/>
    <pair e1="s441.e0" e2="s441.e1" id="s441.p0" relation="true"/>
  </sentence>
  <sentence id="s442" text="Weight gain and growth failure, the hallmarks of hypercortisolism in pediatrics, may be inconsistent, especially in ACTH-independent forms of CS.">
    <entity charOffset="49-65" id="s442.e0" ontology_id="HP_0003118" text="hypercortisolism" type="HP"/>
    <entity charOffset="116-120" id="s442.e1" ontology_id="5443" text="ACTH" type="GENE"/>
    <pair e1="s442.e0" e2="s442.e1" id="s442.p0" relation="true"/>
  </sentence>
  <sentence id="s443" text="Recently, hepaCAM was reported to be implicated in cancer development, and many researchers investigated its biological function in the tumorigenesis of various cancers.">
    <entity charOffset="10-17" id="s443.e0" ontology_id="220296" text="hepaCAM" type="GENE"/>
    <entity charOffset="136-141" id="s443.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s443.e0" e2="s443.e1" id="s443.p0" relation="true"/>
  </sentence>
  <sentence id="s444" text="High expression of GFAT1 was positively associated with lymph node metastasis, pTNM stage and shorter overall survival (OS) in pancreatic cancer patients.">
    <entity charOffset="19-24" id="s444.e0" ontology_id="2673" text="GFAT1" type="GENE"/>
    <entity charOffset="138-144" id="s444.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s444.e0" e2="s444.e1" id="s444.p0" relation="false"/>
  </sentence>
  <sentence id="s445" text="In this study, we found that the expression of GFAT1 was increased in pancreatic cancer samples compared to peri-tumor tissues.">
    <entity charOffset="47-52" id="s445.e0" ontology_id="2673" text="GFAT1" type="GENE"/>
    <entity charOffset="81-87" id="s445.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s445.e0" e2="s445.e1" id="s445.p0" relation="true"/>
  </sentence>
  <sentence id="s446" text="The student's t-test was used to compare FOXP1 expression in the tumour and the adjacent normal tissues.">
    <entity charOffset="41-46" id="s446.e0" ontology_id="27086" text="FOXP1" type="GENE"/>
    <entity charOffset="65-71" id="s446.e1" ontology_id="HP_0002664" text="tumour" type="HP"/>
    <pair e1="s446.e0" e2="s446.e1" id="s446.p0" relation="true"/>
  </sentence>
  <sentence id="s447" text="On the whole, our findings indicated that KLF9 exhibited low expression in pancreatic cancer, and upregulation of KLF9 may inhibit the progression of pancreatic cancer.">
    <entity charOffset="42-46" id="s447.e0" ontology_id="687" text="KLF9" type="GENE"/>
    <entity charOffset="86-92" id="s447.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s447.e0" e2="s447.e1" id="s447.p0" relation="true"/>
  </sentence>
  <sentence id="s448" text="The purpose of the present study was to investigate the expression and functional significance of KLF9 invitro, by assessing the expression of KLF9 in pancreatic cancer tissue samples and its association with the total survival of patients and clinicopathological data.">
    <entity charOffset="98-102" id="s448.e0" ontology_id="687" text="KLF9" type="GENE"/>
    <entity charOffset="163-169" id="s448.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s448.e0" e2="s448.e1" id="s448.p0" relation="true"/>
  </sentence>
  <sentence id="s449" text="Using western blot analyses, we assessed KLF9 expression in human pancreatic cancer cell lines.">
    <entity charOffset="41-45" id="s449.e0" ontology_id="687" text="KLF9" type="GENE"/>
    <entity charOffset="77-83" id="s449.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s449.e0" e2="s449.e1" id="s449.p0" relation="true"/>
  </sentence>
  <sentence id="s450" text="In PANC-1 and BxPC-3 cells, KLF9 overexpression decreased the proliferation of pancreatic cancer cells, induced apoptosis, blocked the cell cycle at the Sphase, and inhibited the migration and invasion of tumor cells.">
    <entity charOffset="28-32" id="s450.e0" ontology_id="687" text="KLF9" type="GENE"/>
    <entity charOffset="90-96" id="s450.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s450.e0" e2="s450.e1" id="s450.p0" relation="true"/>
  </sentence>
  <sentence id="s451" text="With the first filensin (BFSP1) mutation now having been reported to cause a recessive cataract phenotype, there is the suggestion that the mutation could predispose heterozygote carriers to the early onset of age-related nuclear cataract.">
    <entity charOffset="15-23" id="s451.e0" ontology_id="631" text="filensin" type="GENE"/>
    <entity charOffset="87-95" id="s451.e1" ontology_id="HP_0000518" text="cataract" type="HP"/>
    <pair e1="s451.e0" e2="s451.e1" id="s451.p0" relation="true"/>
  </sentence>
  <sentence id="s452" text="We originally discovered TERE1 as a potential tumor suppressor protein based upon reduced expression in bladder and prostate cancer specimens and growth inhibition of tumor cell lines/xenografts upon ectopic expression.">
    <entity charOffset="25-30" id="s452.e0" ontology_id="29914" text="TERE1" type="GENE"/>
    <entity charOffset="46-51" id="s452.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s452.e0" e2="s452.e1" id="s452.p0" relation="true"/>
  </sentence>
  <sentence id="s453" text="We originally discovered TERE1 as a potential tumor suppressor protein based upon reduced expression in bladder and prostate cancer specimens and growth inhibition of tumor cell lines/xenografts upon ectopic expression.">
    <entity charOffset="25-30" id="s453.e0" ontology_id="29914" text="TERE1" type="GENE"/>
    <entity charOffset="125-131" id="s453.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s453.e0" e2="s453.e1" id="s453.p0" relation="true"/>
  </sentence>
  <sentence id="s454" text="Vitamin K-2 is involved in mitochondrial electron transport, SXR nuclear hormone receptor signaling and redox cycling: together these functions may form the basis for tumor suppressor function.">
    <entity charOffset="61-64" id="s454.e0" ontology_id="8856" text="SXR" type="GENE"/>
    <entity charOffset="167-172" id="s454.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s454.e0" e2="s454.e1" id="s454.p0" relation="true"/>
  </sentence>
  <sentence id="s455" text="In vivo, SPINK1 is expressed in the stroma of solid tumours and is routinely detectable in peripheral blood of cancer patients after chemotherapy.">
    <entity charOffset="9-15" id="s455.e0" ontology_id="6690" text="SPINK1" type="GENE"/>
    <entity charOffset="52-58" id="s455.e1" ontology_id="HP_0002664" text="tumour" type="HP"/>
    <pair e1="s455.e0" e2="s455.e1" id="s455.p0" relation="true"/>
  </sentence>
  <sentence id="s456" text="Strikingly, SPINK1 reprograms the expression profile of cancer cells, causing prominent epithelial-endothelial transition (EET), a phenotypic switch mediated by EGFR signaling but hitherto rarely reported for a SASP factor.">
    <entity charOffset="12-18" id="s456.e0" ontology_id="6690" text="SPINK1" type="GENE"/>
    <entity charOffset="56-62" id="s456.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s456.e0" e2="s456.e1" id="s456.p0" relation="true"/>
  </sentence>
  <sentence id="s457" text="These findings designate CYP3A5 as a predictor of therapy response and as a tumor cell-autonomous detoxification mechanism that must be overcome to prevent drug resistance">
    <entity charOffset="25-31" id="s457.e0" ontology_id="1577" text="CYP3A5" type="GENE"/>
    <entity charOffset="76-81" id="s457.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s457.e0" e2="s457.e1" id="s457.p0" relation="true"/>
  </sentence>
  <sentence id="s458" text="A novel hereditary disorder encompassing high blood Mn levels, dystonia, polycythemia, distinctive T1 hyperintense signals in the basal ganglia on magnetic resonance imaging (MRI) brain, and chronic liver disease was recently described.">
    <entity charOffset="63-71" id="s458.e0" ontology_id="HP_0001332" text="dystonia" type="HP"/>
    <entity charOffset="99-101" id="s458.e1" ontology_id="921" text="T1" type="GENE"/>
    <pair e1="s458.e0" e2="s458.e1" id="s458.p0" relation="false"/>
  </sentence>
  <sentence id="s459" text="Our results suggested that variants in DCTN1 are not common risk factors for Chinese sporadic ALS and that the frequency of variants of unknown significance in the cohort study was 0.39%">
    <entity charOffset="39-44" id="s459.e0" ontology_id="1639" text="DCTN1" type="GENE"/>
    <entity charOffset="85-93" id="s459.e1" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <pair e1="s459.e0" e2="s459.e1" id="s459.p0" relation="true"/>
  </sentence>
  <sentence id="s460" text="It has been reported that N-myc downstream regulated gene 1 (NDRG1) is related to the prognosis of non-small cell lung cancer (NSCLC), and associated with c-Myc degradation in NSCLC cell lines.">
    <entity charOffset="26-31" id="s460.e0" ontology_id="4613" text="N-myc" type="GENE"/>
    <entity charOffset="119-125" id="s460.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s460.e0" e2="s460.e1" id="s460.p0" relation="true"/>
  </sentence>
  <sentence id="s461" text="It has been reported that N-myc downstream regulated gene 1 (NDRG1) is related to the prognosis of non-small cell lung cancer (NSCLC), and associated with c-Myc degradation in NSCLC cell lines.">
    <entity charOffset="61-66" id="s461.e0" ontology_id="10397" text="NDRG1" type="GENE"/>
    <entity charOffset="119-125" id="s461.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s461.e0" e2="s461.e1" id="s461.p0" relation="true"/>
  </sentence>
  <sentence id="s462" text="We demonstrated that &lt;i&gt;linc-ADAL&lt;/i&gt; interacts with heterogeneous nuclear ribonucleoprotein U (hnRNPU) and insulin-like growth factor 2 mRNA binding protein 2 (IGF2BP2) at distinct subcellular locations to regulate adipocyte differentiation and lipogenesis">
    <entity charOffset="53-66" id="s462.e0" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <entity charOffset="96-102" id="s462.e1" ontology_id="3192" text="hnRNPU" type="GENE"/>
    <pair e1="s462.e0" e2="s462.e1" id="s462.p0" relation="true"/>
  </sentence>
  <sentence id="s463" text="myocilin (MYOC), optineurin (OPTN), WDR36 and neurotrophin-4 (NTF4) in primary open angle glaucoma (POAG) and CYP1B1 and LTBP2 in congenital and developmental glaucomas.">
    <entity charOffset="10-14" id="s463.e0" ontology_id="4653" text="MYOC" type="GENE"/>
    <entity charOffset="90-98" id="s463.e1" ontology_id="HP_0000501" text="glaucoma" type="HP"/>
    <pair e1="s463.e0" e2="s463.e1" id="s463.p0" relation="true"/>
  </sentence>
  <sentence id="s464" text="myocilin (MYOC), optineurin (OPTN), WDR36 and neurotrophin-4 (NTF4) in primary open angle glaucoma (POAG) and CYP1B1 and LTBP2 in congenital and developmental glaucomas.">
    <entity charOffset="29-33" id="s464.e0" ontology_id="10133" text="OPTN" type="GENE"/>
    <entity charOffset="90-98" id="s464.e1" ontology_id="HP_0000501" text="glaucoma" type="HP"/>
    <pair e1="s464.e0" e2="s464.e1" id="s464.p0" relation="true"/>
  </sentence>
  <sentence id="s465" text="myocilin (MYOC), optineurin (OPTN), WDR36 and neurotrophin-4 (NTF4) in primary open angle glaucoma (POAG) and CYP1B1 and LTBP2 in congenital and developmental glaucomas.">
    <entity charOffset="62-66" id="s465.e0" ontology_id="4909" text="NTF4" type="GENE"/>
    <entity charOffset="90-98" id="s465.e1" ontology_id="HP_0000501" text="glaucoma" type="HP"/>
    <pair e1="s465.e0" e2="s465.e1" id="s465.p0" relation="true"/>
  </sentence>
  <sentence id="s466" text="We show here that another member of the CLCA gene family, CLCA4, is expressed in mammary epithelial cells and is similarly downregulated in breast tumors and in breast cancer cell lines.">
    <entity charOffset="58-63" id="s466.e0" ontology_id="22802" text="CLCA4" type="GENE"/>
    <entity charOffset="168-174" id="s466.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s466.e0" e2="s466.e1" id="s466.p0" relation="true"/>
  </sentence>
  <sentence id="s467" text="In breast cancer, EMT facilitates invasion of surrounding tissues and correlates closely with cancer metastasis and relapse.">
    <entity charOffset="10-16" id="s467.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="18-21" id="s467.e1" ontology_id="3702" text="EMT" type="GENE"/>
    <pair e1="s467.e0" e2="s467.e1" id="s467.p0" relation="true"/>
  </sentence>
  <sentence id="s468" text="Clinically, low expression of CLCA4 signaled lower relapse-free survival in basal and luminal B breast cancers.">
    <entity charOffset="30-35" id="s468.e0" ontology_id="22802" text="CLCA4" type="GENE"/>
    <entity charOffset="103-109" id="s468.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s468.e0" e2="s468.e1" id="s468.p0" relation="true"/>
  </sentence>
  <sentence id="s469" text="Our results identify DDB2 as both a partner and regulator of Wnt signaling, with an important role in suppressing colon cancer development.">
    <entity charOffset="21-25" id="s469.e0" ontology_id="1643" text="DDB2" type="GENE"/>
    <entity charOffset="120-126" id="s469.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s469.e0" e2="s469.e1" id="s469.p0" relation="true"/>
  </sentence>
  <sentence id="s470" text="The mechanism of TMEM98 in conferring chemoresistance of hepatocellular carcinoma might be possibly through activation of the AKT pathway and deactivation of p53.">
    <entity charOffset="57-81" id="s470.e0" ontology_id="HP_0001402" text="hepatocellular carcinoma" type="HP"/>
    <entity charOffset="126-129" id="s470.e1" ontology_id="207" text="AKT" type="GENE"/>
    <pair e1="s470.e0" e2="s470.e1" id="s470.p0" relation="true"/>
  </sentence>
  <sentence id="s471" text="TMEM98 mRNA in tumor tissues was significantly higher than nontumor tissues of patients with hepatocellular carcinoma (P &amp;lt; 0.0001).">
    <entity charOffset="0-6" id="s471.e0" ontology_id="26022" text="TMEM98" type="GENE"/>
    <entity charOffset="15-20" id="s471.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s471.e0" e2="s471.e1" id="s471.p0" relation="true"/>
  </sentence>
  <sentence id="s472" text="We have revealed significant association of FGFR2 and MAP3K1 polymorphisms with breast cancer.">
    <entity charOffset="44-49" id="s472.e0" ontology_id="2263" text="FGFR2" type="GENE"/>
    <entity charOffset="87-93" id="s472.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s472.e0" e2="s472.e1" id="s472.p0" relation="true"/>
  </sentence>
  <sentence id="s473" text="We have revealed significant association of FGFR2 and MAP3K1 polymorphisms with breast cancer.">
    <entity charOffset="54-60" id="s473.e0" ontology_id="4214" text="MAP3K1" type="GENE"/>
    <entity charOffset="87-93" id="s473.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s473.e0" e2="s473.e1" id="s473.p0" relation="true"/>
  </sentence>
  <sentence id="s474" text="The Random Forest algorithm selected FGFR2, MAP3K1 and age as important breast cancer predictors.">
    <entity charOffset="44-50" id="s474.e0" ontology_id="4214" text="MAP3K1" type="GENE"/>
    <entity charOffset="79-85" id="s474.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s474.e0" e2="s474.e1" id="s474.p0" relation="true"/>
  </sentence>
  <sentence id="s475" text="Homozygous RSPO1 mutations cause a syndrome of 46,XX disorder of sexual development (DSD), palmoplantar keratoderma (PPK), and predisposition to squamous cell carcinoma.">
    <entity charOffset="11-16" id="s475.e0" ontology_id="284654" text="RSPO1" type="GENE"/>
    <entity charOffset="145-168" id="s475.e1" ontology_id="HP_0002860" text="squamous cell carcinoma" type="HP"/>
    <pair e1="s475.e0" e2="s475.e1" id="s475.p0" relation="true"/>
  </sentence>
  <sentence id="s476" text="This study allowed the identification of the genetic cause of the retinal dystrophy and the establishment of a correct diagnosis in four families, including a large heterozygous deletion in PRPF31, typically considered one of the pitfalls of this method.">
    <entity charOffset="66-83" id="s476.e0" ontology_id="HP_0000556" text="retinal dystrophy" type="HP"/>
    <entity charOffset="190-196" id="s476.e1" ontology_id="26121" text="PRPF31" type="GENE"/>
    <pair e1="s476.e0" e2="s476.e1" id="s476.p0" relation="true"/>
  </sentence>
  <sentence id="s477" text="ME attenuated the influence of APOB rs512535 and TNFA rs361525 on obesity risk in FMP.">
    <entity charOffset="49-53" id="s477.e0" ontology_id="7124" text="TNFA" type="GENE"/>
    <entity charOffset="66-73" id="s477.e1" ontology_id="HP_0001513" text="obesity" type="HP"/>
    <pair e1="s477.e0" e2="s477.e1" id="s477.p0" relation="true"/>
  </sentence>
  <sentence id="s478" text="Furthermore, a high level of FEZF1 in patients with glioma acted as an independent biomarker to predict reduced survival (P=0.026).">
    <entity charOffset="29-34" id="s478.e0" ontology_id="389549" text="FEZF1" type="GENE"/>
    <entity charOffset="52-58" id="s478.e1" ontology_id="HP_0009733" text="glioma" type="HP"/>
    <pair e1="s478.e0" e2="s478.e1" id="s478.p0" relation="true"/>
  </sentence>
  <sentence id="s479" text="In A549 lung cancer cells, which endogenously express CXCR1, the depletion of REEP5 and REEP6 significantly reduced growth and invasion by downregulating IL-8-stimulated ERK phosphorylation, actin polymerization and the expression of genes related to metastasis.">
    <entity charOffset="13-19" id="s479.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="54-59" id="s479.e1" ontology_id="3577" text="CXCR1" type="GENE"/>
    <pair e1="s479.e0" e2="s479.e1" id="s479.p0" relation="true"/>
  </sentence>
  <sentence id="s480" text="Though KRT5 has been identified to be the causal gene of DDD, the heterogeneity of this disease was displayed: for example, POFUT1 and POGLUT1 were recently identified and confirmed to be additional pathogenic genes of DDD.">
    <entity charOffset="7-11" id="s480.e0" ontology_id="3852" text="KRT5" type="GENE"/>
    <entity charOffset="66-79" id="s480.e1" ontology_id="HP_0001425" text="heterogeneity" type="HP"/>
    <pair e1="s480.e0" e2="s480.e1" id="s480.p0" relation="false"/>
  </sentence>
  <sentence id="s481" text="Though KRT5 has been identified to be the causal gene of DDD, the heterogeneity of this disease was displayed: for example, POFUT1 and POGLUT1 were recently identified and confirmed to be additional pathogenic genes of DDD.">
    <entity charOffset="66-79" id="s481.e0" ontology_id="HP_0001425" text="heterogeneity" type="HP"/>
    <entity charOffset="124-130" id="s481.e1" ontology_id="23509" text="POFUT1" type="GENE"/>
    <pair e1="s481.e0" e2="s481.e1" id="s481.p0" relation="false"/>
  </sentence>
  <sentence id="s482" text="Though KRT5 has been identified to be the causal gene of DDD, the heterogeneity of this disease was displayed: for example, POFUT1 and POGLUT1 were recently identified and confirmed to be additional pathogenic genes of DDD.">
    <entity charOffset="66-79" id="s482.e0" ontology_id="HP_0001425" text="heterogeneity" type="HP"/>
    <entity charOffset="135-142" id="s482.e1" ontology_id="56983" text="POGLUT1" type="GENE"/>
    <pair e1="s482.e0" e2="s482.e1" id="s482.p0" relation="false"/>
  </sentence>
  <sentence id="s483" text="Defects of CIB2, calcium- and integrin-binding protein 2, have been reported to cause isolated deafness, DFNB48 and Usher syndrome type-IJ, characterized by congenital profound deafness, balance defects and blindness.">
    <entity charOffset="11-15" id="s483.e0" ontology_id="10518" text="CIB2" type="GENE"/>
    <entity charOffset="95-103" id="s483.e1" ontology_id="HP_0000365" text="deafness" type="HP"/>
    <pair e1="s483.e0" e2="s483.e1" id="s483.p0" relation="true"/>
  </sentence>
  <sentence id="s484" text="Defects of CIB2, calcium- and integrin-binding protein 2, have been reported to cause isolated deafness, DFNB48 and Usher syndrome type-IJ, characterized by congenital profound deafness, balance defects and blindness.">
    <entity charOffset="11-15" id="s484.e0" ontology_id="10518" text="CIB2" type="GENE"/>
    <entity charOffset="207-216" id="s484.e1" ontology_id="HP_0000618" text="blindness" type="HP"/>
    <pair e1="s484.e0" e2="s484.e1" id="s484.p0" relation="true"/>
  </sentence>
  <sentence id="s485" text="Defects of CIB2, calcium- and integrin-binding protein 2, have been reported to cause isolated deafness, DFNB48 and Usher syndrome type-IJ, characterized by congenital profound deafness, balance defects and blindness.">
    <entity charOffset="105-111" id="s485.e0" ontology_id="10518" text="DFNB48" type="GENE"/>
    <entity charOffset="168-176" id="s485.e1" ontology_id="HP_0012829" text="profound" type="HP"/>
    <pair e1="s485.e0" e2="s485.e1" id="s485.p0" relation="false"/>
  </sentence>
  <sentence id="s486" text="We report here two new nonsense mutations (pGln12* and pTyr110*) in &lt;i&gt;CIB2&lt;/i&gt; patients displaying nonsyndromic profound hearing loss, with no evidence of vestibular or retinal dysfunction.">
    <entity charOffset="71-75" id="s486.e0" ontology_id="10518" text="CIB2" type="GENE"/>
    <entity charOffset="122-134" id="s486.e1" ontology_id="HP_0000365" text="hearing loss" type="HP"/>
    <pair e1="s486.e0" e2="s486.e1" id="s486.p0" relation="true"/>
  </sentence>
  <sentence id="s487" text="In a screen of pancreatic cancer cell lines, AsPC-1 and BxPC-3 cells expressed high levels of Gremlin1, but only AsPC-1 cells exhibited a high expression level of SHH.">
    <entity charOffset="26-32" id="s487.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="164-167" id="s487.e1" ontology_id="6469" text="SHH" type="GENE"/>
    <pair e1="s487.e0" e2="s487.e1" id="s487.p0" relation="true"/>
  </sentence>
  <sentence id="s488" text="Based on the data from the present study, it was concluded that an abnormal expression level of Gremlin1 in pancreatic cancer was induced by SHH signaling, and that the overexpression of Gremlin1 enabled pancreatic cancer progression">
    <entity charOffset="120-126" id="s488.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="142-145" id="s488.e1" ontology_id="6469" text="SHH" type="GENE"/>
    <pair e1="s488.e0" e2="s488.e1" id="s488.p0" relation="true"/>
  </sentence>
  <sentence id="s489" text="Primary human PSCs and pancreatic cancer cell lines were exposed to SHH, cyclopamine, GLI family zinc finger-1(Gli-1) small interfering RNA (siRNA), and Gremlin1 siRNA to examine their associations and effects using an MTT assay, reverse transcription-quantitative polymerase chain reaction analysis, western blot analysis, and migration or invasion assays.">
    <entity charOffset="34-40" id="s489.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="112-115" id="s489.e1" ontology_id="2735" text="Gli" type="GENE"/>
    <pair e1="s489.e0" e2="s489.e1" id="s489.p0" relation="true"/>
  </sentence>
  <sentence id="s490" text="Consequently, the disruption of Ush2a in zebrafish led to a hearing impairment, like that in mammals.">
    <entity charOffset="32-37" id="s490.e0" ontology_id="7399" text="Ush2a" type="GENE"/>
    <entity charOffset="60-78" id="s490.e1" ontology_id="HP_0000365" text="hearing impairment" type="HP"/>
    <pair e1="s490.e0" e2="s490.e1" id="s490.p0" relation="true"/>
  </sentence>
  <sentence id="s491" text="The importance of this process is highlighted in a patient with mitochondrial disease caused by biallelic pathogenic variants in TOP3A, characterized by muscle-restricted mtDNA deletions and chronic progressive external ophthalmoplegia (CPEO) plus syndrome.">
    <entity charOffset="129-134" id="s491.e0" ontology_id="7156" text="TOP3A" type="GENE"/>
    <entity charOffset="199-210" id="s491.e1" ontology_id="HP_0003676" text="progressive" type="HP"/>
    <pair e1="s491.e0" e2="s491.e1" id="s491.p0" relation="false"/>
  </sentence>
  <sentence id="s492" text="We present the native 3D structures of normal and PCD-causing RSPH1-mutant human respiratory cilia in unprecedented detail; this allows comparisons of cilia structure across evolutionarily distant species and reveals the previously unknown primary defect and the heterogeneous secondary defects in RSPH1-mutant cilia.">
    <entity charOffset="62-67" id="s492.e0" ontology_id="89765" text="RSPH1" type="GENE"/>
    <entity charOffset="263-276" id="s492.e1" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <pair e1="s492.e0" e2="s492.e1" id="s492.p0" relation="false"/>
  </sentence>
  <sentence id="s493" text="Our data provide evidence for structural and functional heterogeneity in radial spokes, suggest a mechanism for the milder RSPH1 PCD phenotype and demonstrate that cryo-electron tomography can be applied to human disease by directly imaging patient samples.">
    <entity charOffset="56-69" id="s493.e0" ontology_id="HP_0001425" text="heterogeneity" type="HP"/>
    <entity charOffset="123-128" id="s493.e1" ontology_id="89765" text="RSPH1" type="GENE"/>
    <pair e1="s493.e0" e2="s493.e1" id="s493.p0" relation="true"/>
  </sentence>
  <sentence id="s494" text="The possible involvement of haploinsufficiency for GINS1, a DNA replication complex protein, in the short stature of the patient and her mother requires further studies.">
    <entity charOffset="51-56" id="s494.e0" ontology_id="9837" text="GINS1" type="GENE"/>
    <entity charOffset="100-113" id="s494.e1" ontology_id="HP_0004322" text="short stature" type="HP"/>
    <pair e1="s494.e0" e2="s494.e1" id="s494.p0" relation="true"/>
  </sentence>
  <sentence id="s495" text="TMPRSS2-ERG rearrangement and PTEN loss, events sensitizing to PARPi, occurred frequently along with heterogeneous loss of DNA repair factors 53BP1, JMJD1C and Rev7 (all studied here for the first time in CaP) whose defects may cause resistance to PARPi.">
    <entity charOffset="101-114" id="s495.e0" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <entity charOffset="149-155" id="s495.e1" ontology_id="221037" text="JMJD1C" type="GENE"/>
    <pair e1="s495.e0" e2="s495.e1" id="s495.p0" relation="true"/>
  </sentence>
  <sentence id="s496" text="These results imply that PPI might be modulated by four genotypes - COMT rs4680 (primarily in males), GRIK3 rs1027599, TCF4 rs9960767, and PRODH rs385440 - indicating a role of these gene variations in the development of early information processing deficits in schizophrenia.">
    <entity charOffset="119-123" id="s496.e0" ontology_id="6934" text="TCF4" type="GENE"/>
    <entity charOffset="262-275" id="s496.e1" ontology_id="HP_0100753" text="schizophrenia" type="HP"/>
    <pair e1="s496.e0" e2="s496.e1" id="s496.p0" relation="true"/>
  </sentence>
  <sentence id="s497" text="This close biochemical relationship indicates an oncogenic role for WIP in the physiology of cancer pathology by increasing YAP/TAZ stability">
    <entity charOffset="68-71" id="s497.e0" ontology_id="7456" text="WIP" type="GENE"/>
    <entity charOffset="93-99" id="s497.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s497.e0" e2="s497.e1" id="s497.p0" relation="true"/>
  </sentence>
  <sentence id="s498" text="We find that WIP controls tumor growth by boosting signals that stabilize the YAP/TAZ complex via a mechanism mediated by the endocytic/endosomal system.">
    <entity charOffset="13-16" id="s498.e0" ontology_id="7456" text="WIP" type="GENE"/>
    <entity charOffset="26-31" id="s498.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s498.e0" e2="s498.e1" id="s498.p0" relation="true"/>
  </sentence>
  <sentence id="s499" text="We found that the impaired homeostatic synaptic downscaling in Fmr1 KO neurons is caused by loss-of-function dephosphorylation of an epilepsy-associated ubiquitin E3 ligase, neural precursor cell expressed developmentally down-regulated gene 4-2, Nedd4-2.">
    <entity charOffset="133-141" id="s499.e0" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <entity charOffset="247-254" id="s499.e1" ontology_id="23327" text="Nedd4-2" type="GENE"/>
    <pair e1="s499.e0" e2="s499.e1" id="s499.p0" relation="true"/>
  </sentence>
  <sentence id="s500" text="Humans who carry HNF1B mutations develop heterogeneous renal abnormalities, including multicystic dysplastic kidneys, glomerulocystic kidney disease, renal agenesis, renal hypoplasia, and renal interstitial fibrosis.">
    <entity charOffset="17-22" id="s500.e0" ontology_id="6928" text="HNF1B" type="GENE"/>
    <entity charOffset="41-54" id="s500.e1" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <pair e1="s500.e0" e2="s500.e1" id="s500.p0" relation="true"/>
  </sentence>
  <sentence id="s501" text="Since the original description of the IARS2-related cataracts, growth hormone deficiency, sensory neuropathy, sensorineural hearing loss, skeletal dysplasia syndrome (CAGSSS; OMIM 616007) in an extended consanguineous family of French-Canadian descent, no further patients have been reported.">
    <entity charOffset="38-43" id="s501.e0" ontology_id="55699" text="IARS2" type="GENE"/>
    <entity charOffset="98-108" id="s501.e1" ontology_id="HP_0009830" text="neuropathy" type="HP"/>
    <pair e1="s501.e0" e2="s501.e1" id="s501.p0" relation="true"/>
  </sentence>
  <sentence id="s502" text="We present her clinical features and particularly highlight her skeletal findings, which confirm the presence of a primary SEMD skeletal dysplasia in a growing list of mitochondrial-related disorders including CAGSSS, CODAS, EVEN-PLUS, and X-linked SEMD-MR syndromes">
    <entity charOffset="123-127" id="s502.e0" ontology_id="10371" text="SEMD" type="GENE"/>
    <entity charOffset="128-146" id="s502.e1" ontology_id="HP_0002652" text="skeletal dysplasia" type="HP"/>
    <pair e1="s502.e0" e2="s502.e1" id="s502.p0" relation="true"/>
  </sentence>
  <sentence id="s503" text="Recent clinical, morphological and molecular investigations of CMT families with autosomal recessive inheritance allowed the identification of many genes such as GDAP1, MTMR2, SBF2, NDRG1, EGR2, SH3TC2, PRX, FGD4, and FIG4, implicated in demyelinating forms (ARCMT1 or CMT4), and LMNA, MED25, HINT1, GDAP1, LRSAM1, NEFL, HSPB1 and MFN2 in axonal forms (ARCMT2).">
    <entity charOffset="81-100" id="s503.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="189-193" id="s503.e1" ontology_id="1959" text="EGR2" type="GENE"/>
    <pair e1="s503.e0" e2="s503.e1" id="s503.p0" relation="false"/>
  </sentence>
  <sentence id="s504" text="Recent clinical, morphological and molecular investigations of CMT families with autosomal recessive inheritance allowed the identification of many genes such as GDAP1, MTMR2, SBF2, NDRG1, EGR2, SH3TC2, PRX, FGD4, and FIG4, implicated in demyelinating forms (ARCMT1 or CMT4), and LMNA, MED25, HINT1, GDAP1, LRSAM1, NEFL, HSPB1 and MFN2 in axonal forms (ARCMT2).">
    <entity charOffset="81-100" id="s504.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="286-291" id="s504.e1" ontology_id="55090" text="MED25" type="GENE"/>
    <pair e1="s504.e0" e2="s504.e1" id="s504.p0" relation="false"/>
  </sentence>
  <sentence id="s505" text="Recent clinical, morphological and molecular investigations of CMT families with autosomal recessive inheritance allowed the identification of many genes such as GDAP1, MTMR2, SBF2, NDRG1, EGR2, SH3TC2, PRX, FGD4, and FIG4, implicated in demyelinating forms (ARCMT1 or CMT4), and LMNA, MED25, HINT1, GDAP1, LRSAM1, NEFL, HSPB1 and MFN2 in axonal forms (ARCMT2).">
    <entity charOffset="81-100" id="s505.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="315-319" id="s505.e1" ontology_id="4747" text="NEFL" type="GENE"/>
    <pair e1="s505.e0" e2="s505.e1" id="s505.p0" relation="false"/>
  </sentence>
  <sentence id="s506" text="Recent clinical, morphological and molecular investigations of CMT families with autosomal recessive inheritance allowed the identification of many genes such as GDAP1, MTMR2, SBF2, NDRG1, EGR2, SH3TC2, PRX, FGD4, and FIG4, implicated in demyelinating forms (ARCMT1 or CMT4), and LMNA, MED25, HINT1, GDAP1, LRSAM1, NEFL, HSPB1 and MFN2 in axonal forms (ARCMT2).">
    <entity charOffset="81-100" id="s506.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="269-273" id="s506.e1" ontology_id="54332" text="CMT4" type="GENE"/>
    <pair e1="s506.e0" e2="s506.e1" id="s506.p0" relation="false"/>
  </sentence>
  <sentence id="s507" text="Recent clinical, morphological and molecular investigations of CMT families with autosomal recessive inheritance allowed the identification of many genes such as GDAP1, MTMR2, SBF2, NDRG1, EGR2, SH3TC2, PRX, FGD4, and FIG4, implicated in demyelinating forms (ARCMT1 or CMT4), and LMNA, MED25, HINT1, GDAP1, LRSAM1, NEFL, HSPB1 and MFN2 in axonal forms (ARCMT2).">
    <entity charOffset="101-112" id="s507.e0" ontology_id="HP_0000005" text="inheritance" type="HP"/>
    <entity charOffset="321-326" id="s507.e1" ontology_id="3315" text="HSPB1" type="GENE"/>
    <pair e1="s507.e0" e2="s507.e1" id="s507.p0" relation="false"/>
  </sentence>
  <sentence id="s508" text="Recent clinical, morphological and molecular investigations of CMT families with autosomal recessive inheritance allowed the identification of many genes such as GDAP1, MTMR2, SBF2, NDRG1, EGR2, SH3TC2, PRX, FGD4, and FIG4, implicated in demyelinating forms (ARCMT1 or CMT4), and LMNA, MED25, HINT1, GDAP1, LRSAM1, NEFL, HSPB1 and MFN2 in axonal forms (ARCMT2).">
    <entity charOffset="101-112" id="s508.e0" ontology_id="HP_0000005" text="inheritance" type="HP"/>
    <entity charOffset="218-222" id="s508.e1" ontology_id="9896" text="FIG4" type="GENE"/>
    <pair e1="s508.e0" e2="s508.e1" id="s508.p0" relation="false"/>
  </sentence>
  <sentence id="s509" text="Recent clinical, morphological and molecular investigations of CMT families with autosomal recessive inheritance allowed the identification of many genes such as GDAP1, MTMR2, SBF2, NDRG1, EGR2, SH3TC2, PRX, FGD4, and FIG4, implicated in demyelinating forms (ARCMT1 or CMT4), and LMNA, MED25, HINT1, GDAP1, LRSAM1, NEFL, HSPB1 and MFN2 in axonal forms (ARCMT2).">
    <entity charOffset="101-112" id="s509.e0" ontology_id="HP_0000005" text="inheritance" type="HP"/>
    <entity charOffset="176-180" id="s509.e1" ontology_id="81846" text="SBF2" type="GENE"/>
    <pair e1="s509.e0" e2="s509.e1" id="s509.p0" relation="false"/>
  </sentence>
  <sentence id="s510" text="Recent clinical, morphological and molecular investigations of CMT families with autosomal recessive inheritance allowed the identification of many genes such as GDAP1, MTMR2, SBF2, NDRG1, EGR2, SH3TC2, PRX, FGD4, and FIG4, implicated in demyelinating forms (ARCMT1 or CMT4), and LMNA, MED25, HINT1, GDAP1, LRSAM1, NEFL, HSPB1 and MFN2 in axonal forms (ARCMT2).">
    <entity charOffset="101-112" id="s510.e0" ontology_id="HP_0000005" text="inheritance" type="HP"/>
    <entity charOffset="189-193" id="s510.e1" ontology_id="1959" text="EGR2" type="GENE"/>
    <pair e1="s510.e0" e2="s510.e1" id="s510.p0" relation="false"/>
  </sentence>
  <sentence id="s511" text="Recent clinical, morphological and molecular investigations of CMT families with autosomal recessive inheritance allowed the identification of many genes such as GDAP1, MTMR2, SBF2, NDRG1, EGR2, SH3TC2, PRX, FGD4, and FIG4, implicated in demyelinating forms (ARCMT1 or CMT4), and LMNA, MED25, HINT1, GDAP1, LRSAM1, NEFL, HSPB1 and MFN2 in axonal forms (ARCMT2).">
    <entity charOffset="101-112" id="s511.e0" ontology_id="HP_0000005" text="inheritance" type="HP"/>
    <entity charOffset="208-212" id="s511.e1" ontology_id="121512" text="FGD4" type="GENE"/>
    <pair e1="s511.e0" e2="s511.e1" id="s511.p0" relation="false"/>
  </sentence>
  <sentence id="s512" text="Recent clinical, morphological and molecular investigations of CMT families with autosomal recessive inheritance allowed the identification of many genes such as GDAP1, MTMR2, SBF2, NDRG1, EGR2, SH3TC2, PRX, FGD4, and FIG4, implicated in demyelinating forms (ARCMT1 or CMT4), and LMNA, MED25, HINT1, GDAP1, LRSAM1, NEFL, HSPB1 and MFN2 in axonal forms (ARCMT2).">
    <entity charOffset="101-112" id="s512.e0" ontology_id="HP_0000005" text="inheritance" type="HP"/>
    <entity charOffset="280-284" id="s512.e1" ontology_id="4000" text="LMNA" type="GENE"/>
    <pair e1="s512.e0" e2="s512.e1" id="s512.p0" relation="false"/>
  </sentence>
  <sentence id="s513" text="We successfully showed that the combination of immune cell therapy and CPA was safe, might induce tumor-specific immune responses and clinical efficacy, and was accompanied by a decreased ratio of Tregs in patients with RNF43-positive advanced solid tumors">
    <entity charOffset="98-103" id="s513.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="220-225" id="s513.e1" ontology_id="54894" text="RNF43" type="GENE"/>
    <pair e1="s513.e0" e2="s513.e1" id="s513.p0" relation="true"/>
  </sentence>
  <sentence id="s514" text="Further, two SNPs independent of previously reported signals in ESR1 [rs12525163 odds ratio (OR) = 1.15, P = 4.9  10(-) (4)] and 19p13.1 (rs1864112 OR = 0.84, P = 1.8  10(-) (9)) were associated with TN breast cancer.">
    <entity charOffset="64-68" id="s514.e0" ontology_id="2099" text="ESR1" type="GENE"/>
    <entity charOffset="212-218" id="s514.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s514.e0" e2="s514.e1" id="s514.p0" relation="true"/>
  </sentence>
  <sentence id="s515" text="Associations with TN breast cancer were confirmed for 10 loci (LGR6, MDM4, CASP8, 2q35, 2p24.1, TERT-rs10069690, ESR1, TOX3, 19p13.1, RALY), and we identified associations with TN breast cancer for 15 additional breast cancer loci (P &amp;lt; 0.05: PEX14, 2q24.1, 2q31.1, ADAM29, EBF1, TCF7L2, 11q13.1, 11q24.3, 12p13.1, PTHLH, NTN4, 12q24, BRCA2, RAD51L1-rs2588809, MKL1).">
    <entity charOffset="28-34" id="s515.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="113-117" id="s515.e1" ontology_id="2099" text="ESR1" type="GENE"/>
    <pair e1="s515.e0" e2="s515.e1" id="s515.p0" relation="true"/>
  </sentence>
  <sentence id="s516" text="Associations with TN breast cancer were confirmed for 10 loci (LGR6, MDM4, CASP8, 2q35, 2p24.1, TERT-rs10069690, ESR1, TOX3, 19p13.1, RALY), and we identified associations with TN breast cancer for 15 additional breast cancer loci (P &amp;lt; 0.05: PEX14, 2q24.1, 2q31.1, ADAM29, EBF1, TCF7L2, 11q13.1, 11q24.3, 12p13.1, PTHLH, NTN4, 12q24, BRCA2, RAD51L1-rs2588809, MKL1).">
    <entity charOffset="28-34" id="s516.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="276-280" id="s516.e1" ontology_id="1879" text="EBF1" type="GENE"/>
    <pair e1="s516.e0" e2="s516.e1" id="s516.p0" relation="false"/>
  </sentence>
  <sentence id="s517" text="Associations with TN breast cancer were confirmed for 10 loci (LGR6, MDM4, CASP8, 2q35, 2p24.1, TERT-rs10069690, ESR1, TOX3, 19p13.1, RALY), and we identified associations with TN breast cancer for 15 additional breast cancer loci (P &amp;lt; 0.05: PEX14, 2q24.1, 2q31.1, ADAM29, EBF1, TCF7L2, 11q13.1, 11q24.3, 12p13.1, PTHLH, NTN4, 12q24, BRCA2, RAD51L1-rs2588809, MKL1).">
    <entity charOffset="28-34" id="s517.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="282-288" id="s517.e1" ontology_id="6934" text="TCF7L2" type="GENE"/>
    <pair e1="s517.e0" e2="s517.e1" id="s517.p0" relation="false"/>
  </sentence>
  <sentence id="s518" text="Associations with TN breast cancer were confirmed for 10 loci (LGR6, MDM4, CASP8, 2q35, 2p24.1, TERT-rs10069690, ESR1, TOX3, 19p13.1, RALY), and we identified associations with TN breast cancer for 15 additional breast cancer loci (P &amp;lt; 0.05: PEX14, 2q24.1, 2q31.1, ADAM29, EBF1, TCF7L2, 11q13.1, 11q24.3, 12p13.1, PTHLH, NTN4, 12q24, BRCA2, RAD51L1-rs2588809, MKL1).">
    <entity charOffset="28-34" id="s518.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="324-328" id="s518.e1" ontology_id="8079" text="NTN4" type="GENE"/>
    <pair e1="s518.e0" e2="s518.e1" id="s518.p0" relation="false"/>
  </sentence>
  <sentence id="s519" text="Associations with TN breast cancer were confirmed for 10 loci (LGR6, MDM4, CASP8, 2q35, 2p24.1, TERT-rs10069690, ESR1, TOX3, 19p13.1, RALY), and we identified associations with TN breast cancer for 15 additional breast cancer loci (P &amp;lt; 0.05: PEX14, 2q24.1, 2q31.1, ADAM29, EBF1, TCF7L2, 11q13.1, 11q24.3, 12p13.1, PTHLH, NTN4, 12q24, BRCA2, RAD51L1-rs2588809, MKL1).">
    <entity charOffset="28-34" id="s519.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="134-138" id="s519.e1" ontology_id="22913" text="RALY" type="GENE"/>
    <pair e1="s519.e0" e2="s519.e1" id="s519.p0" relation="true"/>
  </sentence>
  <sentence id="s520" text="Associations with TN breast cancer were confirmed for 10 loci (LGR6, MDM4, CASP8, 2q35, 2p24.1, TERT-rs10069690, ESR1, TOX3, 19p13.1, RALY), and we identified associations with TN breast cancer for 15 additional breast cancer loci (P &amp;lt; 0.05: PEX14, 2q24.1, 2q31.1, ADAM29, EBF1, TCF7L2, 11q13.1, 11q24.3, 12p13.1, PTHLH, NTN4, 12q24, BRCA2, RAD51L1-rs2588809, MKL1).">
    <entity charOffset="28-34" id="s520.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="317-322" id="s520.e1" ontology_id="5744" text="PTHLH" type="GENE"/>
    <pair e1="s520.e0" e2="s520.e1" id="s520.p0" relation="false"/>
  </sentence>
  <sentence id="s521" text="The downstream pathways of Nodal-Foxh1 play a critical role not only in L-R determination in the lateral plate mesoderm but also in myocardial specification and differentiation in the AHF, suggesting that TGA is a phenotype in heterotaxia as well as the primary developmental defect of the AHF.">
    <entity charOffset="33-38" id="s521.e0" ontology_id="8928" text="Foxh1" type="GENE"/>
    <entity charOffset="227-238" id="s521.e1" ontology_id="HP_0030853" text="heterotaxia" type="HP"/>
    <pair e1="s521.e0" e2="s521.e1" id="s521.p0" relation="false"/>
  </sentence>
  <sentence id="s522" text="However, Pdha1&lt;sup&gt;f/Y;&lt;/sup&gt; Cnp&lt;sup&gt;Cre/+&lt;/sup&gt; mice showed reduced fiber density and signs of axonal degeneration in both sciatic and optic nerves from 6 months of age.">
    <entity charOffset="9-14" id="s522.e0" ontology_id="5160" text="Pdha1" type="GENE"/>
    <entity charOffset="97-116" id="s522.e1" ontology_id="HP_0040078" text="axonal degeneration" type="HP"/>
    <pair e1="s522.e0" e2="s522.e1" id="s522.p0" relation="true"/>
  </sentence>
  <sentence id="s523" text="However, as a classical cell surface adhesion molecule, we found ITGA3 correlated negatively with the migration and invasion of ICC cell lines, which differs from other malignant tumors.">
    <entity charOffset="65-70" id="s523.e0" ontology_id="3675" text="ITGA3" type="GENE"/>
    <entity charOffset="179-184" id="s523.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s523.e0" e2="s523.e1" id="s523.p0" relation="false"/>
  </sentence>
  <sentence id="s524" text="To investigate SCRIB-associated proteins that might participate in the responses of breast cancer cells to altered levels of SCRIB, we used mass spectrometry and confocal microscopy.">
    <entity charOffset="15-20" id="s524.e0" ontology_id="23513" text="SCRIB" type="GENE"/>
    <entity charOffset="91-97" id="s524.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s524.e0" e2="s524.e1" id="s524.p0" relation="true"/>
  </sentence>
  <sentence id="s525" text="Focusing on NOS1AP, we observed that NOS1AP colocalizes with both SCRIB and VANGL1 along cellular protrusions in metastatic breast cancer cells, but does not colocalize with either SCRIB or VANGL1 at cell junctions in normal breast cells.">
    <entity charOffset="76-82" id="s525.e0" ontology_id="81839" text="VANGL1" type="GENE"/>
    <entity charOffset="131-137" id="s525.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s525.e0" e2="s525.e1" id="s525.p0" relation="true"/>
  </sentence>
  <sentence id="s526" text="Experimentally, we found that reducing expression of SCRIB by short-hairpin RNAs (shRNAs) reduces the growth of human breast cancer cells in xenograft assays.">
    <entity charOffset="53-58" id="s526.e0" ontology_id="23513" text="SCRIB" type="GENE"/>
    <entity charOffset="125-131" id="s526.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s526.e0" e2="s526.e1" id="s526.p0" relation="true"/>
  </sentence>
  <sentence id="s527" text="In addition, the coexistence of high MACC1 and low NM23-H1 expression and tumor budding was associated with short OS (p&amp;lt;0.001).">
    <entity charOffset="56-58" id="s527.e0" ontology_id="25932" text="H1" type="GENE"/>
    <entity charOffset="74-79" id="s527.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s527.e0" e2="s527.e1" id="s527.p0" relation="false"/>
  </sentence>
  <sentence id="s528" text="We suggest that the combination of reduced NM23-H1, induced MACC1, and the presence of tumor budding are promising biomarkers for the prediction of recurrence and may aid the stratification of patients with stage II colon cancer for adjuvant chemotherapy">
    <entity charOffset="43-47" id="s528.e0" ontology_id="4830" text="NM23" type="GENE"/>
    <entity charOffset="87-92" id="s528.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s528.e0" e2="s528.e1" id="s528.p0" relation="false"/>
  </sentence>
  <sentence id="s529" text="We suggest that the combination of reduced NM23-H1, induced MACC1, and the presence of tumor budding are promising biomarkers for the prediction of recurrence and may aid the stratification of patients with stage II colon cancer for adjuvant chemotherapy">
    <entity charOffset="43-47" id="s529.e0" ontology_id="4830" text="NM23" type="GENE"/>
    <entity charOffset="222-228" id="s529.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s529.e0" e2="s529.e1" id="s529.p0" relation="true"/>
  </sentence>
  <sentence id="s530" text="We suggest that the combination of reduced NM23-H1, induced MACC1, and the presence of tumor budding are promising biomarkers for the prediction of recurrence and may aid the stratification of patients with stage II colon cancer for adjuvant chemotherapy">
    <entity charOffset="60-65" id="s530.e0" ontology_id="346389" text="MACC1" type="GENE"/>
    <entity charOffset="222-228" id="s530.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s530.e0" e2="s530.e1" id="s530.p0" relation="true"/>
  </sentence>
  <sentence id="s531" text="We suggest that the combination of reduced NM23-H1, induced MACC1, and the presence of tumor budding are promising biomarkers for the prediction of recurrence and may aid the stratification of patients with stage II colon cancer for adjuvant chemotherapy">
    <entity charOffset="60-65" id="s531.e0" ontology_id="346389" text="MACC1" type="GENE"/>
    <entity charOffset="87-92" id="s531.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s531.e0" e2="s531.e1" id="s531.p0" relation="false"/>
  </sentence>
  <sentence id="s532" text="The aims of the present study were to evaluate the relation of dysregulated MACC1, c-MET, and NM23-H1 expression with the histopathological features of tumors in recurrence formation in eCC cases.">
    <entity charOffset="99-101" id="s532.e0" ontology_id="25932" text="H1" type="GENE"/>
    <entity charOffset="152-157" id="s532.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s532.e0" e2="s532.e1" id="s532.p0" relation="true"/>
  </sentence>
  <sentence id="s533" text="Recent studies in RAS wild-type (WT) metastatic colorectal cancer (mCRC) suggest that the survival benefits of therapy using anti-epidermal growth factor receptor (anti-EGFR) and anti-vascular endothelial growth factor (anti-VEGF) antibodies combined with chemotherapy are maximized when the anti-EGFR antibody is given as first-line, followed by subsequent anti-VEGF antibody therapy.">
    <entity charOffset="59-65" id="s533.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="225-229" id="s533.e1" ontology_id="7422" text="VEGF" type="GENE"/>
    <pair e1="s533.e0" e2="s533.e1" id="s533.p0" relation="false"/>
  </sentence>
  <sentence id="s534" text="Genes harboring the most significant mutations include PCDH9, KLHL12, DCAF4L1, and VHL in sporadic HBs, and ZNF814, DLG2, RIMS1, PNN, and MUC7 in familial HBs.">
    <entity charOffset="55-60" id="s534.e0" ontology_id="5101" text="PCDH9" type="GENE"/>
    <entity charOffset="90-98" id="s534.e1" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <pair e1="s534.e0" e2="s534.e1" id="s534.p0" relation="false"/>
  </sentence>
  <sentence id="s535" text="Genes harboring the most significant mutations include PCDH9, KLHL12, DCAF4L1, and VHL in sporadic HBs, and ZNF814, DLG2, RIMS1, PNN, and MUC7 in familial HBs.">
    <entity charOffset="62-68" id="s535.e0" ontology_id="59349" text="KLHL12" type="GENE"/>
    <entity charOffset="90-98" id="s535.e1" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <pair e1="s535.e0" e2="s535.e1" id="s535.p0" relation="true"/>
  </sentence>
  <sentence id="s536" text="Genes harboring the most significant mutations include PCDH9, KLHL12, DCAF4L1, and VHL in sporadic HBs, and ZNF814, DLG2, RIMS1, PNN, and MUC7 in familial HBs.">
    <entity charOffset="90-98" id="s536.e0" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <entity charOffset="122-127" id="s536.e1" ontology_id="22999" text="RIMS1" type="GENE"/>
    <pair e1="s536.e0" e2="s536.e1" id="s536.p0" relation="false"/>
  </sentence>
  <sentence id="s537" text="Genes harboring the most significant mutations include PCDH9, KLHL12, DCAF4L1, and VHL in sporadic HBs, and ZNF814, DLG2, RIMS1, PNN, and MUC7 in familial HBs.">
    <entity charOffset="90-98" id="s537.e0" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <entity charOffset="116-120" id="s537.e1" ontology_id="2305" text="DLG2" type="GENE"/>
    <pair e1="s537.e0" e2="s537.e1" id="s537.p0" relation="false"/>
  </sentence>
  <sentence id="s538" text="Five genes, including OTOGL, PLCB4, SCEL, THSD4, and WWOX, have CNVs in the six patients with sporadic HBs, and three genes, including ABCA6, CWC27, and LAMA2, have CNVs in the five patients with familial HBs.">
    <entity charOffset="53-57" id="s538.e0" ontology_id="51741" text="WWOX" type="GENE"/>
    <entity charOffset="94-102" id="s538.e1" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <pair e1="s538.e0" e2="s538.e1" id="s538.p0" relation="true"/>
  </sentence>
  <sentence id="s539" text="Five genes, including OTOGL, PLCB4, SCEL, THSD4, and WWOX, have CNVs in the six patients with sporadic HBs, and three genes, including ABCA6, CWC27, and LAMA2, have CNVs in the five patients with familial HBs.">
    <entity charOffset="94-102" id="s539.e0" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <entity charOffset="142-147" id="s539.e1" ontology_id="10283" text="CWC27" type="GENE"/>
    <pair e1="s539.e0" e2="s539.e1" id="s539.p0" relation="false"/>
  </sentence>
  <sentence id="s540" text="Analyses of our original miRNA expression signatures indicated that both strands of miR-144 (miR-144-5p, the passenger strand; miR-144-3p, the guide strand) showed decreased expression in cancer tissues.">
    <entity charOffset="25-28" id="s540.e0" ontology_id="220972" text="miR" type="GENE"/>
    <entity charOffset="188-194" id="s540.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s540.e0" e2="s540.e1" id="s540.p0" relation="true"/>
  </sentence>
  <sentence id="s541" text="Our results demonstrated that the overall expression of NSUN2 significantly correlated with clinical stage (P=0.027), tumor classification (P=0.012), pathological differentiation (P=0.023), as well as with the expression levels of estrogen receptor (P&amp;lt;0.001), progesterone receptor (P=0.001), and Ki-67 (P&amp;lt;0.001).">
    <entity charOffset="56-61" id="s541.e0" ontology_id="54888" text="NSUN2" type="GENE"/>
    <entity charOffset="118-123" id="s541.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s541.e0" e2="s541.e1" id="s541.p0" relation="true"/>
  </sentence>
  <sentence id="s542" text="NSUN2 expression was shown to be significantly higher in breast cancer cells and tissues than in normal breast epithelial cells and tissues, at both mRNA and protein levels.">
    <entity charOffset="0-5" id="s542.e0" ontology_id="54888" text="NSUN2" type="GENE"/>
    <entity charOffset="64-70" id="s542.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s542.e0" e2="s542.e1" id="s542.p0" relation="true"/>
  </sentence>
  <sentence id="s543" text="To investigate the presence of specific chromosomal and gene alterations, BAP1 protein expression, and their relationship with distant progression free survival (DPFS), we analyzed tumor samples from 63 UM patients (40 men and 23 women, with a median age of 64 years), who underwent eye enucleation by a single cancer ophthalmologist from December 2005 to June 2016.">
    <entity charOffset="74-78" id="s543.e0" ontology_id="154043" text="BAP1" type="GENE"/>
    <entity charOffset="311-317" id="s543.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s543.e0" e2="s543.e1" id="s543.p0" relation="false"/>
  </sentence>
  <sentence id="s544" text="As an important multifunctional protein involved in regulation of mitochondrial metabolism, CHCHD2 was identified as a causative gene for Parkinson's disease (PD), yet the relationship between CHCHD2 and neurodegenerative dementia is not well understood.">
    <entity charOffset="66-79" id="s544.e0" ontology_id="HP_0001427" text="mitochondrial" type="HP"/>
    <entity charOffset="92-98" id="s544.e1" ontology_id="51142" text="CHCHD2" type="GENE"/>
    <pair e1="s544.e0" e2="s544.e1" id="s544.p0" relation="true"/>
  </sentence>
  <sentence id="s545" text="The heterogeneity test, sensitivity analysis, and publication bias test was performed by Review Manager 5.3 software.Overall, 22 case-control studies with 5049 cases and 4157 controls were included in this meta-analysis, which contained 20 studies of MTHFR C677T polymorphism, 12 studies of MTHFR A1298C polymorphism and 4 studies of MTRR A66G polymorphism.">
    <entity charOffset="4-17" id="s545.e0" ontology_id="HP_0001425" text="heterogeneity" type="HP"/>
    <entity charOffset="334-338" id="s545.e1" ontology_id="4552" text="MTRR" type="GENE"/>
    <pair e1="s545.e0" e2="s545.e1" id="s545.p0" relation="false"/>
  </sentence>
  <sentence id="s546" text="Here we report a consanguineous Arab family from Qatar with three children having an early lethal form of arthrogryposis multiplex congenita and a novel frameshift mutation in CNTNAP1.">
    <entity charOffset="106-120" id="s546.e0" ontology_id="HP_0002804" text="arthrogryposis" type="HP"/>
    <entity charOffset="176-183" id="s546.e1" ontology_id="8506" text="CNTNAP1" type="GENE"/>
    <pair e1="s546.e0" e2="s546.e1" id="s546.p0" relation="true"/>
  </sentence>
  <sentence id="s547" text="The TECPR2 gene has been reported as a positive regulator of autophagy which is an essential mechanism for maintaining neuron homeostasis and survival and plays a key role in major adult and pediatric neurodegenerative diseases.">
    <entity charOffset="4-10" id="s547.e0" ontology_id="9895" text="TECPR2" type="GENE"/>
    <entity charOffset="201-227" id="s547.e1" ontology_id="HP_0002180" text="neurodegenerative diseases" type="HP"/>
    <pair e1="s547.e0" e2="s547.e1" id="s547.p0" relation="true"/>
  </sentence>
  <sentence id="s548" text="Our exome analysis indicated the proband as a compound heterozygote for two missense variants in the TECPR2 gene according to a recessive mode of inheritance.">
    <entity charOffset="101-107" id="s548.e0" ontology_id="9895" text="TECPR2" type="GENE"/>
    <entity charOffset="138-157" id="s548.e1" ontology_id="HP_0000005" text="mode of inheritance" type="HP"/>
    <pair e1="s548.e0" e2="s548.e1" id="s548.p0" relation="true"/>
  </sentence>
  <sentence id="s549" text="Importantly, KLF4 inhibitor Kenpaullone sensitizes breast cancer cells and xenograft tumors to Paclitaxel and improves therapeutic effects.">
    <entity charOffset="13-17" id="s549.e0" ontology_id="9314" text="KLF4" type="GENE"/>
    <entity charOffset="58-64" id="s549.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s549.e0" e2="s549.e1" id="s549.p0" relation="true"/>
  </sentence>
  <sentence id="s550" text="Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) are approved for second-line treatment of &lt;i&gt;EGFR&lt;/i&gt; wild-type (&lt;i&gt;EGFR&lt;/i&gt;-wt) nonsmall cell lung cancer (NSCLC).">
    <entity charOffset="61-65" id="s550.e0" ontology_id="1956" text="EGFR" type="GENE"/>
    <entity charOffset="172-178" id="s550.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s550.e0" e2="s550.e1" id="s550.p0" relation="true"/>
  </sentence>
  <sentence id="s551" text="Further analysis revealed a reduced SMARCA4 expression and a complete loss of SMARCA2 expression in tumor cells.">
    <entity charOffset="36-43" id="s551.e0" ontology_id="6597" text="SMARCA4" type="GENE"/>
    <entity charOffset="100-105" id="s551.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s551.e0" e2="s551.e1" id="s551.p0" relation="true"/>
  </sentence>
  <sentence id="s552" text="Further analysis revealed a reduced SMARCA4 expression and a complete loss of SMARCA2 expression in tumor cells.">
    <entity charOffset="78-85" id="s552.e0" ontology_id="6595" text="SMARCA2" type="GENE"/>
    <entity charOffset="100-105" id="s552.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s552.e0" e2="s552.e1" id="s552.p0" relation="true"/>
  </sentence>
  <sentence id="s553" text="Pharmacological manipulation of peripheral CB1 signaling regulates hyperphagia in an adipocyte OGT-dependent manner.">
    <entity charOffset="67-78" id="s553.e0" ontology_id="HP_0002591" text="hyperphagia" type="HP"/>
    <entity charOffset="95-98" id="s553.e1" ontology_id="8473" text="OGT" type="GENE"/>
    <pair e1="s553.e0" e2="s553.e1" id="s553.p0" relation="true"/>
  </sentence>
  <sentence id="s554" text="Conversely, ADAMTS4, 6, 14, and 20 are consistently up-regulated in breast carcinomas (P = 0.005, P &amp;lt; 0.0001, P = 0.003, and P = 0.001, respectively).">
    <entity charOffset="12-19" id="s554.e0" ontology_id="9507" text="ADAMTS4" type="GENE"/>
    <entity charOffset="68-84" id="s554.e1" ontology_id="HP_0003002" text="breast carcinoma" type="HP"/>
    <pair e1="s554.e0" e2="s554.e1" id="s554.p0" relation="true"/>
  </sentence>
  <sentence id="s555" text="Genetic modification of a human prostate cancer cell line to induce miR-101 and suppress CENPF decreased cell migration and invasion.">
    <entity charOffset="41-47" id="s555.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="68-71" id="s555.e1" ontology_id="220972" text="miR" type="GENE"/>
    <pair e1="s555.e0" e2="s555.e1" id="s555.p0" relation="true"/>
  </sentence>
  <sentence id="s556" text="Polymorphisms rs2910164 in miR-146a and rs486907 in the RNASEL gene have both independently been associated with the risk of different cancers, and an interaction between them has been observed in nonmelanoma skin cancer.">
    <entity charOffset="56-62" id="s556.e0" ontology_id="6041" text="RNASEL" type="GENE"/>
    <entity charOffset="200-208" id="s556.e1" ontology_id="HP_0002861" text="melanoma" type="HP"/>
    <pair e1="s556.e0" e2="s556.e1" id="s556.p0" relation="true"/>
  </sentence>
  <sentence id="s557" text="Polymorphisms rs2910164 in miR-146a and rs486907 in the RNASEL gene have both independently been associated with the risk of different cancers, and an interaction between them has been observed in nonmelanoma skin cancer.">
    <entity charOffset="56-62" id="s557.e0" ontology_id="6041" text="RNASEL" type="GENE"/>
    <entity charOffset="135-141" id="s557.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s557.e0" e2="s557.e1" id="s557.p0" relation="true"/>
  </sentence>
  <sentence id="s558" text="In this study, we evaluated the possible interaction between miR-146a and one of its putative targets ribonuclease L (RNASEL) in the risk of sporadic melanoma.">
    <entity charOffset="118-124" id="s558.e0" ontology_id="6041" text="RNASEL" type="GENE"/>
    <entity charOffset="150-158" id="s558.e1" ontology_id="HP_0002861" text="melanoma" type="HP"/>
    <pair e1="s558.e0" e2="s558.e1" id="s558.p0" relation="true"/>
  </sentence>
  <sentence id="s559" text="The results reported in the present study suggest a sex-specific interaction between miR-146a and RNASEL genes in melanoma skin cancer susceptibility, and could account for possible discordant results in association studies when stratification according to sex is not performed">
    <entity charOffset="85-88" id="s559.e0" ontology_id="220972" text="miR" type="GENE"/>
    <entity charOffset="114-122" id="s559.e1" ontology_id="HP_0002861" text="melanoma" type="HP"/>
    <pair e1="s559.e0" e2="s559.e1" id="s559.p0" relation="true"/>
  </sentence>
  <sentence id="s560" text="The results reported in the present study suggest a sex-specific interaction between miR-146a and RNASEL genes in melanoma skin cancer susceptibility, and could account for possible discordant results in association studies when stratification according to sex is not performed">
    <entity charOffset="85-88" id="s560.e0" ontology_id="220972" text="miR" type="GENE"/>
    <entity charOffset="128-134" id="s560.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s560.e0" e2="s560.e1" id="s560.p0" relation="true"/>
  </sentence>
  <sentence id="s561" text="Polo-like kinase 1 (Plk1) is overexpressed in a wide spectrum of human tumors, being frequently considered as an oncogene and an attractive cancer target.">
    <entity charOffset="20-24" id="s561.e0" ontology_id="5347" text="Plk1" type="GENE"/>
    <entity charOffset="71-77" id="s561.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s561.e0" e2="s561.e1" id="s561.p0" relation="true"/>
  </sentence>
  <sentence id="s562" text="Two of these genes were independently mutated in more than one family with similar phenotypes, which substantiates their link to human disease (AKAP6 in intellectual disability and UBR4 in early dementia).">
    <entity charOffset="144-149" id="s562.e0" ontology_id="9472" text="AKAP6" type="GENE"/>
    <entity charOffset="153-176" id="s562.e1" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <pair e1="s562.e0" e2="s562.e1" id="s562.p0" relation="true"/>
  </sentence>
  <sentence id="s563" text="The KEGG enrichment analysis of DEGs showed significantly enriched pathways in cancer, extracellular matrix (ECM)-receptor interaction pathway, and cyclic adenosine monophosphate (cAMP) signaling pathway.">
    <entity charOffset="79-85" id="s563.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="180-184" id="s563.e1" ontology_id="283489" text="cAMP" type="GENE"/>
    <pair e1="s563.e0" e2="s563.e1" id="s563.p0" relation="false"/>
  </sentence>
  <sentence id="s564" text="In addition, the expression of miR-214 inhibited proliferation of ESCC cells in vitro and inhibit the growth of xenograft tumor in vivo.">
    <entity charOffset="31-34" id="s564.e0" ontology_id="220972" text="miR" type="GENE"/>
    <entity charOffset="122-127" id="s564.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s564.e0" e2="s564.e1" id="s564.p0" relation="true"/>
  </sentence>
  <sentence id="s565" text="Targeted exome sequencing identified biallelic mutations in WDR19, encoding an IFT-A subunit previously associated with MZSDS-related chondrodysplasia, Jeune asphyxiating thoracic dysplasia and cranioectodermal dysplasia, linked to primary cilia dysfunction, and in TEKT1 which encodes tektin-1 an uncharacterized member of the tektin family, mutations of which may cause ciliary dyskinesia.">
    <entity charOffset="171-189" id="s565.e0" ontology_id="HP_0006644" text="thoracic dysplasia" type="HP"/>
    <entity charOffset="266-271" id="s565.e1" ontology_id="83659" text="TEKT1" type="GENE"/>
    <pair e1="s565.e0" e2="s565.e1" id="s565.p0" relation="false"/>
  </sentence>
  <sentence id="s566" text="Targeted exome sequencing identified biallelic mutations in WDR19, encoding an IFT-A subunit previously associated with MZSDS-related chondrodysplasia, Jeune asphyxiating thoracic dysplasia and cranioectodermal dysplasia, linked to primary cilia dysfunction, and in TEKT1 which encodes tektin-1 an uncharacterized member of the tektin family, mutations of which may cause ciliary dyskinesia.">
    <entity charOffset="266-271" id="s566.e0" ontology_id="83659" text="TEKT1" type="GENE"/>
    <entity charOffset="372-390" id="s566.e1" ontology_id="HP_0012265" text="ciliary dyskinesia" type="HP"/>
    <pair e1="s566.e0" e2="s566.e1" id="s566.p0" relation="true"/>
  </sentence>
  <sentence id="s567" text="There were no statistically significant associations between phospho-ELK1 expression and tumor grade, presence of concurrent carcinoma in situ or hydronephrosis, or pN status.">
    <entity charOffset="69-73" id="s567.e0" ontology_id="2002" text="ELK1" type="GENE"/>
    <entity charOffset="89-94" id="s567.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s567.e0" e2="s567.e1" id="s567.p0" relation="true"/>
  </sentence>
  <sentence id="s568" text="Homozygous and compound heterozygous mutations in C12orf57 have recently been described to cause an autosomal recessive syndromic form of intellectual disability, including agenesis/hypoplasia of the corpus callosum, optic coloboma, and intractable seizures.">
    <entity charOffset="50-58" id="s568.e0" ontology_id="113246" text="C12orf57" type="GENE"/>
    <entity charOffset="100-119" id="s568.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s568.e0" e2="s568.e1" id="s568.p0" relation="true"/>
  </sentence>
  <sentence id="s569" text="Homozygous and compound heterozygous mutations in C12orf57 have recently been described to cause an autosomal recessive syndromic form of intellectual disability, including agenesis/hypoplasia of the corpus callosum, optic coloboma, and intractable seizures.">
    <entity charOffset="50-58" id="s569.e0" ontology_id="113246" text="C12orf57" type="GENE"/>
    <entity charOffset="249-257" id="s569.e1" ontology_id="HP_0001250" text="seizures" type="HP"/>
    <pair e1="s569.e0" e2="s569.e1" id="s569.p0" relation="true"/>
  </sentence>
  <sentence id="s570" text="Mutations of the sigma subunit of the heterotetrameric adaptor-related protein complex 2 (AP2) impair signalling of the calcium-sensing receptor (CaSR), and cause familial hypocalciuric hypercalcaemia type 3 (FHH3).">
    <entity charOffset="147-151" id="s570.e0" ontology_id="846" text="CaSR" type="GENE"/>
    <entity charOffset="187-201" id="s570.e1" ontology_id="HP_0003072" text="hypercalcaemia" type="HP"/>
    <pair e1="s570.e0" e2="s570.e1" id="s570.p0" relation="false"/>
  </sentence>
  <sentence id="s571" text="We hypothesized that additional rare AP2 variants may also be associated with altered CaSR function and hypercalcaemia, and sought for these by analysing&amp;gt;111995 exomes (&amp;gt;60706 from ExAc and dbSNP, and 51289 from the Geisinger Health System-Regeneron DiscovEHR dataset, which also contains clinical data).">
    <entity charOffset="87-91" id="s571.e0" ontology_id="846" text="CaSR" type="GENE"/>
    <entity charOffset="105-119" id="s571.e1" ontology_id="HP_0003072" text="hypercalcaemia" type="HP"/>
    <pair e1="s571.e0" e2="s571.e1" id="s571.p0" relation="false"/>
  </sentence>
  <sentence id="s572" text="In addition, polymorphisms in apoptosis-related genes such as RNF7, TULP1, and MERTK are associated with fibrosis progression, and DEPDC5 and MICA variants are associated with HCV-related hepatocellular carcinoma.">
    <entity charOffset="62-66" id="s572.e0" ontology_id="9616" text="RNF7" type="GENE"/>
    <entity charOffset="188-212" id="s572.e1" ontology_id="HP_0001402" text="hepatocellular carcinoma" type="HP"/>
    <pair e1="s572.e0" e2="s572.e1" id="s572.p0" relation="false"/>
  </sentence>
  <sentence id="s573" text="In addition, polymorphisms in apoptosis-related genes such as RNF7, TULP1, and MERTK are associated with fibrosis progression, and DEPDC5 and MICA variants are associated with HCV-related hepatocellular carcinoma.">
    <entity charOffset="142-146" id="s573.e0" ontology_id="100507436" text="MICA" type="GENE"/>
    <entity charOffset="188-212" id="s573.e1" ontology_id="HP_0001402" text="hepatocellular carcinoma" type="HP"/>
    <pair e1="s573.e0" e2="s573.e1" id="s573.p0" relation="true"/>
  </sentence>
  <sentence id="s574" text="Eighteen MCPH loci (MCPH1-MCPH18) have been mapped to date from various populations around the world and contain the following genes: Microcephalin, WDR62, CDK5RAP2, CASC5, ASPM, CENPJ, STIL, CEP135, CEP152, ZNF335, PHC1, CDK6, CENPE, SASS6, MFSD2A, ANKLE2, CIT and WDFY3, clarifying our understanding about the molecular basis of microcephaly genetic disorder.">
    <entity charOffset="149-154" id="s574.e0" ontology_id="284403" text="WDR62" type="GENE"/>
    <entity charOffset="331-343" id="s574.e1" ontology_id="HP_0000252" text="microcephaly" type="HP"/>
    <pair e1="s574.e0" e2="s574.e1" id="s574.p0" relation="true"/>
  </sentence>
  <sentence id="s575" text="Eighteen MCPH loci (MCPH1-MCPH18) have been mapped to date from various populations around the world and contain the following genes: Microcephalin, WDR62, CDK5RAP2, CASC5, ASPM, CENPJ, STIL, CEP135, CEP152, ZNF335, PHC1, CDK6, CENPE, SASS6, MFSD2A, ANKLE2, CIT and WDFY3, clarifying our understanding about the molecular basis of microcephaly genetic disorder.">
    <entity charOffset="192-198" id="s575.e0" ontology_id="9662" text="CEP135" type="GENE"/>
    <entity charOffset="331-343" id="s575.e1" ontology_id="HP_0000252" text="microcephaly" type="HP"/>
    <pair e1="s575.e0" e2="s575.e1" id="s575.p0" relation="true"/>
  </sentence>
  <sentence id="s576" text="Eighteen MCPH loci (MCPH1-MCPH18) have been mapped to date from various populations around the world and contain the following genes: Microcephalin, WDR62, CDK5RAP2, CASC5, ASPM, CENPJ, STIL, CEP135, CEP152, ZNF335, PHC1, CDK6, CENPE, SASS6, MFSD2A, ANKLE2, CIT and WDFY3, clarifying our understanding about the molecular basis of microcephaly genetic disorder.">
    <entity charOffset="208-214" id="s576.e0" ontology_id="63925" text="ZNF335" type="GENE"/>
    <entity charOffset="331-343" id="s576.e1" ontology_id="HP_0000252" text="microcephaly" type="HP"/>
    <pair e1="s576.e0" e2="s576.e1" id="s576.p0" relation="true"/>
  </sentence>
  <sentence id="s577" text="Eighteen MCPH loci (MCPH1-MCPH18) have been mapped to date from various populations around the world and contain the following genes: Microcephalin, WDR62, CDK5RAP2, CASC5, ASPM, CENPJ, STIL, CEP135, CEP152, ZNF335, PHC1, CDK6, CENPE, SASS6, MFSD2A, ANKLE2, CIT and WDFY3, clarifying our understanding about the molecular basis of microcephaly genetic disorder.">
    <entity charOffset="216-220" id="s577.e0" ontology_id="1911" text="PHC1" type="GENE"/>
    <entity charOffset="331-343" id="s577.e1" ontology_id="HP_0000252" text="microcephaly" type="HP"/>
    <pair e1="s577.e0" e2="s577.e1" id="s577.p0" relation="true"/>
  </sentence>
  <sentence id="s578" text="Eighteen MCPH loci (MCPH1-MCPH18) have been mapped to date from various populations around the world and contain the following genes: Microcephalin, WDR62, CDK5RAP2, CASC5, ASPM, CENPJ, STIL, CEP135, CEP152, ZNF335, PHC1, CDK6, CENPE, SASS6, MFSD2A, ANKLE2, CIT and WDFY3, clarifying our understanding about the molecular basis of microcephaly genetic disorder.">
    <entity charOffset="222-226" id="s578.e0" ontology_id="1021" text="CDK6" type="GENE"/>
    <entity charOffset="331-343" id="s578.e1" ontology_id="HP_0000252" text="microcephaly" type="HP"/>
    <pair e1="s578.e0" e2="s578.e1" id="s578.p0" relation="true"/>
  </sentence>
  <sentence id="s579" text="Eighteen MCPH loci (MCPH1-MCPH18) have been mapped to date from various populations around the world and contain the following genes: Microcephalin, WDR62, CDK5RAP2, CASC5, ASPM, CENPJ, STIL, CEP135, CEP152, ZNF335, PHC1, CDK6, CENPE, SASS6, MFSD2A, ANKLE2, CIT and WDFY3, clarifying our understanding about the molecular basis of microcephaly genetic disorder.">
    <entity charOffset="235-240" id="s579.e0" ontology_id="163786" text="SASS6" type="GENE"/>
    <entity charOffset="331-343" id="s579.e1" ontology_id="HP_0000252" text="microcephaly" type="HP"/>
    <pair e1="s579.e0" e2="s579.e1" id="s579.p0" relation="true"/>
  </sentence>
  <sentence id="s580" text="Eighteen MCPH loci (MCPH1-MCPH18) have been mapped to date from various populations around the world and contain the following genes: Microcephalin, WDR62, CDK5RAP2, CASC5, ASPM, CENPJ, STIL, CEP135, CEP152, ZNF335, PHC1, CDK6, CENPE, SASS6, MFSD2A, ANKLE2, CIT and WDFY3, clarifying our understanding about the molecular basis of microcephaly genetic disorder.">
    <entity charOffset="242-248" id="s580.e0" ontology_id="84879" text="MFSD2A" type="GENE"/>
    <entity charOffset="331-343" id="s580.e1" ontology_id="HP_0000252" text="microcephaly" type="HP"/>
    <pair e1="s580.e0" e2="s580.e1" id="s580.p0" relation="true"/>
  </sentence>
  <sentence id="s581" text="There are several genetic mutations that lead to ALS development, such as chromosome 9 hexanucleotide repeat 72 (C9ORF72), transactive response DNA-binding protein (TARDBP), superoxide dismutase 1 (SOD1) and fused in sarcoma (FUS).">
    <entity charOffset="198-202" id="s581.e0" ontology_id="6647" text="SOD1" type="GENE"/>
    <entity charOffset="217-224" id="s581.e1" ontology_id="HP_0100242" text="sarcoma" type="HP"/>
    <pair e1="s581.e0" e2="s581.e1" id="s581.p0" relation="false"/>
  </sentence>
  <sentence id="s582" text="Targeted resequencing was used to screen 460 unselected epilepsy patients for variants in SLC6A1.">
    <entity charOffset="56-64" id="s582.e0" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <entity charOffset="90-96" id="s582.e1" ontology_id="6529" text="SLC6A1" type="GENE"/>
    <pair e1="s582.e0" e2="s582.e1" id="s582.p0" relation="true"/>
  </sentence>
  <sentence id="s583" text="Previous reports have identified SLC6A1 variants in patients with generalized epilepsies, such as myoclonic-atonic epilepsy and childhood absence epilepsy.">
    <entity charOffset="33-39" id="s583.e0" ontology_id="6529" text="SLC6A1" type="GENE"/>
    <entity charOffset="78-88" id="s583.e1" ontology_id="HP_0001250" text="epilepsies" type="HP"/>
    <pair e1="s583.e0" e2="s583.e1" id="s583.p0" relation="true"/>
  </sentence>
  <sentence id="s584" text="These findings demonstrate that SLC6A1 is an important contributor to childhood epilepsy and that reduced GAT-1 function is a common consequence of epilepsy-causing SLC6A1 variants">
    <entity charOffset="80-88" id="s584.e0" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <entity charOffset="106-109" id="s584.e1" ontology_id="10249" text="GAT" type="GENE"/>
    <pair e1="s584.e0" e2="s584.e1" id="s584.p0" relation="false"/>
  </sentence>
  <sentence id="s585" text="To better understand the biology of this molecularly distinct tumor subtype, we analyze the microRNA (miRNA) expression profiles of Xp11 RCC compared with normal renal parenchyma using microarray and quantitative reverse-transcription polymerase chain reaction.">
    <entity charOffset="62-67" id="s585.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="102-105" id="s585.e1" ontology_id="220972" text="miR" type="GENE"/>
    <pair e1="s585.e0" e2="s585.e1" id="s585.p0" relation="true"/>
  </sentence>
  <sentence id="s586" text="Mutations in Vps33 isoforms cause pigment dilution in mice (Vps33a, buff) and Drosophila (car) and the neurogenic arthrogryposis, renal dysfunction and cholestasis syndrome in humans (ARC1, VPS33B).">
    <entity charOffset="60-66" id="s586.e0" ontology_id="65082" text="Vps33a" type="GENE"/>
    <entity charOffset="114-128" id="s586.e1" ontology_id="HP_0002804" text="arthrogryposis" type="HP"/>
    <pair e1="s586.e0" e2="s586.e1" id="s586.p0" relation="false"/>
  </sentence>
  <sentence id="s587" text="Mutations in Vps33 isoforms cause pigment dilution in mice (Vps33a, buff) and Drosophila (car) and the neurogenic arthrogryposis, renal dysfunction and cholestasis syndrome in humans (ARC1, VPS33B).">
    <entity charOffset="114-128" id="s587.e0" ontology_id="HP_0002804" text="arthrogryposis" type="HP"/>
    <entity charOffset="190-196" id="s587.e1" ontology_id="26276" text="VPS33B" type="GENE"/>
    <pair e1="s587.e0" e2="s587.e1" id="s587.p0" relation="true"/>
  </sentence>
  <sentence id="s588" text="Liver-specific knockout of murine Bruce impaired ATR activation and exacerbated inflammation, fibrosis and hepatocellular carcinoma, which exhibited a trabecular architecture, closely resembling human HCC.">
    <entity charOffset="34-39" id="s588.e0" ontology_id="57448" text="Bruce" type="GENE"/>
    <entity charOffset="107-131" id="s588.e1" ontology_id="HP_0001402" text="hepatocellular carcinoma" type="HP"/>
    <pair e1="s588.e0" e2="s588.e1" id="s588.p0" relation="true"/>
  </sentence>
  <sentence id="s589" text="The in vivo impact of BRUCE loss on liver tumorigenesis was determined using the hepatocellular carcinoma model induced by genotoxin Diethylnitrosamine.">
    <entity charOffset="22-27" id="s589.e0" ontology_id="57448" text="BRUCE" type="GENE"/>
    <entity charOffset="42-47" id="s589.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s589.e0" e2="s589.e1" id="s589.p0" relation="true"/>
  </sentence>
  <sentence id="s590" text="Three subtypes, &lt;i&gt;PTPN11- , NRAS-&lt;/i&gt;, and &lt;i&gt;KRAS&lt;/i&gt;-mutated JMML, are characterized by heterozygous somatic gain-of-function mutations in non syndromic children, while two subtypes, JMML in neurofibromatosis type 1 and in JMML in children with CBL syndrome, are characterized by germ line RAS disease and acquired biallelic inactivation of the respective tumor suppressor genes in hematopoietic cells.">
    <entity charOffset="29-33" id="s590.e0" ontology_id="4893" text="NRAS" type="GENE"/>
    <entity charOffset="194-211" id="s590.e1" ontology_id="HP_0001067" text="neurofibromatosis" type="HP"/>
    <pair e1="s590.e0" e2="s590.e1" id="s590.p0" relation="false"/>
  </sentence>
  <sentence id="s591" text="Three subtypes, &lt;i&gt;PTPN11- , NRAS-&lt;/i&gt;, and &lt;i&gt;KRAS&lt;/i&gt;-mutated JMML, are characterized by heterozygous somatic gain-of-function mutations in non syndromic children, while two subtypes, JMML in neurofibromatosis type 1 and in JMML in children with CBL syndrome, are characterized by germ line RAS disease and acquired biallelic inactivation of the respective tumor suppressor genes in hematopoietic cells.">
    <entity charOffset="47-51" id="s591.e0" ontology_id="3845" text="KRAS" type="GENE"/>
    <entity charOffset="194-211" id="s591.e1" ontology_id="HP_0001067" text="neurofibromatosis" type="HP"/>
    <pair e1="s591.e0" e2="s591.e1" id="s591.p0" relation="false"/>
  </sentence>
  <sentence id="s592" text="We show that mice lacking COQ8A develop a slowly progressive cerebellar ataxia linked to Purkinje cell dysfunction and mild exercise intolerance, recapitulating ARCA2.">
    <entity charOffset="26-31" id="s592.e0" ontology_id="56997" text="COQ8A" type="GENE"/>
    <entity charOffset="72-78" id="s592.e1" ontology_id="HP_0001251" text="ataxia" type="HP"/>
    <pair e1="s592.e0" e2="s592.e1" id="s592.p0" relation="true"/>
  </sentence>
  <sentence id="s593" text="In this study, we identified EPRS as upregulated in estrogen receptor positive (ER+) human breast tumors in the TCGA and METABRIC cohorts, with copy number gains in nearly 50% of samples in both datasets.">
    <entity charOffset="29-33" id="s593.e0" ontology_id="2058" text="EPRS" type="GENE"/>
    <entity charOffset="98-104" id="s593.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s593.e0" e2="s593.e1" id="s593.p0" relation="true"/>
  </sentence>
  <sentence id="s594" text="EPRS expression is associated with reduced overall survival in patients with ER+ tumors in TCGA and METABRIC datasets.">
    <entity charOffset="0-4" id="s594.e0" ontology_id="2058" text="EPRS" type="GENE"/>
    <entity charOffset="81-87" id="s594.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s594.e0" e2="s594.e1" id="s594.p0" relation="true"/>
  </sentence>
  <sentence id="s595" text="We demonstrated the necessity of EPRS for proliferation of tamoxifen-resistant ER+ breast cancer, but not ER- breast cancer cells.">
    <entity charOffset="33-37" id="s595.e0" ontology_id="2058" text="EPRS" type="GENE"/>
    <entity charOffset="90-96" id="s595.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s595.e0" e2="s595.e1" id="s595.p0" relation="true"/>
  </sentence>
  <sentence id="s596" text="In recent years, genetically determined forms of microangiopathy (e.g. CADASIL, CARASIL, Trex1-related microangiopathies, CARASAL, familial forms of cerebral amyloid angiopathy or CAA) have provided interesting cellular and molecular clues to the pathogenesis of sporadic microvascular disease such as arteriolosclerosis and AD-related CAA">
    <entity charOffset="71-78" id="s596.e0" ontology_id="4854" text="CADASIL" type="GENE"/>
    <entity charOffset="263-271" id="s596.e1" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <pair e1="s596.e0" e2="s596.e1" id="s596.p0" relation="true"/>
  </sentence>
  <sentence id="s597" text="Furthermore, we detected association of rs58978565 near TNR (P = 2.3  10-8), rs28368872 near ATF7IP2 (P = 2.9  10-8) and rs142450006 near MMP9 (P = 0.0006) with progression to choroidal neovascularization but not geographic atrophy.">
    <entity charOffset="56-59" id="s597.e0" ontology_id="7143" text="TNR" type="GENE"/>
    <entity charOffset="178-206" id="s597.e1" ontology_id="HP_0011506" text="choroidal neovascularization" type="HP"/>
    <pair e1="s597.e0" e2="s597.e1" id="s597.p0" relation="true"/>
  </sentence>
  <sentence id="s598" text="Furthermore, we detected association of rs58978565 near TNR (P = 2.3  10-8), rs28368872 near ATF7IP2 (P = 2.9  10-8) and rs142450006 near MMP9 (P = 0.0006) with progression to choroidal neovascularization but not geographic atrophy.">
    <entity charOffset="140-144" id="s598.e0" ontology_id="4318" text="MMP9" type="GENE"/>
    <entity charOffset="178-206" id="s598.e1" ontology_id="HP_0011506" text="choroidal neovascularization" type="HP"/>
    <pair e1="s598.e0" e2="s598.e1" id="s598.p0" relation="true"/>
  </sentence>
  <sentence id="s599" text="The therapeutic capacity of fenretinide (N-[4-hydroxyphenyl] retinamide; 4-HPR) has been demonstrated for several conditions, including cancer, obesity, diabetes, and ocular disease.">
    <entity charOffset="75-78" id="s599.e0" ontology_id="3250" text="HPR" type="GENE"/>
    <entity charOffset="136-142" id="s599.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s599.e0" e2="s599.e1" id="s599.p0" relation="true"/>
  </sentence>
  <sentence id="s600" text="Consistent with a conserved role for this gene in the cochlea, the genetic mapping data presented here support human TMIE as the gene affected at DFNB6, a non-syndromic hearing loss locus.">
    <entity charOffset="117-121" id="s600.e0" ontology_id="259236" text="TMIE" type="GENE"/>
    <entity charOffset="169-181" id="s600.e1" ontology_id="HP_0000365" text="hearing loss" type="HP"/>
    <pair e1="s600.e0" e2="s600.e1" id="s600.p0" relation="true"/>
  </sentence>
  <sentence id="s601" text="Here, we present a familial case of a lethal early-onset epileptic encephalopathy, associated with two novel compound heterozygous missense variants on the TBC1D24 gene, which were detected by exome sequencing.">
    <entity charOffset="67-81" id="s601.e0" ontology_id="HP_0001298" text="encephalopathy" type="HP"/>
    <entity charOffset="156-163" id="s601.e1" ontology_id="57465" text="TBC1D24" type="GENE"/>
    <pair e1="s601.e0" e2="s601.e1" id="s601.p0" relation="true"/>
  </sentence>
  <sentence id="s602" text="Three predicted driver genes (CDKN2A, AKT1, RNF139) were found common in these three cancers by comparative analysis.">
    <entity charOffset="30-36" id="s602.e0" ontology_id="1029" text="CDKN2A" type="GENE"/>
    <entity charOffset="85-91" id="s602.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s602.e0" e2="s602.e1" id="s602.p0" relation="true"/>
  </sentence>
  <sentence id="s603" text="Mutations in the human TRNT1 gene encoding tRNA nucleotidyltransferase (tRNA-NT), an essential enzyme responsible for addition of the CCA (cytidine-cytidine-adenosine) sequence to the 3'-termini of tRNAs, have been linked to disease phenotypes including congenital sideroblastic anemia with B-cell immunodeficiency, periodic fevers and developmental delay (SIFD) or retinitis pigmentosa with erythrocyte microcytosis.">
    <entity charOffset="23-28" id="s603.e0" ontology_id="51095" text="TRNT1" type="GENE"/>
    <entity charOffset="404-416" id="s603.e1" ontology_id="HP_0025066" text="microcytosis" type="HP"/>
    <pair e1="s603.e0" e2="s603.e1" id="s603.p0" relation="true"/>
  </sentence>
  <sentence id="s604" text="Numerous studies have recently demonstrated that HDAC6 expression and activity are increased in kidney disease, such as autosomal dominant polycystic kidney disease (ADPKD), renal fibrosis, and acute kidney injury (AKI), among others.">
    <entity charOffset="49-54" id="s604.e0" ontology_id="10013" text="HDAC6" type="GENE"/>
    <entity charOffset="96-110" id="s604.e1" ontology_id="HP_0000077" text="kidney disease" type="HP"/>
    <pair e1="s604.e0" e2="s604.e1" id="s604.p0" relation="true"/>
  </sentence>
  <sentence id="s605" text="In fact, HDAC6 inhibitors effectively limit the progression of kidney diseases, suggesting that targeting HDAC6 may provide a novel treatment approach.">
    <entity charOffset="9-14" id="s605.e0" ontology_id="10013" text="HDAC6" type="GENE"/>
    <entity charOffset="63-77" id="s605.e1" ontology_id="HP_0000077" text="kidney disease" type="HP"/>
    <pair e1="s605.e0" e2="s605.e1" id="s605.p0" relation="true"/>
  </sentence>
  <sentence id="s606" text="GCNT2-positive cells were significantly lesser in organ-confined disease than in that with extra-capsular extensions, and GCNT2-negative tumors were associated with significantly better prostate-specific antigen-free survival compared with GCNT2-positive tumors.">
    <entity charOffset="0-5" id="s606.e0" ontology_id="2651" text="GCNT2" type="GENE"/>
    <entity charOffset="137-143" id="s606.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s606.e0" e2="s606.e1" id="s606.p0" relation="false"/>
  </sentence>
  <sentence id="s607" text="Focal cortical dysplasia (FCD) and hemimegalencephaly (HME) are epileptogenic neurodevelopmentalmalformations caused by mutations in mTOR pathway genes.">
    <entity charOffset="35-53" id="s607.e0" ontology_id="HP_0007206" text="hemimegalencephaly" type="HP"/>
    <entity charOffset="134-138" id="s607.e1" ontology_id="2475" text="mTOR" type="GENE"/>
    <pair e1="s607.e0" e2="s607.e1" id="s607.p0" relation="true"/>
  </sentence>
  <sentence id="s608" text="In conclusion, truncating variants in TEX15 and FANCD2 are potential breast cancer risk factors, warranting further investigations in other populations.">
    <entity charOffset="48-54" id="s608.e0" ontology_id="2177" text="FANCD2" type="GENE"/>
    <entity charOffset="76-82" id="s608.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s608.e0" e2="s608.e1" id="s608.p0" relation="true"/>
  </sentence>
  <sentence id="s609" text="Mutations in the CPA6 gene have been identified in patients with temporal lobe epilepsy and febrile seizures.">
    <entity charOffset="17-21" id="s609.e0" ontology_id="1548" text="CPA6" type="GENE"/>
    <entity charOffset="100-108" id="s609.e1" ontology_id="HP_0001250" text="seizures" type="HP"/>
    <pair e1="s609.e0" e2="s609.e1" id="s609.p0" relation="true"/>
  </sentence>
  <sentence id="s610" text="Our experiments demonstrate that these mutations in CPA6 are deleterious and provide further evidence for the involvement of CPA6 mutations in the predisposition for several types of epilepsy.">
    <entity charOffset="52-56" id="s610.e0" ontology_id="1548" text="CPA6" type="GENE"/>
    <entity charOffset="183-191" id="s610.e1" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <pair e1="s610.e0" e2="s610.e1" id="s610.p0" relation="false"/>
  </sentence>
  <sentence id="s611" text="Matr3(Gt-ex13) homozygotes are early embryo lethal, but Matr3(Gt-ex13) heterozygotes exhibit incompletely penetrant BAV, CoA and PDA phenotypes similar to those in the human proband, as well as ventricular septal defect (VSD) and double-outlet right ventricle (DORV).">
    <entity charOffset="0-5" id="s611.e0" ontology_id="9782" text="Matr3" type="GENE"/>
    <entity charOffset="194-219" id="s611.e1" ontology_id="HP_0001629" text="ventricular septal defect" type="HP"/>
    <pair e1="s611.e0" e2="s611.e1" id="s611.p0" relation="false"/>
  </sentence>
  <sentence id="s612" text="The 1p breakpoint disrupts the 5' UTR of AHDC1, which encodes AT-hook DNA-binding motif containing-1 protein, and AHDC1-truncating mutations have recently been described in a syndrome that includes developmental delay, but not congenital heart disease [Xia, F., Bainbridge, M.N., Tan, T.Y., Wangler, M.F., Scheuerle, A.E., Zackai, E.H., Harr, M.H., Sutton, V.R., Nalam, R.L., Zhu, W. et al. (2014) De Novo truncating mutations in AHDC1 in individuals with syndromic expressive language delay, hypotonia, and sleep apnea.">
    <entity charOffset="41-46" id="s612.e0" ontology_id="27245" text="AHDC1" type="GENE"/>
    <entity charOffset="198-217" id="s612.e1" ontology_id="HP_0001263" text="developmental delay" type="HP"/>
    <pair e1="s612.e0" e2="s612.e1" id="s612.p0" relation="true"/>
  </sentence>
  <sentence id="s613" text="Other novel mutations detected in unclassified epilepsy patients involve the SCN8A, CACNA1A, GABRB3, GABRA1, IQSEC2, TSC1, VRK2, ATP1A2, PCDH19, SLC9A6 and CHD2 genes.">
    <entity charOffset="47-55" id="s613.e0" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <entity charOffset="117-121" id="s613.e1" ontology_id="7248" text="TSC1" type="GENE"/>
    <pair e1="s613.e0" e2="s613.e1" id="s613.p0" relation="true"/>
  </sentence>
  <sentence id="s614" text="In the present study, we investigated the spatiotemporal distributions of RanGAP1 and 4 representative nucleoporins (GP210, NUP205, NUP107 and NUP50) of NPCs in human Cu/Zn superoxide dismutase-1 mutation transgenic (SOD1-Tg) mice and sporadic ALS patients.">
    <entity charOffset="124-130" id="s614.e0" ontology_id="23165" text="NUP205" type="GENE"/>
    <entity charOffset="235-243" id="s614.e1" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <pair e1="s614.e0" e2="s614.e1" id="s614.p0" relation="true"/>
  </sentence>
  <sentence id="s615" text="In the present study, we investigated the spatiotemporal distributions of RanGAP1 and 4 representative nucleoporins (GP210, NUP205, NUP107 and NUP50) of NPCs in human Cu/Zn superoxide dismutase-1 mutation transgenic (SOD1-Tg) mice and sporadic ALS patients.">
    <entity charOffset="143-148" id="s615.e0" ontology_id="10762" text="NUP50" type="GENE"/>
    <entity charOffset="235-243" id="s615.e1" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <pair e1="s615.e0" e2="s615.e1" id="s615.p0" relation="true"/>
  </sentence>
  <sentence id="s616" text="The present study indicated that the mislocalization of these proteins of NPCs may underlie the pathogenesis of ALS both in SOD1-Tg mice and human sporadic ALS patients, and these dysfunctions may be a fundamental pathway for ALS that is not specific only in C9-ALS but also in SOD1-ALS, which may be amenable to pharmacotherapeutic intervention">
    <entity charOffset="129-131" id="s616.e0" ontology_id="7038" text="Tg" type="GENE"/>
    <entity charOffset="147-155" id="s616.e1" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <pair e1="s616.e0" e2="s616.e1" id="s616.p0" relation="false"/>
  </sentence>
  <sentence id="s617" text="The present study indicated that the mislocalization of these proteins of NPCs may underlie the pathogenesis of ALS both in SOD1-Tg mice and human sporadic ALS patients, and these dysfunctions may be a fundamental pathway for ALS that is not specific only in C9-ALS but also in SOD1-ALS, which may be amenable to pharmacotherapeutic intervention">
    <entity charOffset="147-155" id="s617.e0" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <entity charOffset="259-261" id="s617.e1" ontology_id="735" text="C9" type="GENE"/>
    <pair e1="s617.e0" e2="s617.e1" id="s617.p0" relation="false"/>
  </sentence>
  <sentence id="s618" text="Evidence for association with endometriosis was also found for the AC genotype of the rs10859871 of VEZT.">
    <entity charOffset="30-43" id="s618.e0" ontology_id="HP_0030127" text="endometriosis" type="HP"/>
    <entity charOffset="100-104" id="s618.e1" ontology_id="55591" text="VEZT" type="GENE"/>
    <pair e1="s618.e0" e2="s618.e1" id="s618.p0" relation="true"/>
  </sentence>
  <sentence id="s619" text="In this study, we investigated whether single nucleotide polymorphisms (SNPs) rs7521902, rs10859871 and rs11031006, mapping to WNT4, VEZT and FSHB genetic loci, respectively, are associated with risk for endometriosis in a Greek population.">
    <entity charOffset="127-131" id="s619.e0" ontology_id="54361" text="WNT4" type="GENE"/>
    <entity charOffset="204-217" id="s619.e1" ontology_id="HP_0030127" text="endometriosis" type="HP"/>
    <pair e1="s619.e0" e2="s619.e1" id="s619.p0" relation="true"/>
  </sentence>
  <sentence id="s620" text="Primary hyperoxaluria type 1 (PH1) is a rare but devastating autosomal recessive inherited disease caused by mutations in gene AGXT.">
    <entity charOffset="61-80" id="s620.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="127-131" id="s620.e1" ontology_id="189" text="AGXT" type="GENE"/>
    <pair e1="s620.e0" e2="s620.e1" id="s620.p0" relation="true"/>
  </sentence>
  <sentence id="s621" text="The A Desintegrin And Metalloproteinase 23 (ADAM23) gene is epigenetically silenced in different types of tumors, and silencing is often associated with advanced disease and metastasis.">
    <entity charOffset="44-50" id="s621.e0" ontology_id="10863" text="ADAM23" type="GENE"/>
    <entity charOffset="106-112" id="s621.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s621.e0" e2="s621.e1" id="s621.p0" relation="true"/>
  </sentence>
  <sentence id="s622" text="Rather, we observed that, in ADAM23-heterotypic environments, ADAM23-negative cells promote tumor growth and metastasis by enhancing the proliferation and invasion of adjacent A23-positive cells through the production ofLGI4 (Leucine-rich Glioma Inactivated 4) and nitric oxide (NO).">
    <entity charOffset="29-35" id="s622.e0" ontology_id="10863" text="ADAM23" type="GENE"/>
    <entity charOffset="92-97" id="s622.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s622.e0" e2="s622.e1" id="s622.p0" relation="false"/>
  </sentence>
  <sentence id="s623" text="Here we discuss 'congenital disorders of autophagy' as an emerging subclass of inborn errors of metabolism by using the examples of six recently identified monogenic diseases: EPG5-related Vici syndrome, beta-propeller protein-associated neurodegeneration due to mutations in WDR45, SNX14-associated autosomal-recessive cerebellar ataxia and intellectual disability syndrome, and three forms of hereditary spastic paraplegia, SPG11, SPG15 and SPG49 caused by SPG11, ZFYVE26 and TECPR2 mutations, respectively.">
    <entity charOffset="176-180" id="s623.e0" ontology_id="57724" text="EPG5" type="GENE"/>
    <entity charOffset="320-337" id="s623.e1" ontology_id="HP_0001251" text="cerebellar ataxia" type="HP"/>
    <pair e1="s623.e0" e2="s623.e1" id="s623.p0" relation="false"/>
  </sentence>
  <sentence id="s624" text="Here we discuss 'congenital disorders of autophagy' as an emerging subclass of inborn errors of metabolism by using the examples of six recently identified monogenic diseases: EPG5-related Vici syndrome, beta-propeller protein-associated neurodegeneration due to mutations in WDR45, SNX14-associated autosomal-recessive cerebellar ataxia and intellectual disability syndrome, and three forms of hereditary spastic paraplegia, SPG11, SPG15 and SPG49 caused by SPG11, ZFYVE26 and TECPR2 mutations, respectively.">
    <entity charOffset="283-288" id="s624.e0" ontology_id="57231" text="SNX14" type="GENE"/>
    <entity charOffset="342-365" id="s624.e1" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <pair e1="s624.e0" e2="s624.e1" id="s624.p0" relation="true"/>
  </sentence>
  <sentence id="s625" text="Here we discuss 'congenital disorders of autophagy' as an emerging subclass of inborn errors of metabolism by using the examples of six recently identified monogenic diseases: EPG5-related Vici syndrome, beta-propeller protein-associated neurodegeneration due to mutations in WDR45, SNX14-associated autosomal-recessive cerebellar ataxia and intellectual disability syndrome, and three forms of hereditary spastic paraplegia, SPG11, SPG15 and SPG49 caused by SPG11, ZFYVE26 and TECPR2 mutations, respectively.">
    <entity charOffset="320-337" id="s625.e0" ontology_id="HP_0001251" text="cerebellar ataxia" type="HP"/>
    <entity charOffset="478-484" id="s625.e1" ontology_id="9895" text="TECPR2" type="GENE"/>
    <pair e1="s625.e0" e2="s625.e1" id="s625.p0" relation="false"/>
  </sentence>
  <sentence id="s626" text="Here we discuss 'congenital disorders of autophagy' as an emerging subclass of inborn errors of metabolism by using the examples of six recently identified monogenic diseases: EPG5-related Vici syndrome, beta-propeller protein-associated neurodegeneration due to mutations in WDR45, SNX14-associated autosomal-recessive cerebellar ataxia and intellectual disability syndrome, and three forms of hereditary spastic paraplegia, SPG11, SPG15 and SPG49 caused by SPG11, ZFYVE26 and TECPR2 mutations, respectively.">
    <entity charOffset="406-424" id="s626.e0" ontology_id="HP_0001258" text="spastic paraplegia" type="HP"/>
    <entity charOffset="443-448" id="s626.e1" ontology_id="113612" text="SPG49" type="GENE"/>
    <pair e1="s626.e0" e2="s626.e1" id="s626.p0" relation="true"/>
  </sentence>
  <sentence id="s627" text="Recent studies have reported that SRPX2 overexpression is observed in gastrointestinal cancer, and promotes migration and invasion of cancer cells.">
    <entity charOffset="34-39" id="s627.e0" ontology_id="27286" text="SRPX2" type="GENE"/>
    <entity charOffset="87-93" id="s627.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s627.e0" e2="s627.e1" id="s627.p0" relation="true"/>
  </sentence>
  <sentence id="s628" text="By exome sequencing, we identified three different bi-allelic truncating mutations in TANGO2 in three unrelated individuals with infancy-onset episodic metabolic crises characterized by encephalopathy, hypoglycemia, rhabdomyolysis, arrhythmias, and laboratory findings suggestive of a defect in mitochondrial fatty acid oxidation.">
    <entity charOffset="86-92" id="s628.e0" ontology_id="128989" text="TANGO2" type="GENE"/>
    <entity charOffset="186-200" id="s628.e1" ontology_id="HP_0001298" text="encephalopathy" type="HP"/>
    <pair e1="s628.e0" e2="s628.e1" id="s628.p0" relation="true"/>
  </sentence>
  <sentence id="s629" text="The present study aimed to explore ARHGAP17 expression in cervical cancer and the possible function in tumor progression.">
    <entity charOffset="35-43" id="s629.e0" ontology_id="55114" text="ARHGAP17" type="GENE"/>
    <entity charOffset="103-108" id="s629.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s629.e0" e2="s629.e1" id="s629.p0" relation="true"/>
  </sentence>
  <sentence id="s630" text="These results reveal that ARHGAP17 functions as a tumor suppressor in cervical cancer that suppresses tumor growth, at least partly, through inhibition of PI3K/AKT signaling and up-regulation of P21 and P27 expression">
    <entity charOffset="79-85" id="s630.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="160-163" id="s630.e1" ontology_id="207" text="AKT" type="GENE"/>
    <pair e1="s630.e0" e2="s630.e1" id="s630.p0" relation="true"/>
  </sentence>
  <sentence id="s631" text="Manipulation of ARHGAP17 affected cell proliferation in vitro and tumor growth in vivo.">
    <entity charOffset="16-24" id="s631.e0" ontology_id="55114" text="ARHGAP17" type="GENE"/>
    <entity charOffset="66-71" id="s631.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s631.e0" e2="s631.e1" id="s631.p0" relation="true"/>
  </sentence>
  <sentence id="s632" text="Recently, a few Rho GTPase activating proteins (RhoGAPs) have been identified as tumor suppressors in some human cancers.">
    <entity charOffset="16-19" id="s632.e0" ontology_id="6010" text="Rho" type="GENE"/>
    <entity charOffset="81-86" id="s632.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s632.e0" e2="s632.e1" id="s632.p0" relation="true"/>
  </sentence>
  <sentence id="s633" text="Recently, a few Rho GTPase activating proteins (RhoGAPs) have been identified as tumor suppressors in some human cancers.">
    <entity charOffset="16-19" id="s633.e0" ontology_id="6010" text="Rho" type="GENE"/>
    <entity charOffset="113-119" id="s633.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s633.e0" e2="s633.e1" id="s633.p0" relation="true"/>
  </sentence>
  <sentence id="s634" text="Stepwise investigations demonstrated that ARHGAP17 suppressed malignant phenotype of cervical cancer cells via inhibiting PI3K/AKT signaling pathway.">
    <entity charOffset="42-50" id="s634.e0" ontology_id="55114" text="ARHGAP17" type="GENE"/>
    <entity charOffset="94-100" id="s634.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s634.e0" e2="s634.e1" id="s634.p0" relation="true"/>
  </sentence>
  <sentence id="s635" text="Stepwise investigations demonstrated that ARHGAP17 suppressed malignant phenotype of cervical cancer cells via inhibiting PI3K/AKT signaling pathway.">
    <entity charOffset="94-100" id="s635.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="127-130" id="s635.e1" ontology_id="207" text="AKT" type="GENE"/>
    <pair e1="s635.e0" e2="s635.e1" id="s635.p0" relation="true"/>
  </sentence>
  <sentence id="s636" text="However, correlation between CR-1 and prostate cancer (PCa) remains still unclear.">
    <entity charOffset="29-31" id="s636.e0" ontology_id="1604" text="CR" type="GENE"/>
    <entity charOffset="47-53" id="s636.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s636.e0" e2="s636.e1" id="s636.p0" relation="true"/>
  </sentence>
  <sentence id="s637" text="The Cripto-1 (CR-1) derived EGF-CFC family was overexpressed in tumor development enhancing proliferation, epithelial-mesenchymal transition (EMT) and migration of tumor cells.">
    <entity charOffset="28-31" id="s637.e0" ontology_id="1950" text="EGF" type="GENE"/>
    <entity charOffset="64-69" id="s637.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s637.e0" e2="s637.e1" id="s637.p0" relation="true"/>
  </sentence>
  <sentence id="s638" text="The Cripto-1 (CR-1) derived EGF-CFC family was overexpressed in tumor development enhancing proliferation, epithelial-mesenchymal transition (EMT) and migration of tumor cells.">
    <entity charOffset="32-35" id="s638.e0" ontology_id="6903" text="CFC" type="GENE"/>
    <entity charOffset="64-69" id="s638.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s638.e0" e2="s638.e1" id="s638.p0" relation="true"/>
  </sentence>
  <sentence id="s639" text="Immunohistochemistry was used to observe the Kif2a expression and its correlation with clinicopathologic factors in oral tongue cancer.">
    <entity charOffset="45-50" id="s639.e0" ontology_id="3796" text="Kif2a" type="GENE"/>
    <entity charOffset="128-134" id="s639.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s639.e0" e2="s639.e1" id="s639.p0" relation="true"/>
  </sentence>
  <sentence id="s640" text="In recent years, it has been demonstrated that NgBR plays an important role in human pathophysiological processes, including lipid metabolism, angiogenesis, N-glycosylation, cell apoptosis, chemoresistance in human hepatocellular carcinoma, and epithelial-mesenchymal transition.">
    <entity charOffset="47-51" id="s640.e0" ontology_id="116150" text="NgBR" type="GENE"/>
    <entity charOffset="215-239" id="s640.e1" ontology_id="HP_0001402" text="hepatocellular carcinoma" type="HP"/>
    <pair e1="s640.e0" e2="s640.e1" id="s640.p0" relation="true"/>
  </sentence>
  <sentence id="s641" text="Downregulation of Gli1, Gli2, Gli3 and Kif7 was demonstrated in clinical samples of choriocarcinoma and hydatidiform moles as well as choriocarcinoma cell lines when compared with normal placentas.">
    <entity charOffset="18-22" id="s641.e0" ontology_id="2735" text="Gli1" type="GENE"/>
    <entity charOffset="84-99" id="s641.e1" ontology_id="HP_0100768" text="choriocarcinoma" type="HP"/>
    <pair e1="s641.e0" e2="s641.e1" id="s641.p0" relation="true"/>
  </sentence>
  <sentence id="s642" text="Downregulation of Gli1, Gli2, Gli3 and Kif7 was demonstrated in clinical samples of choriocarcinoma and hydatidiform moles as well as choriocarcinoma cell lines when compared with normal placentas.">
    <entity charOffset="39-43" id="s642.e0" ontology_id="374654" text="Kif7" type="GENE"/>
    <entity charOffset="84-99" id="s642.e1" ontology_id="HP_0100768" text="choriocarcinoma" type="HP"/>
    <pair e1="s642.e0" e2="s642.e1" id="s642.p0" relation="true"/>
  </sentence>
  <sentence id="s643" text="Global Ptchd1 deletion recapitulates learning impairment, hyper-aggression, and motor defects, all of which are insensitive to SK pharmacological targeting and not found in the TRN-restricted deletion mouse.">
    <entity charOffset="7-13" id="s643.e0" ontology_id="139411" text="Ptchd1" type="GENE"/>
    <entity charOffset="64-74" id="s643.e1" ontology_id="HP_0000718" text="aggression" type="HP"/>
    <pair e1="s643.e0" e2="s643.e1" id="s643.p0" relation="true"/>
  </sentence>
  <sentence id="s644" text="Global Ptchd1 deletion recapitulates learning impairment, hyper-aggression, and motor defects, all of which are insensitive to SK pharmacological targeting and not found in the TRN-restricted deletion mouse.">
    <entity charOffset="64-74" id="s644.e0" ontology_id="HP_0000718" text="aggression" type="HP"/>
    <entity charOffset="177-180" id="s644.e1" ontology_id="3842" text="TRN" type="GENE"/>
    <pair e1="s644.e0" e2="s644.e1" id="s644.p0" relation="true"/>
  </sentence>
  <sentence id="s645" text="In this article, we report a clinically recognizable craniofacial disorder characterized by facial dysmorphisms, severe micrognathia, rhizomelic shortening, microcephalic dwarfism, and mild developmental delay due to loss-of-function heterozygous mutations in ARCN1, which encodes the coatomer subunit delta of COPI.">
    <entity charOffset="171-179" id="s645.e0" ontology_id="HP_0003510" text="dwarfism" type="HP"/>
    <entity charOffset="260-265" id="s645.e1" ontology_id="372" text="ARCN1" type="GENE"/>
    <pair e1="s645.e0" e2="s645.e1" id="s645.p0" relation="true"/>
  </sentence>
  <sentence id="s646" text="As a potential target for cancer treatment, the C-Myc high expresses abnormally in a variety of solid tumors and hematological malignancies in humans.">
    <entity charOffset="26-32" id="s646.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="48-53" id="s646.e1" ontology_id="4609" text="C-Myc" type="GENE"/>
    <pair e1="s646.e0" e2="s646.e1" id="s646.p0" relation="true"/>
  </sentence>
  <sentence id="s647" text="Our results provide evidence that inhibition of the denitrosylation of S-nitrosylated procaspase-3 mediated by the redox protein Trx2 is a part of the microglial pro-tumoral activation pathway initiated by glioma cancer cells">
    <entity charOffset="129-133" id="s647.e0" ontology_id="9757" text="Trx2" type="GENE"/>
    <entity charOffset="213-219" id="s647.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s647.e0" e2="s647.e1" id="s647.p0" relation="true"/>
  </sentence>
  <sentence id="s648" text="Furthermore, we identified the activity of nitric oxide synthase 2 (NOS2, also known as iNOS) originating from the glioma cells as a driving stimulus in the control of microglial caspase-3 activity.">
    <entity charOffset="68-72" id="s648.e0" ontology_id="339345" text="NOS2" type="GENE"/>
    <entity charOffset="115-121" id="s648.e1" ontology_id="HP_0009733" text="glioma" type="HP"/>
    <pair e1="s648.e0" e2="s648.e1" id="s648.p0" relation="true"/>
  </sentence>
  <sentence id="s649" text="However, the negative association between 25(OH)D and GRS was modified by obesity and sun exposure.">
    <entity charOffset="54-57" id="s649.e0" ontology_id="597" text="GRS" type="GENE"/>
    <entity charOffset="74-81" id="s649.e1" ontology_id="HP_0001513" text="obesity" type="HP"/>
    <pair e1="s649.e0" e2="s649.e1" id="s649.p0" relation="true"/>
  </sentence>
  <sentence id="s650" text="Results We demonstrated an association between six previously published single nucleotide polymorphisms (rs15869 [ BRCA2], rs1805389 [ LIG4], rs8079544 [ TP53], rs25489 [ XRCC1], rs1673041 [ POLD1], and rs11615 [ ERCC1]) and subsequent CNS tumors in survivors of childhood cancer.">
    <entity charOffset="213-218" id="s650.e0" ontology_id="2067" text="ERCC1" type="GENE"/>
    <entity charOffset="240-246" id="s650.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s650.e0" e2="s650.e1" id="s650.p0" relation="true"/>
  </sentence>
  <sentence id="s651" text="The human KAT6A and KAT6B genes are recurrently mutated in leukemia, non-hematologic malignancies, and multiple developmental disorders displaying intellectual disability and various other abnormalities.">
    <entity charOffset="10-15" id="s651.e0" ontology_id="7994" text="KAT6A" type="GENE"/>
    <entity charOffset="147-170" id="s651.e1" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <pair e1="s651.e0" e2="s651.e1" id="s651.p0" relation="true"/>
  </sentence>
  <sentence id="s652" text="The human KAT6A and KAT6B genes are recurrently mutated in leukemia, non-hematologic malignancies, and multiple developmental disorders displaying intellectual disability and various other abnormalities.">
    <entity charOffset="20-25" id="s652.e0" ontology_id="23522" text="KAT6B" type="GENE"/>
    <entity charOffset="147-170" id="s652.e1" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <pair e1="s652.e0" e2="s652.e1" id="s652.p0" relation="true"/>
  </sentence>
  <sentence id="s653" text="In addition, the BRPF1 gene is mutated in childhood leukemia and adult medulloblastoma.">
    <entity charOffset="17-22" id="s653.e0" ontology_id="7862" text="BRPF1" type="GENE"/>
    <entity charOffset="71-86" id="s653.e1" ontology_id="HP_0002885" text="medulloblastoma" type="HP"/>
    <pair e1="s653.e0" e2="s653.e1" id="s653.p0" relation="true"/>
  </sentence>
  <sentence id="s654" text="We report a pair of siblings carrying a homozygous missense mutation p.P333L in EEF1A2 who exhibited global developmental delay, failure to thrive, dilated cardiomyopathy and epilepsy, ultimately leading to death in early childhood.">
    <entity charOffset="80-85" id="s654.e0" ontology_id="1915" text="EEF1A" type="GENE"/>
    <entity charOffset="108-127" id="s654.e1" ontology_id="HP_0001263" text="developmental delay" type="HP"/>
    <pair e1="s654.e0" e2="s654.e1" id="s654.p0" relation="true"/>
  </sentence>
  <sentence id="s655" text="Here, we sought to find lncRNAs differentially regulated in cancer cells resistant to either TNF-related apoptosis-inducing ligand (TRAIL) or the Mcl-1 inhibitor UMI-77, agents that act through the extrinsic and intrinsic apoptotic pathways, respectively.">
    <entity charOffset="60-66" id="s655.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="93-96" id="s655.e1" ontology_id="7124" text="TNF" type="GENE"/>
    <pair e1="s655.e0" e2="s655.e1" id="s655.p0" relation="true"/>
  </sentence>
  <sentence id="s656" text="This review focuses on the molecular basis of the pathogenesis of cardiac abnormality due to PRKAG2 mutation and will provide current overviews of the mechanism of glycogen regulation by AMPK.">
    <entity charOffset="66-85" id="s656.e0" ontology_id="HP_0001627" text="cardiac abnormality" type="HP"/>
    <entity charOffset="187-191" id="s656.e1" ontology_id="5563" text="AMPK" type="GENE"/>
    <pair e1="s656.e0" e2="s656.e1" id="s656.p0" relation="false"/>
  </sentence>
  <sentence id="s657" text="Ex vivo data showed that DHC2 expression in GBM tissue samples was associated with tumor recurrence after TMZ chemotherapy.">
    <entity charOffset="25-29" id="s657.e0" ontology_id="79659" text="DHC2" type="GENE"/>
    <entity charOffset="83-88" id="s657.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s657.e0" e2="s657.e1" id="s657.p0" relation="true"/>
  </sentence>
  <sentence id="s658" text="De novo heterozygous mutations in STXBP1/Munc18-1 cause early infantile epileptic encephalopathies (EIEE4, OMIM #612164) characterized by infantile epilepsy, developmental delay, intellectual disability, and can include autistic features.">
    <entity charOffset="34-40" id="s658.e0" ontology_id="6812" text="STXBP1" type="GENE"/>
    <entity charOffset="148-156" id="s658.e1" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <pair e1="s658.e0" e2="s658.e1" id="s658.p0" relation="true"/>
  </sentence>
  <sentence id="s659" text="De novo heterozygous mutations in STXBP1/Munc18-1 cause early infantile epileptic encephalopathies (EIEE4, OMIM #612164) characterized by infantile epilepsy, developmental delay, intellectual disability, and can include autistic features.">
    <entity charOffset="34-40" id="s659.e0" ontology_id="6812" text="STXBP1" type="GENE"/>
    <entity charOffset="158-177" id="s659.e1" ontology_id="HP_0001263" text="developmental delay" type="HP"/>
    <pair e1="s659.e0" e2="s659.e1" id="s659.p0" relation="true"/>
  </sentence>
  <sentence id="s660" text="LMO1 is a high-risk neuroblastoma susceptibility gene, but how LMO1 cooperates with MYCN in neuroblastoma tumorigenesis is unclear.">
    <entity charOffset="20-33" id="s660.e0" ontology_id="HP_0003006" text="neuroblastoma" type="HP"/>
    <entity charOffset="84-88" id="s660.e1" ontology_id="4613" text="MYCN" type="GENE"/>
    <pair e1="s660.e0" e2="s660.e1" id="s660.p0" relation="true"/>
  </sentence>
  <sentence id="s661" text="Homozygous recessive mutations in either EFEMP2 (encoding fibulin-4) or FBLN5 (encoding fibulin-5), critical genes for elastogenesis, lead to autosomal recessive cutis laxa types 1B and 1A, respectively.">
    <entity charOffset="41-47" id="s661.e0" ontology_id="30008" text="EFEMP2" type="GENE"/>
    <entity charOffset="142-161" id="s661.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s661.e0" e2="s661.e1" id="s661.p0" relation="true"/>
  </sentence>
  <sentence id="s662" text="With alignment to T2DM susceptibility genes and deafness genes published, KCNJ11 was found to be the only overlapped gene.">
    <entity charOffset="48-56" id="s662.e0" ontology_id="HP_0000365" text="deafness" type="HP"/>
    <entity charOffset="74-80" id="s662.e1" ontology_id="3767" text="KCNJ11" type="GENE"/>
    <pair e1="s662.e0" e2="s662.e1" id="s662.p0" relation="true"/>
  </sentence>
  <sentence id="s663" text="The candidate genes located within the new loci were related to ocular development (LMX1B, HMGA2 and MAP3K1) and glaucoma-related phenotypes (FNDC3B, LMX1B and LOXL1).">
    <entity charOffset="101-107" id="s663.e0" ontology_id="4214" text="MAP3K1" type="GENE"/>
    <entity charOffset="113-121" id="s663.e1" ontology_id="HP_0000501" text="glaucoma" type="HP"/>
    <pair e1="s663.e0" e2="s663.e1" id="s663.p0" relation="false"/>
  </sentence>
  <sentence id="s664" text="The candidate genes located within the new loci were related to ocular development (LMX1B, HMGA2 and MAP3K1) and glaucoma-related phenotypes (FNDC3B, LMX1B and LOXL1).">
    <entity charOffset="113-121" id="s664.e0" ontology_id="HP_0000501" text="glaucoma" type="HP"/>
    <entity charOffset="160-165" id="s664.e1" ontology_id="4016" text="LOXL1" type="GENE"/>
    <pair e1="s664.e0" e2="s664.e1" id="s664.p0" relation="true"/>
  </sentence>
  <sentence id="s665" text="In proximal renal tubules, FGF23 suppresses the membrane expression of the sodium-phosphate cotransporters Npt2a and Npt2c which mediate urinary reabsorption of filtered phosphate.">
    <entity charOffset="3-11" id="s665.e0" ontology_id="HP_0012840" text="proximal" type="HP"/>
    <entity charOffset="27-32" id="s665.e1" ontology_id="8074" text="FGF23" type="GENE"/>
    <pair e1="s665.e0" e2="s665.e1" id="s665.p0" relation="true"/>
  </sentence>
  <sentence id="s666" text="In distal renal tubules, FGF23 signaling activates with-no-lysine kinase 4, leading to increased renal tubular reabsorption of calcium and sodium.">
    <entity charOffset="3-9" id="s666.e0" ontology_id="HP_0012839" text="distal" type="HP"/>
    <entity charOffset="25-30" id="s666.e1" ontology_id="8074" text="FGF23" type="GENE"/>
    <pair e1="s666.e0" e2="s666.e1" id="s666.p0" relation="true"/>
  </sentence>
  <sentence id="s667" text="Mutant mice lacking Lrrc6 show typical PCD defects such as hydrocephalus and laterality defects.">
    <entity charOffset="20-25" id="s667.e0" ontology_id="23639" text="Lrrc6" type="GENE"/>
    <entity charOffset="59-72" id="s667.e1" ontology_id="HP_0000238" text="hydrocephalus" type="HP"/>
    <pair e1="s667.e0" e2="s667.e1" id="s667.p0" relation="true"/>
  </sentence>
  <sentence id="s668" text="Using whole exome sequencing in 14 patients with isolated periventricular nodular heterotopia but no copy number variants, we identified one patient with periventricular nodular heterotopia, developmental delay and epilepsy and a de novo missense mutation in the chromosome 6 open reading frame 70 (C6orf70) gene, mapping in the minimal critical deleted region.">
    <entity charOffset="82-93" id="s668.e0" ontology_id="HP_0002282" text="heterotopia" type="HP"/>
    <entity charOffset="299-306" id="s668.e1" ontology_id="55780" text="C6orf70" type="GENE"/>
    <pair e1="s668.e0" e2="s668.e1" id="s668.p0" relation="true"/>
  </sentence>
  <sentence id="s669" text="Using whole exome sequencing in 14 patients with isolated periventricular nodular heterotopia but no copy number variants, we identified one patient with periventricular nodular heterotopia, developmental delay and epilepsy and a de novo missense mutation in the chromosome 6 open reading frame 70 (C6orf70) gene, mapping in the minimal critical deleted region.">
    <entity charOffset="215-223" id="s669.e0" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <entity charOffset="299-306" id="s669.e1" ontology_id="55780" text="C6orf70" type="GENE"/>
    <pair e1="s669.e0" e2="s669.e1" id="s669.p0" relation="true"/>
  </sentence>
  <sentence id="s670" text="Silencing of C6orf70 in the developing rat neocortex produced periventricular nodular heterotopia that was rescued by concomitant expression of wild-type human C6orf70 protein.">
    <entity charOffset="13-20" id="s670.e0" ontology_id="55780" text="C6orf70" type="GENE"/>
    <entity charOffset="86-97" id="s670.e1" ontology_id="HP_0002282" text="heterotopia" type="HP"/>
    <pair e1="s670.e0" e2="s670.e1" id="s670.p0" relation="true"/>
  </sentence>
  <sentence id="s671" text="The suppression of FoxO1 expression in TAM was induced by the hypoxic condition in the tumor microenviroment.">
    <entity charOffset="19-24" id="s671.e0" ontology_id="2308" text="FoxO1" type="GENE"/>
    <entity charOffset="87-92" id="s671.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s671.e0" e2="s671.e1" id="s671.p0" relation="false"/>
  </sentence>
  <sentence id="s672" text="First, we showed that TAMs expressed reduced levels of FoxO1, which was associated with their protumoral M2 polarization state.">
    <entity charOffset="55-60" id="s672.e0" ontology_id="2308" text="FoxO1" type="GENE"/>
    <entity charOffset="97-102" id="s672.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s672.e0" e2="s672.e1" id="s672.p0" relation="true"/>
  </sentence>
  <sentence id="s673" text="Furthermore, we used FoxO1 conditional knockout mice to show that FoxO1 deficiency in myeloid cells exacerbates tumor growth.">
    <entity charOffset="21-26" id="s673.e0" ontology_id="2308" text="FoxO1" type="GENE"/>
    <entity charOffset="112-117" id="s673.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s673.e0" e2="s673.e1" id="s673.p0" relation="true"/>
  </sentence>
  <sentence id="s674" text="Further functional studies show that forced expression of LHX3 in lung cancer cells obviously promotes cell proliferation and invasion, whereas inhibits cell apoptosis.">
    <entity charOffset="58-62" id="s674.e0" ontology_id="8022" text="LHX3" type="GENE"/>
    <entity charOffset="71-77" id="s674.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s674.e0" e2="s674.e1" id="s674.p0" relation="true"/>
  </sentence>
  <sentence id="s675" text="Furthermore, LHX3 is associated with unfavorable overall survival (n=866, p=0.004) and represents an independent prognostic factor (HR=2.36, p=0.000) in lung adenocarcinoma (ADC) patients, but is not associated with overall survival of squamous cell carcinoma (SCC) patients (n=524, p=0.27).">
    <entity charOffset="13-17" id="s675.e0" ontology_id="8022" text="LHX3" type="GENE"/>
    <entity charOffset="153-172" id="s675.e1" ontology_id="HP_0030078" text="lung adenocarcinoma" type="HP"/>
    <pair e1="s675.e0" e2="s675.e1" id="s675.p0" relation="true"/>
  </sentence>
  <sentence id="s676" text="Pathogenic variant in COCH are a known cause of DFNA9 autosomal dominant progressive hearing loss and vestibular dysfunction with adult onset.">
    <entity charOffset="48-53" id="s676.e0" ontology_id="1690" text="DFNA9" type="GENE"/>
    <entity charOffset="85-97" id="s676.e1" ontology_id="HP_0000365" text="hearing loss" type="HP"/>
    <pair e1="s676.e0" e2="s676.e1" id="s676.p0" relation="true"/>
  </sentence>
  <sentence id="s677" text="An earlier onset of hearing impairment and vestibular dysfunction compared to the dominant hearing loss causing COCH variants is observed">
    <entity charOffset="43-65" id="s677.e0" ontology_id="HP_0001751" text="vestibular dysfunction" type="HP"/>
    <entity charOffset="112-116" id="s677.e1" ontology_id="1690" text="COCH" type="GENE"/>
    <pair e1="s677.e0" e2="s677.e1" id="s677.p0" relation="true"/>
  </sentence>
  <sentence id="s678" text="The K&lt;sup&gt;+&lt;/sup&gt; channel KCNQ1 has been proposed as a tumor suppressor in colorectal cancer (CRC).">
    <entity charOffset="26-31" id="s678.e0" ontology_id="3784" text="KCNQ1" type="GENE"/>
    <entity charOffset="55-60" id="s678.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s678.e0" e2="s678.e1" id="s678.p0" relation="true"/>
  </sentence>
  <sentence id="s679" text="Hence, we focus on the relationship between YAP/TAZ and serine metabolism to control methylation of DNA or histone in breast cancer with LKB1 deficiency.">
    <entity charOffset="125-131" id="s679.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="137-141" id="s679.e1" ontology_id="6794" text="LKB1" type="GENE"/>
    <pair e1="s679.e0" e2="s679.e1" id="s679.p0" relation="true"/>
  </sentence>
  <sentence id="s680" text="Hsp90ab1 is upregulated in numerous solid tumors, which is thought to induce the angiogenesis and promote cancer metastasis.">
    <entity charOffset="0-8" id="s680.e0" ontology_id="3326" text="Hsp90ab1" type="GENE"/>
    <entity charOffset="42-48" id="s680.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s680.e0" e2="s680.e1" id="s680.p0" relation="true"/>
  </sentence>
  <sentence id="s681" text="Hsp90ab1 is upregulated in numerous solid tumors, which is thought to induce the angiogenesis and promote cancer metastasis.">
    <entity charOffset="0-8" id="s681.e0" ontology_id="3326" text="Hsp90ab1" type="GENE"/>
    <entity charOffset="106-112" id="s681.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s681.e0" e2="s681.e1" id="s681.p0" relation="true"/>
  </sentence>
  <sentence id="s682" text="The gonadoblastoma gene, testis-specific protein Y-encoded (TSPY), on the Y chromosome and its X-homologue, TSPX, are cell cycle regulators and function as a proto-oncogene and a tumor suppressor respectively in human oncogenesis.">
    <entity charOffset="4-18" id="s682.e0" ontology_id="HP_0000150" text="gonadoblastoma" type="HP"/>
    <entity charOffset="60-64" id="s682.e1" ontology_id="7258" text="TSPY" type="GENE"/>
    <pair e1="s682.e0" e2="s682.e1" id="s682.p0" relation="true"/>
  </sentence>
  <sentence id="s683" text="The gonadoblastoma gene, testis-specific protein Y-encoded (TSPY), on the Y chromosome and its X-homologue, TSPX, are cell cycle regulators and function as a proto-oncogene and a tumor suppressor respectively in human oncogenesis.">
    <entity charOffset="108-112" id="s683.e0" ontology_id="64061" text="TSPX" type="GENE"/>
    <entity charOffset="179-184" id="s683.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s683.e0" e2="s683.e1" id="s683.p0" relation="true"/>
  </sentence>
  <sentence id="s684" text="Hence, TSPY and TSPX exert opposing effects on the transactivation functions of AR and AR-Vs important for various physiological and disease processes sensitive to male sex hormone actions, thereby not only affecting the pathogenesis of male-specific prostate cancer but also likely contributing to sex differences in the health and diseases of man">
    <entity charOffset="7-11" id="s684.e0" ontology_id="7258" text="TSPY" type="GENE"/>
    <entity charOffset="260-266" id="s684.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s684.e0" e2="s684.e1" id="s684.p0" relation="true"/>
  </sentence>
  <sentence id="s685" text="Hence, TSPY and TSPX exert opposing effects on the transactivation functions of AR and AR-Vs important for various physiological and disease processes sensitive to male sex hormone actions, thereby not only affecting the pathogenesis of male-specific prostate cancer but also likely contributing to sex differences in the health and diseases of man">
    <entity charOffset="16-20" id="s685.e0" ontology_id="64061" text="TSPX" type="GENE"/>
    <entity charOffset="260-266" id="s685.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s685.e0" e2="s685.e1" id="s685.p0" relation="true"/>
  </sentence>
  <sentence id="s686" text="The canonical Hippo tumor suppressor pathway in mammalian cells is primarily composed of the MST1/2-SAV1-LATS1/2-MOB1-YAP/TAZ cascade.">
    <entity charOffset="20-25" id="s686.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="118-121" id="s686.e1" ontology_id="55249" text="YAP" type="GENE"/>
    <pair e1="s686.e0" e2="s686.e1" id="s686.p0" relation="true"/>
  </sentence>
  <sentence id="s687" text="Our results provide evidence that sequence variants in human SIPA1L3 cause autosomal recessive isolated CC and give new insight into the molecular pathogenesis underlying human cataracts.">
    <entity charOffset="61-68" id="s687.e0" ontology_id="23094" text="SIPA1L3" type="GENE"/>
    <entity charOffset="177-185" id="s687.e1" ontology_id="HP_0000518" text="cataract" type="HP"/>
    <pair e1="s687.e0" e2="s687.e1" id="s687.p0" relation="true"/>
  </sentence>
  <sentence id="s688" text="Disorders of signalling of various paracrine factors (FGFs, BMPs, WNTs, PTHrP/IHH, and CNP/NPR2) or genetic defects affecting cartilage extracellular matrix usually cause disproportionate short stature.">
    <entity charOffset="91-95" id="s688.e0" ontology_id="10641" text="NPR2" type="GENE"/>
    <entity charOffset="188-201" id="s688.e1" ontology_id="HP_0004322" text="short stature" type="HP"/>
    <pair e1="s688.e0" e2="s688.e1" id="s688.p0" relation="true"/>
  </sentence>
  <sentence id="s689" text="One presently identified eQTL for the PEX6 gene was rs10948059, which had been associated with prostate cancer from previous association studies.">
    <entity charOffset="38-42" id="s689.e0" ontology_id="5190" text="PEX6" type="GENE"/>
    <entity charOffset="104-110" id="s689.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s689.e0" e2="s689.e1" id="s689.p0" relation="true"/>
  </sentence>
  <sentence id="s690" text="Study of RetGC1 regulation in vitro and its association with fluorescently tagged GCAP in transfected cells showed that R822P substitution in the cyclase dimerization domain causing congenital early onset blindness disrupted RetGC1 ability to bind GCAP but did not eliminate its affinity for another photoreceptor-specific protein, retinal degeneration 3 (RD3).">
    <entity charOffset="82-86" id="s690.e0" ontology_id="2978" text="GCAP" type="GENE"/>
    <entity charOffset="205-214" id="s690.e1" ontology_id="HP_0000618" text="blindness" type="HP"/>
    <pair e1="s690.e0" e2="s690.e1" id="s690.p0" relation="false"/>
  </sentence>
  <sentence id="s691" text="Infantile cerebellar-retinal degeneration associated with mutations in the mitochondrial aconitase 2 gene (ACO2) has been recently described as a neurodegenerative disease of autosomal recessive inheritance.">
    <entity charOffset="107-111" id="s691.e0" ontology_id="50" text="ACO2" type="GENE"/>
    <entity charOffset="175-206" id="s691.e1" ontology_id="HP_0000007" text="autosomal recessive inheritance" type="HP"/>
    <pair e1="s691.e0" e2="s691.e1" id="s691.p0" relation="true"/>
  </sentence>
  <sentence id="s692" text="-Ureidopropionase deficiency is a rare autosomal recessive disease affecting the last step of pyrimidine degradation, and it is caused by a mutation in the UPB1 gene.">
    <entity charOffset="40-59" id="s692.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="157-161" id="s692.e1" ontology_id="51733" text="UPB1" type="GENE"/>
    <pair e1="s692.e0" e2="s692.e1" id="s692.p0" relation="true"/>
  </sentence>
  <sentence id="s693" text="Here, we have identified an epileptic encephalopathy additionally featuring cerebral calcifications and coarse facial features caused by recessive loss-of-function mutations in DENND5A.">
    <entity charOffset="38-52" id="s693.e0" ontology_id="HP_0001298" text="encephalopathy" type="HP"/>
    <entity charOffset="177-184" id="s693.e1" ontology_id="23258" text="DENND5A" type="GENE"/>
    <pair e1="s693.e0" e2="s693.e1" id="s693.p0" relation="true"/>
  </sentence>
  <sentence id="s694" text="Here, we have identified an epileptic encephalopathy additionally featuring cerebral calcifications and coarse facial features caused by recessive loss-of-function mutations in DENND5A.">
    <entity charOffset="76-99" id="s694.e0" ontology_id="HP_0002514" text="cerebral calcifications" type="HP"/>
    <entity charOffset="177-184" id="s694.e1" ontology_id="23258" text="DENND5A" type="GENE"/>
    <pair e1="s694.e0" e2="s694.e1" id="s694.p0" relation="true"/>
  </sentence>
  <sentence id="s695" text="Despite this multisystemic involvement and contrasting with a cachectic appearance, the anthropometric parameters showed marked overgrowth (+4 DS), leading to diagnosis of congenital lipodystrophy, which was confirmed by the presence of the new homozygous c.259C&amp;gt;T (p.Gln87*) mutation in the AGPAT2 gene.">
    <entity charOffset="183-196" id="s695.e0" ontology_id="HP_0009125" text="lipodystrophy" type="HP"/>
    <entity charOffset="295-301" id="s695.e1" ontology_id="10555" text="AGPAT2" type="GENE"/>
    <pair e1="s695.e0" e2="s695.e1" id="s695.p0" relation="true"/>
  </sentence>
  <sentence id="s696" text="Previous genome-wide association studies have identified several genes associated with obesity, including LEP, LEPR, POMC, PCSK1, FTO, MC3R, MC4R, GNPDA2, TMEM18, QPCTL/GIPR, BDNF, ETV5, MAP2K5/SKOR1, SEC16B, SIM1, and TNKS/MSRA.">
    <entity charOffset="87-94" id="s696.e0" ontology_id="HP_0001513" text="obesity" type="HP"/>
    <entity charOffset="201-207" id="s696.e1" ontology_id="89866" text="SEC16B" type="GENE"/>
    <pair e1="s696.e0" e2="s696.e1" id="s696.p0" relation="true"/>
  </sentence>
  <sentence id="s697" text="Previous genome-wide association studies have identified several genes associated with obesity, including LEP, LEPR, POMC, PCSK1, FTO, MC3R, MC4R, GNPDA2, TMEM18, QPCTL/GIPR, BDNF, ETV5, MAP2K5/SKOR1, SEC16B, SIM1, and TNKS/MSRA.">
    <entity charOffset="87-94" id="s697.e0" ontology_id="HP_0001513" text="obesity" type="HP"/>
    <entity charOffset="209-213" id="s697.e1" ontology_id="6492" text="SIM1" type="GENE"/>
    <pair e1="s697.e0" e2="s697.e1" id="s697.p0" relation="true"/>
  </sentence>
  <sentence id="s698" text="Carnitine-acylcarnitine translocase (CACT) deficiency is a rare autosomal recessive disease of fatty acid oxidation, mainly affecting long chain fatty acid utilization.">
    <entity charOffset="37-41" id="s698.e0" ontology_id="788" text="CACT" type="GENE"/>
    <entity charOffset="64-83" id="s698.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s698.e0" e2="s698.e1" id="s698.p0" relation="true"/>
  </sentence>
  <sentence id="s699" text="We have performed WES for 4102 (1847 female; 2255 male) intellectual disability/developmental delay cases and we report five patients with a neurodevelopmental disorder associated with developmental delay, intellectual disability, behavioral problems, hypotonia, speech problems, microcephaly, pachygyria and dysmorphic features in whom we have identified de novo missense and canonical splice site mutations in CSNK2A1, the gene encoding CK2, the catalytic subunit of protein kinase CK2, a ubiquitous serine/threonine kinase composed of two regulatory () and two catalytic ( and/or ') subunits.">
    <entity charOffset="56-79" id="s699.e0" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <entity charOffset="412-419" id="s699.e1" ontology_id="1459" text="CSNK2A1" type="GENE"/>
    <pair e1="s699.e0" e2="s699.e1" id="s699.p0" relation="false"/>
  </sentence>
  <sentence id="s700" text="A high proportion of tumors harbors multiple mutations, especially PIK3CA plus PIK3R1 mutations (9.0%).">
    <entity charOffset="21-27" id="s700.e0" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <entity charOffset="79-85" id="s700.e1" ontology_id="5295" text="PIK3R1" type="GENE"/>
    <pair e1="s700.e0" e2="s700.e1" id="s700.p0" relation="true"/>
  </sentence>
  <sentence id="s701" text="A high proportion of tumors harbors multiple mutations, especially PIK3CA plus PIK3R1 mutations (9.0%).">
    <entity charOffset="21-27" id="s701.e0" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <entity charOffset="67-73" id="s701.e1" ontology_id="5290" text="PIK3CA" type="GENE"/>
    <pair e1="s701.e0" e2="s701.e1" id="s701.p0" relation="true"/>
  </sentence>
  <sentence id="s702" text="Our study reports the first mutations in the VARS2 and TARS2 genes, which encode two mitochondrial aminoacyl-tRNA synthetases, as causes of clinically distinct, early-onset mitochondrial encephalopathies.">
    <entity charOffset="45-50" id="s702.e0" ontology_id="7407" text="VARS2" type="GENE"/>
    <entity charOffset="85-98" id="s702.e1" ontology_id="HP_0001427" text="mitochondrial" type="HP"/>
    <pair e1="s702.e0" e2="s702.e1" id="s702.p0" relation="true"/>
  </sentence>
  <sentence id="s703" text="Our study reports the first mutations in the VARS2 and TARS2 genes, which encode two mitochondrial aminoacyl-tRNA synthetases, as causes of clinically distinct, early-onset mitochondrial encephalopathies.">
    <entity charOffset="55-60" id="s703.e0" ontology_id="80222" text="TARS2" type="GENE"/>
    <entity charOffset="85-98" id="s703.e1" ontology_id="HP_0001427" text="mitochondrial" type="HP"/>
    <pair e1="s703.e0" e2="s703.e1" id="s703.p0" relation="true"/>
  </sentence>
  <sentence id="s704" text="This result suggests that COL4A3 and COL4A4 digenic mutations in cis mimicking an autosomal dominant inheritance should be considered as a novel inheritance pattern of benign familial hematuria, although the disease-causing mechanism remains unknown">
    <entity charOffset="26-32" id="s704.e0" ontology_id="1285" text="COL4A3" type="GENE"/>
    <entity charOffset="101-112" id="s704.e1" ontology_id="HP_0000005" text="inheritance" type="HP"/>
    <pair e1="s704.e0" e2="s704.e1" id="s704.p0" relation="true"/>
  </sentence>
  <sentence id="s705" text="This result suggests that COL4A3 and COL4A4 digenic mutations in cis mimicking an autosomal dominant inheritance should be considered as a novel inheritance pattern of benign familial hematuria, although the disease-causing mechanism remains unknown">
    <entity charOffset="37-43" id="s705.e0" ontology_id="1286" text="COL4A4" type="GENE"/>
    <entity charOffset="101-112" id="s705.e1" ontology_id="HP_0000005" text="inheritance" type="HP"/>
    <pair e1="s705.e0" e2="s705.e1" id="s705.p0" relation="true"/>
  </sentence>
  <sentence id="s706" text="Mutations in the COL4A5 gene result in X-linked Alport syndrome, homozygous or compound heterozygous mutations in COL4A3 or COL4A4 are responsible for autosomal recessive Alport syndrome, and heterozygous mutations in COL4A3 or COL4A4 cause autosomal dominant Alport syndrome or benign familial hematuria.">
    <entity charOffset="114-120" id="s706.e0" ontology_id="1285" text="COL4A3" type="GENE"/>
    <entity charOffset="151-170" id="s706.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s706.e0" e2="s706.e1" id="s706.p0" relation="true"/>
  </sentence>
  <sentence id="s707" text="Surprisingly, either silencing miR-126-3p by LNA-antimiR or overexpressing miR-126-3p by miRNA mimic repressed laser-induced choroidal neovascularization.">
    <entity charOffset="31-34" id="s707.e0" ontology_id="220972" text="miR" type="GENE"/>
    <entity charOffset="125-153" id="s707.e1" ontology_id="HP_0011506" text="choroidal neovascularization" type="HP"/>
    <pair e1="s707.e0" e2="s707.e1" id="s707.p0" relation="true"/>
  </sentence>
  <sentence id="s708" text="The schizophrenia-associated gene GRIN2A (glutamate ionotropic receptor NMDA type subunit 2a) codes for a protein subunit of the NMDA (N-methyl-D-aspartate) receptor that underlies central aspects of human cognition.">
    <entity charOffset="4-17" id="s708.e0" ontology_id="HP_0100753" text="schizophrenia" type="HP"/>
    <entity charOffset="34-40" id="s708.e1" ontology_id="2903" text="GRIN2A" type="GENE"/>
    <pair e1="s708.e0" e2="s708.e1" id="s708.p0" relation="true"/>
  </sentence>
  <sentence id="s709" text="The most significant association with childhood brain tumor risk was for IVS1-401G&amp;gt;C in the AICDA gene [odds ratio (OR) = 2.8; 95% confidence interval (95%CI) = 1.25-6.46]; the polymorphism *9276A&amp;gt;C of CASP14 was associated with decreased brain tumor risk (OR = 0.4; 95%CI = 0.19-0.95).">
    <entity charOffset="54-59" id="s709.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="208-214" id="s709.e1" ontology_id="23581" text="CASP14" type="GENE"/>
    <pair e1="s709.e0" e2="s709.e1" id="s709.p0" relation="false"/>
  </sentence>
  <sentence id="s710" text="We concluded that genetic polymorphisms in AICDA and CASP14 are associated with risk for brain tumor in Korean children.">
    <entity charOffset="53-59" id="s710.e0" ontology_id="23581" text="CASP14" type="GENE"/>
    <entity charOffset="95-100" id="s710.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s710.e0" e2="s710.e1" id="s710.p0" relation="true"/>
  </sentence>
  <sentence id="s711" text="The results revealed that the dual use of the SHH inhibitor and the HDAC inhibitor effectively synergized to inhibit proliferation, and promote apoptosis in liver cancer cells.">
    <entity charOffset="46-49" id="s711.e0" ontology_id="6469" text="SHH" type="GENE"/>
    <entity charOffset="163-169" id="s711.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s711.e0" e2="s711.e1" id="s711.p0" relation="true"/>
  </sentence>
  <sentence id="s712" text="Clinical trials have revealed that inhibition of sonic Hedgehog (SHH) signaling or histone deacetylase (HDAC) holds promise as a treatment for liver cancer.">
    <entity charOffset="65-68" id="s712.e0" ontology_id="6469" text="SHH" type="GENE"/>
    <entity charOffset="149-155" id="s712.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s712.e0" e2="s712.e1" id="s712.p0" relation="true"/>
  </sentence>
  <sentence id="s713" text="In trans-ethnic meta-analyses of U4C and UK Biobank data, we found significant associations between breast cancer risk and the expression of RCCD1 (joint p-value: 3.6x10-06) and DHODH (p-value: 7.1x10-06) in breast tissue, as well as a suggestive association for ANKLE1 (p-value: 9.3x10-05).">
    <entity charOffset="107-113" id="s713.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="263-269" id="s713.e1" ontology_id="126549" text="ANKLE1" type="GENE"/>
    <pair e1="s713.e0" e2="s713.e1" id="s713.p0" relation="true"/>
  </sentence>
  <sentence id="s714" text="Five haplotypes (GTTAT, ATTGT, GCTAC, ACTAC, and ACCAC) were found significantly associated with low &lt;i&gt;CHRM3&lt;/i&gt; mRNA level and contributed to increased susceptibility of bladder cancer in Kaohsiung city after rigid 10000 consecutive permutation tests.">
    <entity charOffset="104-109" id="s714.e0" ontology_id="1131" text="CHRM3" type="GENE"/>
    <entity charOffset="180-186" id="s714.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s714.e0" e2="s714.e1" id="s714.p0" relation="true"/>
  </sentence>
  <sentence id="s715" text="The first decade of the 21st century was marked by progress in understanding the basic biology of generalized epilepsies including generalized/genetic epilepsies with febrile seizures plus (GEFS+) and GGE through studies of large families, discovering causative mutations in SCN1A, SCN1B, GABRG2, and GABRA1.">
    <entity charOffset="110-120" id="s715.e0" ontology_id="HP_0001250" text="epilepsies" type="HP"/>
    <entity charOffset="282-287" id="s715.e1" ontology_id="6324" text="SCN1B" type="GENE"/>
    <pair e1="s715.e0" e2="s715.e1" id="s715.p0" relation="true"/>
  </sentence>
  <sentence id="s716" text="The first decade of the 21st century was marked by progress in understanding the basic biology of generalized epilepsies including generalized/genetic epilepsies with febrile seizures plus (GEFS+) and GGE through studies of large families, discovering causative mutations in SCN1A, SCN1B, GABRG2, and GABRA1.">
    <entity charOffset="175-183" id="s716.e0" ontology_id="HP_0001250" text="seizures" type="HP"/>
    <entity charOffset="275-280" id="s716.e1" ontology_id="6323" text="SCN1A" type="GENE"/>
    <pair e1="s716.e0" e2="s716.e1" id="s716.p0" relation="true"/>
  </sentence>
  <sentence id="s717" text="The first decade of the 21st century was marked by progress in understanding the basic biology of generalized epilepsies including generalized/genetic epilepsies with febrile seizures plus (GEFS+) and GGE through studies of large families, discovering causative mutations in SCN1A, SCN1B, GABRG2, and GABRA1.">
    <entity charOffset="175-183" id="s717.e0" ontology_id="HP_0001250" text="seizures" type="HP"/>
    <entity charOffset="282-287" id="s717.e1" ontology_id="6324" text="SCN1B" type="GENE"/>
    <pair e1="s717.e0" e2="s717.e1" id="s717.p0" relation="true"/>
  </sentence>
  <sentence id="s718" text="The first decade of the 21st century was marked by progress in understanding the basic biology of generalized epilepsies including generalized/genetic epilepsies with febrile seizures plus (GEFS+) and GGE through studies of large families, discovering causative mutations in SCN1A, SCN1B, GABRG2, and GABRA1.">
    <entity charOffset="175-183" id="s718.e0" ontology_id="HP_0001250" text="seizures" type="HP"/>
    <entity charOffset="289-295" id="s718.e1" ontology_id="2566" text="GABRG2" type="GENE"/>
    <pair e1="s718.e0" e2="s718.e1" id="s718.p0" relation="true"/>
  </sentence>
  <sentence id="s719" text="Genome-wide studies examining common genetic risk factors identified common variants in SCN1A, indicating a convergence of shared pathophysiological pathways in various types of epilepsies.">
    <entity charOffset="88-93" id="s719.e0" ontology_id="6323" text="SCN1A" type="GENE"/>
    <entity charOffset="178-188" id="s719.e1" ontology_id="HP_0001250" text="epilepsies" type="HP"/>
    <pair e1="s719.e0" e2="s719.e1" id="s719.p0" relation="true"/>
  </sentence>
  <sentence id="s720" text="Specifically, ADHFE1, HAND2, and GNAO1 were hypermethylated and downregulated in colon cancer, suggesting that the low expression levels of these genes may be regulated by DNA hypermethylation.">
    <entity charOffset="14-20" id="s720.e0" ontology_id="137872" text="ADHFE1" type="GENE"/>
    <entity charOffset="87-93" id="s720.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s720.e0" e2="s720.e1" id="s720.p0" relation="true"/>
  </sentence>
  <sentence id="s721" text="Using exome sequencing, we identified three unrelated patients with bi-allelic mutations in THOC6 associated with intellectual disability and additional clinical features.">
    <entity charOffset="92-97" id="s721.e0" ontology_id="79228" text="THOC6" type="GENE"/>
    <entity charOffset="114-137" id="s721.e1" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <pair e1="s721.e0" e2="s721.e1" id="s721.p0" relation="true"/>
  </sentence>
  <sentence id="s722" text="Our study demonstrated that AURKA rs1047972 TT and (CC+CT) genotypes were significantly associated with an increased risk of gastric cancer.">
    <entity charOffset="28-33" id="s722.e0" ontology_id="6790" text="AURKA" type="GENE"/>
    <entity charOffset="135-141" id="s722.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s722.e0" e2="s722.e1" id="s722.p0" relation="true"/>
  </sentence>
  <sentence id="s723" text="Although a digenic inheritance pattern of hearing impairment has been reported for heterozygous missense variants of ATP2B2 and CDH23, our findings indicate a monogenic cause of hearing impairment in cases with loss-of-function variants of ATP2B2">
    <entity charOffset="11-30" id="s723.e0" ontology_id="HP_0010984" text="digenic inheritance" type="HP"/>
    <entity charOffset="117-123" id="s723.e1" ontology_id="493" text="ATP2B2" type="GENE"/>
    <pair e1="s723.e0" e2="s723.e1" id="s723.p0" relation="true"/>
  </sentence>
  <sentence id="s724" text="Although a digenic inheritance pattern of hearing impairment has been reported for heterozygous missense variants of ATP2B2 and CDH23, our findings indicate a monogenic cause of hearing impairment in cases with loss-of-function variants of ATP2B2">
    <entity charOffset="42-60" id="s724.e0" ontology_id="HP_0000365" text="hearing impairment" type="HP"/>
    <entity charOffset="117-123" id="s724.e1" ontology_id="493" text="ATP2B2" type="GENE"/>
    <pair e1="s724.e0" e2="s724.e1" id="s724.p0" relation="true"/>
  </sentence>
  <sentence id="s725" text="TGFBR3-PLAG1 promotes a tumorigenic phenotype in vitro, and is absent in 723 other salivary gland tumors.">
    <entity charOffset="0-6" id="s725.e0" ontology_id="7049" text="TGFBR3" type="GENE"/>
    <entity charOffset="98-104" id="s725.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s725.e0" e2="s725.e1" id="s725.p0" relation="true"/>
  </sentence>
  <sentence id="s726" text="Brain somatic mutations in the gene encoding mTOR (MTOR) have recently been linked to focal cortical dysplasia and other associated brain pathologies including hemimegalencephaly.">
    <entity charOffset="51-55" id="s726.e0" ontology_id="2475" text="MTOR" type="GENE"/>
    <entity charOffset="160-178" id="s726.e1" ontology_id="HP_0007206" text="hemimegalencephaly" type="HP"/>
    <pair e1="s726.e0" e2="s726.e1" id="s726.p0" relation="true"/>
  </sentence>
  <sentence id="s727" text="There is emerging evidence that BRCA1 gene product (BRCA1) also plays a role in cancer cell migration.">
    <entity charOffset="32-37" id="s727.e0" ontology_id="672" text="BRCA1" type="GENE"/>
    <entity charOffset="80-86" id="s727.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s727.e0" e2="s727.e1" id="s727.p0" relation="true"/>
  </sentence>
  <sentence id="s728" text="We performed a quantitative proteomics study of EOC patient tumor tissues and identified changes in expression of several key regulators of actin cytoskeleton/cell adhesion and cell migration (CAPN1, 14-3-3, CAPG, PFN1, SPTBN1, CFN1) associated with loss of BRCA1 function.">
    <entity charOffset="60-65" id="s728.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="193-198" id="s728.e1" ontology_id="823" text="CAPN1" type="GENE"/>
    <pair e1="s728.e0" e2="s728.e1" id="s728.p0" relation="false"/>
  </sentence>
  <sentence id="s729" text="We performed a quantitative proteomics study of EOC patient tumor tissues and identified changes in expression of several key regulators of actin cytoskeleton/cell adhesion and cell migration (CAPN1, 14-3-3, CAPG, PFN1, SPTBN1, CFN1) associated with loss of BRCA1 function.">
    <entity charOffset="60-65" id="s729.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="214-218" id="s729.e1" ontology_id="5216" text="PFN1" type="GENE"/>
    <pair e1="s729.e0" e2="s729.e1" id="s729.p0" relation="false"/>
  </sentence>
  <sentence id="s730" text="Taken together, our results illustrated that LINC00963-miR-608-NACC1 pathway might be a potential target for melanoma therapy">
    <entity charOffset="63-68" id="s730.e0" ontology_id="112939" text="NACC1" type="GENE"/>
    <entity charOffset="109-117" id="s730.e1" ontology_id="HP_0002861" text="melanoma" type="HP"/>
    <pair e1="s730.e0" e2="s730.e1" id="s730.p0" relation="true"/>
  </sentence>
  <sentence id="s731" text="The eye features were a notable part of this child's presentation and mutations in the linkeropathy genes (XYLT1, XYLT2, B4GALT7, B3GALT6, and B3GAT3) can be associated with ocular findings, including blue sclerae, refractive errors, corneal clouding, strabismus, nystagmus, cataracts, glaucoma, and retinal abnormalities, including retinal detachment.">
    <entity charOffset="107-112" id="s731.e0" ontology_id="64131" text="XYLT1" type="GENE"/>
    <entity charOffset="275-284" id="s731.e1" ontology_id="HP_0000518" text="cataracts" type="HP"/>
    <pair e1="s731.e0" e2="s731.e1" id="s731.p0" relation="true"/>
  </sentence>
  <sentence id="s732" text="The eye features were a notable part of this child's presentation and mutations in the linkeropathy genes (XYLT1, XYLT2, B4GALT7, B3GALT6, and B3GAT3) can be associated with ocular findings, including blue sclerae, refractive errors, corneal clouding, strabismus, nystagmus, cataracts, glaucoma, and retinal abnormalities, including retinal detachment.">
    <entity charOffset="107-112" id="s732.e0" ontology_id="64131" text="XYLT1" type="GENE"/>
    <entity charOffset="333-351" id="s732.e1" ontology_id="HP_0000541" text="retinal detachment" type="HP"/>
    <pair e1="s732.e0" e2="s732.e1" id="s732.p0" relation="true"/>
  </sentence>
  <sentence id="s733" text="The eye features were a notable part of this child's presentation and mutations in the linkeropathy genes (XYLT1, XYLT2, B4GALT7, B3GALT6, and B3GAT3) can be associated with ocular findings, including blue sclerae, refractive errors, corneal clouding, strabismus, nystagmus, cataracts, glaucoma, and retinal abnormalities, including retinal detachment.">
    <entity charOffset="114-119" id="s733.e0" ontology_id="64132" text="XYLT2" type="GENE"/>
    <entity charOffset="234-250" id="s733.e1" ontology_id="HP_0007957" text="corneal clouding" type="HP"/>
    <pair e1="s733.e0" e2="s733.e1" id="s733.p0" relation="true"/>
  </sentence>
  <sentence id="s734" text="The eye features were a notable part of this child's presentation and mutations in the linkeropathy genes (XYLT1, XYLT2, B4GALT7, B3GALT6, and B3GAT3) can be associated with ocular findings, including blue sclerae, refractive errors, corneal clouding, strabismus, nystagmus, cataracts, glaucoma, and retinal abnormalities, including retinal detachment.">
    <entity charOffset="114-119" id="s734.e0" ontology_id="64132" text="XYLT2" type="GENE"/>
    <entity charOffset="252-262" id="s734.e1" ontology_id="HP_0000486" text="strabismus" type="HP"/>
    <pair e1="s734.e0" e2="s734.e1" id="s734.p0" relation="true"/>
  </sentence>
  <sentence id="s735" text="The eye features were a notable part of this child's presentation and mutations in the linkeropathy genes (XYLT1, XYLT2, B4GALT7, B3GALT6, and B3GAT3) can be associated with ocular findings, including blue sclerae, refractive errors, corneal clouding, strabismus, nystagmus, cataracts, glaucoma, and retinal abnormalities, including retinal detachment.">
    <entity charOffset="130-137" id="s735.e0" ontology_id="126792" text="B3GALT6" type="GENE"/>
    <entity charOffset="252-262" id="s735.e1" ontology_id="HP_0000486" text="strabismus" type="HP"/>
    <pair e1="s735.e0" e2="s735.e1" id="s735.p0" relation="true"/>
  </sentence>
  <sentence id="s736" text="The eye features were a notable part of this child's presentation and mutations in the linkeropathy genes (XYLT1, XYLT2, B4GALT7, B3GALT6, and B3GAT3) can be associated with ocular findings, including blue sclerae, refractive errors, corneal clouding, strabismus, nystagmus, cataracts, glaucoma, and retinal abnormalities, including retinal detachment.">
    <entity charOffset="143-149" id="s736.e0" ontology_id="26229" text="B3GAT3" type="GENE"/>
    <entity charOffset="234-250" id="s736.e1" ontology_id="HP_0007957" text="corneal clouding" type="HP"/>
    <pair e1="s736.e0" e2="s736.e1" id="s736.p0" relation="true"/>
  </sentence>
  <sentence id="s737" text="The eye features were a notable part of this child's presentation and mutations in the linkeropathy genes (XYLT1, XYLT2, B4GALT7, B3GALT6, and B3GAT3) can be associated with ocular findings, including blue sclerae, refractive errors, corneal clouding, strabismus, nystagmus, cataracts, glaucoma, and retinal abnormalities, including retinal detachment.">
    <entity charOffset="143-149" id="s737.e0" ontology_id="26229" text="B3GAT3" type="GENE"/>
    <entity charOffset="333-351" id="s737.e1" ontology_id="HP_0000541" text="retinal detachment" type="HP"/>
    <pair e1="s737.e0" e2="s737.e1" id="s737.p0" relation="true"/>
  </sentence>
  <sentence id="s738" text="The eye features were a notable part of this child's presentation and mutations in the linkeropathy genes (XYLT1, XYLT2, B4GALT7, B3GALT6, and B3GAT3) can be associated with ocular findings, including blue sclerae, refractive errors, corneal clouding, strabismus, nystagmus, cataracts, glaucoma, and retinal abnormalities, including retinal detachment.">
    <entity charOffset="143-149" id="s738.e0" ontology_id="26229" text="B3GAT3" type="GENE"/>
    <entity charOffset="286-294" id="s738.e1" ontology_id="HP_0000501" text="glaucoma" type="HP"/>
    <pair e1="s738.e0" e2="s738.e1" id="s738.p0" relation="true"/>
  </sentence>
  <sentence id="s739" text="Mechanistically, TUFM knockdown activated AMPK and phosphorylated GSK3 and increased the nuclear accumulation of -catenin, leading to the induction of EMT and increased migration and metastasis of A549 lung cancer cells.">
    <entity charOffset="42-46" id="s739.e0" ontology_id="5563" text="AMPK" type="GENE"/>
    <entity charOffset="209-215" id="s739.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s739.e0" e2="s739.e1" id="s739.p0" relation="false"/>
  </sentence>
  <sentence id="s740" text="Here, we show that TUFM is downregulated in human cancer tissues.">
    <entity charOffset="19-23" id="s740.e0" ontology_id="7284" text="TUFM" type="GENE"/>
    <entity charOffset="50-56" id="s740.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s740.e0" e2="s740.e1" id="s740.p0" relation="true"/>
  </sentence>
  <sentence id="s741" text="We have identified nine genes of interest that appear to be involved in cervical cancer development: SPARCL1, SYCP2, KIF4A, PRC1, TOP2A, LAMP3, KIF20A, MCM2, and APOBEC3B.">
    <entity charOffset="81-87" id="s741.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="117-122" id="s741.e1" ontology_id="24137" text="KIF4A" type="GENE"/>
    <pair e1="s741.e0" e2="s741.e1" id="s741.p0" relation="true"/>
  </sentence>
  <sentence id="s742" text="We have identified nine genes of interest that appear to be involved in cervical cancer development: SPARCL1, SYCP2, KIF4A, PRC1, TOP2A, LAMP3, KIF20A, MCM2, and APOBEC3B.">
    <entity charOffset="81-87" id="s742.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="110-115" id="s742.e1" ontology_id="10388" text="SYCP2" type="GENE"/>
    <pair e1="s742.e0" e2="s742.e1" id="s742.p0" relation="true"/>
  </sentence>
  <sentence id="s743" text="We have identified nine genes of interest that appear to be involved in cervical cancer development: SPARCL1, SYCP2, KIF4A, PRC1, TOP2A, LAMP3, KIF20A, MCM2, and APOBEC3B.">
    <entity charOffset="81-87" id="s743.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="152-156" id="s743.e1" ontology_id="4176" text="MCM2" type="GENE"/>
    <pair e1="s743.e0" e2="s743.e1" id="s743.p0" relation="true"/>
  </sentence>
  <sentence id="s744" text="Further, we analyzed the expression of these nine genes during the progression of cervical cancer, and found that SPARCL1 is also related to precancerous lesions and migration processes during cervical cancer pathogenesis.">
    <entity charOffset="91-97" id="s744.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="114-121" id="s744.e1" ontology_id="8404" text="SPARCL1" type="GENE"/>
    <pair e1="s744.e0" e2="s744.e1" id="s744.p0" relation="false"/>
  </sentence>
  <sentence id="s745" text="Here, we causally link a previously unreported missense mutation in TUBB2A (c.1249G&amp;gt;A, p.D417N), encoding one of the neuron-specific -tubulin isotype II, to a disorder characterized by progressive spastic paraplegia, peripheral sensory-motor polyneuropathy and ataxia.">
    <entity charOffset="68-74" id="s745.e0" ontology_id="7280" text="TUBB2A" type="GENE"/>
    <entity charOffset="201-219" id="s745.e1" ontology_id="HP_0001258" text="spastic paraplegia" type="HP"/>
    <pair e1="s745.e0" e2="s745.e1" id="s745.p0" relation="true"/>
  </sentence>
  <sentence id="s746" text="We also evaluated GZF1 expression in various kidney diseases including membranous nephropathy, minimal change nephrotic syndrome with or without acute kidney injury, immunoglobulin A nephropathy, diabetic nephropathy, acute tubular necrosis, and antineutrophil cytoplasmic antibody-related glomerulonephritis.">
    <entity charOffset="18-22" id="s746.e0" ontology_id="64412" text="GZF1" type="GENE"/>
    <entity charOffset="71-93" id="s746.e1" ontology_id="HP_0012578" text="membranous nephropathy" type="HP"/>
    <pair e1="s746.e0" e2="s746.e1" id="s746.p0" relation="true"/>
  </sentence>
  <sentence id="s747" text="Overall, our findings establish RASSF4 as a tumor-suppressive hub in MM and provide a mechanistic rationale for combining trametinib with HDAC inhibitors or bortezomib to treat patients with tumors exhibiting low RASSF4 expression.&lt;b&gt;Significance:&lt;/b&gt; These findings provide a mechanistic rationale for combining trametinib with HDAC inhibitors or bortezomib in patients with multiple myeloma whose tumors exhibit low RASSF4 expression.">
    <entity charOffset="32-38" id="s747.e0" ontology_id="54453" text="RASSF4" type="GENE"/>
    <entity charOffset="44-49" id="s747.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s747.e0" e2="s747.e1" id="s747.p0" relation="true"/>
  </sentence>
  <sentence id="s748" text="Biallelic GIPC3 mutations have recently been reported to cause autosomal recessive nonsyndromic sensorineural hearing loss.">
    <entity charOffset="10-15" id="s748.e0" ontology_id="126326" text="GIPC3" type="GENE"/>
    <entity charOffset="110-122" id="s748.e1" ontology_id="HP_0000365" text="hearing loss" type="HP"/>
    <pair e1="s748.e0" e2="s748.e1" id="s748.p0" relation="true"/>
  </sentence>
  <sentence id="s749" text="While there has been growing interest in the homodimeric gene products of CISD1 (mitoNEET) and CISD2 (NAF-1), the importance of the inner mitochondrial CISD3 protein has only recently been recognized in cancer.">
    <entity charOffset="152-157" id="s749.e0" ontology_id="284106" text="CISD3" type="GENE"/>
    <entity charOffset="203-209" id="s749.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s749.e0" e2="s749.e1" id="s749.p0" relation="true"/>
  </sentence>
  <sentence id="s750" text="Here we show in a child with microthrombocytopenia, eosinophilia and inflammatory disease, a homozygous frameshift mutation in ARPC1B (p.Val91Trpfs*30).">
    <entity charOffset="52-64" id="s750.e0" ontology_id="HP_0001880" text="eosinophilia" type="HP"/>
    <entity charOffset="127-133" id="s750.e1" ontology_id="10095" text="ARPC1B" type="GENE"/>
    <pair e1="s750.e0" e2="s750.e1" id="s750.p0" relation="true"/>
  </sentence>
  <sentence id="s751" text="RAD51C and RAD51D have been defined as susceptibility genes for hereditary breast and ovarian cancer syndrome in several studies.">
    <entity charOffset="0-6" id="s751.e0" ontology_id="5889" text="RAD51C" type="GENE"/>
    <entity charOffset="94-100" id="s751.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s751.e0" e2="s751.e1" id="s751.p0" relation="true"/>
  </sentence>
  <sentence id="s752" text="We found that the expression level of Chmp1A is significantly lower in RCC tissues and renal tumor cells compared with adjacent non-tumorous tissues and normal renal cells.">
    <entity charOffset="71-74" id="s752.e0" ontology_id="7515" text="RCC" type="GENE"/>
    <entity charOffset="93-98" id="s752.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s752.e0" e2="s752.e1" id="s752.p0" relation="true"/>
  </sentence>
  <sentence id="s753" text="Additionally, inhibition of Chmp1A expression by shRNA induced tumor formation in normal renal cells.">
    <entity charOffset="28-34" id="s753.e0" ontology_id="5119" text="Chmp1A" type="GENE"/>
    <entity charOffset="63-68" id="s753.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s753.e0" e2="s753.e1" id="s753.p0" relation="true"/>
  </sentence>
  <sentence id="s754" text="However, inhibition of Chmp1A did not significantly affect tumor cell proliferation in vitro and tumor progression in vivo.">
    <entity charOffset="23-29" id="s754.e0" ontology_id="5119" text="Chmp1A" type="GENE"/>
    <entity charOffset="59-64" id="s754.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s754.e0" e2="s754.e1" id="s754.p0" relation="true"/>
  </sentence>
  <sentence id="s755" text="Recent research published in the Journal of Pathology showed that genetic depletion of any of the NOX2 subunits Cyba, Cybb, Ncf1, Ncf2 and Ncf4 reduced the formation of lung metastases following intravenous injection of murine tumor cells.">
    <entity charOffset="118-122" id="s755.e0" ontology_id="1536" text="Cybb" type="GENE"/>
    <entity charOffset="227-232" id="s755.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s755.e0" e2="s755.e1" id="s755.p0" relation="false"/>
  </sentence>
  <sentence id="s756" text="These findings, together with the role of NOX2 in maintaining self-tolerance, imply that NOX2 is a targetable immune checkpoint in cancer.">
    <entity charOffset="42-46" id="s756.e0" ontology_id="1536" text="NOX2" type="GENE"/>
    <entity charOffset="131-137" id="s756.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s756.e0" e2="s756.e1" id="s756.p0" relation="true"/>
  </sentence>
  <sentence id="s757" text="The impact of NOX2 and ROS on cancer development is only partly explored.">
    <entity charOffset="14-18" id="s757.e0" ontology_id="1536" text="NOX2" type="GENE"/>
    <entity charOffset="30-36" id="s757.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s757.e0" e2="s757.e1" id="s757.p0" relation="true"/>
  </sentence>
  <sentence id="s758" text="The impact of NOX2 and ROS on cancer development is only partly explored.">
    <entity charOffset="23-26" id="s758.e0" ontology_id="6098" text="ROS" type="GENE"/>
    <entity charOffset="30-36" id="s758.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s758.e0" e2="s758.e1" id="s758.p0" relation="true"/>
  </sentence>
  <sentence id="s759" text="As previously observed in the mutant mouse carrying a disrupted KCNC1 gene, these findings reveal that individuals with a KCNC1 loss-of-function variant can present intellectual disability without seizure and epilepsy">
    <entity charOffset="64-69" id="s759.e0" ontology_id="3746" text="KCNC1" type="GENE"/>
    <entity charOffset="197-204" id="s759.e1" ontology_id="HP_0001250" text="seizure" type="HP"/>
    <pair e1="s759.e0" e2="s759.e1" id="s759.p0" relation="false"/>
  </sentence>
  <sentence id="s760" text="p.(Arg320His) mutation in the KCNC1 gene in human 11p15.1 has recently been identified in patients with progressive myoclonus epilepsies, a group of rare inherited disorders manifesting with action myoclonus, myoclonic epilepsy, and ataxia.">
    <entity charOffset="30-35" id="s760.e0" ontology_id="3746" text="KCNC1" type="GENE"/>
    <entity charOffset="126-136" id="s760.e1" ontology_id="HP_0001250" text="epilepsies" type="HP"/>
    <pair e1="s760.e0" e2="s760.e1" id="s760.p0" relation="true"/>
  </sentence>
  <sentence id="s761" text="p.(Arg320His) mutation in the KCNC1 gene in human 11p15.1 has recently been identified in patients with progressive myoclonus epilepsies, a group of rare inherited disorders manifesting with action myoclonus, myoclonic epilepsy, and ataxia.">
    <entity charOffset="30-35" id="s761.e0" ontology_id="3746" text="KCNC1" type="GENE"/>
    <entity charOffset="233-239" id="s761.e1" ontology_id="HP_0001251" text="ataxia" type="HP"/>
    <pair e1="s761.e0" e2="s761.e1" id="s761.p0" relation="true"/>
  </sentence>
  <sentence id="s762" text="We initially selected 6 fluoropyrimidine metabolism-related genes (DPYD, ORPT, TYMS, TYMP, TK1, and TK2) and 3 radiotherapy response-related genes (GLUT1, HIF-1, and HIF-2) as targets for gene expression identification in 60 LARC cancer specimens.">
    <entity charOffset="79-83" id="s762.e0" ontology_id="7298" text="TYMS" type="GENE"/>
    <entity charOffset="232-238" id="s762.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s762.e0" e2="s762.e1" id="s762.p0" relation="true"/>
  </sentence>
  <sentence id="s763" text="Recessive mutations in the secreted metalloprotease ADAMTS17 cause ectopia lentis and short stature in humans with Weill-Marchesani-like syndrome and primary open angle glaucoma and ectopia lentis in dogs.">
    <entity charOffset="52-60" id="s763.e0" ontology_id="170691" text="ADAMTS17" type="GENE"/>
    <entity charOffset="86-99" id="s763.e1" ontology_id="HP_0004322" text="short stature" type="HP"/>
    <pair e1="s763.e0" e2="s763.e1" id="s763.p0" relation="true"/>
  </sentence>
  <sentence id="s764" text="Inductions of FosB and phospho-acetylated histone 3 (molecular correlates of dyskinesia) were potentiated in the lesioned striatum of TG mice compared with their WT littermates.">
    <entity charOffset="14-18" id="s764.e0" ontology_id="2354" text="FosB" type="GENE"/>
    <entity charOffset="77-87" id="s764.e1" ontology_id="HP_0100660" text="dyskinesia" type="HP"/>
    <pair e1="s764.e0" e2="s764.e1" id="s764.p0" relation="true"/>
  </sentence>
  <sentence id="s765" text="We show that the miR-106b-25 cluster upregulates NOTCH1 in multiple breast cancer cell lines, representing both estrogen receptor (ER+) and triple negative breast cancer (TNBC) through direct repression of the E3 ubiquitin ligase, NEDD4L.">
    <entity charOffset="17-20" id="s765.e0" ontology_id="220972" text="miR" type="GENE"/>
    <entity charOffset="75-81" id="s765.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s765.e0" e2="s765.e1" id="s765.p0" relation="true"/>
  </sentence>
  <sentence id="s766" text="We show that the miR-106b-25 cluster upregulates NOTCH1 in multiple breast cancer cell lines, representing both estrogen receptor (ER+) and triple negative breast cancer (TNBC) through direct repression of the E3 ubiquitin ligase, NEDD4L.">
    <entity charOffset="49-55" id="s766.e0" ontology_id="4851" text="NOTCH1" type="GENE"/>
    <entity charOffset="75-81" id="s766.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s766.e0" e2="s766.e1" id="s766.p0" relation="true"/>
  </sentence>
  <sentence id="s767" text="We further show that upregulation of NOTCH1 is necessary for TIC induction downstream of miR-106b-25 in both ER+and TNBC breast cancer cells, and that re-expression of NEDD4L is sufficient to reverse miR106b-25-mediated NOTCH1 upregulation and TIC induction.">
    <entity charOffset="130-136" id="s767.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="170-176" id="s767.e1" ontology_id="23327" text="NEDD4L" type="GENE"/>
    <pair e1="s767.e0" e2="s767.e1" id="s767.p0" relation="false"/>
  </sentence>
  <sentence id="s768" text="Further, we show for the first time that NEDD4L expression alone is significantly associated with a better relapse-free prognosis for breast cancer patients.">
    <entity charOffset="41-47" id="s768.e0" ontology_id="23327" text="NEDD4L" type="GENE"/>
    <entity charOffset="141-147" id="s768.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s768.e0" e2="s768.e1" id="s768.p0" relation="true"/>
  </sentence>
  <sentence id="s769" text="Here we identify a novel mechanism of NOTCH regulation and TIC induction in breast cancer via the miR-106b-25 miRNA cluster.">
    <entity charOffset="83-89" id="s769.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="98-101" id="s769.e1" ontology_id="220972" text="miR" type="GENE"/>
    <pair e1="s769.e0" e2="s769.e1" id="s769.p0" relation="false"/>
  </sentence>
  <sentence id="s770" text="Importantly, we demonstrate a significant positive correlation between miR-106b-25 and NOTCH1 protein, yet a significant inverse correlation between miR-106b-25 and NEDD4L mRNA in human breast cancer, suggesting a critical role for the miR106b-25/NEDD4L/NOTCH1 axis in the disease.">
    <entity charOffset="71-74" id="s770.e0" ontology_id="220972" text="miR" type="GENE"/>
    <entity charOffset="193-199" id="s770.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s770.e0" e2="s770.e1" id="s770.p0" relation="false"/>
  </sentence>
  <sentence id="s771" text="Importantly, we demonstrate a significant positive correlation between miR-106b-25 and NOTCH1 protein, yet a significant inverse correlation between miR-106b-25 and NEDD4L mRNA in human breast cancer, suggesting a critical role for the miR106b-25/NEDD4L/NOTCH1 axis in the disease.">
    <entity charOffset="165-171" id="s771.e0" ontology_id="23327" text="NEDD4L" type="GENE"/>
    <entity charOffset="193-199" id="s771.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s771.e0" e2="s771.e1" id="s771.p0" relation="true"/>
  </sentence>
  <sentence id="s772" text="We found that hypertonia-associated mutation impairs Trak1 mitochondrial localization and its ability to facilitate mitochondrial tethering and fusion.">
    <entity charOffset="14-24" id="s772.e0" ontology_id="HP_0001276" text="hypertonia" type="HP"/>
    <entity charOffset="53-58" id="s772.e1" ontology_id="22906" text="Trak1" type="GENE"/>
    <pair e1="s772.e0" e2="s772.e1" id="s772.p0" relation="true"/>
  </sentence>
  <sentence id="s773" text="Our findings uncover a novel function of Trak1 as a regulator of mitochondrial fusion and provide evidence linking dysregulated mitochondrial dynamics to hypertonia pathogenesis">
    <entity charOffset="41-46" id="s773.e0" ontology_id="22906" text="Trak1" type="GENE"/>
    <entity charOffset="154-164" id="s773.e1" ontology_id="HP_0001276" text="hypertonia" type="HP"/>
    <pair e1="s773.e0" e2="s773.e1" id="s773.p0" relation="false"/>
  </sentence>
  <sentence id="s774" text="Biological activities of compounds 3-7 towards human cancer cells, COX-2, ROCK1, and JAK3 were evaluated">
    <entity charOffset="53-59" id="s774.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="74-79" id="s774.e1" ontology_id="6093" text="ROCK1" type="GENE"/>
    <pair e1="s774.e0" e2="s774.e1" id="s774.p0" relation="true"/>
  </sentence>
  <sentence id="s775" text="Based on the generated interaction network, we examine several apoptotic markers to determine the effect of PSMC3IP and EPSTI1 gene expression modulation in two different human breast cancer cell lines to suggest potential molecular mechanisms to unveil their role in the disease.">
    <entity charOffset="120-126" id="s775.e0" ontology_id="94240" text="EPSTI1" type="GENE"/>
    <entity charOffset="184-190" id="s775.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s775.e0" e2="s775.e1" id="s775.p0" relation="true"/>
  </sentence>
  <sentence id="s776" text="Our findings establish lesions in NARS2 as a new cause for nonsyndromic hearing loss and Leigh syndrome.">
    <entity charOffset="34-39" id="s776.e0" ontology_id="79731" text="NARS2" type="GENE"/>
    <entity charOffset="72-84" id="s776.e1" ontology_id="HP_0000365" text="hearing loss" type="HP"/>
    <pair e1="s776.e0" e2="s776.e1" id="s776.p0" relation="true"/>
  </sentence>
  <sentence id="s777" text="We also demonstrate that ATP-binding cassette subfamily C member 2 (ABCC2) gene, responsible for hyperbilirubinemia, is linked to ERLIN1">
    <entity charOffset="68-73" id="s777.e0" ontology_id="1244" text="ABCC2" type="GENE"/>
    <entity charOffset="97-115" id="s777.e1" ontology_id="HP_0002904" text="hyperbilirubinemia" type="HP"/>
    <pair e1="s777.e0" e2="s777.e1" id="s777.p0" relation="true"/>
  </sentence>
  <sentence id="s778" text="The third subject was an infant with growth deficiency, microcephaly, ichthyotic skin lesions, anemia, hypertonia, distinctive facial features, low serine and glycine in plasma and CSF, and a novel homozygous mutation in PHGDH gene.">
    <entity charOffset="56-68" id="s778.e0" ontology_id="HP_0000252" text="microcephaly" type="HP"/>
    <entity charOffset="221-226" id="s778.e1" ontology_id="26227" text="PHGDH" type="GENE"/>
    <pair e1="s778.e0" e2="s778.e1" id="s778.p0" relation="false"/>
  </sentence>
  <sentence id="s779" text="The third subject was an infant with growth deficiency, microcephaly, ichthyotic skin lesions, anemia, hypertonia, distinctive facial features, low serine and glycine in plasma and CSF, and a novel homozygous mutation in PHGDH gene.">
    <entity charOffset="95-101" id="s779.e0" ontology_id="HP_0001903" text="anemia" type="HP"/>
    <entity charOffset="221-226" id="s779.e1" ontology_id="26227" text="PHGDH" type="GENE"/>
    <pair e1="s779.e0" e2="s779.e1" id="s779.p0" relation="false"/>
  </sentence>
  <sentence id="s780" text="The third subject was an infant with growth deficiency, microcephaly, ichthyotic skin lesions, anemia, hypertonia, distinctive facial features, low serine and glycine in plasma and CSF, and a novel homozygous mutation in PHGDH gene.">
    <entity charOffset="103-113" id="s780.e0" ontology_id="HP_0001276" text="hypertonia" type="HP"/>
    <entity charOffset="221-226" id="s780.e1" ontology_id="26227" text="PHGDH" type="GENE"/>
    <pair e1="s780.e0" e2="s780.e1" id="s780.p0" relation="false"/>
  </sentence>
  <sentence id="s781" text="The second was a neonate with growth deficiency, microcephaly, ichthyotic skin lesions, seizures, contractures, hypertonia, distinctive facial features, and a homozygous mutation in PSAT1.">
    <entity charOffset="98-110" id="s781.e0" ontology_id="HP_0001371" text="contractures" type="HP"/>
    <entity charOffset="182-187" id="s781.e1" ontology_id="29968" text="PSAT1" type="GENE"/>
    <pair e1="s781.e0" e2="s781.e1" id="s781.p0" relation="false"/>
  </sentence>
  <sentence id="s782" text="ATL3 is a paralogue of ATL1, a membrane curvature-generating molecule that is involved in spastic paraplegia and hereditary sensory neuropathy.">
    <entity charOffset="0-4" id="s782.e0" ontology_id="25923" text="ATL3" type="GENE"/>
    <entity charOffset="132-142" id="s782.e1" ontology_id="HP_0009830" text="neuropathy" type="HP"/>
    <pair e1="s782.e0" e2="s782.e1" id="s782.p0" relation="true"/>
  </sentence>
  <sentence id="s783" text="Succinate dehydrogenase subunit B and D (SDHB and SDHD) mutations represent the most frequent cause of hereditary pheochromocytoma and paraganglioma (PPGL).">
    <entity charOffset="50-54" id="s783.e0" ontology_id="6392" text="SDHD" type="GENE"/>
    <entity charOffset="135-148" id="s783.e1" ontology_id="HP_0002668" text="paraganglioma" type="HP"/>
    <pair e1="s783.e0" e2="s783.e1" id="s783.p0" relation="true"/>
  </sentence>
  <sentence id="s784" text="In SDHB-related syndrome, PPGL maintenance seems to be reduced compared to SDHD (p = 0.04 vs 0.95) due to higher probability of tumor cell regression in SDHB vs SDHD (p = 0.87 vs 0.00).">
    <entity charOffset="3-7" id="s784.e0" ontology_id="6390" text="SDHB" type="GENE"/>
    <entity charOffset="128-133" id="s784.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s784.e0" e2="s784.e1" id="s784.p0" relation="true"/>
  </sentence>
  <sentence id="s785" text="In SDHB-related syndrome, PPGL maintenance seems to be reduced compared to SDHD (p = 0.04 vs 0.95) due to higher probability of tumor cell regression in SDHB vs SDHD (p = 0.87 vs 0.00).">
    <entity charOffset="75-79" id="s785.e0" ontology_id="6392" text="SDHD" type="GENE"/>
    <entity charOffset="128-133" id="s785.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s785.e0" e2="s785.e1" id="s785.p0" relation="true"/>
  </sentence>
  <sentence id="s786" text="Until now, the role of VGSCs and the relationships between calmodulin (CaM)/CaM-dependent protein kinase II (CaMKII) and VGSCs in low-grade astrocytoma have not been demonstrated.">
    <entity charOffset="71-74" id="s786.e0" ontology_id="889" text="CaM" type="GENE"/>
    <entity charOffset="140-151" id="s786.e1" ontology_id="HP_0009592" text="astrocytoma" type="HP"/>
    <pair e1="s786.e0" e2="s786.e1" id="s786.p0" relation="true"/>
  </sentence>
  <sentence id="s787" text="Membrane transporters (such as ABCs, SLCs and ATPases) act in carcinogenesis and chemoresistance development, but their relevance for prognosis of epithelial ovarian cancer (EOC) remains poorly understood.">
    <entity charOffset="37-40" id="s787.e0" ontology_id="6366" text="SLC" type="GENE"/>
    <entity charOffset="166-172" id="s787.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s787.e0" e2="s787.e1" id="s787.p0" relation="true"/>
  </sentence>
  <sentence id="s788" text="Here we report a novel missense mutation in ARSB gene that is inherited as an autosomal recessive mode and probably explain the clinical status of the proband.">
    <entity charOffset="44-48" id="s788.e0" ontology_id="411" text="ARSB" type="GENE"/>
    <entity charOffset="78-97" id="s788.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s788.e0" e2="s788.e1" id="s788.p0" relation="true"/>
  </sentence>
  <sentence id="s789" text="Mucopolysaccharidosis VI (MPS-VI) is an infrequent autosomal recessive disorder caused by mutations in ARSB gene and deficiency in lysosomal enzyyme ARSB activities subsequently.">
    <entity charOffset="51-70" id="s789.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="103-107" id="s789.e1" ontology_id="411" text="ARSB" type="GENE"/>
    <pair e1="s789.e0" e2="s789.e1" id="s789.p0" relation="true"/>
  </sentence>
  <sentence id="s790" text="We found that KLK10 was significantly overexpressed in tissues of pancreatic intraepithelial neoplasia (PanIN) and PDAC from Pdx1-Cre; LSL-Kras&lt;sup&gt;G12D/+&lt;/sup&gt; mice (KC) and Pdx1-Cre; LSL-Kras&lt;sup&gt;G12D/+&lt;/sup&gt;; LSL-Trp53&lt;sup&gt;R172H/+&lt;/sup&gt; mice (KPC) by immunohistochemical analysis.">
    <entity charOffset="14-19" id="s790.e0" ontology_id="5655" text="KLK10" type="GENE"/>
    <entity charOffset="93-102" id="s790.e1" ontology_id="HP_0002664" text="neoplasia" type="HP"/>
    <pair e1="s790.e0" e2="s790.e1" id="s790.p0" relation="true"/>
  </sentence>
  <sentence id="s791" text="In Mfrprd6 eyes, a significant 1.5- to 2.0-fold decrease was observed among transcripts of genes linked to retinal degeneration, including those involved in visual cycle (Rpe65, Lrat, Rgr), phototransduction (Pde6a, Guca1b, Rgs9), and photoreceptor disc morphogenesis (Rpgrip1 and Fscn2).">
    <entity charOffset="107-127" id="s791.e0" ontology_id="HP_0000546" text="retinal degeneration" type="HP"/>
    <entity charOffset="269-276" id="s791.e1" ontology_id="57096" text="Rpgrip1" type="GENE"/>
    <pair e1="s791.e0" e2="s791.e1" id="s791.p0" relation="true"/>
  </sentence>
  <sentence id="s792" text="In Mfrprd6 eyes, a significant 1.5- to 2.0-fold decrease was observed among transcripts of genes linked to retinal degeneration, including those involved in visual cycle (Rpe65, Lrat, Rgr), phototransduction (Pde6a, Guca1b, Rgs9), and photoreceptor disc morphogenesis (Rpgrip1 and Fscn2).">
    <entity charOffset="107-127" id="s792.e0" ontology_id="HP_0000546" text="retinal degeneration" type="HP"/>
    <entity charOffset="178-182" id="s792.e1" ontology_id="9227" text="Lrat" type="GENE"/>
    <pair e1="s792.e0" e2="s792.e1" id="s792.p0" relation="true"/>
  </sentence>
  <sentence id="s793" text="In Mfrprd6 eyes, a significant 1.5- to 2.0-fold decrease was observed among transcripts of genes linked to retinal degeneration, including those involved in visual cycle (Rpe65, Lrat, Rgr), phototransduction (Pde6a, Guca1b, Rgs9), and photoreceptor disc morphogenesis (Rpgrip1 and Fscn2).">
    <entity charOffset="107-127" id="s793.e0" ontology_id="HP_0000546" text="retinal degeneration" type="HP"/>
    <entity charOffset="184-187" id="s793.e1" ontology_id="5995" text="Rgr" type="GENE"/>
    <pair e1="s793.e0" e2="s793.e1" id="s793.p0" relation="true"/>
  </sentence>
  <sentence id="s794" text="In Mfrprd6 eyes, a significant 1.5- to 2.0-fold decrease was observed among transcripts of genes linked to retinal degeneration, including those involved in visual cycle (Rpe65, Lrat, Rgr), phototransduction (Pde6a, Guca1b, Rgs9), and photoreceptor disc morphogenesis (Rpgrip1 and Fscn2).">
    <entity charOffset="107-127" id="s794.e0" ontology_id="HP_0000546" text="retinal degeneration" type="HP"/>
    <entity charOffset="224-228" id="s794.e1" ontology_id="388531" text="Rgs9" type="GENE"/>
    <pair e1="s794.e0" e2="s794.e1" id="s794.p0" relation="true"/>
  </sentence>
  <sentence id="s795" text="Transcripts of Prss56, a gene associated with angle-closure glaucoma, posterior microphthalmia and myopia, were increased in Mfrprd6 eyes by 17-fold.">
    <entity charOffset="80-94" id="s795.e0" ontology_id="HP_0000568" text="microphthalmia" type="HP"/>
    <entity charOffset="125-129" id="s795.e1" ontology_id="83552" text="Mfrp" type="GENE"/>
    <pair e1="s795.e0" e2="s795.e1" id="s795.p0" relation="false"/>
  </sentence>
  <sentence id="s796" text="Mutations in the membrane frizzled-related protein (MFRP/Mfrp) gene, specifically expressed in the retinal pigment epithelium (RPE) and ciliary body, cause nanophthalmia or posterior microphthalmia with retinitis pigmentosa in humans, and photoreceptor degeneration in mice.">
    <entity charOffset="57-61" id="s796.e0" ontology_id="83552" text="Mfrp" type="GENE"/>
    <entity charOffset="183-197" id="s796.e1" ontology_id="HP_0000568" text="microphthalmia" type="HP"/>
    <pair e1="s796.e0" e2="s796.e1" id="s796.p0" relation="true"/>
  </sentence>
  <sentence id="s797" text="Gorlin syndrome is a rare multisystem inherited disorder which can predispose to basal cell carcinomas (BCCs), childhood medulloblastomas in addition to various developmental abnormalities; the majority of cases are due to mutations in the PTCH1 gene.">
    <entity charOffset="81-102" id="s797.e0" ontology_id="HP_0002671" text="basal cell carcinomas" type="HP"/>
    <entity charOffset="240-245" id="s797.e1" ontology_id="5727" text="PTCH1" type="GENE"/>
    <pair e1="s797.e0" e2="s797.e1" id="s797.p0" relation="true"/>
  </sentence>
  <sentence id="s798" text="Both RPE65 isomerase of the visual cycle and the rhodopsin visual pigment have recently been identified as critical players in mediating light-induced retinal degeneration.">
    <entity charOffset="5-8" id="s798.e0" ontology_id="6120" text="RPE" type="GENE"/>
    <entity charOffset="151-171" id="s798.e1" ontology_id="HP_0000546" text="retinal degeneration" type="HP"/>
    <pair e1="s798.e0" e2="s798.e1" id="s798.p0" relation="true"/>
  </sentence>
  <sentence id="s799" text="Here, we identified, by next generation sequencing, sequence variants affecting function in the PCYT1A gene in three young patients with isolated retinal dystrophy from two different Italian families.">
    <entity charOffset="96-102" id="s799.e0" ontology_id="5130" text="PCYT1A" type="GENE"/>
    <entity charOffset="146-163" id="s799.e1" ontology_id="HP_0000556" text="retinal dystrophy" type="HP"/>
    <pair e1="s799.e0" e2="s799.e1" id="s799.p0" relation="true"/>
  </sentence>
  <sentence id="s800" text="Based on our and published data we propose that the GPKOW gene is essential for fetal development and when disrupted, leads to a severe, male-lethal phenotype characterised by microcephaly and IUGR">
    <entity charOffset="52-57" id="s800.e0" ontology_id="27238" text="GPKOW" type="GENE"/>
    <entity charOffset="129-135" id="s800.e1" ontology_id="HP_0012828" text="severe" type="HP"/>
    <pair e1="s800.e0" e2="s800.e1" id="s800.p0" relation="true"/>
  </sentence>
  <sentence id="s801" text="Here, we report a novel donor splice site variant in the G-patch domain and KOW motifs (GPKOW) gene (NG_021310.2:g.6126G&amp;gt;A, NM_015698.4:c.331+5G&amp;gt;A) that segregates with affected and carrier status in a multigenerational family with an X-linked perinatal lethal condition characterized by severe microcephaly and intrauterine growth restriction (IUGR).">
    <entity charOffset="88-93" id="s801.e0" ontology_id="27238" text="GPKOW" type="GENE"/>
    <entity charOffset="294-300" id="s801.e1" ontology_id="HP_0012828" text="severe" type="HP"/>
    <pair e1="s801.e0" e2="s801.e1" id="s801.p0" relation="true"/>
  </sentence>
  <sentence id="s802" text="Enamel-renal-gingival syndrome (ERGS; OMIM #204690), a rare autosomal recessive disorder caused by mutations in FAM20A, is characterized by nephrocalcinosis, nephrolithiasis, amelogenesis imperfecta, hypoplastic type, gingival fibromatosis and other dental abnormalities, including hypodontia and unerupted teeth with large dental follicles.">
    <entity charOffset="112-118" id="s802.e0" ontology_id="54757" text="FAM20A" type="GENE"/>
    <entity charOffset="140-156" id="s802.e1" ontology_id="HP_0000121" text="nephrocalcinosis" type="HP"/>
    <pair e1="s802.e0" e2="s802.e1" id="s802.p0" relation="true"/>
  </sentence>
  <sentence id="s803" text="Moreover, CpG island methylation status of HACE1, a candidate tumor-suppressor gene, was determined in ANKL samples.">
    <entity charOffset="43-48" id="s803.e0" ontology_id="57531" text="HACE1" type="GENE"/>
    <entity charOffset="62-67" id="s803.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s803.e0" e2="s803.e1" id="s803.p0" relation="true"/>
  </sentence>
  <sentence id="s804" text="Some of the genes causing the Fanconi anemia (FA) syndrome, such as BRCA2, BRIP1, PALB2, and RAD51C, are associated with high or moderate risk of developing breast cancer.">
    <entity charOffset="68-73" id="s804.e0" ontology_id="675" text="BRCA2" type="GENE"/>
    <entity charOffset="164-170" id="s804.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s804.e0" e2="s804.e1" id="s804.p0" relation="true"/>
  </sentence>
  <sentence id="s805" text="Some of the genes causing the Fanconi anemia (FA) syndrome, such as BRCA2, BRIP1, PALB2, and RAD51C, are associated with high or moderate risk of developing breast cancer.">
    <entity charOffset="75-80" id="s805.e0" ontology_id="64979" text="BRIP1" type="GENE"/>
    <entity charOffset="164-170" id="s805.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s805.e0" e2="s805.e1" id="s805.p0" relation="true"/>
  </sentence>
  <sentence id="s806" text="Some of the genes causing the Fanconi anemia (FA) syndrome, such as BRCA2, BRIP1, PALB2, and RAD51C, are associated with high or moderate risk of developing breast cancer.">
    <entity charOffset="82-87" id="s806.e0" ontology_id="79728" text="PALB2" type="GENE"/>
    <entity charOffset="164-170" id="s806.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s806.e0" e2="s806.e1" id="s806.p0" relation="true"/>
  </sentence>
  <sentence id="s807" text="Some of the genes causing the Fanconi anemia (FA) syndrome, such as BRCA2, BRIP1, PALB2, and RAD51C, are associated with high or moderate risk of developing breast cancer.">
    <entity charOffset="93-99" id="s807.e0" ontology_id="5889" text="RAD51C" type="GENE"/>
    <entity charOffset="164-170" id="s807.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s807.e0" e2="s807.e1" id="s807.p0" relation="true"/>
  </sentence>
  <sentence id="s808" text="Here we show, using whole-exome and cancer gene panel sequencing of 79 aGCTs from two independent cohorts, that truncating mutation of the histone lysine methyltransferase gene KMT2D (also known as MLL2) is a recurrent somatic event in aGCT.">
    <entity charOffset="36-42" id="s808.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="177-182" id="s808.e1" ontology_id="8085" text="KMT2D" type="GENE"/>
    <pair e1="s808.e0" e2="s808.e1" id="s808.p0" relation="false"/>
  </sentence>
  <sentence id="s809" text="IHC detects additional non-KMT2D-mutated aGCTs with loss of nuclear KMT2D expression, suggesting that non-genetic KMT2D inactivation may occur in this tumor type.">
    <entity charOffset="27-32" id="s809.e0" ontology_id="8085" text="KMT2D" type="GENE"/>
    <entity charOffset="151-156" id="s809.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s809.e0" e2="s809.e1" id="s809.p0" relation="false"/>
  </sentence>
  <sentence id="s810" text="Adult-type granulosa cell tumors of the ovary (aGCTs) are rare gynecologic malignancies that exhibit a high frequency of somatic FOXL2 c.C402G (p.Cys134Trp) mutation.">
    <entity charOffset="26-32" id="s810.e0" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <entity charOffset="129-134" id="s810.e1" ontology_id="668" text="FOXL2" type="GENE"/>
    <pair e1="s810.e0" e2="s810.e1" id="s810.p0" relation="true"/>
  </sentence>
  <sentence id="s811" text="Moreover, Adenomatous polyposis coli 2 (APC2), a tumor suppressor and a negative regulator of Wnt signaling, was found to be the direct target of miR-3648.">
    <entity charOffset="40-44" id="s811.e0" ontology_id="29882" text="APC2" type="GENE"/>
    <entity charOffset="49-54" id="s811.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s811.e0" e2="s811.e1" id="s811.p0" relation="true"/>
  </sentence>
  <sentence id="s812" text="We conclude that both genes contribute to the phenotypic severity of 3p25 deletion syndrome but that some specific features, such as ptosis and blepharophimosis, are mostly driven by BRPF1 haploinsufficiency">
    <entity charOffset="133-139" id="s812.e0" ontology_id="HP_0000508" text="ptosis" type="HP"/>
    <entity charOffset="183-188" id="s812.e1" ontology_id="7862" text="BRPF1" type="GENE"/>
    <pair e1="s812.e0" e2="s812.e1" id="s812.p0" relation="true"/>
  </sentence>
  <sentence id="s813" text="Among 510 unrelated patients with distal motor neuropathy, we identified mutations in HSPB1 (28 index patients/510; 5.5%) and HSPB8 (four index patients/510; 0.8%) genes.">
    <entity charOffset="34-40" id="s813.e0" ontology_id="HP_0012839" text="distal" type="HP"/>
    <entity charOffset="126-131" id="s813.e1" ontology_id="26353" text="HSPB8" type="GENE"/>
    <pair e1="s813.e0" e2="s813.e1" id="s813.p0" relation="true"/>
  </sentence>
  <sentence id="s814" text="Among 510 unrelated patients with distal motor neuropathy, we identified mutations in HSPB1 (28 index patients/510; 5.5%) and HSPB8 (four index patients/510; 0.8%) genes.">
    <entity charOffset="47-57" id="s814.e0" ontology_id="HP_0009830" text="neuropathy" type="HP"/>
    <entity charOffset="126-131" id="s814.e1" ontology_id="26353" text="HSPB8" type="GENE"/>
    <pair e1="s814.e0" e2="s814.e1" id="s814.p0" relation="true"/>
  </sentence>
  <sentence id="s815" text="In this study, we describe the phenotypic spectrum of distal hereditary motor neuropathy caused by mutations in the small heat shock proteins HSPB1 and HSPB8 and investigate the functional consequences of newly discovered variants.">
    <entity charOffset="54-60" id="s815.e0" ontology_id="HP_0012839" text="distal" type="HP"/>
    <entity charOffset="152-157" id="s815.e1" ontology_id="26353" text="HSPB8" type="GENE"/>
    <pair e1="s815.e0" e2="s815.e1" id="s815.p0" relation="true"/>
  </sentence>
  <sentence id="s816" text="We demonstrate that HSPB1 and HSPB8 mutations are a major cause of inherited motor axonal neuropathy.">
    <entity charOffset="30-35" id="s816.e0" ontology_id="26353" text="HSPB8" type="GENE"/>
    <entity charOffset="90-100" id="s816.e1" ontology_id="HP_0009830" text="neuropathy" type="HP"/>
    <pair e1="s816.e0" e2="s816.e1" id="s816.p0" relation="true"/>
  </sentence>
  <sentence id="s817" text="Malfunctioning of nucleoporins is well known in human malignancies, such as gene fusions of NUP214 and NUP98 in hematological neoplasms and overexpression of NUP88 in a variety of human cancers.">
    <entity charOffset="126-135" id="s817.e0" ontology_id="HP_0002664" text="neoplasms" type="HP"/>
    <entity charOffset="158-163" id="s817.e1" ontology_id="4927" text="NUP88" type="GENE"/>
    <pair e1="s817.e0" e2="s817.e1" id="s817.p0" relation="false"/>
  </sentence>
  <sentence id="s818" text="The core phenotype of X-linked NAA10-related N-terminal-acetyltransferase deficiency in both males and females includes developmental delay, severe intellectual disability, postnatal growth failure with severe microcephaly, and skeletal or cardiac anomalies.">
    <entity charOffset="31-36" id="s818.e0" ontology_id="8260" text="NAA10" type="GENE"/>
    <entity charOffset="240-257" id="s818.e1" ontology_id="HP_0001627" text="cardiac anomalies" type="HP"/>
    <pair e1="s818.e0" e2="s818.e1" id="s818.p0" relation="false"/>
  </sentence>
  <sentence id="s819" text="The core phenotype of X-linked NAA10-related N-terminal-acetyltransferase deficiency in both males and females includes developmental delay, severe intellectual disability, postnatal growth failure with severe microcephaly, and skeletal or cardiac anomalies.">
    <entity charOffset="31-36" id="s819.e0" ontology_id="8260" text="NAA10" type="GENE"/>
    <entity charOffset="120-139" id="s819.e1" ontology_id="HP_0001263" text="developmental delay" type="HP"/>
    <pair e1="s819.e0" e2="s819.e1" id="s819.p0" relation="false"/>
  </sentence>
  <sentence id="s820" text="To further explore this, we investigated the associations of peripheral GR-1&lt;sub&gt;F&lt;/sub&gt; methylation (52 CpGs) with the cortisol stress response (Trier Social Stress Test) and with childhood trauma in three independent studies (total N=241) including healthy controls, patients with schizophrenia and bipolar disorder and unaffected siblings of patients with one of these disorders.">
    <entity charOffset="72-74" id="s820.e0" ontology_id="2908" text="GR" type="GENE"/>
    <entity charOffset="285-298" id="s820.e1" ontology_id="HP_0100753" text="schizophrenia" type="HP"/>
    <pair e1="s820.e0" e2="s820.e1" id="s820.p0" relation="false"/>
  </sentence>
  <sentence id="s821" text="By whole exome sequencing we identified a de novo splicing mutation in FOXP1 in a patient, initially diagnosed as C syndrome, who suffers from syndromic intellectual disability with trigonocephaly.">
    <entity charOffset="71-76" id="s821.e0" ontology_id="27086" text="FOXP1" type="GENE"/>
    <entity charOffset="153-176" id="s821.e1" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <pair e1="s821.e0" e2="s821.e1" id="s821.p0" relation="true"/>
  </sentence>
  <sentence id="s822" text="In addition to replicating previously reported loci, we identify five novel loci significantly associated with endometriosis risk (P&amp;lt;5  10&lt;sup&gt;-8&lt;/sup&gt;), implicating genes involved in sex steroid hormone pathways (FN1, CCDC170, ESR1, SYNE1 and FSHB).">
    <entity charOffset="111-124" id="s822.e0" ontology_id="HP_0030127" text="endometriosis" type="HP"/>
    <entity charOffset="223-230" id="s822.e1" ontology_id="80129" text="CCDC170" type="GENE"/>
    <pair e1="s822.e0" e2="s822.e1" id="s822.p0" relation="true"/>
  </sentence>
  <sentence id="s823" text="It is well known that miR-145-5p (the guide strand) functions as a tumor suppressor in several types of cancer.">
    <entity charOffset="22-25" id="s823.e0" ontology_id="220972" text="miR" type="GENE"/>
    <entity charOffset="67-72" id="s823.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s823.e0" e2="s823.e1" id="s823.p0" relation="true"/>
  </sentence>
  <sentence id="s824" text="It is well known that miR-145-5p (the guide strand) functions as a tumor suppressor in several types of cancer.">
    <entity charOffset="22-25" id="s824.e0" ontology_id="220972" text="miR" type="GENE"/>
    <entity charOffset="104-110" id="s824.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s824.e0" e2="s824.e1" id="s824.p0" relation="true"/>
  </sentence>
  <sentence id="s825" text="Expression levels of miR-145-5p and miR-145-3p were markedly reduced in cancer tissues, and ectopic expression of these miRNAs inhibited cancer cell aggressiveness, suggesting that both miR-145-3p as well as miR-145-5p acted as antitumor miRNAs.">
    <entity charOffset="21-24" id="s825.e0" ontology_id="220972" text="miR" type="GENE"/>
    <entity charOffset="149-163" id="s825.e1" ontology_id="HP_0000718" text="aggressiveness" type="HP"/>
    <pair e1="s825.e0" e2="s825.e1" id="s825.p0" relation="true"/>
  </sentence>
  <sentence id="s826" text="On comparing Nesprin-2 and BRCA1 localization in the ovarian cancer cell lines SKOV-3 and Caov-3, Nesprin-2 and BRCA1 were localized to the NE envelope and the nucleus in SKOV-3, respectively, and to the cytoplasm in Caov-3 cells.">
    <entity charOffset="27-32" id="s826.e0" ontology_id="672" text="BRCA1" type="GENE"/>
    <entity charOffset="61-67" id="s826.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s826.e0" e2="s826.e1" id="s826.p0" relation="true"/>
  </sentence>
  <sentence id="s827" text="The VDR gene FokI CT/TT genotype was associated with an increased papillary thyroid cancer risk (CT vs CC: odds ratio=1.71, 95% confidence interval=1.15-2.76, p=0.028; TT vs CC: odds ratio=2.44, 95% confidence interval=1.29-4.62, p=0.005; CT/TT vs CC: odds ratio=1.88, 95% confidence interval=1.20-2.96, p=0.006; CT/CC vs TT: odds ratio=1.80, 95% confidence interval=1.05-3.20, p=0.041).">
    <entity charOffset="4-7" id="s827.e0" ontology_id="7421" text="VDR" type="GENE"/>
    <entity charOffset="84-90" id="s827.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s827.e0" e2="s827.e1" id="s827.p0" relation="true"/>
  </sentence>
  <sentence id="s828" text="We also provide an example of using the platform to screen compounds for their ability to lower Apolipoprotein B (APOB) produced from iPSC-derived hepatocytes generated from a familial hypercholesterolemia patient.">
    <entity charOffset="114-118" id="s828.e0" ontology_id="338" text="APOB" type="GENE"/>
    <entity charOffset="185-205" id="s828.e1" ontology_id="HP_0003124" text="hypercholesterolemia" type="HP"/>
    <pair e1="s828.e0" e2="s828.e1" id="s828.p0" relation="true"/>
  </sentence>
  <sentence id="s829" text="Overall, 40 of the 73 ICA patients (55%) and 23 of the 56 kindreds (41%) carry mutations located in translated or untranslated exons of &lt;i&gt;RPSA.&lt;/i&gt; Eleven of the 43 kindreds affected by sporadic disease (26%) carry &lt;i&gt;RPSA&lt;/i&gt; mutations, whereas 12 of the 13 multiplex kindreds (92%) carry &lt;i&gt;RPSA&lt;/i&gt; mutations.">
    <entity charOffset="139-143" id="s829.e0" ontology_id="3921" text="RPSA" type="GENE"/>
    <entity charOffset="187-195" id="s829.e1" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <pair e1="s829.e0" e2="s829.e1" id="s829.p0" relation="false"/>
  </sentence>
  <sentence id="s830" text="The tumor suppressor characteristics of cyclindependent kinase 10 (CDK10) in nasopharyngeal carcinoma and breast cancer have been previously demonstrated.">
    <entity charOffset="68-73" id="s830.e0" ontology_id="8558" text="CDK10" type="GENE"/>
    <entity charOffset="114-120" id="s830.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s830.e0" e2="s830.e1" id="s830.p0" relation="true"/>
  </sentence>
  <sentence id="s831" text="Multivariate analysis suggested that CDK10 expression may serve as an independent prognostic predictor (P=0.001) for the progression of gastric cancer.">
    <entity charOffset="37-42" id="s831.e0" ontology_id="8558" text="CDK10" type="GENE"/>
    <entity charOffset="144-150" id="s831.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s831.e0" e2="s831.e1" id="s831.p0" relation="true"/>
  </sentence>
  <sentence id="s832" text="In addition, ectopic CDK10 expression inhibited gastric cancer cell proliferation, migration and invasion, while knockdown of CDK10 promoted these phenotypes.">
    <entity charOffset="21-26" id="s832.e0" ontology_id="8558" text="CDK10" type="GENE"/>
    <entity charOffset="56-62" id="s832.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s832.e0" e2="s832.e1" id="s832.p0" relation="true"/>
  </sentence>
  <sentence id="s833" text="Immunohistochemistry demonstrated that the loss of CDK10 expression, which was observed in 50.8% of primary gastric cancer tissues (n=128), significantly correlated with advanced tumor stage (P&amp;lt;0.001), frequent lymph node metastasis (P&amp;lt;0.001), distant metastasis (P=0.013), tumor differentiation (P=0.004) and unfavorable overall survival (P&amp;lt;0.001).">
    <entity charOffset="51-56" id="s833.e0" ontology_id="8558" text="CDK10" type="GENE"/>
    <entity charOffset="179-184" id="s833.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s833.e0" e2="s833.e1" id="s833.p0" relation="true"/>
  </sentence>
  <sentence id="s834" text="In order to provide an additional insight into its functional role we compared target gene expression levels between human neuroblastoma cells (SH-SY5Y) stably overexpressing &lt;i&gt;FOXP2&lt;/i&gt; cDNA of either humans or the common chimpanzee, Rhesus monkey, and marmoset, respectively.">
    <entity charOffset="123-136" id="s834.e0" ontology_id="HP_0003006" text="neuroblastoma" type="HP"/>
    <entity charOffset="178-183" id="s834.e1" ontology_id="93986" text="FOXP2" type="GENE"/>
    <pair e1="s834.e0" e2="s834.e1" id="s834.p0" relation="true"/>
  </sentence>
  <sentence id="s835" text="We performed a retrospective review of electronic patient records to identify patients with macular dystrophy due to bi-allelic variants in CRB1.">
    <entity charOffset="92-109" id="s835.e0" ontology_id="HP_0007754" text="macular dystrophy" type="HP"/>
    <entity charOffset="140-144" id="s835.e1" ontology_id="23418" text="CRB1" type="GENE"/>
    <pair e1="s835.e0" e2="s835.e1" id="s835.p0" relation="true"/>
  </sentence>
  <sentence id="s836" text="The expression of MLPH in primary prostate tumors was significantly lower in those with the G compared with the T allele and correlated significantly with AR protein.">
    <entity charOffset="18-22" id="s836.e0" ontology_id="79083" text="MLPH" type="GENE"/>
    <entity charOffset="43-49" id="s836.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s836.e0" e2="s836.e1" id="s836.p0" relation="true"/>
  </sentence>
  <sentence id="s837" text="The autosomal recessive disease propionic acidemia (PA) is an inborn error of metabolism with highly variable clinical manifestations, caused by a deficiency of propionyl-CoA carboxylase (PCC) enzyme, due to mutations in either PCCA or PCCB genes, which encode the alpha and beta subunits of the PCC enzyme, respectively.">
    <entity charOffset="4-23" id="s837.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="236-240" id="s837.e1" ontology_id="5096" text="PCCB" type="GENE"/>
    <pair e1="s837.e0" e2="s837.e1" id="s837.p0" relation="true"/>
  </sentence>
  <sentence id="s838" text="Mutations in CAV3 lead to various neuromuscular phenotypes with partial overlap, including limb girdle muscular dystrophy type 1C (LGMD1C), rippling muscle disease, distal myopathy and isolated hyperCKemia.">
    <entity charOffset="13-17" id="s838.e0" ontology_id="859" text="CAV3" type="GENE"/>
    <entity charOffset="172-180" id="s838.e1" ontology_id="HP_0003198" text="myopathy" type="HP"/>
    <pair e1="s838.e0" e2="s838.e1" id="s838.p0" relation="true"/>
  </sentence>
  <sentence id="s839" text="Here we present a series of eight patients from seven families presenting with exercise intolerance and rhabdomyolysis caused by mutations in CAV3 diagnosed by next generation sequencing (NGS) (n=6).">
    <entity charOffset="104-118" id="s839.e0" ontology_id="HP_0003201" text="rhabdomyolysis" type="HP"/>
    <entity charOffset="142-146" id="s839.e1" ontology_id="859" text="CAV3" type="GENE"/>
    <pair e1="s839.e0" e2="s839.e1" id="s839.p0" relation="true"/>
  </sentence>
  <sentence id="s840" text="The ID2 gene expression was increased in the most advanced stage of endometriosis and in ovarian endometriomas, the PRELP was more expressed in peritoneal lesions, and the SMOC2 was highly expressed in both peritoneal and endometrioma lesions.">
    <entity charOffset="68-81" id="s840.e0" ontology_id="HP_0030127" text="endometriosis" type="HP"/>
    <entity charOffset="116-121" id="s840.e1" ontology_id="5549" text="PRELP" type="GENE"/>
    <pair e1="s840.e0" e2="s840.e1" id="s840.p0" relation="false"/>
  </sentence>
  <sentence id="s841" text="With reduced YAP expression using shRNA or YAP inhibitors, TKI-resistant cells become TKI-sensitive. reduced xenograft tumor size in nude mice and Moreover, combined EGFR TKI and a YAP inhibitor, statin, prolonged survival among lung cancer patients analyzed by Taiwan National Health Insurance Research database.">
    <entity charOffset="119-124" id="s841.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="166-170" id="s841.e1" ontology_id="1956" text="EGFR" type="GENE"/>
    <pair e1="s841.e0" e2="s841.e1" id="s841.p0" relation="false"/>
  </sentence>
  <sentence id="s842" text="EGFR tyrosine kinase inhibitors (TKIs) have been used in patients with EGFR-mutant as an effective targeted therapy in lung adenocarcinoma, but drug resistance and tumor recurrence inevitably occurs.">
    <entity charOffset="0-4" id="s842.e0" ontology_id="1956" text="EGFR" type="GENE"/>
    <entity charOffset="119-138" id="s842.e1" ontology_id="HP_0030078" text="lung adenocarcinoma" type="HP"/>
    <pair e1="s842.e0" e2="s842.e1" id="s842.p0" relation="true"/>
  </sentence>
  <sentence id="s843" text="While control subjects with high PGC-1 expression exhibited high PV and Nefh expression, schizophrenia subjects with high PGC-1 expression did not, suggesting dissociation between PGC-1 expression and these targets in schizophrenia.">
    <entity charOffset="73-77" id="s843.e0" ontology_id="4744" text="Nefh" type="GENE"/>
    <entity charOffset="90-103" id="s843.e1" ontology_id="HP_0100753" text="schizophrenia" type="HP"/>
    <pair e1="s843.e0" e2="s843.e1" id="s843.p0" relation="true"/>
  </sentence>
  <sentence id="s844" text="Interestingly, the positive correlation between PGC-1 and PV, Syt2, or Cplx1 expression was lost in schizophrenia patients with low NRF-1 expression, suggesting that NRF-1 is a critical predictor of these genes in disease.">
    <entity charOffset="63-67" id="s844.e0" ontology_id="127833" text="Syt2" type="GENE"/>
    <entity charOffset="101-114" id="s844.e1" ontology_id="HP_0100753" text="schizophrenia" type="HP"/>
    <pair e1="s844.e0" e2="s844.e1" id="s844.p0" relation="true"/>
  </sentence>
  <sentence id="s845" text="The newly reported myoclonus-dystonia gene, RELN, plays also a role in the formation of brain structures.">
    <entity charOffset="29-37" id="s845.e0" ontology_id="HP_0001332" text="dystonia" type="HP"/>
    <entity charOffset="44-48" id="s845.e1" ontology_id="5649" text="RELN" type="GENE"/>
    <pair e1="s845.e0" e2="s845.e1" id="s845.p0" relation="true"/>
  </sentence>
  <sentence id="s846" text="Defects in neurodevelopment likewise seem to be a recurrent scheme underpinning mainly complex dystonias, for example those attributable to biallelic mutations in GCH1, TH, SPR, or to heterozygous TUBB4A mutations.">
    <entity charOffset="95-103" id="s846.e0" ontology_id="HP_0001332" text="dystonia" type="HP"/>
    <entity charOffset="163-167" id="s846.e1" ontology_id="2643" text="GCH1" type="GENE"/>
    <pair e1="s846.e0" e2="s846.e1" id="s846.p0" relation="true"/>
  </sentence>
  <sentence id="s847" text="The novel myoclonus-dystonia genes KCTD17 and CACNA1B also implicate abnormal calcium signaling in dystonia.">
    <entity charOffset="20-28" id="s847.e0" ontology_id="HP_0001332" text="dystonia" type="HP"/>
    <entity charOffset="35-41" id="s847.e1" ontology_id="79734" text="KCTD17" type="GENE"/>
    <pair e1="s847.e0" e2="s847.e1" id="s847.p0" relation="true"/>
  </sentence>
  <sentence id="s848" text="This includes the first two genes linked to recessively inherited isolated dystonia, that is, HPCA (hippocalcin) and COL6A3 (collagen VI alpha 3).">
    <entity charOffset="75-83" id="s848.e0" ontology_id="HP_0001332" text="dystonia" type="HP"/>
    <entity charOffset="117-123" id="s848.e1" ontology_id="1293" text="COL6A3" type="GENE"/>
    <pair e1="s848.e0" e2="s848.e1" id="s848.p0" relation="true"/>
  </sentence>
  <sentence id="s849" text="MESP2, HES7 and DUSP6 genes have been proved to be involved in the etiopathogenesis of congenital scoliosis (CS) in animal embryo studies, however, whether this association was detected in human CS patients also remains unknown.">
    <entity charOffset="0-5" id="s849.e0" ontology_id="145873" text="MESP2" type="GENE"/>
    <entity charOffset="98-107" id="s849.e1" ontology_id="HP_0002650" text="scoliosis" type="HP"/>
    <pair e1="s849.e0" e2="s849.e1" id="s849.p0" relation="true"/>
  </sentence>
  <sentence id="s850" text="MESP2, HES7 and DUSP6 genes may not be involved in the etiopathogenesis of sporadic and non-syndromic CS in Chinese Han population">
    <entity charOffset="7-11" id="s850.e0" ontology_id="84667" text="HES7" type="GENE"/>
    <entity charOffset="75-83" id="s850.e1" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <pair e1="s850.e0" e2="s850.e1" id="s850.p0" relation="true"/>
  </sentence>
  <sentence id="s851" text="No pathogenic mutations were detected in PAX6, FOXC1 or PITX2 in the only patient with a sporadic form of aniridialike phenotype, confirming the genetic heterogeneity associated with this disease.">
    <entity charOffset="41-45" id="s851.e0" ontology_id="5080" text="PAX6" type="GENE"/>
    <entity charOffset="154-167" id="s851.e1" ontology_id="HP_0001425" text="heterogeneity" type="HP"/>
    <pair e1="s851.e0" e2="s851.e1" id="s851.p0" relation="true"/>
  </sentence>
  <sentence id="s852" text="No pathogenic mutations were detected in PAX6, FOXC1 or PITX2 in the only patient with a sporadic form of aniridialike phenotype, confirming the genetic heterogeneity associated with this disease.">
    <entity charOffset="41-45" id="s852.e0" ontology_id="5080" text="PAX6" type="GENE"/>
    <entity charOffset="89-97" id="s852.e1" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <pair e1="s852.e0" e2="s852.e1" id="s852.p0" relation="true"/>
  </sentence>
  <sentence id="s853" text="No pathogenic mutations were detected in PAX6, FOXC1 or PITX2 in the only patient with a sporadic form of aniridialike phenotype, confirming the genetic heterogeneity associated with this disease.">
    <entity charOffset="47-52" id="s853.e0" ontology_id="2296" text="FOXC1" type="GENE"/>
    <entity charOffset="89-97" id="s853.e1" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <pair e1="s853.e0" e2="s853.e1" id="s853.p0" relation="true"/>
  </sentence>
  <sentence id="s854" text="No pathogenic mutations were detected in PAX6, FOXC1 or PITX2 in the only patient with a sporadic form of aniridialike phenotype, confirming the genetic heterogeneity associated with this disease.">
    <entity charOffset="47-52" id="s854.e0" ontology_id="2296" text="FOXC1" type="GENE"/>
    <entity charOffset="154-167" id="s854.e1" ontology_id="HP_0001425" text="heterogeneity" type="HP"/>
    <pair e1="s854.e0" e2="s854.e1" id="s854.p0" relation="false"/>
  </sentence>
  <sentence id="s855" text="No pathogenic mutations were detected in PAX6, FOXC1 or PITX2 in the only patient with a sporadic form of aniridialike phenotype, confirming the genetic heterogeneity associated with this disease.">
    <entity charOffset="56-61" id="s855.e0" ontology_id="5308" text="PITX2" type="GENE"/>
    <entity charOffset="89-97" id="s855.e1" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <pair e1="s855.e0" e2="s855.e1" id="s855.p0" relation="true"/>
  </sentence>
  <sentence id="s856" text="No pathogenic mutations were detected in PAX6, FOXC1 or PITX2 in the only patient with a sporadic form of aniridialike phenotype, confirming the genetic heterogeneity associated with this disease.">
    <entity charOffset="56-61" id="s856.e0" ontology_id="5308" text="PITX2" type="GENE"/>
    <entity charOffset="154-167" id="s856.e1" ontology_id="HP_0001425" text="heterogeneity" type="HP"/>
    <pair e1="s856.e0" e2="s856.e1" id="s856.p0" relation="false"/>
  </sentence>
  <sentence id="s857" text="We identified mutations of WTX in 32%, CTNNB1 in 15%, WT1 in 12% and TP53 in 5% of tumors.">
    <entity charOffset="27-30" id="s857.e0" ontology_id="139285" text="WTX" type="GENE"/>
    <entity charOffset="83-88" id="s857.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s857.e0" e2="s857.e1" id="s857.p0" relation="true"/>
  </sentence>
  <sentence id="s858" text="Here, we determine that non-canonical IKK-RelB pathway activation of KRAS-mutant tumor cells mediates MPE development and this is fueled by host-provided interleukin IL-1.">
    <entity charOffset="70-74" id="s858.e0" ontology_id="3845" text="KRAS" type="GENE"/>
    <entity charOffset="82-87" id="s858.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s858.e0" e2="s858.e1" id="s858.p0" relation="true"/>
  </sentence>
  <sentence id="s859" text="Hence we show that mutant KRAS facilitates IKK-mediated responsiveness of tumor cells to host IL-1, thereby establishing a host-to-tumor signaling circuit that culminates in inflammatory MPE development and drug resistance">
    <entity charOffset="26-30" id="s859.e0" ontology_id="3845" text="KRAS" type="GENE"/>
    <entity charOffset="75-80" id="s859.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s859.e0" e2="s859.e1" id="s859.p0" relation="true"/>
  </sentence>
  <sentence id="s860" text="We investigated molecular mechanisms of degeneration and show that IFT172 protein reduction leads to mislocalization of specific photoreceptor outersegment (OS) proteins (RHO, RP1, IFT139), aberrant light-driven translocation of alpha transducin and altered localization of glioma-associated oncogene family member 1 (GLI1).">
    <entity charOffset="171-174" id="s860.e0" ontology_id="6010" text="RHO" type="GENE"/>
    <entity charOffset="274-280" id="s860.e1" ontology_id="HP_0009733" text="glioma" type="HP"/>
    <pair e1="s860.e0" e2="s860.e1" id="s860.p0" relation="false"/>
  </sentence>
  <sentence id="s861" text="Pompe disease, also called type II glycogen storage disease, is a rare autosomal recessive inherited disease caused by the storage of glycogen in lysosome due to acid -glucosidase (GAA) deficiency, with the most severe conditions in the skeletal muscle, the myocardium, and the smooth muscle.">
    <entity charOffset="71-90" id="s861.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="182-185" id="s861.e1" ontology_id="2548" text="GAA" type="GENE"/>
    <pair e1="s861.e0" e2="s861.e1" id="s861.p0" relation="true"/>
  </sentence>
  <sentence id="s862" text="Unlike previously reported patients with ACAN mutations, our four patients with ACAN variants manifested non-specific short stature with age-appropriate or mildly delayed bone ages, and had parents of normal stature.">
    <entity charOffset="41-45" id="s862.e0" ontology_id="176" text="ACAN" type="GENE"/>
    <entity charOffset="118-131" id="s862.e1" ontology_id="HP_0004322" text="short stature" type="HP"/>
    <pair e1="s862.e0" e2="s862.e1" id="s862.p0" relation="true"/>
  </sentence>
  <sentence id="s863" text="Although mutations in ACAN, FGFR3, NPR2, and SHOX typically lead to skeletal dysplasia, and mutations in GHRHR, GH1, GHR, STAT5B, IGF1, IGFALS, and IGF1R usually underlie hormonal defects of the growth hormone (GH)-insulin-like growth factor 1 (IGF1) axis, such mutations have also been identified in patients with idiopathic short stature (ISS).">
    <entity charOffset="35-39" id="s863.e0" ontology_id="10641" text="NPR2" type="GENE"/>
    <entity charOffset="326-339" id="s863.e1" ontology_id="HP_0004322" text="short stature" type="HP"/>
    <pair e1="s863.e0" e2="s863.e1" id="s863.p0" relation="true"/>
  </sentence>
  <sentence id="s864" text="Although mutations in ACAN, FGFR3, NPR2, and SHOX typically lead to skeletal dysplasia, and mutations in GHRHR, GH1, GHR, STAT5B, IGF1, IGFALS, and IGF1R usually underlie hormonal defects of the growth hormone (GH)-insulin-like growth factor 1 (IGF1) axis, such mutations have also been identified in patients with idiopathic short stature (ISS).">
    <entity charOffset="68-86" id="s864.e0" ontology_id="HP_0002652" text="skeletal dysplasia" type="HP"/>
    <entity charOffset="122-128" id="s864.e1" ontology_id="6777" text="STAT5B" type="GENE"/>
    <pair e1="s864.e0" e2="s864.e1" id="s864.p0" relation="false"/>
  </sentence>
  <sentence id="s865" text="Although mutations in ACAN, FGFR3, NPR2, and SHOX typically lead to skeletal dysplasia, and mutations in GHRHR, GH1, GHR, STAT5B, IGF1, IGFALS, and IGF1R usually underlie hormonal defects of the growth hormone (GH)-insulin-like growth factor 1 (IGF1) axis, such mutations have also been identified in patients with idiopathic short stature (ISS).">
    <entity charOffset="105-110" id="s865.e0" ontology_id="2692" text="GHRHR" type="GENE"/>
    <entity charOffset="326-339" id="s865.e1" ontology_id="HP_0004322" text="short stature" type="HP"/>
    <pair e1="s865.e0" e2="s865.e1" id="s865.p0" relation="true"/>
  </sentence>
  <sentence id="s866" text="Several studies have investigated single nucleotide polymorphisms (SNPs) in a number of genes associated with the susceptibility to or severity and outcome of community-acquired pneumonia (CAP), but no research has yet been conducted on the role of IRF5 gene polymorphisms in CAP.">
    <entity charOffset="178-187" id="s866.e0" ontology_id="HP_0002090" text="pneumonia" type="HP"/>
    <entity charOffset="249-253" id="s866.e1" ontology_id="3663" text="IRF5" type="GENE"/>
    <pair e1="s866.e0" e2="s866.e1" id="s866.p0" relation="false"/>
  </sentence>
  <sentence id="s867" text="The expression levels of NRAS in human clinical specimens were higher in breast cancer tissues when compared to normal tissues.">
    <entity charOffset="25-29" id="s867.e0" ontology_id="4893" text="NRAS" type="GENE"/>
    <entity charOffset="80-86" id="s867.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s867.e0" e2="s867.e1" id="s867.p0" relation="true"/>
  </sentence>
  <sentence id="s868" text="Heparanase (&lt;i&gt;HPSE&lt;/i&gt;) expression was identified in 50% of GBM tumours by immunostaining, and was characterised by a high intratumoural heterogeneity of the presence of the HPSE protein.">
    <entity charOffset="15-19" id="s868.e0" ontology_id="10855" text="HPSE" type="GENE"/>
    <entity charOffset="138-151" id="s868.e1" ontology_id="HP_0001425" text="heterogeneity" type="HP"/>
    <pair e1="s868.e0" e2="s868.e1" id="s868.p0" relation="true"/>
  </sentence>
  <sentence id="s869" text="Heparanase (&lt;i&gt;HPSE&lt;/i&gt;) expression was identified in 50% of GBM tumours by immunostaining, and was characterised by a high intratumoural heterogeneity of the presence of the HPSE protein.">
    <entity charOffset="15-19" id="s869.e0" ontology_id="10855" text="HPSE" type="GENE"/>
    <entity charOffset="65-72" id="s869.e1" ontology_id="HP_0002664" text="tumours" type="HP"/>
    <pair e1="s869.e0" e2="s869.e1" id="s869.p0" relation="true"/>
  </sentence>
  <sentence id="s870" text="RT-PCR analysis showed that the overall transcriptional activity of the main HS biosynthesis-involved genes (&lt;i&gt;EXT1&lt;/i&gt;, &lt;i&gt;EXT2&lt;/i&gt;, &lt;i&gt;NDST1&lt;/i&gt;, &lt;i&gt;NDST2&lt;/i&gt;, &lt;i&gt;GLCE&lt;/i&gt;, &lt;i&gt;HS2ST1&lt;/i&gt;, &lt;i&gt;HS3ST1&lt;/i&gt;, &lt;i&gt;HS3ST2&lt;/i&gt;, &lt;i&gt;HS6ST1&lt;/i&gt;, &lt;i&gt;HS6ST2&lt;/i&gt;, &lt;i&gt;SULF1&lt;/i&gt;, &lt;i&gt;SULF2&lt;/i&gt;, &lt;i&gt;HPSE&lt;/i&gt;) was decreased by 1.5-2-fold in Grade II-III glioma (&lt;i&gt;p&lt;/i&gt; &amp;lt; 0.01) and by 3-fold in Grade IV glioma (glioblastoma multiforme, GBM) (&lt;i&gt;p&lt;/i&gt; &amp;lt; 0.05), as compared with the para-tumourous tissue.">
    <entity charOffset="282-286" id="s870.e0" ontology_id="10855" text="HPSE" type="GENE"/>
    <entity charOffset="336-342" id="s870.e1" ontology_id="HP_0009733" text="glioma" type="HP"/>
    <pair e1="s870.e0" e2="s870.e1" id="s870.p0" relation="true"/>
  </sentence>
  <sentence id="s871" text="Mutations in the KARS gene, which encodes both the cytosolic and mitochondrial isoform of lysyl-tRNA synthetase, cause predominantly neurological diseases that often involve deafness, but have also been linked to cardiomyopathy, developmental delay, and lactic acidosis.">
    <entity charOffset="17-21" id="s871.e0" ontology_id="3735" text="KARS" type="GENE"/>
    <entity charOffset="213-227" id="s871.e1" ontology_id="HP_0001638" text="cardiomyopathy" type="HP"/>
    <pair e1="s871.e0" e2="s871.e1" id="s871.p0" relation="true"/>
  </sentence>
  <sentence id="s872" text="We identified a high frequency of mutations in PTEN (50%) and genes involved in the endometrial cancer-related molecular pathway, which involves the IL-7 signaling pathway (PIK3R1, n=1; AKT2, n=1; FOXO1, n=1).">
    <entity charOffset="47-51" id="s872.e0" ontology_id="5728" text="PTEN" type="GENE"/>
    <entity charOffset="96-102" id="s872.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s872.e0" e2="s872.e1" id="s872.p0" relation="false"/>
  </sentence>
  <sentence id="s873" text="We identified a high frequency of mutations in PTEN (50%) and genes involved in the endometrial cancer-related molecular pathway, which involves the IL-7 signaling pathway (PIK3R1, n=1; AKT2, n=1; FOXO1, n=1).">
    <entity charOffset="96-102" id="s873.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="197-202" id="s873.e1" ontology_id="2308" text="FOXO1" type="GENE"/>
    <pair e1="s873.e0" e2="s873.e1" id="s873.p0" relation="true"/>
  </sentence>
  <sentence id="s874" text="We identified a high frequency of mutations in PTEN (50%) and genes involved in the endometrial cancer-related molecular pathway, which involves the IL-7 signaling pathway (PIK3R1, n=1; AKT2, n=1; FOXO1, n=1).">
    <entity charOffset="96-102" id="s874.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="173-179" id="s874.e1" ontology_id="5295" text="PIK3R1" type="GENE"/>
    <pair e1="s874.e0" e2="s874.e1" id="s874.p0" relation="true"/>
  </sentence>
  <sentence id="s875" text="We identified a high frequency of mutations in PTEN (50%) and genes involved in the endometrial cancer-related molecular pathway, which involves the IL-7 signaling pathway (PIK3R1, n=1; AKT2, n=1; FOXO1, n=1).">
    <entity charOffset="96-102" id="s875.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="186-190" id="s875.e1" ontology_id="208" text="AKT2" type="GENE"/>
    <pair e1="s875.e0" e2="s875.e1" id="s875.p0" relation="true"/>
  </sentence>
  <sentence id="s876" text="The 21 genes comprised 8 tumor suppressor candidates (ATM, MSH2, PIK3R1, PTCH1, PTEN, TET2, TP53, and TSC1) and 13 oncogene candidates (ALK, BCL9, CTNNB1, ERBB2, FGFR2, FLT3, HNF1A, KIT, MTOR, PDGFRA, PPP2R1A, PTPN11, and SF3B1).">
    <entity charOffset="25-30" id="s876.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="169-173" id="s876.e1" ontology_id="2322" text="FLT3" type="GENE"/>
    <pair e1="s876.e0" e2="s876.e1" id="s876.p0" relation="false"/>
  </sentence>
  <sentence id="s877" text="The 21 genes comprised 8 tumor suppressor candidates (ATM, MSH2, PIK3R1, PTCH1, PTEN, TET2, TP53, and TSC1) and 13 oncogene candidates (ALK, BCL9, CTNNB1, ERBB2, FGFR2, FLT3, HNF1A, KIT, MTOR, PDGFRA, PPP2R1A, PTPN11, and SF3B1).">
    <entity charOffset="25-30" id="s877.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="201-208" id="s877.e1" ontology_id="5518" text="PPP2R1A" type="GENE"/>
    <pair e1="s877.e0" e2="s877.e1" id="s877.p0" relation="false"/>
  </sentence>
  <sentence id="s878" text="The 21 genes comprised 8 tumor suppressor candidates (ATM, MSH2, PIK3R1, PTCH1, PTEN, TET2, TP53, and TSC1) and 13 oncogene candidates (ALK, BCL9, CTNNB1, ERBB2, FGFR2, FLT3, HNF1A, KIT, MTOR, PDGFRA, PPP2R1A, PTPN11, and SF3B1).">
    <entity charOffset="25-30" id="s878.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="102-106" id="s878.e1" ontology_id="7248" text="TSC1" type="GENE"/>
    <pair e1="s878.e0" e2="s878.e1" id="s878.p0" relation="true"/>
  </sentence>
  <sentence id="s879" text="The 21 genes comprised 8 tumor suppressor candidates (ATM, MSH2, PIK3R1, PTCH1, PTEN, TET2, TP53, and TSC1) and 13 oncogene candidates (ALK, BCL9, CTNNB1, ERBB2, FGFR2, FLT3, HNF1A, KIT, MTOR, PDGFRA, PPP2R1A, PTPN11, and SF3B1).">
    <entity charOffset="25-30" id="s879.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="141-145" id="s879.e1" ontology_id="607" text="BCL9" type="GENE"/>
    <pair e1="s879.e0" e2="s879.e1" id="s879.p0" relation="false"/>
  </sentence>
  <sentence id="s880" text="The 21 genes comprised 8 tumor suppressor candidates (ATM, MSH2, PIK3R1, PTCH1, PTEN, TET2, TP53, and TSC1) and 13 oncogene candidates (ALK, BCL9, CTNNB1, ERBB2, FGFR2, FLT3, HNF1A, KIT, MTOR, PDGFRA, PPP2R1A, PTPN11, and SF3B1).">
    <entity charOffset="25-30" id="s880.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="59-63" id="s880.e1" ontology_id="4436" text="MSH2" type="GENE"/>
    <pair e1="s880.e0" e2="s880.e1" id="s880.p0" relation="true"/>
  </sentence>
  <sentence id="s881" text="The 21 genes comprised 8 tumor suppressor candidates (ATM, MSH2, PIK3R1, PTCH1, PTEN, TET2, TP53, and TSC1) and 13 oncogene candidates (ALK, BCL9, CTNNB1, ERBB2, FGFR2, FLT3, HNF1A, KIT, MTOR, PDGFRA, PPP2R1A, PTPN11, and SF3B1).">
    <entity charOffset="25-30" id="s881.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="162-167" id="s881.e1" ontology_id="2263" text="FGFR2" type="GENE"/>
    <pair e1="s881.e0" e2="s881.e1" id="s881.p0" relation="false"/>
  </sentence>
  <sentence id="s882" text="The 21 genes comprised 8 tumor suppressor candidates (ATM, MSH2, PIK3R1, PTCH1, PTEN, TET2, TP53, and TSC1) and 13 oncogene candidates (ALK, BCL9, CTNNB1, ERBB2, FGFR2, FLT3, HNF1A, KIT, MTOR, PDGFRA, PPP2R1A, PTPN11, and SF3B1).">
    <entity charOffset="25-30" id="s882.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="175-180" id="s882.e1" ontology_id="6927" text="HNF1A" type="GENE"/>
    <pair e1="s882.e0" e2="s882.e1" id="s882.p0" relation="false"/>
  </sentence>
  <sentence id="s883" text="The 21 genes comprised 8 tumor suppressor candidates (ATM, MSH2, PIK3R1, PTCH1, PTEN, TET2, TP53, and TSC1) and 13 oncogene candidates (ALK, BCL9, CTNNB1, ERBB2, FGFR2, FLT3, HNF1A, KIT, MTOR, PDGFRA, PPP2R1A, PTPN11, and SF3B1).">
    <entity charOffset="25-30" id="s883.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="136-139" id="s883.e1" ontology_id="238" text="ALK" type="GENE"/>
    <pair e1="s883.e0" e2="s883.e1" id="s883.p0" relation="false"/>
  </sentence>
  <sentence id="s884" text="The 21 genes comprised 8 tumor suppressor candidates (ATM, MSH2, PIK3R1, PTCH1, PTEN, TET2, TP53, and TSC1) and 13 oncogene candidates (ALK, BCL9, CTNNB1, ERBB2, FGFR2, FLT3, HNF1A, KIT, MTOR, PDGFRA, PPP2R1A, PTPN11, and SF3B1).">
    <entity charOffset="25-30" id="s884.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="182-185" id="s884.e1" ontology_id="3815" text="KIT" type="GENE"/>
    <pair e1="s884.e0" e2="s884.e1" id="s884.p0" relation="false"/>
  </sentence>
  <sentence id="s885" text="To dissect the genetic architecture of sporadic ALS, we undertook a large sequencing study in 755 apparently sporadic ALS cases and 959 controls, analyzing 10 ALS genes: SOD1, C9orf72, TARDBP, FUS, ANG, CHMP2B, ATXN2, NIPA1, SMN1, and UNC13A.">
    <entity charOffset="39-47" id="s885.e0" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <entity charOffset="198-201" id="s885.e1" ontology_id="283" text="ANG" type="GENE"/>
    <pair e1="s885.e0" e2="s885.e1" id="s885.p0" relation="true"/>
  </sentence>
  <sentence id="s886" text="To dissect the genetic architecture of sporadic ALS, we undertook a large sequencing study in 755 apparently sporadic ALS cases and 959 controls, analyzing 10 ALS genes: SOD1, C9orf72, TARDBP, FUS, ANG, CHMP2B, ATXN2, NIPA1, SMN1, and UNC13A.">
    <entity charOffset="39-47" id="s886.e0" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <entity charOffset="176-183" id="s886.e1" ontology_id="203228" text="C9orf72" type="GENE"/>
    <pair e1="s886.e0" e2="s886.e1" id="s886.p0" relation="true"/>
  </sentence>
  <sentence id="s887" text="In this study, we enrolled 16individuals affected by tooth agenesis, prevalently hypodontia, and we carried out direct Sanger sequencing of paired box9(PAX9) and Msh homeobox1(MSX1) genes in 9subjects.">
    <entity charOffset="82-92" id="s887.e0" ontology_id="HP_0000668" text="hypodontia" type="HP"/>
    <entity charOffset="181-185" id="s887.e1" ontology_id="4487" text="MSX1" type="GENE"/>
    <pair e1="s887.e0" e2="s887.e1" id="s887.p0" relation="false"/>
  </sentence>
  <sentence id="s888" text="Deficiency of the extracellular matrix molecule FRAS1, normally expressed by the ureteric bud, leads to bilateral renal agenesis in humans with Fraser syndrome and blebbed (Fras1(bl/bl)) mice.">
    <entity charOffset="48-53" id="s888.e0" ontology_id="80144" text="FRAS1" type="GENE"/>
    <entity charOffset="104-113" id="s888.e1" ontology_id="HP_0012832" text="bilateral" type="HP"/>
    <pair e1="s888.e0" e2="s888.e1" id="s888.p0" relation="true"/>
  </sentence>
  <sentence id="s889" text="Deficiency of the extracellular matrix molecule FRAS1, normally expressed by the ureteric bud, leads to bilateral renal agenesis in humans with Fraser syndrome and blebbed (Fras1(bl/bl)) mice.">
    <entity charOffset="114-128" id="s889.e0" ontology_id="HP_0000104" text="renal agenesis" type="HP"/>
    <entity charOffset="173-178" id="s889.e1" ontology_id="80144" text="Fras1" type="GENE"/>
    <pair e1="s889.e0" e2="s889.e1" id="s889.p0" relation="false"/>
  </sentence>
  <sentence id="s890" text="The Nodal co-receptor Cripto is expressed transiently during normal germ cell development and is ectopically expressed in non-seminomas that arise from germ cell neoplasia in situ, suggesting that its aberrant expression may underlie germ cell dysregulation and hence germ cell cancer.">
    <entity charOffset="22-28" id="s890.e0" ontology_id="6997" text="Cripto" type="GENE"/>
    <entity charOffset="162-171" id="s890.e1" ontology_id="HP_0002664" text="neoplasia" type="HP"/>
    <pair e1="s890.e0" e2="s890.e1" id="s890.p0" relation="false"/>
  </sentence>
  <sentence id="s891" text="Finally, the proteasome inhibitor bortezomib is a potent enhancer of global developmental delay in our fly model, evidence of a defective proteasome &amp;quot;bounce-back&amp;quot; response that is also observed in nematode and cellular models of NGLY1 Deficiency.">
    <entity charOffset="76-95" id="s891.e0" ontology_id="HP_0001263" text="developmental delay" type="HP"/>
    <entity charOffset="239-244" id="s891.e1" ontology_id="55768" text="NGLY1" type="GENE"/>
    <pair e1="s891.e0" e2="s891.e1" id="s891.p0" relation="true"/>
  </sentence>
  <sentence id="s892" text="In this study, we report the identification of the first insertion mutation, p.W102Vfs*7, in the BSND gene of a newborn girl with acute clinical symptoms including early-onset chronic renal failure.">
    <entity charOffset="97-101" id="s892.e0" ontology_id="7809" text="BSND" type="GENE"/>
    <entity charOffset="184-197" id="s892.e1" ontology_id="HP_0000083" text="renal failure" type="HP"/>
    <pair e1="s892.e0" e2="s892.e1" id="s892.p0" relation="true"/>
  </sentence>
  <sentence id="s893" text="In this study, we report the identification of the first insertion mutation, p.W102Vfs*7, in the BSND gene of a newborn girl with acute clinical symptoms including early-onset chronic renal failure.">
    <entity charOffset="97-101" id="s893.e0" ontology_id="7809" text="BSND" type="GENE"/>
    <entity charOffset="176-183" id="s893.e1" ontology_id="HP_0011010" text="chronic" type="HP"/>
    <pair e1="s893.e0" e2="s893.e1" id="s893.p0" relation="true"/>
  </sentence>
  <sentence id="s894" text="CHK1, both at the mRNA and protein level, is highly expressed in medulloblastoma and elevated CHK1 expression in Group3 medulloblastoma is an adverse prognostic marker.">
    <entity charOffset="0-4" id="s894.e0" ontology_id="1111" text="CHK1" type="GENE"/>
    <entity charOffset="65-80" id="s894.e1" ontology_id="HP_0002885" text="medulloblastoma" type="HP"/>
    <pair e1="s894.e0" e2="s894.e1" id="s894.p0" relation="true"/>
  </sentence>
  <sentence id="s895" text="Methylation of RARB, CD44, PAX5A, GSTP1, IGSF4 (CADM1), PYCARD, CDH13, TP53, and GATA5 classified pTa versus pT1 tumors whereas RARB, CD44, GSTP1, IGSF4, CHFR, PYCARD, TP53, STK11, and GATA5 distinguished LG versus HG tumors.">
    <entity charOffset="15-19" id="s895.e0" ontology_id="5915" text="RARB" type="GENE"/>
    <entity charOffset="113-118" id="s895.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s895.e0" e2="s895.e1" id="s895.p0" relation="true"/>
  </sentence>
  <sentence id="s896" text="Methylation of RARB, CD44, PAX5A, GSTP1, IGSF4 (CADM1), PYCARD, CDH13, TP53, and GATA5 classified pTa versus pT1 tumors whereas RARB, CD44, GSTP1, IGSF4, CHFR, PYCARD, TP53, STK11, and GATA5 distinguished LG versus HG tumors.">
    <entity charOffset="34-39" id="s896.e0" ontology_id="2950" text="GSTP1" type="GENE"/>
    <entity charOffset="113-118" id="s896.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s896.e0" e2="s896.e1" id="s896.p0" relation="true"/>
  </sentence>
  <sentence id="s897" text="Methylation of RARB, CD44, PAX5A, GSTP1, IGSF4 (CADM1), PYCARD, CDH13, TP53, and GATA5 classified pTa versus pT1 tumors whereas RARB, CD44, GSTP1, IGSF4, CHFR, PYCARD, TP53, STK11, and GATA5 distinguished LG versus HG tumors.">
    <entity charOffset="48-53" id="s897.e0" ontology_id="23705" text="CADM1" type="GENE"/>
    <entity charOffset="113-118" id="s897.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s897.e0" e2="s897.e1" id="s897.p0" relation="true"/>
  </sentence>
  <sentence id="s898" text="We evaluated whether methylation of tumor-suppressor genes (TSGs) would classify non-muscle-invasive (NMI) bladder cancer subgroups and predict outcome.">
    <entity charOffset="60-63" id="s898.e0" ontology_id="57045" text="TSG" type="GENE"/>
    <entity charOffset="115-121" id="s898.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s898.e0" e2="s898.e1" id="s898.p0" relation="true"/>
  </sentence>
  <sentence id="s899" text="Herein, we report biallelic pathogenic variants in OTUD6B in 12 individuals from 6 independent families with an intellectual disability syndrome associated with seizures and dysmorphic features.">
    <entity charOffset="51-57" id="s899.e0" ontology_id="51633" text="OTUD6B" type="GENE"/>
    <entity charOffset="161-169" id="s899.e1" ontology_id="HP_0001250" text="seizures" type="HP"/>
    <pair e1="s899.e0" e2="s899.e1" id="s899.p0" relation="true"/>
  </sentence>
  <sentence id="s900" text="Homozygous Otud6b knockout mice were subviable, smaller in size, and had congenital heart defects, consistent with the severity of loss-of-function variants in humans.">
    <entity charOffset="11-17" id="s900.e0" ontology_id="51633" text="Otud6b" type="GENE"/>
    <entity charOffset="73-97" id="s900.e1" ontology_id="HP_0001627" text="congenital heart defects" type="HP"/>
    <pair e1="s900.e0" e2="s900.e1" id="s900.p0" relation="true"/>
  </sentence>
  <sentence id="s901" text="The combination of sensorineural hearing loss and partial agenesis of the corpus callosum is a highly recognizable clinico-radiological entity that should prompt mutational analysis of the GPSM2 gene.">
    <entity charOffset="58-89" id="s901.e0" ontology_id="HP_0001274" text="agenesis of the corpus callosum" type="HP"/>
    <entity charOffset="189-194" id="s901.e1" ontology_id="29899" text="GPSM2" type="GENE"/>
    <pair e1="s901.e0" e2="s901.e1" id="s901.p0" relation="true"/>
  </sentence>
  <sentence id="s902" text="Here, we report the potential clinical implication and biological functions of RIPK4 in cervical squamous cell carcinoma (CSCC).">
    <entity charOffset="79-84" id="s902.e0" ontology_id="54101" text="RIPK4" type="GENE"/>
    <entity charOffset="97-120" id="s902.e1" ontology_id="HP_0002860" text="squamous cell carcinoma" type="HP"/>
    <pair e1="s902.e0" e2="s902.e1" id="s902.p0" relation="true"/>
  </sentence>
  <sentence id="s903" text="Knockdown of RIPK4 reduced cell migration and invasion via inhibition of Vimentin, MMP2 and Fibronectin expression in cervical cancer cells.">
    <entity charOffset="83-87" id="s903.e0" ontology_id="4313" text="MMP2" type="GENE"/>
    <entity charOffset="127-133" id="s903.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s903.e0" e2="s903.e1" id="s903.p0" relation="true"/>
  </sentence>
  <sentence id="s904" text="Here, we identify tumor-associated calcium signal transducer 2 (TACSTD2), one of the most downregulated genes in primary HCC tissue, as a host factor that interacts with CLDN1 and OCLN and regulates their cellular localization.">
    <entity charOffset="18-23" id="s904.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="170-175" id="s904.e1" ontology_id="9076" text="CLDN1" type="GENE"/>
    <pair e1="s904.e0" e2="s904.e1" id="s904.p0" relation="false"/>
  </sentence>
  <sentence id="s905" text="Here, we identify tumor-associated calcium signal transducer 2 (TACSTD2), one of the most downregulated genes in primary HCC tissue, as a host factor that interacts with CLDN1 and OCLN and regulates their cellular localization.">
    <entity charOffset="18-23" id="s905.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="64-71" id="s905.e1" ontology_id="4070" text="TACSTD2" type="GENE"/>
    <pair e1="s905.e0" e2="s905.e1" id="s905.p0" relation="true"/>
  </sentence>
  <sentence id="s906" text="Patients with the combination of dystonia and ataxia and a family history of a neurodegenerative disorder should be tested for SCA31.">
    <entity charOffset="46-52" id="s906.e0" ontology_id="HP_0001251" text="ataxia" type="HP"/>
    <entity charOffset="127-132" id="s906.e1" ontology_id="146227" text="SCA31" type="GENE"/>
    <pair e1="s906.e0" e2="s906.e1" id="s906.p0" relation="true"/>
  </sentence>
  <sentence id="s907" text="Previously there have been no reports of SCA31 associated with dystonia.">
    <entity charOffset="41-46" id="s907.e0" ontology_id="146227" text="SCA31" type="GENE"/>
    <entity charOffset="63-71" id="s907.e1" ontology_id="HP_0001332" text="dystonia" type="HP"/>
    <pair e1="s907.e0" e2="s907.e1" id="s907.p0" relation="true"/>
  </sentence>
  <sentence id="s908" text="We report on the case of a 77-year-old male with genetically proven spinocerebellar ataxia type 31 (SCA31) who had dystonia.">
    <entity charOffset="100-105" id="s908.e0" ontology_id="146227" text="SCA31" type="GENE"/>
    <entity charOffset="115-123" id="s908.e1" ontology_id="HP_0001332" text="dystonia" type="HP"/>
    <pair e1="s908.e0" e2="s908.e1" id="s908.p0" relation="true"/>
  </sentence>
  <sentence id="s909" text="Mutations in CHCHD2 and CHCHD10 were recently reported in a broad spectrum of neurodegenerative diseases, for example, Parkinson's disease, amyotrophic lateral sclerosis, frontotemporal dementia, or mitochondrial myopathy (MM).">
    <entity charOffset="24-31" id="s909.e0" ontology_id="400916" text="CHCHD10" type="GENE"/>
    <entity charOffset="78-104" id="s909.e1" ontology_id="HP_0002180" text="neurodegenerative diseases" type="HP"/>
    <pair e1="s909.e0" e2="s909.e1" id="s909.p0" relation="true"/>
  </sentence>
  <sentence id="s910" text="Focal alterations affected CDKN2A, CCND1, CCNE1, EGFR, EPHA3, EPHB1, FGFR1, JUN, NF1, RB1, RET, TP53, and additional novel amplifications in CCNE1, KIT, EGFR, RET, BRAF, NTRK2 were seen in G3 compared with the G1 tumor areas.">
    <entity charOffset="42-47" id="s910.e0" ontology_id="898" text="CCNE1" type="GENE"/>
    <entity charOffset="213-218" id="s910.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s910.e0" e2="s910.e1" id="s910.p0" relation="true"/>
  </sentence>
  <sentence id="s911" text="Focal alterations affected CDKN2A, CCND1, CCNE1, EGFR, EPHA3, EPHB1, FGFR1, JUN, NF1, RB1, RET, TP53, and additional novel amplifications in CCNE1, KIT, EGFR, RET, BRAF, NTRK2 were seen in G3 compared with the G1 tumor areas.">
    <entity charOffset="55-60" id="s911.e0" ontology_id="2042" text="EPHA3" type="GENE"/>
    <entity charOffset="213-218" id="s911.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s911.e0" e2="s911.e1" id="s911.p0" relation="true"/>
  </sentence>
  <sentence id="s912" text="Focal alterations affected CDKN2A, CCND1, CCNE1, EGFR, EPHA3, EPHB1, FGFR1, JUN, NF1, RB1, RET, TP53, and additional novel amplifications in CCNE1, KIT, EGFR, RET, BRAF, NTRK2 were seen in G3 compared with the G1 tumor areas.">
    <entity charOffset="69-74" id="s912.e0" ontology_id="2260" text="FGFR1" type="GENE"/>
    <entity charOffset="213-218" id="s912.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s912.e0" e2="s912.e1" id="s912.p0" relation="true"/>
  </sentence>
  <sentence id="s913" text="Focal alterations affected CDKN2A, CCND1, CCNE1, EGFR, EPHA3, EPHB1, FGFR1, JUN, NF1, RB1, RET, TP53, and additional novel amplifications in CCNE1, KIT, EGFR, RET, BRAF, NTRK2 were seen in G3 compared with the G1 tumor areas.">
    <entity charOffset="164-168" id="s913.e0" ontology_id="673" text="BRAF" type="GENE"/>
    <entity charOffset="213-218" id="s913.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s913.e0" e2="s913.e1" id="s913.p0" relation="true"/>
  </sentence>
  <sentence id="s914" text="Focal alterations affected CDKN2A, CCND1, CCNE1, EGFR, EPHA3, EPHB1, FGFR1, JUN, NF1, RB1, RET, TP53, and additional novel amplifications in CCNE1, KIT, EGFR, RET, BRAF, NTRK2 were seen in G3 compared with the G1 tumor areas.">
    <entity charOffset="170-175" id="s914.e0" ontology_id="4915" text="NTRK2" type="GENE"/>
    <entity charOffset="213-218" id="s914.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s914.e0" e2="s914.e1" id="s914.p0" relation="true"/>
  </sentence>
  <sentence id="s915" text="The aCGH analysis revealed a pathogenic CNV in the 14q11.2 region, while targeted exome sequencing revealed pathogenic variants in genes associated with intellectual disability (HUWE1, GRIN1), including a gene coding for mandibulofacial dysostosis with microcephaly (EFTUD2).">
    <entity charOffset="185-190" id="s915.e0" ontology_id="114787" text="GRIN1" type="GENE"/>
    <entity charOffset="221-247" id="s915.e1" ontology_id="HP_0005321" text="mandibulofacial dysostosis" type="HP"/>
    <pair e1="s915.e0" e2="s915.e1" id="s915.p0" relation="false"/>
  </sentence>
  <sentence id="s916" text="The aCGH analysis revealed a pathogenic CNV in the 14q11.2 region, while targeted exome sequencing revealed pathogenic variants in genes associated with intellectual disability (HUWE1, GRIN1), including a gene coding for mandibulofacial dysostosis with microcephaly (EFTUD2).">
    <entity charOffset="185-190" id="s916.e0" ontology_id="114787" text="GRIN1" type="GENE"/>
    <entity charOffset="253-265" id="s916.e1" ontology_id="HP_0000252" text="microcephaly" type="HP"/>
    <pair e1="s916.e0" e2="s916.e1" id="s916.p0" relation="false"/>
  </sentence>
  <sentence id="s917" text="The aCGH analysis revealed a pathogenic CNV in the 14q11.2 region, while targeted exome sequencing revealed pathogenic variants in genes associated with intellectual disability (HUWE1, GRIN1), including a gene coding for mandibulofacial dysostosis with microcephaly (EFTUD2).">
    <entity charOffset="221-247" id="s917.e0" ontology_id="HP_0005321" text="mandibulofacial dysostosis" type="HP"/>
    <entity charOffset="267-273" id="s917.e1" ontology_id="9343" text="EFTUD2" type="GENE"/>
    <pair e1="s917.e0" e2="s917.e1" id="s917.p0" relation="true"/>
  </sentence>
  <sentence id="s918" text="The aCGH analysis revealed a pathogenic CNV in the 14q11.2 region, while targeted exome sequencing revealed pathogenic variants in genes associated with intellectual disability (HUWE1, GRIN1), including a gene coding for mandibulofacial dysostosis with microcephaly (EFTUD2).">
    <entity charOffset="253-265" id="s918.e0" ontology_id="HP_0000252" text="microcephaly" type="HP"/>
    <entity charOffset="267-273" id="s918.e1" ontology_id="9343" text="EFTUD2" type="GENE"/>
    <pair e1="s918.e0" e2="s918.e1" id="s918.p0" relation="true"/>
  </sentence>
  <sentence id="s919" text="Despite the identification of several oncogenic driver mutations leading to constitutive JAK-STAT activation, the cellular and molecular biology of myeloproliferative neoplasms (MPN) remains incompletely understood.">
    <entity charOffset="93-97" id="s919.e0" ontology_id="6646" text="STAT" type="GENE"/>
    <entity charOffset="167-176" id="s919.e1" ontology_id="HP_0002664" text="neoplasms" type="HP"/>
    <pair e1="s919.e0" e2="s919.e1" id="s919.p0" relation="false"/>
  </sentence>
  <sentence id="s920" text="Mutations of the CYP21A2 gene encoding adrenal 21-hydroxylase cause congenital adrenal hyperplasia (CAH).">
    <entity charOffset="17-24" id="s920.e0" ontology_id="1589" text="CYP21A2" type="GENE"/>
    <entity charOffset="79-98" id="s920.e1" ontology_id="HP_0008221" text="adrenal hyperplasia" type="HP"/>
    <pair e1="s920.e0" e2="s920.e1" id="s920.p0" relation="true"/>
  </sentence>
  <sentence id="s921" text="Mutations affecting both alleles of TNXB cause a severe, autosomal recessive form of Ehlers-Danlos syndrome (EDS).">
    <entity charOffset="36-40" id="s921.e0" ontology_id="7148" text="TNXB" type="GENE"/>
    <entity charOffset="57-76" id="s921.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s921.e0" e2="s921.e1" id="s921.p0" relation="true"/>
  </sentence>
  <sentence id="s922" text="In humans, &lt;i&gt;NF2&lt;/i&gt; is the gene responsible for the disease neurofibromatosis type II, which results in the development of brain tumors, including acoustic neurinoma and meningioma.">
    <entity charOffset="14-17" id="s922.e0" ontology_id="4771" text="NF2" type="GENE"/>
    <entity charOffset="62-79" id="s922.e1" ontology_id="HP_0001067" text="neurofibromatosis" type="HP"/>
    <pair e1="s922.e0" e2="s922.e1" id="s922.p0" relation="true"/>
  </sentence>
  <sentence id="s923" text="Meesmann epithelial corneal dystrophy (MECD) is a rare autosomal dominant disorder caused by dominant-negative mutations within the KRT3 or KRT12 genes, which encode the cytoskeletal protein keratins K3 and K12, respectively.">
    <entity charOffset="20-37" id="s923.e0" ontology_id="HP_0001131" text="corneal dystrophy" type="HP"/>
    <entity charOffset="132-136" id="s923.e1" ontology_id="3850" text="KRT3" type="GENE"/>
    <pair e1="s923.e0" e2="s923.e1" id="s923.p0" relation="true"/>
  </sentence>
  <sentence id="s924" text="Using whole-exome sequencing in four probands with undiagnosed skin hyperkeratosis/ichthyosis, we identified compound heterozygosity for mutations in KDSR, encoding an enzyme in the de novo synthesis pathway of ceramides.">
    <entity charOffset="68-82" id="s924.e0" ontology_id="HP_0000962" text="hyperkeratosis" type="HP"/>
    <entity charOffset="150-154" id="s924.e1" ontology_id="2531" text="KDSR" type="GENE"/>
    <pair e1="s924.e0" e2="s924.e1" id="s924.p0" relation="true"/>
  </sentence>
  <sentence id="s925" text="Biallelic mutations in FKBP14 cause a recessive form of Ehlers-Danlos syndrome (EDS) characterized by progressive kyphoscoliosis, myopathy, and hearing loss.">
    <entity charOffset="23-29" id="s925.e0" ontology_id="55033" text="FKBP14" type="GENE"/>
    <entity charOffset="102-113" id="s925.e1" ontology_id="HP_0003676" text="progressive" type="HP"/>
    <pair e1="s925.e0" e2="s925.e1" id="s925.p0" relation="true"/>
  </sentence>
  <sentence id="s926" text="Importantly, depletion of CDCA7 strongly reduced the tumorigenicity and distant colonization capacities of TNBC cells in vivo.">
    <entity charOffset="26-31" id="s926.e0" ontology_id="83879" text="CDCA7" type="GENE"/>
    <entity charOffset="53-58" id="s926.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s926.e0" e2="s926.e1" id="s926.p0" relation="true"/>
  </sentence>
  <sentence id="s927" text="Furthermore, CDCA7 increased the expression of EZH2, a marker of aggressive breast cancer that is involved in tumor progression, by enhancing the transcriptional activity of its promoter.">
    <entity charOffset="47-51" id="s927.e0" ontology_id="2146" text="EZH2" type="GENE"/>
    <entity charOffset="110-115" id="s927.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s927.e0" e2="s927.e1" id="s927.p0" relation="true"/>
  </sentence>
  <sentence id="s928" text="Signicant associations between Raf1 expression and invasion and metastasis capability in lung cancer A549 and H1299 cell lines were identied.">
    <entity charOffset="32-36" id="s928.e0" ontology_id="5894" text="Raf1" type="GENE"/>
    <entity charOffset="95-101" id="s928.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s928.e0" e2="s928.e1" id="s928.p0" relation="true"/>
  </sentence>
  <sentence id="s929" text="However, few studies are available on the expression and clinical significance of Raf1 in nonsmall cell lung cancer (NSCLC).">
    <entity charOffset="82-86" id="s929.e0" ontology_id="5894" text="Raf1" type="GENE"/>
    <entity charOffset="110-116" id="s929.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s929.e0" e2="s929.e1" id="s929.p0" relation="true"/>
  </sentence>
  <sentence id="s930" text="Conclusions: The current meta-analysis shows the associations between five SNPs of PALB2 and breast cancer risk">
    <entity charOffset="83-88" id="s930.e0" ontology_id="79728" text="PALB2" type="GENE"/>
    <entity charOffset="100-106" id="s930.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s930.e0" e2="s930.e1" id="s930.p0" relation="true"/>
  </sentence>
  <sentence id="s931" text="the Partner and localizer of BRCA2 (PALB2) gene and risk of breast cancer.">
    <entity charOffset="29-34" id="s931.e0" ontology_id="675" text="BRCA2" type="GENE"/>
    <entity charOffset="67-73" id="s931.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s931.e0" e2="s931.e1" id="s931.p0" relation="true"/>
  </sentence>
  <sentence id="s932" text="Clinical features of affected individuals with LGD variants in NAA15 include variable levels of intellectual disability, delayed speech and motor milestones, and autism spectrum disorder.">
    <entity charOffset="63-68" id="s932.e0" ontology_id="80155" text="NAA15" type="GENE"/>
    <entity charOffset="96-119" id="s932.e1" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <pair e1="s932.e0" e2="s932.e1" id="s932.p0" relation="true"/>
  </sentence>
  <sentence id="s933" text="Twenty-one genes showed single or cross-cancer associations, including novel associations of SDHA in melanoma and PALB2 in stomach adenocarcinoma.">
    <entity charOffset="93-97" id="s933.e0" ontology_id="6389" text="SDHA" type="GENE"/>
    <entity charOffset="101-109" id="s933.e1" ontology_id="HP_0002861" text="melanoma" type="HP"/>
    <pair e1="s933.e0" e2="s933.e1" id="s933.p0" relation="true"/>
  </sentence>
  <sentence id="s934" text="Truncating mutations in the last and penultimate exons of the PPM1D gene were recently described as a cause for mild to severe intellectual disability in fourteen patients.">
    <entity charOffset="62-67" id="s934.e0" ontology_id="8493" text="PPM1D" type="GENE"/>
    <entity charOffset="127-150" id="s934.e1" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <pair e1="s934.e0" e2="s934.e1" id="s934.p0" relation="true"/>
  </sentence>
  <sentence id="s935" text="Considering that CRYBA4 associates with CRYBB2 and that the latter protein has been implicated in microphthalmia, mutational analysis of CRYBA4 was performed in 32 patients affected with microphthalmia (small eye).">
    <entity charOffset="17-23" id="s935.e0" ontology_id="1413" text="CRYBA4" type="GENE"/>
    <entity charOffset="98-112" id="s935.e1" ontology_id="HP_0000568" text="microphthalmia" type="HP"/>
    <pair e1="s935.e0" e2="s935.e1" id="s935.p0" relation="true"/>
  </sentence>
  <sentence id="s936" text="To date, CRYBA4 was the only gene in this cluster not associated with either human or murine cataracts.">
    <entity charOffset="9-15" id="s936.e0" ontology_id="1413" text="CRYBA4" type="GENE"/>
    <entity charOffset="93-101" id="s936.e1" ontology_id="HP_0000518" text="cataract" type="HP"/>
    <pair e1="s936.e0" e2="s936.e1" id="s936.p0" relation="true"/>
  </sentence>
  <sentence id="s937" text="HNF1A variants can cause diabetes and might be involved in the development of primary liver neoplasm.">
    <entity charOffset="0-5" id="s937.e0" ontology_id="6927" text="HNF1A" type="GENE"/>
    <entity charOffset="92-100" id="s937.e1" ontology_id="HP_0002664" text="neoplasm" type="HP"/>
    <pair e1="s937.e0" e2="s937.e1" id="s937.p0" relation="true"/>
  </sentence>
  <sentence id="s938" text="Blocking the expression of PAK1, DIAPH2, and RDX significantly inhibits breast cancer cell migration induced by let-7b repression.">
    <entity charOffset="45-48" id="s938.e0" ontology_id="5962" text="RDX" type="GENE"/>
    <entity charOffset="79-85" id="s938.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s938.e0" e2="s938.e1" id="s938.p0" relation="true"/>
  </sentence>
  <sentence id="s939" text="The aim of the study was to understand the role of SLIT2-ROBO1/2-CDC42 signalling pathways in development of breast cancer (BC).">
    <entity charOffset="65-70" id="s939.e0" ontology_id="998" text="CDC42" type="GENE"/>
    <entity charOffset="116-122" id="s939.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s939.e0" e2="s939.e1" id="s939.p0" relation="true"/>
  </sentence>
  <sentence id="s940" text="Our data demonstrate that G211 mutation in the UGT1A1 gene, ABO incompatibility, G6PD deficiency, and the SS genotype of the repeats in the promoter region of the HO-1 gene are risk factors for neonatal hyperbilirubinemia in Fujian, Southeastern China">
    <entity charOffset="60-63" id="s940.e0" ontology_id="28" text="ABO" type="GENE"/>
    <entity charOffset="203-221" id="s940.e1" ontology_id="HP_0002904" text="hyperbilirubinemia" type="HP"/>
    <pair e1="s940.e0" e2="s940.e1" id="s940.p0" relation="true"/>
  </sentence>
  <sentence id="s941" text="The strongly positive rate of LETM1 in TNBC was 69.2% (74/107), which was significantly higher than in both DCIS 35.7% (15/42) and adjacent non-tumor tissues 12.3% (8/65).">
    <entity charOffset="30-35" id="s941.e0" ontology_id="3954" text="LETM1" type="GENE"/>
    <entity charOffset="144-149" id="s941.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s941.e0" e2="s941.e1" id="s941.p0" relation="true"/>
  </sentence>
  <sentence id="s942" text="In humans and mice ALX4 mutations or loss of function result in a number of skeletal and organ malformations, including polydactyly, tibial hemimelia, omphalocele, biparietal foramina, impaired mammary epithelial morphogenesis, alopecia, coronal craniosynostosis, hypertelorism, depressed nasal bridge and ridge, bifid nasal tip, hypogonadism, and body agenesis.">
    <entity charOffset="19-23" id="s942.e0" ontology_id="60529" text="ALX4" type="GENE"/>
    <entity charOffset="330-342" id="s942.e1" ontology_id="HP_0000135" text="hypogonadism" type="HP"/>
    <pair e1="s942.e0" e2="s942.e1" id="s942.p0" relation="true"/>
  </sentence>
  <sentence id="s943" text="By using exome and capillary sequencing, we here identify biallelic UBE3B mutations in four patients from three unrelated families presenting an autosomal-recessive blepharophimosis-ptosis-intellectual-disability syndrome characterized by developmental delay, growth retardation with a small head circumference, facial dysmorphisms, and low cholesterol levels.">
    <entity charOffset="68-73" id="s943.e0" ontology_id="89910" text="UBE3B" type="GENE"/>
    <entity charOffset="165-181" id="s943.e1" ontology_id="HP_0000581" text="blepharophimosis" type="HP"/>
    <pair e1="s943.e0" e2="s943.e1" id="s943.p0" relation="true"/>
  </sentence>
  <sentence id="s944" text="By using exome and capillary sequencing, we here identify biallelic UBE3B mutations in four patients from three unrelated families presenting an autosomal-recessive blepharophimosis-ptosis-intellectual-disability syndrome characterized by developmental delay, growth retardation with a small head circumference, facial dysmorphisms, and low cholesterol levels.">
    <entity charOffset="68-73" id="s944.e0" ontology_id="89910" text="UBE3B" type="GENE"/>
    <entity charOffset="239-258" id="s944.e1" ontology_id="HP_0001263" text="developmental delay" type="HP"/>
    <pair e1="s944.e0" e2="s944.e1" id="s944.p0" relation="true"/>
  </sentence>
  <sentence id="s945" text="Induction of p53 by 5-Aza-dC was tested in vitro using cancer cells.">
    <entity charOffset="13-16" id="s945.e0" ontology_id="7157" text="p53" type="GENE"/>
    <entity charOffset="55-61" id="s945.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s945.e0" e2="s945.e1" id="s945.p0" relation="true"/>
  </sentence>
  <sentence id="s946" text="Fragile X syndrome (FXS), caused by the loss of functional FMRP, is a leading cause of autism.">
    <entity charOffset="59-63" id="s946.e0" ontology_id="2332" text="FMRP" type="GENE"/>
    <entity charOffset="87-93" id="s946.e1" ontology_id="HP_0000717" text="autism" type="HP"/>
    <pair e1="s946.e0" e2="s946.e1" id="s946.p0" relation="true"/>
  </sentence>
  <sentence id="s947" text="Genetic reduction of Adcy1 also ameliorates autism-related symptoms including repetitive behaviour, defective social interaction and audiogenic seizures.">
    <entity charOffset="21-26" id="s947.e0" ontology_id="107" text="Adcy1" type="GENE"/>
    <entity charOffset="144-152" id="s947.e1" ontology_id="HP_0001250" text="seizures" type="HP"/>
    <pair e1="s947.e0" e2="s947.e1" id="s947.p0" relation="true"/>
  </sentence>
  <sentence id="s948" text="The autosomal recessive forms (LGMD2) are: LGMD2A (calpain 3), LGMD2B (dysferlin), LGMD2C ( sarcoglycan), LGMD2D ( sarcoglycan), LGMD2E ( sarcoglycan), LGMD2F ( sarcoglycan), LGMD2G (telethonin), LGMD2H (TRIM32), LGMD2I (FKRP), LGMD2J (titin), LGMD2K (POMT1), LGMD2L (anoctamin 5), LGMD2M (fukutin), LGMD2N (POMT2), LGMD2O (POMTnG1), LGMD2P (dystroglycan), LGMD2Q (plectin), LGMD2R (desmin), LGMD2S (TRAPPC11), LGMD2T (GMPPB), LGMD2U (ISPD), LGMD2V (Glucosidase, alpha ), LGMD2W (PINCH2)">
    <entity charOffset="4-23" id="s948.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="187-197" id="s948.e1" ontology_id="8557" text="telethonin" type="GENE"/>
    <pair e1="s948.e0" e2="s948.e1" id="s948.p0" relation="true"/>
  </sentence>
  <sentence id="s949" text="The autosomal recessive forms (LGMD2) are: LGMD2A (calpain 3), LGMD2B (dysferlin), LGMD2C ( sarcoglycan), LGMD2D ( sarcoglycan), LGMD2E ( sarcoglycan), LGMD2F ( sarcoglycan), LGMD2G (telethonin), LGMD2H (TRIM32), LGMD2I (FKRP), LGMD2J (titin), LGMD2K (POMT1), LGMD2L (anoctamin 5), LGMD2M (fukutin), LGMD2N (POMT2), LGMD2O (POMTnG1), LGMD2P (dystroglycan), LGMD2Q (plectin), LGMD2R (desmin), LGMD2S (TRAPPC11), LGMD2T (GMPPB), LGMD2U (ISPD), LGMD2V (Glucosidase, alpha ), LGMD2W (PINCH2)">
    <entity charOffset="4-23" id="s949.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="423-428" id="s949.e1" ontology_id="29925" text="GMPPB" type="GENE"/>
    <pair e1="s949.e0" e2="s949.e1" id="s949.p0" relation="true"/>
  </sentence>
  <sentence id="s950" text="The autosomal recessive forms (LGMD2) are: LGMD2A (calpain 3), LGMD2B (dysferlin), LGMD2C ( sarcoglycan), LGMD2D ( sarcoglycan), LGMD2E ( sarcoglycan), LGMD2F ( sarcoglycan), LGMD2G (telethonin), LGMD2H (TRIM32), LGMD2I (FKRP), LGMD2J (titin), LGMD2K (POMT1), LGMD2L (anoctamin 5), LGMD2M (fukutin), LGMD2N (POMT2), LGMD2O (POMTnG1), LGMD2P (dystroglycan), LGMD2Q (plectin), LGMD2R (desmin), LGMD2S (TRAPPC11), LGMD2T (GMPPB), LGMD2U (ISPD), LGMD2V (Glucosidase, alpha ), LGMD2W (PINCH2)">
    <entity charOffset="4-23" id="s950.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="404-412" id="s950.e1" ontology_id="60684" text="TRAPPC11" type="GENE"/>
    <pair e1="s950.e0" e2="s950.e1" id="s950.p0" relation="true"/>
  </sentence>
  <sentence id="s951" text="The autosomal recessive forms (LGMD2) are: LGMD2A (calpain 3), LGMD2B (dysferlin), LGMD2C ( sarcoglycan), LGMD2D ( sarcoglycan), LGMD2E ( sarcoglycan), LGMD2F ( sarcoglycan), LGMD2G (telethonin), LGMD2H (TRIM32), LGMD2I (FKRP), LGMD2J (titin), LGMD2K (POMT1), LGMD2L (anoctamin 5), LGMD2M (fukutin), LGMD2N (POMT2), LGMD2O (POMTnG1), LGMD2P (dystroglycan), LGMD2Q (plectin), LGMD2R (desmin), LGMD2S (TRAPPC11), LGMD2T (GMPPB), LGMD2U (ISPD), LGMD2V (Glucosidase, alpha ), LGMD2W (PINCH2)">
    <entity charOffset="4-23" id="s951.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="225-229" id="s951.e1" ontology_id="79147" text="FKRP" type="GENE"/>
    <pair e1="s951.e0" e2="s951.e1" id="s951.p0" relation="true"/>
  </sentence>
  <sentence id="s952" text="The autosomal recessive forms (LGMD2) are: LGMD2A (calpain 3), LGMD2B (dysferlin), LGMD2C ( sarcoglycan), LGMD2D ( sarcoglycan), LGMD2E ( sarcoglycan), LGMD2F ( sarcoglycan), LGMD2G (telethonin), LGMD2H (TRIM32), LGMD2I (FKRP), LGMD2J (titin), LGMD2K (POMT1), LGMD2L (anoctamin 5), LGMD2M (fukutin), LGMD2N (POMT2), LGMD2O (POMTnG1), LGMD2P (dystroglycan), LGMD2Q (plectin), LGMD2R (desmin), LGMD2S (TRAPPC11), LGMD2T (GMPPB), LGMD2U (ISPD), LGMD2V (Glucosidase, alpha ), LGMD2W (PINCH2)">
    <entity charOffset="4-23" id="s952.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="439-443" id="s952.e1" ontology_id="729920" text="ISPD" type="GENE"/>
    <pair e1="s952.e0" e2="s952.e1" id="s952.p0" relation="true"/>
  </sentence>
  <sentence id="s953" text="In vitro test on colon cancer resistant/susceptible to chemoradioterapy cells, finally prove that XRCC3 deregulation is extensively involved in the chemoresistance mechanisms.">
    <entity charOffset="23-29" id="s953.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="98-103" id="s953.e1" ontology_id="7517" text="XRCC3" type="GENE"/>
    <pair e1="s953.e0" e2="s953.e1" id="s953.p0" relation="true"/>
  </sentence>
  <sentence id="s954" text="Sox2 expression is absent in normal urothelial cells, but it begins to be expressed in pre-neoplastic bladder tumors and continues to be expressed in invasive mouse BCa.">
    <entity charOffset="0-4" id="s954.e0" ontology_id="6657" text="Sox2" type="GENE"/>
    <entity charOffset="110-116" id="s954.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s954.e0" e2="s954.e1" id="s954.p0" relation="true"/>
  </sentence>
  <sentence id="s955" text="Ablation of Sox2-expressing cells within primary invasive BCa led to enhanced tumor regression, supporting the essential role of SOX2-positive cells in regulating BCa maintenance and progression.">
    <entity charOffset="12-16" id="s955.e0" ontology_id="6657" text="Sox2" type="GENE"/>
    <entity charOffset="78-83" id="s955.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s955.e0" e2="s955.e1" id="s955.p0" relation="true"/>
  </sentence>
  <sentence id="s956" text="KRT5 but not KRT6C mRNA expression was increased in chemotherapy resistant primary serous ovarian cancer cells compared to chemotherapy sensitive cells.">
    <entity charOffset="0-4" id="s956.e0" ontology_id="3852" text="KRT5" type="GENE"/>
    <entity charOffset="98-104" id="s956.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s956.e0" e2="s956.e1" id="s956.p0" relation="true"/>
  </sentence>
  <sentence id="s957" text="KRT5 and KRT6 (KRT6A, KRT6B &amp;amp; KRT6C) gene expression was assessed in publically available serous ovarian cancer data sets, ovarian cancer cell lines and primary serous ovarian cancer cells.">
    <entity charOffset="9-13" id="s957.e0" ontology_id="140807" text="KRT6" type="GENE"/>
    <entity charOffset="109-115" id="s957.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s957.e0" e2="s957.e1" id="s957.p0" relation="true"/>
  </sentence>
  <sentence id="s958" text="Our findings suggest that DEGs encoding subunits of NADH, PRIM1, MCM3, MAPK1, STAT3, RAF1, and JAK1 might be associated with the development of lung adenocarcinoma.">
    <entity charOffset="58-63" id="s958.e0" ontology_id="5557" text="PRIM1" type="GENE"/>
    <entity charOffset="144-163" id="s958.e1" ontology_id="HP_0030078" text="lung adenocarcinoma" type="HP"/>
    <pair e1="s958.e0" e2="s958.e1" id="s958.p0" relation="true"/>
  </sentence>
  <sentence id="s959" text="Our findings suggest that DEGs encoding subunits of NADH, PRIM1, MCM3, MAPK1, STAT3, RAF1, and JAK1 might be associated with the development of lung adenocarcinoma.">
    <entity charOffset="65-69" id="s959.e0" ontology_id="4172" text="MCM3" type="GENE"/>
    <entity charOffset="144-163" id="s959.e1" ontology_id="HP_0030078" text="lung adenocarcinoma" type="HP"/>
    <pair e1="s959.e0" e2="s959.e1" id="s959.p0" relation="true"/>
  </sentence>
  <sentence id="s960" text="Our findings suggest that DEGs encoding subunits of NADH, PRIM1, MCM3, MAPK1, STAT3, RAF1, and JAK1 might be associated with the development of lung adenocarcinoma.">
    <entity charOffset="85-89" id="s960.e0" ontology_id="5894" text="RAF1" type="GENE"/>
    <entity charOffset="144-163" id="s960.e1" ontology_id="HP_0030078" text="lung adenocarcinoma" type="HP"/>
    <pair e1="s960.e0" e2="s960.e1" id="s960.p0" relation="true"/>
  </sentence>
  <sentence id="s961" text="Oral squamous cell carcinoma studies have correlated Eps8 expression with metastatic disease and poor prognosis.">
    <entity charOffset="5-28" id="s961.e0" ontology_id="HP_0002860" text="squamous cell carcinoma" type="HP"/>
    <entity charOffset="53-57" id="s961.e1" ontology_id="2059" text="Eps8" type="GENE"/>
    <pair e1="s961.e0" e2="s961.e1" id="s961.p0" relation="true"/>
  </sentence>
  <sentence id="s962" text="A case with ARX (C.700G&amp;gt;A) had seizure controlled for 6 mouths.">
    <entity charOffset="12-15" id="s962.e0" ontology_id="10054" text="ARX" type="GENE"/>
    <entity charOffset="34-41" id="s962.e1" ontology_id="HP_0001250" text="seizure" type="HP"/>
    <pair e1="s962.e0" e2="s962.e1" id="s962.p0" relation="true"/>
  </sentence>
  <sentence id="s963" text="Furthermore, in humans xeroderma pigmentosum complementation group E, a disease characterized by sun sensitivity and increased risk of cutaneous SCC and melanomas, is explained by mutations in DDB2.">
    <entity charOffset="153-162" id="s963.e0" ontology_id="HP_0002861" text="melanomas" type="HP"/>
    <entity charOffset="193-197" id="s963.e1" ontology_id="1643" text="DDB2" type="GENE"/>
    <pair e1="s963.e0" e2="s963.e1" id="s963.p0" relation="true"/>
  </sentence>
  <sentence id="s964" text="We studied a consanguineous Pakistani family with postnatal microcephaly, orofacial dyskinesia, spastic quadriplegia and, on MRI, cortical atrophy with myelination delay, suggestive of a FOXG1-like presentation.">
    <entity charOffset="74-94" id="s964.e0" ontology_id="HP_0002310" text="orofacial dyskinesia" type="HP"/>
    <entity charOffset="187-192" id="s964.e1" ontology_id="2290" text="FOXG1" type="GENE"/>
    <pair e1="s964.e0" e2="s964.e1" id="s964.p0" relation="true"/>
  </sentence>
  <sentence id="s965" text="We studied a consanguineous Pakistani family with postnatal microcephaly, orofacial dyskinesia, spastic quadriplegia and, on MRI, cortical atrophy with myelination delay, suggestive of a FOXG1-like presentation.">
    <entity charOffset="96-116" id="s965.e0" ontology_id="HP_0002510" text="spastic quadriplegia" type="HP"/>
    <entity charOffset="187-192" id="s965.e1" ontology_id="2290" text="FOXG1" type="GENE"/>
    <pair e1="s965.e0" e2="s965.e1" id="s965.p0" relation="true"/>
  </sentence>
  <sentence id="s966" text="The regulation of the post-mitotic neural survival activity of TLE1 depends critically on an interaction with FOXG1, a gene shown to be involved in a postnatal microcephaly syndrome.">
    <entity charOffset="110-115" id="s966.e0" ontology_id="2290" text="FOXG1" type="GENE"/>
    <entity charOffset="160-172" id="s966.e1" ontology_id="HP_0000252" text="microcephaly" type="HP"/>
    <pair e1="s966.e0" e2="s966.e1" id="s966.p0" relation="true"/>
  </sentence>
  <sentence id="s967" text="Additionally, HOXA11 can be a potential tumor suppressor">
    <entity charOffset="14-20" id="s967.e0" ontology_id="3207" text="HOXA11" type="GENE"/>
    <entity charOffset="40-45" id="s967.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s967.e0" e2="s967.e1" id="s967.p0" relation="true"/>
  </sentence>
  <sentence id="s968" text="In conclusion, the hypermethylation of HOXA11 is an independent prognostic biomarker in breast cancer.">
    <entity charOffset="39-45" id="s968.e0" ontology_id="3207" text="HOXA11" type="GENE"/>
    <entity charOffset="95-101" id="s968.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s968.e0" e2="s968.e1" id="s968.p0" relation="true"/>
  </sentence>
  <sentence id="s969" text="Interestingly, REEP1 mutations have been linked to neurodegenerative disorders of upper and lower motor neurons, hereditary spastic paraplegia (HSP) and distal hereditary motor neuropathy type V (dHMN-V).">
    <entity charOffset="15-20" id="s969.e0" ontology_id="65055" text="REEP1" type="GENE"/>
    <entity charOffset="177-187" id="s969.e1" ontology_id="HP_0009830" text="neuropathy" type="HP"/>
    <pair e1="s969.e0" e2="s969.e1" id="s969.p0" relation="true"/>
  </sentence>
  <sentence id="s970" text="Altogether these data demonstrate that mutations in INPP5K cause a congenital muscular dystrophy syndrome with short stature, cataracts, and intellectual disability">
    <entity charOffset="52-58" id="s970.e0" ontology_id="51763" text="INPP5K" type="GENE"/>
    <entity charOffset="126-135" id="s970.e1" ontology_id="HP_0000518" text="cataracts" type="HP"/>
    <pair e1="s970.e0" e2="s970.e1" id="s970.p0" relation="true"/>
  </sentence>
  <sentence id="s971" text="Altogether these data demonstrate that mutations in INPP5K cause a congenital muscular dystrophy syndrome with short stature, cataracts, and intellectual disability">
    <entity charOffset="52-58" id="s971.e0" ontology_id="51763" text="INPP5K" type="GENE"/>
    <entity charOffset="78-96" id="s971.e1" ontology_id="HP_0003560" text="muscular dystrophy" type="HP"/>
    <pair e1="s971.e0" e2="s971.e1" id="s971.p0" relation="true"/>
  </sentence>
  <sentence id="s972" text="Here, we applied domain-focused CRISPR screening to human cancer cell lines to identify the transcription factor (TF) POU2F3 (POU class 2 homeobox 3; also known as SKN-1a/OCT-11) as a powerful dependency in a subset of SCLC lines.">
    <entity charOffset="58-64" id="s972.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="164-167" id="s972.e1" ontology_id="55733" text="SKN" type="GENE"/>
    <pair e1="s972.e0" e2="s972.e1" id="s972.p0" relation="false"/>
  </sentence>
  <sentence id="s973" text="Here, we applied domain-focused CRISPR screening to human cancer cell lines to identify the transcription factor (TF) POU2F3 (POU class 2 homeobox 3; also known as SKN-1a/OCT-11) as a powerful dependency in a subset of SCLC lines.">
    <entity charOffset="58-64" id="s973.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="118-124" id="s973.e1" ontology_id="25833" text="POU2F3" type="GENE"/>
    <pair e1="s973.e0" e2="s973.e1" id="s973.p0" relation="false"/>
  </sentence>
  <sentence id="s974" text="Here, we applied domain-focused CRISPR screening to human cancer cell lines to identify the transcription factor (TF) POU2F3 (POU class 2 homeobox 3; also known as SKN-1a/OCT-11) as a powerful dependency in a subset of SCLC lines.">
    <entity charOffset="58-64" id="s974.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="171-174" id="s974.e1" ontology_id="5362" text="OCT" type="GENE"/>
    <pair e1="s974.e0" e2="s974.e1" id="s974.p0" relation="false"/>
  </sentence>
  <sentence id="s975" text="Moreover, we show that most SCLC tumors can be classified into one of three lineages based on the expression of POU2F3, ASCL1, or NEUROD1.">
    <entity charOffset="33-38" id="s975.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="120-125" id="s975.e1" ontology_id="429" text="ASCL1" type="GENE"/>
    <pair e1="s975.e0" e2="s975.e1" id="s975.p0" relation="true"/>
  </sentence>
  <sentence id="s976" text="The study was conducted to determine the effect of DHA on the distribution of apelin and apelin receptor (APJ) in the central nervous system in 1-methyl-4-phenyl-1, 2, 3, 6 tetrahydropyridine (MPTP)-induced PD model.">
    <entity charOffset="106-109" id="s976.e0" ontology_id="187" text="APJ" type="GENE"/>
    <entity charOffset="118-125" id="s976.e1" ontology_id="HP_0030645" text="central" type="HP"/>
    <pair e1="s976.e0" e2="s976.e1" id="s976.p0" relation="true"/>
  </sentence>
  <sentence id="s977" text="Prior studies that explored the hypothesis that EMT gene variants contribute to epithelial ovarian carcinoma (EOC) risk have been based on small sample sizes and none have sought replication in an independent population.">
    <entity charOffset="48-51" id="s977.e0" ontology_id="3702" text="EMT" type="GENE"/>
    <entity charOffset="91-108" id="s977.e1" ontology_id="HP_0025318" text="ovarian carcinoma" type="HP"/>
    <pair e1="s977.e0" e2="s977.e1" id="s977.p0" relation="true"/>
  </sentence>
  <sentence id="s978" text="Perturbation of MAM function has previously been suggested in Alzheimer's disease (AD) as shown in fibroblasts from AD patients and a neuroblastoma cell line containing familial presenilin-2 AD mutation.">
    <entity charOffset="16-19" id="s978.e0" ontology_id="6445" text="MAM" type="GENE"/>
    <entity charOffset="134-147" id="s978.e1" ontology_id="HP_0003006" text="neuroblastoma" type="HP"/>
    <pair e1="s978.e0" e2="s978.e1" id="s978.p0" relation="true"/>
  </sentence>
  <sentence id="s979" text="CGD is a genetically heterogeneous disease with an X-linked recessive (XR-CGD) form caused by mutations in the CYBB (OMIM #300481) gene encoding the gp91(phox) protein, and an autosomal recessive (AR-CGD) form caused by mutations in the CYBA (OMIM #608508), NCF1 (OMIM #608512), NCF2 (OMIM #608515) and NCF4 (OMIM #601488) genes encoding p22(phox), p47(phox), p67(phox) and p40(phox), respectively.">
    <entity charOffset="21-34" id="s979.e0" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <entity charOffset="111-115" id="s979.e1" ontology_id="1536" text="CYBB" type="GENE"/>
    <pair e1="s979.e0" e2="s979.e1" id="s979.p0" relation="true"/>
  </sentence>
  <sentence id="s980" text="CGD is a genetically heterogeneous disease with an X-linked recessive (XR-CGD) form caused by mutations in the CYBB (OMIM #300481) gene encoding the gp91(phox) protein, and an autosomal recessive (AR-CGD) form caused by mutations in the CYBA (OMIM #608508), NCF1 (OMIM #608512), NCF2 (OMIM #608515) and NCF4 (OMIM #601488) genes encoding p22(phox), p47(phox), p67(phox) and p40(phox), respectively.">
    <entity charOffset="21-34" id="s980.e0" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <entity charOffset="258-262" id="s980.e1" ontology_id="653361" text="NCF1" type="GENE"/>
    <pair e1="s980.e0" e2="s980.e1" id="s980.p0" relation="true"/>
  </sentence>
  <sentence id="s981" text="CGD is a genetically heterogeneous disease with an X-linked recessive (XR-CGD) form caused by mutations in the CYBB (OMIM #300481) gene encoding the gp91(phox) protein, and an autosomal recessive (AR-CGD) form caused by mutations in the CYBA (OMIM #608508), NCF1 (OMIM #608512), NCF2 (OMIM #608515) and NCF4 (OMIM #601488) genes encoding p22(phox), p47(phox), p67(phox) and p40(phox), respectively.">
    <entity charOffset="176-195" id="s981.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="237-241" id="s981.e1" ontology_id="1535" text="CYBA" type="GENE"/>
    <pair e1="s981.e0" e2="s981.e1" id="s981.p0" relation="true"/>
  </sentence>
  <sentence id="s982" text="CGD is a genetically heterogeneous disease with an X-linked recessive (XR-CGD) form caused by mutations in the CYBB (OMIM #300481) gene encoding the gp91(phox) protein, and an autosomal recessive (AR-CGD) form caused by mutations in the CYBA (OMIM #608508), NCF1 (OMIM #608512), NCF2 (OMIM #608515) and NCF4 (OMIM #601488) genes encoding p22(phox), p47(phox), p67(phox) and p40(phox), respectively.">
    <entity charOffset="176-195" id="s982.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="258-262" id="s982.e1" ontology_id="653361" text="NCF1" type="GENE"/>
    <pair e1="s982.e0" e2="s982.e1" id="s982.p0" relation="true"/>
  </sentence>
  <sentence id="s983" text="Taken together, these results suggest the implication of FIBP in a new autosomal recessive MCA.">
    <entity charOffset="57-61" id="s983.e0" ontology_id="9158" text="FIBP" type="GENE"/>
    <entity charOffset="71-90" id="s983.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s983.e0" e2="s983.e1" id="s983.p0" relation="true"/>
  </sentence>
  <sentence id="s984" text="Here, integrated analysis of gene expression in non-small cell lung cancer revealed that SLC39A4 expression is significantly correlated with increased tumour size and regional lymph node spread, as well as shorter overall survival (OS) and disease-free survival (DFS).">
    <entity charOffset="89-96" id="s984.e0" ontology_id="55630" text="SLC39A4" type="GENE"/>
    <entity charOffset="151-157" id="s984.e1" ontology_id="HP_0002664" text="tumour" type="HP"/>
    <pair e1="s984.e0" e2="s984.e1" id="s984.p0" relation="true"/>
  </sentence>
  <sentence id="s985" text="&lt;i&gt;DLEC1&lt;/i&gt; methylation was frequently detected in ESCC tumors and correlated with lymph node metastasis, tumor recurrence and progression, with &lt;i&gt;DLEC1&lt;/i&gt; as the most frequently methylated among the established 3p22.2 tumor suppressors (&lt;i&gt;RASSF1A, PLCD1&lt;/i&gt; and &lt;i&gt;ZMYND10/BLU&lt;/i&gt;).">
    <entity charOffset="3-8" id="s985.e0" ontology_id="9940" text="DLEC1" type="GENE"/>
    <entity charOffset="107-112" id="s985.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s985.e0" e2="s985.e1" id="s985.p0" relation="true"/>
  </sentence>
  <sentence id="s986" text="Mutations in the Pejvakin (Pjvk) gene cause autosomal recessive hearing loss DFNB59 with audiological features of auditory neuropathy spectrum disorder (ANSD) or cochlear dysfunction.">
    <entity charOffset="27-31" id="s986.e0" ontology_id="494513" text="Pjvk" type="GENE"/>
    <entity charOffset="64-76" id="s986.e1" ontology_id="HP_0000365" text="hearing loss" type="HP"/>
    <pair e1="s986.e0" e2="s986.e1" id="s986.p0" relation="true"/>
  </sentence>
  <sentence id="s987" text="Mutations in the Pejvakin (Pjvk) gene cause autosomal recessive hearing loss DFNB59 with audiological features of auditory neuropathy spectrum disorder (ANSD) or cochlear dysfunction.">
    <entity charOffset="27-31" id="s987.e0" ontology_id="494513" text="Pjvk" type="GENE"/>
    <entity charOffset="44-63" id="s987.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s987.e0" e2="s987.e1" id="s987.p0" relation="true"/>
  </sentence>
  <sentence id="s988" text="By contrast, loss of Pjvk in adult OHCs causes a slowly progressive hearing loss associated with OHC degeneration and delayed loss of inner hair cells (IHCs), indicating a primary role for pejvakin in regulating OHC function and survival.">
    <entity charOffset="21-25" id="s988.e0" ontology_id="494513" text="Pjvk" type="GENE"/>
    <entity charOffset="68-80" id="s988.e1" ontology_id="HP_0000365" text="hearing loss" type="HP"/>
    <pair e1="s988.e0" e2="s988.e1" id="s988.p0" relation="true"/>
  </sentence>
  <sentence id="s989" text="Here, we demonstrate that mice with conditional ablation of the Pjvk gene in all sensory hair cells or only in outer hair cells (OHCs) show similar auditory phenotypes with early-onset profound hearing loss.">
    <entity charOffset="64-68" id="s989.e0" ontology_id="494513" text="Pjvk" type="GENE"/>
    <entity charOffset="194-206" id="s989.e1" ontology_id="HP_0000365" text="hearing loss" type="HP"/>
    <pair e1="s989.e0" e2="s989.e1" id="s989.p0" relation="true"/>
  </sentence>
  <sentence id="s990" text="Here, we demonstrate that mice with conditional ablation of the Pjvk gene in all sensory hair cells or only in outer hair cells (OHCs) show similar auditory phenotypes with early-onset profound hearing loss.">
    <entity charOffset="64-68" id="s990.e0" ontology_id="494513" text="Pjvk" type="GENE"/>
    <entity charOffset="185-193" id="s990.e1" ontology_id="HP_0012829" text="profound" type="HP"/>
    <pair e1="s990.e0" e2="s990.e1" id="s990.p0" relation="true"/>
  </sentence>
  <sentence id="s991" text="Moreover, we confirmed that knockdown of LDHA could inhibit tumor growth in vivo.">
    <entity charOffset="41-45" id="s991.e0" ontology_id="3939" text="LDHA" type="GENE"/>
    <entity charOffset="60-65" id="s991.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s991.e0" e2="s991.e1" id="s991.p0" relation="true"/>
  </sentence>
  <sentence id="s992" text="Biotinidase (BTD) deficiency is a rare autosomal recessive metabolic disease, which develops neurological and cutaneous symptoms because of the impaired biotin recycling.">
    <entity charOffset="13-16" id="s992.e0" ontology_id="686" text="BTD" type="GENE"/>
    <entity charOffset="39-58" id="s992.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s992.e0" e2="s992.e1" id="s992.p0" relation="true"/>
  </sentence>
  <sentence id="s993" text="The SNPs rs2124437 (RASGRP3), rs1335022 (GRIK2), rs4512367 (PREX2), rs4748011 (CCDC3), and rs1435218 (LNX1) were analyzed in 500 histopathologically confirmed oral cancers and 500 healthy controls with a minimum of 10years of tobacco usage.">
    <entity charOffset="20-27" id="s993.e0" ontology_id="25780" text="RASGRP3" type="GENE"/>
    <entity charOffset="164-170" id="s993.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s993.e0" e2="s993.e1" id="s993.p0" relation="true"/>
  </sentence>
  <sentence id="s994" text="The SNPs rs2124437 (RASGRP3), rs1335022 (GRIK2), rs4512367 (PREX2), rs4748011 (CCDC3), and rs1435218 (LNX1) were analyzed in 500 histopathologically confirmed oral cancers and 500 healthy controls with a minimum of 10years of tobacco usage.">
    <entity charOffset="60-65" id="s994.e0" ontology_id="80243" text="PREX2" type="GENE"/>
    <entity charOffset="164-170" id="s994.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s994.e0" e2="s994.e1" id="s994.p0" relation="true"/>
  </sentence>
  <sentence id="s995" text="The SNPs rs2124437 (RASGRP3), rs1335022 (GRIK2), rs4512367 (PREX2), rs4748011 (CCDC3), and rs1435218 (LNX1) were analyzed in 500 histopathologically confirmed oral cancers and 500 healthy controls with a minimum of 10years of tobacco usage.">
    <entity charOffset="79-84" id="s995.e0" ontology_id="83643" text="CCDC3" type="GENE"/>
    <entity charOffset="164-170" id="s995.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s995.e0" e2="s995.e1" id="s995.p0" relation="true"/>
  </sentence>
  <sentence id="s996" text="In contrast, patients with the non-hereditary Carney triad, including paraganglioma, GIST, and pulmonary chondroma, usually lack germline SDH mutations and instead show epigenetic SDH complex inactivation through SDHC promoter methylation.">
    <entity charOffset="95-114" id="s996.e0" ontology_id="HP_0031474" text="pulmonary chondroma" type="HP"/>
    <entity charOffset="138-141" id="s996.e1" ontology_id="1757" text="SDH" type="GENE"/>
    <pair e1="s996.e0" e2="s996.e1" id="s996.p0" relation="true"/>
  </sentence>
  <sentence id="s997" text="&lt;b&gt;Conclusions:&lt;/b&gt; The expression of Twist2 in human glioma is positively correlated with the malignant grade of glioma, which may be involved in the malignant progression of glioma by EMT">
    <entity charOffset="38-44" id="s997.e0" ontology_id="117581" text="Twist2" type="GENE"/>
    <entity charOffset="54-60" id="s997.e1" ontology_id="HP_0009733" text="glioma" type="HP"/>
    <pair e1="s997.e0" e2="s997.e1" id="s997.p0" relation="true"/>
  </sentence>
  <sentence id="s998" text="Real-time fluorescence quantitative PCR and Western blot were used to detect the expression level of Twist2 mRNA and protein in 61 cases of fresh glioma tissue (WHO grade  16 cases,  21 cases,  24 cases) and 12 cases of adjacent tissues, and the expression levels of E-cadherin, N-cadherin and vimentin were also investigated in fresh glioma tissue.">
    <entity charOffset="101-107" id="s998.e0" ontology_id="117581" text="Twist2" type="GENE"/>
    <entity charOffset="146-152" id="s998.e1" ontology_id="HP_0009733" text="glioma" type="HP"/>
    <pair e1="s998.e0" e2="s998.e1" id="s998.p0" relation="true"/>
  </sentence>
  <sentence id="s999" text="&lt;b&gt;Methods:&lt;/b&gt; Using immunohistochemical method detected the expression level of Twist2 in 60 cases of gliomas (including WHO grades ,  and , each for 20 cases) and 20 cases of non-tumor brain tissues.">
    <entity charOffset="82-88" id="s999.e0" ontology_id="117581" text="Twist2" type="GENE"/>
    <entity charOffset="185-190" id="s999.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s999.e0" e2="s999.e1" id="s999.p0" relation="true"/>
  </sentence>
  <sentence id="s1000" text="The percentages of Twist2 expression were 75% (15/20), 95% (19/20), and 100% (20/20) in the WHO grades,  and  gliomas, respectively.">
    <entity charOffset="19-25" id="s1000.e0" ontology_id="117581" text="Twist2" type="GENE"/>
    <entity charOffset="113-119" id="s1000.e1" ontology_id="HP_0009733" text="glioma" type="HP"/>
    <pair e1="s1000.e0" e2="s1000.e1" id="s1000.p0" relation="true"/>
  </sentence>
  <sentence id="s1001" text="Detection of key protein expression in EMT by Western blot displayed that the expression of E-cadherin was negatively associated with Twist2 in glioma (&lt;i&gt;r&lt;/i&gt;=-0.972, &lt;i&gt;P&lt;/i&gt;&amp;lt;0.01).">
    <entity charOffset="134-140" id="s1001.e0" ontology_id="117581" text="Twist2" type="GENE"/>
    <entity charOffset="144-150" id="s1001.e1" ontology_id="HP_0009733" text="glioma" type="HP"/>
    <pair e1="s1001.e0" e2="s1001.e1" id="s1001.p0" relation="true"/>
  </sentence>
  <sentence id="s1002" text="Global-genome nucleotide excision repair (GG-NER) prevents ultraviolet (UV) light-induced skin cancer by removing mutagenic cyclobutane pyrimidine dimers (CPDs).">
    <entity charOffset="45-48" id="s1002.e0" ontology_id="7376" text="NER" type="GENE"/>
    <entity charOffset="95-101" id="s1002.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1002.e0" e2="s1002.e1" id="s1002.p0" relation="true"/>
  </sentence>
  <sentence id="s1003" text="MIB1/Ki-67 was low and highlighted 4%-5% tumor nuclei.">
    <entity charOffset="5-7" id="s1003.e0" ontology_id="10197" text="Ki" type="GENE"/>
    <entity charOffset="41-46" id="s1003.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1003.e0" e2="s1003.e1" id="s1003.p0" relation="true"/>
  </sentence>
  <sentence id="s1004" text="This phenotypic variability should be taken into account when treating patients with BRAT1-associated neurodegenerative disease.">
    <entity charOffset="85-90" id="s1004.e0" ontology_id="221927" text="BRAT1" type="GENE"/>
    <entity charOffset="102-127" id="s1004.e1" ontology_id="HP_0002180" text="neurodegenerative disease" type="HP"/>
    <pair e1="s1004.e0" e2="s1004.e1" id="s1004.p0" relation="true"/>
  </sentence>
  <sentence id="s1005" text="Recessive mutations in BRAT1 cause lethal neonatal rigidity and multifocal seizure syndrome, a phenotype characterized by neonatal microcephaly, hypertonia, and refractory epilepsy with premature death by age 2 years.">
    <entity charOffset="23-28" id="s1005.e0" ontology_id="221927" text="BRAT1" type="GENE"/>
    <entity charOffset="172-180" id="s1005.e1" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <pair e1="s1005.e0" e2="s1005.e1" id="s1005.p0" relation="true"/>
  </sentence>
  <sentence id="s1006" text="Here, we report two affected siblings with compound heterozygous truncating mutations in BRAT1 and intra-familial phenotypic heterogeneity, with a less severe disease course in the female sibling.">
    <entity charOffset="89-94" id="s1006.e0" ontology_id="221927" text="BRAT1" type="GENE"/>
    <entity charOffset="125-138" id="s1006.e1" ontology_id="HP_0001425" text="heterogeneity" type="HP"/>
    <pair e1="s1006.e0" e2="s1006.e1" id="s1006.p0" relation="true"/>
  </sentence>
  <sentence id="s1007" text="Moreover, we demonstrated that pharmacological inhibition of 15-PGDH enhanced CYP26A1 expression, leading to depletion of all-trans retinoic acid (ATRA) and expansion of the ALDH1-positive subset in both human PDAC cells and tumor cells of Kras&lt;sup&gt;LSL-G12D/+&lt;/sup&gt;; Ptf1a&lt;sup&gt;Cre/+&lt;/sup&gt; (KC) mice.">
    <entity charOffset="78-85" id="s1007.e0" ontology_id="1592" text="CYP26A1" type="GENE"/>
    <entity charOffset="225-230" id="s1007.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1007.e0" e2="s1007.e1" id="s1007.p0" relation="true"/>
  </sentence>
  <sentence id="s1008" text="Here, we found that 15-PGDH expression was inversely correlated with ALDH1, an important cancer stem cell-associated marker indicative of poor prognosis in humans.">
    <entity charOffset="23-27" id="s1008.e0" ontology_id="26227" text="PGDH" type="GENE"/>
    <entity charOffset="89-95" id="s1008.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1008.e0" e2="s1008.e1" id="s1008.p0" relation="false"/>
  </sentence>
  <sentence id="s1009" text="Here, we found that 15-PGDH expression was inversely correlated with ALDH1, an important cancer stem cell-associated marker indicative of poor prognosis in humans.">
    <entity charOffset="69-74" id="s1009.e0" ontology_id="216" text="ALDH1" type="GENE"/>
    <entity charOffset="89-95" id="s1009.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1009.e0" e2="s1009.e1" id="s1009.p0" relation="true"/>
  </sentence>
  <sentence id="s1010" text="Blood and tissue samples from 48 osteosarcoma patients were obtained, and the following polymorphisms were analyzed; SLC19A1 80G&amp;gt;A, DHFR 829C&amp;gt;T, MTHFR 677C&amp;gt;T, MTHFR 1298A&amp;gt;C, and ATIC 347C&amp;gt;G.">
    <entity charOffset="33-45" id="s1010.e0" ontology_id="HP_0002669" text="osteosarcoma" type="HP"/>
    <entity charOffset="117-124" id="s1010.e1" ontology_id="6573" text="SLC19A1" type="GENE"/>
    <pair e1="s1010.e0" e2="s1010.e1" id="s1010.p0" relation="true"/>
  </sentence>
  <sentence id="s1011" text="Genes involved in tissue development, differentiation, and oncogenesis such as DNAJA4, HES5, IRX1, BMP8A, GATA4, GATA6, ALX3, and P4HTM were hypermethylated in both RMS cell lines and primary samples, implicating aberrant DNA methylation in the pathogenesis of rhabdomyosarcoma.">
    <entity charOffset="87-91" id="s1011.e0" ontology_id="388585" text="HES5" type="GENE"/>
    <entity charOffset="261-277" id="s1011.e1" ontology_id="HP_0002859" text="rhabdomyosarcoma" type="HP"/>
    <pair e1="s1011.e0" e2="s1011.e1" id="s1011.p0" relation="false"/>
  </sentence>
  <sentence id="s1012" text="Genes involved in tissue development, differentiation, and oncogenesis such as DNAJA4, HES5, IRX1, BMP8A, GATA4, GATA6, ALX3, and P4HTM were hypermethylated in both RMS cell lines and primary samples, implicating aberrant DNA methylation in the pathogenesis of rhabdomyosarcoma.">
    <entity charOffset="113-118" id="s1012.e0" ontology_id="2627" text="GATA6" type="GENE"/>
    <entity charOffset="261-277" id="s1012.e1" ontology_id="HP_0002859" text="rhabdomyosarcoma" type="HP"/>
    <pair e1="s1012.e0" e2="s1012.e1" id="s1012.p0" relation="false"/>
  </sentence>
  <sentence id="s1013" text="Genes involved in tissue development, differentiation, and oncogenesis such as DNAJA4, HES5, IRX1, BMP8A, GATA4, GATA6, ALX3, and P4HTM were hypermethylated in both RMS cell lines and primary samples, implicating aberrant DNA methylation in the pathogenesis of rhabdomyosarcoma.">
    <entity charOffset="120-124" id="s1013.e0" ontology_id="257" text="ALX3" type="GENE"/>
    <entity charOffset="261-277" id="s1013.e1" ontology_id="HP_0002859" text="rhabdomyosarcoma" type="HP"/>
    <pair e1="s1013.e0" e2="s1013.e1" id="s1013.p0" relation="false"/>
  </sentence>
  <sentence id="s1014" text="Genes involved in tissue development, differentiation, and oncogenesis such as DNAJA4, HES5, IRX1, BMP8A, GATA4, GATA6, ALX3, and P4HTM were hypermethylated in both RMS cell lines and primary samples, implicating aberrant DNA methylation in the pathogenesis of rhabdomyosarcoma.">
    <entity charOffset="130-135" id="s1014.e0" ontology_id="54681" text="P4HTM" type="GENE"/>
    <entity charOffset="261-277" id="s1014.e1" ontology_id="HP_0002859" text="rhabdomyosarcoma" type="HP"/>
    <pair e1="s1014.e0" e2="s1014.e1" id="s1014.p0" relation="false"/>
  </sentence>
  <sentence id="s1015" text="CNGB1 mutations are one cause of autosomal recessive RP making the CNGB1 mutant dog a valuable large animal model of the condition">
    <entity charOffset="0-5" id="s1015.e0" ontology_id="1258" text="CNGB1" type="GENE"/>
    <entity charOffset="33-52" id="s1015.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s1015.e0" e2="s1015.e1" id="s1015.p0" relation="true"/>
  </sentence>
  <sentence id="s1016" text="This study demonstrates that CSNK2A1 and SIRT6 are indicators of poor prognosis for breast carcinomas and that CSNK2A1-mediated phosphorylation of SIRT6 might be involved in the progression of breast carcinoma">
    <entity charOffset="29-36" id="s1016.e0" ontology_id="1459" text="CSNK2A1" type="GENE"/>
    <entity charOffset="84-100" id="s1016.e1" ontology_id="HP_0003002" text="breast carcinoma" type="HP"/>
    <pair e1="s1016.e0" e2="s1016.e1" id="s1016.p0" relation="true"/>
  </sentence>
  <sentence id="s1017" text="This study demonstrates that CSNK2A1 and SIRT6 are indicators of poor prognosis for breast carcinomas and that CSNK2A1-mediated phosphorylation of SIRT6 might be involved in the progression of breast carcinoma">
    <entity charOffset="41-46" id="s1017.e0" ontology_id="51548" text="SIRT6" type="GENE"/>
    <entity charOffset="84-100" id="s1017.e1" ontology_id="HP_0003002" text="breast carcinoma" type="HP"/>
    <pair e1="s1017.e0" e2="s1017.e1" id="s1017.p0" relation="true"/>
  </sentence>
  <sentence id="s1018" text="Though using the term gray platelets for GATA1 deficiency has been debated, a reduced number of -granules has been described for macrothrombocytopenia due to &lt;i&gt;GATA1&lt;/i&gt; mutations.">
    <entity charOffset="41-46" id="s1018.e0" ontology_id="2623" text="GATA1" type="GENE"/>
    <entity charOffset="130-151" id="s1018.e1" ontology_id="HP_0040185" text="macrothrombocytopenia" type="HP"/>
    <pair e1="s1018.e0" e2="s1018.e1" id="s1018.p0" relation="true"/>
  </sentence>
  <sentence id="s1019" text="Biallelic mutations in NDUFAF6 have been identified as responsible for cases of autosomal recessive Leigh syndrome associated with mitochondrial complex I deficiency.">
    <entity charOffset="23-30" id="s1019.e0" ontology_id="137682" text="NDUFAF6" type="GENE"/>
    <entity charOffset="80-99" id="s1019.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s1019.e0" e2="s1019.e1" id="s1019.p0" relation="true"/>
  </sentence>
  <sentence id="s1020" text="Next, we show that FBXO16 functions as a tumor suppressor in GBM.">
    <entity charOffset="19-25" id="s1020.e0" ontology_id="157574" text="FBXO16" type="GENE"/>
    <entity charOffset="41-46" id="s1020.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1020.e0" e2="s1020.e1" id="s1020.p0" relation="true"/>
  </sentence>
  <sentence id="s1021" text="The fetus inherited an additional likely pathogenic novel missense change to a second MKS gene, CEP290; p.R2210C, suggesting oligogenic inheritance in this disorder">
    <entity charOffset="96-102" id="s1021.e0" ontology_id="80184" text="CEP290" type="GENE"/>
    <entity charOffset="125-147" id="s1021.e1" ontology_id="HP_0010983" text="oligogenic inheritance" type="HP"/>
    <pair e1="s1021.e0" e2="s1021.e1" id="s1021.p0" relation="true"/>
  </sentence>
  <sentence id="s1022" text="&lt;b&gt;Objective:&lt;/b&gt; To investigate the genotype-phenotype correlation in Chinese familial hypertrophic cardiomyopathy (HCM )focusing on the cardiac troponin C gene TNNC1 c.">
    <entity charOffset="101-115" id="s1022.e0" ontology_id="HP_0001638" text="cardiomyopathy" type="HP"/>
    <entity charOffset="162-167" id="s1022.e1" ontology_id="7137" text="TNNC1" type="GENE"/>
    <pair e1="s1022.e0" e2="s1022.e1" id="s1022.p0" relation="true"/>
  </sentence>
  <sentence id="s1023" text="As it is currently unclear whether localized production of either H&lt;sub&gt;2&lt;/sub&gt;S or GSH contributes to retinal homeostasis, we undertook a comparative analysis of CBS and CSE expression in canine, non-human primate (NHP) and human retinas to determine if these antioxidants could play a regulatory role in age-related or disease-associated retinal degeneration.">
    <entity charOffset="163-166" id="s1023.e0" ontology_id="875" text="CBS" type="GENE"/>
    <entity charOffset="340-360" id="s1023.e1" ontology_id="HP_0000546" text="retinal degeneration" type="HP"/>
    <pair e1="s1023.e0" e2="s1023.e1" id="s1023.p0" relation="true"/>
  </sentence>
  <sentence id="s1024" text="However, only recently have genetic studies demonstrated sequence variation in HCN1 and HCN2 genes associated with human epilepsy.">
    <entity charOffset="79-83" id="s1024.e0" ontology_id="348980" text="HCN1" type="GENE"/>
    <entity charOffset="121-129" id="s1024.e1" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <pair e1="s1024.e0" e2="s1024.e1" id="s1024.p0" relation="true"/>
  </sentence>
  <sentence id="s1025" text="A plethora of human diseases are associated with mutations in the genes encoding human SLC26 transporters, including chondrodysplasias with varying severity in SLC26A2 (~50 mutations, 27 point mutations), congenital chloride-losing diarrhea in SLC26A3 (~70 mutations, 31 point mutations) and Pendred Syndrome or deafness autosomal recessive type 4 in SLC26A4 (~500 mutations, 203 point mutations).">
    <entity charOffset="160-167" id="s1025.e0" ontology_id="1836" text="SLC26A2" type="GENE"/>
    <entity charOffset="312-320" id="s1025.e1" ontology_id="HP_0000365" text="deafness" type="HP"/>
    <pair e1="s1025.e0" e2="s1025.e1" id="s1025.p0" relation="false"/>
  </sentence>
  <sentence id="s1026" text="Of the genes detected out, GJB2 gene mutation was with significant difference (&lt;sup&gt;2&lt;/sup&gt;=75.132, p=0.000) between audio-no-pass group (417/1315, 31.711%) and random-selected cohort (159/1000, 15.900%); c.109G&amp;gt;A was the most common allele, as well as the only one with significantly different allele frequency (&lt;sup&gt;2&lt;/sup&gt;=79.327, p=0.000) between audio-no-pass group (392/1315, 16.84%) and random-selected cohort (140/1000, 7.55%), which suggested c.109G&amp;gt;A mutation was critical for newborns' hearing loss.">
    <entity charOffset="27-31" id="s1026.e0" ontology_id="2706" text="GJB2" type="GENE"/>
    <entity charOffset="517-529" id="s1026.e1" ontology_id="HP_0000365" text="hearing loss" type="HP"/>
    <pair e1="s1026.e0" e2="s1026.e1" id="s1026.p0" relation="false"/>
  </sentence>
  <sentence id="s1027" text="Because of the distinct ear anomalies and the hearing loss a HOXA2 mutation was taken into account.">
    <entity charOffset="24-37" id="s1027.e0" ontology_id="HP_0000598" text="ear anomalies" type="HP"/>
    <entity charOffset="61-66" id="s1027.e1" ontology_id="3199" text="HOXA2" type="GENE"/>
    <pair e1="s1027.e0" e2="s1027.e1" id="s1027.p0" relation="true"/>
  </sentence>
  <sentence id="s1028" text="We have generated four thyroid cancer cell lines with a greater than 30-fold increase in acquired resistance to the Src inhibitor dasatinib.">
    <entity charOffset="31-37" id="s1028.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="116-119" id="s1028.e1" ontology_id="6714" text="Src" type="GENE"/>
    <pair e1="s1028.e0" e2="s1028.e1" id="s1028.p0" relation="true"/>
  </sentence>
  <sentence id="s1029" text="We specifically discuss the role of SALL2 in the regulation of cell proliferation and survival within the context of the identified target genes, its interaction with viral oncogenes, and its association with the TP53 tumor suppressor and MYC oncogene.">
    <entity charOffset="36-41" id="s1029.e0" ontology_id="6297" text="SALL2" type="GENE"/>
    <entity charOffset="218-223" id="s1029.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1029.e0" e2="s1029.e1" id="s1029.p0" relation="true"/>
  </sentence>
  <sentence id="s1030" text="Special attention is given to p53-independent SALL2 regulation of pro-apoptotic genes BAX and PMAIP1, and the implication of these findings on the apoptotic response of cancer cells to therapy.">
    <entity charOffset="86-89" id="s1030.e0" ontology_id="581" text="BAX" type="GENE"/>
    <entity charOffset="169-175" id="s1030.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1030.e0" e2="s1030.e1" id="s1030.p0" relation="true"/>
  </sentence>
  <sentence id="s1031" text="Hence, this previously unknown FBW7/Brg1 signaling axis provides the molecular basis and the rationale to target Brg1 in FBW7-compromised human gastric cancers">
    <entity charOffset="31-35" id="s1031.e0" ontology_id="55294" text="FBW7" type="GENE"/>
    <entity charOffset="152-158" id="s1031.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1031.e0" e2="s1031.e1" id="s1031.p0" relation="true"/>
  </sentence>
  <sentence id="s1032" text="In keeping with a tumor suppressive role of FBW7 in human gastric cancer, we find an inverse correlation between FBW7 and Brg1 expression in human gastric cancer clinical samples.">
    <entity charOffset="18-23" id="s1032.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="122-126" id="s1032.e1" ontology_id="6597" text="Brg1" type="GENE"/>
    <pair e1="s1032.e0" e2="s1032.e1" id="s1032.p0" relation="true"/>
  </sentence>
  <sentence id="s1033" text="In keeping with a tumor suppressive role of FBW7 in human gastric cancer, we find an inverse correlation between FBW7 and Brg1 expression in human gastric cancer clinical samples.">
    <entity charOffset="66-72" id="s1033.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="122-126" id="s1033.e1" ontology_id="6597" text="Brg1" type="GENE"/>
    <pair e1="s1033.e0" e2="s1033.e1" id="s1033.p0" relation="true"/>
  </sentence>
  <sentence id="s1034" text="A panel of hypermethylated genes including APC, CSPG2, EPHA5, EYA4, HOXA9, IPF1, ISL1, JAK3, PITX2, SOX1, and TWIST1 predicted cancer-specific survival and SOX1 (HR = 3.46), PITX2 (HR = 4.17), CSPG2 (HR = 5.35), and JAK3 hypermethylation (HR = 0.19) did so independently.">
    <entity charOffset="55-60" id="s1034.e0" ontology_id="2044" text="EPHA5" type="GENE"/>
    <entity charOffset="127-133" id="s1034.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1034.e0" e2="s1034.e1" id="s1034.p0" relation="true"/>
  </sentence>
  <sentence id="s1035" text="A panel of hypermethylated genes including APC, CSPG2, EPHA5, EYA4, HOXA9, IPF1, ISL1, JAK3, PITX2, SOX1, and TWIST1 predicted cancer-specific survival and SOX1 (HR = 3.46), PITX2 (HR = 4.17), CSPG2 (HR = 5.35), and JAK3 hypermethylation (HR = 0.19) did so independently.">
    <entity charOffset="62-66" id="s1035.e0" ontology_id="2070" text="EYA4" type="GENE"/>
    <entity charOffset="127-133" id="s1035.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1035.e0" e2="s1035.e1" id="s1035.p0" relation="true"/>
  </sentence>
  <sentence id="s1036" text="A panel of hypermethylated genes including APC, CSPG2, EPHA5, EYA4, HOXA9, IPF1, ISL1, JAK3, PITX2, SOX1, and TWIST1 predicted cancer-specific survival and SOX1 (HR = 3.46), PITX2 (HR = 4.17), CSPG2 (HR = 5.35), and JAK3 hypermethylation (HR = 0.19) did so independently.">
    <entity charOffset="75-79" id="s1036.e0" ontology_id="8050" text="IPF1" type="GENE"/>
    <entity charOffset="127-133" id="s1036.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1036.e0" e2="s1036.e1" id="s1036.p0" relation="true"/>
  </sentence>
  <sentence id="s1037" text="A panel of hypermethylated genes including APC, CSPG2, EPHA5, EYA4, HOXA9, IPF1, ISL1, JAK3, PITX2, SOX1, and TWIST1 predicted cancer-specific survival and SOX1 (HR = 3.46), PITX2 (HR = 4.17), CSPG2 (HR = 5.35), and JAK3 hypermethylation (HR = 0.19) did so independently.">
    <entity charOffset="81-85" id="s1037.e0" ontology_id="3670" text="ISL1" type="GENE"/>
    <entity charOffset="127-133" id="s1037.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1037.e0" e2="s1037.e1" id="s1037.p0" relation="true"/>
  </sentence>
  <sentence id="s1038" text="A panel of hypermethylated genes including APC, CSPG2, EPHA5, EYA4, HOXA9, IPF1, ISL1, JAK3, PITX2, SOX1, and TWIST1 predicted cancer-specific survival and SOX1 (HR = 3.46), PITX2 (HR = 4.17), CSPG2 (HR = 5.35), and JAK3 hypermethylation (HR = 0.19) did so independently.">
    <entity charOffset="93-98" id="s1038.e0" ontology_id="5308" text="PITX2" type="GENE"/>
    <entity charOffset="127-133" id="s1038.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1038.e0" e2="s1038.e1" id="s1038.p0" relation="true"/>
  </sentence>
  <sentence id="s1039" text="A panel of hypermethylated genes including APC, CSPG2, EPHA5, EYA4, HOXA9, IPF1, ISL1, JAK3, PITX2, SOX1, and TWIST1 predicted cancer-specific survival and SOX1 (HR = 3.46), PITX2 (HR = 4.17), CSPG2 (HR = 5.35), and JAK3 hypermethylation (HR = 0.19) did so independently.">
    <entity charOffset="110-116" id="s1039.e0" ontology_id="7291" text="TWIST1" type="GENE"/>
    <entity charOffset="127-133" id="s1039.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1039.e0" e2="s1039.e1" id="s1039.p0" relation="true"/>
  </sentence>
  <sentence id="s1040" text="Further experiments demonstrated that the MYEOV ceRNA sequestered miR-30c-2-3p from binding its targets TGFBR2 and USP15 mRNAs, which in turn leading to constitutive activation of TGF- signaling and tumor progression in NSCLC.">
    <entity charOffset="66-69" id="s1040.e0" ontology_id="220972" text="miR" type="GENE"/>
    <entity charOffset="200-205" id="s1040.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1040.e0" e2="s1040.e1" id="s1040.p0" relation="true"/>
  </sentence>
  <sentence id="s1041" text="The glutamatergic hypothesis of schizophrenia lead recently to a first successful mGlu2/3 receptor agonistic drug and is underpinned by significant findings in genes regulating the glutamatergic system (SLC1A6, SLC1A2 GRIN1, GRIN2A, GRIA1, NRG1, ErbB4, DTNBP1, DAAO, G72/30, GRM3).">
    <entity charOffset="32-45" id="s1041.e0" ontology_id="HP_0100753" text="schizophrenia" type="HP"/>
    <entity charOffset="246-251" id="s1041.e1" ontology_id="2066" text="ErbB4" type="GENE"/>
    <pair e1="s1041.e0" e2="s1041.e1" id="s1041.p0" relation="true"/>
  </sentence>
  <sentence id="s1042" text="The glutamatergic hypothesis of schizophrenia lead recently to a first successful mGlu2/3 receptor agonistic drug and is underpinned by significant findings in genes regulating the glutamatergic system (SLC1A6, SLC1A2 GRIN1, GRIN2A, GRIA1, NRG1, ErbB4, DTNBP1, DAAO, G72/30, GRM3).">
    <entity charOffset="32-45" id="s1042.e0" ontology_id="HP_0100753" text="schizophrenia" type="HP"/>
    <entity charOffset="240-244" id="s1042.e1" ontology_id="3084" text="NRG1" type="GENE"/>
    <pair e1="s1042.e0" e2="s1042.e1" id="s1042.p0" relation="true"/>
  </sentence>
  <sentence id="s1043" text="Empty spiracles homeobox 2 (EMX2) is a homeodomain-containing transcription factor that plays an essential role in tumorigenesis.">
    <entity charOffset="28-32" id="s1043.e0" ontology_id="2018" text="EMX2" type="GENE"/>
    <entity charOffset="115-120" id="s1043.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1043.e0" e2="s1043.e1" id="s1043.p0" relation="true"/>
  </sentence>
  <sentence id="s1044" text="Global &lt;i&gt;Mpdz&lt;/i&gt; gene deletion or conditional inactivation in Nestin-positive cells led to formation of supratentorial hydrocephalus in the early postnatal period.">
    <entity charOffset="10-14" id="s1044.e0" ontology_id="84708" text="Mpdz" type="GENE"/>
    <entity charOffset="121-134" id="s1044.e1" ontology_id="HP_0000238" text="hydrocephalus" type="HP"/>
    <pair e1="s1044.e0" e2="s1044.e1" id="s1044.p0" relation="true"/>
  </sentence>
  <sentence id="s1045" text="&lt;i&gt;LCAM1&lt;/i&gt; and &lt;i&gt;MPDZ&lt;/i&gt; (&lt;i&gt;MUPP1&lt;/i&gt;) are the only known human gene loci associated with non-syndromic hydrocephalus.">
    <entity charOffset="20-24" id="s1045.e0" ontology_id="84708" text="MPDZ" type="GENE"/>
    <entity charOffset="109-122" id="s1045.e1" ontology_id="HP_0000238" text="hydrocephalus" type="HP"/>
    <pair e1="s1045.e0" e2="s1045.e1" id="s1045.p0" relation="true"/>
  </sentence>
  <sentence id="s1046" text="Expression of miR-17-92a miRNAs improved sensitivity of androgen dependent LNCaP 104-S prostate cancer cells to anti-androgen drug Casodex, AKT inhibitor MK-2206 2HCl, and docetaxel.">
    <entity charOffset="96-102" id="s1046.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="140-143" id="s1046.e1" ontology_id="207" text="AKT" type="GENE"/>
    <pair e1="s1046.e0" e2="s1046.e1" id="s1046.p0" relation="false"/>
  </sentence>
  <sentence id="s1047" text="Our study identifies WDR4 as an oncoprotein that negatively regulates PML via ubiquitination to promote lung cancer progression by fostering an immunosuppressive and prometastatic tumor microenvironment, suggesting the potential of immune-modulatory approaches for treating lung cancer with aberrant PML degradation">
    <entity charOffset="70-73" id="s1047.e0" ontology_id="5371" text="PML" type="GENE"/>
    <entity charOffset="180-185" id="s1047.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1047.e0" e2="s1047.e1" id="s1047.p0" relation="true"/>
  </sentence>
  <sentence id="s1048" text="The WDR4/PML axis induces a set of cell-surface or secreted factors, including CD73, urokinase-type plasminogen activator receptor (uPAR), and serum amyloid A2 (SAA2), which elicit paracrine effects to stimulate migration, invasion, and metastasis in multiple lung cancer models.">
    <entity charOffset="161-165" id="s1048.e0" ontology_id="6289" text="SAA2" type="GENE"/>
    <entity charOffset="265-271" id="s1048.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1048.e0" e2="s1048.e1" id="s1048.p0" relation="true"/>
  </sentence>
  <sentence id="s1049" text="NEK2 overexpression promotes tumorigenesis and is associated with poor prognosis in several cancers.">
    <entity charOffset="0-4" id="s1049.e0" ontology_id="4751" text="NEK2" type="GENE"/>
    <entity charOffset="92-98" id="s1049.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1049.e0" e2="s1049.e1" id="s1049.p0" relation="true"/>
  </sentence>
  <sentence id="s1050" text="The high levels of TNC expression in gastric GISTs was significantly associated with tumor size (P&amp;lt;.001), multivisceral resection (P=.006), metastasis at initial diagnosis (P=.006), mitotic count (P=.002) and NIH risk classification (P=.015).">
    <entity charOffset="19-22" id="s1050.e0" ontology_id="3371" text="TNC" type="GENE"/>
    <entity charOffset="85-90" id="s1050.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1050.e0" e2="s1050.e1" id="s1050.p0" relation="true"/>
  </sentence>
  <sentence id="s1051" text="In particular, the TMEM132D, SPTA1 and VPS13B genes were commonly mutated in both early and late stage tumors, primary tumors and metastases, and tumors before and after chemotherapy, as in the case of the TP53 and RB1 genes.">
    <entity charOffset="19-27" id="s1051.e0" ontology_id="121256" text="TMEM132D" type="GENE"/>
    <entity charOffset="103-109" id="s1051.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s1051.e0" e2="s1051.e1" id="s1051.p0" relation="true"/>
  </sentence>
  <sentence id="s1052" text="Recent GWAS completed for three types of common adult-onset glaucoma have identified novel loci for POAG (primary-open-angle glaucoma) (ABCA1, AFAP1, GMDS, PMM2, TGFBR3, FNDC3B, ARHGEF12, GAS7, FOXC1, ATXN2, TXNRD2); PACG (primary angle-closure glaucoma (EPDR1, CHAT, GLIS3, FERMT2, DPM2-FAM102); and exfoliation syndrome (XFS) glaucoma (CACNA1A).">
    <entity charOffset="60-68" id="s1052.e0" ontology_id="HP_0000501" text="glaucoma" type="HP"/>
    <entity charOffset="268-273" id="s1052.e1" ontology_id="169792" text="GLIS3" type="GENE"/>
    <pair e1="s1052.e0" e2="s1052.e1" id="s1052.p0" relation="true"/>
  </sentence>
  <sentence id="s1053" text="Recent GWAS completed for three types of common adult-onset glaucoma have identified novel loci for POAG (primary-open-angle glaucoma) (ABCA1, AFAP1, GMDS, PMM2, TGFBR3, FNDC3B, ARHGEF12, GAS7, FOXC1, ATXN2, TXNRD2); PACG (primary angle-closure glaucoma (EPDR1, CHAT, GLIS3, FERMT2, DPM2-FAM102); and exfoliation syndrome (XFS) glaucoma (CACNA1A).">
    <entity charOffset="60-68" id="s1053.e0" ontology_id="HP_0000501" text="glaucoma" type="HP"/>
    <entity charOffset="262-266" id="s1053.e1" ontology_id="1103" text="CHAT" type="GENE"/>
    <pair e1="s1053.e0" e2="s1053.e1" id="s1053.p0" relation="true"/>
  </sentence>
  <sentence id="s1054" text="Recent GWAS completed for three types of common adult-onset glaucoma have identified novel loci for POAG (primary-open-angle glaucoma) (ABCA1, AFAP1, GMDS, PMM2, TGFBR3, FNDC3B, ARHGEF12, GAS7, FOXC1, ATXN2, TXNRD2); PACG (primary angle-closure glaucoma (EPDR1, CHAT, GLIS3, FERMT2, DPM2-FAM102); and exfoliation syndrome (XFS) glaucoma (CACNA1A).">
    <entity charOffset="60-68" id="s1054.e0" ontology_id="HP_0000501" text="glaucoma" type="HP"/>
    <entity charOffset="162-168" id="s1054.e1" ontology_id="7049" text="TGFBR3" type="GENE"/>
    <pair e1="s1054.e0" e2="s1054.e1" id="s1054.p0" relation="true"/>
  </sentence>
  <sentence id="s1055" text="Recent GWAS completed for three types of common adult-onset glaucoma have identified novel loci for POAG (primary-open-angle glaucoma) (ABCA1, AFAP1, GMDS, PMM2, TGFBR3, FNDC3B, ARHGEF12, GAS7, FOXC1, ATXN2, TXNRD2); PACG (primary angle-closure glaucoma (EPDR1, CHAT, GLIS3, FERMT2, DPM2-FAM102); and exfoliation syndrome (XFS) glaucoma (CACNA1A).">
    <entity charOffset="60-68" id="s1055.e0" ontology_id="HP_0000501" text="glaucoma" type="HP"/>
    <entity charOffset="188-192" id="s1055.e1" ontology_id="8522" text="GAS7" type="GENE"/>
    <pair e1="s1055.e0" e2="s1055.e1" id="s1055.p0" relation="true"/>
  </sentence>
  <sentence id="s1056" text="Recent GWAS completed for three types of common adult-onset glaucoma have identified novel loci for POAG (primary-open-angle glaucoma) (ABCA1, AFAP1, GMDS, PMM2, TGFBR3, FNDC3B, ARHGEF12, GAS7, FOXC1, ATXN2, TXNRD2); PACG (primary angle-closure glaucoma (EPDR1, CHAT, GLIS3, FERMT2, DPM2-FAM102); and exfoliation syndrome (XFS) glaucoma (CACNA1A).">
    <entity charOffset="60-68" id="s1056.e0" ontology_id="HP_0000501" text="glaucoma" type="HP"/>
    <entity charOffset="208-214" id="s1056.e1" ontology_id="10587" text="TXNRD2" type="GENE"/>
    <pair e1="s1056.e0" e2="s1056.e1" id="s1056.p0" relation="true"/>
  </sentence>
  <sentence id="s1057" text="Recent GWAS completed for three types of common adult-onset glaucoma have identified novel loci for POAG (primary-open-angle glaucoma) (ABCA1, AFAP1, GMDS, PMM2, TGFBR3, FNDC3B, ARHGEF12, GAS7, FOXC1, ATXN2, TXNRD2); PACG (primary angle-closure glaucoma (EPDR1, CHAT, GLIS3, FERMT2, DPM2-FAM102); and exfoliation syndrome (XFS) glaucoma (CACNA1A).">
    <entity charOffset="60-68" id="s1057.e0" ontology_id="HP_0000501" text="glaucoma" type="HP"/>
    <entity charOffset="178-186" id="s1057.e1" ontology_id="23365" text="ARHGEF12" type="GENE"/>
    <pair e1="s1057.e0" e2="s1057.e1" id="s1057.p0" relation="true"/>
  </sentence>
  <sentence id="s1058" text="Recent studies have suggested possible therapeutic targets for some patients with early-onset glaucoma based on the molecular and cellular events caused by MYOC, OPTN and TBK1 mutations.">
    <entity charOffset="94-102" id="s1058.e0" ontology_id="HP_0000501" text="glaucoma" type="HP"/>
    <entity charOffset="162-166" id="s1058.e1" ontology_id="10133" text="OPTN" type="GENE"/>
    <pair e1="s1058.e0" e2="s1058.e1" id="s1058.p0" relation="true"/>
  </sentence>
  <sentence id="s1059" text="Currently the only established high penetrance familial melanoma genes are CDKN2A and CDK4.">
    <entity charOffset="56-64" id="s1059.e0" ontology_id="HP_0002861" text="melanoma" type="HP"/>
    <entity charOffset="75-81" id="s1059.e1" ontology_id="1029" text="CDKN2A" type="GENE"/>
    <pair e1="s1059.e0" e2="s1059.e1" id="s1059.p0" relation="true"/>
  </sentence>
  <sentence id="s1060" text="The classical mammalian isoforms of PLD are PLD1 and PLD2, and the levels of both mRNA were higher at the primary tumor sites than in normal kidney tissues.">
    <entity charOffset="53-57" id="s1060.e0" ontology_id="5338" text="PLD2" type="GENE"/>
    <entity charOffset="114-119" id="s1060.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1060.e0" e2="s1060.e1" id="s1060.p0" relation="true"/>
  </sentence>
  <sentence id="s1061" text="Notably, shRNA-mediated knockdown of PLD2 suppressed the growth and invasion of tumors in nude mouse xenograft models.">
    <entity charOffset="37-41" id="s1061.e0" ontology_id="5338" text="PLD2" type="GENE"/>
    <entity charOffset="80-85" id="s1061.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1061.e0" e2="s1061.e1" id="s1061.p0" relation="true"/>
  </sentence>
  <sentence id="s1062" text="As for genes relating to the tumor invasion of PLD2, we found that angiogenin (ANG) was positively regulated by PLD2.">
    <entity charOffset="29-34" id="s1062.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="79-82" id="s1062.e1" ontology_id="283" text="ANG" type="GENE"/>
    <pair e1="s1062.e0" e2="s1062.e1" id="s1062.p0" relation="false"/>
  </sentence>
  <sentence id="s1063" text="We will systematically examine seven genes (CHN1, MDH1, PCP4, RTN1, SLC14A1, SNAP25 and VSNL1) that are altered in the three neurodegenerative diseases.">
    <entity charOffset="62-66" id="s1063.e0" ontology_id="6252" text="RTN1" type="GENE"/>
    <entity charOffset="125-151" id="s1063.e1" ontology_id="HP_0002180" text="neurodegenerative diseases" type="HP"/>
    <pair e1="s1063.e0" e2="s1063.e1" id="s1063.p0" relation="true"/>
  </sentence>
  <sentence id="s1064" text="The therapeutic strategy to recover immune function through the restoration of impaired Tregs function with the mounting evidences regarding KRAS in autoimmune mediated disorder (MS, SLE, RA, T1D) suggest as working hypothesis the direct targeting KRAS activation using cancer-derived small molecules may be clinically relevant">
    <entity charOffset="141-145" id="s1064.e0" ontology_id="3845" text="KRAS" type="GENE"/>
    <entity charOffset="270-276" id="s1064.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1064.e0" e2="s1064.e1" id="s1064.p0" relation="false"/>
  </sentence>
  <sentence id="s1065" text="In order to investigate whether somatic THPO gene mutations play a role in sporadic pediatric myeloproliferative diseases, we performed a mutation screening of a large representative cohort of pediatric acute myeloid leukemia, myeloid leukemia of Down syndrome, and juvenile myelomonocytic leukemia samples and show that gain-of-function THPO mutations are extremely rare in sporadic pediatric myeloproliferative diseases">
    <entity charOffset="40-44" id="s1065.e0" ontology_id="7066" text="THPO" type="GENE"/>
    <entity charOffset="75-83" id="s1065.e1" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <pair e1="s1065.e0" e2="s1065.e1" id="s1065.p0" relation="true"/>
  </sentence>
  <sentence id="s1066" text="We summarize recent updates on the genes and related clinical syndromes involved in the pathogenesis of early-onset epileptic encephalopathies: Aristaless-related homeobox (ARX), cyclin-dependent kinase-like 5 (CDKL5), syntaxin-binding protein 1 (STXBP1), solute carrier family 25 member 22 (SLC25A22), nonerythrocytic -spectrin-1 (SPTAN1), phospholipase C1 (PLC1), membrane-associated guanylate kinase inverted-2 (MAGI2), polynucleotide kinase 3'-phosphatase (PNKP), sodium channel neuronal type 1 subunit (SCN1A), protocadherin 19 (PCDH19), and pyridoxamine 5-prime-phosphate oxidase (PNPO)">
    <entity charOffset="116-142" id="s1066.e0" ontology_id="HP_0200134" text="epileptic encephalopathies" type="HP"/>
    <entity charOffset="538-544" id="s1066.e1" ontology_id="57526" text="PCDH19" type="GENE"/>
    <pair e1="s1066.e0" e2="s1066.e1" id="s1066.p0" relation="true"/>
  </sentence>
  <sentence id="s1067" text="We summarize recent updates on the genes and related clinical syndromes involved in the pathogenesis of early-onset epileptic encephalopathies: Aristaless-related homeobox (ARX), cyclin-dependent kinase-like 5 (CDKL5), syntaxin-binding protein 1 (STXBP1), solute carrier family 25 member 22 (SLC25A22), nonerythrocytic -spectrin-1 (SPTAN1), phospholipase C1 (PLC1), membrane-associated guanylate kinase inverted-2 (MAGI2), polynucleotide kinase 3'-phosphatase (PNKP), sodium channel neuronal type 1 subunit (SCN1A), protocadherin 19 (PCDH19), and pyridoxamine 5-prime-phosphate oxidase (PNPO)">
    <entity charOffset="116-142" id="s1067.e0" ontology_id="HP_0200134" text="epileptic encephalopathies" type="HP"/>
    <entity charOffset="211-216" id="s1067.e1" ontology_id="6792" text="CDKL5" type="GENE"/>
    <pair e1="s1067.e0" e2="s1067.e1" id="s1067.p0" relation="true"/>
  </sentence>
  <sentence id="s1068" text="We summarize recent updates on the genes and related clinical syndromes involved in the pathogenesis of early-onset epileptic encephalopathies: Aristaless-related homeobox (ARX), cyclin-dependent kinase-like 5 (CDKL5), syntaxin-binding protein 1 (STXBP1), solute carrier family 25 member 22 (SLC25A22), nonerythrocytic -spectrin-1 (SPTAN1), phospholipase C1 (PLC1), membrane-associated guanylate kinase inverted-2 (MAGI2), polynucleotide kinase 3'-phosphatase (PNKP), sodium channel neuronal type 1 subunit (SCN1A), protocadherin 19 (PCDH19), and pyridoxamine 5-prime-phosphate oxidase (PNPO)">
    <entity charOffset="116-142" id="s1068.e0" ontology_id="HP_0200134" text="epileptic encephalopathies" type="HP"/>
    <entity charOffset="418-423" id="s1068.e1" ontology_id="9863" text="MAGI2" type="GENE"/>
    <pair e1="s1068.e0" e2="s1068.e1" id="s1068.p0" relation="true"/>
  </sentence>
  <sentence id="s1069" text="Overall, our results define an oncogenic role of &lt;i&gt;pancEts-1&lt;/i&gt; in neuroblastoma progression through hnRNPK-mediated -catenin stabilization, with potential implications for the clinical therapeutics of neuroblastoma.&lt;b&gt;Significance:&lt;/b&gt; These findings reveal the oncogenic functions of a long noncoding RNA in neuroblastoma progression, offering a potential target for clinical therapeutics.">
    <entity charOffset="69-82" id="s1069.e0" ontology_id="HP_0003006" text="neuroblastoma" type="HP"/>
    <entity charOffset="103-109" id="s1069.e1" ontology_id="3190" text="hnRNPK" type="GENE"/>
    <pair e1="s1069.e0" e2="s1069.e1" id="s1069.p0" relation="true"/>
  </sentence>
  <sentence id="s1070" text="Both &lt;i&gt;pancEts-1&lt;/i&gt; and &lt;i&gt;hnRNPK&lt;/i&gt; were upregulated in clinical neuroblastoma tissues, and were associated with unfavorable outcome of patients.">
    <entity charOffset="29-35" id="s1070.e0" ontology_id="3190" text="hnRNPK" type="GENE"/>
    <entity charOffset="69-82" id="s1070.e1" ontology_id="HP_0003006" text="neuroblastoma" type="HP"/>
    <pair e1="s1070.e0" e2="s1070.e1" id="s1070.p0" relation="true"/>
  </sentence>
  <sentence id="s1071" text="Meier-Gorlin syndrome (MGS) is a genetically heterogeneous primordial dwarfism syndrome known to be caused by biallelic loss-of-function mutations in one of five genes encoding pre-replication complex proteins: ORC1, ORC4, ORC6, CDT1, and CDC6.">
    <entity charOffset="45-58" id="s1071.e0" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <entity charOffset="223-227" id="s1071.e1" ontology_id="23594" text="ORC6" type="GENE"/>
    <pair e1="s1071.e0" e2="s1071.e1" id="s1071.p0" relation="true"/>
  </sentence>
  <sentence id="s1072" text="Meier-Gorlin syndrome (MGS) is a genetically heterogeneous primordial dwarfism syndrome known to be caused by biallelic loss-of-function mutations in one of five genes encoding pre-replication complex proteins: ORC1, ORC4, ORC6, CDT1, and CDC6.">
    <entity charOffset="45-58" id="s1072.e0" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <entity charOffset="217-221" id="s1072.e1" ontology_id="5000" text="ORC4" type="GENE"/>
    <pair e1="s1072.e0" e2="s1072.e1" id="s1072.p0" relation="true"/>
  </sentence>
  <sentence id="s1073" text="Multiple mitochondrial dysfunction syndrome 1 (MMDS1) arises as a result of the missense mutation in NFU1, an Fe/S cluster scaffold protein, which substitutes a glycine near the Fe/S cluster-binding pocket to a cysteine (p.Gly208Cys).">
    <entity charOffset="9-34" id="s1073.e0" ontology_id="HP_0003287" text="mitochondrial dysfunction" type="HP"/>
    <entity charOffset="101-105" id="s1073.e1" ontology_id="27247" text="NFU1" type="GENE"/>
    <pair e1="s1073.e0" e2="s1073.e1" id="s1073.p0" relation="true"/>
  </sentence>
  <sentence id="s1074" text="Retrospectively study revealed that miR-34a expression was downregulated in human primary GC tissues compared with non-tumor tissues and low miR-34a expression was associated with a significantly shorter overall survival and disease-free survival.">
    <entity charOffset="36-39" id="s1074.e0" ontology_id="220972" text="miR" type="GENE"/>
    <entity charOffset="119-124" id="s1074.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1074.e0" e2="s1074.e1" id="s1074.p0" relation="true"/>
  </sentence>
  <sentence id="s1075" text="However, the relationship between miR-34a and luteolin's susceptibility to cancer cells still remains unclear.">
    <entity charOffset="34-37" id="s1075.e0" ontology_id="220972" text="miR" type="GENE"/>
    <entity charOffset="75-81" id="s1075.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1075.e0" e2="s1075.e1" id="s1075.p0" relation="true"/>
  </sentence>
  <sentence id="s1076" text="This case unravels a previously unrecognized phenotype of camptodactyly due to a significant skeletal deformity of PRS with a heterogeneous PAX2 mutation of hexanucleotide duplication.">
    <entity charOffset="126-139" id="s1076.e0" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <entity charOffset="140-144" id="s1076.e1" ontology_id="5076" text="PAX2" type="GENE"/>
    <pair e1="s1076.e0" e2="s1076.e1" id="s1076.p0" relation="true"/>
  </sentence>
  <sentence id="s1077" text="The mTOR pathway was significantly associated with overall and estrogen receptor-negative (ER-) breast cancer risk (P = 0.003 and 0.03, respectively).">
    <entity charOffset="4-8" id="s1077.e0" ontology_id="2475" text="mTOR" type="GENE"/>
    <entity charOffset="103-109" id="s1077.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1077.e0" e2="s1077.e1" id="s1077.p0" relation="true"/>
  </sentence>
  <sentence id="s1078" text="PRKAG3 (Padj = 0.0018) and RPS6KA3 (Padj = 0.061) were the leading genes for the associations with overall breast cancer risk and ER- breast cancer risk, respectively.">
    <entity charOffset="0-6" id="s1078.e0" ontology_id="53632" text="PRKAG3" type="GENE"/>
    <entity charOffset="114-120" id="s1078.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1078.e0" e2="s1078.e1" id="s1078.p0" relation="true"/>
  </sentence>
  <sentence id="s1079" text="CaSR expression is lost in colonic malignancies, indicating that the CaSR is a biomarker for colonic cancer progression.">
    <entity charOffset="0-4" id="s1079.e0" ontology_id="846" text="CaSR" type="GENE"/>
    <entity charOffset="101-107" id="s1079.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1079.e0" e2="s1079.e1" id="s1079.p0" relation="true"/>
  </sentence>
  <sentence id="s1080" text="More important, Col5a2 haploinsufficiency markedly increased the incidence and severity of abdominal aortic aneurysms, and caused aortic arch ruptures and dissections, indicating that 2(V) chain deficits may play roles in these pathologies in humans">
    <entity charOffset="16-22" id="s1080.e0" ontology_id="1290" text="Col5a2" type="GENE"/>
    <entity charOffset="101-117" id="s1080.e1" ontology_id="HP_0004942" text="aortic aneurysms" type="HP"/>
    <pair e1="s1080.e0" e2="s1080.e1" id="s1080.p0" relation="true"/>
  </sentence>
  <sentence id="s1081" text="We aimed to investigate the effect of the AS to FEZF1 gene on non-small cell lung cancer (NSCLC) development.">
    <entity charOffset="48-53" id="s1081.e0" ontology_id="389549" text="FEZF1" type="GENE"/>
    <entity charOffset="82-88" id="s1081.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1081.e0" e2="s1081.e1" id="s1081.p0" relation="true"/>
  </sentence>
  <sentence id="s1082" text="By GEPIA database analysis, we also found that the expression of lncRNA FEZF-AS1 and FEZF1 were significantly higher in tumour tissues than those of the adjacent non-cancerous tissues in 969 NSCLC patients (P&amp;lt;0.05), and lncRNA FEZF-AS1 was positively correlated with FEZF1 (r=0.90, P&amp;lt;0.001).">
    <entity charOffset="85-90" id="s1082.e0" ontology_id="389549" text="FEZF1" type="GENE"/>
    <entity charOffset="120-126" id="s1082.e1" ontology_id="HP_0002664" text="tumour" type="HP"/>
    <pair e1="s1082.e0" e2="s1082.e1" id="s1082.p0" relation="true"/>
  </sentence>
  <sentence id="s1083" text="A systematic study of serial samples from 30 patients show that ASXL1 c.1934dupG is a somatic mutation in haematological neoplasms including MDS, AML, MPN and MDS/MPN and often is associated with somatic mutations of TET2, EZH2, IDH2, RUNX1, NRAS and DNMT3A.">
    <entity charOffset="86-102" id="s1083.e0" ontology_id="HP_0001428" text="somatic mutation" type="HP"/>
    <entity charOffset="242-246" id="s1083.e1" ontology_id="4893" text="NRAS" type="GENE"/>
    <pair e1="s1083.e0" e2="s1083.e1" id="s1083.p0" relation="true"/>
  </sentence>
  <sentence id="s1084" text="A systematic study of serial samples from 30 patients show that ASXL1 c.1934dupG is a somatic mutation in haematological neoplasms including MDS, AML, MPN and MDS/MPN and often is associated with somatic mutations of TET2, EZH2, IDH2, RUNX1, NRAS and DNMT3A.">
    <entity charOffset="86-102" id="s1084.e0" ontology_id="HP_0001428" text="somatic mutation" type="HP"/>
    <entity charOffset="217-221" id="s1084.e1" ontology_id="54790" text="TET2" type="GENE"/>
    <pair e1="s1084.e0" e2="s1084.e1" id="s1084.p0" relation="true"/>
  </sentence>
  <sentence id="s1085" text="A systematic study of serial samples from 30 patients show that ASXL1 c.1934dupG is a somatic mutation in haematological neoplasms including MDS, AML, MPN and MDS/MPN and often is associated with somatic mutations of TET2, EZH2, IDH2, RUNX1, NRAS and DNMT3A.">
    <entity charOffset="86-102" id="s1085.e0" ontology_id="HP_0001428" text="somatic mutation" type="HP"/>
    <entity charOffset="235-240" id="s1085.e1" ontology_id="861" text="RUNX1" type="GENE"/>
    <pair e1="s1085.e0" e2="s1085.e1" id="s1085.p0" relation="true"/>
  </sentence>
  <sentence id="s1086" text="A systematic study of serial samples from 30 patients show that ASXL1 c.1934dupG is a somatic mutation in haematological neoplasms including MDS, AML, MPN and MDS/MPN and often is associated with somatic mutations of TET2, EZH2, IDH2, RUNX1, NRAS and DNMT3A.">
    <entity charOffset="121-130" id="s1086.e0" ontology_id="HP_0002664" text="neoplasms" type="HP"/>
    <entity charOffset="223-227" id="s1086.e1" ontology_id="2146" text="EZH2" type="GENE"/>
    <pair e1="s1086.e0" e2="s1086.e1" id="s1086.p0" relation="false"/>
  </sentence>
  <sentence id="s1087" text="When stratified by tumor histology, three SNPs (ENO1 rs2274971A&amp;gt;G, PFKM rs11168417C&amp;gt;T, and PDK2 rs3785921G&amp;gt;A) were significantly associated with OS and/or DFS only in squamous cell carcinoma, whereas PFKP rs1132173C&amp;gt;T exhibited a significant association with survival outcomes only in adenocarcinoma.">
    <entity charOffset="19-24" id="s1087.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="101-105" id="s1087.e1" ontology_id="5164" text="PDK2" type="GENE"/>
    <pair e1="s1087.e0" e2="s1087.e1" id="s1087.p0" relation="false"/>
  </sentence>
  <sentence id="s1088" text="When stratified by tumor histology, three SNPs (ENO1 rs2274971A&amp;gt;G, PFKM rs11168417C&amp;gt;T, and PDK2 rs3785921G&amp;gt;A) were significantly associated with OS and/or DFS only in squamous cell carcinoma, whereas PFKP rs1132173C&amp;gt;T exhibited a significant association with survival outcomes only in adenocarcinoma.">
    <entity charOffset="19-24" id="s1088.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="215-219" id="s1088.e1" ontology_id="5214" text="PFKP" type="GENE"/>
    <pair e1="s1088.e0" e2="s1088.e1" id="s1088.p0" relation="false"/>
  </sentence>
  <sentence id="s1089" text="When stratified by tumor histology, three SNPs (ENO1 rs2274971A&amp;gt;G, PFKM rs11168417C&amp;gt;T, and PDK2 rs3785921G&amp;gt;A) were significantly associated with OS and/or DFS only in squamous cell carcinoma, whereas PFKP rs1132173C&amp;gt;T exhibited a significant association with survival outcomes only in adenocarcinoma.">
    <entity charOffset="101-105" id="s1089.e0" ontology_id="5164" text="PDK2" type="GENE"/>
    <entity charOffset="182-205" id="s1089.e1" ontology_id="HP_0002860" text="squamous cell carcinoma" type="HP"/>
    <pair e1="s1089.e0" e2="s1089.e1" id="s1089.p0" relation="true"/>
  </sentence>
  <sentence id="s1090" text="Hypermethylated in cancer 1 (HIC1) is frequently deleted or epigenetically silenced in various human cancers.">
    <entity charOffset="19-25" id="s1090.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="29-33" id="s1090.e1" ontology_id="3090" text="HIC1" type="GENE"/>
    <pair e1="s1090.e0" e2="s1090.e1" id="s1090.p0" relation="true"/>
  </sentence>
  <sentence id="s1091" text="The results provide evidence that lncRNA-numb is a newly proposed tumor suppressor that is involved in HIC1-induced phenotypes.">
    <entity charOffset="66-71" id="s1091.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="103-107" id="s1091.e1" ontology_id="3090" text="HIC1" type="GENE"/>
    <pair e1="s1091.e0" e2="s1091.e1" id="s1091.p0" relation="false"/>
  </sentence>
  <sentence id="s1092" text="In this study, we present a male child demonstrating recurrent febrile episodes, spasticity, and basal ganglia calcification suggestive of Aicardi-Goutires syndrome, who carries the same Arg822Gln mutation in IFIH1 previously associated with SMS.">
    <entity charOffset="81-91" id="s1092.e0" ontology_id="HP_0001257" text="spasticity" type="HP"/>
    <entity charOffset="210-215" id="s1092.e1" ontology_id="64135" text="IFIH1" type="GENE"/>
    <pair e1="s1092.e0" e2="s1092.e1" id="s1092.p0" relation="true"/>
  </sentence>
  <sentence id="s1093" text="De novo missense and frameshift mutations and deletions involving TBL1XR1 have been described in patients with intellectual disability and autism, but without any of the dysmorphic findings or malformations associated with Pierpont syndrome, implying a mutation-specific mechanism for the pathogenicity of p.Tyr446Cys.">
    <entity charOffset="66-73" id="s1093.e0" ontology_id="79718" text="TBL1XR1" type="GENE"/>
    <entity charOffset="139-145" id="s1093.e1" ontology_id="HP_0000717" text="autism" type="HP"/>
    <pair e1="s1093.e0" e2="s1093.e1" id="s1093.p0" relation="true"/>
  </sentence>
  <sentence id="s1094" text="Here, we report mutations in PYCR2, which encodes an enzyme in the proline biosynthesis pathway, as the cause of a unique syndrome characterized by postnatal microcephaly, hypomyelination, and reduced cerebral white-matter volume.">
    <entity charOffset="29-34" id="s1094.e0" ontology_id="29920" text="PYCR2" type="GENE"/>
    <entity charOffset="158-170" id="s1094.e1" ontology_id="HP_0000252" text="microcephaly" type="HP"/>
    <pair e1="s1094.e0" e2="s1094.e1" id="s1094.p0" relation="true"/>
  </sentence>
  <sentence id="s1095" text="GATA3, a critical transcription factor involved in the development of the mammary gland, also plays important roles in mammary tumorigenesis by regulating transcription in coordination with two essential DNA repair factors, PARP1 and BRCA1.">
    <entity charOffset="0-5" id="s1095.e0" ontology_id="2625" text="GATA3" type="GENE"/>
    <entity charOffset="127-132" id="s1095.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1095.e0" e2="s1095.e1" id="s1095.p0" relation="true"/>
  </sentence>
  <sentence id="s1096" text="In addition, through data mining analysis, we observed an extremely strong correlation between the expression levels of GATA3 and CtIP in paratumors, but the correlation turned insignificant in mammary tumors.">
    <entity charOffset="130-134" id="s1096.e0" ontology_id="5932" text="CtIP" type="GENE"/>
    <entity charOffset="142-148" id="s1096.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s1096.e0" e2="s1096.e1" id="s1096.p0" relation="true"/>
  </sentence>
  <sentence id="s1097" text="Using vectors encoding GATA3 with mutations frequently occurring in mammary tumors, we found that several mutations on GATA3 led to a dysregulation of CtIP, and therefore HR repair.">
    <entity charOffset="23-28" id="s1097.e0" ontology_id="2625" text="GATA3" type="GENE"/>
    <entity charOffset="76-82" id="s1097.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s1097.e0" e2="s1097.e1" id="s1097.p0" relation="true"/>
  </sentence>
  <sentence id="s1098" text="Multivariate analysis data revealed that ERCC1 and survivin protein expression were independent predictors of overall survival of ESCC patients after chemotherapy and/or radiotherapy (P&amp;lt;.05).ERCC1 overexpression is an important phenotype that is associated with ESCC lymph node metastasis and advanced tumor clinical stages.">
    <entity charOffset="41-46" id="s1098.e0" ontology_id="2067" text="ERCC1" type="GENE"/>
    <entity charOffset="307-312" id="s1098.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1098.e0" e2="s1098.e1" id="s1098.p0" relation="false"/>
  </sentence>
  <sentence id="s1099" text="Multivariate analysis data revealed that ERCC1 and survivin protein expression were independent predictors of overall survival of ESCC patients after chemotherapy and/or radiotherapy (P&amp;lt;.05).ERCC1 overexpression is an important phenotype that is associated with ESCC lymph node metastasis and advanced tumor clinical stages.">
    <entity charOffset="51-59" id="s1099.e0" ontology_id="332" text="survivin" type="GENE"/>
    <entity charOffset="307-312" id="s1099.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1099.e0" e2="s1099.e1" id="s1099.p0" relation="false"/>
  </sentence>
  <sentence id="s1100" text="ERCC1 overexpression associated with advanced tumor clinical stage and lymph node metastasis (P&amp;lt;.05), but not with tumor size, depth of invasion, or differentiation (P&amp;gt;.05).">
    <entity charOffset="0-5" id="s1100.e0" ontology_id="2067" text="ERCC1" type="GENE"/>
    <entity charOffset="46-51" id="s1100.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1100.e0" e2="s1100.e1" id="s1100.p0" relation="true"/>
  </sentence>
  <sentence id="s1101" text="Using homozygosity mapping followed by exome sequencing, we identified a Thr224Asn mutation in the VPS45 gene in infants from consanguineous families who suffered from life-threatening neutropenia, which was refractory to granulocyte CSF, from defective platelet aggregation and myelofibrosis.">
    <entity charOffset="99-104" id="s1101.e0" ontology_id="11311" text="VPS45" type="GENE"/>
    <entity charOffset="244-274" id="s1101.e1" ontology_id="HP_0003540" text="defective platelet aggregation" type="HP"/>
    <pair e1="s1101.e0" e2="s1101.e1" id="s1101.p0" relation="true"/>
  </sentence>
  <sentence id="s1102" text="Importantly, cell line and animal experiments both confirmed that E2F6 promotes ovarian cancer stemness, whereas E2F6 or EZH2 depletion derepressed miR-193a, which opposes cancer stemness, by alleviating DNA methylation and repressive chromatin.">
    <entity charOffset="88-94" id="s1102.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="121-125" id="s1102.e1" ontology_id="2146" text="EZH2" type="GENE"/>
    <pair e1="s1102.e0" e2="s1102.e1" id="s1102.p0" relation="false"/>
  </sentence>
  <sentence id="s1103" text="To decipher a mechanism for this, we previously generated a mathematical model of how estrogen-mediated upregulation of the transcription factor, E2F6, upregulates the ovarian cancer stem/initiating cell marker, c-Kit, by epigenetic silencing the tumor suppressor miR-193a, and a competing endogenous (ceRNA) mechanism.">
    <entity charOffset="212-217" id="s1103.e0" ontology_id="3815" text="c-Kit" type="GENE"/>
    <entity charOffset="247-252" id="s1103.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1103.e0" e2="s1103.e1" id="s1103.p0" relation="true"/>
  </sentence>
  <sentence id="s1104" text="We found that MYST3 was amplified in 11% and/or overexpressed in 15% of breast tumors, and overexpression of MYST3 correlated with worse clinical outcome in estrogen receptor+ (ER+) breast cancers.">
    <entity charOffset="14-19" id="s1104.e0" ontology_id="7994" text="MYST3" type="GENE"/>
    <entity charOffset="189-195" id="s1104.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1104.e0" e2="s1104.e1" id="s1104.p0" relation="false"/>
  </sentence>
  <sentence id="s1105" text="Our study shows that in neuroblastomas, AURKB- or GMNN-based PI provides valuable prognostic information and high PI indicates aggressive disease">
    <entity charOffset="24-38" id="s1105.e0" ontology_id="HP_0003006" text="neuroblastomas" type="HP"/>
    <entity charOffset="50-54" id="s1105.e1" ontology_id="51053" text="GMNN" type="GENE"/>
    <pair e1="s1105.e0" e2="s1105.e1" id="s1105.p0" relation="false"/>
  </sentence>
  <sentence id="s1106" text="Our study shows that in neuroblastomas, AURKB- or GMNN-based PI provides valuable prognostic information and high PI indicates aggressive disease">
    <entity charOffset="24-38" id="s1106.e0" ontology_id="HP_0003006" text="neuroblastomas" type="HP"/>
    <entity charOffset="40-45" id="s1106.e1" ontology_id="9212" text="AURKB" type="GENE"/>
    <pair e1="s1106.e0" e2="s1106.e1" id="s1106.p0" relation="false"/>
  </sentence>
  <sentence id="s1107" text="By whole-exome sequencing, recessive protein-truncating mutations in CWC27 were found in seven unrelated families that show a range of clinical phenotypes, including retinal degeneration, brachydactyly, craniofacial abnormalities, short stature, and neurological defects.">
    <entity charOffset="69-74" id="s1107.e0" ontology_id="10283" text="CWC27" type="GENE"/>
    <entity charOffset="231-244" id="s1107.e1" ontology_id="HP_0004322" text="short stature" type="HP"/>
    <pair e1="s1107.e0" e2="s1107.e1" id="s1107.p0" relation="true"/>
  </sentence>
  <sentence id="s1108" text="By whole-exome sequencing, recessive protein-truncating mutations in CWC27 were found in seven unrelated families that show a range of clinical phenotypes, including retinal degeneration, brachydactyly, craniofacial abnormalities, short stature, and neurological defects.">
    <entity charOffset="69-74" id="s1108.e0" ontology_id="10283" text="CWC27" type="GENE"/>
    <entity charOffset="166-186" id="s1108.e1" ontology_id="HP_0000546" text="retinal degeneration" type="HP"/>
    <pair e1="s1108.e0" e2="s1108.e1" id="s1108.p0" relation="true"/>
  </sentence>
  <sentence id="s1109" text="Remarkably, variable expressivity of the human phenotype can be recapitulated in Cwc27 mutant mouse models, with significant embryonic lethality and severe phenotypes in the complete knockout mice while mice with a partial loss-of-function allele mimic the isolated retinal degeneration phenotype.">
    <entity charOffset="81-86" id="s1109.e0" ontology_id="10283" text="Cwc27" type="GENE"/>
    <entity charOffset="266-286" id="s1109.e1" ontology_id="HP_0000546" text="retinal degeneration" type="HP"/>
    <pair e1="s1109.e0" e2="s1109.e1" id="s1109.p0" relation="true"/>
  </sentence>
  <sentence id="s1110" text="The abnormal regulation of miR-483 may play an important role in tumorigenesis, and Par3 is known to regulate cell polarity, cell migration, and cell division.">
    <entity charOffset="27-30" id="s1110.e0" ontology_id="220972" text="miR" type="GENE"/>
    <entity charOffset="65-70" id="s1110.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1110.e0" e2="s1110.e1" id="s1110.p0" relation="true"/>
  </sentence>
  <sentence id="s1111" text="The abnormal regulation of miR-483 may play an important role in tumorigenesis, and Par3 is known to regulate cell polarity, cell migration, and cell division.">
    <entity charOffset="65-70" id="s1111.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="84-88" id="s1111.e1" ontology_id="2151" text="Par3" type="GENE"/>
    <pair e1="s1111.e0" e2="s1111.e1" id="s1111.p0" relation="false"/>
  </sentence>
  <sentence id="s1112" text="&lt;i&gt;Results:&lt;/i&gt; The number of positive cells of TAZ and YAP in malignant melanoma tumor tissues was significantly higher than that in melanocytic nevi tissues, and the expression of both proteins was positively correlated with malignant melanoma (r = 0.687, P &amp;lt;0.01); TAZ and YAP protein expression in malignant melanoma tissue was significantly correlated with tumor thickness, invasive depth grade, lymph node metastasis and TNM stages (P &amp;lt;0.05), and increased with TNM staging.">
    <entity charOffset="48-51" id="s1112.e0" ontology_id="25937" text="TAZ" type="GENE"/>
    <entity charOffset="82-87" id="s1112.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1112.e0" e2="s1112.e1" id="s1112.p0" relation="true"/>
  </sentence>
  <sentence id="s1113" text="&lt;i&gt;Results:&lt;/i&gt; The number of positive cells of TAZ and YAP in malignant melanoma tumor tissues was significantly higher than that in melanocytic nevi tissues, and the expression of both proteins was positively correlated with malignant melanoma (r = 0.687, P &amp;lt;0.01); TAZ and YAP protein expression in malignant melanoma tissue was significantly correlated with tumor thickness, invasive depth grade, lymph node metastasis and TNM stages (P &amp;lt;0.05), and increased with TNM staging.">
    <entity charOffset="56-59" id="s1113.e0" ontology_id="55249" text="YAP" type="GENE"/>
    <entity charOffset="82-87" id="s1113.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1113.e0" e2="s1113.e1" id="s1113.p0" relation="true"/>
  </sentence>
  <sentence id="s1114" text="Few studies have examined the roles of CRELD1 and GATA4 in cardiac abnormalities or their association with pulmonary artery histopathology.">
    <entity charOffset="39-45" id="s1114.e0" ontology_id="78987" text="CRELD1" type="GENE"/>
    <entity charOffset="59-80" id="s1114.e1" ontology_id="HP_0001627" text="cardiac abnormalities" type="HP"/>
    <pair e1="s1114.e0" e2="s1114.e1" id="s1114.p0" relation="true"/>
  </sentence>
  <sentence id="s1115" text="The melanogenic activity of 6-benzylaminopurine, the compound identified as the most potent, was further verified by measuring green fluorescent protein concentration in tyrp1 a: eGFP (tyrosinase-related protein 1) zebrafish and mitfa: eGFP (microphthalmia associated transcription factor) zebrafish and antioxidative activity.">
    <entity charOffset="170-175" id="s1115.e0" ontology_id="7306" text="tyrp1" type="GENE"/>
    <entity charOffset="242-256" id="s1115.e1" ontology_id="HP_0000568" text="microphthalmia" type="HP"/>
    <pair e1="s1115.e0" e2="s1115.e1" id="s1115.p0" relation="false"/>
  </sentence>
  <sentence id="s1116" text="Here, we applied next-generation sequencing in 89 patients with a clinical diagnosis of distal renal tubular acidosis, analyzing the prevalence of genetic defects in SLC4A1, ATP6V0A4, and ATP6V1B1 genes and the clinical phenotype.">
    <entity charOffset="88-117" id="s1116.e0" ontology_id="HP_0008341" text="distal renal tubular acidosis" type="HP"/>
    <entity charOffset="188-196" id="s1116.e1" ontology_id="525" text="ATP6V1B1" type="GENE"/>
    <pair e1="s1116.e0" e2="s1116.e1" id="s1116.p0" relation="true"/>
  </sentence>
  <sentence id="s1117" text="Cerebellar involvement is an important feature of PMM2-CDG, the congenital muscular dystrophies due to dystroglycanopathy, and SRD5A3-CDG.">
    <entity charOffset="50-54" id="s1117.e0" ontology_id="5373" text="PMM2" type="GENE"/>
    <entity charOffset="75-95" id="s1117.e1" ontology_id="HP_0003560" text="muscular dystrophies" type="HP"/>
    <pair e1="s1117.e0" e2="s1117.e1" id="s1117.p0" relation="false"/>
  </sentence>
  <sentence id="s1118" text="Cerebellar involvement is an important feature of PMM2-CDG, the congenital muscular dystrophies due to dystroglycanopathy, and SRD5A3-CDG.">
    <entity charOffset="75-95" id="s1118.e0" ontology_id="HP_0003560" text="muscular dystrophies" type="HP"/>
    <entity charOffset="127-133" id="s1118.e1" ontology_id="79644" text="SRD5A3" type="GENE"/>
    <pair e1="s1118.e0" e2="s1118.e1" id="s1118.p0" relation="false"/>
  </sentence>
  <sentence id="s1119" text="Double-labeling immunohistochemistry for Pit-1/GH, Pit-1/NFP, Pit-1/MAP2, and NeuN/GH was performed in 9/10 tumors.">
    <entity charOffset="78-82" id="s1119.e0" ontology_id="146713" text="NeuN" type="GENE"/>
    <entity charOffset="108-114" id="s1119.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s1119.e0" e2="s1119.e1" id="s1119.p0" relation="true"/>
  </sentence>
  <sentence id="s1120" text="We investigate the association of MUC1 with castration-resistant prostate cancer (CRPC), bone metastasis, and PC recurrence.">
    <entity charOffset="34-38" id="s1120.e0" ontology_id="4582" text="MUC1" type="GENE"/>
    <entity charOffset="74-80" id="s1120.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1120.e0" e2="s1120.e1" id="s1120.p0" relation="true"/>
  </sentence>
  <sentence id="s1121" text="Logistic regression analysis adjusted for age and gender reported a moderate association between rectal cancer risk and two NLRC5 SNPs, rs1684575 T&amp;gt;G (OR: 1.60, 95% CI: 1.13-2.27, recessive model) and rs3751710 (OR: 0.70, 95% CI: 0.51-0.96, dominant model).">
    <entity charOffset="104-110" id="s1121.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="124-129" id="s1121.e1" ontology_id="84166" text="NLRC5" type="GENE"/>
    <pair e1="s1121.e0" e2="s1121.e1" id="s1121.p0" relation="true"/>
  </sentence>
  <sentence id="s1122" text="Constitutive activation of interferon signaling pathways has been reported in colorectal cancer (CRC), leading to a strong CD8+ T cell response through stimulation of NLRC5 expression.">
    <entity charOffset="89-95" id="s1122.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="167-172" id="s1122.e1" ontology_id="84166" text="NLRC5" type="GENE"/>
    <pair e1="s1122.e0" e2="s1122.e1" id="s1122.p0" relation="false"/>
  </sentence>
  <sentence id="s1123" text="Additionally, CXCL1 increases the metastatic ability of a cancer by enhancing cell migration, matrix metalloproteinase-7 expression and EMT.">
    <entity charOffset="14-19" id="s1123.e0" ontology_id="2919" text="CXCL1" type="GENE"/>
    <entity charOffset="58-64" id="s1123.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1123.e0" e2="s1123.e1" id="s1123.p0" relation="true"/>
  </sentence>
  <sentence id="s1124" text="Inflammatory chemokine CXCL1, present in large amounts in DCs isolated from colon cancer patients, and SW620-conditioned TADCs, enhance CSC characteristics in cancer, supported by enhanced anchorage-independent growth, CD133 expression and aldehyde dehydrogenase activity.">
    <entity charOffset="23-28" id="s1124.e0" ontology_id="2919" text="CXCL1" type="GENE"/>
    <entity charOffset="82-88" id="s1124.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1124.e0" e2="s1124.e1" id="s1124.p0" relation="true"/>
  </sentence>
  <sentence id="s1125" text="Transcriptome analysis of CXCL1-treated SW620 cells indicates that CXCL1 increases potential oncogene expression in colon cancer, including &lt;i&gt;PTHLH&lt;/i&gt;, &lt;i&gt;TYRP1&lt;/i&gt;, &lt;i&gt;FOXO1&lt;/i&gt;, &lt;i&gt;TCF4&lt;/i&gt; and &lt;i&gt;ZNF880&lt;/i&gt;.">
    <entity charOffset="26-31" id="s1125.e0" ontology_id="2919" text="CXCL1" type="GENE"/>
    <entity charOffset="122-128" id="s1125.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1125.e0" e2="s1125.e1" id="s1125.p0" relation="true"/>
  </sentence>
  <sentence id="s1126" text="WES also unraveled pathogenic mutations in genes not commonly linked to FTD, including mutations in Alzheimer (PSEN1, PSEN2), lysosomal (CTSF, 7-exon macro-deletion) and cholesterol homeostasis pathways (CYP27A1).ConclusionOur unbiased approach reveals a wide genetic spectrum underlying clinical FTD, including 11% of seemingly sporadic FTD.">
    <entity charOffset="204-211" id="s1126.e0" ontology_id="1593" text="CYP27A1" type="GENE"/>
    <entity charOffset="329-337" id="s1126.e1" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <pair e1="s1126.e0" e2="s1126.e1" id="s1126.p0" relation="false"/>
  </sentence>
  <sentence id="s1127" text="These include other keratin genes for monilethrix, the HR gene for atrichia congenita, the genes CDSN, APCDD1 and SNRPE for the autosomal dominant form of hypotrichosis simplex, and the genes DSG4, LIPH and LPAR6 for the autosomal recessive forms of hypotrichosis as well as U2HR for hypotrichosis type Marie Unna.">
    <entity charOffset="103-109" id="s1127.e0" ontology_id="147495" text="APCDD1" type="GENE"/>
    <entity charOffset="221-240" id="s1127.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s1127.e0" e2="s1127.e1" id="s1127.p0" relation="false"/>
  </sentence>
  <sentence id="s1128" text="These include other keratin genes for monilethrix, the HR gene for atrichia congenita, the genes CDSN, APCDD1 and SNRPE for the autosomal dominant form of hypotrichosis simplex, and the genes DSG4, LIPH and LPAR6 for the autosomal recessive forms of hypotrichosis as well as U2HR for hypotrichosis type Marie Unna.">
    <entity charOffset="207-212" id="s1128.e0" ontology_id="10161" text="LPAR6" type="GENE"/>
    <entity charOffset="221-240" id="s1128.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s1128.e0" e2="s1128.e1" id="s1128.p0" relation="true"/>
  </sentence>
  <sentence id="s1129" text="Familial microscopic hematuria (FMH) is associated with a genetically heterogeneous group of conditions including the collagen-IV nephropathies, the heritable C3/CFHR5 nephropathy and the glomerulopathy with fibronectin deposits.">
    <entity charOffset="70-83" id="s1129.e0" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <entity charOffset="162-167" id="s1129.e1" ontology_id="81494" text="CFHR5" type="GENE"/>
    <pair e1="s1129.e0" e2="s1129.e1" id="s1129.p0" relation="true"/>
  </sentence>
  <sentence id="s1130" text="On the other hand, tumor suppressor roles of YY1 appear to involve YY1 stimulation of tumor suppressor BRCA1, increased Bax transcription and apoptosis involving cytochrome c release and caspase-3/-7 cleavage, induction of heme oxygenase-1, inhibition of pRb phosphorylation and p21 binding to cyclin D1 and cdk4, reduced expression of long noncoding RNA of SOX2 overlapping transcript, and MUC4/ErbB2/p38/MEF2C-dependent downregulation of MMP-10.">
    <entity charOffset="19-24" id="s1130.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="308-312" id="s1130.e1" ontology_id="1019" text="cdk4" type="GENE"/>
    <pair e1="s1130.e0" e2="s1130.e1" id="s1130.p0" relation="false"/>
  </sentence>
  <sentence id="s1131" text="For example, YY1's roles in tumor growth involve stabilization of hypoxia-inducible factor HIF-1 in a p53 independent manner, negative regulation of miR-9 transcription, control of MYCT1 transcription, a novel miR-193a-5p-YY1-APC axis, intracellular ROS and mitochondrial superoxide generation, p53 reduction and EGFR activation, control of genes associated with mitochondrial energy metabolism and miRNA regulatory networks involving miR-7, miR-9, miR-34a, miR-186, miR-381, miR-584-3p and miR-635.">
    <entity charOffset="28-33" id="s1131.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="314-318" id="s1131.e1" ontology_id="1956" text="EGFR" type="GENE"/>
    <pair e1="s1131.e0" e2="s1131.e1" id="s1131.p0" relation="false"/>
  </sentence>
  <sentence id="s1132" text="For example, YY1's roles in tumor growth involve stabilization of hypoxia-inducible factor HIF-1 in a p53 independent manner, negative regulation of miR-9 transcription, control of MYCT1 transcription, a novel miR-193a-5p-YY1-APC axis, intracellular ROS and mitochondrial superoxide generation, p53 reduction and EGFR activation, control of genes associated with mitochondrial energy metabolism and miRNA regulatory networks involving miR-7, miR-9, miR-34a, miR-186, miR-381, miR-584-3p and miR-635.">
    <entity charOffset="28-33" id="s1132.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="182-187" id="s1132.e1" ontology_id="80177" text="MYCT1" type="GENE"/>
    <pair e1="s1132.e0" e2="s1132.e1" id="s1132.p0" relation="false"/>
  </sentence>
  <sentence id="s1133" text="YY1 expression is associated with that of cancer stem cell markers SOX2, BMI1 and OCT4 across many cancers suggesting multidynamic regulatory control and groups of cancers with distinct molecular signatures.">
    <entity charOffset="42-48" id="s1133.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="82-86" id="s1133.e1" ontology_id="5460" text="out4" type="GENE"/>
    <pair e1="s1133.e0" e2="s1133.e1" id="s1133.p0" relation="true"/>
  </sentence>
  <sentence id="s1134" text="Hepatocyte growth factor (HGF)/c-MET signaling plays an important role in cell proliferation, survival, migration and motility of cancer cells.">
    <entity charOffset="33-36" id="s1134.e0" ontology_id="79811" text="MET" type="GENE"/>
    <entity charOffset="130-136" id="s1134.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1134.e0" e2="s1134.e1" id="s1134.p0" relation="true"/>
  </sentence>
  <sentence id="s1135" text="Functional assays indicate that SPINT2 reactivation ameliorates the malignant phenotype, specifically reducing cell viability, migration and invasion in diverse cancer cell lines.">
    <entity charOffset="32-38" id="s1135.e0" ontology_id="10653" text="SPINT2" type="GENE"/>
    <entity charOffset="161-167" id="s1135.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1135.e0" e2="s1135.e1" id="s1135.p0" relation="true"/>
  </sentence>
  <sentence id="s1136" text="Further, mice heterozygous for either Magoh or Rbm8a exhibit aberrant neurogenesis and microcephaly.">
    <entity charOffset="38-43" id="s1136.e0" ontology_id="4116" text="Magoh" type="GENE"/>
    <entity charOffset="87-99" id="s1136.e1" ontology_id="HP_0000252" text="microcephaly" type="HP"/>
    <pair e1="s1136.e0" e2="s1136.e1" id="s1136.p0" relation="true"/>
  </sentence>
  <sentence id="s1137" text="Further, mice heterozygous for either Magoh or Rbm8a exhibit aberrant neurogenesis and microcephaly.">
    <entity charOffset="47-52" id="s1137.e0" ontology_id="9939" text="Rbm8a" type="GENE"/>
    <entity charOffset="87-99" id="s1137.e1" ontology_id="HP_0000252" text="microcephaly" type="HP"/>
    <pair e1="s1137.e0" e2="s1137.e1" id="s1137.p0" relation="true"/>
  </sentence>
  <sentence id="s1138" text="Using a new conditional allele, we first show that Eif4a3 haploinsufficiency phenocopies aberrant neurogenesis and microcephaly of Magoh and Rbm8a mutant mice.">
    <entity charOffset="115-127" id="s1138.e0" ontology_id="HP_0000252" text="microcephaly" type="HP"/>
    <entity charOffset="141-146" id="s1138.e1" ontology_id="9939" text="Rbm8a" type="GENE"/>
    <pair e1="s1138.e0" e2="s1138.e1" id="s1138.p0" relation="false"/>
  </sentence>
  <sentence id="s1139" text="In MCDS mice expressing the Col10a1.pN617K mutation, CBZ reduced the MCDS-associated expansion of the growth plate hypertrophic zone, attenuated enhanced expression of ER stress markers such as Bip and Atf4, increased bone growth, and reduced skeletal dysplasia.">
    <entity charOffset="194-197" id="s1139.e0" ontology_id="3309" text="Bip" type="GENE"/>
    <entity charOffset="243-261" id="s1139.e1" ontology_id="HP_0002652" text="skeletal dysplasia" type="HP"/>
    <pair e1="s1139.e0" e2="s1139.e1" id="s1139.p0" relation="false"/>
  </sentence>
  <sentence id="s1140" text="In MCDS mice expressing the Col10a1.pN617K mutation, CBZ reduced the MCDS-associated expansion of the growth plate hypertrophic zone, attenuated enhanced expression of ER stress markers such as Bip and Atf4, increased bone growth, and reduced skeletal dysplasia.">
    <entity charOffset="202-206" id="s1140.e0" ontology_id="468" text="Atf4" type="GENE"/>
    <entity charOffset="243-261" id="s1140.e1" ontology_id="HP_0002652" text="skeletal dysplasia" type="HP"/>
    <pair e1="s1140.e0" e2="s1140.e1" id="s1140.p0" relation="false"/>
  </sentence>
  <sentence id="s1141" text="Overall, our findings show how the tumor suppressor SIRT6 is regulated in hepatocellular carcinoma and establish the mechanism underlying UBE3A-mediated tumorigenesis in this disease.&lt;b&gt;Significance:&lt;/b&gt; These findings provide mechanistic insights into regulation of the tumor suppressive sirtuin SIRT6 and its implications for the development of hepatocellular carcinoma.">
    <entity charOffset="35-40" id="s1141.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="52-57" id="s1141.e1" ontology_id="51548" text="SIRT6" type="GENE"/>
    <pair e1="s1141.e0" e2="s1141.e1" id="s1141.p0" relation="true"/>
  </sentence>
  <sentence id="s1142" text="Overall, our findings show how the tumor suppressor SIRT6 is regulated in hepatocellular carcinoma and establish the mechanism underlying UBE3A-mediated tumorigenesis in this disease.&lt;b&gt;Significance:&lt;/b&gt; These findings provide mechanistic insights into regulation of the tumor suppressive sirtuin SIRT6 and its implications for the development of hepatocellular carcinoma.">
    <entity charOffset="74-98" id="s1142.e0" ontology_id="HP_0001402" text="hepatocellular carcinoma" type="HP"/>
    <entity charOffset="138-143" id="s1142.e1" ontology_id="7337" text="UBE3A" type="GENE"/>
    <pair e1="s1142.e0" e2="s1142.e1" id="s1142.p0" relation="false"/>
  </sentence>
  <sentence id="s1143" text="In mouse models of hepatocellular carcinoma, SIRT6 downregulation and consequent induction of ANXA2 were critical for UBE3A-mediated tumorigenesis.">
    <entity charOffset="19-43" id="s1143.e0" ontology_id="HP_0001402" text="hepatocellular carcinoma" type="HP"/>
    <entity charOffset="45-50" id="s1143.e1" ontology_id="51548" text="SIRT6" type="GENE"/>
    <pair e1="s1143.e0" e2="s1143.e1" id="s1143.p0" relation="true"/>
  </sentence>
  <sentence id="s1144" text="In mouse models of hepatocellular carcinoma, SIRT6 downregulation and consequent induction of ANXA2 were critical for UBE3A-mediated tumorigenesis.">
    <entity charOffset="45-50" id="s1144.e0" ontology_id="51548" text="SIRT6" type="GENE"/>
    <entity charOffset="133-138" id="s1144.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1144.e0" e2="s1144.e1" id="s1144.p0" relation="true"/>
  </sentence>
  <sentence id="s1145" text="Corresponding implicated genes, such as TNNI3K, ErbB3, MKL2, MTNR1B and PRKD1, may explain the associations between reproductive factors and heart failure.">
    <entity charOffset="48-53" id="s1145.e0" ontology_id="2065" text="ErbB3" type="GENE"/>
    <entity charOffset="141-154" id="s1145.e1" ontology_id="HP_0001635" text="heart failure" type="HP"/>
    <pair e1="s1145.e0" e2="s1145.e1" id="s1145.p0" relation="true"/>
  </sentence>
  <sentence id="s1146" text="The insulin-secreting pancreatic neuroendocrine tumors, insulinomas, characterized by increased pancreatic islet -cell proliferation, express the phosphorylated isoform of the -cell differentiation factor HLXB9 that interacts with NONO/p54NRB, a survival factor.">
    <entity charOffset="48-54" id="s1146.e0" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <entity charOffset="233-237" id="s1146.e1" ontology_id="4841" text="NONO" type="GENE"/>
    <pair e1="s1146.e0" e2="s1146.e1" id="s1146.p0" relation="false"/>
  </sentence>
  <sentence id="s1147" text="The insulin-secreting pancreatic neuroendocrine tumors, insulinomas, characterized by increased pancreatic islet -cell proliferation, express the phosphorylated isoform of the -cell differentiation factor HLXB9 that interacts with NONO/p54NRB, a survival factor.">
    <entity charOffset="56-67" id="s1147.e0" ontology_id="HP_0012197" text="insulinomas" type="HP"/>
    <entity charOffset="233-237" id="s1147.e1" ontology_id="4841" text="NONO" type="GENE"/>
    <pair e1="s1147.e0" e2="s1147.e1" id="s1147.p0" relation="false"/>
  </sentence>
  <sentence id="s1148" text="The insulin-secreting pancreatic neuroendocrine tumors, insulinomas, characterized by increased pancreatic islet -cell proliferation, express the phosphorylated isoform of the -cell differentiation factor HLXB9 that interacts with NONO/p54NRB, a survival factor.">
    <entity charOffset="56-67" id="s1148.e0" ontology_id="HP_0012197" text="insulinomas" type="HP"/>
    <entity charOffset="207-212" id="s1148.e1" ontology_id="3110" text="HLXB9" type="GENE"/>
    <pair e1="s1148.e0" e2="s1148.e1" id="s1148.p0" relation="true"/>
  </sentence>
  <sentence id="s1149" text="Also, two somatic heterozygous NONO mutations were found in endocrine-related tumors, p.H146R (parathyroid) and p.R293H (small intestine neuroendocrine tumor).">
    <entity charOffset="31-35" id="s1149.e0" ontology_id="4841" text="NONO" type="GENE"/>
    <entity charOffset="152-157" id="s1149.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1149.e0" e2="s1149.e1" id="s1149.p0" relation="true"/>
  </sentence>
  <sentence id="s1150" text="Overall, our results highlight the importance of HLXB9 in conditions of -cell excess (insulinomas) and in conditions of -cell loss or dysfunction (diabetes).">
    <entity charOffset="49-54" id="s1150.e0" ontology_id="3110" text="HLXB9" type="GENE"/>
    <entity charOffset="87-98" id="s1150.e1" ontology_id="HP_0012197" text="insulinomas" type="HP"/>
    <pair e1="s1150.e0" e2="s1150.e1" id="s1150.p0" relation="true"/>
  </sentence>
  <sentence id="s1151" text="Smith-Magenis syndrome (SMS), a neurodevelopmental disorder characterized by dysmorphic features, intellectual disability (ID), and sleep disturbances, results from a 17p11.2 microdeletion or a mutation in the RAI1 gene.">
    <entity charOffset="98-121" id="s1151.e0" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <entity charOffset="210-214" id="s1151.e1" ontology_id="10743" text="RAI1" type="GENE"/>
    <pair e1="s1151.e0" e2="s1151.e1" id="s1151.p0" relation="true"/>
  </sentence>
  <sentence id="s1152" text="Smith-Magenis syndrome (SMS), a neurodevelopmental disorder characterized by dysmorphic features, intellectual disability (ID), and sleep disturbances, results from a 17p11.2 microdeletion or a mutation in the RAI1 gene.">
    <entity charOffset="132-150" id="s1152.e0" ontology_id="HP_0002360" text="sleep disturbances" type="HP"/>
    <entity charOffset="210-214" id="s1152.e1" ontology_id="10743" text="RAI1" type="GENE"/>
    <pair e1="s1152.e0" e2="s1152.e1" id="s1152.p0" relation="true"/>
  </sentence>
  <sentence id="s1153" text="The Gene Expression Profiling Interactive Analyses application (GEPIA) was used to analysis the expression of CLDN10 in breast cancer tissues and normal samples.The polymorphism of rs1325774 was significantly associated with an increased risk of breast cancer (T/G vs T/T: OR=2.073, 95% CI=1.095-3.927, P=.025).">
    <entity charOffset="110-116" id="s1153.e0" ontology_id="9071" text="CLDN10" type="GENE"/>
    <entity charOffset="127-133" id="s1153.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1153.e0" e2="s1153.e1" id="s1153.p0" relation="true"/>
  </sentence>
  <sentence id="s1154" text="Among these genes, mutations in VCP gene involve in inclusion body myopathy with Paget disease of bone and frontotemporal dementia (IBMPFD), familial amyotrophic lateral sclerosis (ALS), autism spectrum disorders (ASD), and hereditary spastic paraplegia (HSP).">
    <entity charOffset="32-35" id="s1154.e0" ontology_id="7415" text="VCP" type="GENE"/>
    <entity charOffset="107-130" id="s1154.e1" ontology_id="HP_0002145" text="frontotemporal dementia" type="HP"/>
    <pair e1="s1154.e0" e2="s1154.e1" id="s1154.p0" relation="true"/>
  </sentence>
  <sentence id="s1155" text="We chose to study UNCL-Sema3E rather than wild type sema3E because unlike full length sema3E, the major p61-Sema3E peptide that is produced by cleavage of sema3E with furin like pro-protein convertases activates signal transduction mediated by the ErbB2 receptor and can promote tumor metastasis in addition to its anti-angiogenic activity.">
    <entity charOffset="167-172" id="s1155.e0" ontology_id="5045" text="furin" type="GENE"/>
    <entity charOffset="279-284" id="s1155.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1155.e0" e2="s1155.e1" id="s1155.p0" relation="true"/>
  </sentence>
  <sentence id="s1156" text="We chose to study UNCL-Sema3E rather than wild type sema3E because unlike full length sema3E, the major p61-Sema3E peptide that is produced by cleavage of sema3E with furin like pro-protein convertases activates signal transduction mediated by the ErbB2 receptor and can promote tumor metastasis in addition to its anti-angiogenic activity.">
    <entity charOffset="248-253" id="s1156.e0" ontology_id="2064" text="ErbB2" type="GENE"/>
    <entity charOffset="279-284" id="s1156.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1156.e0" e2="s1156.e1" id="s1156.p0" relation="true"/>
  </sentence>
  <sentence id="s1157" text="This contributes to the intrinsic aggressiveness of these cells by upregulating Rab27-dependent recycling of the transmembrane matrix metalloprotease, MT1-MMP to promote invasive behaviour leading to basement membrane disruption.">
    <entity charOffset="34-48" id="s1157.e0" ontology_id="HP_0000718" text="aggressiveness" type="HP"/>
    <entity charOffset="151-158" id="s1157.e1" ontology_id="4323" text="MT1-MMP" type="GENE"/>
    <pair e1="s1157.e0" e2="s1157.e1" id="s1157.p0" relation="true"/>
  </sentence>
  <sentence id="s1158" text="However, the relationship between MEGF10 and autism remains poorly understood.">
    <entity charOffset="34-40" id="s1158.e0" ontology_id="84466" text="MEGF10" type="GENE"/>
    <entity charOffset="45-51" id="s1158.e1" ontology_id="HP_0000717" text="autism" type="HP"/>
    <pair e1="s1158.e0" e2="s1158.e1" id="s1158.p0" relation="true"/>
  </sentence>
  <sentence id="s1159" text="While polyglutamine ataxias, linked to CAG repeat expansions in genes such as ATXN1, ATXN2, ATXN3, ATXN7, CACNA1A and TBP, have been extensively characterized in large cohorts, there is a need for comprehensive assessment of frequency and phenotype of more 'conventional' ataxias.">
    <entity charOffset="20-27" id="s1159.e0" ontology_id="HP_0001251" text="ataxias" type="HP"/>
    <entity charOffset="106-113" id="s1159.e1" ontology_id="773" text="CACNA1A" type="GENE"/>
    <pair e1="s1159.e0" e2="s1159.e1" id="s1159.p0" relation="true"/>
  </sentence>
  <sentence id="s1160" text="While polyglutamine ataxias, linked to CAG repeat expansions in genes such as ATXN1, ATXN2, ATXN3, ATXN7, CACNA1A and TBP, have been extensively characterized in large cohorts, there is a need for comprehensive assessment of frequency and phenotype of more 'conventional' ataxias.">
    <entity charOffset="20-27" id="s1160.e0" ontology_id="HP_0001251" text="ataxias" type="HP"/>
    <entity charOffset="99-104" id="s1160.e1" ontology_id="6314" text="ATXN7" type="GENE"/>
    <pair e1="s1160.e0" e2="s1160.e1" id="s1160.p0" relation="true"/>
  </sentence>
  <sentence id="s1161" text="While polyglutamine ataxias, linked to CAG repeat expansions in genes such as ATXN1, ATXN2, ATXN3, ATXN7, CACNA1A and TBP, have been extensively characterized in large cohorts, there is a need for comprehensive assessment of frequency and phenotype of more 'conventional' ataxias.">
    <entity charOffset="20-27" id="s1161.e0" ontology_id="HP_0001251" text="ataxias" type="HP"/>
    <entity charOffset="85-90" id="s1161.e1" ontology_id="6311" text="ATXN2" type="GENE"/>
    <pair e1="s1161.e0" e2="s1161.e1" id="s1161.p0" relation="true"/>
  </sentence>
  <sentence id="s1162" text="While polyglutamine ataxias, linked to CAG repeat expansions in genes such as ATXN1, ATXN2, ATXN3, ATXN7, CACNA1A and TBP, have been extensively characterized in large cohorts, there is a need for comprehensive assessment of frequency and phenotype of more 'conventional' ataxias.">
    <entity charOffset="20-27" id="s1162.e0" ontology_id="HP_0001251" text="ataxias" type="HP"/>
    <entity charOffset="92-97" id="s1162.e1" ontology_id="4287" text="ATXN3" type="GENE"/>
    <pair e1="s1162.e0" e2="s1162.e1" id="s1162.p0" relation="true"/>
  </sentence>
  <sentence id="s1163" text="In conclusion, we identified relevant genetic variations in up to 15% of cases after exclusion of polyglutamine expansion spinocerebellar ataxias, and confirmed CACNA1A and SPG7 as major ataxia genes.">
    <entity charOffset="173-177" id="s1163.e0" ontology_id="6687" text="SPG7" type="GENE"/>
    <entity charOffset="187-193" id="s1163.e1" ontology_id="HP_0001251" text="ataxia" type="HP"/>
    <pair e1="s1163.e0" e2="s1163.e1" id="s1163.p0" relation="true"/>
  </sentence>
  <sentence id="s1164" text="We show that active cofilin, LIMK1, LIMK2, and SSH1 are overexpressed in human CRC and are associated with tumor progression parameters.">
    <entity charOffset="47-51" id="s1164.e0" ontology_id="54434" text="SSH1" type="GENE"/>
    <entity charOffset="107-112" id="s1164.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1164.e0" e2="s1164.e1" id="s1164.p0" relation="true"/>
  </sentence>
  <sentence id="s1165" text="We recently reported a novel human phenotype resulting from a mutation in the critical coding region of the HBS1L gene characterized by facial dysmorphism, severe growth restriction, axial hypotonia, global developmental delay and retinal pigmentary deposits.">
    <entity charOffset="108-113" id="s1165.e0" ontology_id="10767" text="HBS1L" type="GENE"/>
    <entity charOffset="207-226" id="s1165.e1" ontology_id="HP_0001263" text="developmental delay" type="HP"/>
    <pair e1="s1165.e0" e2="s1165.e1" id="s1165.p0" relation="true"/>
  </sentence>
  <sentence id="s1166" text="We recently reported a novel human phenotype resulting from a mutation in the critical coding region of the HBS1L gene characterized by facial dysmorphism, severe growth restriction, axial hypotonia, global developmental delay and retinal pigmentary deposits.">
    <entity charOffset="108-113" id="s1166.e0" ontology_id="10767" text="HBS1L" type="GENE"/>
    <entity charOffset="183-188" id="s1166.e1" ontology_id="HP_0025287" text="axial" type="HP"/>
    <pair e1="s1166.e0" e2="s1166.e1" id="s1166.p0" relation="true"/>
  </sentence>
  <sentence id="s1167" text="We summarize genetic, clinical and neuropathological findings related to the 27 genes reported in the literature since 1997, associated either with autosomal dominant (AD): LRRK2, SNCA, VPS35, GCH1, ATXN2, DNAJC13, TMEM230, GIGYF2, HTRA2, RIC3, EIF4G1, UCHL1, CHCHD2, and GBA; or autosomal recessive (AR) inheritance: PRKN, PINK1, DJ1, ATP13A2, PLA2G6, FBXO7, DNAJC6, SYNJ1, SPG11, VPS13C, PODXL, and PTRHD1; or an X-linked transmission: RAB39B.">
    <entity charOffset="224-230" id="s1167.e0" ontology_id="26058" text="GIGYF2" type="GENE"/>
    <entity charOffset="280-299" id="s1167.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s1167.e0" e2="s1167.e1" id="s1167.p0" relation="false"/>
  </sentence>
  <sentence id="s1168" text="We summarize genetic, clinical and neuropathological findings related to the 27 genes reported in the literature since 1997, associated either with autosomal dominant (AD): LRRK2, SNCA, VPS35, GCH1, ATXN2, DNAJC13, TMEM230, GIGYF2, HTRA2, RIC3, EIF4G1, UCHL1, CHCHD2, and GBA; or autosomal recessive (AR) inheritance: PRKN, PINK1, DJ1, ATP13A2, PLA2G6, FBXO7, DNAJC6, SYNJ1, SPG11, VPS13C, PODXL, and PTRHD1; or an X-linked transmission: RAB39B.">
    <entity charOffset="253-258" id="s1168.e0" ontology_id="7345" text="UCHL1" type="GENE"/>
    <entity charOffset="280-299" id="s1168.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s1168.e0" e2="s1168.e1" id="s1168.p0" relation="false"/>
  </sentence>
  <sentence id="s1169" text="We summarize genetic, clinical and neuropathological findings related to the 27 genes reported in the literature since 1997, associated either with autosomal dominant (AD): LRRK2, SNCA, VPS35, GCH1, ATXN2, DNAJC13, TMEM230, GIGYF2, HTRA2, RIC3, EIF4G1, UCHL1, CHCHD2, and GBA; or autosomal recessive (AR) inheritance: PRKN, PINK1, DJ1, ATP13A2, PLA2G6, FBXO7, DNAJC6, SYNJ1, SPG11, VPS13C, PODXL, and PTRHD1; or an X-linked transmission: RAB39B.">
    <entity charOffset="280-299" id="s1169.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="375-380" id="s1169.e1" ontology_id="80208" text="SPG11" type="GENE"/>
    <pair e1="s1169.e0" e2="s1169.e1" id="s1169.p0" relation="true"/>
  </sentence>
  <sentence id="s1170" text="We summarize genetic, clinical and neuropathological findings related to the 27 genes reported in the literature since 1997, associated either with autosomal dominant (AD): LRRK2, SNCA, VPS35, GCH1, ATXN2, DNAJC13, TMEM230, GIGYF2, HTRA2, RIC3, EIF4G1, UCHL1, CHCHD2, and GBA; or autosomal recessive (AR) inheritance: PRKN, PINK1, DJ1, ATP13A2, PLA2G6, FBXO7, DNAJC6, SYNJ1, SPG11, VPS13C, PODXL, and PTRHD1; or an X-linked transmission: RAB39B.">
    <entity charOffset="280-299" id="s1170.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="345-351" id="s1170.e1" ontology_id="8398" text="PLA2G6" type="GENE"/>
    <pair e1="s1170.e0" e2="s1170.e1" id="s1170.p0" relation="true"/>
  </sentence>
  <sentence id="s1171" text="Murine double minute 2 (MDM2) is the E3 ubiquitin ligase of the tumor suppressor gene, p53, and inhibition of MDM2 can suppress tumor cell growth.">
    <entity charOffset="24-28" id="s1171.e0" ontology_id="4193" text="MDM2" type="GENE"/>
    <entity charOffset="64-69" id="s1171.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1171.e0" e2="s1171.e1" id="s1171.p0" relation="true"/>
  </sentence>
  <sentence id="s1172" text="The APOL1 G1 polymorphism, an identified risk factor for non-diabetic renal disease, was associated with albuminuria.">
    <entity charOffset="4-9" id="s1172.e0" ontology_id="8542" text="APOL1" type="GENE"/>
    <entity charOffset="105-116" id="s1172.e1" ontology_id="HP_0012592" text="albuminuria" type="HP"/>
    <pair e1="s1172.e0" e2="s1172.e1" id="s1172.p0" relation="true"/>
  </sentence>
  <sentence id="s1173" text="Growing evidence suggests that SETX may represent an important genetic modifier locus for sporadic ALS.">
    <entity charOffset="31-35" id="s1173.e0" ontology_id="23064" text="SETX" type="GENE"/>
    <entity charOffset="90-98" id="s1173.e1" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <pair e1="s1173.e0" e2="s1173.e1" id="s1173.p0" relation="true"/>
  </sentence>
  <sentence id="s1174" text="Compared to normal tissues, decorin expression was reduced in CRC patients' tumors, while there were increased Met and VEGFA levels.">
    <entity charOffset="76-82" id="s1174.e0" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <entity charOffset="111-114" id="s1174.e1" ontology_id="4233" text="Met" type="GENE"/>
    <pair e1="s1174.e0" e2="s1174.e1" id="s1174.p0" relation="true"/>
  </sentence>
  <sentence id="s1175" text="Several therapeutic strategies expressing GM-CSF have been employed in clinical trials for treating metastatic colorectal cancer.">
    <entity charOffset="42-48" id="s1175.e0" ontology_id="1437" text="GM-CSF" type="GENE"/>
    <entity charOffset="122-128" id="s1175.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1175.e0" e2="s1175.e1" id="s1175.p0" relation="true"/>
  </sentence>
  <sentence id="s1176" text="The authors report a patient with a novel PAK3 mutation, who presented with intellectual disability, severe automutilation, and epilepsy.">
    <entity charOffset="42-46" id="s1176.e0" ontology_id="8874" text="PAK3" type="GENE"/>
    <entity charOffset="76-99" id="s1176.e1" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <pair e1="s1176.e0" e2="s1176.e1" id="s1176.p0" relation="true"/>
  </sentence>
  <sentence id="s1177" text="PAK3-related intellectual disability is caused by mutations in the gene encoding the p21-activated kinase (PAK) protein.">
    <entity charOffset="13-36" id="s1177.e0" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <entity charOffset="85-88" id="s1177.e1" ontology_id="9338" text="p21" type="GENE"/>
    <pair e1="s1177.e0" e2="s1177.e1" id="s1177.p0" relation="true"/>
  </sentence>
  <sentence id="s1178" text="We observed a higher rate of individuals with a history of high blood pressure among affected versus healthy individuals carrying ANGPTL6 variants, suggesting that ANGPTL6 could trigger cerebrovascular lesions when combined with other risk factors such as hypertension.">
    <entity charOffset="130-137" id="s1178.e0" ontology_id="83854" text="ANGPTL6" type="GENE"/>
    <entity charOffset="256-268" id="s1178.e1" ontology_id="HP_0000822" text="hypertension" type="HP"/>
    <pair e1="s1178.e0" e2="s1178.e1" id="s1178.p0" relation="true"/>
  </sentence>
  <sentence id="s1179" text="High-throughput sequencing analysis has accelerated searches for genes associated with risk for colorectal cancer (CRC); germline mutations in NTHL1, RPS20, FANCM, FAN1, TP53, BUB1, BUB3, LRP6, and PTPN12 have been recently proposed to increase CRC risk.">
    <entity charOffset="107-113" id="s1179.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="157-162" id="s1179.e1" ontology_id="57697" text="FANCM" type="GENE"/>
    <pair e1="s1179.e0" e2="s1179.e1" id="s1179.p0" relation="false"/>
  </sentence>
  <sentence id="s1180" text="High-throughput sequencing analysis has accelerated searches for genes associated with risk for colorectal cancer (CRC); germline mutations in NTHL1, RPS20, FANCM, FAN1, TP53, BUB1, BUB3, LRP6, and PTPN12 have been recently proposed to increase CRC risk.">
    <entity charOffset="107-113" id="s1180.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="176-180" id="s1180.e1" ontology_id="699" text="BUB1" type="GENE"/>
    <pair e1="s1180.e0" e2="s1180.e1" id="s1180.p0" relation="false"/>
  </sentence>
  <sentence id="s1181" text="We found sufficient evidence for NTHL1 to be considered a CRC predisposition gene-members of 3 unrelated Dutch families were homozygous for inactivating p.Gln90Ter mutations; a Canadian woman with polyposis, CRC, and multiple tumors was reported to be heterozygous for the inactivating NTHL1 p.Gln90Ter/c.709+1G&amp;gt;A mutations; and a man with polyposis was reported to carry p.Gln90Ter/p.Gln287Ter; whereas no inactivating homozygous or compound heterozygous mutations were detected in controls.">
    <entity charOffset="33-38" id="s1181.e0" ontology_id="4913" text="NTHL1" type="GENE"/>
    <entity charOffset="226-232" id="s1181.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s1181.e0" e2="s1181.e1" id="s1181.p0" relation="false"/>
  </sentence>
  <sentence id="s1182" text="Over 60 years after the initial description of PDE, we report the first animal model for this disease: an aldh7a1-null zebrafish (&lt;i&gt;Danio rerio&lt;/i&gt;) displaying deficient lysine metabolism and spontaneous and recurrent seizures in the larval stage (10 days postfertilization).">
    <entity charOffset="106-113" id="s1182.e0" ontology_id="501" text="aldh7a1" type="GENE"/>
    <entity charOffset="219-227" id="s1182.e1" ontology_id="HP_0001250" text="seizures" type="HP"/>
    <pair e1="s1182.e0" e2="s1182.e1" id="s1182.p0" relation="true"/>
  </sentence>
  <sentence id="s1183" text="Both single-gene and gene-set enrichment analyses in genome-wide association data from the largest schizophrenia sample to date of 13,689 cases and 18,226 controls show significant association of HIST1H1E and MAPK3, and enrichment of our PSD proteome.">
    <entity charOffset="99-112" id="s1183.e0" ontology_id="HP_0100753" text="schizophrenia" type="HP"/>
    <entity charOffset="209-214" id="s1183.e1" ontology_id="5595" text="MAPK3" type="GENE"/>
    <pair e1="s1183.e0" e2="s1183.e1" id="s1183.p0" relation="true"/>
  </sentence>
  <sentence id="s1184" text="However, the clinical significance and precise role of ZNF687 in cancer progression are largely unknown.">
    <entity charOffset="55-61" id="s1184.e0" ontology_id="57592" text="ZNF687" type="GENE"/>
    <entity charOffset="65-71" id="s1184.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1184.e0" e2="s1184.e1" id="s1184.p0" relation="true"/>
  </sentence>
  <sentence id="s1185" text="Zinc finger protein 687 (ZNF687), identified as a C2H2 zinc finger protein, has been found to be mutated and upregulated in giant cell tumor of bone and acute myeloid leukemia, suggesting an oncogenic role for ZNF687 in cancer.">
    <entity charOffset="25-31" id="s1185.e0" ontology_id="57592" text="ZNF687" type="GENE"/>
    <entity charOffset="220-226" id="s1185.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1185.e0" e2="s1185.e1" id="s1185.p0" relation="false"/>
  </sentence>
  <sentence id="s1186" text="Moreover, ALDOA predicted poor prognosis of pancreatic cancer, partially due to its role in E-cadherin expression regulation, and the results were further validated by analysis of the correlation between ALDOA and E-cadherin expression in pancreatic cancer tissue samples.">
    <entity charOffset="10-15" id="s1186.e0" ontology_id="226" text="ALDOA" type="GENE"/>
    <entity charOffset="55-61" id="s1186.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1186.e0" e2="s1186.e1" id="s1186.p0" relation="true"/>
  </sentence>
  <sentence id="s1187" text="Mechanistically, the role of ALDOA in pancreatic cancer might attribute to its regulation of c-Myc, HIF1 and NRF2 (Nuclear Factor, Erythroid 2-Like 2), which were key regulators of glycolysis and antioxidant response control.">
    <entity charOffset="49-55" id="s1187.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="93-98" id="s1187.e1" ontology_id="4609" text="c-Myc" type="GENE"/>
    <pair e1="s1187.e0" e2="s1187.e1" id="s1187.p0" relation="true"/>
  </sentence>
  <sentence id="s1188" text="Mechanistically, the role of ALDOA in pancreatic cancer might attribute to its regulation of c-Myc, HIF1 and NRF2 (Nuclear Factor, Erythroid 2-Like 2), which were key regulators of glycolysis and antioxidant response control.">
    <entity charOffset="49-55" id="s1188.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="110-114" id="s1188.e1" ontology_id="2551" text="NRF2" type="GENE"/>
    <pair e1="s1188.e0" e2="s1188.e1" id="s1188.p0" relation="true"/>
  </sentence>
  <sentence id="s1189" text="Genetic or small-molecule inhibitor-based ablation of HIF-1/TGF-2-mediated GLI2 signaling effectively reversed the chemoresistance caused by the tumor microenvironment.">
    <entity charOffset="77-81" id="s1189.e0" ontology_id="2736" text="GLI2" type="GENE"/>
    <entity charOffset="147-152" id="s1189.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1189.e0" e2="s1189.e1" id="s1189.p0" relation="true"/>
  </sentence>
  <sentence id="s1190" text="However, the ectopic expression of FSHR was recently discovered in intra-tumoral blood vessels endothelia and/or in tumoral cells of many extra-gonadal human tumors (particularly in endocrine tumours).">
    <entity charOffset="35-39" id="s1190.e0" ontology_id="2492" text="FSHR" type="GENE"/>
    <entity charOffset="158-164" id="s1190.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s1190.e0" e2="s1190.e1" id="s1190.p0" relation="true"/>
  </sentence>
  <sentence id="s1191" text="The paper reviews the data concerning the appearance of ectopic FSHR in particular human neoplasms.">
    <entity charOffset="64-68" id="s1191.e0" ontology_id="2492" text="FSHR" type="GENE"/>
    <entity charOffset="89-98" id="s1191.e1" ontology_id="HP_0002664" text="neoplasms" type="HP"/>
    <pair e1="s1191.e0" e2="s1191.e1" id="s1191.p0" relation="true"/>
  </sentence>
  <sentence id="s1192" text="Patients exhibit a variety of symptoms predominantly linked to the function of FMRP protein in the nervous system like autistic behavior and mild-to-severe intellectual disability.">
    <entity charOffset="79-83" id="s1192.e0" ontology_id="2332" text="FMRP" type="GENE"/>
    <entity charOffset="156-179" id="s1192.e1" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <pair e1="s1192.e0" e2="s1192.e1" id="s1192.p0" relation="true"/>
  </sentence>
  <sentence id="s1193" text="The findings in this study expand our understanding of SRPS locus heterogeneity and demonstrate the importance of DYNC2LI1 in dynein-2 complex stability, cilium function, Hedgehog regulation and skeletogenesis.">
    <entity charOffset="66-79" id="s1193.e0" ontology_id="HP_0001425" text="heterogeneity" type="HP"/>
    <entity charOffset="114-122" id="s1193.e1" ontology_id="51626" text="DYNC2LI1" type="GENE"/>
    <pair e1="s1193.e0" e2="s1193.e1" id="s1193.p0" relation="false"/>
  </sentence>
  <sentence id="s1194" text="Megaconial congenital muscular dystrophy is a disease caused by pathogenic mutations in the gene encoding choline kinase beta (CHKB).">
    <entity charOffset="22-40" id="s1194.e0" ontology_id="HP_0003560" text="muscular dystrophy" type="HP"/>
    <entity charOffset="127-131" id="s1194.e1" ontology_id="1120" text="CHKB" type="GENE"/>
    <pair e1="s1194.e0" e2="s1194.e1" id="s1194.p0" relation="true"/>
  </sentence>
  <sentence id="s1195" text="Similarly, SEPT4 has lymphoid and non-lymphoid forms; SEPT2 has lymphoid and central nervous system (CNS) forms; and SEPT6 and SEPT9 are elevated in lymphoid tissues but both have forms that cluster away from the lymphoid forms.">
    <entity charOffset="11-16" id="s1195.e0" ontology_id="5414" text="SEPT4" type="GENE"/>
    <entity charOffset="77-84" id="s1195.e1" ontology_id="HP_0030645" text="central" type="HP"/>
    <pair e1="s1195.e0" e2="s1195.e1" id="s1195.p0" relation="false"/>
  </sentence>
  <sentence id="s1196" text="Downregulation of miR-29a caused overexpression of LOXL2 and SERPINH1 in lung cancer and IPF, suggesting that these genes are involved in the pathogenesis of these two diseases">
    <entity charOffset="61-69" id="s1196.e0" ontology_id="871" text="SERPINH1" type="GENE"/>
    <entity charOffset="78-84" id="s1196.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1196.e0" e2="s1196.e1" id="s1196.p0" relation="true"/>
  </sentence>
  <sentence id="s1197" text="Overexpression of LOXL2 and SERPINH1 was observed in clinical specimens of lung cancer and fibrotic lesions.">
    <entity charOffset="28-36" id="s1197.e0" ontology_id="871" text="SERPINH1" type="GENE"/>
    <entity charOffset="80-86" id="s1197.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1197.e0" e2="s1197.e1" id="s1197.p0" relation="true"/>
  </sentence>
  <sentence id="s1198" text="While examining pedigrees of JEB patients with LAMA3 mutations, we observed that heterozygous carriers of functional null mutations displayed subtle enamel pitting in the absence of skin fragility or other JEB symptoms.">
    <entity charOffset="47-52" id="s1198.e0" ontology_id="3910" text="LAMA3" type="GENE"/>
    <entity charOffset="182-196" id="s1198.e1" ontology_id="HP_0001030" text="skin fragility" type="HP"/>
    <pair e1="s1198.e0" e2="s1198.e1" id="s1198.p0" relation="true"/>
  </sentence>
  <sentence id="s1199" text="Most often, hypogonadotropic hypogonadism is caused by disorder in secretion of gonadoliberin, the product of gene GNRH1.">
    <entity charOffset="29-41" id="s1199.e0" ontology_id="HP_0000135" text="hypogonadism" type="HP"/>
    <entity charOffset="115-120" id="s1199.e1" ontology_id="2796" text="GNRH1" type="GENE"/>
    <pair e1="s1199.e0" e2="s1199.e1" id="s1199.p0" relation="true"/>
  </sentence>
  <sentence id="s1200" text="Thus, increased expression of gene GNRH1 in blood cells appears to be associated with the isolated form of hypogonadotropic hypogonadism and, in prospect, may be used as one of the disease markers">
    <entity charOffset="35-40" id="s1200.e0" ontology_id="2796" text="GNRH1" type="GENE"/>
    <entity charOffset="124-136" id="s1200.e1" ontology_id="HP_0000135" text="hypogonadism" type="HP"/>
    <pair e1="s1200.e0" e2="s1200.e1" id="s1200.p0" relation="true"/>
  </sentence>
  <sentence id="s1201" text="WTX is also known as a tumor suppressor gene, and somatic mutations in that gene have been identified in Wilms tumors.">
    <entity charOffset="0-3" id="s1201.e0" ontology_id="139285" text="WTX" type="GENE"/>
    <entity charOffset="23-28" id="s1201.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1201.e0" e2="s1201.e1" id="s1201.p0" relation="true"/>
  </sentence>
  <sentence id="s1202" text="RESULTS There was an increased expression of ALG3 in breast cancer tissues compared to normal breast tissues (p&amp;lt;0.05).">
    <entity charOffset="45-49" id="s1202.e0" ontology_id="10195" text="ALG3" type="GENE"/>
    <entity charOffset="60-66" id="s1202.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1202.e0" e2="s1202.e1" id="s1202.p0" relation="true"/>
  </sentence>
  <sentence id="s1203" text="The created databases include ACAD8 (isobutyryl-CoA dehydrogenase deficiency (IBD)), ACADSB (short-chain acyl-CoA dehydrogenase (SCAD) deficiency), AUH (3-methylglutaconic aciduria (3-MGCA)), DHCR7 (Smith-Lemli-Opitz syndrome), HMGCS2 (3-hydroxy-3-methylglutaryl-CoA synthase 2 deficiency), HSD17B10 (17-beta-hydroxysteroid dehydrogenase X deficiency), FKBP14 (Ehlers-Danlos syndrome with progressive kyphoscoliosis, myopathy, and hearing loss; EDSKMH) and ROGDI (Kohlschtter-Tnz syndrome).">
    <entity charOffset="85-91" id="s1203.e0" ontology_id="36" text="ACADSB" type="GENE"/>
    <entity charOffset="401-415" id="s1203.e1" ontology_id="HP_0002751" text="kyphoscoliosis" type="HP"/>
    <pair e1="s1203.e0" e2="s1203.e1" id="s1203.p0" relation="false"/>
  </sentence>
  <sentence id="s1204" text="The created databases include ACAD8 (isobutyryl-CoA dehydrogenase deficiency (IBD)), ACADSB (short-chain acyl-CoA dehydrogenase (SCAD) deficiency), AUH (3-methylglutaconic aciduria (3-MGCA)), DHCR7 (Smith-Lemli-Opitz syndrome), HMGCS2 (3-hydroxy-3-methylglutaryl-CoA synthase 2 deficiency), HSD17B10 (17-beta-hydroxysteroid dehydrogenase X deficiency), FKBP14 (Ehlers-Danlos syndrome with progressive kyphoscoliosis, myopathy, and hearing loss; EDSKMH) and ROGDI (Kohlschtter-Tnz syndrome).">
    <entity charOffset="129-133" id="s1204.e0" ontology_id="35" text="SCAD" type="GENE"/>
    <entity charOffset="401-415" id="s1204.e1" ontology_id="HP_0002751" text="kyphoscoliosis" type="HP"/>
    <pair e1="s1204.e0" e2="s1204.e1" id="s1204.p0" relation="false"/>
  </sentence>
  <sentence id="s1205" text="The created databases include ACAD8 (isobutyryl-CoA dehydrogenase deficiency (IBD)), ACADSB (short-chain acyl-CoA dehydrogenase (SCAD) deficiency), AUH (3-methylglutaconic aciduria (3-MGCA)), DHCR7 (Smith-Lemli-Opitz syndrome), HMGCS2 (3-hydroxy-3-methylglutaryl-CoA synthase 2 deficiency), HSD17B10 (17-beta-hydroxysteroid dehydrogenase X deficiency), FKBP14 (Ehlers-Danlos syndrome with progressive kyphoscoliosis, myopathy, and hearing loss; EDSKMH) and ROGDI (Kohlschtter-Tnz syndrome).">
    <entity charOffset="148-151" id="s1205.e0" ontology_id="549" text="AUH" type="GENE"/>
    <entity charOffset="417-425" id="s1205.e1" ontology_id="HP_0003198" text="myopathy" type="HP"/>
    <pair e1="s1205.e0" e2="s1205.e1" id="s1205.p0" relation="false"/>
  </sentence>
  <sentence id="s1206" text="The created databases include ACAD8 (isobutyryl-CoA dehydrogenase deficiency (IBD)), ACADSB (short-chain acyl-CoA dehydrogenase (SCAD) deficiency), AUH (3-methylglutaconic aciduria (3-MGCA)), DHCR7 (Smith-Lemli-Opitz syndrome), HMGCS2 (3-hydroxy-3-methylglutaryl-CoA synthase 2 deficiency), HSD17B10 (17-beta-hydroxysteroid dehydrogenase X deficiency), FKBP14 (Ehlers-Danlos syndrome with progressive kyphoscoliosis, myopathy, and hearing loss; EDSKMH) and ROGDI (Kohlschtter-Tnz syndrome).">
    <entity charOffset="228-234" id="s1206.e0" ontology_id="3158" text="HMGCS2" type="GENE"/>
    <entity charOffset="401-415" id="s1206.e1" ontology_id="HP_0002751" text="kyphoscoliosis" type="HP"/>
    <pair e1="s1206.e0" e2="s1206.e1" id="s1206.p0" relation="false"/>
  </sentence>
  <sentence id="s1207" text="The created databases include ACAD8 (isobutyryl-CoA dehydrogenase deficiency (IBD)), ACADSB (short-chain acyl-CoA dehydrogenase (SCAD) deficiency), AUH (3-methylglutaconic aciduria (3-MGCA)), DHCR7 (Smith-Lemli-Opitz syndrome), HMGCS2 (3-hydroxy-3-methylglutaryl-CoA synthase 2 deficiency), HSD17B10 (17-beta-hydroxysteroid dehydrogenase X deficiency), FKBP14 (Ehlers-Danlos syndrome with progressive kyphoscoliosis, myopathy, and hearing loss; EDSKMH) and ROGDI (Kohlschtter-Tnz syndrome).">
    <entity charOffset="291-299" id="s1207.e0" ontology_id="3028" text="HSD17B10" type="GENE"/>
    <entity charOffset="417-425" id="s1207.e1" ontology_id="HP_0003198" text="myopathy" type="HP"/>
    <pair e1="s1207.e0" e2="s1207.e1" id="s1207.p0" relation="false"/>
  </sentence>
  <sentence id="s1208" text="The created databases include ACAD8 (isobutyryl-CoA dehydrogenase deficiency (IBD)), ACADSB (short-chain acyl-CoA dehydrogenase (SCAD) deficiency), AUH (3-methylglutaconic aciduria (3-MGCA)), DHCR7 (Smith-Lemli-Opitz syndrome), HMGCS2 (3-hydroxy-3-methylglutaryl-CoA synthase 2 deficiency), HSD17B10 (17-beta-hydroxysteroid dehydrogenase X deficiency), FKBP14 (Ehlers-Danlos syndrome with progressive kyphoscoliosis, myopathy, and hearing loss; EDSKMH) and ROGDI (Kohlschtter-Tnz syndrome).">
    <entity charOffset="291-299" id="s1208.e0" ontology_id="3028" text="HSD17B10" type="GENE"/>
    <entity charOffset="431-443" id="s1208.e1" ontology_id="HP_0000365" text="hearing loss" type="HP"/>
    <pair e1="s1208.e0" e2="s1208.e1" id="s1208.p0" relation="false"/>
  </sentence>
  <sentence id="s1209" text="The created databases include ACAD8 (isobutyryl-CoA dehydrogenase deficiency (IBD)), ACADSB (short-chain acyl-CoA dehydrogenase (SCAD) deficiency), AUH (3-methylglutaconic aciduria (3-MGCA)), DHCR7 (Smith-Lemli-Opitz syndrome), HMGCS2 (3-hydroxy-3-methylglutaryl-CoA synthase 2 deficiency), HSD17B10 (17-beta-hydroxysteroid dehydrogenase X deficiency), FKBP14 (Ehlers-Danlos syndrome with progressive kyphoscoliosis, myopathy, and hearing loss; EDSKMH) and ROGDI (Kohlschtter-Tnz syndrome).">
    <entity charOffset="401-415" id="s1209.e0" ontology_id="HP_0002751" text="kyphoscoliosis" type="HP"/>
    <entity charOffset="457-462" id="s1209.e1" ontology_id="79641" text="ROGDI" type="GENE"/>
    <pair e1="s1209.e0" e2="s1209.e1" id="s1209.p0" relation="false"/>
  </sentence>
  <sentence id="s1210" text="The created databases include ACAD8 (isobutyryl-CoA dehydrogenase deficiency (IBD)), ACADSB (short-chain acyl-CoA dehydrogenase (SCAD) deficiency), AUH (3-methylglutaconic aciduria (3-MGCA)), DHCR7 (Smith-Lemli-Opitz syndrome), HMGCS2 (3-hydroxy-3-methylglutaryl-CoA synthase 2 deficiency), HSD17B10 (17-beta-hydroxysteroid dehydrogenase X deficiency), FKBP14 (Ehlers-Danlos syndrome with progressive kyphoscoliosis, myopathy, and hearing loss; EDSKMH) and ROGDI (Kohlschtter-Tnz syndrome).">
    <entity charOffset="431-443" id="s1210.e0" ontology_id="HP_0000365" text="hearing loss" type="HP"/>
    <entity charOffset="457-462" id="s1210.e1" ontology_id="79641" text="ROGDI" type="GENE"/>
    <pair e1="s1210.e0" e2="s1210.e1" id="s1210.p0" relation="false"/>
  </sentence>
  <sentence id="s1211" text="Homozygous null mutation of tumor suppressor &lt;i&gt;WWOX/Wwox&lt;/i&gt; gene leads to severe neural diseases, metabolic disorders and early death in the newborns of humans, mice and rats.">
    <entity charOffset="28-33" id="s1211.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="48-52" id="s1211.e1" ontology_id="51741" text="WWOX" type="GENE"/>
    <pair e1="s1211.e0" e2="s1211.e1" id="s1211.p0" relation="true"/>
  </sentence>
  <sentence id="s1212" text="There has been virtually no tissue study on the expression of PLZF in prostate cancer (PCa).">
    <entity charOffset="62-66" id="s1212.e0" ontology_id="7704" text="PLZF" type="GENE"/>
    <entity charOffset="79-85" id="s1212.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1212.e0" e2="s1212.e1" id="s1212.p0" relation="true"/>
  </sentence>
  <sentence id="s1213" text="Our findings offer a foundation for understanding MATR3-related neurodegeneration and how nucleic acid binding functions, localization, and pathogenic mutations drive sporadic and familial disease">
    <entity charOffset="50-55" id="s1213.e0" ontology_id="9782" text="MATR3" type="GENE"/>
    <entity charOffset="167-175" id="s1213.e1" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <pair e1="s1213.e0" e2="s1213.e1" id="s1213.p0" relation="false"/>
  </sentence>
  <sentence id="s1214" text="Taken together, these data provide novel information for comprehending the tumor-suppressive role of miR-200a in HCC pathogenesis through inhibition of GAB1 translation">
    <entity charOffset="75-80" id="s1214.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="152-156" id="s1214.e1" ontology_id="128869" text="GAB1" type="GENE"/>
    <pair e1="s1214.e0" e2="s1214.e1" id="s1214.p0" relation="true"/>
  </sentence>
  <sentence id="s1215" text="OX40 and its ligand are members of the TNF/TNF receptor superfamily, which includes various molecules influencing cellular signaling and function of both tumor and immune cells.">
    <entity charOffset="0-4" id="s1215.e0" ontology_id="7293" text="OX40" type="GENE"/>
    <entity charOffset="154-159" id="s1215.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1215.e0" e2="s1215.e1" id="s1215.p0" relation="false"/>
  </sentence>
  <sentence id="s1216" text="CHIME syndrome is a rare autosomal recessive neuroectodermal disorder associated with biallelic mutations in PIGL.">
    <entity charOffset="25-44" id="s1216.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="109-113" id="s1216.e1" ontology_id="9487" text="PIGL" type="GENE"/>
    <pair e1="s1216.e0" e2="s1216.e1" id="s1216.p0" relation="true"/>
  </sentence>
  <sentence id="s1217" text="Noonan syndrome (NS), the commonest RASopathy, is genetically heterogeneous and caused by functional dysregulation of signal transducers and regulatory proteins with roles in the RAS/extracellular signal-regulated kinase (ERK) signal transduction pathway.">
    <entity charOffset="62-75" id="s1217.e0" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <entity charOffset="222-225" id="s1217.e1" ontology_id="2048" text="ERK" type="GENE"/>
    <pair e1="s1217.e0" e2="s1217.e1" id="s1217.p0" relation="false"/>
  </sentence>
  <sentence id="s1218" text="The aim of this study was to investigate the diagnostic sensitivity and specificity of protein induced by vitamin K absence or antagonist-II (PIVKAII), Glypican-3 (GP3), Cystatin B (CSTB), squamous cell carcinoma antigen 1 (SCCA1) and hepatocyte growth factor (HGF) as potential tumour markers for HCC in patients with alcoholic liver cirrhosis (ALC) using imaging techniques (MSCT and MRI) as reference standards.">
    <entity charOffset="152-160" id="s1218.e0" ontology_id="2817" text="Glypican" type="GENE"/>
    <entity charOffset="279-285" id="s1218.e1" ontology_id="HP_0002664" text="tumour" type="HP"/>
    <pair e1="s1218.e0" e2="s1218.e1" id="s1218.p0" relation="true"/>
  </sentence>
  <sentence id="s1219" text="The aim of this study was to investigate the diagnostic sensitivity and specificity of protein induced by vitamin K absence or antagonist-II (PIVKAII), Glypican-3 (GP3), Cystatin B (CSTB), squamous cell carcinoma antigen 1 (SCCA1) and hepatocyte growth factor (HGF) as potential tumour markers for HCC in patients with alcoholic liver cirrhosis (ALC) using imaging techniques (MSCT and MRI) as reference standards.">
    <entity charOffset="182-186" id="s1219.e0" ontology_id="1476" text="CSTB" type="GENE"/>
    <entity charOffset="279-285" id="s1219.e1" ontology_id="HP_0002664" text="tumour" type="HP"/>
    <pair e1="s1219.e0" e2="s1219.e1" id="s1219.p0" relation="true"/>
  </sentence>
  <sentence id="s1220" text="Mice carrying kinase-dead CLP1 also displayed microcephaly and reduced cortical brain volume due to the enhanced cell death of neuronal progenitors that is associated with reduced numbers of cortical neurons.">
    <entity charOffset="26-30" id="s1220.e0" ontology_id="10978" text="CLP1" type="GENE"/>
    <entity charOffset="46-58" id="s1220.e1" ontology_id="HP_0000252" text="microcephaly" type="HP"/>
    <pair e1="s1220.e0" e2="s1220.e1" id="s1220.p0" relation="true"/>
  </sentence>
  <sentence id="s1221" text="Based on screening results, five unique genes (GNPAT, SUMO1, SPINT2, FLI1, and SSX1) significantly potentiated the growth inhibitory effects of CDDO-Me and induced apoptosis in A375, a BRAF mutated melanoma line (P&amp;lt;0.001).">
    <entity charOffset="69-73" id="s1221.e0" ontology_id="2313" text="FLI1" type="GENE"/>
    <entity charOffset="198-206" id="s1221.e1" ontology_id="HP_0002861" text="melanoma" type="HP"/>
    <pair e1="s1221.e0" e2="s1221.e1" id="s1221.p0" relation="true"/>
  </sentence>
  <sentence id="s1222" text="Based on screening results, five unique genes (GNPAT, SUMO1, SPINT2, FLI1, and SSX1) significantly potentiated the growth inhibitory effects of CDDO-Me and induced apoptosis in A375, a BRAF mutated melanoma line (P&amp;lt;0.001).">
    <entity charOffset="79-83" id="s1222.e0" ontology_id="6756" text="SSX1" type="GENE"/>
    <entity charOffset="198-206" id="s1222.e1" ontology_id="HP_0002861" text="melanoma" type="HP"/>
    <pair e1="s1222.e0" e2="s1222.e1" id="s1222.p0" relation="true"/>
  </sentence>
  <sentence id="s1223" text="Our findings indicate that GNPAT, SUMO1, SPINT2, FLI1, and SSX1 play critical roles in synergy with inflammation pathways in modulating melanoma cell survival and could serve as sensitizing targets to enhance CDDO-Me efficacy in melanoma growth control">
    <entity charOffset="27-32" id="s1223.e0" ontology_id="8443" text="GNPAT" type="GENE"/>
    <entity charOffset="136-144" id="s1223.e1" ontology_id="HP_0002861" text="melanoma" type="HP"/>
    <pair e1="s1223.e0" e2="s1223.e1" id="s1223.p0" relation="true"/>
  </sentence>
  <sentence id="s1224" text="Our findings indicate that GNPAT, SUMO1, SPINT2, FLI1, and SSX1 play critical roles in synergy with inflammation pathways in modulating melanoma cell survival and could serve as sensitizing targets to enhance CDDO-Me efficacy in melanoma growth control">
    <entity charOffset="49-53" id="s1224.e0" ontology_id="2313" text="FLI1" type="GENE"/>
    <entity charOffset="136-144" id="s1224.e1" ontology_id="HP_0002861" text="melanoma" type="HP"/>
    <pair e1="s1224.e0" e2="s1224.e1" id="s1224.p0" relation="true"/>
  </sentence>
  <sentence id="s1225" text="Furthermore, we performed invitro assays in breast cancer cell lines, and our results indicated that DCLRE1B, MRPS30, and ATG10 played a vital role in breast tumorigenesis via certain disruption of cell behaviors.">
    <entity charOffset="52-58" id="s1225.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="102-109" id="s1225.e1" ontology_id="64858" text="DCLRE1B" type="GENE"/>
    <pair e1="s1225.e0" e2="s1225.e1" id="s1225.p0" relation="false"/>
  </sentence>
  <sentence id="s1226" text="Here, we report 1 known (c.1489C&amp;gt;T, p.Pro497Ser, P497S) and 3 novel (c.1481C&amp;gt;T, p.Pro494Leu, P494L; c.1498C&amp;gt;T, p.Pro500Ser, P500S; and c.1516C&amp;gt;G, p.Pro506Ala, P506A) missense mutations in the PXX domain of UBQLN2 in familial motor neuron diseases including ALS and spastic paraplegia (SP).">
    <entity charOffset="218-224" id="s1226.e0" ontology_id="29978" text="UBQLN2" type="GENE"/>
    <entity charOffset="277-295" id="s1226.e1" ontology_id="HP_0001258" text="spastic paraplegia" type="HP"/>
    <pair e1="s1226.e0" e2="s1226.e1" id="s1226.p0" relation="true"/>
  </sentence>
  <sentence id="s1227" text="Mosaicism was identified for autosomal dominant (JAG1, COL3A1), autosomal recessive (PYGM), and X-linked (PHKA2, PDHA1, OTC, and SLC6A8) disorders.">
    <entity charOffset="55-61" id="s1227.e0" ontology_id="1281" text="COL3A1" type="GENE"/>
    <entity charOffset="64-83" id="s1227.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s1227.e0" e2="s1227.e1" id="s1227.p0" relation="false"/>
  </sentence>
  <sentence id="s1228" text="Mosaicism was identified for autosomal dominant (JAG1, COL3A1), autosomal recessive (PYGM), and X-linked (PHKA2, PDHA1, OTC, and SLC6A8) disorders.">
    <entity charOffset="64-83" id="s1228.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="120-123" id="s1228.e1" ontology_id="5009" text="OTC" type="GENE"/>
    <pair e1="s1228.e0" e2="s1228.e1" id="s1228.p0" relation="false"/>
  </sentence>
  <sentence id="s1229" text="Mosaicism was identified for autosomal dominant (JAG1, COL3A1), autosomal recessive (PYGM), and X-linked (PHKA2, PDHA1, OTC, and SLC6A8) disorders.">
    <entity charOffset="64-83" id="s1229.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="113-118" id="s1229.e1" ontology_id="5160" text="PDHA1" type="GENE"/>
    <pair e1="s1229.e0" e2="s1229.e1" id="s1229.p0" relation="false"/>
  </sentence>
  <sentence id="s1230" text="Mosaicism was identified for autosomal dominant (JAG1, COL3A1), autosomal recessive (PYGM), and X-linked (PHKA2, PDHA1, OTC, and SLC6A8) disorders.">
    <entity charOffset="64-83" id="s1230.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="106-111" id="s1230.e1" ontology_id="5256" text="PHKA2" type="GENE"/>
    <pair e1="s1230.e0" e2="s1230.e1" id="s1230.p0" relation="false"/>
  </sentence>
  <sentence id="s1231" text="Some individuals with heterozygous PRDM5 mutations demonstrate a carrier ocular phenotype, which includes a mildly reduced corneal thickness, keratoconus and blue sclera.">
    <entity charOffset="35-40" id="s1231.e0" ontology_id="11107" text="PRDM5" type="GENE"/>
    <entity charOffset="142-153" id="s1231.e1" ontology_id="HP_0000563" text="keratoconus" type="HP"/>
    <pair e1="s1231.e0" e2="s1231.e1" id="s1231.p0" relation="true"/>
  </sentence>
  <sentence id="s1232" text="Hyperphosphatasia with mental retardation syndrome (HPMRS) is caused by mutations in PIGV and includes hyperphosphatasia as a diagnostic hallmark.">
    <entity charOffset="85-89" id="s1232.e0" ontology_id="55650" text="PIGV" type="GENE"/>
    <entity charOffset="103-120" id="s1232.e1" ontology_id="HP_0003155" text="hyperphosphatasia" type="HP"/>
    <pair e1="s1232.e0" e2="s1232.e1" id="s1232.p0" relation="true"/>
  </sentence>
  <sentence id="s1233" text="Glutaric acidemia I (GAI) is an autosomal recessive metabolic disease caused by a deficiency of glutaryl-CoA dehydrogenase enzyme (GCDH).">
    <entity charOffset="32-51" id="s1233.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="131-135" id="s1233.e1" ontology_id="2639" text="GCDH" type="GENE"/>
    <pair e1="s1233.e0" e2="s1233.e1" id="s1233.p0" relation="true"/>
  </sentence>
  <sentence id="s1234" text="Extensive IDS gene deletions were identified in four patients; using DNA microarray analysis two patients showed the loss of the entire AFF2 gene, and epilepsy developed in only one of them.">
    <entity charOffset="10-13" id="s1234.e0" ontology_id="3423" text="IDS" type="GENE"/>
    <entity charOffset="151-159" id="s1234.e1" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <pair e1="s1234.e0" e2="s1234.e1" id="s1234.p0" relation="false"/>
  </sentence>
  <sentence id="s1235" text="In vivo experiments were performed in nude mice bearing transfected tumors; results revealed that NET-VMAT2-coexpressing tumors had longer &lt;sup&gt;131&lt;/sup&gt;I-MIBG retention time than NET-expressing tumors.">
    <entity charOffset="68-74" id="s1235.e0" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <entity charOffset="102-107" id="s1235.e1" ontology_id="6571" text="VMAT2" type="GENE"/>
    <pair e1="s1235.e0" e2="s1235.e1" id="s1235.p0" relation="false"/>
  </sentence>
  <sentence id="s1236" text="The reported hypertrophic cardiomyopathy relevant genes MYPN, MYH6 and MYBP3 had also been found in case 1 and 2.">
    <entity charOffset="26-40" id="s1236.e0" ontology_id="HP_0001638" text="cardiomyopathy" type="HP"/>
    <entity charOffset="62-66" id="s1236.e1" ontology_id="4624" text="MYH6" type="GENE"/>
    <pair e1="s1236.e0" e2="s1236.e1" id="s1236.p0" relation="true"/>
  </sentence>
  <sentence id="s1237" text="Given the lack of specific targeted genes and pathways known to be involved in tumour cell dormancy, we proposed enriched candidate genes related to the negative regulation of cell proliferation, signalling pathways regulating pluripotency of stem cells and neuroactive ligand-receptor interaction, and 3hub genes (FTH1, GRM1 and DDIT3).">
    <entity charOffset="79-85" id="s1237.e0" ontology_id="HP_0002664" text="tumour" type="HP"/>
    <entity charOffset="322-326" id="s1237.e1" ontology_id="2911" text="GRM1" type="GENE"/>
    <pair e1="s1237.e0" e2="s1237.e1" id="s1237.p0" relation="false"/>
  </sentence>
  <sentence id="s1238" text="Carriers of CT or TT genotype of CCL2 rs13900 had increased risk of hearing loss at birth and at 6months of age (aOR=3.59; p=0.028 and aOR=4.10; p=0.039, respectively).">
    <entity charOffset="33-37" id="s1238.e0" ontology_id="6347" text="CCL2" type="GENE"/>
    <entity charOffset="68-80" id="s1238.e1" ontology_id="HP_0000365" text="hearing loss" type="HP"/>
    <pair e1="s1238.e0" e2="s1238.e1" id="s1238.p0" relation="true"/>
  </sentence>
  <sentence id="s1239" text="Microfibrillar-associated protein 5 (MFAP5) is a component of extracellular elastic microfibril which has been confirmed to function in tissue development and cancer progression.">
    <entity charOffset="37-42" id="s1239.e0" ontology_id="8076" text="MFAP5" type="GENE"/>
    <entity charOffset="159-165" id="s1239.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1239.e0" e2="s1239.e1" id="s1239.p0" relation="true"/>
  </sentence>
  <sentence id="s1240" text="The present study demonstrated that MFAP5 was up-regulated in breast cancers compared with that in normal breast tissues, and further increased in breast cancer bone metastasis.">
    <entity charOffset="36-41" id="s1240.e0" ontology_id="8076" text="MFAP5" type="GENE"/>
    <entity charOffset="69-75" id="s1240.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1240.e0" e2="s1240.e1" id="s1240.p0" relation="true"/>
  </sentence>
  <sentence id="s1241" text="In terms of prognostic features, a survival analysis revealed that the high GBE1 and HK2 expression group exhibited poorer survival in lung adenocarcinoma patients.">
    <entity charOffset="76-80" id="s1241.e0" ontology_id="2632" text="GBE1" type="GENE"/>
    <entity charOffset="135-154" id="s1241.e1" ontology_id="HP_0030078" text="lung adenocarcinoma" type="HP"/>
    <pair e1="s1241.e0" e2="s1241.e1" id="s1241.p0" relation="true"/>
  </sentence>
  <sentence id="s1242" text="The key clinical features of the patient with SJS1 included short stature, joint contractures, pigeon breast, and myotonia that led to progressive stiffness of the face and limbs; barely discernible kyphosis was also noted.">
    <entity charOffset="46-50" id="s1242.e0" ontology_id="3339" text="SJS1" type="GENE"/>
    <entity charOffset="199-207" id="s1242.e1" ontology_id="HP_0002808" text="kyphosis" type="HP"/>
    <pair e1="s1242.e0" e2="s1242.e1" id="s1242.p0" relation="true"/>
  </sentence>
  <sentence id="s1243" text="The family members harboring 1 heterozygous mutation in HSPG2 did not exhibit any skeletal abnormalities.">
    <entity charOffset="56-61" id="s1243.e0" ontology_id="3339" text="HSPG2" type="GENE"/>
    <entity charOffset="82-104" id="s1243.e1" ontology_id="HP_0000924" text="skeletal abnormalities" type="HP"/>
    <pair e1="s1243.e0" e2="s1243.e1" id="s1243.p0" relation="true"/>
  </sentence>
  <sentence id="s1244" text="In ALDH&lt;sup&gt;+&lt;/sup&gt;CD24&lt;sup&gt;-&lt;/sup&gt;CD44&lt;sup&gt;+&lt;/sup&gt; BCSCs, we identified P4HA2, PTGR1 and RAB40B as potential prognostic markers, which were virtually related to the status of BCSCs and tumor growth in TNBC cells">
    <entity charOffset="90-96" id="s1244.e0" ontology_id="10966" text="RAB40B" type="GENE"/>
    <entity charOffset="186-191" id="s1244.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1244.e0" e2="s1244.e1" id="s1244.p0" relation="true"/>
  </sentence>
  <sentence id="s1245" text="Missense mutations in SCN2A (p.Leu1342Pro) and KCNQ2 (p.Ala306Thr) were found in two patients with no history of epilepsy before the onset of ISs.">
    <entity charOffset="47-52" id="s1245.e0" ontology_id="3785" text="KCNQ2" type="GENE"/>
    <entity charOffset="113-121" id="s1245.e1" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <pair e1="s1245.e0" e2="s1245.e1" id="s1245.p0" relation="true"/>
  </sentence>
  <sentence id="s1246" text="The PCH1sub-types with early death (between ages 1 day and 17 months), seen in patients with p.G31A/EXOSC3 or SLC25A46 mutations have a SMA type 1-like clinical presentation but with global developmental delay, visual and hearing impairment, with or without microcephaly, nystagmus and optic atrophy.">
    <entity charOffset="100-106" id="s1246.e0" ontology_id="51010" text="EXOSC3" type="GENE"/>
    <entity charOffset="258-270" id="s1246.e1" ontology_id="HP_0000252" text="microcephaly" type="HP"/>
    <pair e1="s1246.e0" e2="s1246.e1" id="s1246.p0" relation="true"/>
  </sentence>
  <sentence id="s1247" text="The PCH1sub-types with early death (between ages 1 day and 17 months), seen in patients with p.G31A/EXOSC3 or SLC25A46 mutations have a SMA type 1-like clinical presentation but with global developmental delay, visual and hearing impairment, with or without microcephaly, nystagmus and optic atrophy.">
    <entity charOffset="100-106" id="s1247.e0" ontology_id="51010" text="EXOSC3" type="GENE"/>
    <entity charOffset="286-299" id="s1247.e1" ontology_id="HP_0000648" text="optic atrophy" type="HP"/>
    <pair e1="s1247.e0" e2="s1247.e1" id="s1247.p0" relation="true"/>
  </sentence>
  <sentence id="s1248" text="The PCH1sub-types with early death (between ages 1 day and 17 months), seen in patients with p.G31A/EXOSC3 or SLC25A46 mutations have a SMA type 1-like clinical presentation but with global developmental delay, visual and hearing impairment, with or without microcephaly, nystagmus and optic atrophy.">
    <entity charOffset="110-118" id="s1248.e0" ontology_id="91137" text="SLC25A46" type="GENE"/>
    <entity charOffset="258-270" id="s1248.e1" ontology_id="HP_0000252" text="microcephaly" type="HP"/>
    <pair e1="s1248.e0" e2="s1248.e1" id="s1248.p0" relation="true"/>
  </sentence>
  <sentence id="s1249" text="Other EXOSC3 mutations and EXOSC8 cases are intermediate - SMA type 1-like presentation, spasticity (mostly in EXOSC8) and death between 3 months and 5 years.">
    <entity charOffset="6-12" id="s1249.e0" ontology_id="51010" text="EXOSC3" type="GENE"/>
    <entity charOffset="89-99" id="s1249.e1" ontology_id="HP_0001257" text="spasticity" type="HP"/>
    <pair e1="s1249.e0" e2="s1249.e1" id="s1249.p0" relation="true"/>
  </sentence>
  <sentence id="s1250" text="Other EXOSC3 mutations and EXOSC8 cases are intermediate - SMA type 1-like presentation, spasticity (mostly in EXOSC8) and death between 3 months and 5 years.">
    <entity charOffset="27-33" id="s1250.e0" ontology_id="11340" text="EXOSC8" type="GENE"/>
    <entity charOffset="89-99" id="s1250.e1" ontology_id="HP_0001257" text="spasticity" type="HP"/>
    <pair e1="s1250.e0" e2="s1250.e1" id="s1250.p0" relation="true"/>
  </sentence>
  <sentence id="s1251" text="Mutations with milder presentation (homozygous p.D132A/EXOSC3 or VRK1) may display additionally signs of upper motor neuron impairment, dystonia or ataxia and die at age between 5 and 18 years.">
    <entity charOffset="65-69" id="s1251.e0" ontology_id="7443" text="VRK1" type="GENE"/>
    <entity charOffset="148-154" id="s1251.e1" ontology_id="HP_0001251" text="ataxia" type="HP"/>
    <pair e1="s1251.e0" e2="s1251.e1" id="s1251.p0" relation="true"/>
  </sentence>
  <sentence id="s1252" text="Immunohistochemically, tumor cells of all cases were positive for vimentin (100.0%, 60/60), STAT6 (98.3%, 59/60), CD34 (61.7%, 37/60), and the tumor cells were typically positive for CD99, bcl-2, EMA and SSTR2 as well.Negative for S-100 protein, SOX10, E-cadherin, GFAP.">
    <entity charOffset="23-28" id="s1252.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="189-194" id="s1252.e1" ontology_id="596" text="bcl-2" type="GENE"/>
    <pair e1="s1252.e0" e2="s1252.e1" id="s1252.p0" relation="false"/>
  </sentence>
  <sentence id="s1253" text="Immunohistochemically, tumor cells of all cases were positive for vimentin (100.0%, 60/60), STAT6 (98.3%, 59/60), CD34 (61.7%, 37/60), and the tumor cells were typically positive for CD99, bcl-2, EMA and SSTR2 as well.Negative for S-100 protein, SOX10, E-cadherin, GFAP.">
    <entity charOffset="23-28" id="s1253.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="92-97" id="s1253.e1" ontology_id="6778" text="STAT6" type="GENE"/>
    <pair e1="s1253.e0" e2="s1253.e1" id="s1253.p0" relation="true"/>
  </sentence>
  <sentence id="s1254" text="Immunohistochemically, tumor cells of all cases were positive for vimentin (100.0%, 60/60), STAT6 (98.3%, 59/60), CD34 (61.7%, 37/60), and the tumor cells were typically positive for CD99, bcl-2, EMA and SSTR2 as well.Negative for S-100 protein, SOX10, E-cadherin, GFAP.">
    <entity charOffset="23-28" id="s1254.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="255-263" id="s1254.e1" ontology_id="1015" text="cadherin" type="GENE"/>
    <pair e1="s1254.e0" e2="s1254.e1" id="s1254.p0" relation="false"/>
  </sentence>
  <sentence id="s1255" text="To explore the underlying mechanism of tumor suppression by BLU, its potential to promote apoptosis induced by TRAIL, an effector molecule elaborated by natural killer-T (NKT) cells was investigated.">
    <entity charOffset="39-44" id="s1255.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="60-63" id="s1255.e1" ontology_id="51364" text="BLU" type="GENE"/>
    <pair e1="s1255.e0" e2="s1255.e1" id="s1255.p0" relation="true"/>
  </sentence>
  <sentence id="s1256" text="Here, we have performed a prospective nationwide genetic association study using the Human Exome BeadChip and identified gene variants in encoding dynactin 4 (DCTN4), retinoic acid early transcript 1E (RAET1E), and V-akt murine thymoma viral oncogene homolog 3 (AKT3) to be associated with unfavourable outcome in patients with pneumococcal meningitis.">
    <entity charOffset="262-266" id="s1256.e0" ontology_id="10000" text="AKT3" type="GENE"/>
    <entity charOffset="341-351" id="s1256.e1" ontology_id="HP_0001287" text="meningitis" type="HP"/>
    <pair e1="s1256.e0" e2="s1256.e1" id="s1256.p0" relation="true"/>
  </sentence>
  <sentence id="s1257" text="These findings suggest that ZEB1 is not only driving EMT, but also contributes to the formation of osteolytic bone metastases in breast cancer.">
    <entity charOffset="28-32" id="s1257.e0" ontology_id="6935" text="ZEB1" type="GENE"/>
    <entity charOffset="136-142" id="s1257.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1257.e0" e2="s1257.e1" id="s1257.p0" relation="true"/>
  </sentence>
  <sentence id="s1258" text="Placental mRNA abundance for the folate receptor alpha (&lt;i&gt;FOLR1&lt;/i&gt;) was reduced with obesity, whilst &lt;i&gt;DNMT1&lt;/i&gt; was increased with raised BMI, responses that were unaffected by GD.">
    <entity charOffset="87-94" id="s1258.e0" ontology_id="HP_0001513" text="obesity" type="HP"/>
    <entity charOffset="106-110" id="s1258.e1" ontology_id="1786" text="DNMT" type="GENE"/>
    <pair e1="s1258.e0" e2="s1258.e1" id="s1258.p0" relation="false"/>
  </sentence>
  <sentence id="s1259" text="In a few (non-Swedish) melanoma families, mutations in other genes have been found, including CDK4, TERT, POT1, ACD and TERF2IP.">
    <entity charOffset="23-31" id="s1259.e0" ontology_id="HP_0002861" text="melanoma" type="HP"/>
    <entity charOffset="94-98" id="s1259.e1" ontology_id="1019" text="CDK4" type="GENE"/>
    <pair e1="s1259.e0" e2="s1259.e1" id="s1259.p0" relation="true"/>
  </sentence>
  <sentence id="s1260" text="In a few (non-Swedish) melanoma families, mutations in other genes have been found, including CDK4, TERT, POT1, ACD and TERF2IP.">
    <entity charOffset="23-31" id="s1260.e0" ontology_id="HP_0002861" text="melanoma" type="HP"/>
    <entity charOffset="100-104" id="s1260.e1" ontology_id="7015" text="TERT" type="GENE"/>
    <pair e1="s1260.e0" e2="s1260.e1" id="s1260.p0" relation="true"/>
  </sentence>
  <sentence id="s1261" text="In genes that regulate cellular pigmentation pathways, including MC1R, ASIP, IRF4, TYR, TYRP1 and OCA, there are different common variants that determine complexion traits, and those variants are also associated with different risks of melanoma.">
    <entity charOffset="83-86" id="s1261.e0" ontology_id="7299" text="TYR" type="GENE"/>
    <entity charOffset="236-244" id="s1261.e1" ontology_id="HP_0002861" text="melanoma" type="HP"/>
    <pair e1="s1261.e0" e2="s1261.e1" id="s1261.p0" relation="true"/>
  </sentence>
  <sentence id="s1262" text="Individuals with known mutations in tumor suppressor genes such as CDKN2A and BAP1 require, in addition, follow up for other cancers">
    <entity charOffset="36-41" id="s1262.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="67-73" id="s1262.e1" ontology_id="1029" text="CDKN2A" type="GENE"/>
    <pair e1="s1262.e0" e2="s1262.e1" id="s1262.p0" relation="true"/>
  </sentence>
  <sentence id="s1263" text="Swedish CDKN2A mutation carriers have a young median age of onset of melanoma, increased risks of multiple primary melanoma and of tobacco-associated cancers in respiratory and upper digestive tissues, and also worse survival compared to non-carriers.">
    <entity charOffset="8-14" id="s1263.e0" ontology_id="1029" text="CDKN2A" type="GENE"/>
    <entity charOffset="69-77" id="s1263.e1" ontology_id="HP_0002861" text="melanoma" type="HP"/>
    <pair e1="s1263.e0" e2="s1263.e1" id="s1263.p0" relation="true"/>
  </sentence>
  <sentence id="s1264" text="In case of DLEC1 and ITGA9, expression levels were decreased in 71-78% of tumor samples and significantly different between tumor and normal tissues (P=0.0001).">
    <entity charOffset="21-26" id="s1264.e0" ontology_id="3680" text="ITGA9" type="GENE"/>
    <entity charOffset="75-80" id="s1264.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1264.e0" e2="s1264.e1" id="s1264.p0" relation="true"/>
  </sentence>
  <sentence id="s1265" text="The presented workflow employed three different peptide microarray formats to discover and resolve the epitopes of human autoantibodies and revealed two potentially new autoantigens: MAP3K7 in multiple sclerosis and NRXN1 in narcolepsy.">
    <entity charOffset="216-221" id="s1265.e0" ontology_id="9378" text="NRXN1" type="GENE"/>
    <entity charOffset="225-235" id="s1265.e1" ontology_id="HP_0030050" text="narcolepsy" type="HP"/>
    <pair e1="s1265.e0" e2="s1265.e1" id="s1265.p0" relation="true"/>
  </sentence>
  <sentence id="s1266" text="Previously (Pappas et al., 2015;4:e08352), we reported that Dlx5/6-Cre mediated forebrain deletion of the DYT1 dystonia protein torsinA (Dlx-CKO) causes abnormal twisting and selective degeneration of dorsal striatal cholinergic interneurons (ChI) (Pappas et al., 2015).">
    <entity charOffset="106-110" id="s1266.e0" ontology_id="1861" text="DYT1" type="GENE"/>
    <entity charOffset="111-119" id="s1266.e1" ontology_id="HP_0001332" text="dystonia" type="HP"/>
    <pair e1="s1266.e0" e2="s1266.e1" id="s1266.p0" relation="true"/>
  </sentence>
  <sentence id="s1267" text="Recently, autosomal recessive loss-of-function mutations in EXPH5 (encoding exophilin-5, also known as Slac2-b, a protein involved in intracellular vesicle transport) were identified in a new mechanobullous disease resembling a form of epidermolysis bullosa simplex (EBS).">
    <entity charOffset="10-29" id="s1267.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="60-65" id="s1267.e1" ontology_id="23086" text="EXPH5" type="GENE"/>
    <pair e1="s1267.e0" e2="s1267.e1" id="s1267.p0" relation="true"/>
  </sentence>
  <sentence id="s1268" text="Here, we searched for mutations in EXPH5 in a 4-year-old white boy with EBS in whom initial Sanger sequencing of known genes implicated in intraepidermal skin fragility failed to identify pathogenic mutations.">
    <entity charOffset="35-40" id="s1268.e0" ontology_id="23086" text="EXPH5" type="GENE"/>
    <entity charOffset="154-168" id="s1268.e1" ontology_id="HP_0001030" text="skin fragility" type="HP"/>
    <pair e1="s1268.e0" e2="s1268.e1" id="s1268.p0" relation="false"/>
  </sentence>
  <sentence id="s1269" text="Cognitive impairment or autism-like performance were often identified in these patients, hematuria metabolic diseases screening was normal, no abnormal MRI imaging of the head, and de novo PCDH19 gene mutations were found in their epilepsy gene chip sequencing.">
    <entity charOffset="189-195" id="s1269.e0" ontology_id="57526" text="PCDH19" type="GENE"/>
    <entity charOffset="231-239" id="s1269.e1" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <pair e1="s1269.e0" e2="s1269.e1" id="s1269.p0" relation="true"/>
  </sentence>
  <sentence id="s1270" text="Epilepsy with mental retardation limited to females (EFMR) is a syndrome characterized by early onset heat-sensitive epilepsy of infancy or early childhood and generally limited to females, which previously reported that the cadherin gene superfamily subtype protocadherin 19 (PCDH19) gene is its pathogenic gene.">
    <entity charOffset="117-125" id="s1270.e0" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <entity charOffset="277-283" id="s1270.e1" ontology_id="57526" text="PCDH19" type="GENE"/>
    <pair e1="s1270.e0" e2="s1270.e1" id="s1270.p0" relation="true"/>
  </sentence>
  <sentence id="s1271" text="Nagashima-type palmoplantar keratosis (NPPK) is an autosomal recessive form of palmoplantar keratoderma (PPK), which is caused by mutations in the SERPINB7 gene.">
    <entity charOffset="15-37" id="s1271.e0" ontology_id="HP_0000972" text="palmoplantar keratosis" type="HP"/>
    <entity charOffset="147-155" id="s1271.e1" ontology_id="8710" text="SERPINB7" type="GENE"/>
    <pair e1="s1271.e0" e2="s1271.e1" id="s1271.p0" relation="true"/>
  </sentence>
  <sentence id="s1272" text="Tumor-specific methylation changes at IGF2 DMR2 were observed in 59% of cancer patients, IGF2 DMR0 in 38%, DIRAS3 DMR in 36%, GRB10 ICR in 23%, PEG3 DMR in 21%, MEST ICR in 19%, H19 ICR in 18%, KvDMR in 8% and SNRPN/SNURF ICR in 4%.">
    <entity charOffset="72-78" id="s1272.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="144-148" id="s1272.e1" ontology_id="5178" text="PEG3" type="GENE"/>
    <pair e1="s1272.e0" e2="s1272.e1" id="s1272.p0" relation="true"/>
  </sentence>
  <sentence id="s1273" text="Tumor-specific methylation changes at IGF2 DMR2 were observed in 59% of cancer patients, IGF2 DMR0 in 38%, DIRAS3 DMR in 36%, GRB10 ICR in 23%, PEG3 DMR in 21%, MEST ICR in 19%, H19 ICR in 18%, KvDMR in 8% and SNRPN/SNURF ICR in 4%.">
    <entity charOffset="72-78" id="s1273.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="161-165" id="s1273.e1" ontology_id="4232" text="MEST" type="GENE"/>
    <pair e1="s1273.e0" e2="s1273.e1" id="s1273.p0" relation="true"/>
  </sentence>
  <sentence id="s1274" text="Several candidate genes for obesity and T2D (e.g., IRS1 and VEGFA) were differentially expressed in discordant twins.">
    <entity charOffset="28-35" id="s1274.e0" ontology_id="HP_0001513" text="obesity" type="HP"/>
    <entity charOffset="60-65" id="s1274.e1" ontology_id="7422" text="VEGFA" type="GENE"/>
    <pair e1="s1274.e0" e2="s1274.e1" id="s1274.p0" relation="false"/>
  </sentence>
  <sentence id="s1275" text="The mutations in the PRPS1 gene leads to X-linked Charcot-Marie-Tooth neuropathy type 5 (CMTX5), PRS super activity, Arts syndrome, X-linked deafness-1, breast cancer, and colorectal cancer.">
    <entity charOffset="21-26" id="s1275.e0" ontology_id="5631" text="PRPS1" type="GENE"/>
    <entity charOffset="141-149" id="s1275.e1" ontology_id="HP_0000365" text="deafness" type="HP"/>
    <pair e1="s1275.e0" e2="s1275.e1" id="s1275.p0" relation="true"/>
  </sentence>
  <sentence id="s1276" text="In this review article, we summarize the discovery of TYMP and the potential molecular mechanisms of TYMP involved in the development of various diseases, especially cardiovascular diseases.">
    <entity charOffset="54-58" id="s1276.e0" ontology_id="1890" text="TYMP" type="GENE"/>
    <entity charOffset="166-189" id="s1276.e1" ontology_id="HP_0001626" text="cardiovascular diseases" type="HP"/>
    <pair e1="s1276.e0" e2="s1276.e1" id="s1276.p0" relation="true"/>
  </sentence>
  <sentence id="s1277" text="A total of nine non-coding variants on 11q13.5 predispose men to prostate cancer (PrCa). rs200331695 within the EMSY intron is associated with aggressive PrCa and two high linkage disequilibrium (LD) groups of single-nucleotide polymorphisms (SNPs) in the intergenic region are associated with PrCa death.">
    <entity charOffset="74-80" id="s1277.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="112-116" id="s1277.e1" ontology_id="56946" text="EMSY" type="GENE"/>
    <pair e1="s1277.e0" e2="s1277.e1" id="s1277.p0" relation="false"/>
  </sentence>
  <sentence id="s1278" text="The high LD SNPs (rs143975731, rs12277366, rs2155225, and rs2155222) were associated with DGAT2 expression in both tumors sets (screening P=0.035-0.043; validation P=0.005-0.018).">
    <entity charOffset="90-95" id="s1278.e0" ontology_id="84649" text="DGAT2" type="GENE"/>
    <entity charOffset="115-121" id="s1278.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s1278.e0" e2="s1278.e1" id="s1278.p0" relation="true"/>
  </sentence>
  <sentence id="s1279" text="Altogether, our study provides direct evidence that endogenous Rspo2 and Rspo3 chromosome rearrangements can initiate and maintain tumour development, and indicate a viable therapeutic window for LGK974 treatment of RSPO-fusion cancers">
    <entity charOffset="63-68" id="s1279.e0" ontology_id="340419" text="Rspo2" type="GENE"/>
    <entity charOffset="228-234" id="s1279.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1279.e0" e2="s1279.e1" id="s1279.p0" relation="true"/>
  </sentence>
  <sentence id="s1280" text="We show that both Rspo2 and Rspo3 fusion events are sufficient to initiate hyperplasia and tumour development in vivo, without additional cooperating genetic events.">
    <entity charOffset="28-33" id="s1280.e0" ontology_id="84870" text="Rspo3" type="GENE"/>
    <entity charOffset="91-97" id="s1280.e1" ontology_id="HP_0002664" text="tumour" type="HP"/>
    <pair e1="s1280.e0" e2="s1280.e1" id="s1280.p0" relation="true"/>
  </sentence>
  <sentence id="s1281" text="Here, we describe the generation of transgenic, inducible CRISPR-based mouse systems to engineer and study recurrent colon cancer-associated EIF3E-RSPO2 and PTPRK-RSPO3 chromosome rearrangements in vivo.">
    <entity charOffset="123-129" id="s1281.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="157-162" id="s1281.e1" ontology_id="5796" text="PTPRK" type="GENE"/>
    <pair e1="s1281.e0" e2="s1281.e1" id="s1281.p0" relation="true"/>
  </sentence>
  <sentence id="s1282" text="Our results demonstrate that adenomyoepitheliomas are genetically heterogeneous, and qualify mutations in HRAS, a gene whose mutations are vanishingly rare in common-type breast cancers, as likely drivers of ER-negative adenomyoepitheliomas">
    <entity charOffset="66-79" id="s1282.e0" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <entity charOffset="106-110" id="s1282.e1" ontology_id="3265" text="HRAS" type="GENE"/>
    <pair e1="s1282.e0" e2="s1282.e1" id="s1282.p0" relation="true"/>
  </sentence>
  <sentence id="s1283" text="Hennekam lymphangiectasia-lymphedema syndrome is an autosomal recessive disorder, with 25% of patients having mutations in CCBE1.">
    <entity charOffset="52-71" id="s1283.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="123-128" id="s1283.e1" ontology_id="147372" text="CCBE1" type="GENE"/>
    <pair e1="s1283.e0" e2="s1283.e1" id="s1283.p0" relation="true"/>
  </sentence>
  <sentence id="s1284" text="While there were no significant correlations with both Se status markers, &lt;i&gt;SELENOF&lt;/i&gt;, &lt;i&gt;SELENOK&lt;/i&gt;, and &lt;i&gt;TXNRD1&lt;/i&gt; tumor tissue expression positively correlated with Se, while &lt;i&gt;TXNRD2&lt;/i&gt; and &lt;i&gt;TXNRD3&lt;/i&gt; negatively correlated with &lt;i&gt;SELENOP&lt;/i&gt;.">
    <entity charOffset="124-129" id="s1284.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="247-254" id="s1284.e1" ontology_id="6414" text="SELENOP" type="GENE"/>
    <pair e1="s1284.e0" e2="s1284.e1" id="s1284.p0" relation="false"/>
  </sentence>
  <sentence id="s1285" text="Therefore, STX3 promotes the growth of breast cancer cells by regulating the PTEN-PI3K-Akt-mTOR signaling">
    <entity charOffset="46-52" id="s1285.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="87-90" id="s1285.e1" ontology_id="207" text="Akt" type="GENE"/>
    <pair e1="s1285.e0" e2="s1285.e1" id="s1285.p0" relation="false"/>
  </sentence>
  <sentence id="s1286" text="Therefore, STX3 promotes the growth of breast cancer cells by regulating the PTEN-PI3K-Akt-mTOR signaling">
    <entity charOffset="46-52" id="s1286.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="91-95" id="s1286.e1" ontology_id="2475" text="mTOR" type="GENE"/>
    <pair e1="s1286.e0" e2="s1286.e1" id="s1286.p0" relation="false"/>
  </sentence>
  <sentence id="s1287" text="We find that STX3 promotes the proliferation of breast cancer cells by increasing the activation of the Akt-mTOR signaling, and Akt inhibitor Ipatasertib or MK-2206 represses STX3 effects on the growth of breast cancer cells.">
    <entity charOffset="55-61" id="s1287.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="104-107" id="s1287.e1" ontology_id="207" text="Akt" type="GENE"/>
    <pair e1="s1287.e0" e2="s1287.e1" id="s1287.p0" relation="false"/>
  </sentence>
  <sentence id="s1288" text="The up-regulation of STX3 is correlated with high disease stage and predicts overall and disease-free survival in patients with breast cancer.">
    <entity charOffset="21-25" id="s1288.e0" ontology_id="6809" text="STX3" type="GENE"/>
    <entity charOffset="135-141" id="s1288.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1288.e0" e2="s1288.e1" id="s1288.p0" relation="true"/>
  </sentence>
  <sentence id="s1289" text="Our studies show that DKD susceptibility was linked to mitochondrial dysfunction, mediated largely by Edn1-Ednra in glomerular endothelial cells representing an early event in DKD progression, and suggest that cross talk between glomerular endothelial injury and podocytes leads to defects and depletion, albuminuria, and glomerulosclerosis">
    <entity charOffset="107-112" id="s1289.e0" ontology_id="1909" text="Ednra" type="GENE"/>
    <entity charOffset="305-316" id="s1289.e1" ontology_id="HP_0012592" text="albuminuria" type="HP"/>
    <pair e1="s1289.e0" e2="s1289.e1" id="s1289.p0" relation="false"/>
  </sentence>
  <sentence id="s1290" text="Selective Ednra blockade or mitochondrial-targeted reactive oxygen species scavenging prevented mitochondrial oxidative stress of endothelial cells and ameliorated diabetes-induced endothelial injury, podocyte loss, albuminuria, and glomerulosclerosis.">
    <entity charOffset="10-15" id="s1290.e0" ontology_id="1909" text="Ednra" type="GENE"/>
    <entity charOffset="216-227" id="s1290.e1" ontology_id="HP_0012592" text="albuminuria" type="HP"/>
    <pair e1="s1290.e0" e2="s1290.e1" id="s1290.p0" relation="true"/>
  </sentence>
  <sentence id="s1291" text="The deleted in colorectal cancer (DCC) gene encodes the netrin-1 (NTN1) receptor DCC, a transmembrane protein required for the guidance of commissural axons.">
    <entity charOffset="26-32" id="s1291.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="34-37" id="s1291.e1" ontology_id="1630" text="DCC" type="GENE"/>
    <pair e1="s1291.e0" e2="s1291.e1" id="s1291.p0" relation="true"/>
  </sentence>
  <sentence id="s1292" text="It is a genetic disorder caused by a mutation in the dysferlin gene (DYSF) with an autosomal recessive mode of inheritance.">
    <entity charOffset="69-73" id="s1292.e0" ontology_id="8291" text="DYSF" type="GENE"/>
    <entity charOffset="83-102" id="s1292.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s1292.e0" e2="s1292.e1" id="s1292.p0" relation="true"/>
  </sentence>
  <sentence id="s1293" text="Our results therefore confirm the KCNC3R423H allele as causative for SCA13, through a dominant negative effect on KCNC3WT and links with EGFR that account for dominant inheritance, congenital onset, and disease pathology">
    <entity charOffset="69-74" id="s1293.e0" ontology_id="3748" text="SCA13" type="GENE"/>
    <entity charOffset="168-179" id="s1293.e1" ontology_id="HP_0000005" text="inheritance" type="HP"/>
    <pair e1="s1293.e0" e2="s1293.e1" id="s1293.p0" relation="true"/>
  </sentence>
  <sentence id="s1294" text="Our results therefore confirm the KCNC3R423H allele as causative for SCA13, through a dominant negative effect on KCNC3WT and links with EGFR that account for dominant inheritance, congenital onset, and disease pathology">
    <entity charOffset="137-141" id="s1294.e0" ontology_id="1956" text="EGFR" type="GENE"/>
    <entity charOffset="168-179" id="s1294.e1" ontology_id="HP_0000005" text="inheritance" type="HP"/>
    <pair e1="s1294.e0" e2="s1294.e1" id="s1294.p0" relation="true"/>
  </sentence>
  <sentence id="s1295" text="In the present study, we first analyzed two expression quantitative trait loci (eQTL) datasets in healthy individuals and investigated the associations of eQTL of AHI1 with schizophrenia in independent European samples.">
    <entity charOffset="163-167" id="s1295.e0" ontology_id="54806" text="AHI1" type="GENE"/>
    <entity charOffset="173-186" id="s1295.e1" ontology_id="HP_0100753" text="schizophrenia" type="HP"/>
    <pair e1="s1295.e0" e2="s1295.e1" id="s1295.p0" relation="true"/>
  </sentence>
  <sentence id="s1296" text="Our present study confirmed radiation can promote the in vitro migration and invasion of triple negative breast cancer (TNBC) cells and increase the expression of epithelial-mesenchymal transition (EMT) related transcription factor ZEB1, while had no effect on Snail, Slug or Twist.">
    <entity charOffset="112-118" id="s1296.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="261-266" id="s1296.e1" ontology_id="6615" text="Snail" type="GENE"/>
    <pair e1="s1296.e0" e2="s1296.e1" id="s1296.p0" relation="false"/>
  </sentence>
  <sentence id="s1297" text="Our present study confirmed radiation can promote the in vitro migration and invasion of triple negative breast cancer (TNBC) cells and increase the expression of epithelial-mesenchymal transition (EMT) related transcription factor ZEB1, while had no effect on Snail, Slug or Twist.">
    <entity charOffset="112-118" id="s1297.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="232-236" id="s1297.e1" ontology_id="6935" text="ZEB1" type="GENE"/>
    <pair e1="s1297.e0" e2="s1297.e1" id="s1297.p0" relation="false"/>
  </sentence>
  <sentence id="s1298" text="In vivo imaging, ex vivo imaging and tumor tissue slides showed that PDT further contribute EGFP-EGF1-NP accumulation in tumor.">
    <entity charOffset="37-42" id="s1298.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="97-101" id="s1298.e1" ontology_id="85476" text="EGF1" type="GENE"/>
    <pair e1="s1298.e0" e2="s1298.e1" id="s1298.p0" relation="true"/>
  </sentence>
  <sentence id="s1299" text="In vivo imaging, ex vivo imaging and tumor tissue slides showed that PDT further contribute EGFP-EGF1-NP accumulation in tumor.">
    <entity charOffset="37-42" id="s1299.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="102-104" id="s1299.e1" ontology_id="4860" text="NP" type="GENE"/>
    <pair e1="s1299.e0" e2="s1299.e1" id="s1299.p0" relation="true"/>
  </sentence>
  <sentence id="s1300" text="In this study, a TF-cascade-targeted strategy aiming to disrupt tumor blood vessels was developed by combination of TF-targeted HMME-loaded drug delivery system and PDT.">
    <entity charOffset="17-19" id="s1300.e0" ontology_id="7018" text="TF" type="GENE"/>
    <entity charOffset="64-69" id="s1300.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1300.e0" e2="s1300.e1" id="s1300.p0" relation="true"/>
  </sentence>
  <sentence id="s1301" text="By recruiting the methyltransferase DOT1L, C/EBP can maintain an open chromatin state by H3K79 methylation of multiple drug-resistance genes, thereby augmenting the chemoresistance of tumor cells.">
    <entity charOffset="36-41" id="s1301.e0" ontology_id="84444" text="DOT1L" type="GENE"/>
    <entity charOffset="185-190" id="s1301.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1301.e0" e2="s1301.e1" id="s1301.p0" relation="false"/>
  </sentence>
  <sentence id="s1302" text="Analysis of clinical samples of oral cancer found a strong correlation of these genes with short survival, especially JUN expression associated with metastasis.">
    <entity charOffset="37-43" id="s1302.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="118-121" id="s1302.e1" ontology_id="3725" text="JUN" type="GENE"/>
    <pair e1="s1302.e0" e2="s1302.e1" id="s1302.p0" relation="true"/>
  </sentence>
  <sentence id="s1303" text="Of these, Frem1, Foxo1, and Setd7 have been implicated in the pathogenesis of nephropathy.">
    <entity charOffset="28-33" id="s1303.e0" ontology_id="80854" text="Setd7" type="GENE"/>
    <entity charOffset="78-89" id="s1303.e1" ontology_id="HP_0000112" text="nephropathy" type="HP"/>
    <pair e1="s1303.e0" e2="s1303.e1" id="s1303.p0" relation="true"/>
  </sentence>
  <sentence id="s1304" text="Previous studies have reported the association of prodynorphin (PDYN) promoter polymorphism with temporal lobe epilepsy (TLE) susceptibility, but the results remain inconclusive.">
    <entity charOffset="64-68" id="s1304.e0" ontology_id="5173" text="PDYN" type="GENE"/>
    <entity charOffset="111-119" id="s1304.e1" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <pair e1="s1304.e0" e2="s1304.e1" id="s1304.p0" relation="true"/>
  </sentence>
  <sentence id="s1305" text="In this research, we measured the expression of UQCRC2 protein by immunohistochemistry assay in 89 paired paraffin-embedded tumor tissues and corresponding adjacent normal tissues from patients with colorectal adenocarcinoma and investigated possible correlations of UQCRC2 expression with clinicopathological parameters and prognosis.">
    <entity charOffset="48-54" id="s1305.e0" ontology_id="7385" text="UQCRC2" type="GENE"/>
    <entity charOffset="124-129" id="s1305.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1305.e0" e2="s1305.e1" id="s1305.p0" relation="true"/>
  </sentence>
  <sentence id="s1306" text="These results provided novel insights into the potential role of UQCRC2 in the tumorigenesis and progression of CRC, and revealed that UQCRC2 may serve as a new prognostic and therapeutic target in CRC">
    <entity charOffset="65-71" id="s1306.e0" ontology_id="7385" text="UQCRC2" type="GENE"/>
    <entity charOffset="79-84" id="s1306.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1306.e0" e2="s1306.e1" id="s1306.p0" relation="true"/>
  </sentence>
  <sentence id="s1307" text="Examination of tumor-infiltrating immune cells from mice vaccinated with the GM-CSF-expressing exosomes showed robust tumor-reactive CD8&lt;sup&gt;+&lt;/sup&gt; T effector responses, Th1 cytokine responses, and higher CD8&lt;sup&gt;+&lt;/sup&gt; T effector/CD4&lt;sup&gt;+&lt;/sup&gt;CD25&lt;sup&gt;+&lt;/sup&gt;Foxp3&lt;sup&gt;+&lt;/sup&gt; T regulatory cell ratio in the tumors.">
    <entity charOffset="15-20" id="s1307.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="77-83" id="s1307.e1" ontology_id="1437" text="GM-CSF" type="GENE"/>
    <pair e1="s1307.e0" e2="s1307.e1" id="s1307.p0" relation="true"/>
  </sentence>
  <sentence id="s1308" text="The homeodomain transcription factor SIX3 was recently reported to be a negative regulator of the Wnt pathway and has an emerging role in cancer.">
    <entity charOffset="37-41" id="s1308.e0" ontology_id="6496" text="SIX3" type="GENE"/>
    <entity charOffset="138-144" id="s1308.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1308.e0" e2="s1308.e1" id="s1308.p0" relation="true"/>
  </sentence>
  <sentence id="s1309" text="To avoid this artifactual early priming of the host precluding the study of the interactions between the immune system and tumors at the steady state, we generated a cell line expressing the DBY Ag in an inducible manner.">
    <entity charOffset="123-128" id="s1309.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="191-194" id="s1309.e1" ontology_id="8653" text="DBY" type="GENE"/>
    <pair e1="s1309.e0" e2="s1309.e1" id="s1309.p0" relation="false"/>
  </sentence>
  <sentence id="s1310" text="In this study, we show that the presentation of a MHC class II-restricted model Ag (male, DBY) released by dying tumor cells may last more than 4 wk.">
    <entity charOffset="90-93" id="s1310.e0" ontology_id="8653" text="DBY" type="GENE"/>
    <entity charOffset="113-118" id="s1310.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1310.e0" e2="s1310.e1" id="s1310.p0" relation="true"/>
  </sentence>
  <sentence id="s1311" text="In the case-control analysis, the rs9607195 A&amp;gt;G on intergenic area 250kb away from the ISX gene and the rs12738007 A&amp;gt;G on the intron of the MECR gene were the most strongly associated SNPs with the risk of schizophrenia (P=6.210(-8) , OR=0.50 and P=3.710(-7) , OR=2.39, respectively).">
    <entity charOffset="91-94" id="s1311.e0" ontology_id="91464" text="ISX" type="GENE"/>
    <entity charOffset="213-226" id="s1311.e1" ontology_id="HP_0100753" text="schizophrenia" type="HP"/>
    <pair e1="s1311.e0" e2="s1311.e1" id="s1311.p0" relation="false"/>
  </sentence>
  <sentence id="s1312" text="Clinical presentation of COX deficiency is heterogeneous ranging from mild to severe neuromuscular diseases.">
    <entity charOffset="25-28" id="s1312.e0" ontology_id="1351" text="COX" type="GENE"/>
    <entity charOffset="43-56" id="s1312.e1" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <pair e1="s1312.e0" e2="s1312.e1" id="s1312.p0" relation="true"/>
  </sentence>
  <sentence id="s1313" text="Furthermore, we identified some potential lung cancer driver genes, such as TBX2, MCM4, SLC2A1, BIRC5, and CDC20, whose expression is significantly upregulated in lung cancer, and the copy number of these genes is amplified in the genome of patients with lung cancer.">
    <entity charOffset="47-53" id="s1313.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="82-86" id="s1313.e1" ontology_id="4173" text="MCM4" type="GENE"/>
    <pair e1="s1313.e0" e2="s1313.e1" id="s1313.p0" relation="true"/>
  </sentence>
  <sentence id="s1314" text="Furthermore, we identified some potential lung cancer driver genes, such as TBX2, MCM4, SLC2A1, BIRC5, and CDC20, whose expression is significantly upregulated in lung cancer, and the copy number of these genes is amplified in the genome of patients with lung cancer.">
    <entity charOffset="47-53" id="s1314.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="96-101" id="s1314.e1" ontology_id="332" text="BIRC5" type="GENE"/>
    <pair e1="s1314.e0" e2="s1314.e1" id="s1314.p0" relation="true"/>
  </sentence>
  <sentence id="s1315" text="Furthermore, we identified some potential lung cancer driver genes, such as TBX2, MCM4, SLC2A1, BIRC5, and CDC20, whose expression is significantly upregulated in lung cancer, and the copy number of these genes is amplified in the genome of patients with lung cancer.">
    <entity charOffset="47-53" id="s1315.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="76-80" id="s1315.e1" ontology_id="6909" text="TBX2" type="GENE"/>
    <pair e1="s1315.e0" e2="s1315.e1" id="s1315.p0" relation="true"/>
  </sentence>
  <sentence id="s1316" text="Several important genetic alterations (i.e., mutations, deletions) have been identified to be involved in the initiation and progression of pancreatic cancer, including KRAS and inactivation of tumor suppressors, such as TP53, SMAD4 and CDKN2A.">
    <entity charOffset="151-157" id="s1316.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="169-173" id="s1316.e1" ontology_id="3845" text="KRAS" type="GENE"/>
    <pair e1="s1316.e0" e2="s1316.e1" id="s1316.p0" relation="true"/>
  </sentence>
  <sentence id="s1317" text="Several important genetic alterations (i.e., mutations, deletions) have been identified to be involved in the initiation and progression of pancreatic cancer, including KRAS and inactivation of tumor suppressors, such as TP53, SMAD4 and CDKN2A.">
    <entity charOffset="194-199" id="s1317.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="227-232" id="s1317.e1" ontology_id="4089" text="SMAD4" type="GENE"/>
    <pair e1="s1317.e0" e2="s1317.e1" id="s1317.p0" relation="true"/>
  </sentence>
  <sentence id="s1318" text="The most likely causal variant identified was a novel missense variant in the X-linked GRIA3 gene, which has been implicated in intellectual disability.">
    <entity charOffset="87-92" id="s1318.e0" ontology_id="2892" text="GRIA3" type="GENE"/>
    <entity charOffset="128-151" id="s1318.e1" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <pair e1="s1318.e0" e2="s1318.e1" id="s1318.p0" relation="true"/>
  </sentence>
  <sentence id="s1319" text="In co-culture experiments using F10-OVA melanoma cells and tumor-specific CD3+ T cells, EGCG reduced &lt;i&gt;PD-L1&lt;/i&gt; mRNA expression about 30% in F10-OVA cells and restored &lt;i&gt;interleukin-2&lt;/i&gt; mRNA expression in tumor-specific CD3+ T cells.">
    <entity charOffset="32-35" id="s1319.e0" ontology_id="2159" text="F10" type="GENE"/>
    <entity charOffset="59-64" id="s1319.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1319.e0" e2="s1319.e1" id="s1319.p0" relation="false"/>
  </sentence>
  <sentence id="s1320" text="We here report that (-)-epigallocatechin gallate (EGCG) inhibited programmed cell death ligand 1 (PD-L1) expression in nonsmall-cell lung cancer cells, induced by both interferon (IFN)- and epidermal growth factor (EGF).">
    <entity charOffset="139-145" id="s1320.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="181-184" id="s1320.e1" ontology_id="3439" text="IFN" type="GENE"/>
    <pair e1="s1320.e0" e2="s1320.e1" id="s1320.p0" relation="true"/>
  </sentence>
  <sentence id="s1321" text="Our WES data is largely matched with the earlier 'adenoma-carcinoma model' (APC, KRAS, NRAS and GNAS mutations), but there are newly identified SMAD4, MTOR, ACVR1B, GNAQ, ATM, CNOT1, EP300, ARID2, RET and MAP2K4 mutations in this study.">
    <entity charOffset="58-67" id="s1321.e0" ontology_id="HP_0030731" text="carcinoma" type="HP"/>
    <entity charOffset="144-149" id="s1321.e1" ontology_id="4089" text="SMAD4" type="GENE"/>
    <pair e1="s1321.e0" e2="s1321.e1" id="s1321.p0" relation="true"/>
  </sentence>
  <sentence id="s1322" text="Our WES data is largely matched with the earlier 'adenoma-carcinoma model' (APC, KRAS, NRAS and GNAS mutations), but there are newly identified SMAD4, MTOR, ACVR1B, GNAQ, ATM, CNOT1, EP300, ARID2, RET and MAP2K4 mutations in this study.">
    <entity charOffset="58-67" id="s1322.e0" ontology_id="HP_0030731" text="carcinoma" type="HP"/>
    <entity charOffset="165-169" id="s1322.e1" ontology_id="2776" text="GNAQ" type="GENE"/>
    <pair e1="s1322.e0" e2="s1322.e1" id="s1322.p0" relation="false"/>
  </sentence>
  <sentence id="s1323" text="Our WES data is largely matched with the earlier 'adenoma-carcinoma model' (APC, KRAS, NRAS and GNAS mutations), but there are newly identified SMAD4, MTOR, ACVR1B, GNAQ, ATM, CNOT1, EP300, ARID2, RET and MAP2K4 mutations in this study.">
    <entity charOffset="58-67" id="s1323.e0" ontology_id="HP_0030731" text="carcinoma" type="HP"/>
    <entity charOffset="76-79" id="s1323.e1" ontology_id="324" text="APC" type="GENE"/>
    <pair e1="s1323.e0" e2="s1323.e1" id="s1323.p0" relation="true"/>
  </sentence>
  <sentence id="s1324" text="Our WES data is largely matched with the earlier 'adenoma-carcinoma model' (APC, KRAS, NRAS and GNAS mutations), but there are newly identified SMAD4, MTOR, ACVR1B, GNAQ, ATM, CNOT1, EP300, ARID2, RET and MAP2K4 mutations in this study.">
    <entity charOffset="58-67" id="s1324.e0" ontology_id="HP_0030731" text="carcinoma" type="HP"/>
    <entity charOffset="87-91" id="s1324.e1" ontology_id="4893" text="NRAS" type="GENE"/>
    <pair e1="s1324.e0" e2="s1324.e1" id="s1324.p0" relation="true"/>
  </sentence>
  <sentence id="s1325" text="We identified 22 genes including APC, KRAS, TP53, GNAS, NRAS, SMAD4, ARID2, and PIK3CA with non-silent mutations in the cancer Census Genes.">
    <entity charOffset="38-42" id="s1325.e0" ontology_id="3845" text="KRAS" type="GENE"/>
    <entity charOffset="120-126" id="s1325.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1325.e0" e2="s1325.e1" id="s1325.p0" relation="true"/>
  </sentence>
  <sentence id="s1326" text="We identified 22 genes including APC, KRAS, TP53, GNAS, NRAS, SMAD4, ARID2, and PIK3CA with non-silent mutations in the cancer Census Genes.">
    <entity charOffset="56-60" id="s1326.e0" ontology_id="4893" text="NRAS" type="GENE"/>
    <entity charOffset="120-126" id="s1326.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1326.e0" e2="s1326.e1" id="s1326.p0" relation="true"/>
  </sentence>
  <sentence id="s1327" text="We identified 22 genes including APC, KRAS, TP53, GNAS, NRAS, SMAD4, ARID2, and PIK3CA with non-silent mutations in the cancer Census Genes.">
    <entity charOffset="69-74" id="s1327.e0" ontology_id="196528" text="ARID2" type="GENE"/>
    <entity charOffset="120-126" id="s1327.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1327.e0" e2="s1327.e1" id="s1327.p0" relation="false"/>
  </sentence>
  <sentence id="s1328" text="Factor VII (FVII) activating protease (FSAP) is a circulating serine protease that is likely to be involved in a number of disease conditions such as stroke, atherosclerosis, liver fibrosis, thrombosis and cancer.">
    <entity charOffset="39-43" id="s1328.e0" ontology_id="3026" text="FSAP" type="GENE"/>
    <entity charOffset="206-212" id="s1328.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1328.e0" e2="s1328.e1" id="s1328.p0" relation="true"/>
  </sentence>
  <sentence id="s1329" text="Mining GWAS databases revealed association of cis-eSNPs for more than 50 genes with T2D (e.g. PIK3C2A, RBMS1, UFSP1), gluco-metabolic phenotypes (e.g. INPP5E, SNX17, ERAP2, FN3KRP), and obesity (e.g. POMC, CPEB4).">
    <entity charOffset="94-101" id="s1329.e0" ontology_id="5286" text="PIK3C2A" type="GENE"/>
    <entity charOffset="186-193" id="s1329.e1" ontology_id="HP_0001513" text="obesity" type="HP"/>
    <pair e1="s1329.e0" e2="s1329.e1" id="s1329.p0" relation="false"/>
  </sentence>
  <sentence id="s1330" text="Mining GWAS databases revealed association of cis-eSNPs for more than 50 genes with T2D (e.g. PIK3C2A, RBMS1, UFSP1), gluco-metabolic phenotypes (e.g. INPP5E, SNX17, ERAP2, FN3KRP), and obesity (e.g. POMC, CPEB4).">
    <entity charOffset="110-115" id="s1330.e0" ontology_id="402682" text="UFSP1" type="GENE"/>
    <entity charOffset="186-193" id="s1330.e1" ontology_id="HP_0001513" text="obesity" type="HP"/>
    <pair e1="s1330.e0" e2="s1330.e1" id="s1330.p0" relation="false"/>
  </sentence>
  <sentence id="s1331" text="Mining GWAS databases revealed association of cis-eSNPs for more than 50 genes with T2D (e.g. PIK3C2A, RBMS1, UFSP1), gluco-metabolic phenotypes (e.g. INPP5E, SNX17, ERAP2, FN3KRP), and obesity (e.g. POMC, CPEB4).">
    <entity charOffset="166-171" id="s1331.e0" ontology_id="64167" text="ERAP2" type="GENE"/>
    <entity charOffset="186-193" id="s1331.e1" ontology_id="HP_0001513" text="obesity" type="HP"/>
    <pair e1="s1331.e0" e2="s1331.e1" id="s1331.p0" relation="false"/>
  </sentence>
  <sentence id="s1332" text="Although Sur8 has been shown to be a scaffold protein of the Ras-ERK pathway, its interaction with other signaling pathways and its involvement in tumor malignancy has not been reported.">
    <entity charOffset="9-13" id="s1332.e0" ontology_id="8036" text="Sur8" type="GENE"/>
    <entity charOffset="147-152" id="s1332.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1332.e0" e2="s1332.e1" id="s1332.p0" relation="true"/>
  </sentence>
  <sentence id="s1333" text="The tumor cells expressed MUC4, GLUT-1, and vimentin and were negative for S-100 protein, epithelial membrane antigen, smooth muscle actin, desmin, claudin-1, neurofilament and SOX10.">
    <entity charOffset="4-9" id="s1333.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="26-30" id="s1333.e1" ontology_id="4585" text="MUC4" type="GENE"/>
    <pair e1="s1333.e0" e2="s1333.e1" id="s1333.p0" relation="true"/>
  </sentence>
  <sentence id="s1334" text="Mutations in the ubiquitously expressed pre-mRNA processing factors 3, 8, and 31 (PRPF3, PRPF8, and PRPF31) cause nonsyndromic dominant retinitis pigmentosa in humans, an inherited retinal degeneration.">
    <entity charOffset="89-94" id="s1334.e0" ontology_id="10594" text="PRPF8" type="GENE"/>
    <entity charOffset="181-201" id="s1334.e1" ontology_id="HP_0000546" text="retinal degeneration" type="HP"/>
    <pair e1="s1334.e0" e2="s1334.e1" id="s1334.p0" relation="true"/>
  </sentence>
  <sentence id="s1335" text="Metabolic cutis laxa results from Menkes syndrome, caused by a defect in the ATPase copper transporting alpha (ATP7A) gene; congenital disorders of glycosylation due to mutations in subunit 7 of the component of oligomeric Golgi (COG7)-congenital disorders of glycosylation (CDG) complex; combined disorder of N- and O-linked glycosylation, due to mutations in ATPase H+ transporting V0 subunit a2 (ATP6VOA2) gene; pyrroline-5-carboxylate reductase 1 deficiency; pyrroline-5-carboxylate synthase deficiency; macrocephaly, alopecia, cutis laxa, and scoliosis (MACS) syndrome, due to Ras and Rab interactor 2 (RIN2) mutations; transaldolase deficiency caused by mutations in the transaldolase 1 (TALDO1) gene; Gerodermia osteodysplastica due to mutations in the golgin, RAB6-interacting (GORAB or SCYL1BP1) gene; and mitogen-activated pathway (MAP) kinase defects, caused by mutations in several genes [protein tyrosine phosphatase, non-receptor-type 11 (PTPN11), RAF, NF, HRas proto-oncogene, GTPase (HRAS), B-Raf proto-oncogene, serine/threonine kinase (BRAF), MEK1/2, KRAS proto-oncogene, GTPase (KRAS), SOS Ras/Rho guanine nucleotide exchange factor 2 (SOS2), leucine rich repeat scaffold protein (SHOC2), NRAS proto-oncogene, GTPase (NRAS), and Raf-1 proto-oncogene, serine/threonine kinase (RAF1)], which regulate the Ras-MAPK cascade.">
    <entity charOffset="508-520" id="s1335.e0" ontology_id="HP_0000256" text="macrocephaly" type="HP"/>
    <entity charOffset="1069-1073" id="s1335.e1" ontology_id="3845" text="KRAS" type="GENE"/>
    <pair e1="s1335.e0" e2="s1335.e1" id="s1335.p0" relation="false"/>
  </sentence>
  <sentence id="s1336" text="Metabolic cutis laxa results from Menkes syndrome, caused by a defect in the ATPase copper transporting alpha (ATP7A) gene; congenital disorders of glycosylation due to mutations in subunit 7 of the component of oligomeric Golgi (COG7)-congenital disorders of glycosylation (CDG) complex; combined disorder of N- and O-linked glycosylation, due to mutations in ATPase H+ transporting V0 subunit a2 (ATP6VOA2) gene; pyrroline-5-carboxylate reductase 1 deficiency; pyrroline-5-carboxylate synthase deficiency; macrocephaly, alopecia, cutis laxa, and scoliosis (MACS) syndrome, due to Ras and Rab interactor 2 (RIN2) mutations; transaldolase deficiency caused by mutations in the transaldolase 1 (TALDO1) gene; Gerodermia osteodysplastica due to mutations in the golgin, RAB6-interacting (GORAB or SCYL1BP1) gene; and mitogen-activated pathway (MAP) kinase defects, caused by mutations in several genes [protein tyrosine phosphatase, non-receptor-type 11 (PTPN11), RAF, NF, HRas proto-oncogene, GTPase (HRAS), B-Raf proto-oncogene, serine/threonine kinase (BRAF), MEK1/2, KRAS proto-oncogene, GTPase (KRAS), SOS Ras/Rho guanine nucleotide exchange factor 2 (SOS2), leucine rich repeat scaffold protein (SHOC2), NRAS proto-oncogene, GTPase (NRAS), and Raf-1 proto-oncogene, serine/threonine kinase (RAF1)], which regulate the Ras-MAPK cascade.">
    <entity charOffset="508-520" id="s1336.e0" ontology_id="HP_0000256" text="macrocephaly" type="HP"/>
    <entity charOffset="1248-1253" id="s1336.e1" ontology_id="5894" text="Raf-1" type="GENE"/>
    <pair e1="s1336.e0" e2="s1336.e1" id="s1336.p0" relation="false"/>
  </sentence>
  <sentence id="s1337" text="Metabolic cutis laxa results from Menkes syndrome, caused by a defect in the ATPase copper transporting alpha (ATP7A) gene; congenital disorders of glycosylation due to mutations in subunit 7 of the component of oligomeric Golgi (COG7)-congenital disorders of glycosylation (CDG) complex; combined disorder of N- and O-linked glycosylation, due to mutations in ATPase H+ transporting V0 subunit a2 (ATP6VOA2) gene; pyrroline-5-carboxylate reductase 1 deficiency; pyrroline-5-carboxylate synthase deficiency; macrocephaly, alopecia, cutis laxa, and scoliosis (MACS) syndrome, due to Ras and Rab interactor 2 (RIN2) mutations; transaldolase deficiency caused by mutations in the transaldolase 1 (TALDO1) gene; Gerodermia osteodysplastica due to mutations in the golgin, RAB6-interacting (GORAB or SCYL1BP1) gene; and mitogen-activated pathway (MAP) kinase defects, caused by mutations in several genes [protein tyrosine phosphatase, non-receptor-type 11 (PTPN11), RAF, NF, HRas proto-oncogene, GTPase (HRAS), B-Raf proto-oncogene, serine/threonine kinase (BRAF), MEK1/2, KRAS proto-oncogene, GTPase (KRAS), SOS Ras/Rho guanine nucleotide exchange factor 2 (SOS2), leucine rich repeat scaffold protein (SHOC2), NRAS proto-oncogene, GTPase (NRAS), and Raf-1 proto-oncogene, serine/threonine kinase (RAF1)], which regulate the Ras-MAPK cascade.">
    <entity charOffset="508-520" id="s1337.e0" ontology_id="HP_0000256" text="macrocephaly" type="HP"/>
    <entity charOffset="1054-1058" id="s1337.e1" ontology_id="673" text="BRAF" type="GENE"/>
    <pair e1="s1337.e0" e2="s1337.e1" id="s1337.p0" relation="false"/>
  </sentence>
  <sentence id="s1338" text="Metabolic cutis laxa results from Menkes syndrome, caused by a defect in the ATPase copper transporting alpha (ATP7A) gene; congenital disorders of glycosylation due to mutations in subunit 7 of the component of oligomeric Golgi (COG7)-congenital disorders of glycosylation (CDG) complex; combined disorder of N- and O-linked glycosylation, due to mutations in ATPase H+ transporting V0 subunit a2 (ATP6VOA2) gene; pyrroline-5-carboxylate reductase 1 deficiency; pyrroline-5-carboxylate synthase deficiency; macrocephaly, alopecia, cutis laxa, and scoliosis (MACS) syndrome, due to Ras and Rab interactor 2 (RIN2) mutations; transaldolase deficiency caused by mutations in the transaldolase 1 (TALDO1) gene; Gerodermia osteodysplastica due to mutations in the golgin, RAB6-interacting (GORAB or SCYL1BP1) gene; and mitogen-activated pathway (MAP) kinase defects, caused by mutations in several genes [protein tyrosine phosphatase, non-receptor-type 11 (PTPN11), RAF, NF, HRas proto-oncogene, GTPase (HRAS), B-Raf proto-oncogene, serine/threonine kinase (BRAF), MEK1/2, KRAS proto-oncogene, GTPase (KRAS), SOS Ras/Rho guanine nucleotide exchange factor 2 (SOS2), leucine rich repeat scaffold protein (SHOC2), NRAS proto-oncogene, GTPase (NRAS), and Raf-1 proto-oncogene, serine/threonine kinase (RAF1)], which regulate the Ras-MAPK cascade.">
    <entity charOffset="508-520" id="s1338.e0" ontology_id="HP_0000256" text="macrocephaly" type="HP"/>
    <entity charOffset="953-959" id="s1338.e1" ontology_id="5781" text="PTPN11" type="GENE"/>
    <pair e1="s1338.e0" e2="s1338.e1" id="s1338.p0" relation="false"/>
  </sentence>
  <sentence id="s1339" text="Metabolic cutis laxa results from Menkes syndrome, caused by a defect in the ATPase copper transporting alpha (ATP7A) gene; congenital disorders of glycosylation due to mutations in subunit 7 of the component of oligomeric Golgi (COG7)-congenital disorders of glycosylation (CDG) complex; combined disorder of N- and O-linked glycosylation, due to mutations in ATPase H+ transporting V0 subunit a2 (ATP6VOA2) gene; pyrroline-5-carboxylate reductase 1 deficiency; pyrroline-5-carboxylate synthase deficiency; macrocephaly, alopecia, cutis laxa, and scoliosis (MACS) syndrome, due to Ras and Rab interactor 2 (RIN2) mutations; transaldolase deficiency caused by mutations in the transaldolase 1 (TALDO1) gene; Gerodermia osteodysplastica due to mutations in the golgin, RAB6-interacting (GORAB or SCYL1BP1) gene; and mitogen-activated pathway (MAP) kinase defects, caused by mutations in several genes [protein tyrosine phosphatase, non-receptor-type 11 (PTPN11), RAF, NF, HRas proto-oncogene, GTPase (HRAS), B-Raf proto-oncogene, serine/threonine kinase (BRAF), MEK1/2, KRAS proto-oncogene, GTPase (KRAS), SOS Ras/Rho guanine nucleotide exchange factor 2 (SOS2), leucine rich repeat scaffold protein (SHOC2), NRAS proto-oncogene, GTPase (NRAS), and Raf-1 proto-oncogene, serine/threonine kinase (RAF1)], which regulate the Ras-MAPK cascade.">
    <entity charOffset="508-520" id="s1339.e0" ontology_id="HP_0000256" text="macrocephaly" type="HP"/>
    <entity charOffset="971-975" id="s1339.e1" ontology_id="3265" text="HRas" type="GENE"/>
    <pair e1="s1339.e0" e2="s1339.e1" id="s1339.p0" relation="false"/>
  </sentence>
  <sentence id="s1340" text="Metabolic cutis laxa results from Menkes syndrome, caused by a defect in the ATPase copper transporting alpha (ATP7A) gene; congenital disorders of glycosylation due to mutations in subunit 7 of the component of oligomeric Golgi (COG7)-congenital disorders of glycosylation (CDG) complex; combined disorder of N- and O-linked glycosylation, due to mutations in ATPase H+ transporting V0 subunit a2 (ATP6VOA2) gene; pyrroline-5-carboxylate reductase 1 deficiency; pyrroline-5-carboxylate synthase deficiency; macrocephaly, alopecia, cutis laxa, and scoliosis (MACS) syndrome, due to Ras and Rab interactor 2 (RIN2) mutations; transaldolase deficiency caused by mutations in the transaldolase 1 (TALDO1) gene; Gerodermia osteodysplastica due to mutations in the golgin, RAB6-interacting (GORAB or SCYL1BP1) gene; and mitogen-activated pathway (MAP) kinase defects, caused by mutations in several genes [protein tyrosine phosphatase, non-receptor-type 11 (PTPN11), RAF, NF, HRas proto-oncogene, GTPase (HRAS), B-Raf proto-oncogene, serine/threonine kinase (BRAF), MEK1/2, KRAS proto-oncogene, GTPase (KRAS), SOS Ras/Rho guanine nucleotide exchange factor 2 (SOS2), leucine rich repeat scaffold protein (SHOC2), NRAS proto-oncogene, GTPase (NRAS), and Raf-1 proto-oncogene, serine/threonine kinase (RAF1)], which regulate the Ras-MAPK cascade.">
    <entity charOffset="548-557" id="s1340.e0" ontology_id="HP_0002650" text="scoliosis" type="HP"/>
    <entity charOffset="1200-1205" id="s1340.e1" ontology_id="8036" text="SHOC2" type="GENE"/>
    <pair e1="s1340.e0" e2="s1340.e1" id="s1340.p0" relation="false"/>
  </sentence>
  <sentence id="s1341" text="The deafness genes GJB3, CRYM, GRHL2, DFNA5, and ATP6B1 were expressed in marmoset cochleae in patterns different from those in mouse cochleae.">
    <entity charOffset="4-12" id="s1341.e0" ontology_id="HP_0000365" text="deafness" type="HP"/>
    <entity charOffset="25-29" id="s1341.e1" ontology_id="1428" text="CRYM" type="GENE"/>
    <pair e1="s1341.e0" e2="s1341.e1" id="s1341.p0" relation="true"/>
  </sentence>
  <sentence id="s1342" text="The other tested genes, including the deafness gene COCH, in which mutation recapitulates deafness in mice, were expressed in a similar manner in both species.">
    <entity charOffset="38-46" id="s1342.e0" ontology_id="HP_0000365" text="deafness" type="HP"/>
    <entity charOffset="52-56" id="s1342.e1" ontology_id="1690" text="COCH" type="GENE"/>
    <pair e1="s1342.e0" e2="s1342.e1" id="s1342.p0" relation="true"/>
  </sentence>
  <sentence id="s1343" text="Ectopic expression of Cx31 in mouse skin results in skin abnormalities resembling human EKV.">
    <entity charOffset="52-70" id="s1343.e0" ontology_id="HP_0000951" text="skin abnormalities" type="HP"/>
    <entity charOffset="88-91" id="s1343.e1" ontology_id="2707" text="EKV" type="GENE"/>
    <pair e1="s1343.e0" e2="s1343.e1" id="s1343.p0" relation="false"/>
  </sentence>
  <sentence id="s1344" text="We first develop a doxycycline-inducible cell line expressing GFP-tagged cytoplasmic TDP-43 protein (iGFP-NLSm) as a cell-based system to screen and identify seeding activity of human brain-derived pathological TDP-43 isolated from sporadic FTLD-TDP and familial cases with Granulin (FTLD-TDP-GRN) or C9orf72 repeat expansion mutations (FTLD-TDP-C9+).">
    <entity charOffset="85-91" id="s1344.e0" ontology_id="23435" text="TDP-43" type="GENE"/>
    <entity charOffset="232-240" id="s1344.e1" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <pair e1="s1344.e0" e2="s1344.e1" id="s1344.p0" relation="true"/>
  </sentence>
  <sentence id="s1345" text="To provide new ideas based on the use of corin for risk prediction, prognostic assessment, and clinical treatment of cardiovascular diseases and to promote the implementation of corin as a routine laboratory index, we summarize the latest studies of the association between corin and cardiovascular diseases in recent years and offer some prospective proposals for future research on corin in this review">
    <entity charOffset="41-46" id="s1345.e0" ontology_id="10699" text="corin" type="GENE"/>
    <entity charOffset="117-140" id="s1345.e1" ontology_id="HP_0001626" text="cardiovascular diseases" type="HP"/>
    <pair e1="s1345.e0" e2="s1345.e1" id="s1345.p0" relation="true"/>
  </sentence>
  <sentence id="s1346" text="All these findings indicate that circulating soluble corin has the potential to be a sensitive and specific biomarker for risk prediction and prognostic assessment of cardiovascular diseases.">
    <entity charOffset="53-58" id="s1346.e0" ontology_id="10699" text="corin" type="GENE"/>
    <entity charOffset="167-190" id="s1346.e1" ontology_id="HP_0001626" text="cardiovascular diseases" type="HP"/>
    <pair e1="s1346.e0" e2="s1346.e1" id="s1346.p0" relation="true"/>
  </sentence>
  <sentence id="s1347" text="Mutation analysis of the NDUFA11 is warranted in isolated complex I deficiency presenting with infantile lactic acidemia or encephalocardiomyopathy">
    <entity charOffset="25-32" id="s1347.e0" ontology_id="126328" text="NDUFA11" type="GENE"/>
    <entity charOffset="105-120" id="s1347.e1" ontology_id="HP_0003128" text="lactic acidemia" type="HP"/>
    <pair e1="s1347.e0" e2="s1347.e1" id="s1347.p0" relation="true"/>
  </sentence>
  <sentence id="s1348" text="Although PABPN1 plays a critical role in the regulation of RNA processing, mutation of the gene encoding this ubiquitously expressed RNA binding protein causes a specific form of muscular dystrophy termed oculopharyngeal muscular dystrophy (OPMD).">
    <entity charOffset="9-15" id="s1348.e0" ontology_id="8106" text="PABPN1" type="GENE"/>
    <entity charOffset="179-197" id="s1348.e1" ontology_id="HP_0003560" text="muscular dystrophy" type="HP"/>
    <pair e1="s1348.e0" e2="s1348.e1" id="s1348.p0" relation="true"/>
  </sentence>
  <sentence id="s1349" text="A third of patients with paraganglial tumors, pheochromocytoma, and paraganglioma, carry germline mutations in one of the susceptibility genes, RET, VHL, NF1, SDHAF2, SDHA, SDHB, SDHC, SDHD, TMEM127, and MAX.">
    <entity charOffset="38-44" id="s1349.e0" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <entity charOffset="144-147" id="s1349.e1" ontology_id="5979" text="RET" type="GENE"/>
    <pair e1="s1349.e0" e2="s1349.e1" id="s1349.p0" relation="true"/>
  </sentence>
  <sentence id="s1350" text="A third of patients with paraganglial tumors, pheochromocytoma, and paraganglioma, carry germline mutations in one of the susceptibility genes, RET, VHL, NF1, SDHAF2, SDHA, SDHB, SDHC, SDHD, TMEM127, and MAX.">
    <entity charOffset="38-44" id="s1350.e0" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <entity charOffset="149-152" id="s1350.e1" ontology_id="7428" text="VHL" type="GENE"/>
    <pair e1="s1350.e0" e2="s1350.e1" id="s1350.p0" relation="true"/>
  </sentence>
  <sentence id="s1351" text="A third of patients with paraganglial tumors, pheochromocytoma, and paraganglioma, carry germline mutations in one of the susceptibility genes, RET, VHL, NF1, SDHAF2, SDHA, SDHB, SDHC, SDHD, TMEM127, and MAX.">
    <entity charOffset="38-44" id="s1351.e0" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <entity charOffset="179-183" id="s1351.e1" ontology_id="6391" text="SDHC" type="GENE"/>
    <pair e1="s1351.e0" e2="s1351.e1" id="s1351.p0" relation="true"/>
  </sentence>
  <sentence id="s1352" text="A third of patients with paraganglial tumors, pheochromocytoma, and paraganglioma, carry germline mutations in one of the susceptibility genes, RET, VHL, NF1, SDHAF2, SDHA, SDHB, SDHC, SDHD, TMEM127, and MAX.">
    <entity charOffset="38-44" id="s1352.e0" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <entity charOffset="185-189" id="s1352.e1" ontology_id="6392" text="SDHD" type="GENE"/>
    <pair e1="s1352.e0" e2="s1352.e1" id="s1352.p0" relation="true"/>
  </sentence>
  <sentence id="s1353" text="A third of patients with paraganglial tumors, pheochromocytoma, and paraganglioma, carry germline mutations in one of the susceptibility genes, RET, VHL, NF1, SDHAF2, SDHA, SDHB, SDHC, SDHD, TMEM127, and MAX.">
    <entity charOffset="38-44" id="s1353.e0" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <entity charOffset="191-198" id="s1353.e1" ontology_id="55654" text="TMEM127" type="GENE"/>
    <pair e1="s1353.e0" e2="s1353.e1" id="s1353.p0" relation="true"/>
  </sentence>
  <sentence id="s1354" text="A third of patients with paraganglial tumors, pheochromocytoma, and paraganglioma, carry germline mutations in one of the susceptibility genes, RET, VHL, NF1, SDHAF2, SDHA, SDHB, SDHC, SDHD, TMEM127, and MAX.">
    <entity charOffset="46-62" id="s1354.e0" ontology_id="HP_0002666" text="pheochromocytoma" type="HP"/>
    <entity charOffset="191-198" id="s1354.e1" ontology_id="55654" text="TMEM127" type="GENE"/>
    <pair e1="s1354.e0" e2="s1354.e1" id="s1354.p0" relation="true"/>
  </sentence>
  <sentence id="s1355" text="A third of patients with paraganglial tumors, pheochromocytoma, and paraganglioma, carry germline mutations in one of the susceptibility genes, RET, VHL, NF1, SDHAF2, SDHA, SDHB, SDHC, SDHD, TMEM127, and MAX.">
    <entity charOffset="46-62" id="s1355.e0" ontology_id="HP_0002666" text="pheochromocytoma" type="HP"/>
    <entity charOffset="149-152" id="s1355.e1" ontology_id="7428" text="VHL" type="GENE"/>
    <pair e1="s1355.e0" e2="s1355.e1" id="s1355.p0" relation="true"/>
  </sentence>
  <sentence id="s1356" text="A third of patients with paraganglial tumors, pheochromocytoma, and paraganglioma, carry germline mutations in one of the susceptibility genes, RET, VHL, NF1, SDHAF2, SDHA, SDHB, SDHC, SDHD, TMEM127, and MAX.">
    <entity charOffset="68-81" id="s1356.e0" ontology_id="HP_0002668" text="paraganglioma" type="HP"/>
    <entity charOffset="185-189" id="s1356.e1" ontology_id="6392" text="SDHD" type="GENE"/>
    <pair e1="s1356.e0" e2="s1356.e1" id="s1356.p0" relation="true"/>
  </sentence>
  <sentence id="s1357" text="A third of patients with paraganglial tumors, pheochromocytoma, and paraganglioma, carry germline mutations in one of the susceptibility genes, RET, VHL, NF1, SDHAF2, SDHA, SDHB, SDHC, SDHD, TMEM127, and MAX.">
    <entity charOffset="68-81" id="s1357.e0" ontology_id="HP_0002668" text="paraganglioma" type="HP"/>
    <entity charOffset="144-147" id="s1357.e1" ontology_id="5979" text="RET" type="GENE"/>
    <pair e1="s1357.e0" e2="s1357.e1" id="s1357.p0" relation="true"/>
  </sentence>
  <sentence id="s1358" text="A third of patients with paraganglial tumors, pheochromocytoma, and paraganglioma, carry germline mutations in one of the susceptibility genes, RET, VHL, NF1, SDHAF2, SDHA, SDHB, SDHC, SDHD, TMEM127, and MAX.">
    <entity charOffset="68-81" id="s1358.e0" ontology_id="HP_0002668" text="paraganglioma" type="HP"/>
    <entity charOffset="149-152" id="s1358.e1" ontology_id="7428" text="VHL" type="GENE"/>
    <pair e1="s1358.e0" e2="s1358.e1" id="s1358.p0" relation="true"/>
  </sentence>
  <sentence id="s1359" text="A third of patients with paraganglial tumors, pheochromocytoma, and paraganglioma, carry germline mutations in one of the susceptibility genes, RET, VHL, NF1, SDHAF2, SDHA, SDHB, SDHC, SDHD, TMEM127, and MAX.">
    <entity charOffset="68-81" id="s1359.e0" ontology_id="HP_0002668" text="paraganglioma" type="HP"/>
    <entity charOffset="159-165" id="s1359.e1" ontology_id="54949" text="SDHAF2" type="GENE"/>
    <pair e1="s1359.e0" e2="s1359.e1" id="s1359.p0" relation="true"/>
  </sentence>
  <sentence id="s1360" text="A genetically determined generalized hyperexcitability had been predicted in primarily generalized seizures, but surprisingly the first epilepsy gene discovered, CHRNA4, was in a focal (frontal lobe)-onset syndrome.">
    <entity charOffset="99-107" id="s1360.e0" ontology_id="HP_0001250" text="seizures" type="HP"/>
    <entity charOffset="162-168" id="s1360.e1" ontology_id="1137" text="CHRNA4" type="GENE"/>
    <pair e1="s1360.e0" e2="s1360.e1" id="s1360.p0" relation="false"/>
  </sentence>
  <sentence id="s1361" text="Mutations in the EFHC1 gene (unknown function) occur in other rare JME families, and yet in other families, associations are present between JME (or other generalized epilepsies) and single nucleotide polymorphisms in the BRD2 gene (unknown function) and the malic enzyme 2 (ME2) gene.">
    <entity charOffset="167-177" id="s1361.e0" ontology_id="HP_0001250" text="epilepsies" type="HP"/>
    <entity charOffset="222-226" id="s1361.e1" ontology_id="6046" text="BRD2" type="GENE"/>
    <pair e1="s1361.e0" e2="s1361.e1" id="s1361.p0" relation="true"/>
  </sentence>
  <sentence id="s1362" text="The purpose of this study was to evaluate the frequency of mosaicism detected by next-generation sequencing in genes associated with epilepsy-related neurodevelopmental disorders.MethodsWe conducted a retrospective analysis of 893 probands with epilepsy who had a multigene epilepsy panel or whole-exome sequencing performed in a clinical diagnostic laboratory and were positive for a pathogenic or likely pathogenic variant in one of nine genes (CDKL5, GABRA1, GABRG2, GRIN2B, KCNQ2, MECP2, PCDH19, SCN1A, or SCN2A).">
    <entity charOffset="133-141" id="s1362.e0" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <entity charOffset="447-452" id="s1362.e1" ontology_id="6792" text="CDKL5" type="GENE"/>
    <pair e1="s1362.e0" e2="s1362.e1" id="s1362.p0" relation="false"/>
  </sentence>
  <sentence id="s1363" text="The purpose of this study was to evaluate the frequency of mosaicism detected by next-generation sequencing in genes associated with epilepsy-related neurodevelopmental disorders.MethodsWe conducted a retrospective analysis of 893 probands with epilepsy who had a multigene epilepsy panel or whole-exome sequencing performed in a clinical diagnostic laboratory and were positive for a pathogenic or likely pathogenic variant in one of nine genes (CDKL5, GABRA1, GABRG2, GRIN2B, KCNQ2, MECP2, PCDH19, SCN1A, or SCN2A).">
    <entity charOffset="133-141" id="s1363.e0" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <entity charOffset="510-515" id="s1363.e1" ontology_id="6326" text="SCN2A" type="GENE"/>
    <pair e1="s1363.e0" e2="s1363.e1" id="s1363.p0" relation="false"/>
  </sentence>
  <sentence id="s1364" text="The purpose of this study was to evaluate the frequency of mosaicism detected by next-generation sequencing in genes associated with epilepsy-related neurodevelopmental disorders.MethodsWe conducted a retrospective analysis of 893 probands with epilepsy who had a multigene epilepsy panel or whole-exome sequencing performed in a clinical diagnostic laboratory and were positive for a pathogenic or likely pathogenic variant in one of nine genes (CDKL5, GABRA1, GABRG2, GRIN2B, KCNQ2, MECP2, PCDH19, SCN1A, or SCN2A).">
    <entity charOffset="133-141" id="s1364.e0" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <entity charOffset="500-505" id="s1364.e1" ontology_id="6323" text="SCN1A" type="GENE"/>
    <pair e1="s1364.e0" e2="s1364.e1" id="s1364.p0" relation="false"/>
  </sentence>
  <sentence id="s1365" text="The purpose of this study was to evaluate the frequency of mosaicism detected by next-generation sequencing in genes associated with epilepsy-related neurodevelopmental disorders.MethodsWe conducted a retrospective analysis of 893 probands with epilepsy who had a multigene epilepsy panel or whole-exome sequencing performed in a clinical diagnostic laboratory and were positive for a pathogenic or likely pathogenic variant in one of nine genes (CDKL5, GABRA1, GABRG2, GRIN2B, KCNQ2, MECP2, PCDH19, SCN1A, or SCN2A).">
    <entity charOffset="133-141" id="s1365.e0" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <entity charOffset="454-460" id="s1365.e1" ontology_id="2554" text="GABRA1" type="GENE"/>
    <pair e1="s1365.e0" e2="s1365.e1" id="s1365.p0" relation="false"/>
  </sentence>
  <sentence id="s1366" text="SLC4A3 is important for retinal function and has not previously been associated with spontaneously occurring retinal degenerations in any other species, including humans">
    <entity charOffset="0-6" id="s1366.e0" ontology_id="6508" text="SLC4A3" type="GENE"/>
    <entity charOffset="109-130" id="s1366.e1" ontology_id="HP_0000546" text="retinal degenerations" type="HP"/>
    <pair e1="s1366.e0" e2="s1366.e1" id="s1366.p0" relation="true"/>
  </sentence>
  <sentence id="s1367" text="We report the association of many previously unreported variants with retinal disease, as well as new disease phenotypes associated with known genes, including the first association of the SLC24A1 gene with retinitis pigmentosa.">
    <entity charOffset="70-85" id="s1367.e0" ontology_id="HP_0000479" text="retinal disease" type="HP"/>
    <entity charOffset="189-196" id="s1367.e1" ontology_id="9187" text="SLC24A1" type="GENE"/>
    <pair e1="s1367.e0" e2="s1367.e1" id="s1367.p0" relation="false"/>
  </sentence>
  <sentence id="s1368" text="This study aimed to elucidate the potential functional mechanism of miR-135b-5p in migration, invasion and epithelial-to-mesenchymal transition (EMT) of pancreatic cancer cells.">
    <entity charOffset="68-71" id="s1368.e0" ontology_id="220972" text="miR" type="GENE"/>
    <entity charOffset="164-170" id="s1368.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1368.e0" e2="s1368.e1" id="s1368.p0" relation="true"/>
  </sentence>
  <sentence id="s1369" text="Haplotype GAT for GRM6 markers rs2067011-rs2645339-rs762724 showed significance (P=0.0239), but such association did not remain significant after multiple testing corrections.ConclusionsOur data suggested that genetic variants in GRM6 are associated with high myopia.">
    <entity charOffset="10-13" id="s1369.e0" ontology_id="10249" text="GAT" type="GENE"/>
    <entity charOffset="260-266" id="s1369.e1" ontology_id="HP_0000545" text="myopia" type="HP"/>
    <pair e1="s1369.e0" e2="s1369.e1" id="s1369.p0" relation="false"/>
  </sentence>
  <sentence id="s1370" text="The genetic model analysis found that GRM6-rs11746675 and GRM6-rs2067011 were suggestively associated with high myopia in the recessive model (OR=0.54, P=0.004; OR=0.52, P=0.003; respectively).">
    <entity charOffset="38-42" id="s1370.e0" ontology_id="2916" text="GRM6" type="GENE"/>
    <entity charOffset="112-118" id="s1370.e1" ontology_id="HP_0000545" text="myopia" type="HP"/>
    <pair e1="s1370.e0" e2="s1370.e1" id="s1370.p0" relation="true"/>
  </sentence>
  <sentence id="s1371" text="Fourteen single-nucleotide polymorphisms (SNPs) in three genes were genotyped by the TaqMan method using the real-time PCR system.ResultsThree SNPs GRM6-rs11746675, GRM6-rs2067011, and GRM6-rs2645339 were associated with high myopia (odds ratio (OR)=0.74, P=0.003; OR=0.78, P=0.018; and OR=0.78, P=0.023; respectively).">
    <entity charOffset="148-152" id="s1371.e0" ontology_id="2916" text="GRM6" type="GENE"/>
    <entity charOffset="226-232" id="s1371.e1" ontology_id="HP_0000545" text="myopia" type="HP"/>
    <pair e1="s1371.e0" e2="s1371.e1" id="s1371.p0" relation="true"/>
  </sentence>
  <sentence id="s1372" text="This review highlights recent advances in understanding how the OVOL1-OVOL2 axis modulates cell differentiation and proliferation in human keratinocytes, hair follicles, and benign or malignant skin tumors including squamous cell carcinoma and malignant melanoma.">
    <entity charOffset="64-69" id="s1372.e0" ontology_id="5017" text="OVOL1" type="GENE"/>
    <entity charOffset="244-262" id="s1372.e1" ontology_id="HP_0002861" text="malignant melanoma" type="HP"/>
    <pair e1="s1372.e0" e2="s1372.e1" id="s1372.p0" relation="true"/>
  </sentence>
  <sentence id="s1373" text="This review highlights recent advances in understanding how the OVOL1-OVOL2 axis modulates cell differentiation and proliferation in human keratinocytes, hair follicles, and benign or malignant skin tumors including squamous cell carcinoma and malignant melanoma.">
    <entity charOffset="70-75" id="s1373.e0" ontology_id="58495" text="OVOL2" type="GENE"/>
    <entity charOffset="216-239" id="s1373.e1" ontology_id="HP_0002860" text="squamous cell carcinoma" type="HP"/>
    <pair e1="s1373.e0" e2="s1373.e1" id="s1373.p0" relation="true"/>
  </sentence>
  <sentence id="s1374" text="TCIRG1 knockdown suppressed tumor cell growth and proliferation in HCC cell lines; caused a significant increase in the proportion of cells in the G1/S phase of cell cycle; induced cell death; suppressed the metastatic potential of HCC cells by selectively regulating the epithelial-mesenchymal transition (EMT) regulatory proteins E-cadherin, N-cadherin, Fibronectin, Snail and Slug; and significantly attenuated the metastatic potential of ras-transformed NIH-3T3 cells in vitro and in vivo.">
    <entity charOffset="0-6" id="s1374.e0" ontology_id="10312" text="TCIRG1" type="GENE"/>
    <entity charOffset="28-33" id="s1374.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1374.e0" e2="s1374.e1" id="s1374.p0" relation="true"/>
  </sentence>
  <sentence id="s1375" text="TCIRG1 knockdown suppressed tumor cell growth and proliferation in HCC cell lines; caused a significant increase in the proportion of cells in the G1/S phase of cell cycle; induced cell death; suppressed the metastatic potential of HCC cells by selectively regulating the epithelial-mesenchymal transition (EMT) regulatory proteins E-cadherin, N-cadherin, Fibronectin, Snail and Slug; and significantly attenuated the metastatic potential of ras-transformed NIH-3T3 cells in vitro and in vivo.">
    <entity charOffset="28-33" id="s1375.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="369-374" id="s1375.e1" ontology_id="6615" text="Snail" type="GENE"/>
    <pair e1="s1375.e0" e2="s1375.e1" id="s1375.p0" relation="false"/>
  </sentence>
  <sentence id="s1376" text="Zebrafish with ryroxD1 knock-down recapitulate features of PYROXD1 myopathy with sarcomeric disorganization, myofibrillar aggregates, and marked swimming defect.">
    <entity charOffset="59-66" id="s1376.e0" ontology_id="79912" text="PYROXD1" type="GENE"/>
    <entity charOffset="67-75" id="s1376.e1" ontology_id="HP_0003198" text="myopathy" type="HP"/>
    <pair e1="s1376.e0" e2="s1376.e1" id="s1376.p0" relation="true"/>
  </sentence>
  <sentence id="s1377" text="This finding expands the lists of the ALK-positive tumors, and ALK-positive extramedullary plasmacytoma may benefit from the treatment of ALK inhibitor in the future">
    <entity charOffset="38-41" id="s1377.e0" ontology_id="238" text="ALK" type="GENE"/>
    <entity charOffset="51-57" id="s1377.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s1377.e0" e2="s1377.e1" id="s1377.p0" relation="true"/>
  </sentence>
  <sentence id="s1378" text="This finding expands the lists of the ALK-positive tumors, and ALK-positive extramedullary plasmacytoma may benefit from the treatment of ALK inhibitor in the future">
    <entity charOffset="38-41" id="s1378.e0" ontology_id="238" text="ALK" type="GENE"/>
    <entity charOffset="91-103" id="s1378.e1" ontology_id="HP_0011857" text="plasmacytoma" type="HP"/>
    <pair e1="s1378.e0" e2="s1378.e1" id="s1378.p0" relation="true"/>
  </sentence>
  <sentence id="s1379" text="We studied 46 cases of extramedullary plasmacytoma by immunostaining with anti-ALK antibody and fluorescence in situ hybridization (FISH) analysis using an ALK break-apart probe and found one case to be ALK protein-positive and demonstrated the disruption of the ALK gene in this case.">
    <entity charOffset="38-50" id="s1379.e0" ontology_id="HP_0011857" text="plasmacytoma" type="HP"/>
    <entity charOffset="79-82" id="s1379.e1" ontology_id="238" text="ALK" type="GENE"/>
    <pair e1="s1379.e0" e2="s1379.e1" id="s1379.p0" relation="false"/>
  </sentence>
  <sentence id="s1380" text="Biallelic loss-of-function mutations in TYROBP and TREM2 cause a rare disease that resembles early-onset frontotemporal dementia with bone lesions called polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy (PLOSL).">
    <entity charOffset="51-56" id="s1380.e0" ontology_id="54209" text="TREM2" type="GENE"/>
    <entity charOffset="105-128" id="s1380.e1" ontology_id="HP_0002145" text="frontotemporal dementia" type="HP"/>
    <pair e1="s1380.e0" e2="s1380.e1" id="s1380.p0" relation="true"/>
  </sentence>
  <sentence id="s1381" text="Biallelic loss-of-function mutations in TYROBP and TREM2 cause a rare disease that resembles early-onset frontotemporal dementia with bone lesions called polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy (PLOSL).">
    <entity charOffset="51-56" id="s1381.e0" ontology_id="54209" text="TREM2" type="GENE"/>
    <entity charOffset="211-230" id="s1381.e1" ontology_id="HP_0002352" text="leukoencephalopathy" type="HP"/>
    <pair e1="s1381.e0" e2="s1381.e1" id="s1381.p0" relation="true"/>
  </sentence>
  <sentence id="s1382" text="Dual-specificity tyrosine phosphorylation-regulated kinase 1A (Dyrk1A) is a potential target in Alzheimer's disease (AD) because of the established correlation between its over-expression and generation of neurofibrillary tangles (NFT) as well as the accumulation of amyloid plaques.">
    <entity charOffset="63-69" id="s1382.e0" ontology_id="1859" text="Dyrk1A" type="GENE"/>
    <entity charOffset="206-229" id="s1382.e1" ontology_id="HP_0002185" text="neurofibrillary tangles" type="HP"/>
    <pair e1="s1382.e0" e2="s1382.e1" id="s1382.p0" relation="true"/>
  </sentence>
  <sentence id="s1383" text="Bcl2-associated athanogene 3 (BAG3) mutations have been reported to cause the myofibrillar myopathy (MFM) which shows progressive limb muscle weakness, respiratory failure, and cardiomyopathy.">
    <entity charOffset="30-34" id="s1383.e0" ontology_id="9531" text="BAG3" type="GENE"/>
    <entity charOffset="152-171" id="s1383.e1" ontology_id="HP_0002878" text="respiratory failure" type="HP"/>
    <pair e1="s1383.e0" e2="s1383.e1" id="s1383.p0" relation="true"/>
  </sentence>
  <sentence id="s1384" text="A de novo heterozygous p.Pro209Leu (c.626C&amp;gt;T) mutation in BAG3 was identified in a female myopathy.">
    <entity charOffset="61-65" id="s1384.e0" ontology_id="9531" text="BAG3" type="GENE"/>
    <entity charOffset="93-101" id="s1384.e1" ontology_id="HP_0003198" text="myopathy" type="HP"/>
    <pair e1="s1384.e0" e2="s1384.e1" id="s1384.p0" relation="true"/>
  </sentence>
  <sentence id="s1385" text="We found BAG3 mutation in one patient with neuropathy, myopathy and rigid spine syndrome, and performed electrophysiological study, whole body MRI and muscle biopsy on the patient.">
    <entity charOffset="9-13" id="s1385.e0" ontology_id="9531" text="BAG3" type="GENE"/>
    <entity charOffset="43-53" id="s1385.e1" ontology_id="HP_0009830" text="neuropathy" type="HP"/>
    <pair e1="s1385.e0" e2="s1385.e1" id="s1385.p0" relation="true"/>
  </sentence>
  <sentence id="s1386" text="She showed an axonal sensory-motor polyneuropathy like Charcot-Marie-Tooth disease (CMT), myopathy, rigid spine and respiratory dysfunction; however, she did not show any cardiomyopathy, which is a common symptom in BAG3 mutation.">
    <entity charOffset="90-98" id="s1386.e0" ontology_id="HP_0003198" text="myopathy" type="HP"/>
    <entity charOffset="216-220" id="s1386.e1" ontology_id="9531" text="BAG3" type="GENE"/>
    <pair e1="s1386.e0" e2="s1386.e1" id="s1386.p0" relation="false"/>
  </sentence>
  <sentence id="s1387" text="Mutations in eight of them (PDSS1, PDSS2, COQ2, COQ4, COQ6, ADCK3, ADCK4, and COQ9) cause primary CoQ(10) deficiency, a heterogeneous group of disorders with variable age of onset (from birth to the seventh decade) and associated clinical phenotypes, ranging from a fatal multisystem disease to isolated steroid resistant nephrotic syndrome (SRNS) or isolated central nervous system disease.">
    <entity charOffset="35-40" id="s1387.e0" ontology_id="57107" text="PDSS2" type="GENE"/>
    <entity charOffset="120-133" id="s1387.e1" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <pair e1="s1387.e0" e2="s1387.e1" id="s1387.p0" relation="true"/>
  </sentence>
  <sentence id="s1388" text="Mutations in eight of them (PDSS1, PDSS2, COQ2, COQ4, COQ6, ADCK3, ADCK4, and COQ9) cause primary CoQ(10) deficiency, a heterogeneous group of disorders with variable age of onset (from birth to the seventh decade) and associated clinical phenotypes, ranging from a fatal multisystem disease to isolated steroid resistant nephrotic syndrome (SRNS) or isolated central nervous system disease.">
    <entity charOffset="78-82" id="s1388.e0" ontology_id="57017" text="COQ9" type="GENE"/>
    <entity charOffset="120-133" id="s1388.e1" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <pair e1="s1388.e0" e2="s1388.e1" id="s1388.p0" relation="true"/>
  </sentence>
  <sentence id="s1389" text="Finally, we demonstrate that genetic inactivation of Prss56 rescues axial elongation in a mouse model of myopia caused by a null mutation in Egr1.">
    <entity charOffset="53-59" id="s1389.e0" ontology_id="646960" text="Prss56" type="GENE"/>
    <entity charOffset="105-111" id="s1389.e1" ontology_id="HP_0000545" text="myopia" type="HP"/>
    <pair e1="s1389.e0" e2="s1389.e1" id="s1389.p0" relation="true"/>
  </sentence>
  <sentence id="s1390" text="We have previously identified a role for the secreted serine protease PRSS56 in ocular size determination and PRSS56 variants have been implicated in the etiology of both hyperopia and myopia, highlighting its importance in refractive development.">
    <entity charOffset="70-76" id="s1390.e0" ontology_id="646960" text="PRSS56" type="GENE"/>
    <entity charOffset="185-191" id="s1390.e1" ontology_id="HP_0000545" text="myopia" type="HP"/>
    <pair e1="s1390.e0" e2="s1390.e1" id="s1390.p0" relation="false"/>
  </sentence>
  <sentence id="s1391" text="Here, we investigated associations between genetic variants of Rho GTPases-related genes and cutaneous melanoma-specific survival (CMSS) by re-analyzing a published melanoma genome-wide association study (GWAS) and validating the results in another melanoma GWAS.">
    <entity charOffset="63-66" id="s1391.e0" ontology_id="6010" text="Rho" type="GENE"/>
    <entity charOffset="93-111" id="s1391.e1" ontology_id="HP_0012056" text="cutaneous melanoma" type="HP"/>
    <pair e1="s1391.e0" e2="s1391.e1" id="s1391.p0" relation="true"/>
  </sentence>
  <sentence id="s1392" text="As ubiquitination is a versatile post-translational modification that can affect target turnover, sub-cellular localisation or activity, it is likely that diverse substrates may be differentially affected by TRIM32-mediated ubiquitination, reflecting its multi-faceted roles in muscle physiology, cancer and immunity.">
    <entity charOffset="208-214" id="s1392.e0" ontology_id="22954" text="TRIM32" type="GENE"/>
    <entity charOffset="297-303" id="s1392.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1392.e0" e2="s1392.e1" id="s1392.p0" relation="true"/>
  </sentence>
  <sentence id="s1393" text="In this review, we will focus on the ability of TRIM32 to mark specific substrates for proteasomal degradation discussing how the TRIM32-proteasome axis may (i) be important for muscle homeostasis and for the pathogenesis of muscular dystrophy; and (ii) define either an oncogenic or tumour suppressive role for TRIM32 in the context of different types of cancer">
    <entity charOffset="48-54" id="s1393.e0" ontology_id="22954" text="TRIM32" type="GENE"/>
    <entity charOffset="284-290" id="s1393.e1" ontology_id="HP_0002664" text="tumour" type="HP"/>
    <pair e1="s1393.e0" e2="s1393.e1" id="s1393.p0" relation="false"/>
  </sentence>
  <sentence id="s1394" text="Mice with a neuronal deletion of Arv1 recapitulated the human phenotype, exhibiting seizures and a severe survival defect in adulthood.">
    <entity charOffset="33-37" id="s1394.e0" ontology_id="64801" text="Arv1" type="GENE"/>
    <entity charOffset="84-91" id="s1394.e1" ontology_id="HP_0001250" text="seizure" type="HP"/>
    <pair e1="s1394.e0" e2="s1394.e1" id="s1394.p0" relation="true"/>
  </sentence>
  <sentence id="s1395" text="Here we discuss the heterogeneity of T-bet expressing B cells and related cells">
    <entity charOffset="20-33" id="s1395.e0" ontology_id="HP_0001425" text="heterogeneity" type="HP"/>
    <entity charOffset="39-42" id="s1395.e1" ontology_id="92737" text="bet" type="GENE"/>
    <pair e1="s1395.e0" e2="s1395.e1" id="s1395.p0" relation="true"/>
  </sentence>
  <sentence id="s1396" text="In two large Turkish consanguineous families, a locus for autosomal recessive nonsyndromic hearing loss (ARNSHL) was mapped to chromosome 6p21.3 by genome-wide linkage analysis in an interval overlapping with the loci DFNB53 (COL11A2), DFNB66, and DFNB67.">
    <entity charOffset="58-77" id="s1396.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="218-224" id="s1396.e1" ontology_id="1302" text="DFNB53" type="GENE"/>
    <pair e1="s1396.e0" e2="s1396.e1" id="s1396.p0" relation="true"/>
  </sentence>
  <sentence id="s1397" text="In two large Turkish consanguineous families, a locus for autosomal recessive nonsyndromic hearing loss (ARNSHL) was mapped to chromosome 6p21.3 by genome-wide linkage analysis in an interval overlapping with the loci DFNB53 (COL11A2), DFNB66, and DFNB67.">
    <entity charOffset="91-103" id="s1397.e0" ontology_id="HP_0000365" text="hearing loss" type="HP"/>
    <entity charOffset="218-224" id="s1397.e1" ontology_id="1302" text="DFNB53" type="GENE"/>
    <pair e1="s1397.e0" e2="s1397.e1" id="s1397.p0" relation="true"/>
  </sentence>
  <sentence id="s1398" text="Beyond secretion, GUCY2C is a tumor suppressor universally silenced by loss of expression of its paracrine hormone during carcinogenesis.">
    <entity charOffset="18-24" id="s1398.e0" ontology_id="2984" text="GUCY2C" type="GENE"/>
    <entity charOffset="30-35" id="s1398.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1398.e0" e2="s1398.e1" id="s1398.p0" relation="true"/>
  </sentence>
  <sentence id="s1399" text="Thus, chronic colonization with &lt;i&gt;ETEC&lt;/i&gt; producing ST could contribute to endemic cancer resistance in developing countries, reinforcing a novel paradigm of colorectal cancer chemoprevention with oral GUCY2C-targeted agents">
    <entity charOffset="85-91" id="s1399.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="204-210" id="s1399.e1" ontology_id="2984" text="GUCY2C" type="GENE"/>
    <pair e1="s1399.e0" e2="s1399.e1" id="s1399.p0" relation="false"/>
  </sentence>
  <sentence id="s1400" text="Low-grade fibromyxoid sarcoma (LGFMS) and sclerosing epithelioid fibrosarcoma (SEF) are rare tumors with distinct sets of morphological features, both characterized by MUC4 immunoreactivity.">
    <entity charOffset="93-99" id="s1400.e0" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <entity charOffset="168-172" id="s1400.e1" ontology_id="4585" text="MUC4" type="GENE"/>
    <pair e1="s1400.e0" e2="s1400.e1" id="s1400.p0" relation="true"/>
  </sentence>
  <sentence id="s1401" text="Although disruption of the CDKN2A (INK4A/ARF) locus has been reported in end-stage disease, information is lacking on the status of this key tumor suppressor gene in pleural lesions preceding mesothelioma.">
    <entity charOffset="27-33" id="s1401.e0" ontology_id="1029" text="CDKN2A" type="GENE"/>
    <entity charOffset="141-146" id="s1401.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1401.e0" e2="s1401.e1" id="s1401.p0" relation="true"/>
  </sentence>
  <sentence id="s1402" text="Moreover, we demonstrate that TD-428, which comprises TD-106 linked to a BET inhibitor, JQ1 efficiently induce BET protein degradation in the prostate cancer cell line 22Rv1.">
    <entity charOffset="73-76" id="s1402.e0" ontology_id="92737" text="BET" type="GENE"/>
    <entity charOffset="151-157" id="s1402.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1402.e0" e2="s1402.e1" id="s1402.p0" relation="false"/>
  </sentence>
  <sentence id="s1403" text="CGD is a genetically heterogeneous disease with an X-linked recessive (XR-CGD) form caused by mutations in the CYBB gene encoding the gp91(phox) protein, and an autosomal recessive (AR-CGD) form caused by mutations in the CYBA, NCF1, NCF2, or NCF4 genes encoding p22(phox) , p47(phox) , p67(phox) , and p40(phox) , respectively.">
    <entity charOffset="21-34" id="s1403.e0" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <entity charOffset="222-226" id="s1403.e1" ontology_id="1535" text="CYBA" type="GENE"/>
    <pair e1="s1403.e0" e2="s1403.e1" id="s1403.p0" relation="false"/>
  </sentence>
  <sentence id="s1404" text="CGD is a genetically heterogeneous disease with an X-linked recessive (XR-CGD) form caused by mutations in the CYBB gene encoding the gp91(phox) protein, and an autosomal recessive (AR-CGD) form caused by mutations in the CYBA, NCF1, NCF2, or NCF4 genes encoding p22(phox) , p47(phox) , p67(phox) , and p40(phox) , respectively.">
    <entity charOffset="21-34" id="s1404.e0" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <entity charOffset="243-247" id="s1404.e1" ontology_id="4689" text="NCF4" type="GENE"/>
    <pair e1="s1404.e0" e2="s1404.e1" id="s1404.p0" relation="false"/>
  </sentence>
  <sentence id="s1405" text="CGD is a genetically heterogeneous disease with an X-linked recessive (XR-CGD) form caused by mutations in the CYBB gene encoding the gp91(phox) protein, and an autosomal recessive (AR-CGD) form caused by mutations in the CYBA, NCF1, NCF2, or NCF4 genes encoding p22(phox) , p47(phox) , p67(phox) , and p40(phox) , respectively.">
    <entity charOffset="161-180" id="s1405.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="228-232" id="s1405.e1" ontology_id="653361" text="NCF1" type="GENE"/>
    <pair e1="s1405.e0" e2="s1405.e1" id="s1405.p0" relation="true"/>
  </sentence>
  <sentence id="s1406" text="CGD is a genetically heterogeneous disease with an X-linked recessive (XR-CGD) form caused by mutations in the CYBB gene encoding the gp91(phox) protein, and an autosomal recessive (AR-CGD) form caused by mutations in the CYBA, NCF1, NCF2, or NCF4 genes encoding p22(phox) , p47(phox) , p67(phox) , and p40(phox) , respectively.">
    <entity charOffset="161-180" id="s1406.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="243-247" id="s1406.e1" ontology_id="4689" text="NCF4" type="GENE"/>
    <pair e1="s1406.e0" e2="s1406.e1" id="s1406.p0" relation="true"/>
  </sentence>
  <sentence id="s1407" text="CGD is a genetically heterogeneous disease with an X-linked recessive (XR-CGD) form caused by mutations in the CYBB gene encoding the gp91(phox) protein, and an autosomal recessive (AR-CGD) form caused by mutations in the CYBA, NCF1, NCF2, or NCF4 genes encoding p22(phox) , p47(phox) , p67(phox) , and p40(phox) , respectively.">
    <entity charOffset="161-180" id="s1407.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="222-226" id="s1407.e1" ontology_id="1535" text="CYBA" type="GENE"/>
    <pair e1="s1407.e0" e2="s1407.e1" id="s1407.p0" relation="true"/>
  </sentence>
  <sentence id="s1408" text="Human kallikrein-related peptidases KLK1-15 provide a rich source of serine protease-type biomarkers associated with tumor growth and cancer progression for a variety of malignant diseases.">
    <entity charOffset="36-40" id="s1408.e0" ontology_id="3816" text="KLK1" type="GENE"/>
    <entity charOffset="117-122" id="s1408.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1408.e0" e2="s1408.e1" id="s1408.p0" relation="true"/>
  </sentence>
  <sentence id="s1409" text="Human kallikrein-related peptidases KLK1-15 provide a rich source of serine protease-type biomarkers associated with tumor growth and cancer progression for a variety of malignant diseases.">
    <entity charOffset="36-40" id="s1409.e0" ontology_id="3816" text="KLK1" type="GENE"/>
    <entity charOffset="134-140" id="s1409.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1409.e0" e2="s1409.e1" id="s1409.p0" relation="true"/>
  </sentence>
  <sentence id="s1410" text="For this, KLK4 protein expression was assessed by immunohistochemistry in primary tumor tissue sections (tissue microarrays) of 188 TNBC patients, mainly treated with anthracycline- or CMF-based polychemotherapy.">
    <entity charOffset="10-14" id="s1410.e0" ontology_id="9622" text="KLK4" type="GENE"/>
    <entity charOffset="82-87" id="s1410.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1410.e0" e2="s1410.e1" id="s1410.p0" relation="true"/>
  </sentence>
  <sentence id="s1411" text="In this study, recombinant KLK4 protein was generated and affinity-purified KLK4-directed polyclonal antibody pAb587 established to allow localization of KLK4 protein expression in tumor cell lines and archived formalin-fixed, paraffin-embedded TNBC tumor tissue specimens.">
    <entity charOffset="27-31" id="s1411.e0" ontology_id="9622" text="KLK4" type="GENE"/>
    <entity charOffset="181-186" id="s1411.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1411.e0" e2="s1411.e1" id="s1411.p0" relation="true"/>
  </sentence>
  <sentence id="s1412" text="Using exome sequencing, we discovered missense mutations in AFF4, a core component of the SEC, in three unrelated probands with a new syndrome that phenotypically overlaps Cornelia de Lange syndrome (CdLS) that we have named CHOPS syndrome (C for cognitive impairment and coarse facies, H for heart defects, O for obesity, P for pulmonary involvement and S for short stature and skeletal dysplasia).">
    <entity charOffset="60-64" id="s1412.e0" ontology_id="27125" text="AFF4" type="GENE"/>
    <entity charOffset="379-397" id="s1412.e1" ontology_id="HP_0002652" text="skeletal dysplasia" type="HP"/>
    <pair e1="s1412.e0" e2="s1412.e1" id="s1412.p0" relation="true"/>
  </sentence>
  <sentence id="s1413" text="PRNP and PRND are significantly over-expressed in osteosarcoma.">
    <entity charOffset="0-4" id="s1413.e0" ontology_id="5621" text="PRNP" type="GENE"/>
    <entity charOffset="50-62" id="s1413.e1" ontology_id="HP_0002669" text="osteosarcoma" type="HP"/>
    <pair e1="s1413.e0" e2="s1413.e1" id="s1413.p0" relation="true"/>
  </sentence>
  <sentence id="s1414" text="PRNP and PRND appear involved with some important genes related to tumorigenesis and apoptosis.">
    <entity charOffset="9-13" id="s1414.e0" ontology_id="23627" text="PRND" type="GENE"/>
    <entity charOffset="67-72" id="s1414.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1414.e0" e2="s1414.e1" id="s1414.p0" relation="true"/>
  </sentence>
  <sentence id="s1415" text="Alazami syndrome (AS) (MIM# 615071) is an autosomal recessive microcephalic primordial dwarfism (PD) with recognizable facial features and severe intellectual disability due to depletion or loss of function variants in LARP7.">
    <entity charOffset="146-169" id="s1415.e0" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <entity charOffset="219-224" id="s1415.e1" ontology_id="51574" text="LARP7" type="GENE"/>
    <pair e1="s1415.e0" e2="s1415.e1" id="s1415.p0" relation="true"/>
  </sentence>
  <sentence id="s1416" text="We identified the first de novo variant in KCNMA1 (c.2984A&amp;gt;G (p.(N995S)))-encoding the BK channel-that causes epilepsy, but not paroxysmal dyskinesia, in two independent families.">
    <entity charOffset="43-49" id="s1416.e0" ontology_id="3778" text="KCNMA1" type="GENE"/>
    <entity charOffset="134-155" id="s1416.e1" ontology_id="HP_0007166" text="paroxysmal dyskinesia" type="HP"/>
    <pair e1="s1416.e0" e2="s1416.e1" id="s1416.p0" relation="true"/>
  </sentence>
  <sentence id="s1417" text="The 2016 revised World Health Organization (WHO) classification of lymphoid neoplasms included the category of high-grade B cell lymphomas (HGBLs) with combined MYC and BCL2 and/or BCL6 rearrangements (double-hit, DH).">
    <entity charOffset="76-85" id="s1417.e0" ontology_id="HP_0002664" text="neoplasms" type="HP"/>
    <entity charOffset="181-185" id="s1417.e1" ontology_id="604" text="BCL6" type="GENE"/>
    <pair e1="s1417.e0" e2="s1417.e1" id="s1417.p0" relation="false"/>
  </sentence>
  <sentence id="s1418" text="Using exome sequencing in a multiplex family and three simplex case subjects with an atypical association of LCA with early-onset hearing loss, we identified two heterozygous mutations affecting Arg391 in -tubulin 4B isotype-encoding (TUBB4B).">
    <entity charOffset="109-112" id="s1418.e0" ontology_id="1211" text="LCA" type="GENE"/>
    <entity charOffset="130-142" id="s1418.e1" ontology_id="HP_0000365" text="hearing loss" type="HP"/>
    <pair e1="s1418.e0" e2="s1418.e1" id="s1418.p0" relation="true"/>
  </sentence>
  <sentence id="s1419" text="Using exome sequencing in a multiplex family and three simplex case subjects with an atypical association of LCA with early-onset hearing loss, we identified two heterozygous mutations affecting Arg391 in -tubulin 4B isotype-encoding (TUBB4B).">
    <entity charOffset="130-142" id="s1419.e0" ontology_id="HP_0000365" text="hearing loss" type="HP"/>
    <entity charOffset="236-242" id="s1419.e1" ontology_id="10383" text="TUBB4B" type="GENE"/>
    <pair e1="s1419.e0" e2="s1419.e1" id="s1419.p0" relation="false"/>
  </sentence>
  <sentence id="s1420" text="Independent and pooled analyses verified that higher PYCR1 mRNA levels were significantly associated with poor survival of breast cancer patients, regardless of estrogen receptor (ER) status.">
    <entity charOffset="53-58" id="s1420.e0" ontology_id="5831" text="PYCR1" type="GENE"/>
    <entity charOffset="130-136" id="s1420.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1420.e0" e2="s1420.e1" id="s1420.p0" relation="true"/>
  </sentence>
  <sentence id="s1421" text="For in vitro studies, inhibition of PYCR1 by small-hairpin RNA significantly reduced the growth and invasion capabilities of the cells, while enhancing the cytotoxicity of doxorubicin in breast cancer cell lines MCF-7 (ER positive) and MDA-MB-231 (ER negative).">
    <entity charOffset="36-41" id="s1421.e0" ontology_id="5831" text="PYCR1" type="GENE"/>
    <entity charOffset="194-200" id="s1421.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1421.e0" e2="s1421.e1" id="s1421.p0" relation="true"/>
  </sentence>
  <sentence id="s1422" text="In response to surgical induction of endometriosis, Klf11-/- female mice develop significant fibrosis in contrast to wild-type mice.">
    <entity charOffset="37-50" id="s1422.e0" ontology_id="HP_0030127" text="endometriosis" type="HP"/>
    <entity charOffset="52-57" id="s1422.e1" ontology_id="8462" text="Klf11" type="GENE"/>
    <pair e1="s1422.e0" e2="s1422.e1" id="s1422.p0" relation="true"/>
  </sentence>
  <sentence id="s1423" text="The present study aimed to molecularly define and determine the contribution of two rare, apparently novel CHEK2 LGRs, among Greek breast cancer patients.">
    <entity charOffset="107-112" id="s1423.e0" ontology_id="11200" text="CHEK2" type="GENE"/>
    <entity charOffset="138-144" id="s1423.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1423.e0" e2="s1423.e1" id="s1423.p0" relation="true"/>
  </sentence>
  <sentence id="s1424" text="Patients with HCP show &amp;lt;50% of normal activity and those with the rare autosomal recessive harderoporphyria accumulate harderoporphyrinogen, an intermediate porphyrin of the CPOX reaction.">
    <entity charOffset="74-93" id="s1424.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="177-181" id="s1424.e1" ontology_id="1371" text="CPOX" type="GENE"/>
    <pair e1="s1424.e0" e2="s1424.e1" id="s1424.p0" relation="true"/>
  </sentence>
  <sentence id="s1425" text="To identify the disease-causing defect in these families, we first analysed MFRP gene, then some candidate genes (CHX10, OPA1, MITF, SOX2, CRYBB1-3 and CRYBA4) and loci (MCOP1, NNO1 and NNO2) previously implicated in different forms of microphthalmia.">
    <entity charOffset="76-80" id="s1425.e0" ontology_id="83552" text="MFRP" type="GENE"/>
    <entity charOffset="236-250" id="s1425.e1" ontology_id="HP_0000568" text="microphthalmia" type="HP"/>
    <pair e1="s1425.e0" e2="s1425.e1" id="s1425.p0" relation="false"/>
  </sentence>
  <sentence id="s1426" text="To identify the disease-causing defect in these families, we first analysed MFRP gene, then some candidate genes (CHX10, OPA1, MITF, SOX2, CRYBB1-3 and CRYBA4) and loci (MCOP1, NNO1 and NNO2) previously implicated in different forms of microphthalmia.">
    <entity charOffset="186-190" id="s1426.e0" ontology_id="83552" text="NNO2" type="GENE"/>
    <entity charOffset="236-250" id="s1426.e1" ontology_id="HP_0000568" text="microphthalmia" type="HP"/>
    <pair e1="s1426.e0" e2="s1426.e1" id="s1426.p0" relation="true"/>
  </sentence>
  <sentence id="s1427" text="The results showed that the concentration of inflammatory cytokines [interleukin 1 (IL1) and tumor necrosis factor  (TNF-)], myeloperoxidase (MPO) activity in the lung tissue and blood, protein abundance of toll-like receptor 4 (TLR4), nuclear factor B (NF-B, p65), phosphorylated p65 (p-p65), inhibitor B (IB), and phosphorylated IB (p-IB), and relative mRNA expression of genes associated with inflammation, such as TLR4, NF-B, IL1, interleukin 6 (IL6), and TNF-, were significantly upregulated in the LPS group compared to the PBS group.">
    <entity charOffset="95-100" id="s1427.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="146-149" id="s1427.e1" ontology_id="4353" text="MPO" type="GENE"/>
    <pair e1="s1427.e0" e2="s1427.e1" id="s1427.p0" relation="false"/>
  </sentence>
  <sentence id="s1428" text="Another clinically relevant form of FGF23-related hypophosphatemic disease is tumor-induced osteomalacia (TIO), a paraneoplastic syndrome associated with FGF23-producing tumors.">
    <entity charOffset="36-41" id="s1428.e0" ontology_id="8074" text="FGF23" type="GENE"/>
    <entity charOffset="78-83" id="s1428.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1428.e0" e2="s1428.e1" id="s1428.p0" relation="true"/>
  </sentence>
  <sentence id="s1429" text="Another clinically relevant form of FGF23-related hypophosphatemic disease is tumor-induced osteomalacia (TIO), a paraneoplastic syndrome associated with FGF23-producing tumors.">
    <entity charOffset="36-41" id="s1429.e0" ontology_id="8074" text="FGF23" type="GENE"/>
    <entity charOffset="92-104" id="s1429.e1" ontology_id="HP_0002749" text="osteomalacia" type="HP"/>
    <pair e1="s1429.e0" e2="s1429.e1" id="s1429.p0" relation="true"/>
  </sentence>
  <sentence id="s1430" text="Malonyl coenzyme A (CoA) decarboxylase (EC 4.1.1.9, MCD) deficiency, or malonic aciduria, is a rare inborn error of metabolism characterised by a variable phenotype of developmental delay, seizures, cardiomyopathy and acidosis.">
    <entity charOffset="52-55" id="s1430.e0" ontology_id="23417" text="MCD" type="GENE"/>
    <entity charOffset="168-187" id="s1430.e1" ontology_id="HP_0001263" text="developmental delay" type="HP"/>
    <pair e1="s1430.e0" e2="s1430.e1" id="s1430.p0" relation="true"/>
  </sentence>
  <sentence id="s1431" text="We identified 52 variants contributing to obesity in 2% of cases including multiple novel variants in GNAS, which were sometimes found with accelerated growth rather than short stature as described previously.">
    <entity charOffset="42-49" id="s1431.e0" ontology_id="HP_0001513" text="obesity" type="HP"/>
    <entity charOffset="102-106" id="s1431.e1" ontology_id="2778" text="GNAS" type="GENE"/>
    <pair e1="s1431.e0" e2="s1431.e1" id="s1431.p0" relation="true"/>
  </sentence>
  <sentence id="s1432" text="Besides the hallmark features, this patient also presents problems not previously associated with RIN2 syndrome, including cervical vertebral fusion, mild hearing loss, and colonic fibrosis.">
    <entity charOffset="98-102" id="s1432.e0" ontology_id="54453" text="RIN2" type="GENE"/>
    <entity charOffset="155-167" id="s1432.e1" ontology_id="HP_0000365" text="hearing loss" type="HP"/>
    <pair e1="s1432.e0" e2="s1432.e1" id="s1432.p0" relation="true"/>
  </sentence>
  <sentence id="s1433" text="Through a multi-centric collaboration, we identified three copy-number variant deletions (two de novo and one dominantly inherited in three generations), one de novo disrupting duplication, and nine de novo point mutations (three truncating, one canonical splice site, and five missense mutations) involving RORA in 16 individuals from 13 families with variable neurodevelopmental delay and intellectual disability (ID)-associated autistic features, cerebellar ataxia, and epilepsy.">
    <entity charOffset="308-312" id="s1433.e0" ontology_id="6095" text="RORA" type="GENE"/>
    <entity charOffset="391-414" id="s1433.e1" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <pair e1="s1433.e0" e2="s1433.e1" id="s1433.p0" relation="true"/>
  </sentence>
  <sentence id="s1434" text="Through a multi-centric collaboration, we identified three copy-number variant deletions (two de novo and one dominantly inherited in three generations), one de novo disrupting duplication, and nine de novo point mutations (three truncating, one canonical splice site, and five missense mutations) involving RORA in 16 individuals from 13 families with variable neurodevelopmental delay and intellectual disability (ID)-associated autistic features, cerebellar ataxia, and epilepsy.">
    <entity charOffset="308-312" id="s1434.e0" ontology_id="6095" text="RORA" type="GENE"/>
    <entity charOffset="473-481" id="s1434.e1" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <pair e1="s1434.e0" e2="s1434.e1" id="s1434.p0" relation="true"/>
  </sentence>
  <sentence id="s1435" text="The spontaneous mutant mouse staggerer, with an ataxic gait caused by neurodegeneration of cerebellar Purkinje cells, was discovered two decades ago to result from homozygous intragenic Rora deletions.">
    <entity charOffset="48-59" id="s1435.e0" ontology_id="HP_0002066" text="ataxic gait" type="HP"/>
    <entity charOffset="186-190" id="s1435.e1" ontology_id="6095" text="Rora" type="GENE"/>
    <pair e1="s1435.e0" e2="s1435.e1" id="s1435.p0" relation="true"/>
  </sentence>
  <sentence id="s1436" text="siRNA-mediated suppression of UBE2T inhibited gastric cancer cell proliferation and colony formation by promoting cell cycle arrest at G2/M phase and increasing apoptosis.">
    <entity charOffset="30-35" id="s1436.e0" ontology_id="29089" text="UBE2T" type="GENE"/>
    <entity charOffset="54-60" id="s1436.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1436.e0" e2="s1436.e1" id="s1436.p0" relation="true"/>
  </sentence>
  <sentence id="s1437" text="UBE2T was highly expressed in gastric tumors and gastric cancer cells.">
    <entity charOffset="0-5" id="s1437.e0" ontology_id="29089" text="UBE2T" type="GENE"/>
    <entity charOffset="57-63" id="s1437.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1437.e0" e2="s1437.e1" id="s1437.p0" relation="true"/>
  </sentence>
  <sentence id="s1438" text="Overexpression of Phgdh in CK5-positive cell lineages, and differential protein isoform expression, was additionally found in other tissues and cancer types, suggesting that overexpression of Phgdh is generally associated with CK5 cells, and that oncogenic function may be determined by isoform expression.">
    <entity charOffset="18-23" id="s1438.e0" ontology_id="26227" text="Phgdh" type="GENE"/>
    <entity charOffset="144-150" id="s1438.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1438.e0" e2="s1438.e1" id="s1438.p0" relation="true"/>
  </sentence>
  <sentence id="s1439" text="CONCLUSIONS Gli-1 is highly expressed in human esophageal carcinoma, and could be a marker for use in assessing tumor stage and the deciding on treatment target">
    <entity charOffset="12-15" id="s1439.e0" ontology_id="2735" text="Gli" type="GENE"/>
    <entity charOffset="47-67" id="s1439.e1" ontology_id="HP_0011459" text="esophageal carcinoma" type="HP"/>
    <pair e1="s1439.e0" e2="s1439.e1" id="s1439.p0" relation="true"/>
  </sentence>
  <sentence id="s1440" text="CONCLUSIONS Gli-1 is highly expressed in human esophageal carcinoma, and could be a marker for use in assessing tumor stage and the deciding on treatment target">
    <entity charOffset="12-15" id="s1440.e0" ontology_id="2735" text="Gli" type="GENE"/>
    <entity charOffset="112-117" id="s1440.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1440.e0" e2="s1440.e1" id="s1440.p0" relation="true"/>
  </sentence>
  <sentence id="s1441" text="RESULTS Gli-1 was associated with patient age, gender, lymphatic metastasis, tumor recurrence, and stage, with significantly (P&amp;lt;0.05) positive correlations with age, lymphatic metastasis, tumor recurrence, and stage.">
    <entity charOffset="8-11" id="s1441.e0" ontology_id="2735" text="Gli" type="GENE"/>
    <entity charOffset="77-82" id="s1441.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1441.e0" e2="s1441.e1" id="s1441.p0" relation="true"/>
  </sentence>
  <sentence id="s1442" text="We investigated glioma-associated oncogene protein-1 (Gli-1) expression in human esophageal carcinoma tissue and the inhibition of cyclopamine on EC9706 esophageal carcinoma cell growth.">
    <entity charOffset="54-57" id="s1442.e0" ontology_id="2735" text="Gli" type="GENE"/>
    <entity charOffset="81-101" id="s1442.e1" ontology_id="HP_0011459" text="esophageal carcinoma" type="HP"/>
    <pair e1="s1442.e0" e2="s1442.e1" id="s1442.p0" relation="true"/>
  </sentence>
  <sentence id="s1443" text="Individuals had microcephaly, developmental delay, epilepsy, and recessive mutations in TRIT1.">
    <entity charOffset="51-59" id="s1443.e0" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <entity charOffset="88-93" id="s1443.e1" ontology_id="54802" text="TRIT1" type="GENE"/>
    <pair e1="s1443.e0" e2="s1443.e1" id="s1443.p0" relation="true"/>
  </sentence>
  <sentence id="s1444" text="Our results recognize the sensitivity of tumor cell types to GANT61 in cell culture and support a critical role for GLI factors in tumor progression through restraining apoptosis.">
    <entity charOffset="41-46" id="s1444.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="116-119" id="s1444.e1" ontology_id="2735" text="GLI" type="GENE"/>
    <pair e1="s1444.e0" e2="s1444.e1" id="s1444.p0" relation="false"/>
  </sentence>
  <sentence id="s1445" text="In the present review, 22loci of glaucoma are presented, including the relevant genes (myocilin, interleukin20 receptor subunit B, optineurin, ankyrin repeat and SOCS boxcontaining protein 10, WD repeatcontaining protein 36, EGFcontaining fibulinlike extracellular matrix protein 1, neurotrophin 4, TANKbinding kinase 1, cytochrome P450 subfamily I polypeptide 1, latent transforming growth factor  binding protein 2 and TEK tyrosine kinase endothelial) and 74other genes (including tolllike receptor 4, sine oculis homeobox Drosophila homolog of 1, doublecortinlike kinase 1, RE repeatsencoding gene, retinitis pigmentosa GTPase regulatorinteracting protein, lysyl oxidaselike protein 1, heatshock 70kDa protein 1A, baculoviral IAP repeatcontaining protein 6, 5,10methylenetetrahydrofolate reductase and nitric oxide synthase 3 and nanophthalmos1) that are more closely associated with glaucoma.">
    <entity charOffset="34-42" id="s1445.e0" ontology_id="HP_0000501" text="glaucoma" type="HP"/>
    <entity charOffset="430-433" id="s1445.e1" ontology_id="7010" text="TEK" type="GENE"/>
    <pair e1="s1445.e0" e2="s1445.e1" id="s1445.p0" relation="true"/>
  </sentence>
  <sentence id="s1446" text="In this study, we focused on colon cancer with peritoneal metastasis and investigated the association between the expression of CD133, aldehyde dehydrogenase-1(ALDH1) and leucine-rich repeating G-protein coupled receptor-5(Lgr5), and disease prognosis.">
    <entity charOffset="35-41" id="s1446.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="225-229" id="s1446.e1" ontology_id="8549" text="Lgr5" type="GENE"/>
    <pair e1="s1446.e0" e2="s1446.e1" id="s1446.p0" relation="false"/>
  </sentence>
  <sentence id="s1447" text="In this study, we focused on colon cancer with peritoneal metastasis and investigated the association between the expression of CD133, aldehyde dehydrogenase-1(ALDH1) and leucine-rich repeating G-protein coupled receptor-5(Lgr5), and disease prognosis.">
    <entity charOffset="35-41" id="s1447.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="161-166" id="s1447.e1" ontology_id="216" text="ALDH1" type="GENE"/>
    <pair e1="s1447.e0" e2="s1447.e1" id="s1447.p0" relation="false"/>
  </sentence>
  <sentence id="s1448" text="Here we used an integrative strategy to examine the hypothesis that genetic variants at FOXA1/2 binding elements may be associated with sexual dimorphism of hepatocellular carcinoma (HCC) risk.">
    <entity charOffset="88-93" id="s1448.e0" ontology_id="3169" text="FOXA1" type="GENE"/>
    <entity charOffset="157-181" id="s1448.e1" ontology_id="HP_0001402" text="hepatocellular carcinoma" type="HP"/>
    <pair e1="s1448.e0" e2="s1448.e1" id="s1448.p0" relation="true"/>
  </sentence>
  <sentence id="s1449" text="Human genetic and pharmacological animal studies support this hypothesis, but no studies have explored mGluR5 dysfunction at the molecular level in the postmortem schizophrenia brain.">
    <entity charOffset="103-109" id="s1449.e0" ontology_id="2915" text="mGluR5" type="GENE"/>
    <entity charOffset="163-176" id="s1449.e1" ontology_id="HP_0100753" text="schizophrenia" type="HP"/>
    <pair e1="s1449.e0" e2="s1449.e1" id="s1449.p0" relation="true"/>
  </sentence>
  <sentence id="s1450" text="Conversely, mGluR5 regulatory proteins were expressed at lower levels in schizophrenia subjects compared to controls (Norbin -37%, p &amp;lt; 0.001; Tamalin -30%, p = 0.084; Preso1 -29%, p = 0.001).">
    <entity charOffset="12-18" id="s1450.e0" ontology_id="2915" text="mGluR5" type="GENE"/>
    <entity charOffset="73-86" id="s1450.e1" ontology_id="HP_0100753" text="schizophrenia" type="HP"/>
    <pair e1="s1450.e0" e2="s1450.e1" id="s1450.p0" relation="true"/>
  </sentence>
  <sentence id="s1451" text="We assessed mGluR5 mRNA and protein levels in the dorsolateral prefrontal cortex (DLPFC) using a large cohort of schizophrenia and control subjects (n = 37/group), and additionally measured protein levels of recently discovered mGluR5 endogenous regulators, Norbin (neurochondrin), Tamalin (GRASP-1), and Preso1 (FRMPD4), which regulate mGluR5 localization, internalization and signaling.">
    <entity charOffset="12-18" id="s1451.e0" ontology_id="2915" text="mGluR5" type="GENE"/>
    <entity charOffset="113-126" id="s1451.e1" ontology_id="HP_0100753" text="schizophrenia" type="HP"/>
    <pair e1="s1451.e0" e2="s1451.e1" id="s1451.p0" relation="false"/>
  </sentence>
  <sentence id="s1452" text="While mGluR5 mRNA expression was unchanged, mGluR5 protein levels were significantly higher in schizophrenia subjects compared to controls (total: +22%; dimer: +54%; p &amp;lt; 0.001).">
    <entity charOffset="6-12" id="s1452.e0" ontology_id="2915" text="mGluR5" type="GENE"/>
    <entity charOffset="95-108" id="s1452.e1" ontology_id="HP_0100753" text="schizophrenia" type="HP"/>
    <pair e1="s1452.e0" e2="s1452.e1" id="s1452.p0" relation="true"/>
  </sentence>
  <sentence id="s1453" text="In the present study, we examined whether SASS6 expression is abnormally regulated in colorectal cancers (CRCs).">
    <entity charOffset="42-47" id="s1453.e0" ontology_id="163786" text="SASS6" type="GENE"/>
    <entity charOffset="97-103" id="s1453.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1453.e0" e2="s1453.e1" id="s1453.p0" relation="true"/>
  </sentence>
  <sentence id="s1454" text="Next, using DLD-1 colon cancer cells inducibly expressing SASS6, SASS6 overexpression was shown to induce centrosome amplification, mitotic abnormalities such as chromosomal misalignment and lagging chromosome, and chromosomal numerical changes.">
    <entity charOffset="24-30" id="s1454.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="58-63" id="s1454.e1" ontology_id="163786" text="SASS6" type="GENE"/>
    <pair e1="s1454.e0" e2="s1454.e1" id="s1454.p0" relation="true"/>
  </sentence>
  <sentence id="s1455" text="To date, the genetic alteration of SASS6 has not been reported in human cancers.">
    <entity charOffset="35-40" id="s1455.e0" ontology_id="163786" text="SASS6" type="GENE"/>
    <entity charOffset="72-78" id="s1455.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1455.e0" e2="s1455.e1" id="s1455.p0" relation="true"/>
  </sentence>
  <sentence id="s1456" text="Here, we show that human spSCC tumours also feature strong nuclear localisation of YAP and overexpression of activated YAP (NLS-YAP-5SA) with Keratin-5 (K5-CreERt) is sufficient to induce rapid formation of both SCC and spSCC in mice.">
    <entity charOffset="31-38" id="s1456.e0" ontology_id="HP_0002664" text="tumours" type="HP"/>
    <entity charOffset="83-86" id="s1456.e1" ontology_id="55249" text="YAP" type="GENE"/>
    <pair e1="s1456.e0" e2="s1456.e1" id="s1456.p0" relation="true"/>
  </sentence>
  <sentence id="s1457" text="The aminoacyl tRNA synthetase complex-interacting multifunctional protein 2 (AIMP2) splice variant designated DX2 is induced by cigarette smoke carcinogens and is often detected in human lung cancer specimens.">
    <entity charOffset="77-82" id="s1457.e0" ontology_id="7965" text="AIMP2" type="GENE"/>
    <entity charOffset="192-198" id="s1457.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1457.e0" e2="s1457.e1" id="s1457.p0" relation="true"/>
  </sentence>
  <sentence id="s1458" text="The aim of our study was to determine the impact of genetic polymorphisms in the caspase (CASP) genes on prognosis of hepatocellular carcinoma (HCC).">
    <entity charOffset="90-94" id="s1458.e0" ontology_id="10491" text="CASP" type="GENE"/>
    <entity charOffset="118-142" id="s1458.e1" ontology_id="HP_0001402" text="hepatocellular carcinoma" type="HP"/>
    <pair e1="s1458.e0" e2="s1458.e1" id="s1458.p0" relation="true"/>
  </sentence>
  <sentence id="s1459" text="In addition, we demonstrated that XIAP-enhanced tumor growth is dependent on depletion of p62 in vivo.">
    <entity charOffset="34-38" id="s1459.e0" ontology_id="331" text="XIAP" type="GENE"/>
    <entity charOffset="48-53" id="s1459.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1459.e0" e2="s1459.e1" id="s1459.p0" relation="true"/>
  </sentence>
  <sentence id="s1460" text="Furthermore, XIAP enhanced cancer cell proliferation, viability, and colony formation in vitro via suppression of p62.">
    <entity charOffset="13-17" id="s1460.e0" ontology_id="331" text="XIAP" type="GENE"/>
    <entity charOffset="27-33" id="s1460.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1460.e0" e2="s1460.e1" id="s1460.p0" relation="true"/>
  </sentence>
  <sentence id="s1461" text="In this study, we aimed to clarify the phenotypic spectrum of COL4A1/A2 mutations in the context of cortical malformations that include schizencephaly, polymicrogyria and/or heterotopia">
    <entity charOffset="62-68" id="s1461.e0" ontology_id="1282" text="COL4A1" type="GENE"/>
    <entity charOffset="136-150" id="s1461.e1" ontology_id="HP_0010636" text="schizencephaly" type="HP"/>
    <pair e1="s1461.e0" e2="s1461.e1" id="s1461.p0" relation="true"/>
  </sentence>
  <sentence id="s1462" text="Functional studies support intraocular pressure-related influences of FMNL2 and LMX1B, with certain Lmx1b mutations causing high IOP and glaucoma resembling POAG in mice.">
    <entity charOffset="80-85" id="s1462.e0" ontology_id="4010" text="LMX1B" type="GENE"/>
    <entity charOffset="137-145" id="s1462.e1" ontology_id="HP_0000501" text="glaucoma" type="HP"/>
    <pair e1="s1462.e0" e2="s1462.e1" id="s1462.p0" relation="false"/>
  </sentence>
  <sentence id="s1463" text="Functional studies support intraocular pressure-related influences of FMNL2 and LMX1B, with certain Lmx1b mutations causing high IOP and glaucoma resembling POAG in mice.">
    <entity charOffset="100-105" id="s1463.e0" ontology_id="4010" text="Lmx1b" type="GENE"/>
    <entity charOffset="137-145" id="s1463.e1" ontology_id="HP_0000501" text="glaucoma" type="HP"/>
    <pair e1="s1463.e0" e2="s1463.e1" id="s1463.p0" relation="true"/>
  </sentence>
  <sentence id="s1464" text="Our results demonstrated pairwise epistatic interactions between ERCC6 and ERCC8 SNPs that ERCC6 rs1917799-ERCC8 rs158572 combination was associated with decreased risk of chronic atrophic gastritis and increased risk of gastric cancer.">
    <entity charOffset="65-70" id="s1464.e0" ontology_id="2074" text="ERCC6" type="GENE"/>
    <entity charOffset="229-235" id="s1464.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1464.e0" e2="s1464.e1" id="s1464.p0" relation="true"/>
  </sentence>
  <sentence id="s1465" text="Our results demonstrated pairwise epistatic interactions between ERCC6 and ERCC8 SNPs that ERCC6 rs1917799-ERCC8 rs158572 combination was associated with decreased risk of chronic atrophic gastritis and increased risk of gastric cancer.">
    <entity charOffset="75-80" id="s1465.e0" ontology_id="1161" text="ERCC8" type="GENE"/>
    <entity charOffset="229-235" id="s1465.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1465.e0" e2="s1465.e1" id="s1465.p0" relation="true"/>
  </sentence>
  <sentence id="s1466" text="In conclusion, ERCC6 rs1917799, ERCC8 rs158572 and rs158916 demonstrated pairwise epistatic interactions to associate with chronic atrophic gastritis and gastric cancer risk.">
    <entity charOffset="15-20" id="s1466.e0" ontology_id="2074" text="ERCC6" type="GENE"/>
    <entity charOffset="162-168" id="s1466.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1466.e0" e2="s1466.e1" id="s1466.p0" relation="true"/>
  </sentence>
  <sentence id="s1467" text="In conclusion, ERCC6 rs1917799, ERCC8 rs158572 and rs158916 demonstrated pairwise epistatic interactions to associate with chronic atrophic gastritis and gastric cancer risk.">
    <entity charOffset="32-37" id="s1467.e0" ontology_id="1161" text="ERCC8" type="GENE"/>
    <entity charOffset="162-168" id="s1467.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1467.e0" e2="s1467.e1" id="s1467.p0" relation="true"/>
  </sentence>
  <sentence id="s1468" text="In situ ERCC6 and ERCC8 protein expression were detected by immunohistochemistry in 109 chronic superficial gastritis, 109 chronic atrophic gastritis and 109 gastric cancer cases.">
    <entity charOffset="8-13" id="s1468.e0" ontology_id="2074" text="ERCC6" type="GENE"/>
    <entity charOffset="166-172" id="s1468.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1468.e0" e2="s1468.e1" id="s1468.p0" relation="true"/>
  </sentence>
  <sentence id="s1469" text="In situ ERCC6 and ERCC8 protein expression were detected by immunohistochemistry in 109 chronic superficial gastritis, 109 chronic atrophic gastritis and 109 gastric cancer cases.">
    <entity charOffset="18-23" id="s1469.e0" ontology_id="1161" text="ERCC8" type="GENE"/>
    <entity charOffset="166-172" id="s1469.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1469.e0" e2="s1469.e1" id="s1469.p0" relation="true"/>
  </sentence>
  <sentence id="s1470" text="ERCC6 rs1917799 also showed a significant interaction with ERCC8 rs158916 to reduce gastric cancer risk.">
    <entity charOffset="59-64" id="s1470.e0" ontology_id="1161" text="ERCC8" type="GENE"/>
    <entity charOffset="92-98" id="s1470.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1470.e0" e2="s1470.e1" id="s1470.p0" relation="true"/>
  </sentence>
  <sentence id="s1471" text="ABHD12 mutations have been linked to neurodegenerative PHARC (polyneuropathy, hearing loss, ataxia, retinitis pigmentosa, and early-onset cataract), a rare, progressive, autosomal, recessive disease.">
    <entity charOffset="0-6" id="s1471.e0" ontology_id="26090" text="ABHD12" type="GENE"/>
    <entity charOffset="157-168" id="s1471.e1" ontology_id="HP_0003676" text="progressive" type="HP"/>
    <pair e1="s1471.e0" e2="s1471.e1" id="s1471.p0" relation="true"/>
  </sentence>
  <sentence id="s1472" text="ABHD12 mutations have been linked to neurodegenerative PHARC (polyneuropathy, hearing loss, ataxia, retinitis pigmentosa, and early-onset cataract), a rare, progressive, autosomal, recessive disease.">
    <entity charOffset="0-6" id="s1472.e0" ontology_id="26090" text="ABHD12" type="GENE"/>
    <entity charOffset="92-98" id="s1472.e1" ontology_id="HP_0001251" text="ataxia" type="HP"/>
    <pair e1="s1472.e0" e2="s1472.e1" id="s1472.p0" relation="true"/>
  </sentence>
  <sentence id="s1473" text="BBN tumors showed overexpression of markers of basal cancer subtype, and had a high mutation burden with frequent Trp53 (80%), Kmt2d (70%), and Kmt2c (90%) mutations by exome sequencing, similar to human MIBC.">
    <entity charOffset="4-10" id="s1473.e0" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <entity charOffset="144-149" id="s1473.e1" ontology_id="58508" text="Kmt2c" type="GENE"/>
    <pair e1="s1473.e0" e2="s1473.e1" id="s1473.p0" relation="true"/>
  </sentence>
  <sentence id="s1474" text="Here, we report that TRIP13 is highly overexpressed in multiple lung adenocarcinoma cell lines and tumor tissues.">
    <entity charOffset="21-27" id="s1474.e0" ontology_id="9319" text="TRIP13" type="GENE"/>
    <entity charOffset="99-104" id="s1474.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1474.e0" e2="s1474.e1" id="s1474.p0" relation="true"/>
  </sentence>
  <sentence id="s1475" text="Our study indicates the novel WDR73 p.W371G missense mutation causes infantile onset intellectual disability and cerebellar hypoplasia in recessive mode of inheritance.">
    <entity charOffset="30-35" id="s1475.e0" ontology_id="84942" text="WDR73" type="GENE"/>
    <entity charOffset="113-134" id="s1475.e1" ontology_id="HP_0001321" text="cerebellar hypoplasia" type="HP"/>
    <pair e1="s1475.e0" e2="s1475.e1" id="s1475.p0" relation="true"/>
  </sentence>
  <sentence id="s1476" text="Our study indicates the novel WDR73 p.W371G missense mutation causes infantile onset intellectual disability and cerebellar hypoplasia in recessive mode of inheritance.">
    <entity charOffset="30-35" id="s1476.e0" ontology_id="84942" text="WDR73" type="GENE"/>
    <entity charOffset="85-108" id="s1476.e1" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <pair e1="s1476.e0" e2="s1476.e1" id="s1476.p0" relation="true"/>
  </sentence>
  <sentence id="s1477" text="Our study indicates the novel WDR73 p.W371G missense mutation causes infantile onset intellectual disability and cerebellar hypoplasia in recessive mode of inheritance.">
    <entity charOffset="30-35" id="s1477.e0" ontology_id="84942" text="WDR73" type="GENE"/>
    <entity charOffset="148-167" id="s1477.e1" ontology_id="HP_0000005" text="mode of inheritance" type="HP"/>
    <pair e1="s1477.e0" e2="s1477.e1" id="s1477.p0" relation="true"/>
  </sentence>
  <sentence id="s1478" text="Our findings imply that microcephaly is a variable phenotype in WDR73-related disease, suggest WDR73 to be a candidate gene of severe intellectual disability and cerebellar hypoplasia, and expand the molecular spectrum of WDR73-related disease">
    <entity charOffset="24-36" id="s1478.e0" ontology_id="HP_0000252" text="microcephaly" type="HP"/>
    <entity charOffset="64-69" id="s1478.e1" ontology_id="84942" text="WDR73" type="GENE"/>
    <pair e1="s1478.e0" e2="s1478.e1" id="s1478.p0" relation="true"/>
  </sentence>
  <sentence id="s1479" text="Subsequent quantitative PCR experiments confirmed that PRDX4, CKS2, MAGED2, and an EST (GenBank accession number BF696304) were expressed at significantly higher levels in tumors with metastasis.">
    <entity charOffset="62-66" id="s1479.e0" ontology_id="1164" text="CKS2" type="GENE"/>
    <entity charOffset="172-178" id="s1479.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s1479.e0" e2="s1479.e1" id="s1479.p0" relation="true"/>
  </sentence>
  <sentence id="s1480" text="Here, we show that selective overexpression of the stress protein, heme oxygenase-1 (HO-1) in astrocytes of GFAP.HMOX1 transgenic mice between 8.5 and 19months of age results in nigrostriatal hypodopaminergia associated with locomotor incoordination and stereotypy; downregulation of tyrosine hydroxylase, DAT, LMX1B, Nurr1, Pitx3 and DJ-1 mRNA and/or protein; overproduction of -synuclein and ubiquitin; oxidative stress; basal ganglia siderosis; mitochondrial damage/mitophagy; and augmented GABAergic systems (increased GABA, GAD67 and reelin).">
    <entity charOffset="236-250" id="s1480.e0" ontology_id="HP_0002311" text="incoordination" type="HP"/>
    <entity charOffset="319-324" id="s1480.e1" ontology_id="4929" text="Nurr1" type="GENE"/>
    <pair e1="s1480.e0" e2="s1480.e1" id="s1480.p0" relation="false"/>
  </sentence>
  <sentence id="s1481" text="Of the 465,447 CpG sites analyzed, 12 showed differential methylation (false discovery rate &amp;lt;0.15), including markers within genes associated with monogenic diabetes (HNF4A) or obesity (RREB1).">
    <entity charOffset="170-175" id="s1481.e0" ontology_id="3172" text="HNF4A" type="GENE"/>
    <entity charOffset="180-187" id="s1481.e1" ontology_id="HP_0001513" text="obesity" type="HP"/>
    <pair e1="s1481.e0" e2="s1481.e1" id="s1481.p0" relation="false"/>
  </sentence>
  <sentence id="s1482" text="Of the 465,447 CpG sites analyzed, 12 showed differential methylation (false discovery rate &amp;lt;0.15), including markers within genes associated with monogenic diabetes (HNF4A) or obesity (RREB1).">
    <entity charOffset="180-187" id="s1482.e0" ontology_id="HP_0001513" text="obesity" type="HP"/>
    <entity charOffset="189-194" id="s1482.e1" ontology_id="6239" text="RREB1" type="GENE"/>
    <pair e1="s1482.e0" e2="s1482.e1" id="s1482.p0" relation="true"/>
  </sentence>
  <sentence id="s1483" text="CD164 was co-expressed with KIR3DL2 on circulating CD4&lt;sup&gt;+&lt;/sup&gt; T cells from high tumor burden SS patients, further providing strong support for CD164 as a disease relevant surface biomarker">
    <entity charOffset="28-35" id="s1483.e0" ontology_id="3812" text="KIR3DL2" type="GENE"/>
    <entity charOffset="85-90" id="s1483.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1483.e0" e2="s1483.e1" id="s1483.p0" relation="true"/>
  </sentence>
  <sentence id="s1484" text="Oropharyngeal cancer associations were limited to the human leukocyte antigen (HLA) region, and classical HLA allele imputation showed a protective association with the class II haplotype HLA-DRB1*1301-HLA-DQA1*0103-HLA-DQB1*0603 (odds ratio (OR) = 0.59, P = 2.7  10&lt;sup&gt;-9&lt;/sup&gt;).">
    <entity charOffset="14-20" id="s1484.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="216-224" id="s1484.e1" ontology_id="3119" text="HLA-DQB1" type="GENE"/>
    <pair e1="s1484.e0" e2="s1484.e1" id="s1484.p0" relation="true"/>
  </sentence>
  <sentence id="s1485" text="Oral and pharyngeal cancers combined were associated with loci at 6p21.32 (rs3828805, HLA-DQB1), 10q26.13 (rs201982221, LHPP) and 11p15.4 (rs1453414, OR52N2-TRIM5).">
    <entity charOffset="20-26" id="s1485.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="120-124" id="s1485.e1" ontology_id="64077" text="LHPP" type="GENE"/>
    <pair e1="s1485.e0" e2="s1485.e1" id="s1485.p0" relation="true"/>
  </sentence>
  <sentence id="s1486" text="The contiguous deletion of NDP and its neighbouring genes, MAOA/B and EFHC2, reportedly leads to syndromic clinical features such as microcephaly, intellectual disability, and epilepsy.">
    <entity charOffset="27-30" id="s1486.e0" ontology_id="4693" text="NDP" type="GENE"/>
    <entity charOffset="147-170" id="s1486.e1" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <pair e1="s1486.e0" e2="s1486.e1" id="s1486.p0" relation="true"/>
  </sentence>
  <sentence id="s1487" text="The contiguous deletion of NDP and its neighbouring genes, MAOA/B and EFHC2, reportedly leads to syndromic clinical features such as microcephaly, intellectual disability, and epilepsy.">
    <entity charOffset="70-75" id="s1487.e0" ontology_id="80258" text="EFHC2" type="GENE"/>
    <entity charOffset="133-145" id="s1487.e1" ontology_id="HP_0000252" text="microcephaly" type="HP"/>
    <pair e1="s1487.e0" e2="s1487.e1" id="s1487.p0" relation="true"/>
  </sentence>
  <sentence id="s1488" text="Since this is an atypical but previously described rare presentation of PHP1b, we reemphasize STX16 deletions and PHP1b as a rare cause for early onset obesity and macrosomia.">
    <entity charOffset="94-99" id="s1488.e0" ontology_id="8675" text="STX16" type="GENE"/>
    <entity charOffset="152-159" id="s1488.e1" ontology_id="HP_0001513" text="obesity" type="HP"/>
    <pair e1="s1488.e0" e2="s1488.e1" id="s1488.p0" relation="true"/>
  </sentence>
  <sentence id="s1489" text="Here, we identified three families with mutations in ADD3, encoding for adducin-, with intellectual disability, microcephaly, cataracts and skeletal defects.">
    <entity charOffset="53-57" id="s1489.e0" ontology_id="120" text="ADD3" type="GENE"/>
    <entity charOffset="88-111" id="s1489.e1" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <pair e1="s1489.e0" e2="s1489.e1" id="s1489.p0" relation="true"/>
  </sentence>
  <sentence id="s1490" text="Here, we identified three families with mutations in ADD3, encoding for adducin-, with intellectual disability, microcephaly, cataracts and skeletal defects.">
    <entity charOffset="53-57" id="s1490.e0" ontology_id="120" text="ADD3" type="GENE"/>
    <entity charOffset="113-125" id="s1490.e1" ontology_id="HP_0000252" text="microcephaly" type="HP"/>
    <pair e1="s1490.e0" e2="s1490.e1" id="s1490.p0" relation="true"/>
  </sentence>
  <sentence id="s1491" text="We report a novel gene duplication syndrome (10q21.2q21.3 microduplication) and present a new evidence for VIPR2 duplication, as a candidate gene for autism.">
    <entity charOffset="107-112" id="s1491.e0" ontology_id="7434" text="VIPR2" type="GENE"/>
    <entity charOffset="150-156" id="s1491.e1" ontology_id="HP_0000717" text="autism" type="HP"/>
    <pair e1="s1491.e0" e2="s1491.e1" id="s1491.p0" relation="true"/>
  </sentence>
  <sentence id="s1492" text="This review reflects the existing Eph/ephrin literature while focusing on breast cancer heterogeneity.">
    <entity charOffset="34-37" id="s1492.e0" ontology_id="2041" text="Eph" type="GENE"/>
    <entity charOffset="81-87" id="s1492.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1492.e0" e2="s1492.e1" id="s1492.p0" relation="true"/>
  </sentence>
  <sentence id="s1493" text="Depletion of the exon 3-containing long isoform of MRPL33 (MRPL33-L) led to impaired proliferation and increased apoptosis in cancer cell lines and in a xenograft model.">
    <entity charOffset="51-57" id="s1493.e0" ontology_id="9553" text="MRPL33" type="GENE"/>
    <entity charOffset="126-132" id="s1493.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1493.e0" e2="s1493.e1" id="s1493.p0" relation="true"/>
  </sentence>
  <sentence id="s1494" text="In summary, our findings underscore the biological significance of MRPL33-L and hnRNPK in the tumor formation and identifies hnRNPK as a critical splicing regulator of MRPL33 pre-mRNA in cancer cells">
    <entity charOffset="67-73" id="s1494.e0" ontology_id="9553" text="MRPL33" type="GENE"/>
    <entity charOffset="187-193" id="s1494.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1494.e0" e2="s1494.e1" id="s1494.p0" relation="false"/>
  </sentence>
  <sentence id="s1495" text="Glutaric aciduria type I (GA-I) is a rare organic aciduria caused by the autosomal recessive inherited deficiency of glutaryl-CoA dehydrogenase (GCDH).">
    <entity charOffset="42-58" id="s1495.e0" ontology_id="HP_0001992" text="organic aciduria" type="HP"/>
    <entity charOffset="145-149" id="s1495.e1" ontology_id="2639" text="GCDH" type="GENE"/>
    <pair e1="s1495.e0" e2="s1495.e1" id="s1495.p0" relation="true"/>
  </sentence>
  <sentence id="s1496" text="Glutaric aciduria type I (GA-I) is a rare organic aciduria caused by the autosomal recessive inherited deficiency of glutaryl-CoA dehydrogenase (GCDH).">
    <entity charOffset="73-92" id="s1496.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="145-149" id="s1496.e1" ontology_id="2639" text="GCDH" type="GENE"/>
    <pair e1="s1496.e0" e2="s1496.e1" id="s1496.p0" relation="true"/>
  </sentence>
  <sentence id="s1497" text="The correlations between the expressions of CTHRC1 with clinicopathologic features,E-cadherin and Vimentin expression were analyzed.&lt;b&gt;Result:&lt;/b&gt;CTHRC1 protein expression levels in papillary thyroid carcinoma tissue were significantly higher than those in adjacent normal thyroid tissue and benign disease(&lt;i&gt;P&lt;/i&gt;&amp;lt;0.01);CTHRC1 expression was significantly correlated with lymph node metastases(&lt;i&gt;P&lt;/i&gt;&amp;lt;0.05).">
    <entity charOffset="85-93" id="s1497.e0" ontology_id="1015" text="cadherin" type="GENE"/>
    <entity charOffset="182-209" id="s1497.e1" ontology_id="HP_0002895" text="papillary thyroid carcinoma" type="HP"/>
    <pair e1="s1497.e0" e2="s1497.e1" id="s1497.p0" relation="false"/>
  </sentence>
  <sentence id="s1498" text="&lt;b&gt;Objective:&lt;/b&gt;To investigate the expression and significance of CTHRC1 in patients with papillary thyroid cancinoma.&lt;b&gt;Method:&lt;/b&gt;We collected 63 specimens of papillary thyroid carcinoma tissue with 36 specimens of the adjacent normal thyroid tissue and 23 specimens of thyroid nodular goiter.">
    <entity charOffset="67-73" id="s1498.e0" ontology_id="115908" text="CTHRC1" type="GENE"/>
    <entity charOffset="162-189" id="s1498.e1" ontology_id="HP_0002895" text="papillary thyroid carcinoma" type="HP"/>
    <pair e1="s1498.e0" e2="s1498.e1" id="s1498.p0" relation="false"/>
  </sentence>
  <sentence id="s1499" text="Finally, we show evidence that abnormal protein homeostasis is a prevalent mechanism responsible for UROS deficiency and that modulators of UROS proteolysis such as proteasome inhibitors or chemical chaperones may represent an attractive therapeutic option to reduce porphyrin accumulation and prevent skin photosensitivity in CEP patients when the genotype includes a missense variant">
    <entity charOffset="101-105" id="s1499.e0" ontology_id="7390" text="UROS" type="GENE"/>
    <entity charOffset="302-323" id="s1499.e1" ontology_id="HP_0000992" text="skin photosensitivity" type="HP"/>
    <pair e1="s1499.e0" e2="s1499.e1" id="s1499.p0" relation="false"/>
  </sentence>
  <sentence id="s1500" text="Single marker-based association tests for corneal astigmatism identified four genome-wide significant loci (P&amp;lt;510&lt;sup&gt;-8&lt;/sup&gt;) near the genes ZC3H11B (1q41), LINC00340 (6p22.3), HERC2/OCA2 (15q13.1) and NPLOC4/TSPAN10 (17q25.3).">
    <entity charOffset="50-61" id="s1500.e0" ontology_id="HP_0000483" text="astigmatism" type="HP"/>
    <entity charOffset="187-192" id="s1500.e1" ontology_id="8924" text="HERC2" type="GENE"/>
    <pair e1="s1500.e0" e2="s1500.e1" id="s1500.p0" relation="true"/>
  </sentence>
  <sentence id="s1501" text="These loci have previously demonstrated association with axial length (ZC3H11B), myopia (NPLOC4), spherical equivalent refractive error (LINC00340) and eye colour (HERC2).">
    <entity charOffset="81-87" id="s1501.e0" ontology_id="HP_0000545" text="myopia" type="HP"/>
    <entity charOffset="89-95" id="s1501.e1" ontology_id="55666" text="NPLOC4" type="GENE"/>
    <pair e1="s1501.e0" e2="s1501.e1" id="s1501.p0" relation="true"/>
  </sentence>
  <sentence id="s1502" text="Aim of this study was to analyze the CMG2 mRNA and protein expression in soft tissue sarcoma and their association with patient outcome.">
    <entity charOffset="37-41" id="s1502.e0" ontology_id="118429" text="CMG2" type="GENE"/>
    <entity charOffset="85-92" id="s1502.e1" ontology_id="HP_0100242" text="sarcoma" type="HP"/>
    <pair e1="s1502.e0" e2="s1502.e1" id="s1502.p0" relation="true"/>
  </sentence>
  <sentence id="s1503" text="CMG2 mRNA was measured in 121 tumor samples of soft tissue sarcoma patients using quantitative real-time PCR.">
    <entity charOffset="0-4" id="s1503.e0" ontology_id="118429" text="CMG2" type="GENE"/>
    <entity charOffset="59-66" id="s1503.e1" ontology_id="HP_0100242" text="sarcoma" type="HP"/>
    <pair e1="s1503.e0" e2="s1503.e1" id="s1503.p0" relation="true"/>
  </sentence>
  <sentence id="s1504" text="As the first report in Korea, this study identified three KIF5A mutations as the underlying cause of axonal peripheral neuropathy with or without the HSP phenotype.">
    <entity charOffset="58-63" id="s1504.e0" ontology_id="3798" text="KIF5A" type="GENE"/>
    <entity charOffset="119-129" id="s1504.e1" ontology_id="HP_0009830" text="neuropathy" type="HP"/>
    <pair e1="s1504.e0" e2="s1504.e1" id="s1504.p0" relation="true"/>
  </sentence>
  <sentence id="s1505" text="As the first report in Korea, this study identified three KIF5A mutations as the underlying cause of axonal peripheral neuropathy with or without the HSP phenotype.">
    <entity charOffset="58-63" id="s1505.e0" ontology_id="3798" text="KIF5A" type="GENE"/>
    <entity charOffset="108-118" id="s1505.e1" ontology_id="HP_0030646" text="peripheral" type="HP"/>
    <pair e1="s1505.e0" e2="s1505.e1" id="s1505.p0" relation="true"/>
  </sentence>
  <sentence id="s1506" text="Mutations in the KIF5A showed a wide phenotypic spectrum from hereditary spastic paraplegia (HSP) to axonal Charcot-Marie-Tooth peripheral neuropathy type 2 (CMT2).">
    <entity charOffset="17-22" id="s1506.e0" ontology_id="3798" text="KIF5A" type="GENE"/>
    <entity charOffset="128-138" id="s1506.e1" ontology_id="HP_0030646" text="peripheral" type="HP"/>
    <pair e1="s1506.e0" e2="s1506.e1" id="s1506.p0" relation="true"/>
  </sentence>
  <sentence id="s1507" text="Here, we show that biallelic &lt;i&gt;Dicer1&lt;/i&gt; deletion with &lt;i&gt;aP2-Cre&lt;/i&gt; drives aggressive and metastatic angiosarcoma independent of other genetically engineered oncogenes or tumor suppressor loss.">
    <entity charOffset="32-38" id="s1507.e0" ontology_id="23405" text="Dicer1" type="GENE"/>
    <entity charOffset="105-117" id="s1507.e1" ontology_id="HP_0200058" text="angiosarcoma" type="HP"/>
    <pair e1="s1507.e0" e2="s1507.e1" id="s1507.p0" relation="true"/>
  </sentence>
  <sentence id="s1508" text="Here, we show that biallelic &lt;i&gt;Dicer1&lt;/i&gt; deletion with &lt;i&gt;aP2-Cre&lt;/i&gt; drives aggressive and metastatic angiosarcoma independent of other genetically engineered oncogenes or tumor suppressor loss.">
    <entity charOffset="32-38" id="s1508.e0" ontology_id="23405" text="Dicer1" type="GENE"/>
    <entity charOffset="175-180" id="s1508.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1508.e0" e2="s1508.e1" id="s1508.p0" relation="false"/>
  </sentence>
  <sentence id="s1509" text="These studies illustrate that Dicer1 can function as a traditional loss-of-function tumor suppressor gene, and they provide a fully penetrant animal model for the study of angiosarcoma development and metastasis.">
    <entity charOffset="30-36" id="s1509.e0" ontology_id="23405" text="Dicer1" type="GENE"/>
    <entity charOffset="84-89" id="s1509.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1509.e0" e2="s1509.e1" id="s1509.p0" relation="true"/>
  </sentence>
  <sentence id="s1510" text="Functional studies suggested that CAB39L functions as a tumor suppressor, as overexpression of CAB39L elicited suppression of multiple cancer phenotypes both in GC cells and an orthotopic mouse model; whilst its knockdown promoted tumorigenesis.">
    <entity charOffset="34-40" id="s1510.e0" ontology_id="81617" text="CAB39L" type="GENE"/>
    <entity charOffset="56-61" id="s1510.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1510.e0" e2="s1510.e1" id="s1510.p0" relation="true"/>
  </sentence>
  <sentence id="s1511" text="Functional studies suggested that CAB39L functions as a tumor suppressor, as overexpression of CAB39L elicited suppression of multiple cancer phenotypes both in GC cells and an orthotopic mouse model; whilst its knockdown promoted tumorigenesis.">
    <entity charOffset="34-40" id="s1511.e0" ontology_id="81617" text="CAB39L" type="GENE"/>
    <entity charOffset="135-141" id="s1511.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1511.e0" e2="s1511.e1" id="s1511.p0" relation="false"/>
  </sentence>
  <sentence id="s1512" text="Our data demonstrate that CAB39L is a novel tumor suppressor which suppresses tumorigenesis by promoting LKB1-AMPK-PGC1 axis, thereby preventing a metabolic shift that drives carcinogenesis.">
    <entity charOffset="44-49" id="s1512.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="110-114" id="s1512.e1" ontology_id="5563" text="AMPK" type="GENE"/>
    <pair e1="s1512.e0" e2="s1512.e1" id="s1512.p0" relation="true"/>
  </sentence>
  <sentence id="s1513" text="Moreover, knockdown of LKB1 reversed growth inhibitory effect of CAB39L, indicating that tumor suppression by CAB39L depended on LKB1-AMPK.">
    <entity charOffset="65-71" id="s1513.e0" ontology_id="81617" text="CAB39L" type="GENE"/>
    <entity charOffset="89-94" id="s1513.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1513.e0" e2="s1513.e1" id="s1513.p0" relation="true"/>
  </sentence>
  <sentence id="s1514" text="This disease is an autosomal recessive disorder, and the gene CSTB, which encodes cystatin B, a cysteine protease inhibitor, is the only gene known to be associated with ULD.">
    <entity charOffset="19-38" id="s1514.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="62-66" id="s1514.e1" ontology_id="1476" text="CSTB" type="GENE"/>
    <pair e1="s1514.e0" e2="s1514.e1" id="s1514.p0" relation="false"/>
  </sentence>
  <sentence id="s1515" text="SAA1 was identified from MS analysis, and its level was revealed to be correlated with the disease grade, clinical severity, and survival rate of patients with gliomas.">
    <entity charOffset="0-4" id="s1515.e0" ontology_id="6288" text="SAA1" type="GENE"/>
    <entity charOffset="160-167" id="s1515.e1" ontology_id="HP_0009733" text="gliomas" type="HP"/>
    <pair e1="s1515.e0" e2="s1515.e1" id="s1515.p0" relation="true"/>
  </sentence>
  <sentence id="s1516" text="Keratitis-ichthyosis-deafness (KID) syndrome is a rare genodermatosis that typically results from mutations of the GJB2 gene or, less commonly, the GJB6 gene.">
    <entity charOffset="21-29" id="s1516.e0" ontology_id="HP_0000365" text="deafness" type="HP"/>
    <entity charOffset="148-152" id="s1516.e1" ontology_id="10804" text="GJB6" type="GENE"/>
    <pair e1="s1516.e0" e2="s1516.e1" id="s1516.p0" relation="true"/>
  </sentence>
  <sentence id="s1517" text="Keratitis-ichthyosis-deafness (KID) syndrome is a rare genodermatosis that typically results from mutations of the GJB2 gene or, less commonly, the GJB6 gene.">
    <entity charOffset="21-29" id="s1517.e0" ontology_id="HP_0000365" text="deafness" type="HP"/>
    <entity charOffset="115-119" id="s1517.e1" ontology_id="2706" text="GJB2" type="GENE"/>
    <pair e1="s1517.e0" e2="s1517.e1" id="s1517.p0" relation="true"/>
  </sentence>
  <sentence id="s1518" text="p53R2 overexpression is associated with increased risk of pelvic lymph node metastasis (PLNM, p = 0.001) and cancer relapse (p = 0.009).">
    <entity charOffset="0-3" id="s1518.e0" ontology_id="7157" text="p53" type="GENE"/>
    <entity charOffset="109-115" id="s1518.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1518.e0" e2="s1518.e1" id="s1518.p0" relation="true"/>
  </sentence>
  <sentence id="s1519" text="IGSF1 (Immunoglobulin Superfamily 1) gene defects cause central hypothyroidism and macroorchidism.">
    <entity charOffset="0-5" id="s1519.e0" ontology_id="3547" text="IGSF1" type="GENE"/>
    <entity charOffset="56-63" id="s1519.e1" ontology_id="HP_0030645" text="central" type="HP"/>
    <pair e1="s1519.e0" e2="s1519.e1" id="s1519.p0" relation="true"/>
  </sentence>
  <sentence id="s1520" text="IGSF1 (Immunoglobulin Superfamily 1) gene defects cause central hypothyroidism and macroorchidism.">
    <entity charOffset="0-5" id="s1520.e0" ontology_id="3547" text="IGSF1" type="GENE"/>
    <entity charOffset="64-78" id="s1520.e1" ontology_id="HP_0000821" text="hypothyroidism" type="HP"/>
    <pair e1="s1520.e0" e2="s1520.e1" id="s1520.p0" relation="true"/>
  </sentence>
  <sentence id="s1521" text="In conclusion, two relevant molecular mechanisms linked to central hypothyroidism and macroorchidism in IGSF1 deficiency are identified, revealing IGSF1 as an important regulator of TGF/Activin pathways in the pituitary">
    <entity charOffset="86-100" id="s1521.e0" ontology_id="HP_0000053" text="macroorchidism" type="HP"/>
    <entity charOffset="104-109" id="s1521.e1" ontology_id="3547" text="IGSF1" type="GENE"/>
    <pair e1="s1521.e0" e2="s1521.e1" id="s1521.p0" relation="false"/>
  </sentence>
  <sentence id="s1522" text="Our report of variant in ARMC9 Leading to Joubert syndrome phenotype (JS30), elucidates the genetic heterogeneity of Joubert syndrome, and expands the gene list for ciliopathies">
    <entity charOffset="25-30" id="s1522.e0" ontology_id="80210" text="ARMC9" type="GENE"/>
    <entity charOffset="100-113" id="s1522.e1" ontology_id="HP_0001425" text="heterogeneity" type="HP"/>
    <pair e1="s1522.e0" e2="s1522.e1" id="s1522.p0" relation="true"/>
  </sentence>
  <sentence id="s1523" text="The mitochondrial protein SLC25A46 has been recently identified as a novel pathogenic cause in a wide spectrum of neurological diseases, including inherited optic atrophy, Charcot-Marie-Tooth type 2, Leigh syndrome, progressive myoclonic ataxia and lethal congenital pontocerebellar hypoplasia.">
    <entity charOffset="26-34" id="s1523.e0" ontology_id="91137" text="SLC25A46" type="GENE"/>
    <entity charOffset="272-293" id="s1523.e1" ontology_id="HP_0001321" text="cerebellar hypoplasia" type="HP"/>
    <pair e1="s1523.e0" e2="s1523.e1" id="s1523.p0" relation="true"/>
  </sentence>
  <sentence id="s1524" text="The mitochondrial protein SLC25A46 has been recently identified as a novel pathogenic cause in a wide spectrum of neurological diseases, including inherited optic atrophy, Charcot-Marie-Tooth type 2, Leigh syndrome, progressive myoclonic ataxia and lethal congenital pontocerebellar hypoplasia.">
    <entity charOffset="26-34" id="s1524.e0" ontology_id="91137" text="SLC25A46" type="GENE"/>
    <entity charOffset="157-170" id="s1524.e1" ontology_id="HP_0000648" text="optic atrophy" type="HP"/>
    <pair e1="s1524.e0" e2="s1524.e1" id="s1524.p0" relation="true"/>
  </sentence>
  <sentence id="s1525" text="In summary, our results reveal that rare loss-of-function variants in GABRA3 increase the risk for a varying combination of epilepsy, intellectual disability/developmental delay and dysmorphic features, presenting in some pedigrees with an X-linked inheritance pattern">
    <entity charOffset="70-76" id="s1525.e0" ontology_id="2556" text="GABRA3" type="GENE"/>
    <entity charOffset="134-157" id="s1525.e1" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <pair e1="s1525.e0" e2="s1525.e1" id="s1525.p0" relation="true"/>
  </sentence>
  <sentence id="s1526" text="MATERIAL AND METHODS The proliferation of prostate cancer cells was determined by CCK-8 assay.">
    <entity charOffset="51-57" id="s1526.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="82-85" id="s1526.e1" ontology_id="885" text="CCK" type="GENE"/>
    <pair e1="s1526.e0" e2="s1526.e1" id="s1526.p0" relation="true"/>
  </sentence>
  <sentence id="s1527" text="In these tumors, RET gene fusion product provides a constitutively active tyrosine kinase (TKR), leading to uncontrolled cellular proliferation, differentiation, and migration.">
    <entity charOffset="9-15" id="s1527.e0" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <entity charOffset="91-94" id="s1527.e1" ontology_id="8277" text="TKR" type="GENE"/>
    <pair e1="s1527.e0" e2="s1527.e1" id="s1527.p0" relation="true"/>
  </sentence>
  <sentence id="s1528" text="TNFAIP8 mRNA is induced by NF-kB, and overexpression of TNFAIP8 has been correlated with poor prognosis in many cancers.">
    <entity charOffset="0-7" id="s1528.e0" ontology_id="25816" text="TNFAIP8" type="GENE"/>
    <entity charOffset="112-118" id="s1528.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1528.e0" e2="s1528.e1" id="s1528.p0" relation="false"/>
  </sentence>
  <sentence id="s1529" text="TNFAIP8 mRNA is induced by NF-kB, and overexpression of TNFAIP8 has been correlated with poor prognosis in many cancers.">
    <entity charOffset="27-29" id="s1529.e0" ontology_id="23114" text="NF" type="GENE"/>
    <entity charOffset="112-118" id="s1529.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1529.e0" e2="s1529.e1" id="s1529.p0" relation="false"/>
  </sentence>
  <sentence id="s1530" text="Depending on the tumor cell type, knockdown of TNFAIP8 was found to be associated with increased mRNA expression of several antiproliferative and apoptotic genes (e.g., IL-24, FAT3, LPHN2, EPHA3) and fatty acid oxidation gene ACADL, and decreased mRNA levels of oncogenes (e.g., NFAT5, MALAT1, MET, FOXA1, KRAS, S100P, OSTF1) and glutamate transporter gene SLC1A1.">
    <entity charOffset="17-22" id="s1530.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="299-304" id="s1530.e1" ontology_id="3169" text="FOXA1" type="GENE"/>
    <pair e1="s1530.e0" e2="s1530.e1" id="s1530.p0" relation="true"/>
  </sentence>
  <sentence id="s1531" text="Depending on the tumor cell type, knockdown of TNFAIP8 was found to be associated with increased mRNA expression of several antiproliferative and apoptotic genes (e.g., IL-24, FAT3, LPHN2, EPHA3) and fatty acid oxidation gene ACADL, and decreased mRNA levels of oncogenes (e.g., NFAT5, MALAT1, MET, FOXA1, KRAS, S100P, OSTF1) and glutamate transporter gene SLC1A1.">
    <entity charOffset="17-22" id="s1531.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="176-180" id="s1531.e1" ontology_id="120114" text="FAT3" type="GENE"/>
    <pair e1="s1531.e0" e2="s1531.e1" id="s1531.p0" relation="true"/>
  </sentence>
  <sentence id="s1532" text="Depending on the tumor cell type, knockdown of TNFAIP8 was found to be associated with increased mRNA expression of several antiproliferative and apoptotic genes (e.g., IL-24, FAT3, LPHN2, EPHA3) and fatty acid oxidation gene ACADL, and decreased mRNA levels of oncogenes (e.g., NFAT5, MALAT1, MET, FOXA1, KRAS, S100P, OSTF1) and glutamate transporter gene SLC1A1.">
    <entity charOffset="17-22" id="s1532.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="47-54" id="s1532.e1" ontology_id="25816" text="TNFAIP8" type="GENE"/>
    <pair e1="s1532.e0" e2="s1532.e1" id="s1532.p0" relation="true"/>
  </sentence>
  <sentence id="s1533" text="Downregulation of TNFAIP8 expression has been associated with decreased pulmonary colonization of human tumor cells, and enhanced sensitivities of tumor xenografts to radiation and docetaxel.">
    <entity charOffset="18-25" id="s1533.e0" ontology_id="25816" text="TNFAIP8" type="GENE"/>
    <entity charOffset="104-109" id="s1533.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1533.e0" e2="s1533.e1" id="s1533.p0" relation="true"/>
  </sentence>
  <sentence id="s1534" text="Here we have investigated the effects of depletion of TNFAIP8 on the mRNA, microRNA and protein expression profiles in prostate and breast cancers and melanoma.">
    <entity charOffset="54-61" id="s1534.e0" ontology_id="25816" text="TNFAIP8" type="GENE"/>
    <entity charOffset="139-145" id="s1534.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1534.e0" e2="s1534.e1" id="s1534.p0" relation="true"/>
  </sentence>
  <sentence id="s1535" text="We analyzed the nucleotide repeat lengths of 6 genes (ATXN8, ATXN10, PPP2R2B, NOP56, DMPK, and JPH3) that have previously been associated with neurologic or neuromuscular disorders, in several hundred sporadic patients with ALS and healthy control subjects.">
    <entity charOffset="61-67" id="s1535.e0" ontology_id="25814" text="ATXN10" type="GENE"/>
    <entity charOffset="201-209" id="s1535.e1" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <pair e1="s1535.e0" e2="s1535.e1" id="s1535.p0" relation="true"/>
  </sentence>
  <sentence id="s1536" text="Bio-functional investigation revealed that LTBP1 inhibited cell proliferation in HCC cell lines, suggesting its potential role as a tumor suppressor in HCC.">
    <entity charOffset="43-48" id="s1536.e0" ontology_id="4052" text="LTBP1" type="GENE"/>
    <entity charOffset="132-137" id="s1536.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1536.e0" e2="s1536.e1" id="s1536.p0" relation="true"/>
  </sentence>
  <sentence id="s1537" text="Reduced representation bisulfite sequencing (RRBS) and gene expression microarrays were performed in the HCC tumor and non-HCC liver tissues to investigate the molecular mechanisms of COX-2-driven HCC.">
    <entity charOffset="109-114" id="s1537.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="184-187" id="s1537.e1" ontology_id="1351" text="COX" type="GENE"/>
    <pair e1="s1537.e0" e2="s1537.e1" id="s1537.p0" relation="true"/>
  </sentence>
  <sentence id="s1538" text="In conclusion, this study demonstrated for the first time that enhanced COX-2 expression in hepatocytes is sufficient to induce HCC through inducing promoter hypermethylation by reducing TET1, silencing tumor-suppressive genes and activating key oncogenic pathways.">
    <entity charOffset="187-191" id="s1538.e0" ontology_id="80312" text="TET1" type="GENE"/>
    <entity charOffset="203-208" id="s1538.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1538.e0" e2="s1538.e1" id="s1538.p0" relation="true"/>
  </sentence>
  <sentence id="s1539" text="We characterize adult-onset, progressive clinical symptoms of two afflicted kindred and introduce the symptom of profound spasticity not previously associated with the SCA13 phenotype.">
    <entity charOffset="113-121" id="s1539.e0" ontology_id="HP_0012829" text="profound" type="HP"/>
    <entity charOffset="168-173" id="s1539.e1" ontology_id="3748" text="SCA13" type="GENE"/>
    <pair e1="s1539.e0" e2="s1539.e1" id="s1539.p0" relation="true"/>
  </sentence>
  <sentence id="s1540" text="Likely haploinsufficiency of one or several of the 19 genes in the common deleted interval (ACTN1, DCAF5, EXD2, GALNTL1, ERH, SLC39A9, PLEKHD1, CCDC177, KIAA0247, LOC100289511, SRSF5, SLC10A1, SMOC1, SLC8A3, ADAM21P1, COX16, SYNJ2BP, SYNJ2BP-COX16, ADAM21) was responsible for these manifestations, but apart from SMOC1, mutations in which cause autosomal recessive Waardenburg anophthalmia syndrome, and ACTN1, mutations in which are associated with congenital macrothrombocytopenia, no disease associations have so far been reported for the other genes.">
    <entity charOffset="106-110" id="s1540.e0" ontology_id="55218" text="EXD2" type="GENE"/>
    <entity charOffset="346-365" id="s1540.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s1540.e0" e2="s1540.e1" id="s1540.p0" relation="false"/>
  </sentence>
  <sentence id="s1541" text="Likely haploinsufficiency of one or several of the 19 genes in the common deleted interval (ACTN1, DCAF5, EXD2, GALNTL1, ERH, SLC39A9, PLEKHD1, CCDC177, KIAA0247, LOC100289511, SRSF5, SLC10A1, SMOC1, SLC8A3, ADAM21P1, COX16, SYNJ2BP, SYNJ2BP-COX16, ADAM21) was responsible for these manifestations, but apart from SMOC1, mutations in which cause autosomal recessive Waardenburg anophthalmia syndrome, and ACTN1, mutations in which are associated with congenital macrothrombocytopenia, no disease associations have so far been reported for the other genes.">
    <entity charOffset="121-124" id="s1541.e0" ontology_id="2079" text="ERH" type="GENE"/>
    <entity charOffset="462-483" id="s1541.e1" ontology_id="HP_0040185" text="macrothrombocytopenia" type="HP"/>
    <pair e1="s1541.e0" e2="s1541.e1" id="s1541.p0" relation="false"/>
  </sentence>
  <sentence id="s1542" text="Likely haploinsufficiency of one or several of the 19 genes in the common deleted interval (ACTN1, DCAF5, EXD2, GALNTL1, ERH, SLC39A9, PLEKHD1, CCDC177, KIAA0247, LOC100289511, SRSF5, SLC10A1, SMOC1, SLC8A3, ADAM21P1, COX16, SYNJ2BP, SYNJ2BP-COX16, ADAM21) was responsible for these manifestations, but apart from SMOC1, mutations in which cause autosomal recessive Waardenburg anophthalmia syndrome, and ACTN1, mutations in which are associated with congenital macrothrombocytopenia, no disease associations have so far been reported for the other genes.">
    <entity charOffset="121-124" id="s1542.e0" ontology_id="2079" text="ERH" type="GENE"/>
    <entity charOffset="346-365" id="s1542.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s1542.e0" e2="s1542.e1" id="s1542.p0" relation="false"/>
  </sentence>
  <sentence id="s1543" text="Likely haploinsufficiency of one or several of the 19 genes in the common deleted interval (ACTN1, DCAF5, EXD2, GALNTL1, ERH, SLC39A9, PLEKHD1, CCDC177, KIAA0247, LOC100289511, SRSF5, SLC10A1, SMOC1, SLC8A3, ADAM21P1, COX16, SYNJ2BP, SYNJ2BP-COX16, ADAM21) was responsible for these manifestations, but apart from SMOC1, mutations in which cause autosomal recessive Waardenburg anophthalmia syndrome, and ACTN1, mutations in which are associated with congenital macrothrombocytopenia, no disease associations have so far been reported for the other genes.">
    <entity charOffset="126-133" id="s1543.e0" ontology_id="55334" text="SLC39A9" type="GENE"/>
    <entity charOffset="462-483" id="s1543.e1" ontology_id="HP_0040185" text="macrothrombocytopenia" type="HP"/>
    <pair e1="s1543.e0" e2="s1543.e1" id="s1543.p0" relation="false"/>
  </sentence>
  <sentence id="s1544" text="Likely haploinsufficiency of one or several of the 19 genes in the common deleted interval (ACTN1, DCAF5, EXD2, GALNTL1, ERH, SLC39A9, PLEKHD1, CCDC177, KIAA0247, LOC100289511, SRSF5, SLC10A1, SMOC1, SLC8A3, ADAM21P1, COX16, SYNJ2BP, SYNJ2BP-COX16, ADAM21) was responsible for these manifestations, but apart from SMOC1, mutations in which cause autosomal recessive Waardenburg anophthalmia syndrome, and ACTN1, mutations in which are associated with congenital macrothrombocytopenia, no disease associations have so far been reported for the other genes.">
    <entity charOffset="153-161" id="s1544.e0" ontology_id="9766" text="KIAA0247" type="GENE"/>
    <entity charOffset="346-365" id="s1544.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s1544.e0" e2="s1544.e1" id="s1544.p0" relation="false"/>
  </sentence>
  <sentence id="s1545" text="Likely haploinsufficiency of one or several of the 19 genes in the common deleted interval (ACTN1, DCAF5, EXD2, GALNTL1, ERH, SLC39A9, PLEKHD1, CCDC177, KIAA0247, LOC100289511, SRSF5, SLC10A1, SMOC1, SLC8A3, ADAM21P1, COX16, SYNJ2BP, SYNJ2BP-COX16, ADAM21) was responsible for these manifestations, but apart from SMOC1, mutations in which cause autosomal recessive Waardenburg anophthalmia syndrome, and ACTN1, mutations in which are associated with congenital macrothrombocytopenia, no disease associations have so far been reported for the other genes.">
    <entity charOffset="177-182" id="s1545.e0" ontology_id="6430" text="SRSF5" type="GENE"/>
    <entity charOffset="462-483" id="s1545.e1" ontology_id="HP_0040185" text="macrothrombocytopenia" type="HP"/>
    <pair e1="s1545.e0" e2="s1545.e1" id="s1545.p0" relation="false"/>
  </sentence>
  <sentence id="s1546" text="Likely haploinsufficiency of one or several of the 19 genes in the common deleted interval (ACTN1, DCAF5, EXD2, GALNTL1, ERH, SLC39A9, PLEKHD1, CCDC177, KIAA0247, LOC100289511, SRSF5, SLC10A1, SMOC1, SLC8A3, ADAM21P1, COX16, SYNJ2BP, SYNJ2BP-COX16, ADAM21) was responsible for these manifestations, but apart from SMOC1, mutations in which cause autosomal recessive Waardenburg anophthalmia syndrome, and ACTN1, mutations in which are associated with congenital macrothrombocytopenia, no disease associations have so far been reported for the other genes.">
    <entity charOffset="193-198" id="s1546.e0" ontology_id="64093" text="SMOC1" type="GENE"/>
    <entity charOffset="346-365" id="s1546.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s1546.e0" e2="s1546.e1" id="s1546.p0" relation="true"/>
  </sentence>
  <sentence id="s1547" text="Likely haploinsufficiency of one or several of the 19 genes in the common deleted interval (ACTN1, DCAF5, EXD2, GALNTL1, ERH, SLC39A9, PLEKHD1, CCDC177, KIAA0247, LOC100289511, SRSF5, SLC10A1, SMOC1, SLC8A3, ADAM21P1, COX16, SYNJ2BP, SYNJ2BP-COX16, ADAM21) was responsible for these manifestations, but apart from SMOC1, mutations in which cause autosomal recessive Waardenburg anophthalmia syndrome, and ACTN1, mutations in which are associated with congenital macrothrombocytopenia, no disease associations have so far been reported for the other genes.">
    <entity charOffset="200-206" id="s1547.e0" ontology_id="6547" text="SLC8A3" type="GENE"/>
    <entity charOffset="462-483" id="s1547.e1" ontology_id="HP_0040185" text="macrothrombocytopenia" type="HP"/>
    <pair e1="s1547.e0" e2="s1547.e1" id="s1547.p0" relation="false"/>
  </sentence>
  <sentence id="s1548" text="Likely haploinsufficiency of one or several of the 19 genes in the common deleted interval (ACTN1, DCAF5, EXD2, GALNTL1, ERH, SLC39A9, PLEKHD1, CCDC177, KIAA0247, LOC100289511, SRSF5, SLC10A1, SMOC1, SLC8A3, ADAM21P1, COX16, SYNJ2BP, SYNJ2BP-COX16, ADAM21) was responsible for these manifestations, but apart from SMOC1, mutations in which cause autosomal recessive Waardenburg anophthalmia syndrome, and ACTN1, mutations in which are associated with congenital macrothrombocytopenia, no disease associations have so far been reported for the other genes.">
    <entity charOffset="200-206" id="s1548.e0" ontology_id="6547" text="SLC8A3" type="GENE"/>
    <entity charOffset="346-365" id="s1548.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s1548.e0" e2="s1548.e1" id="s1548.p0" relation="false"/>
  </sentence>
  <sentence id="s1549" text="Likely haploinsufficiency of one or several of the 19 genes in the common deleted interval (ACTN1, DCAF5, EXD2, GALNTL1, ERH, SLC39A9, PLEKHD1, CCDC177, KIAA0247, LOC100289511, SRSF5, SLC10A1, SMOC1, SLC8A3, ADAM21P1, COX16, SYNJ2BP, SYNJ2BP-COX16, ADAM21) was responsible for these manifestations, but apart from SMOC1, mutations in which cause autosomal recessive Waardenburg anophthalmia syndrome, and ACTN1, mutations in which are associated with congenital macrothrombocytopenia, no disease associations have so far been reported for the other genes.">
    <entity charOffset="208-214" id="s1549.e0" ontology_id="8747" text="ADAM21" type="GENE"/>
    <entity charOffset="462-483" id="s1549.e1" ontology_id="HP_0040185" text="macrothrombocytopenia" type="HP"/>
    <pair e1="s1549.e0" e2="s1549.e1" id="s1549.p0" relation="false"/>
  </sentence>
  <sentence id="s1550" text="Likely haploinsufficiency of one or several of the 19 genes in the common deleted interval (ACTN1, DCAF5, EXD2, GALNTL1, ERH, SLC39A9, PLEKHD1, CCDC177, KIAA0247, LOC100289511, SRSF5, SLC10A1, SMOC1, SLC8A3, ADAM21P1, COX16, SYNJ2BP, SYNJ2BP-COX16, ADAM21) was responsible for these manifestations, but apart from SMOC1, mutations in which cause autosomal recessive Waardenburg anophthalmia syndrome, and ACTN1, mutations in which are associated with congenital macrothrombocytopenia, no disease associations have so far been reported for the other genes.">
    <entity charOffset="218-223" id="s1550.e0" ontology_id="51241" text="COX16" type="GENE"/>
    <entity charOffset="462-483" id="s1550.e1" ontology_id="HP_0040185" text="macrothrombocytopenia" type="HP"/>
    <pair e1="s1550.e0" e2="s1550.e1" id="s1550.p0" relation="false"/>
  </sentence>
  <sentence id="s1551" text="Likely haploinsufficiency of one or several of the 19 genes in the common deleted interval (ACTN1, DCAF5, EXD2, GALNTL1, ERH, SLC39A9, PLEKHD1, CCDC177, KIAA0247, LOC100289511, SRSF5, SLC10A1, SMOC1, SLC8A3, ADAM21P1, COX16, SYNJ2BP, SYNJ2BP-COX16, ADAM21) was responsible for these manifestations, but apart from SMOC1, mutations in which cause autosomal recessive Waardenburg anophthalmia syndrome, and ACTN1, mutations in which are associated with congenital macrothrombocytopenia, no disease associations have so far been reported for the other genes.">
    <entity charOffset="225-232" id="s1551.e0" ontology_id="55333" text="SYNJ2BP" type="GENE"/>
    <entity charOffset="462-483" id="s1551.e1" ontology_id="HP_0040185" text="macrothrombocytopenia" type="HP"/>
    <pair e1="s1551.e0" e2="s1551.e1" id="s1551.p0" relation="false"/>
  </sentence>
  <sentence id="s1552" text="Zic2 overexpression promoted, whereas Zic2 knockdown inhibited, cell proliferation and migration invitro as well as tumor growth and metastasis invivo.">
    <entity charOffset="0-4" id="s1552.e0" ontology_id="7546" text="Zic2" type="GENE"/>
    <entity charOffset="117-122" id="s1552.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1552.e0" e2="s1552.e1" id="s1552.p0" relation="true"/>
  </sentence>
  <sentence id="s1553" text="Zic2 has been shown to be crucial to the progression of human cancers.">
    <entity charOffset="0-4" id="s1553.e0" ontology_id="7546" text="Zic2" type="GENE"/>
    <entity charOffset="62-68" id="s1553.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1553.e0" e2="s1553.e1" id="s1553.p0" relation="true"/>
  </sentence>
  <sentence id="s1554" text="Our data showed that Zic2 expression gradually increased from normal to cancer to metastatic tissues.">
    <entity charOffset="21-25" id="s1554.e0" ontology_id="7546" text="Zic2" type="GENE"/>
    <entity charOffset="72-78" id="s1554.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1554.e0" e2="s1554.e1" id="s1554.p0" relation="true"/>
  </sentence>
  <sentence id="s1555" text="In a tumor with inv(12), exon 3 of HMGA2 was fused to a sequence in intron 1 of the CRADD gene from 12q22.">
    <entity charOffset="5-10" id="s1555.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="84-89" id="s1555.e1" ontology_id="8738" text="CRADD" type="GENE"/>
    <pair e1="s1555.e0" e2="s1555.e1" id="s1555.p0" relation="true"/>
  </sentence>
  <sentence id="s1556" text="In a tumor with inv(12), exon 3 of HMGA2 was fused to a sequence in intron 1 of the CRADD gene from 12q22.">
    <entity charOffset="5-10" id="s1556.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="35-40" id="s1556.e1" ontology_id="8091" text="HMGA2" type="GENE"/>
    <pair e1="s1556.e0" e2="s1556.e1" id="s1556.p0" relation="true"/>
  </sentence>
  <sentence id="s1557" text="In the leiomyomas with 12q rearrangements, both HMGA2 and PLAG1 were expressed whereas in the tumors with 8q aberrations, only PLAG1 was expressed.">
    <entity charOffset="48-53" id="s1557.e0" ontology_id="8091" text="HMGA2" type="GENE"/>
    <entity charOffset="94-99" id="s1557.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1557.e0" e2="s1557.e1" id="s1557.p0" relation="true"/>
  </sentence>
  <sentence id="s1558" text="We extend the KATNB1 associated phenotype by describing a syndrome characterized by primordial dwarfism, lissencephaly, polysyndactyly, and dental anomalies, which is caused by a homozygous truncating KATNB1 mutation">
    <entity charOffset="14-20" id="s1558.e0" ontology_id="10300" text="KATNB1" type="GENE"/>
    <entity charOffset="95-103" id="s1558.e1" ontology_id="HP_0003510" text="dwarfism" type="HP"/>
    <pair e1="s1558.e0" e2="s1558.e1" id="s1558.p0" relation="true"/>
  </sentence>
  <sentence id="s1559" text="We extend the KATNB1 associated phenotype by describing a syndrome characterized by primordial dwarfism, lissencephaly, polysyndactyly, and dental anomalies, which is caused by a homozygous truncating KATNB1 mutation">
    <entity charOffset="14-20" id="s1559.e0" ontology_id="10300" text="KATNB1" type="GENE"/>
    <entity charOffset="105-118" id="s1559.e1" ontology_id="HP_0001339" text="lissencephaly" type="HP"/>
    <pair e1="s1559.e0" e2="s1559.e1" id="s1559.p0" relation="true"/>
  </sentence>
  <sentence id="s1560" text="We extend the KATNB1 associated phenotype by describing a syndrome characterized by primordial dwarfism, lissencephaly, polysyndactyly, and dental anomalies, which is caused by a homozygous truncating KATNB1 mutation">
    <entity charOffset="14-20" id="s1560.e0" ontology_id="10300" text="KATNB1" type="GENE"/>
    <entity charOffset="140-156" id="s1560.e1" ontology_id="HP_0000164" text="dental anomalies" type="HP"/>
    <pair e1="s1560.e0" e2="s1560.e1" id="s1560.p0" relation="true"/>
  </sentence>
  <sentence id="s1561" text="Interestingly, de novo loss-of-function and missense variants in KDM5B were identified in patients with intellectual disability (ID) and autism spectrum disorder (ASD) but also in unaffected individuals.">
    <entity charOffset="65-70" id="s1561.e0" ontology_id="10765" text="KDM5B" type="GENE"/>
    <entity charOffset="104-127" id="s1561.e1" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <pair e1="s1561.e0" e2="s1561.e1" id="s1561.p0" relation="true"/>
  </sentence>
  <sentence id="s1562" text="Proteomic analysis of 12 tumours from an mTOR-driven hepatocellular carcinoma mouse model revealed that NME1 and NME2, the only known mammalian histidine kinases, were upregulated.">
    <entity charOffset="41-45" id="s1562.e0" ontology_id="2475" text="mTOR" type="GENE"/>
    <entity charOffset="53-77" id="s1562.e1" ontology_id="HP_0001402" text="hepatocellular carcinoma" type="HP"/>
    <pair e1="s1562.e0" e2="s1562.e1" id="s1562.p0" relation="true"/>
  </sentence>
  <sentence id="s1563" text="Proteomic analysis of 12 tumours from an mTOR-driven hepatocellular carcinoma mouse model revealed that NME1 and NME2, the only known mammalian histidine kinases, were upregulated.">
    <entity charOffset="53-77" id="s1563.e0" ontology_id="HP_0001402" text="hepatocellular carcinoma" type="HP"/>
    <entity charOffset="113-117" id="s1563.e1" ontology_id="4831" text="NME2" type="GENE"/>
    <pair e1="s1563.e0" e2="s1563.e1" id="s1563.p0" relation="true"/>
  </sentence>
  <sentence id="s1564" text="Finally, in patients with hepatocellular carcinoma, low expression of LHPP correlated with increased tumour severity and reduced overall survival.">
    <entity charOffset="26-50" id="s1564.e0" ontology_id="HP_0001402" text="hepatocellular carcinoma" type="HP"/>
    <entity charOffset="70-74" id="s1564.e1" ontology_id="64077" text="LHPP" type="GENE"/>
    <pair e1="s1564.e0" e2="s1564.e1" id="s1564.p0" relation="true"/>
  </sentence>
  <sentence id="s1565" text="To gain an insight into the likely molecular basis of their observed cytotoxic effects, Autodock Vina binding free energies of each of the isolated compounds with seven molecular targets implicated in cancer development (MAPK8, MAPK10, MAP3K12, MAPK3, MAPK1, MAPK7 and VEGF), were calculated.">
    <entity charOffset="201-207" id="s1565.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="228-234" id="s1565.e1" ontology_id="5602" text="MAPK10" type="GENE"/>
    <pair e1="s1565.e0" e2="s1565.e1" id="s1565.p0" relation="true"/>
  </sentence>
  <sentence id="s1566" text="To gain an insight into the likely molecular basis of their observed cytotoxic effects, Autodock Vina binding free energies of each of the isolated compounds with seven molecular targets implicated in cancer development (MAPK8, MAPK10, MAP3K12, MAPK3, MAPK1, MAPK7 and VEGF), were calculated.">
    <entity charOffset="201-207" id="s1566.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="252-257" id="s1566.e1" ontology_id="5594" text="MAPK1" type="GENE"/>
    <pair e1="s1566.e0" e2="s1566.e1" id="s1566.p0" relation="true"/>
  </sentence>
  <sentence id="s1567" text="To gain an insight into the likely molecular basis of their observed cytotoxic effects, Autodock Vina binding free energies of each of the isolated compounds with seven molecular targets implicated in cancer development (MAPK8, MAPK10, MAP3K12, MAPK3, MAPK1, MAPK7 and VEGF), were calculated.">
    <entity charOffset="201-207" id="s1567.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="269-273" id="s1567.e1" ontology_id="7422" text="VEGF" type="GENE"/>
    <pair e1="s1567.e0" e2="s1567.e1" id="s1567.p0" relation="true"/>
  </sentence>
  <sentence id="s1568" text="A large, complex, and robust gene network containing well-known lung cancer-related genes, including EGFR and TERT, was identified from combined gene lists for lung adenocarcinoma.">
    <entity charOffset="69-75" id="s1568.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="110-114" id="s1568.e1" ontology_id="7015" text="TERT" type="GENE"/>
    <pair e1="s1568.e0" e2="s1568.e1" id="s1568.p0" relation="true"/>
  </sentence>
  <sentence id="s1569" text="A large, complex, and robust gene network containing well-known lung cancer-related genes, including EGFR and TERT, was identified from combined gene lists for lung adenocarcinoma.">
    <entity charOffset="101-105" id="s1569.e0" ontology_id="1956" text="EGFR" type="GENE"/>
    <entity charOffset="160-179" id="s1569.e1" ontology_id="HP_0030078" text="lung adenocarcinoma" type="HP"/>
    <pair e1="s1569.e0" e2="s1569.e1" id="s1569.p0" relation="true"/>
  </sentence>
  <sentence id="s1570" text="Using whole-exome sequencing, we identified a novel de novo missense (c.1132G&amp;gt;C, p.V378L) KCNB1 mutation in a patient with global developmental delay, intellectual disability, severe speech impairment, but no episode of epilepsy until the lastly examined age of 6 years old.">
    <entity charOffset="93-98" id="s1570.e0" ontology_id="3745" text="KCNB1" type="GENE"/>
    <entity charOffset="186-203" id="s1570.e1" ontology_id="HP_0002167" text="speech impairment" type="HP"/>
    <pair e1="s1570.e0" e2="s1570.e1" id="s1570.p0" relation="true"/>
  </sentence>
  <sentence id="s1571" text="Using whole-exome sequencing, we identified a novel de novo missense (c.1132G&amp;gt;C, p.V378L) KCNB1 mutation in a patient with global developmental delay, intellectual disability, severe speech impairment, but no episode of epilepsy until the lastly examined age of 6 years old.">
    <entity charOffset="93-98" id="s1571.e0" ontology_id="3745" text="KCNB1" type="GENE"/>
    <entity charOffset="223-231" id="s1571.e1" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <pair e1="s1571.e0" e2="s1571.e1" id="s1571.p0" relation="true"/>
  </sentence>
  <sentence id="s1572" text="KCNB1 mutations are known to cause early-onset infantile epilepsy.">
    <entity charOffset="0-5" id="s1572.e0" ontology_id="3745" text="KCNB1" type="GENE"/>
    <entity charOffset="57-65" id="s1572.e1" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <pair e1="s1572.e0" e2="s1572.e1" id="s1572.p0" relation="true"/>
  </sentence>
  <sentence id="s1573" text="We present a case of myoclonus-dystonia syndrome illustrated by three videos in which we found a novel SGCE mutation.">
    <entity charOffset="21-30" id="s1573.e0" ontology_id="HP_0001336" text="myoclonus" type="HP"/>
    <entity charOffset="103-107" id="s1573.e1" ontology_id="8910" text="SGCE" type="GENE"/>
    <pair e1="s1573.e0" e2="s1573.e1" id="s1573.p0" relation="true"/>
  </sentence>
  <sentence id="s1574" text="In this study, we have found that TPI1 expression was greatly decreased in clinical HCC samples, positively correlated with overall survival, and negatively associated with histological differentiation, tumor size and organ metastasis.">
    <entity charOffset="34-38" id="s1574.e0" ontology_id="7167" text="TPI1" type="GENE"/>
    <entity charOffset="203-208" id="s1574.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1574.e0" e2="s1574.e1" id="s1574.p0" relation="true"/>
  </sentence>
  <sentence id="s1575" text="Five variants were previously reported to confer risk of various malignant or benign tumors (rs78378222 in TP53, rs10069690 in TERT, rs1800057 and rs1801516 in ATM, and rs7907606 at OBFC1) and four signals are located at established risk loci for hormone-related traits (endometriosis and breast cancer) at 1q36.12 (CDC42/WNT4), 2p25.1 (GREB1), 20p12.3 (MCM8), and 6q26.2 (SYNE1/ESR1).">
    <entity charOffset="127-131" id="s1575.e0" ontology_id="7015" text="TERT" type="GENE"/>
    <entity charOffset="296-302" id="s1575.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1575.e0" e2="s1575.e1" id="s1575.p0" relation="false"/>
  </sentence>
  <sentence id="s1576" text="We noted that Sirtuin 1 (SIRT1) is overexpressed in HPV-infected cervical cancer cells and hypothesized that SIRT1 counteracts antiviral immunity.">
    <entity charOffset="25-30" id="s1576.e0" ontology_id="23411" text="SIRT1" type="GENE"/>
    <entity charOffset="74-80" id="s1576.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1576.e0" e2="s1576.e1" id="s1576.p0" relation="true"/>
  </sentence>
  <sentence id="s1577" text="In conclusion, SIRT1 enabled HPV-infected cervical cancer cells to continue growing by nullifying AIM2 inflammasome-mediated immunity.">
    <entity charOffset="51-57" id="s1577.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="98-102" id="s1577.e1" ontology_id="9447" text="AIM2" type="GENE"/>
    <pair e1="s1577.e0" e2="s1577.e1" id="s1577.p0" relation="false"/>
  </sentence>
  <sentence id="s1578" text="Without SIRT1, cervical cancer cells could no longer survive because of the derepression of the AIM2 inflammasome.">
    <entity charOffset="24-30" id="s1578.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="96-100" id="s1578.e1" ontology_id="9447" text="AIM2" type="GENE"/>
    <pair e1="s1578.e0" e2="s1578.e1" id="s1578.p0" relation="false"/>
  </sentence>
  <sentence id="s1579" text="Furthermore, the growth of cervical cancer xenografts was significantly inhibited by either SIRT1-targeting siRNAs or SIRT1-knockdown-derived extracellular vesicles.">
    <entity charOffset="36-42" id="s1579.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="92-97" id="s1579.e1" ontology_id="23411" text="SIRT1" type="GENE"/>
    <pair e1="s1579.e0" e2="s1579.e1" id="s1579.p0" relation="true"/>
  </sentence>
  <sentence id="s1580" text="However, the functions of GLIS3 in the thyroid gland and the mechanism by which GLIS3 dysfunction causes hypothyroidism are unknown.">
    <entity charOffset="26-31" id="s1580.e0" ontology_id="169792" text="GLIS3" type="GENE"/>
    <entity charOffset="105-119" id="s1580.e1" ontology_id="HP_0000821" text="hypothyroidism" type="HP"/>
    <pair e1="s1580.e0" e2="s1580.e1" id="s1580.p0" relation="false"/>
  </sentence>
  <sentence id="s1581" text="Deficiency in Krppel-like zinc finger transcription factor GLI-similar 3 (GLIS3) in humans is associated with the development of congenital hypothyroidism.">
    <entity charOffset="75-80" id="s1581.e0" ontology_id="169792" text="GLIS3" type="GENE"/>
    <entity charOffset="141-155" id="s1581.e1" ontology_id="HP_0000821" text="hypothyroidism" type="HP"/>
    <pair e1="s1581.e0" e2="s1581.e1" id="s1581.p0" relation="true"/>
  </sentence>
  <sentence id="s1582" text="We found that JIP3 was markedly increased in TLE patients and a mouse model of epileptic seizures; mice underexpressing JIP3 through lentivirus bearing LV-Letm1-RNAi showed decreased susceptibility, delayed first seizure and decreased seizure duration response to the epileptogenic properties of KA.">
    <entity charOffset="14-18" id="s1582.e0" ontology_id="23162" text="JIP3" type="GENE"/>
    <entity charOffset="89-97" id="s1582.e1" ontology_id="HP_0001250" text="seizures" type="HP"/>
    <pair e1="s1582.e0" e2="s1582.e1" id="s1582.p0" relation="true"/>
  </sentence>
  <sentence id="s1583" text="Four established melanoma susceptibility genes achieved nominal statistical significance, MC1R (p=.0014), MITF (p=.0165) BRCA2 (p=.0206), and MTAP (p=.0393).">
    <entity charOffset="17-25" id="s1583.e0" ontology_id="HP_0002861" text="melanoma" type="HP"/>
    <entity charOffset="148-152" id="s1583.e1" ontology_id="4507" text="MTAP" type="GENE"/>
    <pair e1="s1583.e0" e2="s1583.e1" id="s1583.p0" relation="true"/>
  </sentence>
  <sentence id="s1584" text="The data indicate a significant role of HDAC11 for mitotic cell cycle progression and survival of MYCN-amplified neuroblastoma cells, and suggests that HDAC11 could be a valuable drug target">
    <entity charOffset="40-46" id="s1584.e0" ontology_id="79885" text="HDAC11" type="GENE"/>
    <entity charOffset="113-126" id="s1584.e1" ontology_id="HP_0003006" text="neuroblastoma" type="HP"/>
    <pair e1="s1584.e0" e2="s1584.e1" id="s1584.p0" relation="true"/>
  </sentence>
  <sentence id="s1585" text="Mutations in GJB2 or GJB6 and the mitochondrial A7445G mutation, known to be the major causes of diverse Inherited Palmoplantar Keratodermas -hearing loss syndromes were not detected by Sanger sequencing.">
    <entity charOffset="13-17" id="s1585.e0" ontology_id="2706" text="GJB2" type="GENE"/>
    <entity charOffset="142-154" id="s1585.e1" ontology_id="HP_0000365" text="hearing loss" type="HP"/>
    <pair e1="s1585.e0" e2="s1585.e1" id="s1585.p0" relation="true"/>
  </sentence>
  <sentence id="s1586" text="The Spi-B-expressing cancer cells coexpressed vimentin but repressed E-cadherin and exhibited invasive behavior.">
    <entity charOffset="4-9" id="s1586.e0" ontology_id="6689" text="Spi-B" type="GENE"/>
    <entity charOffset="21-27" id="s1586.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1586.e0" e2="s1586.e1" id="s1586.p0" relation="true"/>
  </sentence>
  <sentence id="s1587" text="Markers such as SERPINI1, ZCCHC24, and ZMYND8 were modulated by ABBV-075 and other BET inhibitors across cancer cell lines and xenograft tumors but not in blood and skin.">
    <entity charOffset="26-33" id="s1587.e0" ontology_id="219654" text="ZCCHC24" type="GENE"/>
    <entity charOffset="137-143" id="s1587.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s1587.e0" e2="s1587.e1" id="s1587.p0" relation="true"/>
  </sentence>
  <sentence id="s1588" text="Markers such as SERPINI1, ZCCHC24, and ZMYND8 were modulated by ABBV-075 and other BET inhibitors across cancer cell lines and xenograft tumors but not in blood and skin.">
    <entity charOffset="39-45" id="s1588.e0" ontology_id="23613" text="ZMYND8" type="GENE"/>
    <entity charOffset="137-143" id="s1588.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s1588.e0" e2="s1588.e1" id="s1588.p0" relation="true"/>
  </sentence>
  <sentence id="s1589" text="Markers such as SERPINI1, ZCCHC24, and ZMYND8 were modulated by ABBV-075 and other BET inhibitors across cancer cell lines and xenograft tumors but not in blood and skin.">
    <entity charOffset="83-86" id="s1589.e0" ontology_id="92737" text="BET" type="GENE"/>
    <entity charOffset="137-143" id="s1589.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s1589.e0" e2="s1589.e1" id="s1589.p0" relation="true"/>
  </sentence>
  <sentence id="s1590" text="Markers such as SERPINI1, ZCCHC24, and ZMYND8 were modulated by ABBV-075 and other BET inhibitors across cancer cell lines and xenograft tumors but not in blood and skin.">
    <entity charOffset="83-86" id="s1590.e0" ontology_id="92737" text="BET" type="GENE"/>
    <entity charOffset="105-111" id="s1590.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1590.e0" e2="s1590.e1" id="s1590.p0" relation="true"/>
  </sentence>
  <sentence id="s1591" text="Until recently, four loci (DFN2, DFN3, DFN4, and DFN6) had been implicated in nonsyndromic X-linked hearing loss; however, a new classification (DFNX1-5) has been proposed to reduce confusion in the terminology.">
    <entity charOffset="33-37" id="s1591.e0" ontology_id="5456" text="DFN3" type="GENE"/>
    <entity charOffset="100-112" id="s1591.e1" ontology_id="HP_0000365" text="hearing loss" type="HP"/>
    <pair e1="s1591.e0" e2="s1591.e1" id="s1591.p0" relation="true"/>
  </sentence>
  <sentence id="s1592" text="Until recently, four loci (DFN2, DFN3, DFN4, and DFN6) had been implicated in nonsyndromic X-linked hearing loss; however, a new classification (DFNX1-5) has been proposed to reduce confusion in the terminology.">
    <entity charOffset="100-112" id="s1592.e0" ontology_id="HP_0000365" text="hearing loss" type="HP"/>
    <entity charOffset="145-150" id="s1592.e1" ontology_id="5631" text="DFNX1" type="GENE"/>
    <pair e1="s1592.e0" e2="s1592.e1" id="s1592.p0" relation="true"/>
  </sentence>
  <sentence id="s1593" text="To better understand LTBP4 and its role in modifying muscular dystrophy, we created transgenic mice overexpressing the protective murine allele of LTBP4 specifically in mature myofibers using the human skeletal actin promoter.">
    <entity charOffset="21-26" id="s1593.e0" ontology_id="8425" text="LTBP4" type="GENE"/>
    <entity charOffset="53-71" id="s1593.e1" ontology_id="HP_0003560" text="muscular dystrophy" type="HP"/>
    <pair e1="s1593.e0" e2="s1593.e1" id="s1593.p0" relation="true"/>
  </sentence>
  <sentence id="s1594" text="Several myotubularins have been genetically linked to human diseases: MTM1 is mutated in the congenital myopathy X-linked centronuclear or myotubular myopathy (XLCNM) and MTMR14 (JUMPY) has been linked to an autosomal form of such disease, while MTMR2 and MTMR13 are mutated in Charcot-Marie-Tooth (CMT) neuropathies.">
    <entity charOffset="70-74" id="s1594.e0" ontology_id="4534" text="MTM1" type="GENE"/>
    <entity charOffset="104-112" id="s1594.e1" ontology_id="HP_0003198" text="myopathy" type="HP"/>
    <pair e1="s1594.e0" e2="s1594.e1" id="s1594.p0" relation="true"/>
  </sentence>
  <sentence id="s1595" text="Several myotubularins have been genetically linked to human diseases: MTM1 is mutated in the congenital myopathy X-linked centronuclear or myotubular myopathy (XLCNM) and MTMR14 (JUMPY) has been linked to an autosomal form of such disease, while MTMR2 and MTMR13 are mutated in Charcot-Marie-Tooth (CMT) neuropathies.">
    <entity charOffset="104-112" id="s1595.e0" ontology_id="HP_0003198" text="myopathy" type="HP"/>
    <entity charOffset="246-251" id="s1595.e1" ontology_id="8898" text="MTMR2" type="GENE"/>
    <pair e1="s1595.e0" e2="s1595.e1" id="s1595.p0" relation="false"/>
  </sentence>
  <sentence id="s1596" text="Several myotubularins have been genetically linked to human diseases: MTM1 is mutated in the congenital myopathy X-linked centronuclear or myotubular myopathy (XLCNM) and MTMR14 (JUMPY) has been linked to an autosomal form of such disease, while MTMR2 and MTMR13 are mutated in Charcot-Marie-Tooth (CMT) neuropathies.">
    <entity charOffset="104-112" id="s1596.e0" ontology_id="HP_0003198" text="myopathy" type="HP"/>
    <entity charOffset="256-262" id="s1596.e1" ontology_id="81846" text="MTMR13" type="GENE"/>
    <pair e1="s1596.e0" e2="s1596.e1" id="s1596.p0" relation="false"/>
  </sentence>
  <sentence id="s1597" text="Whole exome sequencing in triple negative breast cancer cases (n=8) and targeted sequencing in healthy controls (n=48) revealed BRIP1 rs552752779 (MAF: 75% vs. 6.25%, OR 45.00, 95% CI 9.43-243.32), ERBB2 rs527779103 (MAF: 62.5% vs. 7.29%, OR 21.19, 95% CI 5.11-94.32), ERCC2 rs121913016 (MAF: 56.25% vs. 7.29%, OR 16.34, 95% CI 4.02-70.41), MSH6 rs2020912 (MAF: 56.25% vs. 1.04%, OR 122.13, 95% CI 12.29-2985.48) as risk factors for triple negative breast cancer.">
    <entity charOffset="49-55" id="s1597.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="151-154" id="s1597.e1" ontology_id="4094" text="MAF" type="GENE"/>
    <pair e1="s1597.e0" e2="s1597.e1" id="s1597.p0" relation="true"/>
  </sentence>
  <sentence id="s1598" text="Whole exome sequencing in triple negative breast cancer cases (n=8) and targeted sequencing in healthy controls (n=48) revealed BRIP1 rs552752779 (MAF: 75% vs. 6.25%, OR 45.00, 95% CI 9.43-243.32), ERBB2 rs527779103 (MAF: 62.5% vs. 7.29%, OR 21.19, 95% CI 5.11-94.32), ERCC2 rs121913016 (MAF: 56.25% vs. 7.29%, OR 16.34, 95% CI 4.02-70.41), MSH6 rs2020912 (MAF: 56.25% vs. 1.04%, OR 122.13, 95% CI 12.29-2985.48) as risk factors for triple negative breast cancer.">
    <entity charOffset="49-55" id="s1598.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="202-207" id="s1598.e1" ontology_id="2064" text="ERBB2" type="GENE"/>
    <pair e1="s1598.e0" e2="s1598.e1" id="s1598.p0" relation="true"/>
  </sentence>
  <sentence id="s1599" text="Whole exome sequencing in triple negative breast cancer cases (n=8) and targeted sequencing in healthy controls (n=48) revealed BRIP1 rs552752779 (MAF: 75% vs. 6.25%, OR 45.00, 95% CI 9.43-243.32), ERBB2 rs527779103 (MAF: 62.5% vs. 7.29%, OR 21.19, 95% CI 5.11-94.32), ERCC2 rs121913016 (MAF: 56.25% vs. 7.29%, OR 16.34, 95% CI 4.02-70.41), MSH6 rs2020912 (MAF: 56.25% vs. 1.04%, OR 122.13, 95% CI 12.29-2985.48) as risk factors for triple negative breast cancer.">
    <entity charOffset="49-55" id="s1599.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="345-349" id="s1599.e1" ontology_id="2956" text="MSH6" type="GENE"/>
    <pair e1="s1599.e0" e2="s1599.e1" id="s1599.p0" relation="true"/>
  </sentence>
  <sentence id="s1600" text="We found that rs1042752-located in the 3'-UTR of POU2AF1, which plays a vital role in lymphomagenesis-was significantly associated with lymphoma risk in a case-control study with 793 patients and 939 controls.">
    <entity charOffset="49-56" id="s1600.e0" ontology_id="5450" text="POU2AF1" type="GENE"/>
    <entity charOffset="86-94" id="s1600.e1" ontology_id="HP_0002665" text="lymphoma" type="HP"/>
    <pair e1="s1600.e0" e2="s1600.e1" id="s1600.p0" relation="true"/>
  </sentence>
  <sentence id="s1601" text="Cystinuria is a heterogeneous, rare but important cause of inherited kidney stone disease due to mutations in 2 genes: SLC3A1 and SLC7A9.">
    <entity charOffset="16-29" id="s1601.e0" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <entity charOffset="119-125" id="s1601.e1" ontology_id="6519" text="SLC3A1" type="GENE"/>
    <pair e1="s1601.e0" e2="s1601.e1" id="s1601.p0" relation="true"/>
  </sentence>
  <sentence id="s1602" text="These studies suggest that compound 4d behaves well in lowering body weight and maintaining energy expenditure without a chance of hyperglycaemia, 4d has strong clinical potential as an efficient GLP-1/GCGR agonist in the prevention and treatment of obesity and dyslipidemia">
    <entity charOffset="202-206" id="s1602.e0" ontology_id="2642" text="GCGR" type="GENE"/>
    <entity charOffset="250-257" id="s1602.e1" ontology_id="HP_0001513" text="obesity" type="HP"/>
    <pair e1="s1602.e0" e2="s1602.e1" id="s1602.p0" relation="true"/>
  </sentence>
  <sentence id="s1603" text="We conducted further optimization of dual enzymatic inhibitions towards FGFR1 and DDR2, two important kinases in lung squamous cell carcinoma.">
    <entity charOffset="72-77" id="s1603.e0" ontology_id="2260" text="FGFR1" type="GENE"/>
    <entity charOffset="118-141" id="s1603.e1" ontology_id="HP_0002860" text="squamous cell carcinoma" type="HP"/>
    <pair e1="s1603.e0" e2="s1603.e1" id="s1603.p0" relation="true"/>
  </sentence>
  <sentence id="s1604" text="Familial hypercholesterolemia (FH) is mostly caused by low-density lipoprotein receptor (LDLR) mutations and results in an increased risk of early-onset cardiovascular disease due to marked elevation of LDL cholesterol (LDL-C) in blood.">
    <entity charOffset="89-93" id="s1604.e0" ontology_id="3949" text="LDLR" type="GENE"/>
    <entity charOffset="153-175" id="s1604.e1" ontology_id="HP_0001626" text="cardiovascular disease" type="HP"/>
    <pair e1="s1604.e0" e2="s1604.e1" id="s1604.p0" relation="true"/>
  </sentence>
  <sentence id="s1605" text="Basic immunological assessments have confirmed that this strain of human CD3 EDG-replaced mice are entirely immune competent, and we have also demonstrated that a bispecific antibody that simultaneously binds to human CD3 and a tumor-associated antigen (e.g. ERBB2 or GPC3) can be evaluated in human CD3 EDG-replaced mice engrafted with tumors.">
    <entity charOffset="228-233" id="s1605.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="259-264" id="s1605.e1" ontology_id="2064" text="ERBB2" type="GENE"/>
    <pair e1="s1605.e0" e2="s1605.e1" id="s1605.p0" relation="true"/>
  </sentence>
  <sentence id="s1606" text="In severe bilateral cases (anophthalmia or severe microphthalmia) the genetic cause is now identifiable in approximately 80 percent of cases, with de novo heterozygous loss-of-function mutations in SOX2 or OTX2 being the most common.">
    <entity charOffset="27-39" id="s1606.e0" ontology_id="HP_0000528" text="anophthalmia" type="HP"/>
    <entity charOffset="198-202" id="s1606.e1" ontology_id="6657" text="SOX2" type="GENE"/>
    <pair e1="s1606.e0" e2="s1606.e1" id="s1606.p0" relation="true"/>
  </sentence>
  <sentence id="s1607" text="In severe bilateral cases (anophthalmia or severe microphthalmia) the genetic cause is now identifiable in approximately 80 percent of cases, with de novo heterozygous loss-of-function mutations in SOX2 or OTX2 being the most common.">
    <entity charOffset="50-64" id="s1607.e0" ontology_id="HP_0000568" text="microphthalmia" type="HP"/>
    <entity charOffset="198-202" id="s1607.e1" ontology_id="6657" text="SOX2" type="GENE"/>
    <pair e1="s1607.e0" e2="s1607.e1" id="s1607.p0" relation="true"/>
  </sentence>
  <sentence id="s1608" text="Concurrently, global transcriptional profiling analysis reveals that multiple tumor-associated genes such as CCND3, E2F1/2, HOXA1, Bcl2 modifying factor (BMF), Met, and Myc; and signaling pathways of cellular dedifferentiation, proliferation, adhesion, survival including p53, cadherin, Myc, and anti-apoptotic pathways are differentially expressed or significantly altered in these lung epithelial cells upon downregulation of H2Bub1.">
    <entity charOffset="78-83" id="s1608.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="124-129" id="s1608.e1" ontology_id="3198" text="HOXA1" type="GENE"/>
    <pair e1="s1608.e0" e2="s1608.e1" id="s1608.p0" relation="true"/>
  </sentence>
  <sentence id="s1609" text="Concurrently, global transcriptional profiling analysis reveals that multiple tumor-associated genes such as CCND3, E2F1/2, HOXA1, Bcl2 modifying factor (BMF), Met, and Myc; and signaling pathways of cellular dedifferentiation, proliferation, adhesion, survival including p53, cadherin, Myc, and anti-apoptotic pathways are differentially expressed or significantly altered in these lung epithelial cells upon downregulation of H2Bub1.">
    <entity charOffset="78-83" id="s1609.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="160-163" id="s1609.e1" ontology_id="4233" text="Met" type="GENE"/>
    <pair e1="s1609.e0" e2="s1609.e1" id="s1609.p0" relation="true"/>
  </sentence>
  <sentence id="s1610" text="Consistent with our description of this pathway and the phenotype of patients with FGD1 mutations, mice with a targeted deletion of Mlk3 displayed multiple skeletal defects, including dental abnormalities, deficient calvarial mineralization, and reduced bone mass.">
    <entity charOffset="83-87" id="s1610.e0" ontology_id="2245" text="FGD1" type="GENE"/>
    <entity charOffset="184-204" id="s1610.e1" ontology_id="HP_0000164" text="dental abnormalities" type="HP"/>
    <pair e1="s1610.e0" e2="s1610.e1" id="s1610.p0" relation="true"/>
  </sentence>
  <sentence id="s1611" text="We describe two families in which two different homozygous PUS7 mutations (missense and frameshift deletion) segregate with a phenotype comprising intellectual disability and progressive microcephaly.">
    <entity charOffset="59-63" id="s1611.e0" ontology_id="54517" text="PUS7" type="GENE"/>
    <entity charOffset="187-199" id="s1611.e1" ontology_id="HP_0000252" text="microcephaly" type="HP"/>
    <pair e1="s1611.e0" e2="s1611.e1" id="s1611.p0" relation="true"/>
  </sentence>
  <sentence id="s1612" text="An array of tumor syndromes caused by complex II-associated gene mutations, in both succinate dehydrogenase and associated accessory factor genes (SDHA, SDHB, SDHC, SDHD, SDHAF1, SDHAF2), have been identified over the last 12 years and include hereditary paraganglioma-pheochromocytomas, a diverse group of renal cell carcinomas, and a specific subtype of gastrointestinal stromal tumors (GIST).">
    <entity charOffset="12-17" id="s1612.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="159-163" id="s1612.e1" ontology_id="6391" text="SDHC" type="GENE"/>
    <pair e1="s1612.e0" e2="s1612.e1" id="s1612.p0" relation="true"/>
  </sentence>
  <sentence id="s1613" text="An array of tumor syndromes caused by complex II-associated gene mutations, in both succinate dehydrogenase and associated accessory factor genes (SDHA, SDHB, SDHC, SDHD, SDHAF1, SDHAF2), have been identified over the last 12 years and include hereditary paraganglioma-pheochromocytomas, a diverse group of renal cell carcinomas, and a specific subtype of gastrointestinal stromal tumors (GIST).">
    <entity charOffset="147-151" id="s1613.e0" ontology_id="6389" text="SDHA" type="GENE"/>
    <entity charOffset="307-328" id="s1613.e1" ontology_id="HP_0005584" text="renal cell carcinomas" type="HP"/>
    <pair e1="s1613.e0" e2="s1613.e1" id="s1613.p0" relation="true"/>
  </sentence>
  <sentence id="s1614" text="An array of tumor syndromes caused by complex II-associated gene mutations, in both succinate dehydrogenase and associated accessory factor genes (SDHA, SDHB, SDHC, SDHD, SDHAF1, SDHAF2), have been identified over the last 12 years and include hereditary paraganglioma-pheochromocytomas, a diverse group of renal cell carcinomas, and a specific subtype of gastrointestinal stromal tumors (GIST).">
    <entity charOffset="153-157" id="s1614.e0" ontology_id="6390" text="SDHB" type="GENE"/>
    <entity charOffset="307-328" id="s1614.e1" ontology_id="HP_0005584" text="renal cell carcinomas" type="HP"/>
    <pair e1="s1614.e0" e2="s1614.e1" id="s1614.p0" relation="true"/>
  </sentence>
  <sentence id="s1615" text="An array of tumor syndromes caused by complex II-associated gene mutations, in both succinate dehydrogenase and associated accessory factor genes (SDHA, SDHB, SDHC, SDHD, SDHAF1, SDHAF2), have been identified over the last 12 years and include hereditary paraganglioma-pheochromocytomas, a diverse group of renal cell carcinomas, and a specific subtype of gastrointestinal stromal tumors (GIST).">
    <entity charOffset="153-157" id="s1615.e0" ontology_id="6390" text="SDHB" type="GENE"/>
    <entity charOffset="255-268" id="s1615.e1" ontology_id="HP_0002668" text="paraganglioma" type="HP"/>
    <pair e1="s1615.e0" e2="s1615.e1" id="s1615.p0" relation="true"/>
  </sentence>
  <sentence id="s1616" text="An array of tumor syndromes caused by complex II-associated gene mutations, in both succinate dehydrogenase and associated accessory factor genes (SDHA, SDHB, SDHC, SDHD, SDHAF1, SDHAF2), have been identified over the last 12 years and include hereditary paraganglioma-pheochromocytomas, a diverse group of renal cell carcinomas, and a specific subtype of gastrointestinal stromal tumors (GIST).">
    <entity charOffset="153-157" id="s1616.e0" ontology_id="6390" text="SDHB" type="GENE"/>
    <entity charOffset="269-286" id="s1616.e1" ontology_id="HP_0002666" text="pheochromocytomas" type="HP"/>
    <pair e1="s1616.e0" e2="s1616.e1" id="s1616.p0" relation="true"/>
  </sentence>
  <sentence id="s1617" text="An array of tumor syndromes caused by complex II-associated gene mutations, in both succinate dehydrogenase and associated accessory factor genes (SDHA, SDHB, SDHC, SDHD, SDHAF1, SDHAF2), have been identified over the last 12 years and include hereditary paraganglioma-pheochromocytomas, a diverse group of renal cell carcinomas, and a specific subtype of gastrointestinal stromal tumors (GIST).">
    <entity charOffset="159-163" id="s1617.e0" ontology_id="6391" text="SDHC" type="GENE"/>
    <entity charOffset="255-268" id="s1617.e1" ontology_id="HP_0002668" text="paraganglioma" type="HP"/>
    <pair e1="s1617.e0" e2="s1617.e1" id="s1617.p0" relation="true"/>
  </sentence>
  <sentence id="s1618" text="Three loci with high mutation frequencies, the 138665410 FOXL2 gene variant, the 23862952 MYH6 gene variant, and the 71098693 HYDIN gene variant were found to be significantly associated with sporadic ASD (P&amp;lt;0.05); variants in FOXL2 and MYH6 were found in patients with isolated, sporadic ASD (P&amp;lt;510^-4).">
    <entity charOffset="57-62" id="s1618.e0" ontology_id="668" text="FOXL2" type="GENE"/>
    <entity charOffset="192-200" id="s1618.e1" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <pair e1="s1618.e0" e2="s1618.e1" id="s1618.p0" relation="false"/>
  </sentence>
  <sentence id="s1619" text="A principal feature of AD is the presence of neurofibrillary tangles (NFT) induced by the aberrant phosphorylation of the microtubule-associated protein tau in the brains of affected individuals.">
    <entity charOffset="45-68" id="s1619.e0" ontology_id="HP_0002185" text="neurofibrillary tangles" type="HP"/>
    <entity charOffset="153-156" id="s1619.e1" ontology_id="4137" text="tau" type="GENE"/>
    <pair e1="s1619.e0" e2="s1619.e1" id="s1619.p0" relation="true"/>
  </sentence>
  <sentence id="s1620" text="Pre-treatment testing of the localized cutaneous tumor lesion on a lymphoid amplicon panel demonstrated an &lt;i&gt;MYD88&lt;/i&gt; p.L265P mutation.">
    <entity charOffset="49-54" id="s1620.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="110-115" id="s1620.e1" ontology_id="4615" text="MYD88" type="GENE"/>
    <pair e1="s1620.e0" e2="s1620.e1" id="s1620.p0" relation="true"/>
  </sentence>
  <sentence id="s1621" text="The expression pattern of HCRP1 in gastric cancer tissue and adjacent non-cancerous tissue was detected by immunohistochemistry.">
    <entity charOffset="26-31" id="s1621.e0" ontology_id="137492" text="HCRP1" type="GENE"/>
    <entity charOffset="43-49" id="s1621.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1621.e0" e2="s1621.e1" id="s1621.p0" relation="true"/>
  </sentence>
  <sentence id="s1622" text="While none of these miRNAs have been previously linked to glaucoma, miR-122-5p may target three glaucoma-associated genes: OPTN, TMCO1 and TGF-1.">
    <entity charOffset="58-66" id="s1622.e0" ontology_id="HP_0000501" text="glaucoma" type="HP"/>
    <entity charOffset="129-134" id="s1622.e1" ontology_id="54499" text="TMCO1" type="GENE"/>
    <pair e1="s1622.e0" e2="s1622.e1" id="s1622.p0" relation="true"/>
  </sentence>
  <sentence id="s1623" text="While none of these miRNAs have been previously linked to glaucoma, miR-122-5p may target three glaucoma-associated genes: OPTN, TMCO1 and TGF-1.">
    <entity charOffset="58-66" id="s1623.e0" ontology_id="HP_0000501" text="glaucoma" type="HP"/>
    <entity charOffset="123-127" id="s1623.e1" ontology_id="10133" text="OPTN" type="GENE"/>
    <pair e1="s1623.e0" e2="s1623.e1" id="s1623.p0" relation="true"/>
  </sentence>
</document>
